<SEC-DOCUMENT>0001671284-21-000023.txt : 20211115
<SEC-HEADER>0001671284-21-000023.hdr.sgml : 20211115
<ACCEPTANCE-DATETIME>20211115080317
ACCESSION NUMBER:		0001671284-21-000023
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		80
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211115
DATE AS OF CHANGE:		20211115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bright Health Group Inc.
		CENTRAL INDEX KEY:			0001671284
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				474991296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40537
		FILM NUMBER:		211406464

	BUSINESS ADDRESS:	
		STREET 1:		8000 NORMAN CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55437
		BUSINESS PHONE:		612-238-1321

	MAIL ADDRESS:	
		STREET 1:		8000 NORMAN CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55437

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bright Health Inc.
		DATE OF NAME CHANGE:	20160404
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bhg-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5,d:e0abfeeb2ed84c58ba5d72efec1af66e--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:bhg="http://www.brighthealthgroup.com/20210930" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bhg-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV8yLTEtMS0xLTA_f678998e-4f9a-4d75-8a2b-301bbfa0a9b8">0001671284</ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV8zLTEtMS0xLTA_e9d987bc-be11-44e6-a28e-eb1ad72be302">false</ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV80LTEtMS0xLTA_11322794-45ac-4bb7-b494-815c72d4d640">2021</ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV81LTEtMS0xLTA_fdfe1a15-9180-4b02-99fd-d7d2809713f1">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV82LTEtMS0xLTA_e14cd8b0-ae7c-44d5-bc83-aa512e770ad8">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_20fcd581-8099-4149-a9b3-a33d8739be45">http://fasb.org/us-gaap/2021-01-31#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_a0d2339f-d88e-46c2-a091-0b6fdb8cc411">http://fasb.org/us-gaap/2021-01-31#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_b6886748-2b1d-491d-a844-5aaa0be8f223">http://fasb.org/us-gaap/2021-01-31#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_c9024cd6-16f8-4b26-b6df-f343d19c9d24">http://fasb.org/us-gaap/2021-01-31#ServiceMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bhg-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8c3a276f58cf46b487a48d33d62cf375_I20211104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i28f7521b4a234009aa828e733e8f9a3c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8393f93f84a6414b91b167951bef057f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6f868825a854ad29b00d7c27d6e2c83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4871efe74704f978b993ba51fc2ad6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411ffa67bd024b8fba87e9c64077fcf2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0137f0a50f174a078570affe987b9897_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1a3fb2febf422abccd9d03e715acf0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd11786a418e4ce4b107cb2441a2f8de_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib168a2810cb14711aa2a509c2b7bec5b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e3312456d94b45b58360f1365cce93_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73597c3d3a334263ab2aa9d6b4f46f20_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i896eec808e0343cfbae2f717934e71b4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59037bc717a449289317ac0d87adea87_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e4858120f3454984bb4f44d0b45435_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c76927d0c87485f81b0c99ec31fe573_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5496876444a4be489375b4c022ef150_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da7eda6089f40dc80394423712bac8c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3747e34d1b8945a2b35ae65a0c95b283_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1632e2cf7834f558bc296dd7d180324_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9381960dce441ae877f25e0db8e3933_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib20155a3f7a940acb68c19efd45e42d9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7a6f0ef29542f884edade6bd7d8ef0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253d2d1e76de471f92bb9665c552586f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib665d31bf9d7437591781fd1d77c6b99_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie46639bd73344ddebb19d877ee0b947c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i649e794681cf4cca99c2536e968dc812_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ef0d69fb47479bb3350e333c9f7181_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie606262a9d784da09df56adafa6c1538_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie882f1e05dbb484bb99d78576ac4d175_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac918bc38544218819b0a101da9f295_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4e64ca59c864ed9a6e56e45243b353f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4aa6030d8ef4580b4eb924a05e135f7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc061278f0da4aa9a0f13da8c2ab475d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice6dc6d47370425b9fce3a98c5650ffc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544c254ae4234f02a8ea8433f7111c6b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9545d10c15f3484799e95f2fa94df37a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad985bb842b24424b5f51535a74e0d20_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1467d7e2eba4616ad00ffd76e8ea421_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715014b57d1441db9f72b2c4fc26c971_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib18c4a2f0ce64d00b414ff7d7e5d76d7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab3b38cf004a47bfb5f9ff6a8663bb04_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97167ac64ec4bb6b360504ece6d65a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d60eac239514d1986be1ece58c50aff_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439d50f322e748c2a9db9431eb49add8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbdb64c5b993489fa19ab055445e7cb5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d52ed33ef14b8d95901deef872bce1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ee8a98ff3284e9a89cb462c1a5975cb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ed5988a89248598fb835a3d6eb8fb1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i217634c8da0246ab92821d26990e7ab8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1208c83ea17943c393f48af48a7323f6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e9df45a4ef406badd359c74e03a99e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffb20b6c43f4e73b4c1baaed88a2476_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fb28b0bad874df383fc182d52bcd000_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e7b09a7c5084223a5134c48364d9483_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2d75a8b417104e2e99acca850c6fd16f_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-28</xbrli:startDate><xbrli:endDate>2021-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8f1c51b74e14129bd0f91602963e036_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb69ad6e15b4395bf5d632879271c37_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8955d418b9e348a09575068e6bd96030_D20210628-20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-28</xbrli:startDate><xbrli:endDate>2021-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21467a131f241a8b54be2659b98dd34_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122e578042ed4e84b1d841704471a4a9_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b79375e653b4c6ab22e579ba0de8468_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd914077e9f404a9da2a417b56c4672_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i837392de0aa64e87bfdcc482e5eb4682_I20210628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5759a0d876be449aac313ca0615a3807_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">bhg:ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if396eed261f24ec59dcf755f4bcd3906_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">bhg:ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic898e99881d641128dfcfc367e765db9_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="healthcenter"><xbrli:measure>bhg:healthCenter</xbrli:measure></xbrli:unit><xbrli:context id="i107c6a9c6a5f4b72b6a388858fbcfaf8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f62b97d0d14e2a80908c5ba5ce1ce7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437f51b176c14704a8d187469131515e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a20a27e64cb4a15b3a57eea10b70269_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8c4c3b025d849189363e133e0b11e87_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifacffe1d832f42b7bdf2a5102beadd9c_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic41d330372d542e286128a811bcd3408_D20200701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906967f82f324f7e83d7e378327d6632_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36358997c9554e299250c29d1edc21ce_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b87a30e39784613942ef3b1ffe359c9_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic68b8f77cc0c4feb964ea6ff561a07fc_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0973903cab4deeb08dfc70ef9dd0e8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e7e862b6f944cf1a7a7807ff6aa4abf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ea924109b24362b4aa90947da7cb3d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia24617e1d9eb4076b54c7d7e70276339_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7786594de6244ae6a5a8034a5ce9da7e_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0afeba703f4eecbfd79b0b0ac66c51_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c829a59ac144c2a6c38f54d48e9328_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88d85b6051d4282a78fa46340280420_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5d4bddbfcfe456aa8f422cf2a237786_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3914765d423b4a628de3214723906cf7_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d081fc23d14e75a64545999d205679_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b028119331454b86c135bc40e6d46f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabcc40d305134dce85d3cf3faaea6c2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:PremierMedicalAssociatesOfFloridaLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f1e0f30291346f1bd501e797f389c07_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:PremierMedicalAssociatesOfFloridaLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-30</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ecbee92cb12427db0c1287be74eabff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-30</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-30</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02d119c5e70e49299a5a771390922e80_D20200430-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-30</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if157b21998ca4b74bcf79e7477729fc8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49f9b0edbc5d4e6eb845493d5559b678_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999a85020f9f4f10a9aa47b8f908b339_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i876397b0696242c1a07ad1299e40876b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba93dbe931f244d8966ac1d962a2fea4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62e383ba4c874ed1a61aa4f77bf40523_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1821e67a709400081ca8ffa683a8944_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93edb636370844a0929f4e4375a579b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b616b4492d4f57b6587e8013fa8e17_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48170a5de4b440f692e33f62a6d27726_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60813677512b434bacaebec6e08f0443_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95f63630eb2b4c619abf10dae7347361_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd1d1e14a644d769d623a268712ab39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="investment"><xbrli:measure>bhg:investment</xbrli:measure></xbrli:unit><xbrli:context id="idcc35cb44c3a44e4988de9c09f1145a2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ae3dff21f514bee8dcfb24fbbee065c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i783a66cb5f2448f3acd95db34f27a159_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4a304ce1df419a88d9585aceafdead_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01db93ebd12c41889a5bbe280eed1eae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcf21177884c41bc92c0b8c908d78a52_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ea779896ada4159a7f60019e9927bf8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5121369128bf46f1b28d027064b97268_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c3c88b8b464936985a142c13ba59a1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063bcb9e20df488faba4c86ff6b2d2d7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6321a1eae6741258bc2ebec56ccdd2b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ba12124710a41d09f79459538d7f774_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112615aabc29458c80feb79df5325cfe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39a7e8b71f6b44ef93ee44e051b98fa8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff31328bf070411aa7d0bb0ec25452ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42079981bc19457ea93081a70515a67d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98131e51113d4be280910ddde875e482_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa4d5d4769ec49aaba6b4e6a10a70938_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c32f01079e74ada8aa45c870e22b903_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b929d612cbd4848b4301f794170eb0f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d8e5514c7c84b5f9a6699e445d92f2f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i698a8a675a8841d99a8e4be9969c21ca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1a14e6cf3d416f975eed2bfba93422_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8342f62d3a84412587f448f9c68dd462_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df04854b56f4e59a9948d081a560768_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9068fd2eb5c468fa8aebe290cd9eda3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673e75bed3d843009499b44448ad15e0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b8d872078b641849ec57b4e0288f932_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if899da5bf1bd41409a4b68a13470cbf1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieddace9853a649deacee98a11a13ee5b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5ff1faea03c41699fda03aeeb1f558b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5492bc70b174482b6c39dce60f8004f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063b0bab67784b50bd90eab8e6ad0e9e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d6a5781117748b8957106e1ea54500b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ccdb626bf0477288751a9c0cd4833c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabca06f9fbf9459aa74bd97191815ac5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8214960907014dcdb3065f18a818a891_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb1d5009fb76492bba7eb7f3ef9c1bbd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8868207423f4dc1886e5e83a2c9ffec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d031fe827d4ae9bb2cf648e3ce20cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519d21ea4f4f4131b47e685212e69fed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b475d1c4f864fecb3191e434e9a05c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia41095a8fe9f4f45b4e41448fef3fe52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa2422a2e3c425fbdb4444361bec7c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353f273f34ba4a6e86802cad11918d1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42019d07c89a4eaaa3ce1cbaa7ce9040_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e872c51cbe14f019f7cc9f67921a34b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if69d42f4ef924ebf801a45ca4af8b600_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8bd31902240473494b2cbd44c479592_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibba8cbf1ad1841b888da8acba5f7f620_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fcfc92e884043cda965149401c427a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia40fa98b862c45d08dfdaee06d40d302_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6394f5129932421ab1a4974a1a1a6b00_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf297a460c204ec2b1885acfc0c94a10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b5c730df6314669bb5151635d49120b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38fe77be60140f48090522f63c9a39a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74044123d230403ea1b8d392ee592a83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d7fe7922944855967728940bb7a2db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec41e2a7ebf48839293841bdf908142_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b04c47b17f04e9080c84e6237ce8133_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84d8e18b6b5493c8c2f73fae745b71f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987b1607278642e6bdb251b05e65b8ff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia43a6f4851ae408aa78991f992f90d3d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44343e4888bb4fdd8ef28262ba0a829f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb05d51535c4c5fb8505b007c999ba9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebad86f24bb445b8b965a4431d284e5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a78bf8567442f181de5c4cac29fe31_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i603837f5d76a430db5a4b8b5127fbac9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b82a503cd044fe590aa67341061d910_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59812274cf5a4c7396e08ab5b517c05c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if38815aebdb74f77a02060f060d0869d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7434d9096c64a1bb923b544c8f1389d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4c1482377444818d26fe58a951011d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3ed3d5f5ef4a70bf392309669bd29c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id470f6c918dd495a836d00f9b203e39e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1946250bcb8b4f35ae19d843abace6b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c97e7f2726740aab3e591c631f1086c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec66f7f13b74426818220faa08b44bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d8836b93dd4f33b7d7aadeba06f167_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1192b7a40dd4bf8901438bfe5d81d4c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06271373575042ab95c33d25a8ca9392_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic724acf3709143ae92b0205c01aff95b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5706b49442c42cc92ff686adc9c2f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc51d73723524b38a531dfff6500d1bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e079ad5fea45d1896564cab3657124_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2347919b5a0f402dbe70c10597badc81_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a5e9f871cd340148867c6e71fdf972e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5263022fb5924aec8717109210e85b4e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f4e995deff4436ac164dccfef41665_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d60d46058494a0c9b1c382560f26baf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac76b89cd7144e9aae00bd7925215e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc5b9d2a29e04e838afb62706696b06b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32dc3e4609c14b56bb221bfee7c43e94_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i239b6a8206b34281a2d7bdb5f1c2ecb9_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia89038a50c124021864f208e24672ab8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d71d04cf62a46bc8ec80068d333d865_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cb0c464b5b74f17a7e2b16b4ca83666_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica442b5ba7794e58b4b714aa57dcfb75_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04162a13ce44bbcbac57b063ee86f28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab3ef9a574ff42738e7c366e77b92366_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52eea78557244659324ce8e6c2bb202_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vestingtranche"><xbrli:measure>bhg:vestingTranche</xbrli:measure></xbrli:unit><xbrli:context id="ie498ad30294744b1ac90b3f7364ad523_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i043ba02e46a04d3d9c3801cac0f40005_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a06652cd21144e68f470720d0b26e59_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1803b1c56bb045a9a7e1425efd488b53_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc0670e71004cc7a5aaf2b1e4d07c2e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i096b128e354942a2943cc883c2a582eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bhg:segment</xbrli:measure></xbrli:unit><xbrli:context id="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f653fc2a4d47c4a01311be6348f994_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820545dd461745cb9b88d3b536970633_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe36d5030b44213aa037bd2cd8a869f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1edb8fe9719f4576984692641eb7fb92_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37b7a5485404128a642a44330167703_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ec0bf0ed7741758e2d7b0b6a2cd127_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29660353a02b48e987417294a4c7d8ee_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001671284</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">bhg:ControllingInterestHolderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA4_935de9f1-6e2c-42e1-9e08-8a0bcb80aab2">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6MzM1MDg1ZDc0ZDZkNDg2NGJhM2NiOTM5OGQzY2VhNmUvdGFibGVyYW5nZTozMzUwODVkNzRkNmQ0ODY0YmEzY2I5Mzk4ZDNjZWE2ZV8wLTAtMS0xLTA_91c20a62-15b4-472b-9737-a6710f3191a3">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xMzU_8db6b377-f08b-49b6-9021-1166e2027d36">September&#160;30, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6MmY2NDJiMDQ4ZjE2NGFjM2EyODRmYzUzY2JlMjk5YjEvdGFibGVyYW5nZToyZjY0MmIwNDhmMTY0YWMzYTI4NGZjNTNjYmUyOTliMV8wLTAtMS0xLTA_8527df41-87e9-4fc1-83a0-a18738dcf7e7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA0_79a1a663-aa62-4763-a780-21a9bba07b15">001-40537</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEw_89d1a4d8-647f-41bc-a101-a50789bbeac2">BRIGHT HEALTH GROUP, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8wLTAtMS0xLTA_7bf637f9-5d46-4869-8ffc-ccc295ddd5ae">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8wLTEtMS0xLTA_8d6ac5ff-d60a-4e31-99c9-face29932909">47-4991296</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF81_d0576bb7-94ef-4ba8-ae94-7fcd420702a4">8000 Norman Center Drive, Suite 1200</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF85_90b90c02-3bce-4638-b69d-0122d74b9a05">Minneapolis</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF8xMw_74f034e1-17f1-4d85-8272-eeea068a934b">MN</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTEtMS0xLTA_d9d15483-4c63-4b0a-be80-d41e0afb12c0">55437</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEx_fbe7ebff-58ff-4dee-bd72-de907aac3215">612</ix:nonNumeric>) <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA1_3f1b67b0-8338-4c39-986b-cf90a0da42c2">238-1321</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Title of each class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Symbol(s)&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.22pt;padding-right:3.22pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="padding-left:3.22pt;padding-right:3.22pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">on which registered</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTAtMS0xLTA_73d9d79c-68af-4bfa-a5a1-79bb31fe3719">Common Stock, $0.0001 par value</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTItMS0xLTA_fbaea789-7b18-44a5-81d5-6cf346efcd4d">BHG</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTQtMS0xLTA_db458478-2fdf-42d9-96b2-aaeee70abe9e">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xMDk5NTExNjI5ODAy_586fb65c-42bf-48d8-a1ee-1d6171e66393">Yes</ix:nonNumeric>&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA3_51bae1d8-5f6a-4f4c-ab15-71660a5a8b24">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8xLTAtMS0xLTA_667808d2-e00c-426d-bc95-90a07c596bba">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8xLTMtMS0xLTA_6edb7b3e-ddc1-4512-9178-12833602d5eb">o</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8yLTEtMS0xLTA_21b4a7dc-002a-4830-99bd-7b4eedd18610">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.45pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEy_820328a5-8d73-4b83-9c6d-647e2949e604">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">November&#160;4, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the registrant had</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i8c3a276f58cf46b487a48d33d62cf375_I20211104" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xOTM0_1a32f493-59cb-4a35-8da7-01f13e334189">628,315,180</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:2.7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_13">PART&#160;I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_13">2</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_16">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_16">2</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.8pt;padding-right:0.8pt;text-indent:-10.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_19">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_19">2</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.8pt;padding-right:0.8pt;text-indent:-10.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_22">Condensed Consolidated Statements of Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_22">3</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_25">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_25">4</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_28">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_28">5</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_31">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_31">7</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_34">8</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_76">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_76">28</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_112">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_112">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_112">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_112">4</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_115">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_115">44</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_118">PART&#160;II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_118">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_118">45</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_121">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_121">45</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_124">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_124">45</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_127">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_127">Unregistered Sale of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_127">46</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_130">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_130">Defaults upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_130">47</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_133">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_133">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_133">47</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_136">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_136">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_136">47</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_139">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_139">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_139">47</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Statements made in this Quarterly Report that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements, and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;estimates,&#8221; &#8220;projections,&#8221; &#8220;should,&#8221; &#8220;might,&#8221; &#8220;may,&#8221; &#8220;will&#8221; and other similar expressions. These forward-looking statements include any statements regarding our plans and expectations with respect to Bright Health Group, Inc. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: a lack of acceptance or slow adoption of our business model; our ability to retain existing consumers and expand consumer enrollment; our ability to contract with care providers and arrange for the provision of quality care; our ability to accurately estimate our medical expenses, effectively manage our costs and claims liabilities or appropriately price our products and charge premiums; the impact of the COVID-19 pandemic on our business and results of operations; the risks associated with our reliance on third-party providers to operate our business; the impact of modifications or changes to the U.S. health insurance markets; our ability to manage the growth of our business; our ability to operate, update or implement our technology platform and other information technology systems; our ability to retain key executives; our ability to successfully pursue acquisitions and integrate acquired businesses; the occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest; our ability to prevent and contain data security incidents and the impact of data security incidents on our members, patients, employees and financial results; and the other factors set forth under the heading &#8220;Risk Factors&#8221; in this Quarterly Report and Bright Health Group&#8217;s prospectus dated June 23, 2021 (File No.333-256286), as filed with the United States Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preceding list is not intended to be an exhaustive list of all of the factors that might affect our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Other sections of this Quarterly Report may include additional factors that could adversely impact our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or to changes in our expectations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_16"></div><div style="margin-top:10pt"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_19"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNC0xLTEtMS0w_1b0ff1e7-1962-40de-a463-628a6cc44630">956,189</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNC0zLTEtMS0w_7ff72dea-b7b3-453f-a888-e384da439230">488,371</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNS0xLTEtMS0w_7b6d7c1d-6a6c-4ec2-a413-c1f055e0c874">331,719</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNS0zLTEtMS0w_98525ea5-afe5-4d10-b6b3-9fdd865ccad6">499,928</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;padding-right:2.75pt;text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0wLTEtMS0wL3RleHRyZWdpb246NmE1OTBhY2Q4MGQ2NDdkYTkyMTFhZmFjOThmYzNiNzVfNDY_2158b21a-3af9-4457-b89d-d2b35166fe0d">5,701</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0wLTEtMS0wL3RleHRyZWdpb246NmE1OTBhY2Q4MGQ2NDdkYTkyMTFhZmFjOThmYzNiNzVfNTM_3a98ee64-c222-40ca-a04b-fc8ed9af581f">2,602</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0xLTEtMS0w_c7d0a51e-68e0-43a5-bc8b-02f0462c9ea6">99,216</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0zLTEtMS0w_e9cb5416-8278-4ac5-b523-6c654b708ad2">60,522</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNy0xLTEtMS0w_1d81f186-3fb2-4e65-8636-07740b37dff8">240,545</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNy0zLTEtMS0w_c8b70fe0-bc84-492c-82e5-05c1b5bcdaf2">130,986</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfOC0xLTEtMS0w_d871878b-d6bc-4533-a94d-b055ec3c47a7">1,627,669</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfOC0zLTEtMS0w_439ec089-faa3-4b19-9777-34d5fad21907">1,179,807</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTAtMS0xLTEtMA_c71fc472-ce06-4f94-8e46-d3cd852e138b">681,923</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTAtMy0xLTEtMA_54e8afce-0215-49f8-875f-aa7f59e8ebd3">175,176</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTEtMS0xLTEtMA_6c7ee1d8-d0f5-414d-ba80-a2713ac52795">30,932</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTEtMy0xLTEtMA_7be5ade0-1f12-4bca-a6bc-8621efb0715c">12,264</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTItMS0xLTEtMA_a31fa781-00b4-4ba9-b615-1dd9cde68bba">842,301</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTItMy0xLTEtMA_74ccd4fc-ce95-4743-a7db-f84a4e690190">263,035</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTMtMS0xLTEtMA_dff4361f-bcdf-4d7b-98e8-5fc87eb2a615">351,519</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTMtMy0xLTEtMA_26cf9409-a4cb-4404-8b68-731e7dbd6f53">152,211</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTQtMS0xLTEtMA_aa59f171-91ca-45a1-837c-cafe6998673a">40,751</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTQtMy0xLTEtMA_eb322103-97b0-46ed-94c4-8d8a2e4f2e85">28,309</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTUtMS0xLTEtMA_ca73b916-ce77-4466-8b25-9d5eee163f0e">1,947,426</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTUtMy0xLTEtMA_41ea3093-62a8-4cbd-b1f9-c6245b5b200b">630,995</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTYtMS0xLTEtMA_052c8b95-844d-4bf4-bfa0-076bc60c5c0f">3,575,095</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTYtMy0xLTEtMA_9c6080da-a1fa-40b9-b677-0d8e721f8616">1,810,802</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders&#8217;  Equity (Deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTktMS0xLTEtMA_ef0887f6-f77c-4d58-a7fe-c5927289f8d4">685,045</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTktMy0xLTEtMA_b758101e-5b28-4df3-bfc7-584333c8d539">249,777</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjAtMS0xLTEtMA_e998353a-6a67-48eb-be85-57e23d918d6b">95,161</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjAtMy0xLTEtMA_f57a35fb-c6b2-48a0-985f-2fb35590eb0e">57,252</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjEtMS0xLTEtMA_ca8bc902-739d-4266-bbf7-e14027a2822f">34,917</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjEtMy0xLTEtMA_76deb62d-fe6e-4055-97b6-80dc352e6158">34,628</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:RiskAdjustmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjItMS0xLTEtMA_3ba2b01a-c199-4752-8245-93c7a4b994eb">548,352</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:RiskAdjustmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjItMy0xLTEtMA_7d305c8d-3052-458d-9dd1-6e9576516114">187,777</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjMtMS0xLTEtMA_bbdf18d1-4428-42bb-8821-2c0abbfeea03">88,133</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjMtMy0xLTEtMA_28dd6489-c7ac-4587-8c42-2c51aa7b65a9">35,847</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjQtMS0xLTEtMA_36cc15ac-7d4e-4e9f-9834-2fed1e0e3fd9">1,451,608</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjQtMy0xLTEtMA_3f0a73ae-6828-44d2-90ef-534f4eaa4029">565,281</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjUtMS0xLTEtMA_08dd5e18-f327-425b-85e6-4456e8ae86d3">56,254</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjUtMy0xLTEtMA_9b44af78-d49b-4425-adff-332b6466905f">28,578</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjYtMS0xLTEtMA_ae9374a0-916a-4a76-bfc4-2f8c4b856f3d">1,507,862</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjYtMy0xLTEtMA_1c2ff6d5-d2c6-49f2-aa1b-cb4e8df0fb00">593,859</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjctMS0xLTEtMA_da033e98-6965-4c78-9655-f649fb3401a7"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjctMy0xLTEtMA_7d5a864a-105b-4db4-8b4d-d0761e78fc2c"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjgtMS0xLTEtMA_b01a9df3-1273-4b1c-a25a-fb43814018cb">130,029</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjgtMy0xLTEtMA_94716611-e55f-4994-abea-7b641ca95944">39,600</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzMy_a1ffd200-9d22-43b9-a46b-094edfaf3a83"><ix:nonFraction unitRef="usdPerShare" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzMy_a4ec96b4-0e8a-496e-9838-046c5833394a">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzQ2_fb0b7800-7c59-4509-98c0-2120fe40f8c2">100,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzUz_22d6919d-a2d5-4912-9c71-01f9e365d83f">166,307,087</ix:nonFraction> shares authorized in 2021 and 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzEwNg_6a216446-fe12-4f0f-be78-82f82d077a32"><ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzEwNg_d4552f62-9647-44b2-8fcf-c501f1da58a3">&#8212;</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzExMw_e0e40049-284d-4988-b3a6-049e9ef5b739"><ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzExMw_ff9ae91e-392d-491e-9186-60ad7c47c9c0">164,244,893</ix:nonFraction></ix:nonFraction> shares issued and outstanding in 2021 and 2020, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMS0xLTEtMA_9f62b27f-a259-4a41-9645-afa634a389bf">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMy0xLTEtMA_3b968852-9428-4191-b108-7d95dda47354">1,681,015</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders&#8217; equity (deficit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-0.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzE5_2ff76094-bbf3-473d-bbfe-79db23a5aecd"><ix:nonFraction unitRef="usdPerShare" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzE5_3a35a252-9ba4-4b8f-bf32-a8862c4c7d45">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzMz_78fdfc21-f77f-452a-8097-ee0bd8fe7a4f">3,000,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzQw_eed1e4c9-bd15-4ab4-8355-66cd1000e5bc">658,993,725</ix:nonFraction> shares authorized in 2021 and 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzkz_adb046de-e667-49b8-ba17-67d4279f49d7"><ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzkz_f4d1f09f-aa15-4b0b-a820-704fd0fbcbbf">628,133,782</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzEwMA_3bc0329f-5116-4dbf-ab7b-f4d641887b0c"><ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzEwMA_cdc73177-dc1a-47f8-b696-ec7198783ae5">137,662,698</ix:nonFraction></ix:nonFraction> shares issued and outstanding in 2021 and 2020, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMS0xLTEtMA_177204ec-fee9-4f0c-8373-1e1a94c692b2">63</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMy0xLTEtMA_a47d16c1-83db-4cb7-9f77-a74371ea5ca3">14</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzItMS0xLTEtMA_61456a0b-4a6b-4572-828b-0386e21e038e">2,823,244</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzItMy0xLTEtMA_1d51bad1-3e84-4ebb-bcbf-a162769b864e">9,877</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzMtMS0xLTEtMA_25a34ef7-b499-49ee-b9e5-34e34d74e6b7">886,333</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzMtMy0xLTEtMA_9fc345f1-4689-439b-b5d2-3b44cb3154ad">515,989</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzQtMS0xLTEtMA_3a4a27d1-2546-4c92-85ef-58616b36ed25">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzQtMy0xLTEtMA_290e47b7-a0ae-4b4b-8c43-0af2ecb3631c">2,426</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzUtMS0xLTEtMA_1b05494f-1a20-44c4-bc47-bb6c5460c284">1,937,204</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzUtMy0xLTEtMA_b5cdf807-f808-49d1-802f-fa0453b4b14b">503,672</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders&#8217; equity (deficit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzYtMS0xLTEtMA_af4b928f-795f-4e4a-a50b-5fc637460ae9">3,575,095</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzYtMy0xLTEtMA_f5bd0a36-61a9-4f4b-9689-0eb16e611568">1,810,802</ix:nonFraction></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income (Loss)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premium revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy0xLTEtMS0w_c7798e10-b376-4a05-becb-63e5084c9c38">1,020,233</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy0zLTEtMS0w_abb99cc3-23b9-4b21-8d50-de3304ea6639">345,426</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy01LTEtMS0w_1e0aed5c-b431-476d-9dd8-d96a7b072e34">2,922,950</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy03LTEtMS0w_32c62f59-320d-4568-bbe7-05bc571a24b7">827,135</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_20fcd581-8099-4149-a9b3-a33d8739be45"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_a0d2339f-d88e-46c2-a091-0b6fdb8cc411"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_b6886748-2b1d-491d-a844-5aaa0be8f223"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_c9024cd6-16f8-4b26-b6df-f343d19c9d24">Service revenue</span></span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0xLTEtMS0w_992676d3-6b0b-491b-888d-18cd8dc5d912">11,079</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0zLTEtMS0w_9c49c068-3321-4cb9-900c-f88b6479fa4e">4,920</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC01LTEtMS0w_02072bb6-6de9-4e1b-8013-484b00715101">31,602</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC03LTEtMS0w_a5e39362-e3c4-4360-9c66-bcdc00cce80b">13,344</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS0xLTEtMS0w_19c65c49-dfa2-4012-b047-8a49b0b6181c">47,345</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS0zLTEtMS0w_cfd6368c-adaf-4679-8040-f2dc56711fe2">1,774</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS01LTEtMS0w_395bae77-6b7c-44d0-bb5f-4860e5125dfd">112,503</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS03LTEtMS0w_e0e5822f-241b-4f6f-be43-3b7f5be64feb">7,063</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi0xLTEtMS0w_07eda825-494f-4713-a7da-1eb3682fb48a">1,078,657</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi0zLTEtMS0w_7f0c7c8d-7417-4ab1-b4ff-178ffb13252c">352,120</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi01LTEtMS0w_f9943f6a-2b38-4e97-a86e-cce312e5a2a8">3,067,055</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi03LTEtMS0w_2fca7333-ea69-4199-bd4b-64f7346a8b20">847,542</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC0xLTEtMS0w_954eda2e-4938-4ee8-899b-7b58fb628baf">1,050,943</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC0zLTEtMS0w_a188073e-347a-4288-b0c6-33df887e3bf7">311,319</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC01LTEtMS0w_88005777-c07e-4be4-bac2-832a2eed2243">2,640,143</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC03LTEtMS0w_afdb4079-6a17-46ce-b2d9-dd51cba4b438">675,114</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS0xLTEtMS0w_5b8bfd2c-d00d-41d5-bc48-3d1eab7f5c3d">309,790</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS0zLTEtMS0w_899e5a31-607e-48d1-a7b4-72a57db1d687">97,379</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS01LTEtMS0w_f2dfad5b-80f8-4900-a3ee-006ec1ce2a68">779,090</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS03LTEtMS0w_3bbd102c-0442-40dc-b6ee-98be5ba7c2de">260,650</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtMS0xLTEtMA_e9382d54-5eb4-4579-b4aa-346b8c19c016">14,205</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtMy0xLTEtMA_bddf0f66-020f-4f69-950e-9e4236798ef0">2,678</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtNS0xLTEtMA_593fcfa2-a92c-4f9b-a20c-30368bf4be89">25,981</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtNy0xLTEtMA_49c8d267-0be1-41cf-bff4-fc3862e06860">5,550</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtMS0xLTEtMA_32fc2ad4-e509-4ebe-a491-712c52d1b077">1,374,938</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtMy0xLTEtMA_c42b761e-e7cb-4ad1-b663-eaf0126e9ae9">411,376</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtNS0xLTEtMA_31aeef63-da1e-4214-b3b0-d152e293f791">3,445,214</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtNy0xLTEtMA_9c8381d0-41ee-490e-9300-5b621cd31c1f">941,314</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItMS0xLTEtMA_be9741d7-cb87-40ce-92c7-7baf6928063e">296,281</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItMy0xLTEtMA_eeace158-050f-435b-8d4c-de5ee714260b">59,256</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItNS0xLTEtMA_faf77327-75a0-4414-b7a3-e9f0831feda8">378,159</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItNy0xLTEtMA_54672f40-b889-4bc6-afc9-ff7f278a0804">93,772</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtMS0xLTEtMA_08d6817d-9d87-49d6-9842-56c673a7a245">1,594</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtMy0xLTEtMA_3e1cd0ab-48f5-47fe-be42-8c5c66f984d4">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtNS0xLTEtMA_376a9a49-ed0a-43a7-b1b0-b22dba359305">6,282</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtNy0xLTEtMA_daa003e9-1c03-40d5-be9a-717e13685fd5">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMS0xLTEtNDI2Mw_1fbef73b-4148-4061-b8dc-ad17c9ab841a">1,226</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMy0xLTEtNDI2Mw_b5c8470e-5f14-41e7-8bc2-b4e48eadbdea">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNS0xLTEtNDI2Mw_7eef9cfe-4e7c-4760-aa8c-37a596373a4a">1,226</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherNonoperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNy0xLTEtNDI2Mw_fc5bcf4c-b0c2-492f-b041-26932e685445">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMS0xLTEtMA_7712f6e9-528d-4bfc-9570-1d20cab4a084">296,649</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMy0xLTEtMA_ee4d4da8-7631-47fa-8368-3f690782cae7">59,256</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNS0xLTEtMA_9991ff3e-e746-4d85-ad40-43b25a5d4611">383,215</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNy0xLTEtMA_d77e1192-ca71-45e5-b742-986401a3b751">93,772</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtMS0xLTEtMA_9d2a8c5b-1f61-44f0-80a2-30563b3e3a42">73</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtMy0xLTEtMA_818d0454-65b1-4e01-b088-de0b76a83c1e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtNS0xLTEtMA_bba3ddf7-092e-424a-9435-f9ff37858623">18,225</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtNy0xLTEtMA_9b45469a-8e6b-44ce-a47c-89367000acfa">9,162</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtMS0xLTEtMA_72b30769-913a-48d1-9cb2-f3571200cd16">296,722</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtMy0xLTEtMA_7df64348-e821-49c8-b0e5-4a781c413fdd">59,256</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtNS0xLTEtMA_5c2d21ce-a2dd-4a46-bceb-3dc0608ef21b">364,990</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtNy0xLTEtMA_7069c192-199c-4785-8c01-4bcb58bad40f">84,610</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctMS0xLTEtMA_e8061af5-d702-46d0-917e-fd988a074a8c">3,942</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctMy0xLTEtMA_7b8a2f3d-bc4c-4ced-a936-688a1c7afc9c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctNS0xLTEtMA_4a3d5f9a-22a3-45e7-859f-433a4de35d65">5,354</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctNy0xLTEtMA_5f3e0c75-e3e7-402a-a966-f521c5d752e2">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net loss attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtMS0xLTEtMA_b7be0adb-9f32-4624-82cf-fdb669364fc1">300,664</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtMy0xLTEtMA_baaf684e-ddab-492d-abab-7ab8aec45969">59,256</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtNS0xLTEtMA_8181e3f2-30a6-44fa-93ba-3fdc5995d4b7">370,344</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtNy0xLTEtMA_ce2262c7-3a93-484c-b529-922556b1ba89">84,610</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and diluted loss per share attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMS0xLTEtMA_aac3ab39-1705-41b0-9572-0e271ca70e35"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMS0xLTEtMA_ad20cdb9-7ab4-4673-aaa1-1f5b0dd5648d">0.48</ix:nonFraction></ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMy0xLTEtMA_0a5e24de-ef13-4f90-ba23-8552a21627b7"><ix:nonFraction unitRef="usdPerShare" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMy0xLTEtMA_3eda63a8-3beb-4dcf-98be-778feb77d912">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNS0xLTEtMA_2f7eedea-9607-4ff7-b9e3-447759c04b3a"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNS0xLTEtMA_a613000f-3f36-42ac-9596-75e578799c38">1.19</ix:nonFraction></ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNy0xLTEtMA_4909bbe2-0ca8-4633-9209-53ecf538a6b5"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNy0xLTEtMA_a1e88855-2769-4a56-a429-926aeaddec88">0.62</ix:nonFraction></ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMS0xLTEtMA_a1e49d9d-c6d9-4e5f-a504-0c62735c5036"><ix:nonFraction unitRef="shares" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMS0xLTEtMA_fe826953-6e32-4cc6-b55e-55bc7747d4b8">630,378</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMy0xLTEtMA_28008c6e-353c-4f23-bec2-eb390cc2564d"><ix:nonFraction unitRef="shares" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMy0xLTEtMA_a0fea8b9-ddc1-43b6-96b0-ca8973b38f49">136,337</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNS0xLTEtMA_aa239402-2c7a-4fda-b13e-4b6184d42efa"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNS0xLTEtMA_ca308be1-9bdd-4408-9fac-a44a098e2e06">312,294</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNy0xLTEtMA_53545a93-d311-4ae0-aef9-a06f6ba175ca"><ix:nonFraction unitRef="shares" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNy0xLTEtMA_61647438-4c25-4f03-a32e-c0b1b50ad007">135,926</ix:nonFraction></ix:nonFraction></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (Loss)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi0xLTEtMS0w_ada715cf-1c53-4010-9874-7664b9c93a8f">296,722</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi0zLTEtMS0w_2cb73325-7848-40b3-a462-62473e78db3b">59,256</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi01LTEtMS0w_5e8e57d4-bbd1-4913-be5c-bd8ceefe0362">364,990</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi03LTEtMS0w_84c75df7-0f61-4ff5-a055-6fd92b701e7c">84,610</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized investment holding (losses) gains arising during the year, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfODg_1ec579ab-5502-4210-808a-0a60d678110d"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfODg_857b3e8b-a91c-4c57-a633-dbb543ccbbed">0</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfOTU_969a50d2-abb8-489d-8e00-81f38fc84fac"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfOTU_ffdd43ec-8c41-458c-a7d5-3d5ea2c91517">0</ix:nonFraction></ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0xLTEtMS0w_a8327ceb-72e4-482a-8861-709daa035f5a">143</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0zLTEtMS0w_64d1285f-24b4-40d3-b50f-7f869d0c3aaf">958</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC01LTEtMS0w_242680cc-7ee0-4a24-a727-f9ba3537f7ba">1,808</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC03LTEtMS0w_5cfe8c21-6528-40f1-b70e-adaba62513ec">2,326</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: reclassification adjustments for investment gains, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfODQ_5490daf4-5922-4e32-ad97-a1572b14f532"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfODQ_c8a69801-6d25-42b3-83a9-0722beafe28a">0</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfOTE_b7d9ae40-b52d-4ee3-9a6c-aa4c44050707"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfOTE_d62c6ee8-ec63-4ad0-8386-df06e94fbebd">0</ix:nonFraction></ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0xLTEtMS0w_7d1c6907-dce8-4bd3-91af-c6936a96327d">160</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0zLTEtMS0w_a83f8e4e-9db2-401e-9f23-eb3fb60a14d8">119</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS01LTEtMS0w_fda19eb7-124f-41bf-ad7a-30f5a9e19325">388</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS03LTEtMS0w_d7c21a13-f51d-4e37-92c2-194e9a269427">68</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi0xLTEtMS0w_9a98ac3f-ecc1-4244-bf99-66e286dd957e">303</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi0zLTEtMS0w_db5ecf01-b31c-4c71-9775-b0d7939605ea">1,077</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi01LTEtMS0w_3464ecab-7829-4066-b33e-2d287fa20a2c">2,196</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi03LTEtMS0w_860411d7-791f-43ac-9e40-ac367046df36">2,258</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy0xLTEtMS0w_d0981608-54de-4ec6-aaa8-588387aa3b56">297,025</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy0zLTEtMS0w_5ef6e0f5-2e92-4e72-8600-67e8740814cb">60,333</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy01LTEtMS0w_c510312f-4187-4a10-86c5-bdf21a84a342">367,186</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy03LTEtMS0w_78cf56fa-cdec-44c1-ad68-81ed61d20329">82,352</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC0xLTEtMS0w_f2d3ff3c-23c7-40ad-a4e2-262007b67c0b">3,942</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC0zLTEtMS0w_0c37d675-472e-4975-b4c3-b759cc309757">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC01LTEtMS0w_39ab8e49-ec67-4652-b8d4-4a5fc1d8deda">5,354</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC03LTEtMS0w_0aab2d61-dc92-418e-9777-847e5ce11619">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Comprehensive loss attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS0xLTEtMS0w_a6a53d58-9269-433a-8ac9-ba15d74a98ae">300,967</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS0zLTEtMS0w_12d23d06-4e7b-4fa0-a47b-baf898e462f3">60,333</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS01LTEtMS0w_0e132ec4-8ab2-499a-bc7d-1f37874c81af">372,540</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS03LTEtMS0w_1c601869-95ca-41cd-8c96-9675e42dd42a">82,352</ix:nonFraction>)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.682%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xLTEtMS0w_4475b077-f707-4f08-84a7-5e5d2786ba51">164,245</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0zLTEtMS0w_5c4819c1-8c67-4744-ae78-aca8842dbc0b">1,681,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8393f93f84a6414b91b167951bef057f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi02LTEtMS0w_a5d2c439-3737-43d6-be10-80126fbfe82e">137,663</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8393f93f84a6414b91b167951bef057f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi04LTEtMS0w_fd7a8852-ffe3-44a5-a337-f4288034ab12">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f868825a854ad29b00d7c27d6e2c83_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xMC0xLTEtMA_2844f652-0c18-49ac-8e6a-5e365463bd1b">9,877</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4871efe74704f978b993ba51fc2ad6d_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xMi0xLTEtMA_375b5867-e1de-4cff-a530-074e58fc920c">515,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411ffa67bd024b8fba87e9c64077fcf2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xNC0xLTEtMA_2abf39a3-7876-4b25-b166-e45ff80d7f5e">2,426</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xNi0xLTEtMA_4722b5b0-65ad-4842-b09b-7c0cc0c49437">503,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0137f0a50f174a078570affe987b9897_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMy0xMi0xLTEtMA_60bed3eb-f2d7-4471-b771-ec85e318e99d">25,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMy0xNi0xLTEtMA_85bd7640-1792-422c-9c62-3dbe145f8314">25,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNC0xLTEtMS0w_3f6c3f7e-ff9c-4f94-b4d3-491b2232b17a">1,420</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNC0zLTEtMS0w_9d6f5b59-0ea6-41e9-90e9-bf6c28c5e046">55,137</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1a3fb2febf422abccd9d03e715acf0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS02LTEtMS0w_c001c112-5043-4809-b056-fbe8738b37c4">4,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS0xMC0xLTEtMA_6c5d3856-6b93-4687-b5e9-70dd2a6c420c">4,893</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS0xNi0xLTEtMA_cbbb4290-0caa-44a9-bb2d-4f25fb205149">4,893</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNi0xMC0xLTEtMA_f8a8eacf-8a36-4a25-b596-451ec2f97e6d">5,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNi0xNi0xLTEtMA_db1ca29e-930f-4220-b971-b9f3262825c2">5,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd11786a418e4ce4b107cb2441a2f8de_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNy0xNC0xLTEtMA_dc65baa4-c0c1-4cda-a2bf-42419167fdd1">1,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNy0xNi0xLTEtMA_480d8284-57f7-42c2-aedc-83be6fa443cc">1,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xLTEtMS0w_7facd64e-ed25-485a-b92d-99e4440d9c0e">165,665</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0zLTEtMS0w_46edea63-cc07-48bc-a484-edcdb9f86fac">1,736,152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30e3312456d94b45b58360f1365cce93_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC02LTEtMS0w_2047dd24-f3c4-41aa-bb09-2da6b3b58e8e">142,324</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e3312456d94b45b58360f1365cce93_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC04LTEtMS0w_309c1fe7-6c05-4097-96ce-1ee3bda186cc">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73597c3d3a334263ab2aa9d6b4f46f20_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xMC0xLTEtMA_da7c0db4-9ede-4345-9873-d81b7668dcd7">19,946</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896eec808e0343cfbae2f717934e71b4_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xMi0xLTEtMA_3ebe8cd3-24a9-4b74-b6ab-6cb8583e057b">541,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59037bc717a449289317ac0d87adea87_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xNC0xLTEtMA_fe5275f7-a772-4e72-b397-bad2345a8f2e">1,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xNi0xLTEtMA_a7776c1b-b4da-4ad9-b8c5-b16f525d6b38">519,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63e4858120f3454984bb4f44d0b45435_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTAtMTItMS0xLTA_f778e27c-1384-4092-8216-56812045233a">44,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTAtMTYtMS0xLTA_a2bfd734-0811-4baa-8855-d6e0ca324151">44,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTEtMS0xLTEtMA_158471c0-fc49-4040-8195-6657033101e4">2,067</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTEtMy0xLTEtMA_cfb5f77f-bf8f-4cc7-8d73-6db03706a403">79,807</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of preferred stock to common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquitySharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMS0xLTEtMA_0153c4d6-fcf5-4c47-9fa3-293fe3e4c69e">167,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquityValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMy0xLTEtMA_1e9d8a46-e847-431d-9f94-3c4d5659c8e3">1,815,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItNi0xLTEtMA_111aff56-7cf9-4aa3-b48f-344d99e89c95">427,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItOC0xLTEtMA_bf660ecb-2c13-4d54-bbe4-52f3d0dd43f1">43</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMTAtMS0xLTA_799288f1-dea1-4c8a-93ed-db39ba5d23f5">1,815,916</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMTYtMS0xLTA_568c135c-6590-4e3b-a1d7-9afa859b547e">1,815,959</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtNi0xLTEtMA_284a103a-9bc8-4c04-8bbe-f420d762cf32">4,120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtOC0xLTEtMA_f1b773b4-4a48-4a63-baf7-ac73d865fc1e">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtMTAtMS0xLTA_0665b48c-565d-4e35-8247-2fb44c4e4b0f">4,722</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtMTYtMS0xLTA_457c6b56-5d77-435a-a21c-41b564f07444">4,723</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sale of common stock from IPO, net of offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtNi0xLTEtMA_10f6324e-5c58-4714-a67d-d43260877b40">51,350</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtOC0xLTEtMA_d71e4583-1989-4c66-8da9-5e1149da25e6">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c76927d0c87485f81b0c99ec31fe573_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtMTAtMS0xLTA_fd387ab3-1708-4de7-937c-356b776587c7">880,637</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5496876444a4be489375b4c022ef150_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtMTYtMS0xLTA_22e60191-e2e8-4dab-81a4-78ba2ff51d40">880,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTUtMTAtMS0xLTA_6d5c1ba0-2ef0-4cd1-a6ad-898b6f8b7a7b">13,878</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTUtMTYtMS0xLTA_51697592-7d33-4169-bdd7-54f980e91f13">13,878</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0da7eda6089f40dc80394423712bac8c_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTYtMTQtMS0xLTA_2b7bf60b-74ee-48d4-8305-afe9334cec25">851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTYtMTYtMS0xLTA_86d913b7-84b1-4d4b-9c2b-db8c1fa9cc49">851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMS0xLTEtMA_eaa28c60-872d-4667-a0a0-2b58a48b3649">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMy0xLTEtMA_079bb022-9d2d-4406-ba5a-ea6e9ea302a4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1632e2cf7834f558bc296dd7d180324_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctNi0xLTEtMA_ccac810e-0125-4c54-b4c4-585faff2103b">625,691</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1632e2cf7834f558bc296dd7d180324_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctOC0xLTEtMA_dbe5423a-d834-4e02-97d3-b01f6535e901">63</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9381960dce441ae877f25e0db8e3933_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTAtMS0xLTA_70fc8d73-e726-4f9e-9bf1-bcb840fe48bf">2,735,099</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib20155a3f7a940acb68c19efd45e42d9_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTItMS0xLTA_f03ee7dd-976b-4bd5-bce7-76a514003078">585,669</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7a6f0ef29542f884edade6bd7d8ef0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTQtMS0xLTA_2c9fb4ab-ee89-4de9-8842-4e2bb4a4972b">533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTYtMS0xLTA_fc24b667-975c-4081-8a85-119586076ff2">2,150,026</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i253d2d1e76de471f92bb9665c552586f_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTktMTItMS0xLTM0_106217ea-9756-4104-920f-cd92b903a4a5">300,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTktMTYtMS0xLTM0_25b2cc3e-b65c-49e2-903f-752270221d9e">300,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItNi0xLTEtMzQ_d319058e-f00f-4a55-b418-b4b161af236f">4,965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTAtMS0xLTM0_ec6c983e-b893-4838-a4a7-f2980516428a">75,965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTYtMS0xLTM0_8d19f43b-5de7-44e6-b01d-bae283bf0c46">75,965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return of common stock from escrow settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bhg:StockReturnedDuringPeriodSharesEscrowSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItNi0xLTEtMTk1MDM_f975a6b1-67c3-45d8-8009-ab4167dba6d3">2,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:StockReturnedDuringPeriodValueEscrowSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTAtMS0xLTE5NTAz_7f58ccdf-9a71-4434-be8b-acf43004a10e">12,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:StockReturnedDuringPeriodValueEscrowSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTYtMS0xLTE5NTAz_b83d3335-a1ed-44ea-9d31-5170ba6c3599">12,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjQtMTAtMS0xLTM0_a61eb33a-ce88-4165-ad94-8c5fdc5cf606">24,180</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjQtMTYtMS0xLTM0_29134cb8-9551-4990-adc4-d5b0a721f734">24,180</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib665d31bf9d7437591781fd1d77c6b99_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjUtMTQtMS0xLTM0_25a598d1-9a96-4408-9a04-476357d26107">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjUtMTYtMS0xLTM0_ed2491bb-5fba-489c-bed2-043dcf94fcd2">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMS0xLTEtMzQ_725a07d5-39d2-40b1-b232-1e9ff6c734a5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMy0xLTEtMzQ_44083351-a6d6-44ac-ae04-2f488525da55">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie46639bd73344ddebb19d877ee0b947c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtNi0xLTEtMzQ_e8caf6f4-41e4-4719-9118-ab4cae669ec2">628,134</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46639bd73344ddebb19d877ee0b947c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtOC0xLTEtMzQ_deffabb0-8a99-47bb-8ac5-822da8dd9220">63</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649e794681cf4cca99c2536e968dc812_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTAtMS0xLTM0_7f7b66c6-522a-40f0-847b-26bf9e0f06c7">2,823,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ef0d69fb47479bb3350e333c9f7181_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTItMS0xLTM0_673d596f-8b79-4a2f-8f63-f3a38cf232e1">886,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie606262a9d784da09df56adafa6c1538_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTQtMS0xLTM0_53411568-18cf-457c-90a3-230ba01b17d9">230</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTYtMS0xLTM0_577ce409-821a-4eab-83e0-1404855c1831">1,937,204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.682%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xLTEtMS0w_77050885-1b4c-4101-bb5f-599adc9f8f7d">119,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0zLTEtMS0w_ace55c25-c433-4124-813c-9b53ca6bd5c8">871,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi02LTEtMS0w_a07a1a3b-8ec3-4ac2-9d70-3cab636a6a99">135,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi04LTEtMS0w_09cd96f4-4dd4-4fd1-8bf3-82a3432b61c1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie882f1e05dbb484bb99d78576ac4d175_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xMC0xLTEtMA_8b4aa729-d821-4768-86a5-318fde22d549">3,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ac918bc38544218819b0a101da9f295_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xMi0xLTEtMA_221ed5b7-288b-4f38-ba14-24b40fa04202">267,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e64ca59c864ed9a6e56e45243b353f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xNC0xLTEtMA_2267141c-33cd-4354-868e-d532d13e4d4c">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xNi0xLTEtMA_2389b285-fa7c-4c72-9281-fff617238023">263,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4aa6030d8ef4580b4eb924a05e135f7_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMy0xMi0xLTEtMA_421dbca6-156d-4b11-9db3-ff49c0daceed">7,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMy0xNi0xLTEtMA_ed1f0b8f-f6e9-4cec-8df6-f29b562a9415">7,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc061278f0da4aa9a0f13da8c2ab475d_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS02LTEtMS0w_1a701978-721a-463a-94f6-4df3320415cf">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS0xMC0xLTEtMA_039b0406-2486-4f33-b144-d42d9efc30b1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS0xNi0xLTEtMA_016ec1f2-fcb0-4046-9f8c-1b8ac8f024a8">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNi0xMC0xLTEtMA_1815a57d-8c17-4665-8edd-47d1b9392649">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNi0xNi0xLTEtMA_73f537a7-004f-4958-8523-c63a7cea3822">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6dc6d47370425b9fce3a98c5650ffc_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNy0xNC0xLTEtMA_965ddb0b-7ef8-431f-b7bc-a4e8b0c71a44">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNy0xNi0xLTEtMA_d49e72bb-7376-4b05-a7fd-91e336ff8d9d">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xLTEtMS0w_f5f9f221-7368-4dba-852c-482f65ed8f54">119,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0zLTEtMS0w_121e384f-cc61-46c3-804b-c9d218a46bfc">871,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9545d10c15f3484799e95f2fa94df37a_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC02LTEtMS0w_8fa0c9f4-8601-45bd-9cd4-c6fccc25bdec">135,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9545d10c15f3484799e95f2fa94df37a_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC04LTEtMS0w_6f88f04c-0c4c-452f-96ca-fcb66e358a70">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad985bb842b24424b5f51535a74e0d20_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xMC0xLTEtMA_ebeb0c8a-e4a9-4aa0-b610-af91b90c040c">4,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1467d7e2eba4616ad00ffd76e8ea421_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xMi0xLTEtMA_9b5484d1-8183-4993-b7cd-f544e8a29b99">274,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715014b57d1441db9f72b2c4fc26c971_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xNC0xLTEtMA_7c5f2480-2aad-44f2-801c-8ff957619224">1,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xNi0xLTEtMA_de893070-e91d-4796-95c3-bc6006a95e22">268,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib18c4a2f0ce64d00b414ff7d7e5d76d7_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTAtMTItMS0xLTA_24082b03-0073-4bb8-b94d-7c35b327e5e5">18,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTAtMTYtMS0xLTA_d882a518-57ca-40f2-a9d0-2c08cbeed81d">18,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTEtMS0xLTEtMA_35429a30-d0b6-4c6f-aba0-dd577d6005fb">19,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTEtMy0xLTEtMA_49d05bc7-8cf9-4a17-9f88-62f3a4dfcac3">291,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3b38cf004a47bfb5f9ff6a8663bb04_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItNi0xLTEtMA_18b3ca66-d2a9-4346-8775-c1857fcc71d7">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItMTAtMS0xLTA_dae5a6db-b4ad-47c2-af4c-00e969e3443b">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItMTYtMS0xLTA_1f3661b4-6aae-4f55-b368-45b64850cfa4">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTMtMTAtMS0xLTA_cd83b1be-c134-4ca6-a0ff-4ccb8059b378">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTMtMTYtMS0xLTA_92886c85-c2f1-4efc-b652-be02a9ddc108">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97167ac64ec4bb6b360504ece6d65a6_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTQtMTQtMS0xLTA_82491d38-108e-4bfb-bca3-59904657bf3b">2,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTQtMTYtMS0xLTA_7f794942-245c-45ad-b6bd-7b89a0541a85">2,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMS0xLTEtMA_a4d00140-48e5-4e63-a209-8274978000c0">138,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMy0xLTEtMA_400fcb58-534f-4a46-a92a-51afe9635360">1,163,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i439d50f322e748c2a9db9431eb49add8_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtNi0xLTEtMA_61e7dcd2-72fc-414c-8a54-37fd15caae1c">135,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439d50f322e748c2a9db9431eb49add8_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtOC0xLTEtMA_24050008-aaa1-4610-8ae4-c5f9032f4629">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbdb64c5b993489fa19ab055445e7cb5_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTAtMS0xLTA_85e49611-5b82-493a-a936-e35b090a1c30">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3d52ed33ef14b8d95901deef872bce1_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTItMS0xLTA_e9b33ff7-eac3-4d89-b886-5e2cd69bf41b">292,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee8a98ff3284e9a89cb462c1a5975cb_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTQtMS0xLTA_ca293984-fe2f-47a0-94ca-21a35beec912">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTYtMS0xLTA_ac7d2e5e-47fe-4fb8-814d-f706aee4e13a">283,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9ed5988a89248598fb835a3d6eb8fb1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTYtMTItMS0xLTExNQ_714a9275-0785-46a0-8a2f-24af9ec1b179">59,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTYtMTYtMS0xLTExNQ_321f8b5f-91fe-4b4b-9f87-21cb8e338485">59,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTctMS0xLTEtMTE1_eff6e9a0-14f4-4782-98d7-c854eb146f30">23,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTctMy0xLTEtMTE1_c0d842d3-19eb-49fa-831a-648071c24acd">475,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i217634c8da0246ab92821d26990e7ab8_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtNi0xLTEtMTE1_79f2685e-e671-4081-8952-6c876b9f8038">882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtMTAtMS0xLTExNQ_0bb10c77-98d2-4832-998a-fdaae900b9cf">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtMTYtMS0xLTExNQ_6902a456-e0fb-4d35-9c28-5a2cb4a4a5bf">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTktMTAtMS0xLTExNQ_0701cdae-43a5-44e8-bfaa-3922dff346ac">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTktMTYtMS0xLTExNQ_e9ccffee-c4a6-43d6-83e5-093ce622d258">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1208c83ea17943c393f48af48a7323f6_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjAtMTQtMS0xLTExNQ_9c9cd2ab-e2e8-4199-8b97-bb03c5988776">1,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjAtMTYtMS0xLTExNQ_aa120371-ba97-4a06-a62c-91052bf48c00">1,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMS0xLTEtMTE1_c8648b3b-fdc4-4087-aec2-4c4ed388d6d6">162,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMy0xLTEtMTE1_9d0d6785-ed4f-4cab-bb45-57dfc54262d5">1,638,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtNi0xLTEtMTE1_1a3170e5-b016-429e-badf-6abf631237e9">136,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtOC0xLTEtMTE1_90e9fff9-ee3b-459c-833d-fa3d1b566bf3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffb20b6c43f4e73b4c1baaed88a2476_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTAtMS0xLTExNQ_29d43dba-ba1a-4e34-bcea-89cb4edcbfb7">7,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fb28b0bad874df383fc182d52bcd000_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTItMS0xLTExNQ_25b9c16e-dfd6-44fb-808c-659b9fb80da9">352,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7b09a7c5084223a5134c48364d9483_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTQtMS0xLTExNQ_785cea7e-e36b-46c5-b0a2-49865764666d">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTYtMS0xLTExNQ_85970654-701d-41a5-b8c6-66e6e5561ba7">341,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright Health Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMy0xLTEtMS0w_13dce82c-948e-4556-8971-9043780816e1">370,344</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMy0zLTEtMS0w_a4c05e3d-06dc-4430-9a27-d044da0bb4b6">84,610</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNS0xLTEtMS0w_1c8255cf-70ed-4129-a8f9-a9c590c370d1">25,981</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNS0zLTEtMS0w_bc8391ae-89a0-4a00-987a-b79d45013df6">5,550</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNi0xLTEtMS0w_4a57a2e8-420a-4175-901c-27a6d797cb70">43,234</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNi0zLTEtMS0w_81f7af3b-065b-43ff-a0ac-d24c377c367c">3,722</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNy0xLTEtMS0w_74d1eeb3-76fb-4753-82ff-c8246a22b296">17,946</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNy0zLTEtMS0w_4005c66a-b4de-4e49-9076-011d2e9b5477">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOC0xLTEtMS0w_df51f6e3-7145-4002-a7b4-384ded0ed736">109,012</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOC0zLTEtMS0w_92c9d5e9-4024-447a-9b35-94376f38fe38">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOS0xLTEtMS0w_62197662-9875-4162-bd03-857b1f76a28b">14,555</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOS0zLTEtMS0w_29878fd9-fb07-4d16-b85b-fe1b6578923b">1,022</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquired assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTEtMS0xLTEtMA_a63826ca-4498-4c75-ab76-daa4fb11ffb7">18,683</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTEtMy0xLTEtMA_64d8288f-862a-4d45-a188-4dc6080e9fba">27,508</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTItMS0xLTEtMA_1c5f169a-0fa2-43ef-b5cd-9e8050366c41">86,836</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTItMy0xLTEtMA_607e09c8-ba1f-4bb6-89a2-65c548258a61">24,980</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical cost payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTMtMS0xLTEtMA_c6fb4930-a219-446e-b22f-fd97635538c8">342,531</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTMtMy0xLTEtMA_729a6cdd-91a4-45d1-b643-f0aefa815dc8">35,458</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:IncreaseDecreaseInRiskAdjustmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTQtMS0xLTEtMA_82eee0e6-ae31-4eba-9142-e4357af5afd2">359,257</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:IncreaseDecreaseInRiskAdjustmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTQtMy0xLTEtMA_53b6180d-ba29-4555-9f86-b75cb69b38f6">68,186</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTUtMS0xLTEtMA_fa8bf980-530a-4f4c-a681-9a69775f3ee0">53,853</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTUtMy0xLTEtMA_1b4fb938-6d08-4f97-a09c-51fc33c2c104">22,015</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTYtMS0xLTEtMA_8d911c33-ad14-4f65-870c-16bb33d4ae96">3,476</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInUnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTYtMy0xLTEtMA_9d0edee8-6555-41a1-874c-c4ad012af3e7">1,498</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTctMS0xLTEtMA_a2e7ea62-7d6a-479a-ab51-6c7deffb0f42">233,114</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTctMy0xLTEtMA_c72cc86a-f505-4bc7-a9b8-7566e29a3206">11,339</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTktMS0xLTEtMA_df3320a7-d26b-488e-9239-3c4ea67b7032">736,838</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTktMy0xLTEtMA_823abf5e-5064-426b-aa72-005073ae0650">702,672</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales, paydown, and maturities of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjAtMS0xLTEtMA_e2485174-4180-40a2-9388-1fea916f7f59">536,110</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjAtMy0xLTEtMA_5a1ac7c6-43d0-42c2-99cc-b9f78c58a87f">349,113</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjEtMS0xLTEtMA_1512b9a6-6949-4905-b267-f0e1e571aca7">20,682</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjEtMy0xLTEtMA_9a938933-dfc9-4fec-b4aa-e4eb8a8be739">1,181</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjItMS0xLTEtMA_6eb81685-6052-4b79-8577-64bb3d85d2e0">431,718</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjItMy0xLTEtMA_48209369-4a91-47fe-9f50-b7c98a9bc012">174,090</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjMtMS0xLTEtMA_153d330c-8d11-4c00-b687-c412a9e0d34f">653,128</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjMtMy0xLTEtMA_e297b26f-83da-46b9-a78d-398bc469b92b">528,830</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjUtMS0xLTEtMA_bb36ddcc-66a7-4a90-aa0d-a5bb9975b0c3">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjUtMy0xLTEtMA_031798a8-e375-48ee-88c1-70569daf8a95">686,840</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjYtMS0xLTEtMA_12f3329e-7023-418b-a8ef-6fa18fa147c5">10,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjYtMy0xLTEtMA_1948dcf5-3fc9-4055-8be2-bf49a70955e6">874</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjctMS0xLTEtMA_513bbc1f-affa-4ef0-a946-a7d86d86185f">200,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjctMy0xLTEtMA_13ac0763-14d8-4ca5-ac5d-dece959c1c6f">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjgtMS0xLTEtMA_8456ba5e-0e65-4ccc-86c1-dacb5f04b390">200,000</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RepaymentsOfShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjgtMy0xLTEtMA_772c1aea-3898-45d6-825a-21ade6717a5d">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjktMS0xLTEtMA_ab75ee20-828a-4c94-8a6e-d7707df2169c">3,391</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjktMy0xLTEtMA_d1ee9448-0384-467a-aee8-9854301e0ba1">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from IPO</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzAtMS0xLTEtMA_bcf1c563-dc10-4247-9fdc-07bd430398f1">887,328</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzAtMy0xLTEtMA_c3e18c8f-f0fc-4dd5-898a-d7c7e3df232b">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for IPO offering costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzEtMS0xLTEtMA_c69e8dfe-cca3-41ba-b861-939c67c63319">6,686</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzEtMy0xLTEtMA_e95a163b-5c83-4e33-ab34-055b8684e618">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzItMS0xLTEtMA_3169a830-2135-482f-a6ff-d65a154751d9">887,832</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzItMy0xLTEtMA_1d1cabf5-29f2-46ed-94cb-406a97288c81">687,714</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzMtMS0xLTEtMA_189068e0-ef9e-4cbc-88d9-1af4e1db46c5">467,818</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzMtMy0xLTEtMA_83d83b74-0442-4fe8-addf-530440f83aac">170,223</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents&#8201;&#8211;&#8201;beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzQtMS0xLTEtMA_fe284fa2-e0d4-4246-8c22-3c2b6f8d41a3">488,371</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzQtMy0xLTEtMA_1c2a9960-e880-4bc8-8f85-77b70788262e">522,910</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents&#8201;&#8211;&#8201;end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzUtMS0xLTEtMA_a4a96b33-21dc-4515-8dec-4ddf9873c13f">956,189</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzUtMy0xLTEtMA_0841eb24-f28e-4f1f-bc15-9c98847987a5">693,133</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in unrealized (loss) gain on available-for-sale securities in OCI</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzctMS0xLTEtMA_693b4a4a-b2ed-4f22-8244-3bc69161da1d">2,196</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzctMy0xLTEtMA_b0068be7-0096-4d8d-aab9-77d01a0dd1a9">2,258</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzgtMS0xLTEtMA_09061390-de89-4c51-b849-8f38696a58d2">3,865</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzgtMy0xLTEtMA_9b4d4eb4-4e74-440f-86a3-5c694603668b">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock issued for acquisitions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDAtMS0xLTEtMA_c18e7fb1-f188-4355-9633-22104b086297">134,944</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDAtMy0xLTEtMA_4aba2f8a-2cf0-43a9-9d0f-bccde11dcf7a">80,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDEtMS0xLTEtMA_719179a7-120d-471c-8f5d-61f358a79b90">1,815,916</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ConversionOfStockAmountConverted1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDEtMy0xLTEtMA_feafd902-bf17-4700-86c6-9efd66608c5d">&#8212;</ix:nonFraction></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_34"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE3Mg_82ef1e59-276e-47b0-a9be-183282729844" continuedAt="ib54d559084ab4e28bbcd5adeb8ab8c9e" escape="true">ORGANIZATION AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib54d559084ab4e28bbcd5adeb8ab8c9e" continuedAt="i970f1e26b9354d7d8ec014aacd92a701"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright Health Group, Inc. and subsidiaries (collectively, &#8220;Bright Health,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or the &#8220;Company&#8221;) was founded in 2015 to transform healthcare. Our mission of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Making Healthcare Right.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Together.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is built upon the belief that by connecting and aligning the local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, reduce systemic waste, lower costs, and optimize clinical outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Split:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On June&#160;2, 2021, we effected a stock split of the Company&#8217;s common stock on a 1-for-<ix:nonFraction unitRef="number" contextRef="i2d75a8b417104e2e99acca850c6fd16f_D20210602-20210602" decimals="4" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNjA0_27178124-a48e-43a3-8bf6-ead085cf0c1f">3</ix:nonFraction> basis (the &#8220;Stock Split&#8221;). In connection with the Stock Split, the conversion rate for the Company&#8217;s preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was increased in proportion to the Stock Split. Accordingly, all common stock share and per share amounts for all periods presented in these financial statements have been retroactively adjusted to reflect this Stock Split. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On June&#160;28, 2021, we completed our initial public offering (&#8220;IPO&#8221;) in which we issued and sold </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTE2NA_a24cd11c-3aaa-4969-86fc-410ef0447062">51,350,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ia8f1c51b74e14129bd0f91602963e036_I20210628" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTIwMQ_635bbff4-7e85-4ace-84e3-a3f5980ccd8f">0.0001</ix:nonFraction> per share, at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3eb69ad6e15b4395bf5d632879271c37_I20210628" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTIzOQ_f4d9f4fb-9c86-47e6-b9dc-84ee4b21893b">18.00</ix:nonFraction> per share. We received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTI4MQ_c3ef0712-f243-4834-90a8-fa7f6627fec3">887.3</ix:nonFraction> million from the sale of our common stock, after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTM3Nw_e2263d8e-b301-410e-8fb0-9113708b48b3">37.0</ix:nonFraction> million. We used a portion of the net proceeds from our IPO to repay in full our outstanding borrowings under our revolving credit facility, as well as to fund the acquisition of Centrum Medical Holdings, LLC (&#8220;Centrum&#8221;). Refer to Note 2, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 7, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Borrowings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Common Stock is traded on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;BHG&#8221;. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $<ix:nonFraction unitRef="usd" contextRef="i3eb69ad6e15b4395bf5d632879271c37_I20210628" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTgwOQ_8c068719-19c7-4938-849c-54fcea979c41">6.7</ix:nonFraction>&#160;million of deferred offering costs consisting primarily of accounting, legal and other fees related to our IPO, which were recorded against IPO proceeds within additional paid-in capital upon closing of our IPO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion of Preferred Stock into Common Stock: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;28, 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="i8955d418b9e348a09575068e6bd96030_D20210628-20210628" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjA5Mg_d5c98b8f-cea7-49d5-a5bd-108f14b86f9e">427,897,381</ix:nonFraction> shares of common stock upon conversion (the &#8220;Conversion&#8221;) of all outstanding shares of its Series A Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ia21467a131f241a8b54be2659b98dd34_I20210628" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjIyOA_12b18de4-a989-486d-b62c-5db5c695e794">0.0001</ix:nonFraction> per share, Series B Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i122e578042ed4e84b1d841704471a4a9_I20210628" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjI4NA_88ce0548-84dd-4cc2-8280-cb6cf367eb25">0.0001</ix:nonFraction> per share, Series C Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i1b79375e653b4c6ab22e579ba0de8468_I20210628" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjM0MA_c88ad710-d12f-4862-8983-b4adfa03cb59">0.0001</ix:nonFraction> per share, Series D Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="iffd914077e9f404a9da2a417b56c4672_I20210628" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjM5Ng_6c1eea27-149a-4be9-86a5-d40ca0d90fbc">0.0001</ix:nonFraction> per share, and Series E Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i837392de0aa64e87bfdcc482e5eb4682_I20210628" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjQ1Ng_7e8156f8-bbad-430b-bec3-8fb16896449e">0.0001</ix:nonFraction> per share (collectively, the &#8220;Preferred Stock&#8221;), pursuant to its eighth amended and restated certificate of incorporation. Conversion of the preferred stock into shares of common stock occurred automatically immediately prior to the closing of our IPO. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2Nw_3630325c-b2c6-4cfb-93e9-191a8d3f8a50" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our audited consolidated financial statements, unless the information contained in those disclosures materially changed or is required by GAAP. As such, the condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes thereto as of and for the year ended December&#160;31, 2020 included in the prospectus dated June 23, 2021 (File No.333-256286) (the &#8220;Prospectus&#8221;), as filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. The accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for fair presentation of the interim financial statements.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2OA_f7ddd0de-5fb9-4aab-b8b7-aa7a3a577823" continuedAt="i749bad65fd71404391c5663b0bc5910b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Our most significant estimates include medical costs payable, risk adjustment revenue and associated payables and receivables, valuation and impairment of goodwill and other intangible assets, valuation and impairment of investments and estimates of share-based compensation. Actual results could differ from these estimate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. </span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $<ix:nonFraction unitRef="usd" contextRef="i5759a0d876be449aac313ca0615a3807_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="bhg:RiskAdjustmentPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMzI5ODUzNDg4OTkwMg_b2af109b-1b20-49ed-a83d-f3c92303b310"><ix:nonFraction unitRef="usd" contextRef="if396eed261f24ec59dcf755f4bcd3906_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMzI5ODUzNDg4OTkwMg_fc85ae02-0bc0-47e4-a645-4c2717130656">134.0</ix:nonFraction></ix:nonFraction>&#160;million as a result of updated data inputs used to calculate Individual and Family Plan (&#8220;IFP&#8221;) members&#8217; expected full year risk scores, which resulted in an increase in risk adjustment </span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i970f1e26b9354d7d8ec014aacd92a701"><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i749bad65fd71404391c5663b0bc5910b">payable in the Condensed Consolidated Balance Sheets and a reduction in premium revenue in the Condensed Consolidated Statements of Income (Loss).</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE3MQ_c4eb35d3-eda5-4403-aa1f-ad83917c6f01" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our operating costs, by functional classification for the three and nine months ended September&#160;30, 2021 and 2020, are as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and fringe benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi0xLTEtMS0w_751e4777-13ae-42c8-8748-559f4e571f40">100,062</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi0zLTEtMS0w_2ba4de35-a5aa-4c70-b608-7a0388a99a47">35,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi01LTEtMS0w_8ab901db-1917-4281-9c14-eade34b62c6a">234,467</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi03LTEtMS0w_e947fbe7-0149-482e-8a4b-59815c2ee571">92,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy0xLTEtMS0w_235e0bf2-3840-4370-b0e6-bda36a6a1952">61,483</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy0zLTEtMS0w_6cd96d67-6506-492a-afb5-fd0ae7a5f2c9">20,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy01LTEtMS0w_3cc94820-01a9-4df2-9039-3cfa79bf38a9">143,248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy03LTEtMS0w_e747442f-a9ec-40b1-addc-c40b1740829c">53,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and selling expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC0xLTEtMS0w_7006e803-0bdd-4345-b59b-6bd234f5a731">69,443</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC0zLTEtMS0w_3c42d053-a516-49b4-9f27-f95e86512a5d">15,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC01LTEtMS0w_a92a8ad4-d627-4a5c-b9a4-a21919750dbf">183,636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC03LTEtMS0w_cf194595-fe5e-42b3-bc84-fe91b5996cb9">39,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS0xLTEtMS0w_80462aba-c069-4312-b915-fe0fa7afdddd">78,802</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS0zLTEtMS0w_506cd38e-493b-4099-aae5-0edf4e5e88e0">25,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS01LTEtMS0w_5b2a08cf-37bd-4b0a-8fed-02c91cfc0bb2">217,739</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherCostAndExpenseOperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS03LTEtMS0w_3af3b10c-c9bb-48e2-a8b3-337b38ec246f">75,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi0xLTEtMS0w_4abe31d2-08b5-4d9f-966b-7da9186236ab">309,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi0zLTEtMS0w_4c9abd31-fc2c-4472-b759-3871eaba64ab">97,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi01LTEtMS0w_d04a8d1a-9041-4fe5-aa81-5bc99ec48c56">779,090</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi03LTEtMS0w_8a15a02c-6734-4af1-9342-b419edbb87cd">260,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2OQ_97cff50c-9915-423c-9c5d-b8fa8f8f66ef" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Pronouncements:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting pronouncements that were recently issued and not yet adopted or adopted since our audited consolidated financial statements that had, or are expected to have, a material impact on our consolidated financial position, results of operations, or cash flows.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMjE_b80a2819-c1fe-4b1e-bb22-1801296d46b5" continuedAt="icdbbf731fa3d4fbd87ad56c3717d0427" escape="true">BUSINESS COMBINATIONS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icdbbf731fa3d4fbd87ad56c3717d0427" continuedAt="i95ba20af96f94a7d9bf0565759b5e00a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centrum Acquisition: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2021, we acquired <ix:nonFraction unitRef="number" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNzc_30c91311-5a2b-449f-a760-801d44b24b69">75</ix:nonFraction>% of the outstanding equity interests of Centrum for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTUz_7a410543-3fb7-4f02-9e5c-6102edc1b31f">222.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTY4_dec0fe50-5052-4a74-847a-419af4a4493b">75.0</ix:nonFraction> million of common stock, for total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjMy_0ab7fbd2-3ac6-40dd-8826-80c1794cb6ef">296.2</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjUx_55ce50bd-2894-4767-9740-dbc70dbe22b9">1.2</ix:nonFraction> million of cash acquired. Centrum is a value-based primary care focused, multi-specialty medical group based in Florida. Centrum operates <ix:nonFraction unitRef="healthcenter" contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701" decimals="INF" name="bhg:NumberOfHealthCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNDQy_7d7a7ce2-f4a2-4ac7-a667-79684ab35294">17</ix:nonFraction> health centers in Florida, serving Commercial, Medicare, and Medicaid consumers across multiple payors, with secured expansion locations in Texas and North Carolina. Centrum is included in our NeueHealth reportable segment. Transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i107c6a9c6a5f4b72b6a388858fbcfaf8_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjkw_74740334-60d8-4531-8c01-5b627ab86a8f"><ix:nonFraction unitRef="usd" contextRef="i42f62b97d0d14e2a80908c5ba5ce1ce7_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjkw_788d13b1-415a-4423-ad89-1a374c766da5">1.0</ix:nonFraction></ix:nonFraction> million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September 30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the Centrum acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill, which is predominantly attributable to the incremental financial benefits achievable through Bright Health Group&#8217;s integrated care delivery model, whereby Bright HealthCare members are cared for under value-based arrangements with Centrum. This model brings together the financing, distribution, and delivery of high-quality healthcare and provides the opportunity to enhance overall margin potential for the Company.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i95ba20af96f94a7d9bf0565759b5e00a" continuedAt="iba90d7d49cef456f94e171b5ca7f5ca5"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTA_fa45499f-bf89-4f50-af52-4ac1846f77b5" continuedAt="i3d3719f7d2a44ff1bd2527d5cf47526f" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the Centrum acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:105%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMC0xLTEtMS0w_3ffa90f2-040b-4d99-92ad-8b1dd3916746">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMS0xLTEtMS0w_ba977207-3413-460a-8e90-d701505c7c5c">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMi0xLTEtMS0w_6954410a-1580-4f8b-b827-ba33dbdf44f9">2,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMy0xLTEtMS0w_5a4c7b31-06b0-4aa2-93e8-f27a656b97dc">102,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNC0xLTEtMS0w_06d4b018-9bd9-4070-8a55-f702a292ac52">8,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNS0xLTEtMS0w_47a2f2a1-a17c-44e4-bbb4-16f03a20ebe1">116,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNi0xLTEtMS0yMDM4Nw_157799f5-cd7f-4973-afc0-6c76d949cd7e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNy0xLTEtMS0w_634679b3-cf40-4f1b-bc4b-454d94bdba88">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfOC0xLTEtMS0w_7054e98f-a016-4d06-8af8-2a8f109f54b1">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfOS0xLTEtMS0w_adde30d0-dfe0-46d4-8aa8-1368a2f52a84">11,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTAtMS0xLTEtMA_a892def0-cb1d-44a1-8a5a-e55722168a5a">12,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTEtMS0xLTEtMA_4bce3801-3808-4797-9772-d10e948b6436">103,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTItMS0xLTEtMA_faedb5c4-8474-439e-b211-2716e707ac4d">277,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTMtMS0xLTEtMA_1c8b8ef8-886f-4097-b59d-01e9ba58815f">85,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic898e99881d641128dfcfc367e765db9_I20210701" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTQtMS0xLTEtMA_4657a8fe-0de0-4564-9f4d-e52a25ba017f">296,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. The Company is in process of identifying any additional intangible assets that would reduce the goodwill recognized. The fair values of certain assets and liabilities have changed from previous disclosure. We obtained additional information to estimate the fair value of the right-of-use lease asset and liability included within other assets and other liabilities. We also updated the fair value of intangible assets based on the methodologies described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the Centrum acquisition consists of trade names with a <ix:nonNumeric contextRef="i437f51b176c14704a8d187469131515e_D20210701-20210701" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI3MQ_90fafed6-f7dc-466e-ba4d-4d4a8501df1c">15-year</ix:nonNumeric> useful life, customer relationships with <ix:nonNumeric contextRef="i6a20a27e64cb4a15b3a57eea10b70269_D20210701-20210701" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI4MQ_33d45df1-ff1a-4bba-842a-7b7bfbf11b53">2</ix:nonNumeric>- to <ix:nonNumeric contextRef="id8c4c3b025d849189363e133e0b11e87_D20210701-20210701" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI5OQ_8e19ca58-aa6d-4494-a2d7-aaeeded230e8">15-year</ix:nonNumeric> useful lives, and a reacquired contract between Bright HealthCare and Centrum with a useful life of <ix:nonNumeric contextRef="ifacffe1d832f42b7bdf2a5102beadd9c_D20210701-20210701" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNTE4MA_fe52c3b5-6563-49ad-9259-242342592247">4.5</ix:nonNumeric> years. The value of the trade name was determined using the relief of royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements. The fair value of noncontrolling interest was determined using a market approach and included a discount to account for the lack of marketability of the noncontrolling interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Centrum would not have had a material impact on our revenue or net loss had it been included in the consolidated results of the Company for the nine months ended September 30, 2021 or the three and nine months ended September 30, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Central Health Plan&#160;Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On April&#160;1, 2021, we acquired all of the outstanding shares of Central Health Plan of California, Inc. (&#8220;CHP&#8221;) for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzE5NA_158859be-a2fd-42cc-ae35-2803c8d12fc4">276.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzIwMQ_306fa0a2-8ccc-46f4-abed-c6e75e1ea82f">79.8</ix:nonFraction> million in Series&#160;E preferred stock, for total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI2OQ_94469042-1fa4-4068-81b8-8956ffe2a903">271.7</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI4MA_94fb9007-ca65-4f93-985f-e8e52128c35b">84.1</ix:nonFraction> million of cash acquired. CHP is an insurance provider of Medicare Advantage (&#8220;MA&#8221;) HMO services. CHP is included in our Bright HealthCare reportable segment. Transaction costs </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $<ix:nonFraction unitRef="usd" contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzQ1NQ_c6bffa1c-e0b4-4108-a6c2-2cf8355f147e">0.2</ix:nonFraction> million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September&#160;30, 2021, out of $<ix:nonFraction unitRef="usd" contextRef="ic41d330372d542e286128a811bcd3408_D20200701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzYyNw_34cc9316-1d43-44f9-b239-22c28b190c21">1.4</ix:nonFraction> million of total transaction cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s we have incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the CHP acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for CHP is attributable to synergies from leveraging CHP&#8217;s clinical model and California consumer expertise to continue to expand our MA business in the California market. The goodwill is not deductible for tax purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="iba90d7d49cef456f94e171b5ca7f5ca5" continuedAt="i469c940dd73545c9a3beac82efc9c4f8"><ix:continuation id="i3d3719f7d2a44ff1bd2527d5cf47526f" continuedAt="ief76503821aa4d4dad62d0be001293fd"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the CHP acquisition&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMC0xLTEtMS0w_fbb0fa98-c7b8-4bad-af17-80beac92db63">16,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMS0xLTEtMS0w_5af65ec7-0451-4bd8-b9b1-861201074180">19,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMi0xLTEtMS0w_04ca1d24-3726-4954-b031-20b324b0a9b0">25,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMy0xLTEtMS0w_3f002b2a-c526-4339-9d5d-4e9f0c4d067d">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNC0xLTEtMS0w_e34fc267-5078-4002-8f7b-535949f2929d">102,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNS0xLTEtMS0w_8f039dc8-2a42-4c2c-82d3-60dd3b221470">163,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNi0xLTEtMS0w_f07e62dc-698d-4b75-bcdd-77d018ba8082">79,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNy0xLTEtMS0w_68da8408-cb49-44cc-b0eb-ee66c5860965">2,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfOC0xLTEtMS0w_e814d530-ff35-4b21-8015-12361847e5ca">17,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfOS0xLTEtMS0w_7befabbb-b107-4d4b-b244-0aad61bd51c1">28,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTAtMS0xLTEtMA_900dd331-f6b0-4542-867a-96293a588469">127,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTEtMS0xLTEtMA_4f6abbf2-e3e7-4fb5-b3b6-0bd348c684d2">35,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTItMS0xLTEtMA_f153de26-d9e0-47fa-8987-25810ede284c">236,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906967f82f324f7e83d7e378327d6632_I20210401" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTMtMS0xLTEtMA_f4ed06fc-9f76-4101-b1a3-c07e1faa05d7">271,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the CHP acquisition consists of customer relationships with a <ix:nonNumeric contextRef="i36358997c9554e299250c29d1edc21ce_D20210401-20210401" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTU_493f4843-420b-4bad-b839-f9f6596c4421">10-year</ix:nonNumeric> useful life, trade names with a <ix:nonNumeric contextRef="i6b87a30e39784613942ef3b1ffe359c9_D20210401-20210401" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTY_1e74c042-b254-4673-a94e-6ae2991cb48b">15-year</ix:nonNumeric> useful life and the provider network with a <ix:nonNumeric contextRef="ic68b8f77cc0c4feb964ea6ff561a07fc_D20210401-20210401" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDM_75df13d9-7462-4718-b345-d9efafa6f061">7-year</ix:nonNumeric> useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTc_1ff217de-85be-4cb9-bf82-4efecff2b6df" continuedAt="ia077b6d5261348309f04dd13882a87a6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if CHP had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and the three and nine months ended September&#160;30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC0xLTEtMS0w_13f4405d-3ba5-49ac-bf43-585d0070f621">502,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC0zLTEtMS0w_32ec7da6-c683-485e-961e-928078c81983">3,195,925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC01LTEtMS0w_220d89b4-b7e7-4979-ad7d-08634de302be">1,263,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS0xLTEtMS0w_2ad846db-07af-41c0-9274-54bfdec552de">49,157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS0zLTEtMS0w_e72531de-cda1-4318-8060-44e10fff3afe">358,935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS01LTEtMS0w_1db468c7-1e01-4465-83da-bfa977e02184">70,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">True Health New Mexico and Zipnosis Acquisitions:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On March&#160;31, 2021 we acquired all of the outstanding equity interests of True Health New Mexico, Inc. (&#8220;THNM&#8221;) for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjA3Nw_85ce01cb-5c9f-44dc-9e95-405b5cecf362">27.5</ix:nonFraction> million, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjEwNQ_b883c748-5a18-4954-b2b9-0e0b3c0f09f2">24.1</ix:nonFraction> million, for total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjE0NQ_c66fcbe0-2200-494c-8835-dc3c3a7e11f0">3.4</ix:nonFraction> million. THNM is a physician-led health insurance company offering policies available through the commercial market for individual on- and off-exchange and employer-sponsored health coverage. THNM is included in our Bright HealthCare reportable segment. In addition, on March&#160;31, 2021, we acquired Zipnosis, Inc. (&#8220;Zipnosis&#8221;), which is a telehealth platform that offers virtual care to health systems around the U.S., for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjU4OQ_2450b375-627f-40e8-b3e3-82923be27e39">73.0</ix:nonFraction> million, including $<ix:nonFraction unitRef="usd" contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjYwMw_d41fcf46-9f0a-411c-b3ca-8bf34defc574">55.1</ix:nonFraction> million in Series&#160;E preferred stock and adjusted for $<ix:nonFraction unitRef="usd" contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationTangibleNetEquityAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjE5OTAyMzI3NjY1Mw_3866a03c-63a2-41d7-b3f3-8052aefb4620">0.5</ix:nonFraction> million of tangible net equity adjustments. We acquired $<ix:nonFraction unitRef="usd" contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjY0Nw_80542684-5fcd-4bbc-bb16-1388993172a0">3.2</ix:nonFraction> million of cash as part of the Zipnosis acquisition, for net total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjczNQ_fa9aa802-c7f7-4049-ae17-15e4f0119f4a">69.8</ix:nonFraction> million. Zipnosis is included in our NeueHealth reportable segment. Transaction costs of $<ix:nonFraction unitRef="usd" contextRef="idd0973903cab4deeb08dfc70ef9dd0e8_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjgxOQ_8712f7f3-fef2-4165-8aa4-c5c6e5d5aaf4"><ix:nonFraction unitRef="usd" contextRef="i0e7e862b6f944cf1a7a7807ff6aa4abf_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjgxOQ_bff74120-beb6-4975-99aa-e8eda98faf2c">0.5</ix:nonFraction></ix:nonFraction> million incurred in connection with these acquisitions are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i469c940dd73545c9a3beac82efc9c4f8" continuedAt="ibf20f085ed93440487d44ee493ddc9d4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the THNM and Zipnosis acquisitions is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for THNM is attributable to synergies from leveraging THNM&#8217;s strong local clinical model of care and the ability to enter into a new state of strategic interest for future growth and expansion. The goodwill from the Zipnosis acquisition is attributable to benefits from the ability to enhance our proprietary technology platform, DocSquad, and Zipnosis&#8217; attractive virtual care capabilities to enhance Bright Health&#8217;s consumer and provider connectivity. The goodwill from the THNM and Zipnosis acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ief76503821aa4d4dad62d0be001293fd" continuedAt="ia81b82104cc040e286e0c8300e6acbb1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the THNM and Zipnosis acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THNM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zipnosis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMS0xLTEtMS0w_b631c8e6-d954-4dea-8491-21ca74033962">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMS0zLTEtMS0w_7de52ead-f015-4a52-8c8b-ab8c4b67450a">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMi0xLTEtMS0w_d9d09805-1a8e-46ac-ab3d-d74ff7661451">4,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMi0zLTEtMS0w_4456ad66-0f3e-4d2a-b080-f5b713cb385d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMy0xLTEtMS0w_06c75007-2b23-4394-8005-560bd05b62c4">8,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMy0zLTEtMS0w_a394e7ac-4509-470b-a981-1923cb269d2c">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNC0xLTEtMS0w_edd8687b-f597-4731-8de6-3e9fca80e594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNC0zLTEtMS0w_808861c6-3b84-4676-9966-dda973eab51b">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNS0xLTEtMS0w_d04852c2-5062-4e5b-8a15-9bc7024ff45d">7,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNS0zLTEtMS0w_c08add9c-39b8-46ba-be94-68782449111e">8,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNi0xLTEtMS0w_b7d90633-537f-4ae0-bf15-6fdedd7e3c5e">13,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNi0zLTEtMS0w_0fff8c28-e8e1-47b5-8c38-57b1a1071239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNy0xLTEtMS0w_d0d050b8-49d8-4041-a3f1-942bf2bb6caa">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNy0zLTEtMS0w_ff65fbdf-3843-415e-b83e-cb1486bb0943">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOC0xLTEtMS0w_d3da9ea3-a216-4ccf-9687-b823b1b3cc9a">35,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOC0zLTEtMS0w_d90576e5-80f8-4152-9207-7b09eec69eb1">11,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOS0xLTEtMS0w_e225e50f-7df8-41c1-a7bc-e06b5e1f1432">13,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOS0zLTEtMS0w_0e7f2fcf-a82f-491d-8ff8-82e04c20a5c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTAtMS0xLTEtMA_a2d3f781-276c-4505-bc1e-b755efcdc5eb">14,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTAtMy0xLTEtMA_4e683c89-7e85-4d07-91b4-2c0aa00fa1ca">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTEtMS0xLTEtMA_52fae9ef-de02-4bec-a8cb-09651d38f3c2">3,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTEtMy0xLTEtMA_0e6fd782-b810-4acc-bd5f-b1dadd7c82c9">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTItMS0xLTEtMA_318133cc-d26f-4070-aa6a-a9cd3567b5cc">2,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTItMy0xLTEtMA_1ac43013-a761-4b1f-8320-1bd60bbf5307">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTMtMS0xLTEtMA_7137a724-faef-4c84-a80f-7f8270836128">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTMtMy0xLTEtMA_28be34e3-24de-4f44-95f2-ecff19d96d1c">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTQtMS0xLTEtMA_be4e6fb4-b696-4630-bb39-ebefa576a2f3">36,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTQtMy0xLTEtMA_e7529ed0-ce15-4f25-88f8-f158dd7e6cf1">3,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTUtMS0xLTEtMA_ab08b527-1cab-449c-823c-5412ae193ff2">1,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTUtMy0xLTEtMA_a56594cf-28a2-4aae-9538-81126208b394">7,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTYtMS0xLTEtMA_40eb46c7-13b7-43e1-8bfe-f18cc8008352">4,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTYtMy0xLTEtMA_15015785-9865-4ddd-99b8-3898ee430c1e">62,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTctMS0xLTEtMA_62b76945-5596-4dcb-8316-3368417b5fab">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTctMy0xLTEtMA_3334633c-93e3-406a-ab0a-89d9336f99f7">69,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the THNM acquisition consists of customer relationships with <ix:nonNumeric contextRef="ia24617e1d9eb4076b54c7d7e70276339_D20210331-20210331" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfODM5Mw_f82849ea-bafa-440c-a119-b653fde3007f">10</ix:nonNumeric>-to <ix:nonNumeric contextRef="i7786594de6244ae6a5a8034a5ce9da7e_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDc_a39f9c93-f7b8-4a24-af93-4774f243ad79">14-year</ix:nonNumeric> useful lives, trade names with a <ix:nonNumeric contextRef="i9f0afeba703f4eecbfd79b0b0ac66c51_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTk_a3f8817a-04a7-4e57-9e0b-5ad68bf2d3e9">15-year</ix:nonNumeric> useful life and the provider network with a <ix:nonNumeric contextRef="if9c829a59ac144c2a6c38f54d48e9328_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDg_14ff9cec-72b1-40da-9d4c-ab3850aef60e">7-year</ix:nonNumeric> useful life. For the Zipnosis acquisition, our preliminary estimate of intangible assets consists of customer relationships with a <ix:nonNumeric contextRef="ib88d85b6051d4282a78fa46340280420_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTM_8eaad204-cc8f-4610-a9d8-d97d92cce7f3">15-year</ix:nonNumeric> useful life, trade names with a <ix:nonNumeric contextRef="id5d4bddbfcfe456aa8f422cf2a237786_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDU_e919231a-edaf-469d-850e-b4bd33df593e">5-year</ix:nonNumeric> useful life and developed technology with a <ix:nonNumeric contextRef="i3914765d423b4a628de3214723906cf7_D20210331-20210331" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMjA_fb7384f8-3262-479d-a00d-b2ff6d4a4cd5">7-year</ix:nonNumeric> useful life. For these acquisitions the value of the trade names and developed technology was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ibf20f085ed93440487d44ee493ddc9d4" continuedAt="i44dc550aea064947b2d62637e75fbd1d"><ix:continuation id="ia077b6d5261348309f04dd13882a87a6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if THNM and Zipnosis had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and three and nine months ended September&#160;30, 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d081fc23d14e75a64545999d205679_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC0xLTEtMS0w_b238d08c-7f3a-4353-be0e-62affac78cee">384,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC0zLTEtMS0w_5b08c176-63e8-4669-b85f-d6ca82d5f7dc">3,114,954</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b028119331454b86c135bc40e6d46f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC01LTEtMS0w_fe455ac4-5075-4718-8960-745c9d2454dd">943,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4d081fc23d14e75a64545999d205679_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS0xLTEtMS0w_104a4939-b3af-49a3-8b4b-3be9f7f6cf0f">57,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS0zLTEtMS0w_692eaa46-a5a4-432c-8c1c-f3f8c12c279b">372,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88b028119331454b86c135bc40e6d46f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS01LTEtMS0w_7f4dfd99-d573-474b-a147-cc1c632a6f49">85,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PMA Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December&#160;31, 2020, we acquired a <ix:nonFraction unitRef="number" contextRef="iabcc40d305134dce85d3cf3faaea6c2c_I20201231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfOTI4Mw_5c09806c-d59f-4d1b-aad4-ca76ea0ccf9a">62</ix:nonFraction>% controlling interest in Premier Medical Associates of Florida, LLC (&#8220;PMA&#8221;) in exchange for $<ix:nonFraction unitRef="usd" contextRef="i3f1e0f30291346f1bd501e797f389c07_D20201231-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfOTM3Nw_74c20ddc-9ef0-4d67-a027-2be2179ce356">74.2</ix:nonFraction> million. PMA provides care services to Medicare and Medicaid patients in Florida through a network of primary care providers and population health-focused specialists. The acquisition of PMA is expected to enhance our clinical capabilities to better serve enrollees as part of our Florida market expansion. The total purchase consideration for the PMA acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The purchase price allocation is preliminary and subject to change, including the valuation of property, equipment and capitalized software and intangible assets, among other items. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BND Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On April&#160;30, 2020, we acquired all of the outstanding shares of Universal Care, Inc. (d.b.a. Brand New Day) (&#8220;BND&#8221;). BND is a leader in providing healthcare services in California and serves Medicare eligible seniors and special needs populations through their extensive network of primary care providers and specialists. BND combines analytics and evidence-based clinical programs with aligned provider relationships to provide high quality, affordable care for complex and vulnerable populations. The total consideration included $<ix:nonFraction unitRef="usd" contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA4NTQ_3642fdbc-992c-40cc-85db-d8c62da0b98a">206.9</ix:nonFraction> million in cash and $<ix:nonFraction unitRef="usd" contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA4Njk_38b8fc10-376a-4c6b-b895-0c3d26d4bcda">80.0</ix:nonFraction> million in Bright Health Series&#160;D preferred stock. We have since applied indemnity escrow adjustments of $<ix:nonFraction unitRef="usd" contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationEscrowAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA5Njk_9cd8d5d4-4129-4afb-8097-cb3167961f95">44.0</ix:nonFraction> million to the acquisition price, bringing total consideration to $<ix:nonFraction unitRef="usd" contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEwMzA_55711c84-ebfa-4647-9347-0c0b9a8320e4">210.1</ix:nonFraction> million, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEwNTg_30c42261-b993-47aa-be7e-1ebdd6ddcd1e">32.8</ix:nonFraction> million. Transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i9ecbee92cb12427db0c1287be74eabff_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEyMDI_57a8140e-e042-46c6-85a3-5af23255a8c2">3.8</ix:nonFraction> million incurred in connection with the acquisition are included in operating costs in the Consolidated Statements of Income (Loss) for the year ended December&#160;31, 2020. If BND had been included in the consolidated results of the Company for the nine months ended September&#160;30, 2020, our pro&#160;forma revenue would have been $<ix:nonFraction unitRef="usd" contextRef="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTE0OTM_d2b89d85-531a-44b0-971c-87556a1265c7">1.0</ix:nonFraction> billion, and our pro forma net loss would have been $(<ix:nonFraction unitRef="usd" contextRef="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTE1NjI_26a67c4a-501f-4364-9d2d-c97a898d8807">100.9</ix:nonFraction>) million. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i44dc550aea064947b2d62637e75fbd1d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase consideration for the BND acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The goodwill is attributable to synergies from leveraging BND&#8217;s strong clinical model of care to drive growth in our MA business outside of California. The goodwill from the BND acquisition is not deductible for tax purposes. <ix:continuation id="ia81b82104cc040e286e0c8300e6acbb1" continuedAt="ifccce5631511496ba95f1597f7420539">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the BND acquisition, as well as measurement adjustments made in the nine&#160;months ended September&#160;30, 2021 to the amounts initially recorded in 2020&#160;</ix:continuation></span><ix:continuation id="ifccce5631511496ba95f1597f7420539" continuedAt="icad43725cf4d456eb13fba44edc3680b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:continuation></div><div style="margin-top:10pt"><ix:continuation id="icad43725cf4d456eb13fba44edc3680b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized as of <br/>Acquisition Date<br/>(as previously reported)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Measurement <br/>Period <br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized as of <br/>Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS0xLTEtMS0w_e20621ea-5ea6-42d2-b962-f64a34c43c69">74,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS0zLTEtMS0w_0530fd3b-4ede-41ca-a086-95d20bff9760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS01LTEtMS0w_d7d06615-c731-42df-ad32-7a895f78f2c1">74,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other currents assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi0xLTEtMS0w_d933cb2b-dd18-4648-96b1-fdd02096631e">30,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi0zLTEtMS0w_7f609542-5acf-4e25-8691-ca8918a11b87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi01LTEtMS0w_df4c5f1b-cfcd-4dd7-aad4-9ad0b4325447">30,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy0xLTEtMS0w_bba5041f-edee-4f0d-9a47-141d4ea57d29">4,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy0zLTEtMS0w_753c61c4-e24f-4a63-a078-159ea55b6b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy01LTEtMS0w_e753e30e-f688-41ae-aac5-dd7469ce4943">4,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC0xLTEtMS0w_1a8ea41e-8931-4e55-aea7-b197ea1c9fa4">72,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC0zLTEtMS0w_c41d77eb-b5fc-447a-a381-67912a2beede">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC01LTEtMS0w_655f986c-c554-4254-8437-dd10b987c7b3">74,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS0xLTEtMS0w_128c14f4-5f8a-420d-a125-5e17abb6220a">2,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS0zLTEtMS0w_dbc72335-ed29-4a42-aa70-20d3c0e9b060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS01LTEtMS0w_b6d04310-c57e-42b1-a6ef-20c02aecfe4d">2,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi0xLTEtMS0w_33b444a0-28ee-4da1-8e71-04e24fce3093">184,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi0zLTEtMS0w_c599e8c2-7227-4a9a-b492-405093328dd5">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi01LTEtMS0w_e72c046c-c6a2-48e9-838b-28e1aa382182">186,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy0xLTEtMS0w_3b50d57d-d62a-4b62-98ef-829a2b3e5d62">119,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy0zLTEtMS0w_e485db4f-a392-4371-96d9-17494b8992f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy01LTEtMS0w_d8572d42-4bc4-4cc1-abc1-1192268a701e">119,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC0xLTEtMS0w_c5be1a9a-f36f-4138-b1e3-fdbbd99001d9">51,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC0zLTEtMS0w_74a7f158-2e6f-4991-a48b-145dce0b9453">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC01LTEtMS0w_832b326c-17a0-49ac-907c-b1950d9c2146">51,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS0xLTEtMS0w_6b6d12ee-0d83-430d-87b4-d63b414eaa6a">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS0zLTEtMS0w_46d51f30-748b-4eac-b22d-64db6144cb60">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS01LTEtMS0w_12bb9982-6e28-459d-be86-804ca4d59331">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtMS0xLTEtMA_1d0a6851-a2c4-4ab2-94a5-73eee3aaaf55">172,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtMy0xLTEtMA_744744a5-a93e-4840-a77a-731e97ea2810">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtNS0xLTEtMA_936a8838-4435-4b68-b98b-d523b42bfba4">172,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtMS0xLTEtMA_04c338ac-6d27-4edc-973f-0af96b33895f">12,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtMy0xLTEtMA_de701ede-3889-475a-964f-efa189421954">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtNS0xLTEtMA_60dd9f7c-30d4-4581-93d4-586b321ba9f9">13,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItMS0xLTEtMA_fda4360e-7b7a-4bae-9ec4-61d9b62555bf">197,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItMy0xLTEtMA_73d126cc-8596-4e38-8698-de6ee204c9e0">1,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItNS0xLTEtMA_21c972a2-dc55-48b4-bd5e-1a97d7295e97">196,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtMS0xLTEtMA_2fd1f57b-ec4c-41b0-9376-56cb6c8566f7">210,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtMy0xLTEtMA_7acd0d02-d2d7-44ef-8d2c-b501592b5b83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtNS0xLTEtMA_7e69e759-18cf-4be6-b983-c61cabd19d41">210,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurement period adjustments above primarily resulted from completing valuations for certain intangible assets. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the acquisition date is immaterial to the consolidated financial statements. We recognized intangible assets related to the BND acquisition, which consist of $<ix:nonFraction unitRef="usd" contextRef="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI3NzI_e2ee9baa-702a-4829-9bbd-7e0df6dd24ba">25.6</ix:nonFraction> million for the BND trade name with an estimated useful life of <ix:nonNumeric contextRef="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI4MzE_9279d56b-c4e1-40f6-ac8a-5dc8231780f0">15</ix:nonNumeric> years, customer relationships valued at $<ix:nonFraction unitRef="usd" contextRef="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI4Njg_93fcbf9e-5f69-4438-afe7-8d8dfbfe4464">46.9</ix:nonFraction> million with a <ix:nonNumeric contextRef="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTQ_5839e013-aa89-482d-a3b4-0a8b0ce73e2a">12-year</ix:nonNumeric> useful life, and $<ix:nonFraction unitRef="usd" contextRef="i02d119c5e70e49299a5a771390922e80_D20200430-20200430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI5MDM_732f9ec9-aab4-47f2-9834-f35de862a4cb">2.0</ix:nonFraction> million of other intangibles related to the provider network with a <ix:nonNumeric contextRef="i02d119c5e70e49299a5a771390922e80_D20200430-20200430" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDQ_44b2b1ac-dd88-4dce-961f-ad34ca9c6d6c">10-year</ix:nonNumeric> useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_43"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNg_81dc440a-d7b5-47b3-a955-f9414df5618a" continuedAt="i23c78b66df6c47499df92189eff256fc" escape="true">INVESTMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i23c78b66df6c47499df92189eff256fc" continuedAt="ide3ac56bde62471495c69c15cbe2e58b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fixed Maturity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale securities are reported at fair value as of September&#160;30, 2021 and December&#160;31, 2020. Held-to-maturity securities are reported at amortized cost as of September&#160;30, 2021 and December&#160;31, 2020. <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:HeldToMaturitySecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNw_15c455d6-b94b-4b2d-b4af-2094e975a224" continuedAt="id0143d61f3d24192a400e36824c6acf5" escape="true"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNw_da41689e-1e28-42d4-8d48-c311338ea27c" continuedAt="i7f7ee36279ec46dfba9799f02eb353b7" escape="true">The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;</ix:nonNumeric></ix:nonNumeric></span><ix:continuation id="id0143d61f3d24192a400e36824c6acf5" continuedAt="ie2b7b5f02e6845ceb8da33d6b2153563"><ix:continuation id="i7f7ee36279ec46dfba9799f02eb353b7" continuedAt="iea6ed2f38a204d36b6de90d5999aa33e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:continuation></ix:continuation></div><ix:continuation id="ie2b7b5f02e6845ceb8da33d6b2153563"><ix:continuation id="iea6ed2f38a204d36b6de90d5999aa33e"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi0xLTEtMS0w_fd94cc42-3b92-4cb0-90c9-c05ed9b33890">271,984</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi0zLTEtMS0w_6d65ad89-609f-45d9-94b6-36906314dd05">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi01LTEtMS0w_22c69237-5964-4f0a-8dcd-c54a814e358a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi03LTEtMS0w_9aa05b49-b316-4aae-9dce-132eebbb82ae">271,984</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC0xLTEtMS0w_4c54999f-7c6d-407a-9aa4-f69550d60d8f">501,343</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC0zLTEtMS0w_38e9150f-bc79-477a-a06a-712c75910cd5">283</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC01LTEtMS0w_17525d79-072d-494e-b32e-5e0e294c5fbd">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC03LTEtMS0w_ff0a8554-4c37-4e09-97e2-56c8ca2db8d5">501,250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS0xLTEtMS0w_3d7d06f7-5ae5-4f03-b8d5-7a2655ba97d2">290,917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS0zLTEtMS0w_a812565a-453f-4105-a0d5-5f860522e4b4">384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS01LTEtMS0w_bac4081a-ac66-42f0-8915-646d5bce9ab4">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS03LTEtMS0w_100cfa56-d4bc-4ee2-b1dc-2a0313dbe9c1">291,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi0xLTEtMS0w_5abbb522-344a-4d49-a8c4-5c7d60be6b17">15,437</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi0zLTEtMS0w_f0742d68-2c3c-406f-af98-d22ea7364a06">51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi01LTEtMS0w_9d71f5a6-9db0-4dca-855b-137fe97ef64f">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi03LTEtMS0w_54d8358a-9f66-4968-b050-94acc71413ac">15,485</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876397b0696242c1a07ad1299e40876b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy0xLTEtMS0w_29d9d29e-2ad1-433c-b1e6-429bb48caf63">5,160</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876397b0696242c1a07ad1299e40876b_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy0zLTEtMS0w_5f2cc3ca-444e-4004-bfba-06be0d418b55">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876397b0696242c1a07ad1299e40876b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy01LTEtMS0w_e2ea0df2-8580-4aba-9257-d728b86d746e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876397b0696242c1a07ad1299e40876b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy03LTEtMS0w_b524e805-1185-4ff6-9524-03c3b50a0045">5,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC0xLTEtMS0w_20f168f2-58c5-4cf7-9120-d10b401b4b15">26,809</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC0zLTEtMS0w_01314aff-8c34-469b-a696-b967443334e9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC01LTEtMS0w_c8f12ebe-6e67-43ee-a295-aa0b8fffc3af">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC03LTEtMS0w_96889d0a-9cb5-4cc1-b6f2-1f2d4490b442">26,809</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS0xLTEtMS0w_bdc482a0-fe24-4799-a090-ce4ab1cfa5a9">2,533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS0zLTEtMS0w_2800df66-588a-44b6-9380-8938a4a364c4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS01LTEtMS0w_6a1cbf29-d22e-4775-97cf-2b2b19779c7f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS03LTEtMS0w_41b7c8ac-dcbf-4c5e-8bf5-08d565d8dcf8">2,533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtMS0xLTEtMA_eb43b856-7950-4928-87bf-76a651251be8">12,876</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtMy0xLTEtMA_a513a1e8-2bc2-4c16-bdf6-14fc07f1f953">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtNS0xLTEtMA_b1508cdf-cb10-4e9c-b6b7-4b436ec232ce">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtNy0xLTEtMA_1f6be2a7-7cf8-4f7e-9198-24275e9566ea">12,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtMS0xLTEtMA_51a14961-d131-4228-8434-f428e26d9976">855,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtMy0xLTEtMA_cc0d9546-3242-49bc-88fa-9430635d44fd">724</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtNS0xLTEtMA_037149e7-1759-4289-ad64-0ab030c0eeb7">493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtNy0xLTEtMA_4f6d0aaa-96b4-448b-a8b1-6810514c7b59">855,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtMS0xLTEtMA_98d79643-1a0d-4ec1-aebc-78ca3f992dde">7,745</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtMy0xLTEtMA_54b9ddb7-d182-452b-848b-a98670aeaee1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtNS0xLTEtMA_f6fd52d7-8f7b-4560-9f34-7665e3655bd7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtNy0xLTEtMA_19293abf-7a29-4d4a-8f28-cdbb165366f6">7,745</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtMS0xLTEtMA_8a6f56e7-590a-4420-b9e5-ee7f84bffc8c">1,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtMy0xLTEtMA_654e5309-316b-4660-a245-b9633452e5da">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtNS0xLTEtMA_f4041325-4c1f-46e2-8959-c5e684885f0f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtNy0xLTEtMA_f18030cd-a526-4d48-836b-0db186acb45e">1,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtMS0xLTEtMA_936d03ba-14be-4304-8d21-e5cc858f447a">9,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtMy0xLTEtMA_0ec06250-48e7-407f-b6f1-4adcfc5dda07">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtNS0xLTEtMA_ad5a3fb1-e10d-4d91-97ec-6e535a40a53f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtNy0xLTEtMA_4039cb90-683e-4363-81ae-fb1831620674">9,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtMS0xLTEtMA_ead5dc37-1a88-49dd-b606-dda8d9758e84">1,136,251</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtMy0xLTEtMA_cf84bbeb-1269-4fd8-9312-07bfe3c65527">725</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtNS0xLTEtMA_fabf08fb-400f-4023-9163-b1311b122e6b">494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtNy0xLTEtMA_bbf6fa41-75ee-4b4b-9c1e-03390b2250f1">1,136,482</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi0xLTEtMS0w_f5e485df-5146-4c4d-b549-a172016de0aa">153,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:fixed-zero" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi0zLTEtMS0w_a1038cb1-e20d-4f56-a288-fa65c6b35b71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi01LTEtMS0w_6fbb0ee0-b53e-430a-938f-2f73956c5f3c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi03LTEtMS0w_6eb612b7-0526-405b-a256-c14cc7768b2d">153,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC0xLTEtMS0w_3f4b3953-6b86-4462-ad42-46d7810d43e1">291,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC0zLTEtMS0w_c50eaad1-a6dd-48da-8bc8-082259195412">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC01LTEtMS0w_26db30d0-3540-404e-b029-3eeb27fd8e12">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC03LTEtMS0w_a365add9-fa90-420f-b164-ae1aeffa48fe">293,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS0xLTEtMS0w_54c2aed5-3050-438e-97a5-b5b526b7e3cf">280,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS0zLTEtMS0w_14056ec8-b4aa-4b68-af3b-7da4b1a3d819">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS01LTEtMS0w_d26926e8-6294-41ba-9376-2a0b2083d64e">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS03LTEtMS0w_0221c200-1c56-4d09-a2f6-817756a4b4da">281,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi0xLTEtMS0w_40a5f349-ffd1-4b24-9c2e-665c10f462f3">18,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi0zLTEtMS0w_2b1f84c9-edff-4d29-b4ef-514a74a1f5b4">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi01LTEtMS0w_ffa2e059-3916-45ac-9456-c57bde3a76c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi03LTEtMS0w_661a96a5-9953-4a3e-926f-d4c1dc1e581f">18,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy0xLTEtMS0w_680e3652-a366-4b55-be93-0c924682e1a8">14,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy0zLTEtMS0w_2e2e7366-a391-49c2-ae0e-35bf389e0814">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy01LTEtMS0w_083f32d2-dc62-493b-8ac9-271d231e5be3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy03LTEtMS0w_630a37c9-2579-4d8c-8745-0494d7cbc95c">14,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC0xLTEtMS0w_b22a8726-99d6-4bca-ae98-168dc4e70807">53,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC0zLTEtMS0w_ae0ea7e9-a4a9-472a-8182-4355eb0f6cae">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC01LTEtMS0w_d626480a-7e22-4042-a369-b4e5c113615c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC03LTEtMS0w_a04bdec0-5c0d-468e-a8ca-3a3373270f25">53,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93edb636370844a0929f4e4375a579b3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS0xLTEtMS0w_2a308c81-6c4c-4126-bb22-0220946de12e">5,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93edb636370844a0929f4e4375a579b3_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS0zLTEtMS0w_132dbf88-24b3-4d28-b74d-25c6d5bcbd55">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93edb636370844a0929f4e4375a579b3_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS01LTEtMS0w_e9004648-8ab5-483d-9425-a2672e78759c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93edb636370844a0929f4e4375a579b3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS03LTEtMS0w_77805d9e-3559-4870-9836-fa4624025a20">5,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtMS0xLTEtMA_5989a651-ff93-4128-a30b-156c7c05ca1f">664,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtMy0xLTEtMA_828e7405-c3cd-4c64-9297-7d7406f3b318">2,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtNS0xLTEtMA_02f195e3-1a01-423a-8c46-fdf5b72fa514">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtNy0xLTEtMA_634cdbb3-c576-4243-ad6c-35d8994bc2c7">667,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItMS0xLTEtMA_f79b1f6d-98d2-4b02-901b-1458f42cbadf">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItMy0xLTEtMA_a0982f12-934f-4edb-98df-cf6206345d1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItNS0xLTEtMA_b146488a-9c0b-415a-876f-8bc784450f3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItNy0xLTEtMA_e7820b09-e929-4ef6-a2e2-53be1e70b9e6">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtMS0xLTEtMA_d02a9a16-16d3-4ceb-870a-8d36a96ddb65">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtMy0xLTEtMA_18e99bdd-085f-4a02-9401-dc4071e12f27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtNS0xLTEtMA_a904556a-7bde-4010-ab69-a0688613232b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtNy0xLTEtMA_55ec74c4-def0-4dbd-947e-fdc77d1358b7">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtMS0xLTEtMA_66de834e-1a7d-4f3a-ba69-2d83533d8279">7,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtMy0xLTEtMA_6a6ae2b4-406a-4b26-b5c6-14113d4d5d6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtNS0xLTEtMA_443b71b7-fda3-486f-9347-413a3c20b353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtNy0xLTEtMA_41d11704-fa5b-4495-b628-c294859ef9a8">7,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtMS0xLTEtMA_ada42ca6-f317-4caa-9cf7-abde8fea317e">826,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtMy0xLTEtMA_a1377c5b-28ce-408f-b4dc-ae8c2eaea0af">2,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtNS0xLTEtMA_ee01023a-9e7c-414e-a407-82737b65da8c">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtNy0xLTEtMA_ebf1d976-00cb-4d31-b2b4-0942be929fd2">828,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ide3ac56bde62471495c69c15cbe2e58b" continuedAt="i8d5759dd8b9744e698617e1731df3e30"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNA_7b72fca1-14a9-481c-be19-712ae6bc4d77" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale investments, including those that are cash equivalents, with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position at September&#160;30, 2021 and December&#160;31, 2020 were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xLTEtMS0yMTU5Mw_fcfbf7ca-55fe-4cc5-9755-2fe7059186d8">9,643</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0zLTEtMS0yMTU5Mw_952dba22-4591-4f08-8095-9969e4e22644">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy01LTEtMS0yMTU5Mw_3a900b0f-ccb8-482f-a72e-c1965b48a293">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy03LTEtMS0yMTU5Mw_29d34333-d6f8-4d33-b6b9-a8b9da71e1ee">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy05LTEtMS0yMTU5Mw_f63a0c56-66db-4124-8c73-5b52061a5068">9,643</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xMS0xLTEtMjE1OTM_9cd74148-eb01-449f-90e8-74faa5959846">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xLTEtMS0w_291ea341-b327-481d-a605-f11b65252ec9">347,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0zLTEtMS0w_99204cad-2079-417c-810e-e5f56333d1f2">376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy01LTEtMS0w_5c6abad0-ef96-437b-b8b9-3c2ec87ef4c5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy03LTEtMS0w_402a8e76-5484-410d-ae13-939806380023">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy05LTEtMS0w_319d33ef-77bc-4fd5-8c64-460367fdc2ab">347,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xMS0xLTEtMA_c7a2f3b3-bad8-4f45-96e2-5ed53f5240c8">376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0xLTEtMS0w_9d56f03a-fad6-4250-9e48-ca4f47e8f17d">137,456</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0zLTEtMS0w_47ebc460-7c03-4c0f-999b-933b2cf7d3ed">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC01LTEtMS0w_56137da1-1f5a-4680-bc57-ade286a39903">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC03LTEtMS0w_1a566d69-c801-4101-bf97-88b975108471">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC05LTEtMS0w_106a69b1-4464-4527-ba62-e1c2a6a337e1">137,456</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0xMS0xLTEtMA_27885750-a4c8-45e3-a419-e7955f83ae34">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0xLTEtMS0w_ceb68820-4069-43cf-aa1e-9652e64225a1">2,812</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0zLTEtMS0w_c90a5b11-4a8b-4ca2-a096-b8e82ffb4556">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS01LTEtMS0w_6bd48e85-df6c-488f-81b6-b0aa80bfa16b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS03LTEtMS0w_3efcd72c-52d6-4a96-ab72-8ab5cae4cb31">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS05LTEtMS0w_2d6ecf7e-5a68-4c0b-80fa-81f139bd05da">2,812</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0xMS0xLTEtMA_45d87775-996b-4e86-8f47-ea5c66e9b92e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0xLTEtMS0xNzkzMw_b393eb9e-d666-449f-85bf-424535b0497b">10,950</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0zLTEtMS0xNzkzMw_c9904620-9bb7-46bf-83c6-2bc40f00119f">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy01LTEtMS0xNzkzMw_95119808-c419-4e8d-9101-6c2ed3e79f7a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy03LTEtMS0xNzkzMw_a0034a67-cf55-4a70-8d60-9efca2b0f120">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy05LTEtMS0xNzkzMw_b2a868f1-65e0-4dac-9253-19777c2f44db">10,950</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60813677512b434bacaebec6e08f0443_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0xMS0xLTEtMTc5MzM_a0406218-f598-4396-a588-a72e30f50aaf">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0xLTEtMS0w_43e49949-9ccb-48d2-9233-3c3fe1bfbfbe">508,596</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0zLTEtMS0w_0f650a1c-df27-4da4-8389-462d011705bc">494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi01LTEtMS0w_974cbb05-f812-46b4-816e-0246db6ed608">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi03LTEtMS0w_5e308840-c498-46de-a405-d56e359f7d0f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi05LTEtMS0w_8d06d8ec-daf8-476a-8476-b94f98bc772e">508,596</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0xMS0xLTEtMA_bbe90bec-6278-477e-b2ed-64097ee9f5ff">494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0xLTEtMS0w_df9afeea-91c0-44a6-ae4a-bf8cd7099359">25,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0zLTEtMS0w_0be53ac2-b523-4ace-84d7-c1b8a82f323a">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy01LTEtMS0w_5a2a8b95-a8a5-4085-a4a5-0e446ad7f9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy03LTEtMS0w_383d4d15-f466-4d49-b188-264f162021ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy05LTEtMS0w_6ac50732-712e-4425-a64e-b11070e66b8d">25,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0xMS0xLTEtMA_9a9cd305-5ddb-41c7-aa2a-e819e3d2113c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0xLTEtMS0w_c1cca3cf-3550-4504-9fdb-4f1044148c93">12,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0zLTEtMS0w_350b4833-10a6-4208-bde6-36f83f07b2eb">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC01LTEtMS0w_4c6a8d09-2c28-42c0-8738-78d0bd5c674d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC03LTEtMS0w_ffa9888c-f4fe-4cfd-baa5-91996465fe2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC05LTEtMS0w_09a625a6-f3c9-4c44-b415-5c1bb5c047dc">12,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0xMS0xLTEtMA_09eee942-e887-4b86-8fc5-8c4d4532ac38">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0xLTEtMS0w_7e90d08e-4087-4eff-8402-2e6e2eca2d93">121,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0zLTEtMS0w_5fcccefd-9ba9-4955-bd4d-45c9f4b735aa">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS01LTEtMS0w_d0944aef-0ed7-4804-816e-242efd7c25f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS03LTEtMS0w_ba505db6-0505-46a3-a442-dfd603318113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS05LTEtMS0w_b6512414-907b-450e-8133-05406eee352b">121,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0xMS0xLTEtMA_e23f8040-5869-4835-9d87-b5c0e6dd4787">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0xLTEtMS0w_ad898831-1a1e-48b6-a73b-0cae84b2dbee">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0zLTEtMS0w_4a69b30a-9369-4ecd-80b1-34fcbce2cc39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi01LTEtMS0w_363916a0-e7ca-444b-bcea-98ac9dad0314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi03LTEtMS0w_1b47a112-ce49-4459-a4bb-b6f1d0bd9680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi05LTEtMS0w_0a3199c2-c458-492d-bd45-1fa399e5f84b">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0xMS0xLTEtMA_4577409e-306d-4a70-a1ac-7620265bfdab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0xLTEtMS0w_cea27401-1814-4ed6-a7c2-98de597d5ec6">14,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0zLTEtMS0w_44bb9b8d-7758-4000-9ba6-7b6c494808e6">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy01LTEtMS0w_f40d3656-f204-44e2-9852-498de62b779f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy03LTEtMS0w_f42a7674-db36-46b7-aa6e-6099fb439d43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy05LTEtMS0w_f13bc3a1-9fee-4f77-ab05-bde10bccb7f6">14,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0xMS0xLTEtMA_f18bd9fe-10e9-49eb-9d6a-2d0eed492f9f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0xLTEtMS0w_8a35b84f-3a29-4768-88af-2dc0a359f555">173,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0zLTEtMS0w_26543038-8df6-4830-8c64-5a09c94dfe9e">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC01LTEtMS0w_08889603-985f-40c3-9b03-640328cb7452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC03LTEtMS0w_9742cc41-8e47-4430-9afc-0b41b850915e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC05LTEtMS0w_ec4f43c9-cb4a-42de-b59f-9d0e858b2e6e">173,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0xMS0xLTEtMA_b6a42ca3-ab27-4aba-880d-cdc4ab38422f">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="investment" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" name="bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjA1_01206786-83cd-40d1-86eb-dedd1b0aa5d7">744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> investment positions out of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="investment" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjM2_3c1fbbb2-90f7-4768-95f0-87ca869547b3">1,859</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that were in an unrealized loss position. As of December&#160;31, 2020, we had <ix:nonFraction unitRef="investment" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" name="bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjk4_404fb9dc-2f2a-44ad-9502-348c9b9cacee">117</ix:nonFraction> investment positions out of <ix:nonFraction unitRef="investment" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNzI5_9a7dc90f-72b9-4e32-9598-2584a48f70bf">1,917</ix:nonFraction> that were in an unrealized loss position. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. At each reporting period, we evaluate securities for impairment when the fair value of the investment is less than its amortized cost. We evaluated the underlying credit quality and credit ratings of the issuers, noting no significant deterioration since purchase. As of September&#160;30, 2021, we did not have the intent to sell any of the securities in an unrealized loss position. Therefore, we believe these losses to be temporary.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxMw_25eafef3-7bea-4c5a-a748-c9151db19e0b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the maturity of available-for-sale securities, by contractual maturity, reflected at amortized cost and fair value were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMS0xLTEtMS0w_be046eba-ca11-4f01-8a08-48b869db9e66">203,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMS0zLTEtMS0w_7884897c-8323-45cd-a5a2-49320f5e608f">203,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMi0xLTEtMS0w_c23789df-332b-4176-943a-9e32a54f2c36">651,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMi0zLTEtMS0w_8d79625f-cc46-4ef7-b745-1ac93ed62595">651,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMy0xLTEtMS0w_a2f20c1b-aefc-4c96-b386-9a62c07f5164">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMy0zLTEtMS0w_7c71bf54-de57-49bf-8c52-eb27e1511825">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 10 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNC0xLTEtMS0w_37807d1e-d890-452a-8978-b0d08766d596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNC0zLTEtMS0w_1546126f-112e-4c6d-bcf9-ad46e2a906ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNS0xLTEtMS0w_c8acb43f-772e-45d6-b1c0-45f8ad64139a">855,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNS0zLTEtMS0w_59872048-8bbd-4768-b380-7425c1e76cf0">855,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i8d5759dd8b9744e698617e1731df3e30" continuedAt="i80f8e3a66fe345f5a551bafe3e4a0172"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021 and 2020, was $<ix:nonFraction unitRef="usd" contextRef="idcc35cb44c3a44e4988de9c09f1145a2_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTc2Mg_2320e388-55b8-4e40-a24e-2f52f72c44ab">3.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5ae3dff21f514bee8dcfb24fbbee065c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTc3MA_0362d44c-4238-45c3-95a9-f8ec42ad9a00">7.1</ix:nonFraction> million, respectively, related to our fixed maturity securities. Realized gains (losses) from our fixed maturity securities of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTg5Mg_116f5c3a-2218-4a1b-b65e-099dc39b8759">0.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTg5OQ_7726977d-0368-4823-b9af-8a83eb9177ca">0.1</ix:nonFraction> million are included within total investment income, and reclassified out of accumulated other comprehensive income, for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Securities</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i80f8e3a66fe345f5a551bafe3e4a0172">On April 1, 2021 we completed the purchase of <ix:nonFraction unitRef="shares" contextRef="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="bhg:EquitySecuritiesFVNISharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjEyNg_21c1e116-b041-4feb-ad82-c4e5f36d56b4">1.6</ix:nonFraction> million shares of equity securities for aggregate cash consideration of $<ix:nonFraction unitRef="usd" contextRef="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjE5Mw_bf14c2ad-cfa5-4ed3-8068-20ffc3b6022a">40.1</ix:nonFraction> million. As of September&#160;30, 2021, the equity securities had a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjI1Mw_e7546457-2c7d-4a61-9adb-760aefbd2ae4">149.1</ix:nonFraction> million, which is included in short-term investments in the Condensed Consolidated Balance Sheet. We recognized an unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjM4Mg_ffc20a0e-4df7-4921-a49b-84c0b162502a">46.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjM4OQ_af015972-653e-4d08-ad00-3a92495bf029">109.0</ix:nonFraction> million in investment income in the Condensed Consolidated Statements of Income (Loss) for the three and nine&#160;months ended September&#160;30, 2021, respectively.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc1OA_d1faffa5-a467-48e6-aef7-a5add1639787" continuedAt="id0a73c28a2dc4fd29bb0f57e571021da" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id0a73c28a2dc4fd29bb0f57e571021da" continuedAt="i9f9fb58afc7d45c49da43a32d90d1ab1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of fair value measurement:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices for similar assets or liabilities in active markets or quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value in the condensed consolidated financial statements or have fair values disclosed in the notes to the condensed consolidated financial statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, except for the equity securiti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es, see note 5 of notes to the audited consolidated financial statements included in our Prospectus filed with the SEC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the equity securities was determined based on the quoted market price of the underlying securities in an active market.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i9f9fb58afc7d45c49da43a32d90d1ab1" continuedAt="i4dda90e3642347b3a43496ab71839566"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc1OQ_07395cc7-4412-4430-8d4f-47283b3bcd9e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for assets measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy0xLTEtMS0w_43716266-c572-49db-9551-9027fb95dd77">209,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy0zLTEtMS0w_d697b242-edf0-4795-aacf-84c53391124a">35,507</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy01LTEtMS0w_806694d2-6d23-4bb1-8333-51deca36880a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy03LTEtMS0w_e101b8e0-74c9-4f49-bf83-56c86b01c3f7">245,234</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ea779896ada4159a7f60019e9927bf8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS0xLTEtMS0w_09d4c502-ae13-4ce4-bf96-0605f4956fb3">358,202</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5121369128bf46f1b28d027064b97268_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS0zLTEtMS0w_fc5e3e2d-4f9d-4170-b5a1-144ba7bf8509">143,048</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c3c88b8b464936985a142c13ba59a1_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS01LTEtMS0w_d7a31b01-d915-4bc7-873c-58a2e8b4134b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063bcb9e20df488faba4c86ff6b2d2d7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS03LTEtMS0w_a4dadce3-1476-49bc-8ace-b106dd5fb246">501,250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6321a1eae6741258bc2ebec56ccdd2b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi0xLTEtMS0w_757e871d-0e69-4f5d-9094-91ea82058d5b">2,234</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ba12124710a41d09f79459538d7f774_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi0zLTEtMS0w_1428af79-9505-49bd-b732-2942cef4da64">288,961</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112615aabc29458c80feb79df5325cfe_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi01LTEtMS0w_95b31d77-436a-46ca-94ae-4f213b12f616">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a7e8b71f6b44ef93ee44e051b98fa8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi03LTEtMS0w_63c3b525-f849-4e9a-9406-1a0d8a4a26d5">291,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff31328bf070411aa7d0bb0ec25452ee_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy0xLTEtMS0w_defcbb00-53c1-4d89-b59b-51014d6f5282">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42079981bc19457ea93081a70515a67d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy0zLTEtMS0w_c281a420-f3a9-415c-9d9d-72d0f4261cb3">15,485</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98131e51113d4be280910ddde875e482_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy01LTEtMS0w_661c97ad-b654-4367-bd2a-a17fbd95e434">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4d5d4769ec49aaba6b4e6a10a70938_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy03LTEtMS0w_2dc8ca50-2a24-4d77-b2c5-d3bf5861487b">15,485</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c32f01079e74ada8aa45c870e22b903_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC0xLTEtMS0w_7dd6be67-f29a-4734-84ae-19fda58f7f38">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b929d612cbd4848b4301f794170eb0f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC0zLTEtMS0w_d18eb323-cbbf-4602-915d-9e9612cb8823">5,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8e5514c7c84b5f9a6699e445d92f2f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC01LTEtMS0w_8ea79438-361d-41bf-a2f7-392d76aa0d91">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698a8a675a8841d99a8e4be9969c21ca_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC03LTEtMS0w_bbf7c353-f094-456e-85ca-b9b1ccd69108">5,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1a14e6cf3d416f975eed2bfba93422_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS0xLTEtMS0w_e270f99e-dae7-4513-8990-6333a85c0a1e">18,738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8342f62d3a84412587f448f9c68dd462_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS0zLTEtMS0w_75f5c014-b629-461e-9b11-8e41c3ff6b96">8,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df04854b56f4e59a9948d081a560768_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS01LTEtMS0w_325cb66e-dc2f-4bef-828e-ce8b6d2a1013">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9068fd2eb5c468fa8aebe290cd9eda3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS03LTEtMS0w_8a1966d6-82ab-4712-9e5c-fbcb39d0360f">26,809</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673e75bed3d843009499b44448ad15e0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtMS0xLTEtMA_cd4ef7f6-0a8d-401d-9170-29a798cc5308">2,533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8d872078b641849ec57b4e0288f932_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtMy0xLTEtMA_21e38c4e-3acf-4150-8cca-317182b1ce83">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if899da5bf1bd41409a4b68a13470cbf1_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtNS0xLTEtMA_e542f316-7ca2-4044-8a06-78fe96a9b057">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieddace9853a649deacee98a11a13ee5b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtNy0xLTEtMA_dec44fa9-481f-4f59-abc6-3decde1efef8">2,533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ff1faea03c41699fda03aeeb1f558b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtMS0xLTEtMA_0e1d6db9-37ef-41b8-9e03-7fab5e331f8b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5492bc70b174482b6c39dce60f8004f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtMy0xLTEtMA_37e745b1-e3cf-4b22-9f8b-219eb8bf35a6">12,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063b0bab67784b50bd90eab8e6ad0e9e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtNS0xLTEtMA_19cd3180-176a-4d65-b185-caf1ccd535a3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6a5781117748b8957106e1ea54500b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtNy0xLTEtMA_f2a8341f-9e6b-4a8c-80d4-f1df7d30ff92">12,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available for sale:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItMS0xLTEtMA_ecd13da5-9e23-4a6f-a7e9-9c7b669cde1a">381,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItMy0xLTEtMA_f974e6d6-2e9a-4412-afe6-fc261feb18d4">473,599</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItNS0xLTEtMA_097654cf-609a-4bfd-beb2-08d2f7c96e92">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItNy0xLTEtMA_40bacac0-f102-4e6c-8568-04eb3fa832da">855,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtMS0xLTEtMA_2508e96e-a79e-4619-8e88-55f894c46d64">149,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtMy0xLTEtMA_800d99a4-2356-4d4d-a85b-9cdadc054f89">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtNS0xLTEtMA_1d15a258-525e-44d6-920d-6df07e8dc3ea">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtNy0xLTEtMA_bf0d1fc8-5c3e-4548-acb4-1a92567bbc31">149,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtMS0xLTEtMA_44f5384e-ae00-4ba9-8b65-be476d6a872f">740,578</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtMy0xLTEtMA_fabc017d-a447-4b22-9f72-559cc00d4f71">509,106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtNS0xLTEtMA_01abf0a1-6d3c-455f-8f34-99619bb172bd">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtNy0xLTEtMA_776b3829-2953-4d62-91ef-d6fca2d65f87">1,249,684</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtMS0xLTEtMA_f73bde14-0272-436c-96bd-94192d6a38db">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtMy0xLTEtMA_3aa37110-c6eb-4e2b-b88a-5a4fc82dec13">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtNS0xLTEtMA_fee8a1a8-e421-4668-a148-7aae5baf5d33">7,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtNy0xLTEtMA_b774a2c1-f603-4a3f-87cc-442c58ae02a6">7,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy0xLTEtMS0w_caebb803-3af3-4471-af96-f8960907aea8">149,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy0zLTEtMS0w_f90b7609-82ff-46e6-9e8b-d5230f7a2f1a">4,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy01LTEtMS0w_c8695c80-5539-4abf-9b7d-bfef5f20cf13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8214960907014dcdb3065f18a818a891_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy03LTEtMS0w_0ffa3047-a30c-476b-a9d9-4142d0b4c927">153,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb1d5009fb76492bba7eb7f3ef9c1bbd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS0xLTEtMS0w_87e4b551-54fa-4c4f-b4b6-623a23468c3c">197,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8868207423f4dc1886e5e83a2c9ffec_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS0zLTEtMS0w_780e4156-aa6e-4819-af7e-4270f1496391">95,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d031fe827d4ae9bb2cf648e3ce20cd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS01LTEtMS0w_83d4dd90-0cd6-4d19-b76a-803502eb7e41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519d21ea4f4f4131b47e685212e69fed_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS03LTEtMS0w_1b6f9b19-8180-4aa3-8a65-0c99bad8732f">293,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b475d1c4f864fecb3191e434e9a05c6_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi0xLTEtMS0w_f133b50e-a62e-43a0-804f-11a346fa86ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41095a8fe9f4f45b4e41448fef3fe52_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi0zLTEtMS0w_ea49f920-06ac-426d-9b01-1bae53d4e2cf">281,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa2422a2e3c425fbdb4444361bec7c7_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi01LTEtMS0w_037a5441-a724-4766-b261-84229ab5c701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353f273f34ba4a6e86802cad11918d1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi03LTEtMS0w_4099e476-19fc-444b-a36d-a7bf3eedd2b7">281,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42019d07c89a4eaaa3ce1cbaa7ce9040_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy0xLTEtMS0w_48df0122-7881-4eed-9769-4ca20f43de1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e872c51cbe14f019f7cc9f67921a34b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy0zLTEtMS0w_4d3c974b-fa31-4dc2-83c0-6efb09e7a6b7">18,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if69d42f4ef924ebf801a45ca4af8b600_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy01LTEtMS0w_e10d33bd-bcf7-448f-b2b1-8ba0ef66790f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8bd31902240473494b2cbd44c479592_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy03LTEtMS0w_f15cbbb0-7782-4bfe-bfe6-481ca4e6e874">18,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba8cbf1ad1841b888da8acba5f7f620_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC0xLTEtMS0w_bd149bd1-6527-490f-9b43-79ad535d54fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fcfc92e884043cda965149401c427a5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC0zLTEtMS0w_6a8ec128-2a20-4bcb-9437-2d76fce94842">14,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia40fa98b862c45d08dfdaee06d40d302_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC01LTEtMS0w_81bfb47f-05b3-482c-83e4-780910f8c9bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6394f5129932421ab1a4974a1a1a6b00_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC03LTEtMS0w_ead40728-5aff-46f8-bad8-127d1abace98">14,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf297a460c204ec2b1885acfc0c94a10_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS0xLTEtMS0w_79d1c133-8a7f-44b5-a038-c63d55c7d033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5c730df6314669bb5151635d49120b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS0zLTEtMS0w_a8acf426-2ef9-4951-a21c-348f69ada1ac">53,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38fe77be60140f48090522f63c9a39a_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS01LTEtMS0w_a2eebe53-e61f-4ab6-9e6f-90268bfc4f4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74044123d230403ea1b8d392ee592a83_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS03LTEtMS0w_480c0c93-1110-4d19-932a-30ea0678649b">53,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d7fe7922944855967728940bb7a2db_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtMS0xLTEtMA_a588c4fb-1edf-44a6-b9b9-78f5bd2a17ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec41e2a7ebf48839293841bdf908142_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtMy0xLTEtMA_ae726cb6-aaca-46ff-9539-4709fbc48397">5,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b04c47b17f04e9080c84e6237ce8133_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtNS0xLTEtMA_e12f477a-9b4c-438a-816f-fcc6c6f01db8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84d8e18b6b5493c8c2f73fae745b71f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtNy0xLTEtMA_afc3a00b-07a9-41f6-b257-a5f0edbc7367">5,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtMS0xLTEtMA_e8648c8c-c80a-4b91-9e50-2b34f7baaecf">347,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtMy0xLTEtMA_9a1450dd-2374-4f62-a59c-ab38cd1a6723">473,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtNS0xLTEtMA_3325e7f0-76c2-4709-a83b-7ee8649964cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8214960907014dcdb3065f18a818a891_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtNy0xLTEtMA_b3ff33f0-9b8c-4ee4-a099-2c3349a30794">820,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtMS0xLTEtMA_66060e07-2aa3-4494-be94-033619ad5059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtMy0xLTEtMA_78dd8f9e-c185-4d72-ba3b-eaab602a4db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtNS0xLTEtMA_b940cf9f-f63b-4479-9ea2-4a6ccf72153c">5,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8214960907014dcdb3065f18a818a891_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtNy0xLTEtMA_31a8f2c2-0e46-48af-a145-50681a1e4bc9">5,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc2MA_ed4fe861-3da7-4fbb-82a3-b468704420d5" continuedAt="i7cea699e005647ca852b404397c7fb25" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the Company&#8217;s fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for certain financial instruments not measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987b1607278642e6bdb251b05e65b8ff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi0xLTEtMS0w_925db249-c8c5-47b2-bbb7-7e3343615c89">26,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43a6f4851ae408aa78991f992f90d3d_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi0zLTEtMS0w_46208aee-45c0-4b7c-abd5-0841413fa2bc">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi01LTEtMS0w_3c306262-c524-4d01-b3db-f399f2bddbf3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi03LTEtMS0w_11355ac3-36e7-42c2-b598-af94768922f4">26,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44343e4888bb4fdd8ef28262ba0a829f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC0xLTEtMS0w_a9a30c45-f7ec-4c7f-bf4e-b99e348549be">7,768</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb05d51535c4c5fb8505b007c999ba9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC0zLTEtMS0w_0617db4d-467a-4eb3-baa6-2069a944a88a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebad86f24bb445b8b965a4431d284e5_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC01LTEtMS0w_5a775ba2-b5af-49d5-b5c0-66dd0aa19099">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC03LTEtMS0w_001ca7f9-7721-4540-8bfb-5cdf51751fe6">7,768</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3a78bf8567442f181de5c4cac29fe31_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS0xLTEtMS0w_73f25c94-aba5-4f18-aa0c-6f561bffcd36">1,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i603837f5d76a430db5a4b8b5127fbac9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS0zLTEtMS0w_70fd2cab-3dc6-4bc8-ac87-14993a561168">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b82a503cd044fe590aa67341061d910_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS01LTEtMS0w_55feed2d-8c1a-4fb7-b0ba-f0158de9f25f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS03LTEtMS0w_ccb6b637-78c6-49e5-bfbc-ed9099352821">1,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987b1607278642e6bdb251b05e65b8ff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi0xLTEtMS0w_87294f2c-e130-4a06-8a21-dae474bd2812">35,965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43a6f4851ae408aa78991f992f90d3d_I20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi0zLTEtMS0w_66d9c4de-c4ad-4f1a-ab7b-dd0d348f1f16">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930" decimals="-3" format="ixt:fixed-zero" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi01LTEtMS0w_fab09d0e-a1c9-4280-8916-aa9f2b732779">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi03LTEtMS0w_a64ae1d6-d549-4767-8640-24000bd62e3c">35,965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i4dda90e3642347b3a43496ab71839566"><div style="margin-top:10pt"><ix:continuation id="i7cea699e005647ca852b404397c7fb25"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59812274cf5a4c7396e08ab5b517c05c_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi0xLTEtMS0w_6661978d-2fd1-4b82-81d2-aaf58f4cc186">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi0zLTEtMS0w_20984ecd-fdac-4351-ab1e-5d6303291e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38815aebdb74f77a02060f060d0869d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi01LTEtMS0w_24e63ed2-9215-43e0-a102-82ada1221829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi03LTEtMS0w_2bd0b01a-c85a-4b3d-9e25-eb45e00b82b2">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7434d9096c64a1bb923b544c8f1389d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC0xLTEtMS0w_d2c6e90b-2abf-4d8f-a5fc-81f7c3d010e5">6,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4c1482377444818d26fe58a951011d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC0zLTEtMS0w_82d7ec42-b535-4900-9550-7d0dba356d94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3ed3d5f5ef4a70bf392309669bd29c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC01LTEtMS0w_8f85baff-81c3-4782-b26c-6b9f7fc620e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC03LTEtMS0w_13f13552-b0ff-478b-ab5e-17e0c3548e45">6,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id470f6c918dd495a836d00f9b203e39e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS0xLTEtMS0w_1f5d1834-f715-4d41-9aa9-fa33d00a5efe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1946250bcb8b4f35ae19d843abace6b1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS0zLTEtMS0w_361aa957-d516-49c1-b391-1f6113b4c74c">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c97e7f2726740aab3e591c631f1086c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS01LTEtMS0w_64546121-d08c-486a-a26d-a3eb4f4f8511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS03LTEtMS0w_f36b0d14-10e5-48a9-aa9b-4095276eaba8">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59812274cf5a4c7396e08ab5b517c05c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi0xLTEtMS0w_2285eaba-056a-4dda-a01b-dcf572f37c8c">6,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi0zLTEtMS0w_7fdf0e92-a437-4841-90d7-ceb4ef3949a3">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38815aebdb74f77a02060f060d0869d_I20201231" decimals="-3" format="ixt:fixed-zero" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi01LTEtMS0w_3ffed9fa-c845-4bea-8642-fc5c00e3a9dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi03LTEtMS0w_c3091063-d1ac-4199-85f4-d32bcee3d36b">8,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no transfers of assets or liabilities into or out of Level&#160;3 of the fair value hierarchy. The contingent consideration liability related to the acquisition of AssociatesMD Medical Group, Inc. is measured using Level&#160;3 inputs based on a formulaic multiple of forecasted 2023 EBITDA per the terms of the purchase agreement discounted back to net present value. <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc2MQ_c71b04f5-de4a-47d9-b800-8968cc321e07" continuedAt="iff8a422b9a9e404e8d22aac0927e2808" escape="true">The following table presents the changes in fair value of the contingent consideration liability for the nine&#160;months ended September&#160;30, 2021 and year ended December&#160;31, 2020&#160;</ix:nonNumeric></span><ix:continuation id="iff8a422b9a9e404e8d22aac0927e2808" continuedAt="i71cd23e11fc0452e82ea6ed02c9035b2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:continuation></div><div style="margin-top:10pt"><ix:continuation id="i71cd23e11fc0452e82ea6ed02c9035b2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec66f7f13b74426818220faa08b44bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMS0xLTEtMS0w_c8f278eb-e5f6-42d6-b93a-3ac79a9ecd6b">5,716</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d8836b93dd4f33b7d7aadeba06f167_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMS0zLTEtMS0w_378df671-4333-4317-b8ec-846a8fc5ac84">5,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1192b7a40dd4bf8901438bfe5d81d4c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMi0xLTEtMS0w_7748b9b3-64ee-4f2e-b8c0-b816bd033746">1,363</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06271373575042ab95c33d25a8ca9392_D20200101-20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMi0zLTEtMS0w_88a1db37-1669-49d9-85d3-6ab81c3557b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic724acf3709143ae92b0205c01aff95b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMy0xLTEtMS0w_113da0f6-141d-4b29-a509-e51835a190da">7,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec66f7f13b74426818220faa08b44bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMy0zLTEtMS0w_71635b64-6b4a-4db2-ab05-bad2d4bf7ae4">5,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported on the Condensed Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value due to their short-term nature. These assets and liabilities are not included in the tables above.</span></div></ix:continuation><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 5.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYx_b4759f26-7cbe-47a4-867b-d504cecd47be" continuedAt="ie144668c5fe242c585b83cbb6a245e54" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ie144668c5fe242c585b83cbb6a245e54" continuedAt="i898b64ff3adb4e85a233ddfd8e9ccf29"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYy_b18a168c-01c0-48c0-88be-f5d2722b32fd" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5706b49442c42cc92ff686adc9c2f6a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi0xLTEtMS0w_4d482d20-0c98-4bf2-8dad-87690abd5e4d">197,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5706b49442c42cc92ff686adc9c2f6a_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi0zLTEtMS0w_2686fad7-e7d6-4432-a072-e1213984b9ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc51d73723524b38a531dfff6500d1bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi01LTEtMS0w_2885311e-11bb-461e-9e67-ec9e7fe1cf46">65,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc51d73723524b38a531dfff6500d1bb_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi03LTEtMS0w_87d890e6-dd25-42ac-b90b-af5b1c096a51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMy0xLTEtMS0w_4e173899-165f-42ac-80a1-367f4100e010">240,776</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMy01LTEtMS0w_6d42c618-fbb6-45ed-ae66-8d3e9e0572fc">340,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNC0xLTEtMS0w_17cd66d5-6747-447f-8555-fc2fa3a5ba61">1,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNC01LTEtMS0w_0ff3413e-12f6-4960-a31d-10c120f626e4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e079ad5fea45d1896564cab3657124_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS0xLTEtMS0w_bf80aace-f20d-409d-b167-b3ab6da6936e">437,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e079ad5fea45d1896564cab3657124_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS0zLTEtMS0w_be7b624a-c8b6-4542-8ef9-f3545b30cf68">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2347919b5a0f402dbe70c10597badc81_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS01LTEtMS0w_a143d19b-ebd2-45ef-9b45-5c205449e7c7">405,257</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2347919b5a0f402dbe70c10597badc81_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS03LTEtMS0w_bbd1b2bc-85ed-4f93-a711-486d8607592a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYz_c2605254-411b-4c58-89fa-75d95c11b4ea" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value and accumulated amortization for definite-lived intangible assets were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5e9f871cd340148867c6e71fdf972e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi0xLTEtMS0w_6619ce4d-a4bd-4904-8ea5-f917ad1d51cf">209,321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5e9f871cd340148867c6e71fdf972e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi0zLTEtMS0w_c955ab0b-3e34-4f8d-9d68-6eda1e0955f8">19,257</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi01LTEtMS0w_c3ef689d-22eb-4924-993c-faeb91fbcc59">117,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi03LTEtMS0w_ca020142-23df-4269-b93e-b57068ab4e58">3,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5263022fb5924aec8717109210e85b4e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy0xLTEtMS0w_64ebb993-1133-48f7-8883-b606445becfa">99,231</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5263022fb5924aec8717109210e85b4e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy0zLTEtMS0w_9d07120f-938e-4e9a-89ad-7836248bf595">5,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f4e995deff4436ac164dccfef41665_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy01LTEtMS0w_89bd466e-18f0-485e-aae6-f9c1d6f516cb">38,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f4e995deff4436ac164dccfef41665_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy03LTEtMS0w_e7fede40-61e6-4721-af16-d91c75aec52c">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60d46058494a0c9b1c382560f26baf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0xLTEtMS0yMjQzMA_ad88fc79-b1f3-4c75-b40b-a012ee318f14">59,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d60d46058494a0c9b1c382560f26baf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0zLTEtMS0yMjQzMA_58a41e15-2c64-488c-86e3-d1eb0321bc66">3,278</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac76b89cd7144e9aae00bd7925215e4_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC01LTEtMS0yMjQzMA_aebbedfd-1893-489e-b8c9-a5fee290ba64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac76b89cd7144e9aae00bd7925215e4_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC03LTEtMS0yMjQzMA_88b01b30-6061-4646-95b9-94aeb058c87a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5b9d2a29e04e838afb62706696b06b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0xLTEtMS0w_395f1546-197e-4fd5-9abd-b0fe82bb43ab">6,200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5b9d2a29e04e838afb62706696b06b_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0zLTEtMS0w_50f71744-4e26-414e-969f-2d5ce247da37">443</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC01LTEtMS0w_83bd54fa-333b-4092-8e3b-5ea5b2444342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC03LTEtMS0w_7d6741eb-330b-45ac-a470-1f7422460af8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32dc3e4609c14b56bb221bfee7c43e94_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS0xLTEtMS0w_07a6e122-c10b-49d7-90df-266ee9cc54d9">6,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32dc3e4609c14b56bb221bfee7c43e94_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS0zLTEtMS0w_cf8e6747-f6db-4dc6-9630-282cfcfeb998">598</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS01LTEtMS0w_36bdb557-ed2e-4e05-8ea8-78c47062fc77">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS03LTEtMS0w_e55148db-ad67-48f0-8270-ea3d366ced53">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi0xLTEtMS0w_9d213263-51ab-4351-b3ef-d99c825663fc">380,152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi0zLTEtMS0w_ab7736c0-45d5-47e3-8767-723659050c59">28,633</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi01LTEtMS0w_c06c096a-ddc5-4802-a526-102cda799e79">157,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi03LTEtMS0w_658965da-bab9-4057-8fac-8a122d1a7dea">5,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i898b64ff3adb4e85a233ddfd8e9ccf29"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODY0_0081e498-5158-4578-b4ef-357c088f6a3b" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to definite-lived intangible assets acquired during the nine&#160;months ended September&#160;30, 2021&#160;were as follows </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMS0xLTEtMS0w_ae0c9a1c-e1cd-4d98-b352-559782a3100a">90,670</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMS0zLTEtMS0w_c0fd3527-1dcb-425e-95f4-392e10fe372a">16.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMi0xLTEtMS0w_253918fc-719a-4197-8ae6-4e043b192cae">60,370</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMi0zLTEtMS0w_132e3dd2-5e49-4a76-bf03-b766795ed905">14.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0xLTEtMS0yMjQ1NQ_3471c3d3-d7f0-4e81-ac9a-81e188be8671">59,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0zLTEtMS0yMjQ1NQ_03421972-aae0-437b-900e-cbf9afa2baa8">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0xLTEtMS0w_0a516fdd-6f11-4350-9eb9-deb3d59a66b7">6,200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0zLTEtMS0w_1a11632b-1b8c-4163-ba37-040a972af215">7.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNC0xLTEtMS0w_afe6a061-8869-49c3-972f-f4a0c2c187aa">4,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNC0zLTEtMS0w_17ef1f2d-9bda-4cfb-8796-a7a4ad226afa">7.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNS0xLTEtMS0w_1d4281fa-493e-45e7-a6c9-1e029469f6fe">220,640</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNS0zLTEtMS0w_7d02fa8f-89d1-4374-ba61-cbdd7f289faf">9.8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense relating to intangible assets for the three months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNTQ4_0e793b99-9a79-4de4-8752-85415af5ad69">13.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNTYz_4bfdcb77-0eb1-4fa0-ae82-02003d4ff674">1.8</ix:nonFraction> million, respectively, and amortization expense for the nine&#160;months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNjUy_c2e46d93-26fd-4dd0-aad9-40ea302579bb">23.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNjY3_a6bc855f-3d4f-4006-9449-63c2208547f2">3.6</ix:nonFraction> million, respectively. <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODY1_3087d401-04a5-4778-a74a-2d0e6330c7d7" continuedAt="i6495a2cd163a4b8bbda414328aeede0c" escape="true">Estimated amortization expense relating to intangible assets for the remainder of 2021 and for each of the next five full&#160;years ending December&#160;31 is as follows&#160;</ix:nonNumeric></span><ix:continuation id="i6495a2cd163a4b8bbda414328aeede0c" continuedAt="i738c56603d424f7385aeb8a4c0902f1e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:continuation></div><div style="margin-top:10pt"><ix:continuation id="i738c56603d424f7385aeb8a4c0902f1e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (October-December)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMC0xLTEtMS0w_e2851202-aa45-43cd-b8c6-f60c2f8cc918">10,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMS0xLTEtMS0w_13ce2a17-ac5d-40cf-ad48-a50e468eafbc">42,050</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMi0xLTEtMS0w_1f5ddf63-dbb7-476b-bb66-2d69c9d1f744">42,029</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMy0xLTEtMS0w_9d742bff-1f8c-4c57-8c74-96cb20a3568c">41,890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfNC0xLTEtMS0w_001cbd4c-accb-44bd-81e9-a6d77805e3a5">41,890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfNS0xLTEtMS0w_d386dfa3-7063-48d8-8003-e61b40c1e2cf">26,323</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:InsuranceDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfNzkx_59691a29-7ab3-4e9d-baa5-f51f0b040331" continuedAt="ib10333981c3b499288b5fa89f66fe15a" escape="true">MEDICAL COSTS PAYABLE</ix:nonNumeric></span></div><ix:continuation id="ib10333981c3b499288b5fa89f66fe15a" continuedAt="idc99ad1c91674b15a4364adc7b77375c"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfNzky_c7bc368a-7798-4c00-a7aa-b417c6a4ac19" continuedAt="i6a4e987a49234cab95cf76e2b8741a51" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMS0xLTEtMS0w_ebee9f3c-3c31-480d-804a-aad3c7b1b827">249,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMS0zLTEtMS0w_9e16e3c9-5aff-4dd1-b1d9-413bea7c507c">44,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMy0xLTEtMS0w_5724daa7-a7cd-4876-aecd-9b9d491a50b8">2,647,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMy0zLTEtMS0w_503d73de-cba8-4d97-ae91-6abf588904f8">685,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNC0xLTEtMS0w_ac207006-8e0a-4562-840c-e57fa089f6e3">1,726</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNC0zLTEtMS0w_d99e5f25-a565-4f69-a4c7-2302104535db">9,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNS0xLTEtMS0w_c3dfd05a-b8f0-4c70-afd1-1b543528b9c8">2,649,445</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNS0zLTEtMS0w_c852be96-6b46-4f20-9eb7-d6129ff632b7">676,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNy0xLTEtMS0w_a1fa8bf7-c17a-4d36-bc95-f97a4686da84">2,074,602</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNy0zLTEtMS0w_ea1332c0-65fe-43b1-a52a-691d8b6e9978">610,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOC0xLTEtMS0w_bb27e156-b437-4b30-a9f0-016a8063c9c3">232,312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOC0zLTEtMS0w_27ee2962-e591-444d-a052-e7a5e3adb4a5">29,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOS0xLTEtMS0w_7bdd12b1-3fff-48be-b5d3-3fdb35e05cc4">2,306,914</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOS0zLTEtMS0w_117cd026-cc6a-4a60-a4ec-aa82b8d0a80a">640,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired claims liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTEtMS0xLTEtMA_1e5df162-cecc-4098-b6d6-c01b4a99201f">92,737</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTEtMy0xLTEtMA_61cb3482-9a7e-4d21-8e40-abfd9e5d91a2">118,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTItMS0xLTEtMA_5669bfb7-9d06-47c4-a2c3-3169499a0ee9">685,045</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTItMy0xLTEtMA_d1c99c0b-2672-49de-bdfc-cb903e200a40">199,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Medical costs payable attributable to prior&#160;years increased by $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfMjI0_2e158d56-3e6c-464c-9dd2-8b7a64aad9e3">1.7</ix:nonFraction> million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> decreased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfMjQ0_5de70e28-1cbd-470e-9a29-3f6425fdf4ad">9.3</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively. Medical costs payable estimates are adjusted as additional information becomes known regarding claims; there were no significant changes to estimation methodologies during the periods.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="idc99ad1c91674b15a4364adc7b77375c"><ix:continuation id="i6a4e987a49234cab95cf76e2b8741a51"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below details the components making up the medical costs payable as of September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims unpaid</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMS0xLTEtMS0w_860e0e60-91fb-4152-8153-c127d9f6fb98">42,488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMS0zLTEtMS0w_398316a0-f749-4dde-a7e0-6686e17e7233">25,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider incentive payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMi0xLTEtMS0w_f445a27d-88a7-437f-986c-de87cb7c2f2e">69,274</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMi0zLTEtMS0w_77af4614-1dd9-4220-8ff0-b14421a224f3">10,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims adjustment expense liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMy0xLTEtMS0w_5d7e9e51-56a2-4f54-8400-fb080bc7464a">12,413</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMy0zLTEtMS0w_57e2fb5f-18c3-4a71-8366-e9d38815d3ac">2,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred but not reported</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNC0xLTEtMS0w_d97dc4ac-1154-4e71-8387-e5962e29b266">560,870</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNC0zLTEtMS0w_2942bcd9-6d59-4352-8384-db82fbb28d10">160,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNS0xLTEtMS0w_decfaa5e-38e3-40b3-a78a-ae74e161f047">685,045</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNS0zLTEtMS0w_bb91307e-3fbd-4183-918d-c249424c06d2">199,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable are primarily related to the current year. The Company has recorded claims adjustment expense as a component of operating costs in the Condensed Consolidated Statements of Income (Loss).</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMTIyNg_9fafe0b6-f392-4c83-92d0-eb620a1dea6a" continuedAt="iaab630fbfb4640baaee3f40943f0d33f" escape="true">SHORT-TERM BORROWINGS</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="iaab630fbfb4640baaee3f40943f0d33f">On March&#160;1, 2021, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i239b6a8206b34281a2d7bdb5f1c2ecb9_I20210301" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNjI_0c34c934-2e4f-4c6b-8741-177ce0becb82">350.0</ix:nonFraction> million revolving credit agreement with a syndicate of banks (the &#8220;Credit Agreement&#8221;). On August 2, 2021, the Credit Agreement was amended to change the definition of &#8220;Qualified IPO&#8221; by reducing the net proceeds required to be received by the Company from $<ix:nonFraction unitRef="usd" contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301" decimals="-8" format="ixt:num-dot-decimal" name="bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMzEz_77705990-041b-4cd1-8843-57415cc8dc2b">1.0</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802" decimals="-5" name="bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMzE5_c16ff4fe-1e88-4117-8e29-825b64101bde">850.0</ix:nonFraction> million. In addition, prior to such amendment, the Credit Agreement contained a covenant that required the Company to maintain a total debt to capitalization ratio of (a) <ix:nonFraction unitRef="number" contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301" decimals="2" name="bhg:DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNDkz_6c1482ac-41c6-40b1-80be-9101583d182c">0.25</ix:nonFraction> to 1.00 prior to a Qualified IPO, and (b) <ix:nonFraction unitRef="number" contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301" decimals="2" name="bhg:DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNTM2_03f2270c-fcdf-4417-8a0c-16141d33a3ba">0.30</ix:nonFraction> to 1.00 after a Qualified IPO. The Amendment changed this covenant by removing the increase in the ratio after a Qualified IPO such that the Company is now required to maintain a total debt to capitalization ratio of <ix:nonFraction unitRef="number" contextRef="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802" decimals="2" name="bhg:DebtInstrumentCovenantTotalDebtToCapitalizationRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNzU0_643ca6b7-7a36-4c6a-9856-8cf14a551f86">0.25</ix:nonFraction> to 1.00. On August 4, 2021, we elected to extend the maturity date of the Credit Agreement from February 28, 2022 to February 28, 2024. During the second quarter of 2021, we utilized a portion of the net IPO proceeds to repay the $<ix:nonFraction unitRef="usd" contextRef="ia89038a50c124021864f208e24672ab8_D20210401-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfOTUw_cdcec9a5-52a0-43ac-b502-046a5f99abec">200.0</ix:nonFraction> million principal balance of indebtedness outstanding under our revolving credit agreement originally entered into on March 1, 2021 and the associated interest and other costs of $<ix:nonFraction unitRef="usd" contextRef="ia89038a50c124021864f208e24672ab8_D20210401-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMTEyNA_6c182cfd-f276-4e5f-85ec-64f3cb153191">3.2</ix:nonFraction>&#160;million. As of September&#160;30, 2021, we have no borrowings outstanding under the Credit Agreement.</ix:continuation> </span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE1OQ_1a849814-5f19-4906-8c16-7af13a7b4b4b" continuedAt="i88522b52a5244763b6fd8d1facbb3b65" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i88522b52a5244763b6fd8d1facbb3b65" continuedAt="iebc972cf65a14496909d9b58815b6489"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted its 2016 Stock Incentive Plan (the &#8220;2016 Incentive Plan&#8221;) in March 2016. The 2016 Incentive Plan allowed for the Company to grant stock options, restricted stock awards (&#8220;RSAs&#8221;), and restricted stock units (&#8220;RSUs&#8221;) to certain employees, consultants and non-employee directors. The 2016 Incentive Plan was initially adopted on March 25, 2016, and most recently amended in December 2020. Following the effectiveness of our 2021 Omnibus Plan (the &#8220;2021 Incentive Plan&#8221;), no further awards will be granted under the 2016 Incentive Plan. However, all outstanding awards granted under the 2016 Incentive Plan will continue to be governed by the existing terms of the 2016 Incentive Plan and the applicable award agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Incentive Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Incentive Plan was adopted by our Board of Directors on May 21, 2021 and approved by our stockholders on May 25, 2021 and June 5, 2021. The 2021 Incentive Plan allows the Company to grant stock options, RSAs, RSUs, stock appreciation rights, other equity based awards, and cash based incentive awards to certain employees, consultants and non-employee directors. There are <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTIwMw_51d6104c-3757-47da-83e7-33e6c71b4afc">42.0</ix:nonFraction> million shares of common stock authorized for issuance under the 2021 Incentive Plan. As of September&#160;30, 2021, a total of <ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTMxMw_f1380601-854a-4adc-aca5-12e9546f2f5f">26.8</ix:nonFraction> million shares of common stock were available for future issuance under the 2021 Incentive Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTQ5OA_27b35603-05ac-40fb-a679-cee2250bad85">43.2</ix:nonFraction> million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTUwNQ_41d75780-e963-4b54-aa83-166f36aef41f">3.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="iebc972cf65a14496909d9b58815b6489" continuedAt="i858229edb7d140dbb44f1d7a6c1fe5a0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors or the Compensation Committee of the Board of Directors determines the exercise price, vesting periods and expiration date at the time of the grant. Stock options granted prior to the third quarter of 2021 generally vest <ix:nonFraction unitRef="number" contextRef="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTg0OQ_eeb5db3e-5914-48eb-8994-f17f8543eaa7">25</ix:nonFraction>% at <ix:nonNumeric contextRef="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTg1NQ_3d0c85f9-ea0c-4190-abd1-270bf7f583d6">one year</ix:nonNumeric> from the grant date, then ratably over the next <ix:nonNumeric contextRef="i8d71d04cf62a46bc8ec80068d333d865_D20210101-20210630" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTkwNg_7dd026b1-873a-473d-87b0-0ab4a9bc4041">36</ix:nonNumeric> months with continuous employee service. Stock options granted after the beginning of the third quarter of 2021 generally vest ratably over <ix:nonNumeric contextRef="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg5MDg4NQ_7ea83466-055f-4a1d-ad09-1fc8e010c317">three years</ix:nonNumeric>. Option grants generally expire <ix:nonNumeric contextRef="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTk3NA_5ad67d31-e36a-41b5-8897-ff1533f33a21">10</ix:nonNumeric> years from the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2MA_05657c18-0c7b-4cbe-aa3c-dc647bfd3381" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculated value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted-average assumptions for options granted during the nine months ended September&#160;30, 2021:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMS0xLTEtMS0w_1823d1d3-cef3-4b55-982b-b7283a89662a">0.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMi0xLTEtMS0w_004975ad-846e-4059-a0e5-af560dde253c">33.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMy0xLTEtMS0w_ebdd71d2-4edd-479a-bf75-cd0cd665e0b1">0.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="3" name="bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfNC0xLTEtMS0w_7fc56359-f534-49c5-84d2-fbaf46e6871a">14.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfNS0xLTEtMS0w_a9ce8b48-e4b0-4dad-bb3f-28e18ecd1922">6.1</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of our publicly traded industry peers. We use historical data to estimate option forfeitures within the valuation model. The expected lives of options granted represent the period of time that the awards granted are expected to be outstanding based on historical exercise patterns.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2MQ_883425e6-85ff-47c5-89f0-2ec363018844" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity for the stock options for the nine&#160;months ended September&#160;30, 2021 is as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except exercise price and contractual life)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(In Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate <br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS0xLTEtMS0w_88285ebf-8d98-48bb-9d9e-79d5aa4c48c2">63,925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS0zLTEtMS0w_56067eee-40f3-4dd6-bcca-4c20455680ce">1.47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1cb0c464b5b74f17a7e2b16b4ca83666_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS01LTEtMS0w_57d71fe8-931b-498a-ae80-a22bd00c790e">8.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS03LTEtMS0w_b1f198b4-3f47-49b1-90bb-d5509e47dc2d">53,573</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMi0xLTEtMS0w_b8fb0795-2a4b-4b42-bc9f-a9526f980d3c">20,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMi0zLTEtMS0w_82c85e8f-9c8c-4544-85f7-30f33e6a52e4">2.58</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMy0xLTEtMS0w_17c079a7-a5e2-4d23-8b8f-4d7da6d95910">9,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMy0zLTEtMS0w_06347df1-b917-4d3b-a304-df62be6aa141">1.09</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNC0xLTEtMS0w_ad419884-6297-4621-9374-dee58fd7d8a2">4,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNC0zLTEtMS0w_918087d5-fb53-4b25-acf7-98b35a143677">1.75</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNS0xLTEtMS0w_afe00fc1-c764-479a-8e9b-4208b96110d0">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNS0zLTEtMS0w_20866f90-8562-4a74-9b22-2bb1d2b44e6c">1.09</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi0xLTEtMS0w_43507012-b93d-4beb-8c68-af995288b34e">70,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi0zLTEtMS0w_e23b7bd5-77ae-4876-b198-430a59fb9f38">1.83</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi01LTEtMS0w_8611e609-4e6f-48e6-9373-8e26838a785a">8.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi03LTEtMS0w_a667153c-d466-4f19-b343-0fec3ebe8894">445,246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted during the nine months ended September&#160;30, 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMjkwNw_6386a480-df09-49e7-8fb3-e5d20eca2b30">10.86</ix:nonFraction> per share. At September&#160;30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMjkzOA_7ab7f584-7cf4-4155-8bb9-409f31058887">150.7</ix:nonFraction> million of unrecognized compensation expense related to stock options that is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ica442b5ba7794e58b4b714aa57dcfb75_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzA3MQ_6255c7dd-81c7-419c-8660-3ce3fd29d9a1">3.4</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i858229edb7d140dbb44f1d7a6c1fe5a0" continuedAt="ib06ed4ca46ef48d692300a360abe0b54"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">RSUs represent the right to receive shares of our common stock at a specified date in the future and generally vest over a <ix:nonNumeric contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg4ODU1Mw_2eefd16d-f628-403c-9627-45f148d975cb">three-year</ix:nonNumeric> period. The fair value of RSUs is determined based on the closing market price of our common stock on the date of grant. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg4ODUzOA_68821993-4bca-4267-a3c3-1dae25617c45" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes RSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in thousands, except weighted average grant date fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic04162a13ce44bbcbac57b063ee86f28_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMi0xLTEtMS00MTkz_01bddf23-4bfe-4d4d-b087-80984d8bcb25">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic04162a13ce44bbcbac57b063ee86f28_I20201231" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMi0zLTEtMS00MTkz_017d322e-55ab-43f1-b1bb-4083838cb476">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMy0xLTEtMS00MTkz_6b4d6a7d-f72f-4976-894f-e042b8219658">364</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMy0zLTEtMS00MTkz_0d5b74cd-2ea1-44c1-9aa6-39a32a4894a4">9.11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNC0xLTEtMS00MTkz_c1bea6cc-dd7e-4d12-88c7-19da2d2edf7e">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNC0zLTEtMS00MTkz_90cd6770-9ae3-4ddb-b16a-6f39ab3c47b4">9.01</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNS0xLTEtMS00MTkz_8f95b8a7-b4ea-4dd1-84ae-625eb6995226">345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNS0zLTEtMS00MTkz_c7c92e35-f423-4570-82d2-f17b7a79635b">9.11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense related to RSUs of $<ix:nonFraction unitRef="usd" contextRef="ic52eea78557244659324ce8e6c2bb202_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg0Ng_ac397302-84e1-4eb1-81c6-c997e7812991"><ix:nonFraction unitRef="usd" contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg0Ng_b440f649-ffa3-43b0-a391-65833dda2181">0.2</ix:nonFraction></ix:nonFraction> million for the three and nine months ended September 30, 2021, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). As of September 30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg2Mg_d40cb9fb-3545-4942-ad27-43a15dda8875">2.5</ix:nonFraction> million of unrecognized compensation expense related to the RSU grants, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg3NQ_5d14900e-0939-4bf0-95d8-40e65d54c10d">2.7</ix:nonNumeric> years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Restricted Stock Units (&#8220;PSUs&#8221;)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our IPO, our Board of Directors approved the grant of PSUs to members of our executive leadership team. The grant encompasses a total of <ix:nonFraction unitRef="shares" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI4Mw_4dea8784-ba6e-4605-b26c-2ef4f09c7a17">14.7</ix:nonFraction>&#160;million PSUs, separated into <ix:nonFraction unitRef="vestingtranche" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzMwNw_b0baca40-ddba-44b1-b04c-8da845f2806b">four</ix:nonFraction> equal tranches, each of which are eligible to vest based on the achievement of predetermined stock price goals and a minimum service period of <ix:nonNumeric contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDA4Ng_5bf590a7-4bd6-49e2-a4cc-0a24620ccb31">3</ix:nonNumeric> years. This grant is intended to retain and incentivize our executive leadership to lead the Company to sustained, long-term financial and operational performance. The fair value of the PSUs is determined using a Monte-Carlo simulation.</span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2Mw_346cabbb-5e20-4b43-a63c-7915cfe67d4f" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except weighted average grant date fair value)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of PSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie498ad30294744b1ac90b3f7364ad523_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMi0xLTEtMS0w_7e57f4ed-50df-4d60-8915-506f253828e0">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie498ad30294744b1ac90b3f7364ad523_I20201231" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMi0zLTEtMS0w_0ba03ee7-b5a5-431c-8662-902b80b5cd25">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMy0xLTEtMS0w_ba08099a-2ca5-4238-932c-21f8cd790416">14,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMy0zLTEtMS0w_e753ff97-00a5-4697-be93-f98192e3a8b9">9.30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNC0xLTEtMS0w_43a720ba-d7b7-4252-8042-51740f49f679">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNC0zLTEtMS0w_deb0eb6f-3093-4437-bfea-68f094726826">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNS0xLTEtMS0w_72856d61-0602-4f40-a93b-ea3c88c059b3">14,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNS0zLTEtMS0w_0e92ca77-4f9d-42ff-8b07-5f7df83c33c9">9.30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib06ed4ca46ef48d692300a360abe0b54">We recognized share-based compensation expense related to the PSU grant of $<ix:nonFraction unitRef="usd" contextRef="i043ba02e46a04d3d9c3801cac0f40005_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzk2OQ_a2921132-3569-47aa-aa04-8589239372a4">10.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzk4OA_bc6c58ae-bdf2-4721-b268-eb15719826ac">10.3</ix:nonFraction> million for the three and nine months ended September 30, 2021, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). At September 30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDAwOA_33cb74b5-bc6f-4cb6-8a39-bf50094af0b0">108.5</ix:nonFraction> million of unrecognized compensation expense related to the PSU grant, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDAyNQ_1406a67f-6475-47c1-82ae-9ed106645f7e">2.7</ix:nonNumeric> years.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_61"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg3_c05b7896-95e3-4442-9163-ed07d303dff7" continuedAt="ica6e0e59de604d2d9e94329e64968dfe" escape="true">NET LOSS PER SHARE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ica6e0e59de604d2d9e94329e64968dfe"><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg4_10076d33-f7d4-40d5-91e0-aa5544a650c2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine&#160;months ended September 30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except for per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0xLTEtMS0w_be378bf5-df61-4db3-9767-4e55d97227ce"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0xLTEtMS0w_c240808b-7cb4-4f85-9eb2-4abdc36895eb">300,664</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0zLTEtMS0w_17e33b4a-7002-45dc-9c2a-ab20fba58b4d"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0zLTEtMS0w_a6fcad10-904f-4c4a-8e74-799d4a11cff8">59,256</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi01LTEtMS0w_ab372f2f-9f93-4930-a9b4-1c53bdea4ad2"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi01LTEtMS0w_f118e6dc-90e5-440d-8eba-36ce956dee08">370,344</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi03LTEtMS0w_8d3b51fe-8118-4ed8-9f3a-962046e8788f"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi03LTEtMS0w_cd552a16-72f1-45e5-85a4-50ee414c3804">84,610</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0xLTEtMS0w_9fed6671-40dc-480b-9ede-466144ea2e5f"><ix:nonFraction unitRef="shares" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0xLTEtMS0w_ee1b2b88-b4a8-447b-a6a8-0cfbcef484d3">630,378</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0zLTEtMS0w_dcf21e50-3e84-4077-9967-9f4b253a3e83"><ix:nonFraction unitRef="shares" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0zLTEtMS0w_de8a6abb-5825-4ac2-9e5b-ce755c11f896">136,337</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy01LTEtMS0w_11dfa6cb-f23e-4f93-a6ac-3818046bb839"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy01LTEtMS0w_8253e7b7-dc2d-45e4-86c8-9fa298a6c3a3">312,294</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy03LTEtMS0w_ab2be6ac-80e5-4ac2-ab13-f0f39f95d6fa"><ix:nonFraction unitRef="shares" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy03LTEtMS0w_fc9fd2be-599c-4b32-8d62-04f2d26e8b37">135,926</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0xLTEtMS0w_3beb7439-9747-44ff-ae9b-5aee1f7d3641"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0xLTEtMS0w_f7e89b0a-1fd0-4231-b72b-297716d91b93">0.48</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0zLTEtMS0w_98a81166-a470-41bb-bcd0-7c083975bc4f"><ix:nonFraction unitRef="usdPerShare" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0zLTEtMS0w_e9685030-bb94-426a-b329-f2042759b42d">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC01LTEtMS0w_66990a6e-ac03-47f2-9ca8-c951bc8d4c48"><ix:nonFraction unitRef="usdPerShare" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC01LTEtMS0w_c3ed9573-1948-420a-bccd-ec0eb6709eb0">1.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC03LTEtMS0w_b65c419e-de0c-4a74-94aa-2a439b456e81"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC03LTEtMS0w_d19a12ab-e674-4bee-8587-bfdb6f707a7c">0.62</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg5_2ac8ca1d-8c9b-439a-8fe3-7fa64de3b037" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (as converted to common stock)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a06652cd21144e68f470720d0b26e59_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMi0xLTEtMS0w_51d776c9-d8e1-4e48-82cd-2ca8b2b0d0ad">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1803b1c56bb045a9a7e1425efd488b53_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMi0zLTEtMS0w_e49d8b1a-0c85-4ab7-96fe-9fb1b78fd107">411,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fc0670e71004cc7a5aaf2b1e4d07c2e_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMy0xLTEtMS0w_96f16785-0fc4-4920-904c-245e25951656">70,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i096b128e354942a2943cc883c2a582eb_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMy0zLTEtMS0w_a237c557-a8d9-46e7-a3bf-4c444691b7a4">58,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfNC0xLTEtMS0w_e726733a-6840-4c5b-99fe-e83c9879b903">70,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfNC0zLTEtMS0w_020cf02b-dbc6-44e0-b418-e2bcfcb0661d">469,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_64"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82NC9mcmFnOjU2MmE1OTlkMzY2YjQzOWM4ZWFhNTZmZDUyYTg2YWVjL3RleHRyZWdpb246NTYyYTU5OWQzNjZiNDM5YzhlYWE1NmZkNTJhODZhZWNfNDE0_23abb6be-d16d-441f-ab84-dc3e1c100738" continuedAt="i68e74b3b7dd44456a052bf65c2abd96b" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><ix:continuation id="i68e74b3b7dd44456a052bf65c2abd96b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal proceedings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In the normal course of business, we could be involved in various legal proceedings such as, but not limited to, the following: lawsuits alleging negligence in care or general liability, violation of regulatory bodies&#8217; rules and regulations, or violation of federal and/or state laws. At September&#160;30, 2021 and December&#160;31, 2020, there were no material known contingent liabilities.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_67"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTI4_db74de57-a8ad-461b-9e43-421a9bbf7be7" continuedAt="iaef7017dca1d44ee838f268165215bcd" escape="true">SEGMENTS AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iaef7017dca1d44ee838f268165215bcd" continuedAt="iaa30fbeb1f2845cf85fcf3ed154c2d38"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our <ix:nonFraction unitRef="segment" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTc_b5adb8ea-b1e7-44bf-baf1-cdc739902da3">two</ix:nonFraction> reportable segments are Bright HealthCare and NeueHealth.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTI3_534eec34-4861-4499-b419-da8c895d0e69" continuedAt="ibda7a170ea6c4ef0b94c23656ee52b79" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the reportable segment financial information for the three and nine&#160;months ended September&#160;30, 2021 and 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS0yLTEtMS0w_d46b55f3-a8b6-4c62-b132-f1e5c763de9e">994,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS00LTEtMS0w_dd385604-61f1-4fa8-bcc5-3767a4710975">25,647</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS04LTEtMS0w_727dc2d9-eb82-4ed8-81fa-029796650ce3">1,020,233</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi0yLTEtMS0w_de2a264e-ccea-4073-a42d-b351188885cc">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi00LTEtMS0w_959fcb50-93c8-4709-97d9-7bcba78af714">11,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi04LTEtMS0w_68de158e-0515-448e-82ca-c90064001272">11,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy0yLTEtMS0w_82c5fd90-9032-4903-b8ae-68de50880ed1">1,087</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy00LTEtMS0w_8e472aa2-d3c5-4221-918e-d2c34ff0a4a8">46,258</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy04LTEtMS0w_92e835d5-f091-4fbd-946d-81554c0cb283">47,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC0yLTEtMS0w_2f59d6fc-93d1-4ad5-ac57-4883b15e6822">995,612</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC00LTEtMS0w_5e23791c-ee6f-4403-a2fe-dacdf2878ccd">83,045</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC04LTEtMS0w_8367a7e6-a9ca-4463-9d53-788499a09644">1,078,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f653fc2a4d47c4a01311be6348f994_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNS00LTEtMS0w_9c6fb966-538b-4733-8f74-44d3e190ee78">139,759</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820545dd461745cb9b88d3b536970633_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNS02LTEtMS0w_2b53169e-1236-4482-b942-26f3a164ce72">139,759</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi0yLTEtMS0w_b2607bc0-5634-47bb-a858-7c52f2b86b13">995,612</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi00LTEtMS0w_46893bc4-dcd6-4135-872a-9acd7da2da92">222,804</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820545dd461745cb9b88d3b536970633_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi02LTEtMS0w_a0cca743-b458-4336-bdda-44c76e230a35">139,759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi04LTEtMS0w_488e109a-1c97-4977-9116-011a07183b1f">1,078,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy0yLTEtMS0w_79fcc966-7eb9-4f61-94e2-36beba6a3cbe">303,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy00LTEtMS0w_88dce8b9-bd59-4aae-8c5c-1ce8644bb4af">6,990</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy04LTEtMS0w_54eb5c80-ec98-4302-9c32-48e6e4eedc17">296,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS0yLTEtMS0w_88ed7237-e0d1-4450-ad7d-1eed333af350">4,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS00LTEtMS0w_b98a8758-3b11-4975-9981-d34cf5741843">9,621</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS04LTEtMS0w_31c49c95-7188-41d1-9359-50f7f4bfddd8">14,205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS0yLTEtMS0w_50f9365e-5466-48a3-b91c-83094d0fcef7">343,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS00LTEtMS0w_292e506a-7c7f-45f0-a0de-b5744ffd377c">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS04LTEtMS0w_8b939c19-3509-4bd3-a126-c2497fb18b37">345,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi0yLTEtMS0w_b5d6d332-e17b-4a0d-a094-53f789452426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi00LTEtMS0w_f122963f-ab3c-40df-a49e-902d3866e9a6">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi04LTEtMS0w_4bd03362-7ba0-44e0-911b-d7b35fd5f733">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy0yLTEtMS0w_c583201f-cb23-4811-a570-b3e9e768bc7a">1,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy00LTEtMS0w_46fba6da-6880-43fb-87ce-6f4a245debbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy04LTEtMS0w_05fd6d0d-2517-4aa3-a152-067329f99765">1,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC0yLTEtMS0w_910415e0-9656-4f41-9b2a-c7b18fa2fbce">345,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC00LTEtMS0w_9c540976-95cd-43a1-9197-5866cb5a00cb">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC04LTEtMS0w_57ddeb3a-34b2-41be-9176-fc374372ae97">352,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe36d5030b44213aa037bd2cd8a869f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNS00LTEtMS0w_46e8b08a-6b25-4696-ab4a-d519935e79b4">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNS02LTEtMS0w_2eeeb83c-0565-4eaf-8200-fbdea3406dbf">2,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi0yLTEtMS0w_6ad75f97-7cd8-4cd9-bcfc-afe654942182">345,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi00LTEtMS0w_66e35fa5-6a3a-4455-a0c1-2dd0f3ce0874">9,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi02LTEtMS0w_3864d91a-f164-4d2d-b0bb-8be1c560a2c3">2,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi04LTEtMS0w_64eaf3bc-6273-4f07-9adb-398bda0201e8">352,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy0yLTEtMS0w_e23aa623-af6a-417f-9e35-70dc36a26517">57,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy00LTEtMS0w_f159dd9c-7f8e-42f1-aa0e-54e0d6dcd983">1,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy04LTEtMS0w_786e0142-c892-454f-bda6-9fdd9f7ea15f">59,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS0yLTEtMS0w_5a3ab653-c220-4aac-bceb-3b7a1c8a4fb3">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS00LTEtMS0w_52cc06cb-c42c-4257-9dcf-d25c8a5f9f18">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS04LTEtMS0w_a84032f3-c391-4b22-b1fd-bd78b28b523d">2,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS0yLTEtMS0w_552db94f-64dc-4cb5-8ea5-97f99a070a5f">2,860,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS00LTEtMS0w_ffa79949-9f00-4c60-a87c-d422058e0a76">62,680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS04LTEtMS0w_47dfcf54-1763-47ec-b0b5-6fc83b86ab6d">2,922,950</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi0yLTEtMS0w_17b0e373-3287-4e84-a026-900d846ce810">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi00LTEtMS0w_74318cc5-7e79-456e-bf92-93b81e8bc860">31,573</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi04LTEtMS0w_78b18684-6f7d-4c19-9c73-786e6d08a67a">31,602</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy0yLTEtMS0w_be8402c4-7831-49bd-9ee5-01c361dc0881">3,491</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy00LTEtMS0w_446ff442-892c-4873-a137-8c190281e664">109,012</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy04LTEtMS0w_6f905598-fda1-4998-bad4-be0e53adb69f">112,503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC0yLTEtMS0w_4af8a4b4-2eee-4fe0-91e5-847fba5d1a8c">2,863,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC00LTEtMS0w_b8ec085e-d99e-4cfc-8a15-23ec1d43dbab">203,265</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC04LTEtMS0w_1f480a6b-ef14-4ce5-872d-0e07cd5115b3">3,067,055</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edb8fe9719f4576984692641eb7fb92_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNS00LTEtMS0w_eb0e07fd-ef04-4c6d-9578-de52e114c891">182,392</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNS02LTEtMS0w_1a5963b7-f0b5-4685-9e58-c84a298d14ae">182,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi0yLTEtMS0w_b3e11d8f-30b2-4707-a047-fb2d4bb260ad">2,863,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi00LTEtMS0w_e763618b-5323-4859-b34d-19dac62c66af">385,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi02LTEtMS0w_d81dba8a-67fd-47be-a09e-c26a8b8bfa03">182,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi04LTEtMS0w_656ed9db-1afb-48bb-ba53-f51c2a3f8665">3,067,055</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy0yLTEtMS0w_97a99c45-629a-4515-9a49-7f00173aea90">443,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy00LTEtMS0w_c4e7049e-f3a1-4191-91b5-0207c4ad03ca">65,291</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy04LTEtMS0w_7953385b-8efa-4dbd-8525-d4c6db9b674b">378,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS0yLTEtMS0w_205c0c9b-2276-4425-9659-a97e1e9ef4fd">11,524</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS00LTEtMS0w_c9d2d4d6-dd1f-46e1-a86c-49404baaae82">14,457</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS04LTEtMS0w_dcf98da9-5e60-429d-a2b3-cd96f5fd8190">25,981</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="iaa30fbeb1f2845cf85fcf3ed154c2d38"><div style="margin-top:10pt"><ix:continuation id="ibda7a170ea6c4ef0b94c23656ee52b79"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS0yLTEtMS0w_7dee23cd-9d08-4238-924d-c48fe56666c8">821,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS00LTEtMS0w_01430f10-85c6-4752-bb38-622a22f560ef">5,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS04LTEtMS0w_dca7afa3-9a30-4aad-9d24-a57a8d6be667">827,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi0yLTEtMS0w_943c24ac-e271-4433-b8ac-f99fe9dc2801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi00LTEtMS0w_31dbcb1d-ad82-40c4-ad41-87ae7ea0203d">13,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi04LTEtMS0w_27ed585e-1656-4455-be7e-98f58bdd8287">13,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy0yLTEtMS0w_c3ada224-0629-40ba-bb87-c3e052d8f43e">7,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy00LTEtMS0w_9b11271c-ae0b-4a36-982c-01f7f8aacfc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bhg:InvestmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy04LTEtMS0w_08f603e1-a2aa-4573-b07e-9c6187090a8b">7,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC0yLTEtMS0w_4334924e-6bd1-4898-bb9b-8fb244b5ee87">828,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC00LTEtMS0w_eecced60-6b6e-44fe-9406-1ed4a6348966">19,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC04LTEtMS0w_04769b59-98cc-4cbb-95ec-aa4f38bae9fc">847,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ec0bf0ed7741758e2d7b0b6a2cd127_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNS00LTEtMS0w_be0e5679-137e-4f16-bf66-49062f3f072b">8,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNS02LTEtMS0w_16b1e009-6807-443c-9f16-706be585a8d9">8,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi0yLTEtMS0w_2cc7a0c1-49ae-4fdf-b0a1-299acec9b9ad">828,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi00LTEtMS0w_0b747850-f001-4476-9f5e-ff03dff391e1">27,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi02LTEtMS0w_933e200e-a6ff-4c39-bbe9-76fa56a15a72">8,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi04LTEtMS0w_c5ebff26-87ad-41d2-bb3a-78d3ae7010b7">847,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy0yLTEtMS0w_fb2c524d-5a0f-4004-880c-d8b029ca0446">88,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy00LTEtMS0w_1787ebb6-efdf-4310-84d5-a1b90ce1219c">5,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy04LTEtMS0w_b392cbc6-b702-4dc2-b7fb-d6477d05759e">93,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS0yLTEtMS0w_6bfe3484-f555-4724-a68c-9885d68ba7f1">4,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS00LTEtMS0w_75cdc431-8099-4f8d-856f-c0ecbcd7fb28">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS04LTEtMS0w_db35ffab-88b1-4574-8388-c06226657cdd">5,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods presented, all of our long-lived assets were located in the United States, and all revenues were earned in the United States. We do not include asset information by reportable segment in the reporting provided to the chief operating decision maker.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfMTU0Nw_6dff9069-8ef0-4fb7-a314-42786eb73c7b" continuedAt="i01433eb1653c46ef84931035faa7d33c" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i01433eb1653c46ef84931035faa7d33c" continuedAt="id15a5d8c92ae4fde9784fa4bdf73974d"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) was an expense of $<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfNTI_1e337a04-05aa-4ee3-ba96-33835f8ff829">0.1</ix:nonFraction> million and a benefit of $<ix:nonFraction unitRef="usd" contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfNTk_1f362860-e579-4cb8-a88d-b2dacc146108">18.2</ix:nonFraction> million for the three and nine&#160;months ended September&#160;30, 2021, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The impact from income taxes varies from the federal statutory rate of 21.0% due to changes in the valuation allowance for deferred tax assets and adjustments for permanent differences. For the three months ended September&#160;30, 2021, the expense largely relates to amortization of originating goodwill from asset acquisitions. For the nine&#160;months ended September&#160;30, 2021, the overall tax benefit is primarily due to the release of valuation allowance in connection with new deferred tax liabilities recorded on identifiable intangibles as part of business combination accounting for the BND, Zipnosis, THNM, and CHP stock acquisitions. The Centrum acquisition was treated as an asset acquisition, and accordingly, no deferred tax assets or liabilities were recorded as part of business-combination accounting.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id15a5d8c92ae4fde9784fa4bdf73974d">We assess whether sufficient future taxable income will be generated to permit the use of deferred tax assets. This assessment includes consideration of the cumulative losses incurred over the three-year period ended September&#160;30, 2021. Such objective evidence limits the ability to consider other subjective evidence, such as the Company&#8217;s projections for future earnings. On the basis of this evaluation, we have recorded a valuation allowance for deferred tax assets to the extent that they cannot be supported by reversals of existing cumulative temporary differences. Any federal tax benefit generated from losses in 2021 is expected to require an offsetting adjustment to the valuation allowance for deferred tax assets, and thus have no net effect on the income tax provision.</ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.  <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMjgy_5aaddeda-9e9e-4770-9055-28a354851a58" continuedAt="i21d59a1a7e9449b8b3ed5914b285c185" escape="true">REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i21d59a1a7e9449b8b3ed5914b285c185" continuedAt="i535825732c9640838051dd06f470f4d4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Centrum acquisition on July 1, 2021, we entered into put/call agreements with respect to the equity interests in Centrum held by the controlling interest holder. The call options allow for the Company to purchase the <ix:nonFraction unitRef="number" contextRef="i29660353a02b48e987417294a4c7d8ee_I20210701" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMzI5ODUzNDg4NTU2MQ_d6f38227-ab5a-40af-b2ce-10da0c4f9757">25</ix:nonFraction>% noncontrolling interest equity over time beginning on September 30, 2022, or under certain other accelerating events as defined in the agreement, solely at the Company&#8217;s discretion. The put options allow the noncontrolling interest holder the ability to cause the Company to purchase their noncontrolling equity interest on consistent terms with the call options. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the nature of the put option&#8217;s redemption features, which are outside the control of the Company, the noncontrolling interests are classified as redeemable in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021. The put option redemption feature that is outside the control of the Company is settled based on EBITDA, which is an other than </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bright Health Group, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i535825732c9640838051dd06f470f4d4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value settlement amount. As such, we will make a measurement adjustment when the put option redemption price exceeds the carrying amount as calculated under ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was <ix:nonFraction unitRef="usd" contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfNjE_635862f9-d06b-4609-a4f2-4694dd8ebd00">no</ix:nonFraction> redeemable noncontrolling interest during the three and nine&#160;months ended September&#160;30, 2020. <ix:nonNumeric contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMjgz_1f78a7f1-5ce0-4477-84b6-5186a69c0fb3" continuedAt="i2e00f41288c04a408af0d02fe6a8e63c" escape="true">The following table provides details of our redeemable noncontrolling interest activity for the three and nine&#160;months e</ix:nonNumeric></span><ix:continuation id="i2e00f41288c04a408af0d02fe6a8e63c" continuedAt="ie361b461cbb9414c9f64523b38709f5f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nded September&#160;30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:continuation></div><div style="margin-top:10pt"><ix:continuation id="ie361b461cbb9414c9f64523b38709f5f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMS0xLTEtMS0w_49d86db2-1ef2-4fdd-bc87-d819a281be73">39,600</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMi0xLTEtMS0w_3f8cceac-3de4-420d-b047-8df05de87fb8">288</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMy0xLTEtMS0w_7c77c5de-4448-46a4-9bf9-abe18215ec92">329</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNC0xLTEtMS0w_cb6a114d-9673-4d88-ba9e-d59aee3cb02a">40,217</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNS0xLTEtMS0w_1e958b0f-17dc-41c2-9cfd-97748f64a71e">640</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNi0xLTEtMS0w_fff3f942-8b35-4f98-a573-5b682be44f10">155</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNy0xLTEtMS0w_2a65ce0c-f38e-44ee-a202-8159415f20b2">41,012</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOC0xLTEtMS0xOTE0Nw_9dbb7770-57c7-48fc-a53f-a0c755a6f38a">85,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOC0xLTEtMS0yMjU_888f9d5f-64a0-4d18-b468-02312face3d9">4,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOS0xLTEtMS0yMjU_4eb8caf6-39b7-42eb-9f42-cd32067cb9a9">8,519</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMTAtMS0xLTEtMjI1_acbcfb93-2785-4c12-8927-e5eb65f867b9">130,029</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and accompanying notes and the &#8220;Risk Factors&#8221; included elsewhere in this Quarterly Report on Form 10-Q and Bright Health Group, Inc.&#8217;s audited consolidated financial statements and the accompanying notes as well as the &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Bright Health Group, Inc.&#8217;s Prospectus dated June 23, 2021 (File No. 333-256286), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the &#8220;Prospectus&#8221;). Unless the context otherwise indicates or requires, the terms &#8220;we&#8221;, &#8220;our&#8221;, and the &#8220;Company&#8221; as used herein refer to Bright Health Group, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_79"></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright Health Group was founded in 2015 to transform healthcare. Our mission of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Making Healthcare Right. Together.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is built upon the belief that by connecting and aligning the best local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, reduce systemic waste, lower costs, and optimize clinical outcomes. We believe that for too long, U.S. healthcare, primarily designed to cater to employers and large institutions, has failed the consumer through unnecessary complexity, a lack of transparency, and rising costs. We are making healthcare&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">simple, personal, and affordable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To execute on our mission, we have developed a model for healthcare transformation built upon the delivery, financing, and optimization of care. By bringing these three core pillars together, we aim to build the national, integrated healthcare system of the future, designed to break down historical barriers and create an environment in which all stakeholders&#8201;&#8212;&#8201;from the consumer, to the provider, to the payor&#8201;&#8212;&#8201;can win.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright Health Group consists of two reportable segments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NeueHealth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright HealthCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth is critical to our differentiated, aligned model of care. While Bright HealthCare is currently a larger contributor to revenue, due in part to the significant health plan premium revenue contribution from our consumers, we believe NeueHealth has a disproportional impact on our enterprise today and anticipate it will become increasingly important to our business and prospects, contributing an increasing percentage of our overall revenue in the long-term. We have presented NeueHealth first in the following discussion, consistent with management&#8217;s view of our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">NeueHealth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Our healthcare enablement and technology business, NeueHealth, is developing the next generation, integrated healthcare system. NeueHealth significantly reduces the friction and current lack of coordination between payors and providers to enable a truly consumer-centric healthcare experience. As of September 2021, NeueHealth works with nearly 250,000 care provider partners and delivers high-quality virtual and in-person clinical care through our 44 owned primary care clinics within its integrated care delivery system. Through those risk-bearing clinics, NeueHealth maintains over 200,000 unique patient relationships as of September 30, 2021, over 170,000 of which are served through value-based arrangements, across multiple payors. In addition to our directly owned clinics, NeueHealth manages care for an additional 87 clinics through its additional affiliated clinics. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth engages in local, personalized care delivery in multiple ways, including: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Integrated Care Delivery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8201;&#8211;&#8201;NeueHealth operates clinics providing comprehensive care to all populations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bright Health Network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8201;&#8211;&#8201;A key component of our NeueHealth business is our ecosystem of Care Partners with whom we contract in service of Bright HealthCare today.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Value Services Organization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8201;&#8211;&#8201;NeueHealth empowers high-performing primary care practices and care delivery organizations to succeed in their evolution towards risk-bearing care delivery. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth receives network rental fees from Bright HealthCare for the delivery of NeueHealth&#8217;s Care Partner and network services. In addition, NeueHealth contracts directly with Bright HealthCare to provide care through its managed and affiliated </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinics. Other NeueHealth customers include external payors, third party administrators, affiliated providers and direct-to-government programs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bright HealthCare.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our healthcare financing and distribution business, Bright HealthCare, delivers simple, personal, and affordable solutions to integrate the consumer into Bright Health&#8217;s alignment model. Bright HealthCare currently aggregates and delivers healthcare benefits to over 720,000 consumers through its various offerings, serving consumers across multiple product lines in 14 states and 99 markets. We also participate in a number of specialized plans and recently began offering employer group plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright HealthCare&#8217;s customers include commercial health plans across 11 states, which serve approximately 607,000 individuals, as well as MA products </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 11 stat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es, which serve approximately 114,000 lives and generally focus on higher risk, special needs populations. We believe we are well-positioned to grow our Medicaid and Employer administrative services only (&#8220;ASO&#8221;) products, which would provide strategic diversification and be highly complementary to our aligned model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Factors Affecting Our Performance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the growth and future success of our business depends on a number of factors described below. While each of these factors presents significant opportunities for our business, they also pose important challenges that we must successfully address to sustain our growth and continue to improve results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright HealthCare&#8217;s ability to grow membership and retain consumers drives revenue growth</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright HealthCare products are primarily sold for the following year through an annual selling season, which includes the open enrollment period for </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and Family Plan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and annual enrollment period for Medicare Advantage. Outside of an annual selling season, IFP and MA products typically can only be sold during special enrollment periods based on the consumer&#8217;s eligibility status and certain life events. It is critical to effectively engage both prospective and existing consumers through our multi-channel distribution strategy. For both IFP and MA products, we aim to offer competitive benefits at an affordable price to meet the needs of our consumers. Our IFP products membership typically peaks after the open enrollment period and experiences modest levels of attrition until year-end. We have historically increased our MA consumer base during special enrollment periods, given our consumers' eligibility to enroll during those periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MA business is afforded additional in-year growth opportunity due to its focus on serving low-income seniors and special needs individuals, who can enroll in and change MA health plans at any time. Therefore, constant engagement with this population is critical to effectively retain membership and drive in-year growth. MA products are generally associated with higher revenue and higher medical cost ratios (&#8220;MCR&#8221;) as compared to IFP products, particularly with respect to special needs plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright HealthCare&#8217;s ability to capture complete and accurate risk adjustment data affects revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of premium revenue from our IFP products and MA plans are determined by the applicable Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) risk adjustment models, which compensate insurers based on the underlying health status (acuity) of insured consumers. CMS requires that a consumer&#8217;s health status be documented annually and accurately submitted to CMS to determine the appropriate risk adjustment. Ensuring that complete and accurate health conditions of our consumers are captured within documentation submitted to CMS is critical to recognizing accurate risk adjustment, which is reflected in our revenue year-over-year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright HealthCare&#8217;s ability to drive lower unit costs and medical utilization reduces medical costs and MCR</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright HealthCare utilizes our Bright Health Network to provide healthcare services primarily within its exclusive provider networks under capitated contracts and fee-for-service arrangements. Certain provider and payor contracts include value-based incentive compensation based on providers meeting contractually defined quality and financial performance metrics. To effectively manage medical costs, Bright HealthCare must ensure a consumer&#8217;s healthcare needs are primarily delivered through its Care Partners to recognize discounted contracted rates, which limits the amount of out-of-network utilization that </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">can have an adverse financial impact on medical costs and MCR. Out-of-network utilization is typically higher upon entry into new markets, which increases medical costs during periods of market expansion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is generally affected by the seasonal patterns of medical expenses. With respect to IFP products, medical costs tend to be lower early in the year and increase toward the end of year, driven by high deductible plan designs and out-of-pocket maximums over the course of the policy year, which shift more costs to us in the second half of the year as we pay a higher proportion of claims. With respect to MA plans, medical costs are impacted by the severity of the flu season, generally from December to March, and we typically experience slightly higher Part D medical costs early in the year, which decline toward the end of year due to standard plan design. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NeueHealth&#8217;s ability to identify and align with high-performing care delivery partners drives performance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth engages providers through a variety of alignment options ranging from having providers participate in our networks to having providers employed by us. As we enter new markets and expand our offerings, we must build an ecosystem of care delivery assets capable of supporting both our Bright HealthCare business as well as third-party payors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NeueHealth&#8217;s ability to deliver and enable high-quality, value-based care drives revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth supports and manages providers in fee-for-service and value-based contracts with payors. We help organizations enter value-based arrangements designed around their needs, while simultaneously empowering them with the tools and capabilities necessary to maximize their success. In order to drive financial performance, NeueHealth must effectively manage risk and continue to develop and deliver tools and services supporting both managed and affiliated providers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright Health Group&#8217;s ability to achieve operating cost efficiencies and scale profitably</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright Health Group, including Bright HealthCare and NeueHealth, will need to continue investing in operating platforms, processes, people, and resources to enable our businesses to scale profitably. We leverage centralized shared services for operational, clinical, technological, and administrative functions to support the segments in a cost-effective and efficient manner.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from premiums, including value-based provider revenue, and fee-for-service provider revenue received from consumers and payors, as well as income from our investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue is derived primarily from Bright HealthCare IFP products and MA plans sold to consumers as well as NeueHealth value-based provider revenue from serving patients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bright HealthCare Commercial premium revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of commercial premium revenue are primarily IFP products which are comprised of advanced premium tax credit subsidies that are based on consumers income levels and compensated directly by the federal government, as well as billed consumer premiums. IFP products reflect adjustments related to the Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) risk adjustment program, which adjusts premium revenue based on the demographic factors and health status of each consumer as derived from current-year medical diagnoses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bright HealthCare MA premium revenue</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of MA premium revenue are Medicare Part C premiums related to consumers&#8217; medical benefit coverage and Part D premiums related to consumers&#8217; prescription drug benefit coverage. Medicare Part C premiums are comprised of CMS monthly </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capitation premiums that are risk adjusted based on CMS defined formulas using consumers&#8217; demographics and prior-year medical diagnoses. Medicare Part D premiums are comprised of CMS monthly capitation premiums that are risk adjusted, consumer billed premiums and CMS low-income premium subsidies for the Company&#8217;s insurance risk coverage. Medicare Part D premiums are subject to risk sharing with CMS under the risk corridor provisions based on profitability of the Part D benefit. As a percentage of our total consolidated revenue, premium revenues from CMS were 30% and 37% for the nine months ended September 30, 2021 and 2020, respectively, which are included in our Bright HealthCare segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NeueHealth premium revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NeueHealth premium revenue represents revenue under value-based arrangements entered into by NeueHealth&#8217;s Value Services Organization and affiliated medical groups in which the responsibility for control of an attributed patient&#8217;s medical care is transferred, in part or wholly, to such medical groups. Such revenue includes capitation payments, as well as quality incentive payments, and shared savings distributions payable upon achievement of certain financial and quality metrics. Value-based revenue shifts responsibility for control over the medical care delivered to attributed patients to the Company and aligns incentives around the overall well-being of the payor&#8217;s consumers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that as our NeueHealth business continues to grow, NeueHealth premium revenue will become an increasing proportion of our overall revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue primarily represents revenue from fee-for-service payments received by NeueHealth&#8217;s affiliated medical groups. These include patient copayments and deductibles collected directly from patients and payments from private and government payors based upon contractual terms that define the fee-for-service reimbursement for specific procedures performed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, service revenue includes network service revenue generated by NeueHealth&#8217;s Bright Health Network. Bright HealthCare is currently the only customer of Bright Health Network. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of investment income are interest income and realized gains and losses derived from the Company&#8217;s investment portfolio that is comprised of debt securities of the U.S. government and other government agencies, corporate investment grade, money market funds and various other securities, as well as realized and unrealized gains and losses from equity securities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs consist of reimbursements to providers for medical services, costs of prescription drugs, supplemental benefits, reinsurance and quality incentive and shared savings compensation to providers. The Company contracts with hospitals, physicians and other providers of healthcare primarily within its exclusive provider networks under fee-for-service and value-based arrangements. Emergency medical services incurred out-of-network are a covered benefit to consumers and reimbursed to providers according to the Company&#8217;s payment policies that are based on applicable regulations. Prescription drug costs are determined based on the contract with our pharmacy benefits manager, which includes pharmacy rebates that are received for certain drug utilization levels or contracted minimums. Dental, vision, and other supplemental medical services are provided to consumers under capitated arrangements. Reinsurance arrangements enable us to cede a specified percent of our premiums and claims to our third-party reinsurers. Under such contracts, the reinsurer is paid to cover claims-related losses over a specified amount, which mitigates catastrophic risk. We make quality incentive and shared savings compensation payments to certain providers in accordance with the terms of the contractual arrangement upon the achievement of certain financial and quality metrics. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating costs are comprised of the expenses necessary to execute the Company&#8217;s business operations. These include employee compensation for salaries and related benefit costs, share-based compensation, outsourced vendor contracted service and technology fees, professional services, technological infrastructure and service fees, facilities costs and other administrative expenses. Operating costs also include payments made by Bright HealthCare to NeueHealth for the provision of Bright Health Network services; selling and marketing expenses from external broker commissions and advertising, primarily related to consumer acquisition; and premium taxes, exchange fees and other regulatory costs, which are primarily based on premium revenue. We expect operating costs to increase in absolute amounts as our business grows, but to decrease as a percentage of our revenue in the long-term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization consist of depreciation of property, equipment and capitalized software, as well as amortization of definite-lived intangible assets acquired in business combinations, including trade names, customer relationships, and reacquired rights. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) consists primarily of changes to our current and deferred federal tax assets and liabilities net of applicable valuation allowances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2021, the Company&#8217;s Registration Statement on Form S-1 for the initial public offering of shares of common stock was declared effective by the U.S. Securities &amp; Exchange Commission. The Company&#8217;s common stock began trading on the NYSE under the ticker symbol &#8220;BHG&#8221; on June 24, 2021. The IPO closed on June 28, 2021 and the Company sold 51,350,000 shares of common stock at a price of $18.00 per share. In aggregate, the shares issued in the offering generated $887.3 million in net proceeds, the amount of which is net of $37.0 million in underwriters&#8217; discounts and commissions. Immediately effective upon the closing of our IPO, all 167,731,830 shares of our then outstanding preferred stock were converted into 427,897,381 shares of common stock, causing the Company to reclassify $1.8 billion from redeemable preferred stock within temporary equity to common stock and additional paid-in capital on our consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilized a portion of the net proceeds to repay the $200.0 million principal balance of indebtedness outstanding under our revolving credit agreement originally entered into on March 1, 2021 and the associated interest and other costs of $3.2 million. Additionally, we used a portion of the proceeds to fund the acquisition of Centrum as described in Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remainder of the net proceeds will be used for general corporate purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion related to the IPO as described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Bright Health Group, Inc.&#8217;s unaudited condensed consolidated financial statements. </span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Update</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, including its effect on the macroeconomic environment, and the response of our local, state, and federal governments to contain and manage the virus, continues to impact our business. The emergence of COVID-19 variants in the United States and abroad continues to prolong the risk of additional surges of the virus. In addition, some individuals have delayed or are not seeking routine medical care to avoid COVID-19 exposure. These and other responses to the COVID-19 pandemic have meant that our MCR may be subject to additional uncertainty as certain segments of the economy and workforce come back on line, members resume care that may have been foregone, and the broader population becomes vaccinated. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced impacts to our business from COVID-19, which have varied as the pandemic progressed. Initially, as a result of the suspension of elective surgeries and deferral of medical care, we experienced decreased medical utilization, particularly in the second quarter of 2020. Since then, medical utilization has returned to more normal levels and adverse financial impacts from inpatient admissions emerged primarily due to increased average length of stays. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n the third quarter of 2021, our results were impacted by COVID-19 trends in two of our largest IFP markets. Florida and North Carolina both saw significant increases in COVID-19 cases in the third quarter, with Centers for Disease Control and Prevention (&#8220;CDC&#8221;) data indicating average daily COVID-19 case counts were up nearly 300% in each state when compared to the second quarter of 2021. In addition, during the third quarter of 2021, the Southeast United States experienced average daily COVID-19 counts increasing nearly 250% when compared against the second quarter of 2021. This drove our COVID-19 expense in the third quarter of 2021 up 65.6% from the second quarter and our IFP COVID expense was up more than 160% compared to the second quarter of 2021. Fo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r the three months ended September 30, 2021 and 2020, the impact of COVID-19 increased our MCR by 540 basis points and 390 basis points, respectively, reflecting an increase in medical costs of $55.6 million and $13.3 million, respectively. For the nine months ended September 30, 2021 and 2020, the impact of COVID-19 increased our MCR by 420 basis points and 290 basis points, respectively, reflecting an increase in medical costs of $124.0 million and $23.8 million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall measures to contain the COVID-19 outbreak may remain in place for a significant period of time, as certain geographic regions have experienced a resurgence of COVID-19 infections and new strains of COVID-19 that appear to be more transmissible have emerged. Although the number of people who have been vaccinated has been increasing, the duration and severity of this pandemic is unknown and the extent of the business disruption and financial impact depends on factors beyond our knowledge and control. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Update</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to make progress on our model that aligns the financing of care with the delivery of care. We are focused on serving the consumer in retail healthcare marketplaces, including the exchange and government direct-to-consumer markets. Both businesses are supported by our Bright Health Intelligent Operating System (&#8220;BiOS&#8221;) technology platform, where we continue to see efficiencies due to that investment. We view the following five key themes as important in connection with our third quarter and year-to-date results:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We continue to demonstrate significant growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; We continue to experience strong growth across both of our businesses. Bright HealthCare now serves over 720,000 consumers as of September 30, 2021, up 247% compared to the third quarter of 2020. This includes over 114,000 MA members. In commercial, the growth in members reflects the extended 2021 Special Enrollment Period in IFP with enrollment of nearly 607,000 consumers at the end of the third quarter of 2021 up nearly 10% from the end of the second quarter of 2021. NeueHealth also continues to demonstrate growth with a total of 131 owned and affiliated Primary Care Clinics serving over 170,000 patients under value-based arrangements as of September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We have delivered consistent performance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Our third quarter 2021 results reflect quarterly variability due to the negative impact of an increase in direct COVID-19 costs, as well as risk adjustment pressures from the significant contribution of new 2021 membership and COVID-19 related challenges in member engagement. The extended Special Enrollment Period led to significant membership growth beyond the interim capacity within the owned and affiliated parts of our integrated systems of care, which we have alleviated through an accelerated pace of clinic and affiliate development and additional investments in our operating platform. While we did experience a modest reduction in utilization from non-COVID related procedures, such as certain elective inpatient surgeries and other diagnostic tests, the cost benefit was more than offset by the negative impact to appropriately diagnose our newly attributed members, which resulted in an increase in our risk adjustment payable. We believe our year-to-date results better reflect the underlying performance of our business than the third quarter results. We expect a number of the factors that drove volatility in the third quarter of 2021 to normalize in 2022 as the contribution from retained consumers increases, direct COVID-19 costs decrease, and as capacity improvements in our aligned integrated systems of care drive improved gross margin.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We are driving differentiation through NeueHealth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; We are seeing strong growth in NeueHealth&#8217;s revenue and operating income that we believe highlights the power of our owned clinics and our affiliates within our aligned model. The growth in our NeueHealth business reflects the continued investments we are making in value-based care, as well as the Centrum acquisition, which closed on July 1, 2021. We are continuing to expand on this model in Florida, as well as bringing this model to new markets, including Texas and North Carolina in 2022. Our previous target to open more than 25 de novo clinics in 2022 is still on track. We are also bringing in more affiliates into a fully aligned model, where providers are clinically, financially, and technologically aligned with Bright HealthCare. In addition, we have a robust pipeline of third-party payors interested in leveraging our integrated model across multiple populations as we go into 2022 and, as a result, expect to see growth in health plan customers in 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We are building one technology platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; We continue investing in the BiOS back-end infrastructure, DocSquad consumer and provider-facing tools, and acquisition integration. We have been making investments and accelerating our timeline for integration to one platform, which has resulted in some near-term cost structure headwinds. We are making progress on integrating the health plan assets we acquired, with integration of appropriate corporate office and support functions expected to be completed in 2022, our Bright HealthCare IFP business expected on a single platform in 2023, and full operating platform unification to follow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Continued future growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; NeueHealth will continue to be an increasingly important component of our business.  We expect growth for the business in 2022 and continued integration of NeueHealth with our Bright HealthCare business. In Florida and Texas, we expect to see movement toward health plan offerings that leverage our owned and affiliated clinics within our aligned Integrated Systems of Care. Direct Contracting also provides a new growth opportunity for NeueHealth, adding to the total lives in fully aligned value-based arrangements and contributing to revenue in a capital efficient model. In Bright HealthCare, we expect growth in our core MA markets with a focus on higher complexity patient populations, including C-SNP and D-SNP products, specific ethnic communities requiring culturally competent care and service models, and states with an opportunity for IFP consumers to age into MA plans. In IFP, we are well-positioned based on where we have set rates for 2022, with our plans consistently the lowest or second-lowest cost silver plan in core growth markets. Additionally, we are expanding our addressable market next year, entering four new states including Texas and Georgia, and offering IFP plans for the first time California, which represent three of the largest ACA markets in the country. At the same time, we will remain disciplined in our growth, making appropriate rate adjustments based on our 2021 experience and competitive positioning. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_88"></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Metrics and Non-GAAP Financial Measures</span></div><div style="margin-top:8.55pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our GAAP financial information, we review a number of operating and financial metrics, including the following key metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate our business plan and make strategic decisions.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright HealthCare Consumers Served</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,594</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth Patients</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-based Care Patient Lives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;padding-left:10.43pt;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial plans include IFP and employer plans. Prior to 2021, our commercial business was solely comprised of IFP products. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bright HealthCare Consumers Served</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumers served include Bright HealthCare individual lives served via health insurance policies across multiple lines of business, primarily attributable to IFP products and MA plans in markets across the country. We believe growth in the number of consumers is a key indicator of the performance of our Bright HealthCare business. It also informs our management of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operational, clinical, technological and administrative functional area needs that will require further investment to support expected future consumer growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value-Based Care Patients</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Value-based care patients are patients attributed to providers contracted under varied value-based care delivery models in which the responsibility for control of an attributed patient&#8217;s medical care is transferred, in part or wholly, to our NeueHealth managed medical groups. We believe growth in the number of value-based care patients is a key indicator of the performance of our NeueHealth business. It also informs our management of the operational, clinical, technological and administrative functional area needs that will require further investment to support expected future patient growth. Over time, we expect our value-based care patients will increase as we convert fee-for-service arrangements into value-based care financial arrangements.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(364,990)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(245,918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">See &#8220;Non-GAAP Financial Measures&#8221; below for reconciliations to the most directly comparable financial measures calculated in accordance with GAAP and related disclosures.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_91"></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as net loss excluding interest expense, income taxes, depreciation and amortization, adjusted for the impact of acquisition and financing-related transaction costs, share-based compensation, changes in the fair value of contingent consideration and contract termination costs. Adjusted EBITDA has been presented in this Quarterly Report as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP, because we believe it assists management and investors in comparing our operating performance across reporting periods on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes Adjusted EBITDA is useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses Adjusted EBITDA to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is not a recognized term under GAAP and should not be considered as an alternative to net income (loss) as a measure of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, this measure is not intended to be a measure of free cash flow available for management&#8217;s discretionary use as we do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. The presentation of this measure has limitations as an analytical tool and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentation of this measure may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of net loss to Adjusted EBITDA for the periods presented:</span></div><div style="margin-top:7.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(364,990)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,594</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,981</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">448</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,180</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(245,918)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,084)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290,757)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:0.25pt"><span><br/></span></div><div style="margin-top:0.95pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Transaction costs include accounting, tax, valuation, consulting, legal and investment banking fees directly relating to business combinations and certain costs associated with our initial public offering. These costs can vary from period to period and impact comparability, and we do not believe such transaction costs reflect the ongoing performance of our business.</span></div><div style="margin-top:0.95pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents non-cash compensation expense related to stock option and restricted stock award grants, which can vary from period to period based on a number of factors, including the timing, quantity and grant date fair value of the awards.</span></div><div style="margin-top:0.95pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents the non-cash change in fair value of contingent consideration from business combinations, which is remeasured at fair value each reporting period. There was no material activity for periods prior to the first quarter of 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents amount paid for early termination of an existing vendor contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our unaudited Condensed Consolidated Statements of Income (Loss) data and other financial information for the three and nine months ended September 30, 2021 and 2020.</span></div><div style="margin-top:7.95pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Income (loss) and operating data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,020,233</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,426</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,922,950</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827,135</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,602</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,345</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112,503</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,078,657</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,067,055</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,542</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,050,943</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,640,143</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,114</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">309,790</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,379</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">779,090</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,650</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,205</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,981</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,550</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,374,938</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411,376</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,445,214</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,314</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,281)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(378,159)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,772)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,594</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,282</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,226)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,226)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,649)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(383,215)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,772)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,225)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,162)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,722)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(364,990)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;non-controlling interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,942)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,354)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss attributable to Bright Health<br/>Group, Inc. common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(300,664)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(370,344)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(245,918)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,084)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290,757)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,188)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Cost Ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Cost Ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8%</span></td></tr></table></div><div style="margin-top:7.95pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Medical Cost Ratio is defined as medical costs divided by premium revenue.</span></div><div style="margin-top:7.95pt;padding-left:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Operating Cost Ratio is defined as operating costs divided by total revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s increased by $726.5 million, or 206.3%, for the three months ended September 30, 2021 as compared to the same period in 2020, which was largely </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">driven by an increase in Bright HealthCare consumers of approximately 513,000 consumer lives, or 247.2%, primarily from organic growth in IFP within our Commercial business, including the 2021 Special Enrollment Period, as well as organic and inorganic contributions from the MA business. Increases in our risk adjustment liability partially offset the total revenue increases. For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $134.0 million due to a change in our risk adjustment payable accrual as a result of updated data inputs used to calculate IFP members&#8217; expected full year risk scores, of which $89.3 million related to the first six months of 2021. The three months ended September 30, 2021 included $200.0 million from the acquisitions of PMA, THNM, Zipnosis, CHP and Centrum. Total revenues increased by $2.2 billion, or 261.9%, for the nine months ended September 30, 2021 as compared to the same period in 2020, primarily driven by organic consumer growth in our Commercial business, as well as favorable rate impacts in our Commercial business. The nine months ended September 30, 2021 included $699.8 million from acquisitions for which there was no comparable amount in the nine months ended September 30, 2020. The three and nine months ended September 30, 2021 also experienced an increase in investment income compared to the same periods in 2020, primarily driven by unrealized gains from investments in equity securities of $46.3 million and $109.0 million, respectively.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs increased by $739.6 million, or 237.6%, for the three months ended September 30, 2021 as compared to the same period in 2020. The increase in medical costs was driven by an increase in consumers through both organic growth in our Commercial and MA businesses and inorganic growth attributable to the acquisitions of PMA, THNM, CHP and Centrum, as well as increased medical costs from COVID-19. Medical costs increased by $2.0 billion, or 291.1%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in medical costs was driven by consistent factors with the three months ended September 30, 2021 with additional impact from the acquisition of Brand New Day, which was acquired on April 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCR of 103.0% for the </span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ended September 30, 2021 increased 1,290 basis points compared to the same period in 2020. </span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Special Enrollment Period and our overall growth created challenges for capturing underlying risk, and we were impacted by COVID-19 related costs given the significant portion of our consumers in Florida, as well as our significant mix of new members given our consumer growth in 2021. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCR for the three months ended September 30, 2021 included a 540 basis point unfavorable impac</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t from COVID-19 related costs and a 900 basis point unfavorable impact from non-COVID prior period developments (&#8220;PPD&#8221;) primarily related to a reduction in premium revenue related to an increase in our risk adjustment payable. Our MCR for the three months ended September 30, 2020 included a 390 basis point unfavorable impact from COVID-19 costs and a 530 basis point favorable impact from non-COVID PPD.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCR</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of 90.3%</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the nine months ended September 30, 20</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21 increased 870 basis points compared to the same period in 2020, which reflected the challenges of COVID-19, significant growth and the Special Enrollment Period. Our MCR for the nine</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended September 30, 2021 included a 420 basis point unfavorable impact from COVID-19 related costs and a 90 basis point unfavorable impact from non-COVID PPD. Our MCR for the nine months ended September 30, 2020 included a 290 basis point unfavorable impact from COVID-19 costs, a 200 basis point favorable impact from non-COVID PPD and a 150 basis point favorable impact due to deferred utilization. T</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he MCR in both 2021 periods was also impacted by increased medical costs from MA product mix as a result of the Brand New Day and CHP acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating costs increased by $212.4 million, or 218.1%, for the three months ended September 30, 2021 as compared to the same period in 2020. Operating costs increased by $518.4 million, or 198.9%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in operating costs in both periods was primarily due to increases in operating costs from new market entry, increased marketing and selling expenses related to the 2021 special enrollment period in our Commercial business and increased compensation and benefit costs driven by an increase in employees and an increase in share-based compensation costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating cost ratio of 28.7% for the three months ended September 30, 2021, increased 100 basis points compared to the same period in 2020 primarily due to increased compensation and benefit costs driven by an increase in employees and an increase in share-based compensation costs as well as an early contract termination charge in the current-year period. Our operating cost ratio of 25.4% for the nine months ended September 30, 2021 improved 540 basis points compared to the same period in 2020 primarily due to operating costs increasing at a slower rate than the increased premium revenues earned due to consumer growth, as we continue to gain leverage on our operating costs as we grow, partially offset by an increase in broker commission costs associated with new membership growth .</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased by $11.5 million, or 430.4%, for the three months ended September 30, 2021 as compared to the same period in 2020, primarily due to the $11.3 million of amortization expense resulting from intangible assets acquired in the PMA, THNM, Zipnosis, CHP, and Centrum acquisitions, for which there were no comparable amounts in the three months ended September 30, 2020. Depreciation and amortization increased by $20.4 million, or 368.1%, for the nine months ended September 30, 2021 as compared to the same period in 2020, primarily due to $19.5 million from intangible assets acquired for which there were no comparable amounts in the nine months ended September 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $1.6 million and $6.3 million for the three and nine months ended September 30, 2021, respectively, which was due to interest on the Credit Agreement we entered into in March 2021, as well as amortization of debt issuance costs. We did not have any interest expense for either of the comparable periods in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax was an expense of $0.1 million and a benefit of $18.2 million for the three and nine months ended September 30, 2021, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021, the income tax expense largely relates to amortization of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">originating goodwill from asset acquisitions. For the nine&#160;months ended September&#160;30, 2021, the overall tax benefit is primarily due to the release of valuation allowance in connection with new deferred tax liabilities recorded on identifiable intangibles as part of business combination accounting for the Zipnosis, THNM, and CHP stock acquisitions, as well as a measurement period adjustment related to the BND acquisition.</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognized an income tax benefit of $9.2 million during the nine months ended September 30, 2020, which was due to the impact of goodwill and intangible assets acquired in the Brand New Day acquisition in April 2020. </span></div><div style="margin-top:8.1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Bright HealthCare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of income (loss) and operating data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bright HealthCare:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">625,926</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,930,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">368,599</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">929,374</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,491</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">995,612</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,863,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,019,081</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,588,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">275,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">707,520</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,298,883</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,307,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(303,271)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,263)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443,450)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Cost Ratio (MCR)</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">102.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial reven</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue increase</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d by $455.5 million, or 267.3%, for the three months ended September 30, 2021 as compared to the same period in 2020. Commercial revenue increased by $1.4 billion, or 277.9%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in revenues in both 2021 periods compared to 2020, was driven by an increase in consumer lives of approximately 513,000 due to organic growth, higher net premium rates in certain markets, plan mix, and inorganic growth from the acquisition of THNM, which are partially offset by an increase in risk adjustment payables. The three months ended September 30, 2021 included a change in estimate for the expected full-year risk adjustment scoring impact of $134.0 million, of which $89.3 million related to the first six months of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MA reven</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue increased by $195.6</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million, or 113.0%, for the three months ended September 30, 2021 as compared to the same period in 2020. MA reven</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue increased by $619.1</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million, or 199.5%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The three and nine months ended September 30, 2021 included $125.7 million and $266.8 million, respectively, of revenue from our acquisition of CHP on April 1, 2021. The remaining increase was primarily driven by volume increases due to organic growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs increased by $707.8 million, or 227.3%, for the three months ended September 30, 2021 as compared to the same period in 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021 and 2020, the impact of COVID-19 increased our medical costs $55.6 million and $13.3 million, respectively. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs increased by $1.9 billion, or 283.4%, for the nine months ended September 30, 2021 as compared to the same period in 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021 and 2020, the impact of COVID-19 increased our medical costs by $124.0 million and $23.8 million, respectively. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in both 2021 periods is also due to an increase in consumers driven by organic growth, unfavorable medical cost rates and inorganic growth as a result of acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCR of 102.5% for the three months ended September 30, 2021 increased 1,180 basis points compared to the same period in 2020. Our MCR for the three months ended September 30, 2021 included a 560 basis point unfavorable impact from COVID-19 related costs and a 910 basis p</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oint unfavorable impact from non-COVID PPD related to risk adjustment. Our MCR </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended September 30, 2020 included a 390 basis point unfavorable impact from COVID-19 costs and a 530 basis point favorable impact from non-COVID PPD. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCR of 90.5% for the nine months ended September 30, 2021 increased 830 basis points compared to the same period in 2020. Our MCR for the nine months ended September 30, 2021 included a 430 basis point unfavorable impact from COVID-19 related costs and a 90 basis p</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oint unfavorable impact from non-COVID PPD. Our MCR for the nine months ended September 30, 2020 included a 290 basis point unfavorable impact from COVID-19 costs, a 210 basis point favorable impact from non-COVID P</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PD and a 150 basis point unfavorable impact from deferred utilization. The MCR in both 2021 periods was also impacted by increased medical costs from MA product mix as a result of the Brand New Day and CHP acquisitions and an increase in risk adjustment payable, which was partially offset by favorable market mix and rate in IFP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating costs increased by $186.3 million, or 209.5%, for the three months ended September 30, 2021 as compared to the same period in 2020. Operating costs increased by $470.1 million, or 198.0%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in both periods during 2021 compared to the same periods in 2020 was primarily due to increases in operating costs from new market entry, increased marketing and selling expenses related to the 2021 SEP in our Commercial business and increased compensation and benefit costs driven by an increase in employees and an increase in share-based compensation costs. In addition, the 2021 periods also have increased operating costs from acquisitions, which do not have a comparable prior period impact.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased by $2.3 million, or 101.6%, for the three months ended September 30, 2021 as compared to the same period in 2020. Depreciation and amortization increased by $7.4 million, or 179.0%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in the three and nine month periods ended September 30, 2021 was primarily due to amortization expense of $2.6 million and $7.0 million, respectively, resulting primarily from intangible assets acquired for which there were no comparable amounts in the 2020 periods.</span></div><div style="margin-top:8.15pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of income (loss) and operating data:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NeueHealth:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">221,836</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,258</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109,012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">385,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">211,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94,733</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,457</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">215,814</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">320,366</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Cost Ratio (MCR)</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenue increased by $155.0 million for the three months ended September 30, 2021 as compared to the same period in 2020. Premium revenue increased by $215.9 million for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in premium revenue for the three and nine months ended September 30, 2021 include</span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s $137.2 million and $170.3 million, re</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spectively, from the acquisitions of PMA and Centrum, as well as an organic increase in patient lives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by $11.9 million, or 155.7%, for the three months ended September 30, 2021 as compared to the same period in 2020. Service revenue increased by $33.3 million, or 154.7%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in service revenue in both 2021 periods is primarily driven by increased intercompany network contract service revenue with our Bright HealthCare segment, which is charged on a per consumer per month basis and has increased due to market expansion and an increase in consumer lives. The acquisitions of PMA on December 31, 2020 and Zipnosis on March 31, 2021 also contributed to the year-over-year increase in service revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income was $46.3 million and $109.0 million for the three and nine months ending September 30, 2021, respectively, due to unrealized gains on equity securities acquired in 2021. NeueHealth did not hold any investments during the three and nine months ended September 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs were $163.3 million and $211.2 million for the three and nine months ended September 30, 2021, respectively,  which were primarily driven by an increase in patient lives as a result of the PMA and Centrum acquisitions, as well as organic growth in our value-based arrangements. MCR was 104.0% and 95.2% in the three and nine months ended September 30, 2021, respectively. There were no medical costs in the three and nine months ended September 30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating costs increased by $31.7 million, or 283.5%, for the three months ended September 30, 2021 as compared to the same period in 2020. Operating costs increased by $63.3 million, or 201.7%, for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in both 2021 periods was primarily due to increased compensation and benefit costs from more employees, and outsourced vendor fees in support of consumer growth, as well as costs from the PMA, Zipnosis and Centrum acquisitions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased by $9.2 million for the three months ended September 30, 2021 as compared to the same period in 2020. Depreciation and amortization increased by $13.0 million for the nine months ended September 30, 2021 as compared to the same period in 2020. The increase in the three and nine months ended September 30, 2021 was primarily due to amortization expense of $8.8 million and $12.4 million, respectively, resulting from intangible assets acquired for which there were no comparable amounts in the 2020 periods.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess our liquidity in terms of our ability to generate adequate amounts of cash to meet current and future needs. Our expected primary uses on a short-term and long-term basis are for geographic and service offering expansion, acquisitions, and other general corporate purposes. We have historically funded our operations and acquisitions primarily through the sale of preferred stock, and more recently, through sales of our common stock, which generated cash proceeds of $887.3 million upon closing of our IPO on June 28,</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and investment balances held at regulated insurance entities are subject to regulatory restrictions and can only be accessed through dividends declared to the non-regulated parent company or through reimbursements from administrative services agreements with the parent company. The Company has declared one dividend from the regulated insurance entities to the parent company during the nine months ended September 30, 2021, and had no dividends for the same period in 2020. The regulated legal entities are required to hold certain minimum levels of risk-based capital and surplus to meet regulatory requirements. As of September 30, 2021 and December 31, 2020, the amounts held in risk-based capital and surplus at regulated insurance legal entities was in excess of the minimum requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expect to continue to incur operating losses and generate negative cash flows from operations for the foreseeable future due to the investments we intend to continue to make in expanding our operations and due to additional general and administrative costs we expect to incur in connection with operating as a public company. We believe that existing cash on hand, investments and amounts available under our Credit Agreement described below will be sufficient to satisfy our anticipated cash requirements for the next twelve months. However, we may seek additional capital to support our future growth plans and other strategic opportunities that may arise.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we entered into a $350.0 million revolving credit agreement with a syndicate of banks (the &#8220;Credit Agreement&#8221;). On August 2, 2021, the Credit Agreement was amended to change the definition of &#8220;Qualified IPO&#8221; by reducing the net proceeds required to be received by the Company from $1.0 billion to $850.0 million. In addition, prior to such amendment, the Credit Agreement contained a covenant that required the Company to maintain a total debt to capitalization ratio of (a) 0.25 to 1.00 prior to a Qualified IPO, and (b) 0.30 to 1.00 after a Qualified IPO. The Amendment changed this covenant by removing the increase in the ratio after a Qualified IPO such that the Company is now required to maintain a total debt to capitalization ratio of 0.25 to 1.00.  On August 4, 2021, we elected to extend the maturity date of the Credit Agreement from February 28, 2022 to February 28, 2024. We utilized a portion of the net IPO proceeds to repay the $200.0 million principal balance of indebtedness outstanding under our revolving credit agreement originally entered into on March 1, 2021 and the associated interest and other costs of $3.2 million. During the second quarter of 2021, we repaid the full amount and as of September 30, 2021, we have no borrowings outstanding under the Credit Agreement.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains a covenant that require us to maintain a minimum liquidity of $150.0 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the Credit Agreement are secured by substantially all of the assets of the Company and its wholly owned subsidiaries that are designated as guarantors, including a pledge of the equity of each of its subsidiaries. Borrowings under the Credit Agreement accrue interest at the Company&#8217;s election either at a rate of: the (i) the sum of (a) the greatest of (1) the Prime Rate (as defined in the Credit Agreement), (2) the rate of the Federal Reserve Bank of New York in effect plus 1&#8725;2 of 1.0% per annum, and (3) London interbank offered rate (&#8220;LIBOR&#8221;), plus 1% per annum, and (b) a margin of 4.0%; or (ii) the sum of (a) the LIBOR multiplied by a statutory reserve rate and (b) a margin of 5.0%. In addition, the commitment fee is 0.75% of the unused amount of the Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the Credit Agreement contains covenants that, among other things, restrict the ability of the Company and its subsidiaries to make dividends or other distributions, incur additional debt, engage in certain asset sales, mergers, acquisitions or similar transactions, create liens on assets, engage in certain transactions with affiliates, change its business or make investments. In addition, the Credit Agreement contains other customary covenants, representations and events of default.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_106"></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had $956.2 million in cash and cash equivalents, $331.7 million in short-term investments and $681.9 million long-term investments on the consolidated balance sheet. Our cash and investments are held at non-regulated entities and regulated insurance entities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had non-regulated cash and cash equivalents of $207.9 million, short-term investments of $206.8 million and long-term investments of $88.3 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had regulated insurance entity cash and cash equivalents of $748.3 million, short-term investments of $124.9 million, of which $3.5 million was restricted, and long-term investments of $593.6 million, of which $4.1 million was restricted. </span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_109"></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:9.45pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of our cash flows for the periods shown:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">233,114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(653,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528,830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">887,832</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">467,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">956,189</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693,133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:0.35pt"><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, net cash provided by operating activities increased by $221.8 million compared to the nine-month period ended September 30, 2020, primarily driven by the increase in consumer growth driving the increased medical costs and risk adjustment payables, as well as accounts payables and other liabilities, and increased medical costs in the MA business driven by the Brand New Day and CHP acquisitions, partially offset by an increase in our net loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, net cash used in investing activities increased by $124.3 million compared to the nine-month period ended September 30, 2020. The increase was primarily attributable to a $257.6 million increase in cash used for acquisitions, which was partially offset by a decrease in purchases of investments, net of proceeds from sales, paydowns and maturities of investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, net cash provided by financing activities increased by $200.1 million compared to the nine-month period ended September 30, 2020, primarily driven by $887.3 million of proceeds from our IPO in June 2021, offset by $6.7 million of cash paid for IPO offering costs, and an increase in proceeds from the issuance of common stock resulting from stock option exercise in the nine months ended September 30, 2021. These increases were partially offset by $686.8 million of proceeds from issuance of preferred stock in the nine months ended September 30, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting policies that reflect our more significant judgements and estimates used in the preparation of our condensed consolidated financial statements include those described in the Prospectus under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; Critical Accounting Policies and Estimates.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates disclosed in the Prospectus. </span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recently issued accounting pronouncements, see Note 1,</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Organization and Basis of Presentation</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in our condensed consolidated financial statements of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The level of our pretax earnings is subject to market risk due to changes in interest rates and the resulting impact on investment income and interest expense. We invest in a professionally managed portfolio of securities, which includes debt securities of publicly traded companies, obligations of the U.S. government, domestic government agencies, and state and political subdivisions. At September 30, 2021 our net unrealized gain position was $0.2 million, compared to a net unrealized gain position of $2.4 million at December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on effectiveness of controls and procedures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2021, our disclosure controls and procedures were not effective due to the material weakness in our internal control over financial reporting described below. In light of this fact, our management has performed additional analyses, reconciliations, and other post-closing procedures and has concluded that, notwithstanding the material weaknesses in our internal control over financial reporting, the condensed consolidated financial statements for the periods covered by and included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Previously Reported Material Weakness in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in the section entitled Risk Factors in our Prospectus, we previously identified a material weakness in Brand New Day&#8217;s internal control over financial reporting. As of September 30, 2021, we continue to have a material weakness in Brand New Day&#8217;s internal control over financial reporting. So far in 2021, we have taken a number of remediation steps to enhance the control environment at Brand New Day, including actions to further centralize accounting and other financial responsibilities, enhance controls, procedures and documentation supporting key accounts and processes, and hire additional resources to oversee accounting, reporting and other activities occurring within Brand New Day. With these improvements, management is now focused on demonstrating consistency in the performance of these controls and procedures from period to period. Additionally, we migrated Brand New Day&#8217;s financial accounting and reporting activities over to Bright Health&#8217;s legacy enterprise resource planning system in the third quarter of 2021. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the material weakness remediation actions discussed above as changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Management continues to advance its remediation program to ensure that control deficiencies contributing to the material weakness are remediated.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Part II. OTHER INFORMATION</span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_121"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not presently a party to any litigation the outcomes of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows, or financial condition.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q should be read in conjunction with the risk factors included in our Prospectus. There have been no material changes to the risk factors disclosed under the heading &#8220;Risk Factors&#8221; in our Prospectus, except for the following risk factor, which supplements the &#8220;Risk Factors&#8221; section in our Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security incidents or breaches, loss of data and other disruptions to our or our third-party service providers&#8217; systems, information technology infrastructure, and networks could compromise sensitive or legally protected information related to our business or consumers, disrupt our business operations, and expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we receive, collect, store, use, process, transmit and disclose (&#8220;Process&#8221;) sensitive data, including protected health information (&#8220;PHI&#8221;), and other types of personal data, personal information or personally identifiable information protected by various laws and regulations (collectively, &#8220;PII&#8221;). We also use third-party service providers to Process PHI, PII, sensitive information and other confidential information, including that of our consumers and service providers. We manage and maintain our technology platform and data using a combination of on-site systems, managed data center systems and cloud-based systems. Because of the sensitivity of the PHI, other PII and other confidential information we and our consumers and service providers process, the security of our technology platform and other aspects of our services, including those provided or facilitated by our third-party service providers, are critically important to our operations and business strategy.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operation, stability, integrity and availability of our technology platform and underlying network infrastructure are critical to the implementation of our business strategy, our financial results, our brand and reputation, our relationship with our Care Partners, consumers, network providers, broker network, third-party providers and other key constituents. Any system failure, including network, software or hardware failure, that causes an interruption in our network or a decrease in the responsiveness of our technology platform could result in dissatisfaction and a loss of trust with those constituents and adversely impact our business and reputation. Although we have redundancies in place that will permit us to respond, at least to some degree, to service outages, it could take significant time to have all systems fully operational and our third-party cloud providers are also subject to vulnerabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Security incidents and breaches of our infrastructure or our third-party service providers&#8217; infrastructure, including physical or electronic break-ins, computer viruses, ransomware, or other malware, employee or contractor error or malfeasance, can disrupt or shut down our systems, or allow unauthorized access to, or misuse, disclosure, modifications or loss of confidential information, PHI, and other PII. Such breaches could result in legal claims or proceedings, liability under laws and regulations that protect the privacy of PHI or other PII, such as the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), the California Consumer Privacy Act (&#8220;CCPA&#8221;), and other state and federal laws and regulations. We may also be required to notify government authorities, individuals, the media, and other third parties in connection with a security incident or breach involving PHI or other PII, and could become subject to investigations, consent decrees, resolution agreements, monitoring agreements and similar agreements, and civil penalties. We require business associates and other outsourcing subcontractors who handle consumer and patient information to enter into business associate agreements, if applicable, and to agree to use reasonable efforts to safeguard PHI, other PII and other sensitive information. However, these measures may not adequately protect us from the risks associated with the Processing of such information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, one of our subsidiaries, True Health New Mexico, Inc. (&#8220;True Health&#8221;) experienced a data security incident. Upon learning of the incident, we promptly took steps to secure and contain the impacted True Health systems and supplemented our internal response teams with leading cyber security defense firms and other outside experts. Th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ese steps included taking preventative measures, including shutting down certain systems where necessary, as well as taking steps to supplement existing security monitoring, scanning and protective measures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">True Health has restored its principal operations with no material day-to-day impact to its operations. Our investigation of the attack is substantially complete, and we are also </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">working with law enforcement officials on their ongoing criminal investigation of this matter. True Health has notified appropriate governmental authorities and will provide additional notices to impacted parties as required. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, breaches of our security systems or those systems used by our third-party service providers or other cyber security incidents could also result in the misappropriation of confidential or proprietary information of ourselves, our consumers, our patients, or other third parties; viruses, spyware, ransomware or other malware being served from our network, platform or systems; the deletion or modification of content or the display of unauthorized content on our platform; the loss of access to critical data or systems through ransomware, destructive attacks or other means; and business delays, service or system disruptions such as denials of service attacks. For example, although none of our consumers PHI or PII was put at risk, earlier this year, one of our third-party suppliers of certain services was recently subject to a ransomware attack, which caused delays in our claims payment processing to consumers. We cannot guarantee that our recovery protocols and backup systems will be sufficient to prevent data loss now or in the future, or that our remedies against third-party service providers will be sufficient to protect us in the event such service provider suffers a security breach or similar incident.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not or are perceived to not be able to prevent such security breaches or privacy violations or implement acceptable remedial measures, we may be unable to operate our platform, perform our services, provide consumer assistance services, maintain accurate patient medical records, conduct research and development activities, collect, process and prepare company financial information, or provide information about our current and future products. There can be no assurance that we will be able to prevent another security incident such as occurred with True Health or that any future incidents will not have a more significant impact on our operations. There is an increased risk that we may experience cybersecurity-related events such as COVID-19-themed phishing attacks and other security challenges as a result of our employees and service providers working remotely from non-corporate-managed networks during the ongoing pandemic and beyond. The True Health breach and any future such breaches and violations may result in fines and penalties, require us to comply with breach notification laws, require us to verify the accuracy of database contents, and expose us to material operating expenses related to investigation, remediation and resolution of claims, all of which could result in increased costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we could suffer a loss of business and we may suffer reputational harm, adverse impacts on consumer and investor confidence and negative impact to our results of operations.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sale of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2021, we issued 4,388,811 shares of common stock, par value $0.0001 per share, to security holders of Centrum in connection with our acquisition of Centrum. This transaction was deemed exempt from the registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving any public offering. The recipients of the securities in this transaction represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were placed upon the stock certificates issued in this transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Proceeds from Initial Public Offering of Common Stock</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June&#160;28, 2021, we completed our IPO in which we issued and sold 51,350,000 shares of common stock, par value $0.0001 per share, at an offering price of $18.00 per share. The offer and sale of all of the shares in the IPO were registered under the Securities Act pursuant to the Company&#8217;s registration statement on Form S-1 (File No. 333-256286), as amended, which was declared effective by the SEC on June 23, 2021. We received net proceeds of $880.6 million from the sale of our common stock, after deducting underwriting discounts and commissions of $37.0 million and other offering expenses of $6.7 million. We used a portion of the net proceeds from our IPO to repay the $200.0 million principal balance of indebtedness outstanding under our revolving credit facility agreement originally entered into on March 1, 2021 and the associated interest and other costs of $3.2 million. We used $222.4 million to fund the acquisition of Centrum as described in Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The remainder of the net proceeds will be used for general corporate purposes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The representatives of the underwriters of our IPO were J.P. Morgan Securities LLC, Goldman Sachs &amp; Co. LLC, Morgan Stanley &amp; Co. LLC and Barclays Capital Inc. No payments were made by us to directors, officers, or persons owning ten percent or more of our common stock or to their associates, or to our affiliates, other than payments in the ordinary course of business to officers for salaries and to non-employee directors pursuant to our director compensation policy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon completion of the sale of the shares of our common stock in the IPO, the IPO terminated. There has been no material change in the planned use of proceeds from our IPO from those disclosed in our final prospectus filed with the SEC on June 25, 2021, pursuant to Rule 424(b) under the Securities Act of 1933.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_139"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1671284/000110465921086281/tm217793d23_ex4-1.htm">Ninth Amended and Restated Certificate of Incorporation of Bright Health Group, Inc. (incorporated by reference to Exhibit 4.1 filed with the Registrant&#8217;s Registration Statement on Form S-8 filed on June 28, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1671284/000110465921086281/tm217793d23_ex4-2.htm">Amended and Restated Bylaws of Bright Health Group, Inc. (incorporated by reference to Exhibit 4.2 filed with the Registrant&#8217;s Registration Statement on Form S-8 filed on June 28, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311_111521.htm">Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312_111521.htm">Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321_111521.htm">Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline" href="exhibit321_111521.htm">(1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322_111521.htm">Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline" href="exhibit322_111521.htm">(1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from our Quarterly Report on Form 10-Q for the third quarter of fiscal 2021, filed with the SEC on November 15, 2021, formatted in Inline Extensible Business Reporting Language (&#8220;iXBRL&#8221;)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and embedded within Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline">(1)    </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The certifications in Exhibit 32.1 to this Quarterly Report on Form 10-Q shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.</span></div><div style="text-align:center"><span><br/></span></div><div id="ie0abfeeb2ed84c58ba5d72efec1af66e_142"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie0abfeeb2ed84c58ba5d72efec1af66e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRIGHT HEALTH GROUP, INC.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 15, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ G. Mike Mikan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G. Mike Mikan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chairman, President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Catherine R. Smith</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catherine R. Smith</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Administrative Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey J. Scherman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey J. Scherman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311_111521.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4d5b9ecbfced4e32b8dfe81d925ec0c6_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, G. Mike Mikan, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Bright Health Group, Inc.&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#91;Omitted&#93;&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 15, 2021</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; G. Mike Mikan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G. Mike Mikan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chairman, President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312_111521.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9abedd7039874b7694c48711b611a61d_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Catherine R. Smith, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Bright Health Group, Inc.&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#91;Omitted&#93;&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 15, 2021</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Catherine R. Smith</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catherine R. Smith</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Administrative Officer</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321_111521.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia835881344644bfeb26339a211e9e893_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Bright Health Group, Inc. (the &#8220;Company&#8221;) for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 15, 2021</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; G. Mike Mikan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G. Mike Mikan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322_111521.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3358862d922c4aa78938497bf14ce445_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Bright Health Group, Inc. (the &#8220;Company&#8221;) for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.365%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 15, 2021</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Catherine R. Smith</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catherine R. Smith</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Administrative Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bhg-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhg="http://www.brighthealthgroup.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.brighthealthgroup.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhg-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhg-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhg-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhg-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.brighthealthgroup.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATION" roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationConsolidationandPresentationofFinancialStatementsPolicies" roleURI="http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies">
        <link:definition>2202201 - Disclosure - Organization, Consolidation and Presentation of Financial Statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATIONTables" roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables">
        <link:definition>2303301 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails">
        <link:definition>2404401 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails" roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails">
        <link:definition>2405402 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONS" roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS">
        <link:definition>2106102 - Disclosure - BUSINESS COMBINATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSTables" roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables">
        <link:definition>2307302 - Disclosure - BUSINESS COMBINATIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails">
        <link:definition>2408403 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails">
        <link:definition>2409404 - Disclosure - BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails" roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails">
        <link:definition>2410405 - Disclosure - BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTS">
        <link:definition>2111103 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSTables">
        <link:definition>2312303 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentSecuritiesDetails" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails">
        <link:definition>2413406 - Disclosure - INVESTMENTS - Schedule of Investment Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails">
        <link:definition>2414407 - Disclosure - INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails">
        <link:definition>2415408 - Disclosure - INVESTMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails" roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails">
        <link:definition>2416409 - Disclosure - INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2117104 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2318304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails">
        <link:definition>2419410 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails">
        <link:definition>2420411 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails" roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails">
        <link:definition>2421412 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2122105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2323305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails">
        <link:definition>2424413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails">
        <link:definition>2425414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails">
        <link:definition>2426415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails">
        <link:definition>2427416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICALCOSTSPAYABLE" roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE">
        <link:definition>2128106 - Disclosure - MEDICAL COSTS PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICALCOSTSPAYABLETables" roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables">
        <link:definition>2329306 - Disclosure - MEDICAL COSTS PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails" roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails">
        <link:definition>2430417 - Disclosure - MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICALCOSTSPAYABLENarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails">
        <link:definition>2431418 - Disclosure - MEDICAL COSTS PAYABLE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails" roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails">
        <link:definition>2432419 - Disclosure - MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMBORROWINGS" roleURI="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS">
        <link:definition>2133107 - Disclosure - SHORT-TERM BORROWINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMBORROWINGSDetails" roleURI="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails">
        <link:definition>2434420 - Disclosure - SHORT-TERM BORROWINGS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>2135108 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2336307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2437421 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails">
        <link:definition>2438422 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails">
        <link:definition>2439423 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails" roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails">
        <link:definition>2440424 - Disclosure - SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARE" roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHARE">
        <link:definition>2141109 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARETables" roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables">
        <link:definition>2342308 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofNetLossPershareDetails" roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails">
        <link:definition>2443425 - Disclosure - NET LOSS PER SHARE - Schedule of Net Loss Per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails" roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails">
        <link:definition>2444426 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2145110 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICALINFORMATION" roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION">
        <link:definition>2146111 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICALINFORMATIONTables" roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables">
        <link:definition>2347309 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails">
        <link:definition>2448427 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails" roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails">
        <link:definition>2449428 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.brighthealthgroup.com/role/INCOMETAXES">
        <link:definition>2150112 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.brighthealthgroup.com/role/INCOMETAXESDetails">
        <link:definition>2451429 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REDEEMABLENONCONTROLLINGINTEREST" roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2152113 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REDEEMABLENONCONTROLLINGINTERESTTables" roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables">
        <link:definition>2353310 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
        <link:definition>2454430 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails" roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails">
        <link:definition>2455431 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhg_BrightHealthCareMember" abstract="true" name="BrightHealthCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" abstract="false" name="DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_StockReturnedDuringPeriodValueEscrowSettlement" abstract="false" name="StockReturnedDuringPeriodValueEscrowSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" abstract="true" name="ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" abstract="false" name="LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_PremierMedicalAssociatesOfFloridaLLCMember" abstract="true" name="PremierMedicalAssociatesOfFloridaLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_TrueHealthNewMexicoMember" abstract="true" name="TrueHealthNewMexicoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" abstract="false" name="CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" abstract="false" name="CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_THNMAndZipnosisMember" abstract="true" name="THNMAndZipnosisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_UniversalCareIncBrandNewDayMember" abstract="true" name="UniversalCareIncBrandNewDayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_CentrumMedicalHoldingsLLCMember" abstract="true" name="CentrumMedicalHoldingsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_ZipnosisMember" abstract="true" name="ZipnosisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_NeueHealthMember" abstract="true" name="NeueHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_ControllingInterestHolderMember" abstract="true" name="ControllingInterestHolderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_BusinessCombinationEscrowAdjustment" abstract="false" name="BusinessCombinationEscrowAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_CentralHealthPlanOfCaliforniaIncMember" abstract="true" name="CentralHealthPlanOfCaliforniaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" abstract="false" name="DebtInstrumentCovenantTotalDebtToCapitalizationRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" abstract="false" name="DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_TemporaryEquityValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_NumberOfHealthCenters" abstract="false" name="NumberOfHealthCenters" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_EquitySecuritiesFVNISharesPurchased" abstract="false" name="EquitySecuritiesFVNISharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquitySharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhg_RiskAdjustmentPayableCurrent" abstract="false" name="RiskAdjustmentPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_StockReturnedDuringPeriodSharesEscrowSettlement" abstract="false" name="StockReturnedDuringPeriodSharesEscrowSettlement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_InvestmentIncomeLoss" abstract="false" name="InvestmentIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bhg_BusinessCombinationTangibleNetEquityAdjustment" abstract="false" name="BusinessCombinationTangibleNetEquityAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_IncreaseDecreaseInRiskAdjustmentPayable" abstract="false" name="IncreaseDecreaseInRiskAdjustmentPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bhg_ShortTermAndLongTermInvestmentsMember" abstract="true" name="ShortTermAndLongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_ProviderNetworkMember" abstract="true" name="ProviderNetworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bhg_ReacquiredContractsMember" abstract="true" name="ReacquiredContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bhg-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_07c3c620-8c93-425e-a014-d2c6adad289f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_856a41e8-ee08-4c69-8dec-3c5498209045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_07c3c620-8c93-425e-a014-d2c6adad289f" xlink:to="loc_us-gaap_LiabilitiesCurrent_856a41e8-ee08-4c69-8dec-3c5498209045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_12f9df30-5918-4da6-9dd9-cc55cf035c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_07c3c620-8c93-425e-a014-d2c6adad289f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_12f9df30-5918-4da6-9dd9-cc55cf035c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e73cba7-a8f2-49d5-aca2-d148643d9c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1efa9d71-ebf3-4d49-b528-f503d1f3a792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e73cba7-a8f2-49d5-aca2-d148643d9c14" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1efa9d71-ebf3-4d49-b528-f503d1f3a792" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3530e285-a5ea-4a2b-b296-699d246a828f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e73cba7-a8f2-49d5-aca2-d148643d9c14" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3530e285-a5ea-4a2b-b296-699d246a828f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b65ef5e1-88e3-4ac8-8356-0c0d2f7b5bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e73cba7-a8f2-49d5-aca2-d148643d9c14" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b65ef5e1-88e3-4ac8-8356-0c0d2f7b5bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4d6a7ddb-7bb7-49cc-a6ed-25809f258a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e73cba7-a8f2-49d5-aca2-d148643d9c14" xlink:to="loc_us-gaap_CommonStockValue_4d6a7ddb-7bb7-49cc-a6ed-25809f258a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e6acfd83-e2ba-4277-8296-b17f6d2fee76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bae9fa33-0d02-431c-84df-ebfaa7f48eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6acfd83-e2ba-4277-8296-b17f6d2fee76" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bae9fa33-0d02-431c-84df-ebfaa7f48eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_33c53c88-68b0-49a1-bc7a-9af1fa254dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6acfd83-e2ba-4277-8296-b17f6d2fee76" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_33c53c88-68b0-49a1-bc7a-9af1fa254dcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_72fffc7a-ab17-4fe2-bdce-41bffb2feec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6acfd83-e2ba-4277-8296-b17f6d2fee76" xlink:to="loc_us-gaap_ShortTermInvestments_72fffc7a-ab17-4fe2-bdce-41bffb2feec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7666b5c3-91e3-4830-9444-2182670b1d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6acfd83-e2ba-4277-8296-b17f6d2fee76" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7666b5c3-91e3-4830-9444-2182670b1d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_RiskAdjustmentPayableCurrent_e2ee89b0-4ff0-4ae4-9655-7cb16ad446dc" xlink:href="bhg-20210930.xsd#bhg_RiskAdjustmentPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:to="loc_bhg_RiskAdjustmentPayableCurrent_e2ee89b0-4ff0-4ae4-9655-7cb16ad446dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e392b52c-5df5-4cd7-98fd-c89789ed8d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e392b52c-5df5-4cd7-98fd-c89789ed8d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_985251ce-cd3f-4655-b261-38dc63c77dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_985251ce-cd3f-4655-b261-38dc63c77dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_4ba28f7b-f30a-403a-a9be-ef59015d0463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnearnedPremiums"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:to="loc_us-gaap_UnearnedPremiums_4ba28f7b-f30a-403a-a9be-ef59015d0463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0be3d7a9-7e2a-4b40-8fa6-b41326f182af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26d2c832-bfb7-438f-a0de-235054df6892" xlink:to="loc_us-gaap_AccountsPayableCurrent_0be3d7a9-7e2a-4b40-8fa6-b41326f182af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_06849f60-4cd7-4a33-bd4f-7b1a599200aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_06849f60-4cd7-4a33-bd4f-7b1a599200aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d931c59e-db6b-4787-9370-2b6391692e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d931c59e-db6b-4787-9370-2b6391692e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c00cefff-3033-4827-9cd7-5ed828cb8a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c00cefff-3033-4827-9cd7-5ed828cb8a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7b0d6e19-7d34-4e75-9683-c3746dc1a77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:to="loc_us-gaap_StockholdersEquity_7b0d6e19-7d34-4e75-9683-c3746dc1a77d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_babd8033-06b5-4197-9bbd-5a3995660fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b433ec2f-8507-413a-ba91-927290a96890" xlink:to="loc_us-gaap_Liabilities_babd8033-06b5-4197-9bbd-5a3995660fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_405d30b9-f552-481f-bcac-9b19987f5212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_a1b56664-e192-45da-8487-0c3be0841e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_405d30b9-f552-481f-bcac-9b19987f5212" xlink:to="loc_us-gaap_AssetsNoncurrent_a1b56664-e192-45da-8487-0c3be0841e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b063845b-7f08-44c4-864c-eb25a75da4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_405d30b9-f552-481f-bcac-9b19987f5212" xlink:to="loc_us-gaap_AssetsCurrent_b063845b-7f08-44c4-864c-eb25a75da4cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fe8aa7d8-f762-4c4c-818e-7ec0ba9a75a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fe8aa7d8-f762-4c4c-818e-7ec0ba9a75a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e5523ac0-809e-454c-85da-874b625e83f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e5523ac0-809e-454c-85da-874b625e83f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da18b47f-211d-417f-a85c-9ebf02c33b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da18b47f-211d-417f-a85c-9ebf02c33b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e8458801-1f5c-405f-9daa-174b2e0c8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:to="loc_us-gaap_Goodwill_e8458801-1f5c-405f-9daa-174b2e0c8c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0379e994-e41e-47ec-bb7d-a5972be98a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_da3ddcf0-e847-4532-b2aa-4e4650e59d5f" xlink:to="loc_us-gaap_LongTermInvestments_0379e994-e41e-47ec-bb7d-a5972be98a1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e0d20bf9-38a2-4034-a3fa-2ad2507d3a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0265d80a-43f4-4a50-98c4-5025c386c4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e0d20bf9-38a2-4034-a3fa-2ad2507d3a1e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0265d80a-43f4-4a50-98c4-5025c386c4a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_67015df4-a339-41f1-ba5d-167b675bfd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e0d20bf9-38a2-4034-a3fa-2ad2507d3a1e" xlink:to="loc_us-gaap_PremiumsEarnedNet_67015df4-a339-41f1-ba5d-167b675bfd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_cf043047-0899-4ff7-85aa-2c7dd1796cac" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e0d20bf9-38a2-4034-a3fa-2ad2507d3a1e" xlink:to="loc_bhg_InvestmentIncomeLoss_cf043047-0899-4ff7-85aa-2c7dd1796cac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_649120d0-7f2e-428f-826d-4564b15aa1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91551a6d-4e75-43f0-8095-1925ec3f4893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_649120d0-7f2e-428f-826d-4564b15aa1b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91551a6d-4e75-43f0-8095-1925ec3f4893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_89e14386-7241-41e5-bdff-73f5c0031193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_649120d0-7f2e-428f-826d-4564b15aa1b8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_89e14386-7241-41e5-bdff-73f5c0031193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59228330-7462-4ac8-b47f-25c96414f031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f36365c4-d473-4030-a67f-ec14508c23b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59228330-7462-4ac8-b47f-25c96414f031" xlink:to="loc_us-gaap_InterestExpense_f36365c4-d473-4030-a67f-ec14508c23b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4146f5ae-61a3-4612-9e8a-f2f8168054e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59228330-7462-4ac8-b47f-25c96414f031" xlink:to="loc_us-gaap_OperatingIncomeLoss_4146f5ae-61a3-4612-9e8a-f2f8168054e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_7020add9-240a-44a2-8adb-e335f9fbdfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59228330-7462-4ac8-b47f-25c96414f031" xlink:to="loc_us-gaap_OtherNonoperatingIncome_7020add9-240a-44a2-8adb-e335f9fbdfc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d93fc795-ee9a-4a11-bc15-fa774149220b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_53044b8a-5889-4b4e-8564-f8ef06d886eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d93fc795-ee9a-4a11-bc15-fa774149220b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_53044b8a-5889-4b4e-8564-f8ef06d886eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_85414ec7-5a82-493c-97c6-8478e89cac6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d93fc795-ee9a-4a11-bc15-fa774149220b" xlink:to="loc_us-gaap_ProfitLoss_85414ec7-5a82-493c-97c6-8478e89cac6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e0059385-3c18-45e7-bb06-1c51cfa21e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dc5a3bf2-37a7-4985-99b5-d8182620460e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e0059385-3c18-45e7-bb06-1c51cfa21e2a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dc5a3bf2-37a7-4985-99b5-d8182620460e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e3405e05-fb19-4124-9d9f-6e9feb4094eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e0059385-3c18-45e7-bb06-1c51cfa21e2a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e3405e05-fb19-4124-9d9f-6e9feb4094eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_186589ae-c137-4fbd-a235-c7f25447827b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e0059385-3c18-45e7-bb06-1c51cfa21e2a" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_186589ae-c137-4fbd-a235-c7f25447827b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_51064fce-a6e4-46c4-84f8-ab0fcdad0af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bda8124c-67cd-40fb-a7b6-9963f9d54022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_51064fce-a6e4-46c4-84f8-ab0fcdad0af1" xlink:to="loc_us-gaap_ProfitLoss_bda8124c-67cd-40fb-a7b6-9963f9d54022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c13b8d8-4e13-4179-9f04-cc793c27f841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_51064fce-a6e4-46c4-84f8-ab0fcdad0af1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c13b8d8-4e13-4179-9f04-cc793c27f841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b8fa99f3-5f63-4b90-bd39-fdc8766f73e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_4edeaccc-53a8-4e91-9db7-c6134dd26fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b8fa99f3-5f63-4b90-bd39-fdc8766f73e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_4edeaccc-53a8-4e91-9db7-c6134dd26fb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fa42beed-c1e3-4367-b2cd-e575a48960bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b8fa99f3-5f63-4b90-bd39-fdc8766f73e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fa42beed-c1e3-4367-b2cd-e575a48960bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_45668899-334d-40ed-9da4-d22d436e330a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4e97f4b5-764b-46b1-9e2f-896a6e291123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_45668899-334d-40ed-9da4-d22d436e330a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4e97f4b5-764b-46b1-9e2f-896a6e291123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6ff67f6c-c06f-48d2-8be8-e50e23ed9ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_45668899-334d-40ed-9da4-d22d436e330a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6ff67f6c-c06f-48d2-8be8-e50e23ed9ea5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_4c2a8641-12b4-4b2f-947d-b66550a6f312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_4c2a8641-12b4-4b2f-947d-b66550a6f312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_a8dd0e11-63e7-4ac6-8c68-4543fc3f98b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_a8dd0e11-63e7-4ac6-8c68-4543fc3f98b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_6661b0ea-337c-4e72-bca0-be25e81111f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_6661b0ea-337c-4e72-bca0-be25e81111f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e0a4b4af-4b97-4074-8d8c-ff4628f41d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e0a4b4af-4b97-4074-8d8c-ff4628f41d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ad77cf52-e549-4956-a4e1-db4b5f4fc046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ad77cf52-e549-4956-a4e1-db4b5f4fc046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_dcf68fb4-c010-4f7b-ab1c-4479f0601757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_dcf68fb4-c010-4f7b-ab1c-4479f0601757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_29f8ec1a-b072-467a-9b27-3b61a1a8d937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_669b859d-c7ca-4f40-a66d-90edf24d19b2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_29f8ec1a-b072-467a-9b27-3b61a1a8d937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e18e76fd-a29e-4c05-b358-04a10e8548cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2a93e827-7ff1-4c61-bd80-8160c7522285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e18e76fd-a29e-4c05-b358-04a10e8548cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2a93e827-7ff1-4c61-bd80-8160c7522285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_475b3245-1b08-4b34-8e92-2b7ce3eae244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e18e76fd-a29e-4c05-b358-04a10e8548cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_475b3245-1b08-4b34-8e92-2b7ce3eae244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c6715d7-c17c-4b52-b08a-26e2d27ece83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e18e76fd-a29e-4c05-b358-04a10e8548cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c6715d7-c17c-4b52-b08a-26e2d27ece83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_704a6b57-3a46-45a2-9492-d7803e359d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e4e16cb8-2f23-403f-b6b2-bbc4c5911a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_704a6b57-3a46-45a2-9492-d7803e359d20" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e4e16cb8-2f23-403f-b6b2-bbc4c5911a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_8cae5698-dc0d-4fa7-a03b-115c49aa6d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_704a6b57-3a46-45a2-9492-d7803e359d20" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_8cae5698-dc0d-4fa7-a03b-115c49aa6d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2cccb65f-a283-4e5b-9d2f-cc883bcd34be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_704a6b57-3a46-45a2-9492-d7803e359d20" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2cccb65f-a283-4e5b-9d2f-cc883bcd34be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dff16bbe-0f43-42c8-bde4-4b2ade60f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_704a6b57-3a46-45a2-9492-d7803e359d20" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dff16bbe-0f43-42c8-bde4-4b2ade60f6f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_532de2c9-6819-4e8b-8f75-6d6103b5146c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_532de2c9-6819-4e8b-8f75-6d6103b5146c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_40625df9-27e7-4bdf-b3d7-a80c7c5f5aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_40625df9-27e7-4bdf-b3d7-a80c7c5f5aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5decf79e-3503-4468-9476-a606c28e91fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5decf79e-3503-4468-9476-a606c28e91fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_54521fb3-beed-462f-9817-d967086f1fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_ShareBasedCompensation_54521fb3-beed-462f-9817-d967086f1fd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b85db61d-c34f-4455-b68e-8affd96820ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_NetIncomeLoss_b85db61d-c34f-4455-b68e-8affd96820ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c6eab0e5-25e0-4974-88be-35d260bae555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c6eab0e5-25e0-4974-88be-35d260bae555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable_4d78f473-6b26-4223-8064-86ec0b12332d" xlink:href="bhg-20210930.xsd#bhg_IncreaseDecreaseInRiskAdjustmentPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable_4d78f473-6b26-4223-8064-86ec0b12332d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_4356b8b0-0900-4dee-b88c-02d9a0600b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_4356b8b0-0900-4dee-b88c-02d9a0600b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1e73192f-50d5-4189-a9ef-b8c2220905c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1e73192f-50d5-4189-a9ef-b8c2220905c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_e4ceadfd-8861-4a15-9f41-2d74bf1c7995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_e4ceadfd-8861-4a15-9f41-2d74bf1c7995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ac4b95e-e195-4c12-b251-8f39ab61e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ac4b95e-e195-4c12-b251-8f39ab61e9fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_66bac334-2bf6-404b-a3ea-ca9ac66482eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f2260d4-648a-4281-b6ee-9fd5fe40b925" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_66bac334-2bf6-404b-a3ea-ca9ac66482eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_62d06a03-cc7a-420d-bf5b-8b29a089335c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_7b0d7608-aadf-4fd5-9183-b53eddd1f9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_62d06a03-cc7a-420d-bf5b-8b29a089335c" xlink:to="loc_us-gaap_ProfessionalFees_7b0d7608-aadf-4fd5-9183-b53eddd1f9c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_c2e43dce-bf7e-4a5a-8963-8d84713cbeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_62d06a03-cc7a-420d-bf5b-8b29a089335c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_c2e43dce-bf7e-4a5a-8963-8d84713cbeb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_7d4c650b-bb5e-4cec-b34f-5b5a0e4abec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_62d06a03-cc7a-420d-bf5b-8b29a089335c" xlink:to="loc_us-gaap_LaborAndRelatedExpense_7d4c650b-bb5e-4cec-b34f-5b5a0e4abec0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_446634b4-9cb4-4419-9e93-6f01cdb88c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_62d06a03-cc7a-420d-bf5b-8b29a089335c" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_446634b4-9cb4-4419-9e93-6f01cdb88c09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1452ddc1-b793-4441-b073-55f212e55de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d8386b10-6407-4b1b-83b7-3eb3efd3a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1452ddc1-b793-4441-b073-55f212e55de8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d8386b10-6407-4b1b-83b7-3eb3efd3a4ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0831a5fb-349d-4d7c-ae6c-b63be3364e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1452ddc1-b793-4441-b073-55f212e55de8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0831a5fb-349d-4d7c-ae6c-b63be3364e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_443f0025-dafa-4bcb-a971-f97d09190b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1452ddc1-b793-4441-b073-55f212e55de8" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_443f0025-dafa-4bcb-a971-f97d09190b93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationEscrowAdjustment_729f58c9-ed67-4338-99d4-2b1b1de9ef60" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationEscrowAdjustment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1452ddc1-b793-4441-b073-55f212e55de8" xlink:to="loc_bhg_BusinessCombinationEscrowAdjustment_729f58c9-ed67-4338-99d4-2b1b1de9ef60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fad49369-6c54-4ddd-8885-3bdec123fd46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fad49369-6c54-4ddd-8885-3bdec123fd46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59e8cbf4-0f77-45ba-80f5-0659b041b012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59e8cbf4-0f77-45ba-80f5-0659b041b012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4f33cf17-2c3b-4d55-8160-6b12a7ce4872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4f33cf17-2c3b-4d55-8160-6b12a7ce4872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_1d128f86-0d87-48f3-b323-bad999136778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_1d128f86-0d87-48f3-b323-bad999136778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8e5c9ae6-2e08-4a13-b481-29c805d72e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8e5c9ae6-2e08-4a13-b481-29c805d72e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33a3ce93-1f4d-4282-a351-3232100ac8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33a3ce93-1f4d-4282-a351-3232100ac8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_2390eb30-2ed6-4675-88a2-a5bd36c449f3" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d445aeb3-4161-44bd-ae97-8392be238cf9" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_2390eb30-2ed6-4675-88a2-a5bd36c449f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_7870a93f-703b-4358-8f54-3692da4c3759" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_f5344620-a5c6-4e7e-803b-31b6ad8e0cfc" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_7870a93f-703b-4358-8f54-3692da4c3759" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_f5344620-a5c6-4e7e-803b-31b6ad8e0cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_5476497b-500f-4180-ba47-43a9b10bd5ae" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_7870a93f-703b-4358-8f54-3692da4c3759" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_5476497b-500f-4180-ba47-43a9b10bd5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_85578c6c-6d0a-4b07-b46d-4d65f1edb7cd" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_65bc2281-e34f-4aed-a3da-486551f417f8" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_85578c6c-6d0a-4b07-b46d-4d65f1edb7cd" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_65bc2281-e34f-4aed-a3da-486551f417f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_be977e58-aa30-454d-9a5a-43b81356803c" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_85578c6c-6d0a-4b07-b46d-4d65f1edb7cd" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_be977e58-aa30-454d-9a5a-43b81356803c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_4e4fc488-55c0-4365-accf-3bd99e3d5e72" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_85578c6c-6d0a-4b07-b46d-4d65f1edb7cd" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_4e4fc488-55c0-4365-accf-3bd99e3d5e72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6701d282-c8a4-4630-8b43-569dd3dd3de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6701d282-c8a4-4630-8b43-569dd3dd3de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_32270a9f-1bad-4f65-8273-badbc8838405" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_32270a9f-1bad-4f65-8273-badbc8838405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_abe8585c-f437-40f0-a3cc-0248e2652f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_abe8585c-f437-40f0-a3cc-0248e2652f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a345b21b-ec64-4f7d-84af-558b6b3f96a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a345b21b-ec64-4f7d-84af-558b6b3f96a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_3320027c-4a70-4bf2-a417-f86e7313984a" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bc8a3a08-9a38-492a-a865-df2dfcbb5580" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_3320027c-4a70-4bf2-a417-f86e7313984a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_c2171b75-00a3-4071-8ea3-b3e31338e854" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_c2171b75-00a3-4071-8ea3-b3e31338e854" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c48f5143-10be-491b-8bf8-46873561597f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c48f5143-10be-491b-8bf8-46873561597f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_b45c866d-644d-4862-a156-89bec76bf0c2" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_b45c866d-644d-4862-a156-89bec76bf0c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_c204982b-96ed-4a84-a21e-3ba659486b3e" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_c204982b-96ed-4a84-a21e-3ba659486b3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_df31fea3-5bdb-4810-bc53-9c7ee9ec876a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_30588d78-5ca6-4d56-90a5-6ddc16f8a3cb" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_df31fea3-5bdb-4810-bc53-9c7ee9ec876a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_88061510-f021-4758-93b4-b85d16a7f54f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_036e7524-8e21-4696-b0cf-76a0070b8ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_88061510-f021-4758-93b4-b85d16a7f54f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_036e7524-8e21-4696-b0cf-76a0070b8ff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a012235a-6be1-4ac4-bab5-560845d2890c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_88061510-f021-4758-93b4-b85d16a7f54f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a012235a-6be1-4ac4-bab5-560845d2890c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_4f9a98be-9f7e-4cd7-9ea8-e9d36e9a993f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_f4d03db1-7934-4c80-8d62-1b9e263c13a3" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_4f9a98be-9f7e-4cd7-9ea8-e9d36e9a993f" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_f4d03db1-7934-4c80-8d62-1b9e263c13a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d6be8cce-9e8c-4c01-8b3e-4d76962ce8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_4f9a98be-9f7e-4cd7-9ea8-e9d36e9a993f" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d6be8cce-9e8c-4c01-8b3e-4d76962ce8ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad7eb40b-6c22-477f-85e6-159f9d5a2b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a327f47b-5773-4646-9751-f114a198cc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad7eb40b-6c22-477f-85e6-159f9d5a2b14" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a327f47b-5773-4646-9751-f114a198cc7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2dab87ad-cf1b-48b8-9c59-8606f2c8e7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad7eb40b-6c22-477f-85e6-159f9d5a2b14" xlink:to="loc_us-gaap_Goodwill_2dab87ad-cf1b-48b8-9c59-8606f2c8e7c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_50f30673-462d-4b25-bf01-24f8682c863c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad7eb40b-6c22-477f-85e6-159f9d5a2b14" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_50f30673-462d-4b25-bf01-24f8682c863c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_3c4ee901-6374-48ed-a519-1ea53179a0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92c36b8d-9b56-489a-af9b-b4dbff5d5e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_3c4ee901-6374-48ed-a519-1ea53179a0ef" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92c36b8d-9b56-489a-af9b-b4dbff5d5e16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_98a2c23f-ff18-4d12-8766-3dc82bc69d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_3c4ee901-6374-48ed-a519-1ea53179a0ef" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_98a2c23f-ff18-4d12-8766-3dc82bc69d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d474d6f3-4046-4cac-b898-88baa0a0cd5b" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_3c4ee901-6374-48ed-a519-1ea53179a0ef" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d474d6f3-4046-4cac-b898-88baa0a0cd5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6b7adeb1-c5ff-4a7f-be5d-1e68e1ff6ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3c95e6d-be72-45c5-b21f-70d03777f7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6b7adeb1-c5ff-4a7f-be5d-1e68e1ff6ae0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f3c95e6d-be72-45c5-b21f-70d03777f7e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_26c92329-193a-4eec-ad0f-e3bcb28d0fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6b7adeb1-c5ff-4a7f-be5d-1e68e1ff6ae0" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_26c92329-193a-4eec-ad0f-e3bcb28d0fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_af035c12-25cf-4dd2-ab55-e3d5983f1702" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6b7adeb1-c5ff-4a7f-be5d-1e68e1ff6ae0" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_af035c12-25cf-4dd2-ab55-e3d5983f1702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_f3a2c875-59c5-482e-bf42-fefb08abc1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ab6d8b88-acf3-4fd9-9f86-8a4591c23e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_f3a2c875-59c5-482e-bf42-fefb08abc1d5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ab6d8b88-acf3-4fd9-9f86-8a4591c23e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_2d6cac73-6fbd-4df7-b84d-7e31dfd838cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_f3a2c875-59c5-482e-bf42-fefb08abc1d5" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_2d6cac73-6fbd-4df7-b84d-7e31dfd838cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_58f494ea-6fec-4a02-931e-63569efc8d74" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_f3a2c875-59c5-482e-bf42-fefb08abc1d5" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_58f494ea-6fec-4a02-931e-63569efc8d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_68602da6-f00f-4e1f-9a71-651392966ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eca88300-f90b-4859-ae1a-9fcb1b8d3db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_68602da6-f00f-4e1f-9a71-651392966ddf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eca88300-f90b-4859-ae1a-9fcb1b8d3db1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_85a9a12a-b5d3-43b6-97d7-ff50f29a3f26" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_68602da6-f00f-4e1f-9a71-651392966ddf" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_85a9a12a-b5d3-43b6-97d7-ff50f29a3f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_b841d05e-d7ca-4f9d-ad99-f803b5dc16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_68602da6-f00f-4e1f-9a71-651392966ddf" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_b841d05e-d7ca-4f9d-ad99-f803b5dc16e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_415afcca-8c02-4998-9e8c-b50719216e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f878369e-ed49-4b73-b452-6b0178a3c925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_415afcca-8c02-4998-9e8c-b50719216e97" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f878369e-ed49-4b73-b452-6b0178a3c925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b33e3952-0022-4523-9794-63d8b5080918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_415afcca-8c02-4998-9e8c-b50719216e97" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b33e3952-0022-4523-9794-63d8b5080918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_db8df3b3-a08b-4797-a9e2-36552c319b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_9826d9e5-0f04-4b09-b729-391aff6a93aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_db8df3b3-a08b-4797-a9e2-36552c319b57" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_9826d9e5-0f04-4b09-b729-391aff6a93aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d77c49ac-52a5-4822-b78b-1f36ffa436a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_db8df3b3-a08b-4797-a9e2-36552c319b57" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d77c49ac-52a5-4822-b78b-1f36ffa436a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0000f5f8-a86a-4fd1-a101-32b480fbce55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_39083dd7-ccd8-42e2-9765-20a7500c6370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0000f5f8-a86a-4fd1-a101-32b480fbce55" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_39083dd7-ccd8-42e2-9765-20a7500c6370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5e841bba-77e6-4ef3-b593-eccea4878ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0000f5f8-a86a-4fd1-a101-32b480fbce55" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5e841bba-77e6-4ef3-b593-eccea4878ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_07bf9758-dd09-4969-814b-d03db1a90376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0000f5f8-a86a-4fd1-a101-32b480fbce55" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_07bf9758-dd09-4969-814b-d03db1a90376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_65eb25bf-d14e-40a2-a8a9-3dc310bb4c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0000f5f8-a86a-4fd1-a101-32b480fbce55" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_65eb25bf-d14e-40a2-a8a9-3dc310bb4c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dcb63a13-4437-489a-b6c8-2b30446b9373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8216db4d-c0d7-4f97-a50e-fcd9e626391b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dcb63a13-4437-489a-b6c8-2b30446b9373" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8216db4d-c0d7-4f97-a50e-fcd9e626391b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_9024f1df-3212-4765-8cc1-472660a59a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dcb63a13-4437-489a-b6c8-2b30446b9373" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_9024f1df-3212-4765-8cc1-472660a59a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_ec61ae41-13e5-42ac-af5a-e846f9f4a2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dcb63a13-4437-489a-b6c8-2b30446b9373" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_ec61ae41-13e5-42ac-af5a-e846f9f4a2be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_9f2a1d56-d225-4bca-9a74-f28e3c4b7a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dcb63a13-4437-489a-b6c8-2b30446b9373" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_9f2a1d56-d225-4bca-9a74-f28e3c4b7a8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_187f3248-80e1-4bc3-bbb4-14e1ee5587c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1e24d86e-05ce-429f-a37d-770935908512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_187f3248-80e1-4bc3-bbb4-14e1ee5587c3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1e24d86e-05ce-429f-a37d-770935908512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_69fc506f-6024-481e-8e84-11923b82a361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_187f3248-80e1-4bc3-bbb4-14e1ee5587c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_69fc506f-6024-481e-8e84-11923b82a361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ccdf550b-8352-4b4e-bdd6-430ba3c6a97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_187f3248-80e1-4bc3-bbb4-14e1ee5587c3" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ccdf550b-8352-4b4e-bdd6-430ba3c6a97f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_f4442c70-09bf-480f-8c7b-0e8642f237c2" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e432df68-7be1-4a23-bbd4-c2ea581cc511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_f4442c70-09bf-480f-8c7b-0e8642f237c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e432df68-7be1-4a23-bbd4-c2ea581cc511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_ffcce637-cac7-4e56-b98b-ec50940a651e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_f4442c70-09bf-480f-8c7b-0e8642f237c2" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_ffcce637-cac7-4e56-b98b-ec50940a651e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f0432f38-e32d-4e66-84fc-7335417d1c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_06c5f1e4-8680-4d46-b055-818265783f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f0432f38-e32d-4e66-84fc-7335417d1c7a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_06c5f1e4-8680-4d46-b055-818265783f58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2655939e-1fca-4ede-b149-2a7f20c1fd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f0432f38-e32d-4e66-84fc-7335417d1c7a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2655939e-1fca-4ede-b149-2a7f20c1fd2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2585199-eafa-42f6-97a3-eb1fd7d6b51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_1c657117-1be1-400f-b8cc-9144818453e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2585199-eafa-42f6-97a3-eb1fd7d6b51e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_1c657117-1be1-400f-b8cc-9144818453e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_cdf385f6-2301-428b-9499-eb4c8c8e37e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2585199-eafa-42f6-97a3-eb1fd7d6b51e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_cdf385f6-2301-428b-9499-eb4c8c8e37e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b774c141-b576-442a-84a6-50ef374f054d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_73df4b98-f8bd-4075-954c-52252dafbe27" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b774c141-b576-442a-84a6-50ef374f054d" xlink:to="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_73df4b98-f8bd-4075-954c-52252dafbe27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_52965734-abd0-413e-b98e-3d2a2f4eade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b774c141-b576-442a-84a6-50ef374f054d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_52965734-abd0-413e-b98e-3d2a2f4eade6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_f39a9b13-facf-42d3-8e39-a665555a7378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b774c141-b576-442a-84a6-50ef374f054d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_f39a9b13-facf-42d3-8e39-a665555a7378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_1ceef5c4-87ce-4c36-8e39-fbce3f6a2b48" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b774c141-b576-442a-84a6-50ef374f054d" xlink:to="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_1ceef5c4-87ce-4c36-8e39-fbce3f6a2b48" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bhg-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i74ec1922a5e04bc0b6a914f9a1287c26_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b1418afd-b2b9-4f67-953a-7f6d8c51d876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b1418afd-b2b9-4f67-953a-7f6d8c51d876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fa1535a9-0892-44d8-888b-da3a67454f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fa1535a9-0892-44d8-888b-da3a67454f57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_b3ea16a5-378f-457f-8575-2929906475a6" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_b3ea16a5-378f-457f-8575-2929906475a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a49f305c-5ef1-4ea2-9bed-94cedcdb978d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a49f305c-5ef1-4ea2-9bed-94cedcdb978d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_464f25eb-573f-4b80-ae08-d289420ab11c" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_464f25eb-573f-4b80-ae08-d289420ab11c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_bfaf20ec-ead0-41e5-b7ae-76f108f4bca1" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_bfaf20ec-ead0-41e5-b7ae-76f108f4bca1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_91b2c13a-b0b9-46d0-8812-2b1ddc329a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_89dcf60c-b6d8-49f1-9ea0-a94d7f8fc64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_23b3a92d-df5a-490a-b373-a8a6abb2f214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_23b3a92d-df5a-490a-b373-a8a6abb2f214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9a36ee31-3233-475d-b3ee-b5eee38d0500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockholdersEquity_9a36ee31-3233-475d-b3ee-b5eee38d0500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9afa5710-bc74-4115-82b5-8def7e71fa44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_NetIncomeLoss_9afa5710-bc74-4115-82b5-8def7e71fa44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_bb923fc4-d0a1-4985-ba8a-ecb3f73b52ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_bb923fc4-d0a1-4985-ba8a-ecb3f73b52ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d84c0025-73fe-44b3-a23b-04a61a9242ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d84c0025-73fe-44b3-a23b-04a61a9242ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_af96cb18-7f3d-43d5-a8ae-896fdc0e8786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_af96cb18-7f3d-43d5-a8ae-896fdc0e8786" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ccf537bf-e5f6-404c-bfaa-e77c4cee3078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ccf537bf-e5f6-404c-bfaa-e77c4cee3078" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_e0b4cd95-44d1-48bf-9b05-56495ada64c8" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodSharesEscrowSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_e0b4cd95-44d1-48bf-9b05-56495ada64c8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement_1b05d008-80db-4caa-8203-a4f3ca60225d" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodValueEscrowSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement_1b05d008-80db-4caa-8203-a4f3ca60225d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0c104c4e-580e-46e1-980c-a1f371a13a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0c104c4e-580e-46e1-980c-a1f371a13a3a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f95cb96e-ecc7-4a39-aa81-d85684cb90a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f95cb96e-ecc7-4a39-aa81-d85684cb90a5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9040b6e8-d592-4ae1-8053-cbeeb9883144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_775ce976-6161-4536-8f1c-71379611f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:to="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_94fc974c-92a0-4d40-accc-84021b771bf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:to="loc_us-gaap_EquityComponentDomain_94fc974c-92a0-4d40-accc-84021b771bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:to="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_13be7c83-48d3-47dc-bf43-9563011d8200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_CommonStockMember_13be7c83-48d3-47dc-bf43-9563011d8200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3cccfd2b-be80-4390-9288-6066c332274f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3cccfd2b-be80-4390-9288-6066c332274f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f6e39c2d-85de-452c-8ed1-79ab2a559a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_RetainedEarningsMember_f6e39c2d-85de-452c-8ed1-79ab2a559a12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af5cbd66-c640-4594-bff2-b4dd5d263769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af5cbd66-c640-4594-bff2-b4dd5d263769" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4899d88-4eeb-448f-88c5-c05cfe145a32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4899d88-4eeb-448f-88c5-c05cfe145a32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_242d37b2-9e15-4014-a6e3-d591234a86a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:to="loc_us-gaap_IPOMember_242d37b2-9e15-4014-a6e3-d591234a86a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="extended" id="i4a4d5e301d6449a7bdd42118428a20ca_ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_137216ca-ec36-4c42-9f0d-e6f9c43f7817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_137216ca-ec36-4c42-9f0d-e6f9c43f7817" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f1e2d3fe-bd36-4418-a7de-1b915c7fc1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f1e2d3fe-bd36-4418-a7de-1b915c7fc1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_399d1c67-95fa-47e8-88b0-2e463ae73041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_399d1c67-95fa-47e8-88b0-2e463ae73041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1a9fd3c-ee90-4376-908b-7fa52d7383ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1a9fd3c-ee90-4376-908b-7fa52d7383ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ad21974-6509-41d2-a1e3-4ad14d91ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ad21974-6509-41d2-a1e3-4ad14d91ebe5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_a9796f75-a2a9-433c-8a20-fc6b8fc59024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_DeferredOfferingCosts_a9796f75-a2a9-433c-8a20-fc6b8fc59024" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3dc654cb-19d2-4f6d-878e-216f58eb0e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3dc654cb-19d2-4f6d-878e-216f58eb0e6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_b035c3d1-8315-4c58-85a0-4f91f7a3010a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_b035c3d1-8315-4c58-85a0-4f91f7a3010a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9aec8afa-6634-4666-9303-cfb8ba76a323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9aec8afa-6634-4666-9303-cfb8ba76a323" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_RiskAdjustmentPayableCurrent_81d35e0c-c508-4a52-a439-a702287baf52" xlink:href="bhg-20210930.xsd#bhg_RiskAdjustmentPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_bhg_RiskAdjustmentPayableCurrent_81d35e0c-c508-4a52-a439-a702287baf52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_d0f7dd12-ab07-47c9-902b-6d93e9101fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_PremiumsEarnedNet_d0f7dd12-ab07-47c9-902b-6d93e9101fb3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab68d5d6-169b-4189-9ee7-ba02facd1ef6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab68d5d6-169b-4189-9ee7-ba02facd1ef6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_20dc7635-9fca-4ff3-901d-8aca7d8d16a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:to="loc_us-gaap_IPOMember_20dc7635-9fca-4ff3-901d-8aca7d8d16a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0273d9e-0a4f-493a-8d63-482c22711441_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:to="loc_us-gaap_ClassOfStockDomain_a0273d9e-0a4f-493a-8d63-482c22711441_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:to="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f1a1ff45-958d-4a91-8023-12f5fc2fcf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f1a1ff45-958d-4a91-8023-12f5fc2fcf2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0c9af9ce-4e38-41c1-8c91-3b1217689808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0c9af9ce-4e38-41c1-8c91-3b1217689808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_b3359d66-2d8d-4157-a2fd-a30d3477ba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_b3359d66-2d8d-4157-a2fd-a30d3477ba4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_bf3efaac-f9c6-4786-860a-af678d95b264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_bf3efaac-f9c6-4786-860a-af678d95b264" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_d99da406-b619-4350-a820-b9480071a941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_d99da406-b619-4350-a820-b9480071a941" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_929224dd-21ff-4501-a9b4-833e134e1499_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_929224dd-21ff-4501-a9b4-833e134e1499_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_8dba2c99-3496-4a49-9444-304349e64b7a" xlink:href="bhg-20210930.xsd#bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:to="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_8dba2c99-3496-4a49-9444-304349e64b7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="extended" id="i34f7657ee10940f19f1dec2ea7ecff0b_BUSINESSCOMBINATIONSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_87d35f24-458e-4320-a5eb-c00830983113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_87d35f24-458e-4320-a5eb-c00830983113" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ae2cfcd4-e0c6-4e8f-8dea-c50af3a49f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ae2cfcd4-e0c6-4e8f-8dea-c50af3a49f86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6bdc7417-3df9-4461-9828-f60b699ac090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6bdc7417-3df9-4461-9828-f60b699ac090" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d663ef45-af63-4c86-9c83-dd9ffe74ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d663ef45-af63-4c86-9c83-dd9ffe74ecc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1dcd7be8-1f2a-48af-9c28-8c59dc7009a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1dcd7be8-1f2a-48af-9c28-8c59dc7009a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NumberOfHealthCenters_df2393eb-a021-4047-95fa-9941cdf6701a" xlink:href="bhg-20210930.xsd#bhg_NumberOfHealthCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_NumberOfHealthCenters_df2393eb-a021-4047-95fa-9941cdf6701a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e11d1ee2-a920-4750-bee8-18f61641fa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e11d1ee2-a920-4750-bee8-18f61641fa4b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a9fa81f9-827c-4993-9b79-47996035c543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a9fa81f9-827c-4993-9b79-47996035c543" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment_e4570fa3-04e6-407f-8ca1-f12f683239b9" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationTangibleNetEquityAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment_e4570fa3-04e6-407f-8ca1-f12f683239b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationEscrowAdjustment_2f204f8a-f3eb-458c-a3e2-2510d4aa1b71" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationEscrowAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_BusinessCombinationEscrowAdjustment_2f204f8a-f3eb-458c-a3e2-2510d4aa1b71" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_721fa298-ec1f-4657-a198-6a17e2736f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_721fa298-ec1f-4657-a198-6a17e2736f95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e2af2b63-caf7-4971-8b7a-ac79e9896383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e2af2b63-caf7-4971-8b7a-ac79e9896383" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_225f074b-0ba0-4750-8410-277354197ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_225f074b-0ba0-4750-8410-277354197ac8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c70473ca-039f-48aa-a856-108acd97accd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c70473ca-039f-48aa-a856-108acd97accd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_6d931190-921f-4ac6-8a41-e9a7e944431f" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_6d931190-921f-4ac6-8a41-e9a7e944431f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_29d3411d-ffd1-48a7-8c3e-e49008250a1b" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_29d3411d-ffd1-48a7-8c3e-e49008250a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TrueHealthNewMexicoMember_3891b777-7ef7-4c5b-b902-35f7f4f51d97" xlink:href="bhg-20210930.xsd#bhg_TrueHealthNewMexicoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_TrueHealthNewMexicoMember_3891b777-7ef7-4c5b-b902-35f7f4f51d97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ZipnosisMember_2320fe09-0595-423a-8a54-97c042c0a032" xlink:href="bhg-20210930.xsd#bhg_ZipnosisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_ZipnosisMember_2320fe09-0595-423a-8a54-97c042c0a032" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember_2a3d9c6e-1b5c-4c18-8021-0a3ae45f27c0" xlink:href="bhg-20210930.xsd#bhg_PremierMedicalAssociatesOfFloridaLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember_2a3d9c6e-1b5c-4c18-8021-0a3ae45f27c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_UniversalCareIncBrandNewDayMember_134f8b5d-9b9e-4987-9079-909bc6aaa3d1" xlink:href="bhg-20210930.xsd#bhg_UniversalCareIncBrandNewDayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_UniversalCareIncBrandNewDayMember_134f8b5d-9b9e-4987-9079-909bc6aaa3d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a46371be-c8ad-4bcb-b1df-1ced295a92d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a46371be-c8ad-4bcb-b1df-1ced295a92d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_7f659267-0e80-4806-81b8-911ac3272845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_TradeNamesMember_7f659267-0e80-4806-81b8-911ac3272845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3ffd0348-5ede-4382-9c54-6f0624b5cee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3ffd0348-5ede-4382-9c54-6f0624b5cee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_5697ac25-6429-4c94-bb06-553bfeed1a84" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_bhg_ReacquiredContractsMember_5697ac25-6429-4c94-bb06-553bfeed1a84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ProviderNetworkMember_bc264707-89a4-4352-a1b1-461e4259cdbd" xlink:href="bhg-20210930.xsd#bhg_ProviderNetworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_bhg_ProviderNetworkMember_bc264707-89a4-4352-a1b1-461e4259cdbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_41ad8b3c-bf1c-4005-af7c-824107680a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_41ad8b3c-bf1c-4005-af7c-824107680a22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_75387a1d-043e-491e-9f08-67079d068308_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:to="loc_srt_RangeMember_75387a1d-043e-491e-9f08-67079d068308_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:to="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5995c0e-b294-4995-b0f8-77d5d8508e03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:to="loc_srt_MinimumMember_f5995c0e-b294-4995-b0f8-77d5d8508e03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98e492e3-2991-4417-9f4b-88ba8dfdd996" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:to="loc_srt_MaximumMember_98e492e3-2991-4417-9f4b-88ba8dfdd996" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="extended" id="i595a61289dca4d5b818c2e7687e7f97e_BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_718fa3ff-ac6e-49ea-9eb0-85646667ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_718fa3ff-ac6e-49ea-9eb0-85646667ca14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_720f1b7e-6a89-45bc-98cf-fd3b1cee4195" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_720f1b7e-6a89-45bc-98cf-fd3b1cee4195" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_092494ef-ce54-469c-b0f2-c81de290d699" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_092494ef-ce54-469c-b0f2-c81de290d699" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_40ee9a86-719a-4b6f-a0d4-d670916856fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_40ee9a86-719a-4b6f-a0d4-d670916856fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_f1cc8688-29bd-4b72-bf74-e86409063796" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_f1cc8688-29bd-4b72-bf74-e86409063796" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50642b85-c5ad-45f7-ac1e-16b2fcb795c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50642b85-c5ad-45f7-ac1e-16b2fcb795c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_95671a19-1556-4115-aef6-df0bfc8532c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_95671a19-1556-4115-aef6-df0bfc8532c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6740b92b-f5a6-4d96-87c7-ff7414b32275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6740b92b-f5a6-4d96-87c7-ff7414b32275" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_62f75756-7b3a-4a29-a87a-370ffb18e396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_62f75756-7b3a-4a29-a87a-370ffb18e396" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_9197b412-6249-4a45-9269-2843a47fcba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_9197b412-6249-4a45-9269-2843a47fcba4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b0e62083-dd5e-46cb-9463-9b670f09f4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b0e62083-dd5e-46cb-9463-9b670f09f4fa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_6832599b-4b4b-4684-8487-3ca6d0b3f4ae" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_6832599b-4b4b-4684-8487-3ca6d0b3f4ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f6c715b2-914b-441f-9336-c6d4fb03d413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f6c715b2-914b-441f-9336-c6d4fb03d413" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_2a1e4fd4-03de-4ba5-8af6-f3f054945fce" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_2a1e4fd4-03de-4ba5-8af6-f3f054945fce" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_9ba92f2c-ff21-48e5-a1f0-d398c5f81ffc" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_9ba92f2c-ff21-48e5-a1f0-d398c5f81ffc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_031684b0-eae0-4382-967a-db1a2b629639" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_031684b0-eae0-4382-967a-db1a2b629639" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1c6b50a4-0bce-4b9a-bb24-9f6cecff96d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1c6b50a4-0bce-4b9a-bb24-9f6cecff96d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_d14327ff-9ce9-4fa3-8e1f-84486f8196a0" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_d14327ff-9ce9-4fa3-8e1f-84486f8196a0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e3780ce3-66d3-4612-8413-4eda2255bead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e3780ce3-66d3-4612-8413-4eda2255bead" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_2f8ba4a6-3928-40a3-afc3-9b6c7929afb0" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_2f8ba4a6-3928-40a3-afc3-9b6c7929afb0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c04ab06d-4838-46d8-987e-b0a7288138c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c04ab06d-4838-46d8-987e-b0a7288138c6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4ae4294b-dd97-4099-b088-42d902a2d594" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4ae4294b-dd97-4099-b088-42d902a2d594" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ebe69615-e1dc-4f7a-9ff1-2615d44e7da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ebe69615-e1dc-4f7a-9ff1-2615d44e7da1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_b43aa41d-a678-4712-abba-fed24c687968" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_b43aa41d-a678-4712-abba-fed24c687968" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eec5ca10-d89c-4d10-9809-85c26e536a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eec5ca10-d89c-4d10-9809-85c26e536a0e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_03e52ca7-c511-49d3-927f-949743a7361f" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_03e52ca7-c511-49d3-927f-949743a7361f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c44c938b-8dec-4849-a336-685192ffd10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_Goodwill_c44c938b-8dec-4849-a336-685192ffd10c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6be1e459-70b3-4e5f-b866-8f483bb3a911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6be1e459-70b3-4e5f-b866-8f483bb3a911" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d136178b-4b3a-41f1-98b6-b29cdd99e2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d136178b-4b3a-41f1-98b6-b29cdd99e2cf" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea6e42ad-638f-4159-92bd-a3e6cacf04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea6e42ad-638f-4159-92bd-a3e6cacf04a0" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7e3e3716-481c-4afa-ad66-0104c9035415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7e3e3716-481c-4afa-ad66-0104c9035415" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_235f075d-9f7f-438c-8992-5655187909ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_235f075d-9f7f-438c-8992-5655187909ed" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3c96dfa-96a5-4124-b34f-a9b531893efb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3c96dfa-96a5-4124-b34f-a9b531893efb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_2b6bd0ac-6f28-44b8-9be8-6d4c4b06ea73" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_2b6bd0ac-6f28-44b8-9be8-6d4c4b06ea73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_5992e80f-ba86-403d-9efc-a3982c564cdc" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_5992e80f-ba86-403d-9efc-a3982c564cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TrueHealthNewMexicoMember_3d263fc9-2f31-4bde-9119-84bd18b3a572" xlink:href="bhg-20210930.xsd#bhg_TrueHealthNewMexicoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_TrueHealthNewMexicoMember_3d263fc9-2f31-4bde-9119-84bd18b3a572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ZipnosisMember_7853b6cb-c2cc-4f41-9d91-072a5d55f01b" xlink:href="bhg-20210930.xsd#bhg_ZipnosisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_ZipnosisMember_7853b6cb-c2cc-4f41-9d91-072a5d55f01b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_UniversalCareIncBrandNewDayMember_b0743c4b-8837-4737-bd46-863d8df3d1d8" xlink:href="bhg-20210930.xsd#bhg_UniversalCareIncBrandNewDayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_UniversalCareIncBrandNewDayMember_b0743c4b-8837-4737-bd46-863d8df3d1d8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails" xlink:type="extended" id="i2517c8efeee04bc98639d90296f6e455_BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0250d8e1-3c07-475f-9b12-d118374cfc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0250d8e1-3c07-475f-9b12-d118374cfc3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2c010375-a3ab-4d71-bf0f-f5f4ccddf672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2c010375-a3ab-4d71-bf0f-f5f4ccddf672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a14ca8c3-0040-48b4-a2cc-3090615aa6e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a14ca8c3-0040-48b4-a2cc-3090615aa6e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_0d377a40-757f-4b42-8ae5-66579fcc7878" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_0d377a40-757f-4b42-8ae5-66579fcc7878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_THNMAndZipnosisMember_109d3ec2-1071-4abc-8ac2-89b1779ac577" xlink:href="bhg-20210930.xsd#bhg_THNMAndZipnosisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_THNMAndZipnosisMember_109d3ec2-1071-4abc-8ac2-89b1779ac577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_90ba0a9c-a9a9-4d32-8d41-8fae4cf3f6c3" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_90ba0a9c-a9a9-4d32-8d41-8fae4cf3f6c3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="extended" id="i37906ff6fb394b76be4cff53b9a4d2ed_INVESTMENTSScheduleofInvestmentSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_f944fd01-8777-41d5-bb57-98301de7f186" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_f944fd01-8777-41d5-bb57-98301de7f186" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5fa2963d-cb99-4855-8dd5-6a7e076be4fb" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5fa2963d-cb99-4855-8dd5-6a7e076be4fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4b5a7c-eef3-4cdb-a3a3-042caefaa3e8" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4b5a7c-eef3-4cdb-a3a3-042caefaa3e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_8eb91c42-2347-4aa9-ad0d-73d71fa4f8fa" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_8eb91c42-2347-4aa9-ad0d-73d71fa4f8fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a1f7e12-bd35-4687-96f3-32482b9ac7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a1f7e12-bd35-4687-96f3-32482b9ac7bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8ea50541-954e-433a-a65e-75bc4473af0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8ea50541-954e-433a-a65e-75bc4473af0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5b1b1103-23d9-49a6-98bb-5b0e5d5ddd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5b1b1103-23d9-49a6-98bb-5b0e5d5ddd96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_548c103d-d1d5-4157-b306-f32b0229eda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_548c103d-d1d5-4157-b306-f32b0229eda8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b7008590-bfbb-4bfe-87a1-610b0156d82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b7008590-bfbb-4bfe-87a1-610b0156d82e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d95a93df-f7a3-46e7-933e-6b215355e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d95a93df-f7a3-46e7-933e-6b215355e75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_8d4ced04-01c4-46d6-b6fa-dc396ec6334e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_8d4ced04-01c4-46d6-b6fa-dc396ec6334e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_67ceff7d-b99d-4aa0-bbf0-8235967e9fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_67ceff7d-b99d-4aa0-bbf0-8235967e9fbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f1ee484c-4507-4259-80cd-5a7777b53e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f1ee484c-4507-4259-80cd-5a7777b53e7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_1397dbd8-d504-4b67-83c5-8d53355763ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_1397dbd8-d504-4b67-83c5-8d53355763ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_4d58451a-e63c-4d9b-95e4-dd28c9f270c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_4d58451a-e63c-4d9b-95e4-dd28c9f270c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_493d61a9-46bc-4634-9306-ca20f8f5974b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_493d61a9-46bc-4634-9306-ca20f8f5974b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_e3f6b25a-bc17-48b3-872d-7b512c6b20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_e3f6b25a-bc17-48b3-872d-7b512c6b20d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_4d15341e-b223-489c-b785-d53ffff24c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_4d15341e-b223-489c-b785-d53ffff24c72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f6fc266-9436-4797-86f7-de7a6a795fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f6fc266-9436-4797-86f7-de7a6a795fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2f6fc266-9436-4797-86f7-de7a6a795fb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_775f2198-e7f6-4376-91b6-f27f874280a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_8758f813-736c-47fd-9da8-cd58b6656d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_3b8827bf-e374-42e6-b656-0628940db084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f44457a8-b5c1-43e7-94f1-a63ec0911839_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f44457a8-b5c1-43e7-94f1-a63ec0911839_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShortTermAndLongTermInvestmentsMember_664e5fd9-2cc9-4558-a1b8-251186816893" xlink:href="bhg-20210930.xsd#bhg_ShortTermAndLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:to="loc_bhg_ShortTermAndLongTermInvestmentsMember_664e5fd9-2cc9-4558-a1b8-251186816893" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="extended" id="if0a7033aa6b74c7f85c2df62cd356d7f_INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_bed725ab-8596-4d3f-971b-455c9e454d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_bed725ab-8596-4d3f-971b-455c9e454d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_50306641-dbed-466c-80f1-c9d0ccf2f884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_50306641-dbed-466c-80f1-c9d0ccf2f884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7100ca73-5de6-4341-9e23-03578548ba6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7100ca73-5de6-4341-9e23-03578548ba6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_74e7ffba-ff22-4ca2-aaef-517a2ed988b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_74e7ffba-ff22-4ca2-aaef-517a2ed988b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_42e81caa-1e65-4610-b49d-b7f641469d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_42e81caa-1e65-4610-b49d-b7f641469d75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f1d74d47-6282-46ed-be17-19197f095fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f1d74d47-6282-46ed-be17-19197f095fbd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97b96bf1-5fd1-417e-baff-527134dc2b86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97b96bf1-5fd1-417e-baff-527134dc2b86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_141661ea-3bde-4e92-ac1c-6d150098f4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_141661ea-3bde-4e92-ac1c-6d150098f4fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_71adfd52-aed7-4d46-8e54-dc99d5f79848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_71adfd52-aed7-4d46-8e54-dc99d5f79848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4bf6c135-d7c7-4146-a44b-44a1ce1ef59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4bf6c135-d7c7-4146-a44b-44a1ce1ef59e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_6d380b58-0282-4b1a-9216-287db32b7d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_6d380b58-0282-4b1a-9216-287db32b7d04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_fe783adc-0dbf-4061-9c45-96d557fedcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_fe783adc-0dbf-4061-9c45-96d557fedcb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_0adda21d-e67a-4ae8-87a2-c46b154b413f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_0adda21d-e67a-4ae8-87a2-c46b154b413f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6145ebb3-52e3-47ab-95cc-a59f04a15a4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6145ebb3-52e3-47ab-95cc-a59f04a15a4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_33d08e91-4512-407b-88a4-56842e60d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_33d08e91-4512-407b-88a4-56842e60d12f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShortTermAndLongTermInvestmentsMember_f247c5cc-fc8a-4153-a157-6f60c8c773b8" xlink:href="bhg-20210930.xsd#bhg_ShortTermAndLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:to="loc_bhg_ShortTermAndLongTermInvestmentsMember_f247c5cc-fc8a-4153-a157-6f60c8c773b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended" id="i76f05408654c48cbb8b36d390c5be644_INVESTMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_cddc5bf0-7399-4917-bb7e-32ff20f6ff77" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_cddc5bf0-7399-4917-bb7e-32ff20f6ff77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_1a8b530f-2777-45c3-8cc8-fb51ba498027" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_1a8b530f-2777-45c3-8cc8-fb51ba498027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_9ab10281-704e-4d9c-912b-861070ab717c" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_InvestmentIncomeLoss_9ab10281-704e-4d9c-912b-861070ab717c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesRealizedGainLoss_03987a9d-d1f9-4cdf-941a-2cc1e29ec1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_DebtSecuritiesRealizedGainLoss_03987a9d-d1f9-4cdf-941a-2cc1e29ec1d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_EquitySecuritiesFVNISharesPurchased_b71f7a57-4e9d-4913-9921-9e5e5eda67db" xlink:href="bhg-20210930.xsd#bhg_EquitySecuritiesFVNISharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_EquitySecuritiesFVNISharesPurchased_b71f7a57-4e9d-4913-9921-9e5e5eda67db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_6284fc2f-2007-42ca-b4cb-6f6ad86ac07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_6284fc2f-2007-42ca-b4cb-6f6ad86ac07a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7fa37f5b-f816-4989-9337-e661e061aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7fa37f5b-f816-4989-9337-e661e061aca4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_418ce551-a312-4e77-894b-5dc366cb6ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_418ce551-a312-4e77-894b-5dc366cb6ebf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0397bce-eb88-4025-8980-ac94ec675fb4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0397bce-eb88-4025-8980-ac94ec675fb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_30f1bc81-17b8-4c56-977f-e461dd2a2f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:to="loc_us-gaap_DebtSecuritiesMember_30f1bc81-17b8-4c56-977f-e461dd2a2f5f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="extended" id="i0a3ffa3adcec4e949ecd693598d1e269_FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc381515-7452-4bad-b671-3a21632e1674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc381515-7452-4bad-b671-3a21632e1674" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49fe9514-2523-4637-be84-67d01d4b7ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49fe9514-2523-4637-be84-67d01d4b7ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_802b355d-8058-4d58-b232-123d5de67116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_802b355d-8058-4d58-b232-123d5de67116" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bf42eb83-4d68-41fe-827d-9b11188ac055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bf42eb83-4d68-41fe-827d-9b11188ac055" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd646c4e-d012-45d2-b3f0-e2050786bf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd646c4e-d012-45d2-b3f0-e2050786bf1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10a240a6-6498-4154-8b49-ec92a8b4547e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10a240a6-6498-4154-8b49-ec92a8b4547e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_60443a75-ae9a-445d-a1fd-418fcc60461d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_60443a75-ae9a-445d-a1fd-418fcc60461d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d50ec95-2593-4e6e-8399-90f11abc523d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d50ec95-2593-4e6e-8399-90f11abc523d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6e1ab09c-ae54-48d8-8950-9714b2339989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6e1ab09c-ae54-48d8-8950-9714b2339989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d4e9d9e0-649f-4ab0-b0e9-c128ca4d51f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d4e9d9e0-649f-4ab0-b0e9-c128ca4d51f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2fcd2a6f-e3b7-41d1-9a4b-8b29e937eb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2fcd2a6f-e3b7-41d1-9a4b-8b29e937eb02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3129dd0c-3b02-448f-8669-a56cdadc8715_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3129dd0c-3b02-448f-8669-a56cdadc8715_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1f38b5d4-9903-49bf-979a-47a7e802ffde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1f38b5d4-9903-49bf-979a-47a7e802ffde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8098fb34-8f30-44ca-a1ae-d92515d93b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8098fb34-8f30-44ca-a1ae-d92515d93b3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_749e9feb-1cb5-40ee-a88c-78ad1cc74f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_749e9feb-1cb5-40ee-a88c-78ad1cc74f86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_1da32e01-85fd-43e3-bf6f-09b23654cbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_1da32e01-85fd-43e3-bf6f-09b23654cbf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1fc45918-4ba5-4b73-9439-383491de3ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1fc45918-4ba5-4b73-9439-383491de3ec5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_4705f7be-4928-4472-a7c6-93ac3e9a1ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_4705f7be-4928-4472-a7c6-93ac3e9a1ab2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dd7f895f-fcab-42ab-9042-f6de8ed73ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dd7f895f-fcab-42ab-9042-f6de8ed73ec4" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="extended" id="ice18c086668b4ea29a76c3a875887d50_FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_96b54611-da4b-439a-8c67-3133fbc946c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_96b54611-da4b-439a-8c67-3133fbc946c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_420ac0e5-51da-49f1-a7ba-ca721b68e03f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_420ac0e5-51da-49f1-a7ba-ca721b68e03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_db94cbfb-08c5-417f-97a3-a49806bccaf5" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_db94cbfb-08c5-417f-97a3-a49806bccaf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4de6ada-6b73-4806-94dd-de6e68f3c68f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4de6ada-6b73-4806-94dd-de6e68f3c68f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c9fff374-a337-4044-90b6-586b4f3b7347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c9fff374-a337-4044-90b6-586b4f3b7347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_96a0c874-8aa9-48c8-b6b3-9c0e84ac783a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_96a0c874-8aa9-48c8-b6b3-9c0e84ac783a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_67e5990f-bca6-4097-b712-f80b43404f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_67e5990f-bca6-4097-b712-f80b43404f2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12bd7909-797c-4dc4-826b-c1c22307c9f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_12bd7909-797c-4dc4-826b-c1c22307c9f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5f715f5b-45f5-4cb6-b68b-8cb0e180c8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5f715f5b-45f5-4cb6-b68b-8cb0e180c8fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_a8c5c027-146e-489a-bfea-7171df98fd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:to="loc_us-gaap_CertificatesOfDepositMember_a8c5c027-146e-489a-bfea-7171df98fd09" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails" xlink:type="extended" id="i02d04cb5fe544ea5b56368f30db62251_FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83a9e5c9-5895-4c8f-8134-060114c341f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83a9e5c9-5895-4c8f-8134-060114c341f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_122bbac2-0a60-4645-a084-1c44af9801b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_122bbac2-0a60-4645-a084-1c44af9801b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f34651af-bd37-4d79-8726-4fcc2c5cc0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_21f721bd-6a9f-4916-bd70-aa25c12cd651_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_21f721bd-6a9f-4916-bd70-aa25c12cd651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ContingentConsiderationLiabilityMember_f187441d-132d-46b3-a424-5d4e9707c422" xlink:href="bhg-20210930.xsd#bhg_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:to="loc_bhg_ContingentConsiderationLiabilityMember_f187441d-132d-46b3-a424-5d4e9707c422" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended" id="i2324f4e592c74193ba30202996590a59_GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:to="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_7036a7de-2a6d-42c9-a4fa-918868528e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillGross_7036a7de-2a6d-42c9-a4fa-918868528e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a4edf6a2-9e3a-4764-bdbe-bc9da700f26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a4edf6a2-9e3a-4764-bdbe-bc9da700f26c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1b319736-cbab-4580-8a27-2af8b082f9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1b319736-cbab-4580-8a27-2af8b082f9a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_47b407ed-820e-4c31-b407-853ca6537301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_36f18eda-db03-43a5-81a2-6c7288ea86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_36f18eda-db03-43a5-81a2-6c7288ea86fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_364a8372-e659-4d88-9858-40de35053ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cdb980fb-7072-44f0-a9b3-7de2ec21da16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:to="loc_us-gaap_SegmentDomain_cdb980fb-7072-44f0-a9b3-7de2ec21da16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:to="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BrightHealthCareMember_0f6a6aa6-5dde-4e3f-8fdc-e1935512d18e" xlink:href="bhg-20210930.xsd#bhg_BrightHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:to="loc_bhg_BrightHealthCareMember_0f6a6aa6-5dde-4e3f-8fdc-e1935512d18e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NeueHealthMember_047de5e6-1b8c-4f09-9f59-2317210287d2" xlink:href="bhg-20210930.xsd#bhg_NeueHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:to="loc_bhg_NeueHealthMember_047de5e6-1b8c-4f09-9f59-2317210287d2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails" xlink:type="extended" id="i51b56242eb9b43768e8cee2d02c1ac22_GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_de114207-396f-486a-975a-8f031106c37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_de114207-396f-486a-975a-8f031106c37c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca625490-3655-4395-b5b2-e5a2767ba94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca625490-3655-4395-b5b2-e5a2767ba94f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63778909-fa00-4406-9974-ce9f8c5f1dc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_63778909-fa00-4406-9974-ce9f8c5f1dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_55069ae7-586d-4fa6-9d8d-836d71f17740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_55069ae7-586d-4fa6-9d8d-836d71f17740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_53fb8f0a-3bc4-452a-a66c-7802937d575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_TradeNamesMember_53fb8f0a-3bc4-452a-a66c-7802937d575a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_31755e01-c132-40b7-8b6a-6a977dc3307e" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_bhg_ReacquiredContractsMember_31755e01-c132-40b7-8b6a-6a977dc3307e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d5a96782-77a8-43a8-9c6f-51ff4bb14bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d5a96782-77a8-43a8-9c6f-51ff4bb14bfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_7e80e70d-add7-4355-9b46-d2c5010bf23e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_7e80e70d-add7-4355-9b46-d2c5010bf23e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails" xlink:type="extended" id="ib216ad32d523411e9b7bf8670325b652_GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_bdfa11ea-2d0e-426e-8f80-17a40839ae8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_bdfa11ea-2d0e-426e-8f80-17a40839ae8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b5ddb361-5b16-46cd-a216-a03325e4358f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b5ddb361-5b16-46cd-a216-a03325e4358f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84698143-baea-4260-864b-46388f84631f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84698143-baea-4260-864b-46388f84631f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9279ec43-bc5f-454e-b395-eb416cb20e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9279ec43-bc5f-454e-b395-eb416cb20e4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3c8d8093-76dc-45ca-8d01-371243345c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_TradeNamesMember_3c8d8093-76dc-45ca-8d01-371243345c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_92420b15-8670-413a-908b-91aa445074f6" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_bhg_ReacquiredContractsMember_92420b15-8670-413a-908b-91aa445074f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_928c0117-76fe-44ff-ad76-f96dc762bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_928c0117-76fe-44ff-ad76-f96dc762bc02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f464f97c-52ef-47bd-81ba-d8b4d082e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f464f97c-52ef-47bd-81ba-d8b4d082e78a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHORTTERMBORROWINGSDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails" xlink:type="extended" id="i6c1a9c26b11e4d23a246e8361859c4a0_SHORTTERMBORROWINGSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c8e2f0b9-f8a9-45d2-ae1e-91187f2d5f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c8e2f0b9-f8a9-45d2-ae1e-91187f2d5f69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_0f1bf1d2-6ea6-437f-9908-413a82b7b14a" xlink:href="bhg-20210930.xsd#bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_0f1bf1d2-6ea6-437f-9908-413a82b7b14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_bc0474d4-1b75-4a64-a6ae-fe61ffa0bf7b" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_bc0474d4-1b75-4a64-a6ae-fe61ffa0bf7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_cf4dd80e-c6d6-4d3e-93c5-fca5dc5be3f6" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_cf4dd80e-c6d6-4d3e-93c5-fca5dc5be3f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_2a917b2e-a6ae-41c5-be4d-8dc3d7e78ddd" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_2a917b2e-a6ae-41c5-be4d-8dc3d7e78ddd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_320b7693-1da0-4973-b13a-561ff2842442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_320b7693-1da0-4973-b13a-561ff2842442" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseShortTermBorrowings_21f8a44a-f7d5-466a-b7e5-02cc9c720713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_InterestExpenseShortTermBorrowings_21f8a44a-f7d5-466a-b7e5-02cc9c720713" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:to="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6f080be0-d97b-4706-9f41-f4a1760cdb01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:to="loc_us-gaap_CreditFacilityDomain_6f080be0-d97b-4706-9f41-f4a1760cdb01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:to="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c750532c-7105-4335-818a-9b926e5ff867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c750532c-7105-4335-818a-9b926e5ff867" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e6c8ac97-a477-4401-b346-29bf3522429d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e6c8ac97-a477-4401-b346-29bf3522429d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_13127ea8-a360-433d-b763-e998d2630a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:to="loc_us-gaap_LineOfCreditMember_13127ea8-a360-433d-b763-e998d2630a2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="idc48d9559b8e4e979bd8fb7e737a4097_SHAREBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_da183675-d06b-46e0-b233-f2d4648568f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_da183675-d06b-46e0-b233-f2d4648568f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8c74d60c-ca83-4f8b-a9e5-c807da9ea3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8c74d60c-ca83-4f8b-a9e5-c807da9ea3ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c9a06930-022b-44ad-bd26-00a4ba66a10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c9a06930-022b-44ad-bd26-00a4ba66a10b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0a046da8-0ae1-432b-9d3a-dff11c28069b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0a046da8-0ae1-432b-9d3a-dff11c28069b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d7113f17-8a19-43ab-b11d-99e6f51c8321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d7113f17-8a19-43ab-b11d-99e6f51c8321" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_edc04bd0-692f-4bbd-942c-4a97767aa38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_edc04bd0-692f-4bbd-942c-4a97767aa38e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22bac9d9-0f0e-444e-801a-4ca2f9be3163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22bac9d9-0f0e-444e-801a-4ca2f9be3163" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_41729bcc-3362-4c4a-b98d-1824fa795600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_41729bcc-3362-4c4a-b98d-1824fa795600" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd0b42aa-83c1-4549-bda7-e3d30358efed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd0b42aa-83c1-4549-bda7-e3d30358efed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e9ad72fc-9601-43dc-902f-f26848874090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e9ad72fc-9601-43dc-902f-f26848874090" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dfdbb2f2-3997-4e26-a701-4a5a06cc2eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dfdbb2f2-3997-4e26-a701-4a5a06cc2eb5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_3dbc30c9-f61a-4d89-86b1-fa8da73f2175" xlink:href="bhg-20210930.xsd#bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_3dbc30c9-f61a-4d89-86b1-fa8da73f2175" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_c40b5bd7-4712-40d6-b557-746e8534e958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_c40b5bd7-4712-40d6-b557-746e8534e958" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:to="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_43525e04-a838-4a10-8d10-791d97667e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:to="loc_us-gaap_VestingDomain_43525e04-a838-4a10-8d10-791d97667e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:to="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b43e8576-c1d0-40b0-8dd2-7cc8a7199395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b43e8576-c1d0-40b0-8dd2-7cc8a7199395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1e81418-32cc-4872-b078-894ad747f211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1e81418-32cc-4872-b078-894ad747f211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:to="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a4363440-2f72-45cc-b491-1a3913218d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a4363440-2f72-45cc-b491-1a3913218d1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e3bc1cd8-c09f-4b09-9fda-c019cd609df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e3bc1cd8-c09f-4b09-9fda-c019cd609df8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3ecb20ee-0ac0-46b4-a01a-a40ac9213b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_PerformanceSharesMember_3ecb20ee-0ac0-46b4-a01a-a40ac9213b2a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails" xlink:type="extended" id="i660edc08d4d54d08a7959b8af8f33904_SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c424ec55-44a6-4611-9cbb-02e390cc4378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c424ec55-44a6-4611-9cbb-02e390cc4378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_595cc71a-eae5-4b1b-b5a5-0b592cbac402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_595cc71a-eae5-4b1b-b5a5-0b592cbac402" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1a3ebc4b-7888-4c8f-a02c-bdbf62b1a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1a3ebc4b-7888-4c8f-a02c-bdbf62b1a43f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04ed4962-92c4-4902-85d5-539950725b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b946dfb6-0848-4ddf-9caa-a380ff48fa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b946dfb6-0848-4ddf-9caa-a380ff48fa3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5ded8c85-06da-4836-9a08-d7dd83a924ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5ded8c85-06da-4836-9a08-d7dd83a924ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d54debc1-55e3-4bc1-9ca6-05fb10140e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d54debc1-55e3-4bc1-9ca6-05fb10140e36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce48be07-a4fe-4b1f-9841-9b1f9c8b9dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:to="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef46bb39-c9bf-4b85-a802-c712aac7dad4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef46bb39-c9bf-4b85-a802-c712aac7dad4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fdbe7e11-50d8-4925-94e5-973e33c4940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fdbe7e11-50d8-4925-94e5-973e33c4940f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c190c3bc-f5e1-4415-9b48-9cb18aac2829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:to="loc_us-gaap_PerformanceSharesMember_c190c3bc-f5e1-4415-9b48-9cb18aac2829" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails" xlink:type="extended" id="ifd3dd1a9bbd04894a54b118cd1b5b1a5_NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_346cc9e2-62b4-424f-b782-1b50989f39b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_346cc9e2-62b4-424f-b782-1b50989f39b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c681a3ae-a00e-436b-912e-ed28c105a090_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c681a3ae-a00e-436b-912e-ed28c105a090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_2c385cbe-a62d-437a-83c5-c88e96b814f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_2c385cbe-a62d-437a-83c5-c88e96b814f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_53a41ed7-04f7-4bbf-bc98-f29dbcfbb19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_53a41ed7-04f7-4bbf-bc98-f29dbcfbb19f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails" xlink:type="extended" id="i0215f8eef52d45ecb7b17d77129cc2ec_SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4d57865d-4fe4-4b42-943c-07957567517b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_PremiumsEarnedNet_4d57865d-4fe4-4b42-943c-07957567517b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6867ab-ca96-4bdd-b75c-8289e022a443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6867ab-ca96-4bdd-b75c-8289e022a443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_b1c9abd5-0343-4f5b-8965-c839accd8d53" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_bhg_InvestmentIncomeLoss_b1c9abd5-0343-4f5b-8965-c839accd8d53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d73de6bc-8b6a-4459-bf1f-01d0ff8896ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_Revenues_d73de6bc-8b6a-4459-bf1f-01d0ff8896ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d422a1d9-ccf4-45ad-baf0-9e9abd4bec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_OperatingIncomeLoss_d422a1d9-ccf4-45ad-baf0-9e9abd4bec0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_264a72f4-801f-456c-a472-06d9d2225b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_264a72f4-801f-456c-a472-06d9d2225b0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:to="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_899378f4-02b7-46f5-af58-a6cafaa9df93_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:to="loc_srt_ConsolidationItemsDomain_899378f4-02b7-46f5-af58-a6cafaa9df93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:to="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4665c153-da49-40ae-98b0-fb40dd4583c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:to="loc_us-gaap_OperatingSegmentsMember_4665c153-da49-40ae-98b0-fb40dd4583c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_fd9f952c-77df-4238-be7d-2bac7c2e6ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:to="loc_us-gaap_IntersegmentEliminationMember_fd9f952c-77df-4238-be7d-2bac7c2e6ad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70a6cd56-40aa-45d5-a6b1-ba1f99249f81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:to="loc_us-gaap_SegmentDomain_70a6cd56-40aa-45d5-a6b1-ba1f99249f81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:to="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BrightHealthCareMember_c7448346-d407-457d-8530-e00eb46a8b14" xlink:href="bhg-20210930.xsd#bhg_BrightHealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:to="loc_bhg_BrightHealthCareMember_c7448346-d407-457d-8530-e00eb46a8b14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NeueHealthMember_8a2b400e-ac4a-4620-85d0-ba82bbc1cbed" xlink:href="bhg-20210930.xsd#bhg_NeueHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:to="loc_bhg_NeueHealthMember_8a2b400e-ac4a-4620-85d0-ba82bbc1cbed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended" id="i10b9eadd6832463989e954e670c31a1e_REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_77653ca2-d2d5-4e0e-aa86-13d6ce8d196c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_77653ca2-d2d5-4e0e-aa86-13d6ce8d196c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:to="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:to="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_569d5449-f47e-46e4-9b64-a8826efeafba_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:to="loc_dei_EntityDomain_569d5449-f47e-46e4-9b64-a8826efeafba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:to="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ControllingInterestHolderMember_a04bea7a-539e-40f5-9d5b-7099fe049ca5" xlink:href="bhg-20210930.xsd#bhg_ControllingInterestHolderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:to="loc_bhg_ControllingInterestHolderMember_a04bea7a-539e-40f5-9d5b-7099fe049ca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:to="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_52ea8277-f08d-48d2-a9f4-52c95b890976_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:to="loc_srt_OwnershipDomain_52ea8277-f08d-48d2-a9f4-52c95b890976_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:to="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_c09396ce-b91c-4694-a479-e355175bc614" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_c09396ce-b91c-4694-a479-e355175bc614" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bhg-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bhg_ZipnosisMember_802674d8-b6c4-4287-a89e-b2947e8ddfbf_terseLabel_en-US" xlink:label="lab_bhg_ZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zipnosis</link:label>
    <link:label id="lab_bhg_ZipnosisMember_label_en-US" xlink:label="lab_bhg_ZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zipnosis [Member]</link:label>
    <link:label id="lab_bhg_ZipnosisMember_documentation_en-US" xlink:label="lab_bhg_ZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zipnosis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ZipnosisMember" xlink:href="bhg-20210930.xsd#bhg_ZipnosisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ZipnosisMember" xlink:to="lab_bhg_ZipnosisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_a806601d-5f54-448e-a763-657741ef2049_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through 10 years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_c369a2f0-8f0c-40da-a2a8-ca8c70945245_negatedTerseLabel_en-US" xlink:label="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock</link:label>
    <link:label id="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value Conversion Of Convertible Securities</link:label>
    <link:label id="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:to="lab_bhg_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_37e50e36-96cc-4f81-8ece-4c66db0ca4ba_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9f94c2f0-a5bd-4e0a-a828-e3b913082504_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_cbdfe3cf-87f2-41bc-8c2d-ce13c95b3955_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Bright Health Group, Inc. common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4879da0e-5103-4b69-a5de-3640c3b8b7c6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_eec29b34-2be7-45b8-af35-f22d31ff0595_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Prepaid and other current assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid And Other Currents Assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid And Other Currents Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b5a5929c-38fa-45b6-b53c-b89e1300b615_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_6d3dbafd-abf1-457a-b67d-44ac9da90d1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_9fc5ef0b-453b-49bb-b090-5a0f30338619_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0141baad-a3d6-40b8-b58a-5ac3121b1fa7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_643ac5dc-2893-40ce-9fc1-df18f21b9ce5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1f4ce6f0-9b68-4c38-ac5f-7c183c286853_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ab06c72b-3cae-4deb-b8df-3cc7837fcf40_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_f65c5f4f-82c3-4f9d-a42f-6149ab39e29c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_59af6708-0fc6-487c-89bb-7d2826ab233e_terseLabel_en-US" xlink:label="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Updated Risk Score Data</link:label>
    <link:label id="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_label_en-US" xlink:label="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Risk Adjustment Estimate, Updated Risk Score Data [Member]</link:label>
    <link:label id="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_documentation_en-US" xlink:label="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Risk Adjustment Estimate, Updated Risk Score Data</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:href="bhg-20210930.xsd#bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:to="lab_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_9b0b8640-e9ae-449b-88c5-0b7a8376f3d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims unpaid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d3268b31-2f0e-4654-8c47-1fe733298129_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity security market value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_65890a4b-2050-409d-8d20-19a4dd541084_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_92b2f04d-8985-4e4b-b00c-46866673e782_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_13fbeef7-7729-49c6-9952-761b02ce2599_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d1cf9e4c-53c6-4477-88b8-26e06a865d2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_77dfe217-7c0e-41cd-8310-3b0d9d8349c3_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_5e25eac5-7b83-403a-a1d6-d7a7855d2ff5_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_5224e67e-00b9-4ee2-9a5d-6addcca87792_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9fed5879-9da8-4743-b537-a832e1aff422_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9022885a-7c76-4d85-ba4d-ff3382c7b599_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7dd0ba05-b629-42a7-b890-41307059e772_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment_81b0ccfa-b4b1-46d2-85c6-40f19bb0ecff_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible net equity adjustment</link:label>
    <link:label id="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment_label_en-US" xlink:label="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Tangible Net Equity Adjustment</link:label>
    <link:label id="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Tangible Net Equity Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationTangibleNetEquityAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:to="lab_bhg_BusinessCombinationTangibleNetEquityAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_29fb5d36-77eb-40fa-8f5d-0d2b95d891a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_38fb544f-1446-4f1c-adc8-c88581fc4ecc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9272b926-6f8e-44fe-a7dc-e0d9384ce989_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_e4c852ce-6317-42d2-a11f-b4de5581860b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9d4ac6ec-fc07-4f12-9726-54b3e9db0d10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dff54a5b-373f-4c35-8b35-b0ec0390ebc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_84ce7d84-6c04-4e94-a28b-15d224585a45_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_47927dae-abd8-4231-8579-af989ac3541a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_426876d5-b634-4dad-adba-ecf80ab0f4b2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6af17d7e-7b55-4aff-bdbc-f8fb36daae71_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_4c7646f8-3311-413d-a111-7b0a5914840f_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_4b5a9336-aff0-45f3-9009-90616aa5ecfd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b19acf70-ad28-40dc-9592-63c715e2ffef_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ContingentConsiderationLiabilityMember_55cde83a-8553-476e-a031-0827bde269ae_terseLabel_en-US" xlink:label="lab_bhg_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:label id="lab_bhg_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_bhg_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_bhg_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_bhg_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ContingentConsiderationLiabilityMember" xlink:href="bhg-20210930.xsd#bhg_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ContingentConsiderationLiabilityMember" xlink:to="lab_bhg_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_31f91ad3-edfc-450b-972b-3a37b5082f02_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3d48e55a-a483-4c9b-bb5b-dc5ad97f2c41_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_54e8299a-3d6e-4d30-a0f8-c8d5baa55e60_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e4d33fb8-68c0-4f4a-aa03-84e13d331b8c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3e2f8acc-76b5-4360-a19e-962a985c1fb5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_cec7a0f8-fc72-467e-886d-f684b692e574_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_061ec489-d5bc-427a-8dd8-efa68a95b47d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesTextBlock_6af376f8-d623-4618-8249-9023bc033512_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities, Held-to-maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_3bd13f88-c9e3-4b0e-92bc-2ca5fbc95e4f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_b8c38c69-97dd-46c2-aa1d-8ff8eea35d3f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_59425c09-d45b-40ce-b0bc-cef5609f002d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_056e8390-454c-4e0f-a87a-5924b6a26e79_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_790d6036-93eb-43bb-870e-618c8b3df1e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Performance Shares, Activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_dcd75fb2-cda9-424d-8870-b018c87d55b3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized investment holding (losses) gains arising during the year, net of tax of $0 and $0, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2eb59f0-d298-4ce0-8eb4-857068afecd0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1ed607fa-d457-48ce-b334-a27ca5bcb7ff_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d6a2d14e-54e1-4c18-b957-99a22e2b89cf_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_37513282-cc9d-4e0c-8932-8d2b7af7657e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_b594a532-2629-4013-93ab-cf24985b1344_terseLabel_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_label_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_documentation_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:href="bhg-20210930.xsd#bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0dcbde43-2f5d-4850-bbfc-51bff129de4e_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Impairment, Beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f0487ca2-8016-4680-8df6-4b88332a5deb_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Impairment, Ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_09565b27-67de-4f97-b0ec-579e37b99c6f_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and municipal obligations</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_41d90cd8-e18f-4912-bfb3-18578af8e690_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_707e3716-b99d-4bdb-aa29-bfcfcc6eef53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BrightHealthCareMember_6b5e63e2-80cc-49ec-a788-31a1edf0df2c_terseLabel_en-US" xlink:label="lab_bhg_BrightHealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bright HealthCare</link:label>
    <link:label id="lab_bhg_BrightHealthCareMember_label_en-US" xlink:label="lab_bhg_BrightHealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bright HealthCare [Member]</link:label>
    <link:label id="lab_bhg_BrightHealthCareMember_documentation_en-US" xlink:label="lab_bhg_BrightHealthCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bright HealthCare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BrightHealthCareMember" xlink:href="bhg-20210930.xsd#bhg_BrightHealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BrightHealthCareMember" xlink:to="lab_bhg_BrightHealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_486fad6c-7f72-4d1d-9680-8048cb1d24a6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_e589dfff-5df1-4cca-8015-e8ce4e5b269e_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Other current liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_e5eeb28d-ad57-4d22-a82f-8967c7adebcd_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_83d07f10-4524-463d-9af4-b8bc4f42a686_verboseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e3b5994c-0e03-440b-aad7-e42ba32b56f1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_94360979-e7e9-4382-9b72-9484659efc67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_27c1e56c-b3c3-4695-8ef1-8cc08a1d290b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_63035365-24bc-44d1-aba9-f7a362ae901e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_cb475dd6-b8f6-43fe-9d3e-42077841983b_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_f3af8254-4212-47f8-814a-cd69235ebe24_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_63725d31-12c7-4378-aefc-4c43ba5b9b59_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_0b348bf1-46e7-468a-b3f1-8e4068106dc4_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_73f4e8a2-facb-4292-a77b-47f961d0c837_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c34f2dab-c250-4dff-830f-0469b63c427f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_52819535-ea28-495b-8647-968d8e794fef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84fbf4ed-3a64-46c3-a4f9-a088c2c4d8b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_af043c71-8399-4b24-9efe-dce5868f2886_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_3b25361f-1ca0-4684-966c-fd92374a9525_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Investment With Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_906db2c8-bbb3-45e6-a225-8e1cf9eb5305_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_fe86869f-9adf-42d9-b91a-9966bbf1886e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_f11c6e2a-d5a7-4c9d-bdbd-7d9dca6e47d5_verboseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held to maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_a9d4012b-0e29-4bad-98b0-6a25e33f9434_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_fdf3f441-e7d2-4d94-95fb-9e12acf25357_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5ddeb81d-471c-432d-ba80-588515fddea4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e2ea9428-ea46-4141-90ea-34a31355c0f1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a96e1292-2283-4ed3-8899-c4a04ae065ec_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aacba7e-5014-4593-add1-4f9157890bbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c79d1c3b-7b7b-4f2c-99d5-578c2ecdb790_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_366355bb-14af-449f-a4f6-ef098449f29a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ddd01220-feae-4193-950d-b2d59901c559_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_3d7ca16d-ba84-4325-9323-fd8c68c7be6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_da509049-667d-4bf2-8449-32633a874416_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d42c19b5-6974-4da2-b973-0f098c6b3036_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cee1ad50-bdaf-412f-bc06-453b77ceefc8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fb3a6f90-059b-4f51-95a0-3c03b632dbce_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_656341fe-4e45-4e5f-9aa3-a3c50f20b47e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4b5a304e-f72b-4179-a571-07df99a3a2c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_de130cf3-9ca6-40b5-8c41-4c5c630508b0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1d27b176-4d28-4d44-b185-c96fc3a37d21_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6fb23bef-3a59-4833-b638-aea2f9c8d14d_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b6980345-af45-4027-9f56-d7b10144810b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_6a33e85d-cb1c-4bc1-8666-295f912c5215_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_642b4975-c19e-4846-b1ce-546cc6838f7e_terseLabel_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims adjustment expense liability</link:label>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_label_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Adjustment Expense Liability</link:label>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_documentation_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Adjustment Expense Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:to="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0d9c84b6-1115-4db7-8074-cf6321468dcb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e116cb19-1855-4341-85a5-4b8fe179bb23_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identified assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_807ad563-c61d-4815-8f33-ea182063b39c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_abaea705-4c38-488b-9557-33cffb00253f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_d1c1d776-d57e-47bf-987f-a65dc84398ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_2f937024-bb79-4a62-9943-a3be5d051ed5_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Other liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_91cf7f9d-8b00-4283-966b-fcb066a0f947_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums_7d531f47-1ec6-48d6-8eb9-35106ad65c68_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:to="lab_us-gaap_IncreaseDecreaseInUnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_43e423fa-bf71-4225-b505-51f1948e1bbc_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_563e87d8-44cf-4e5f-b3cd-c87bf1f21523_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_a2b1c7de-37c8-4d6f-88cd-5cf3a480d0af_totalLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Net identified assets acquired</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identified Assets Acquired</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identified Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_b2e99bd7-5097-48c8-bf25-6a3796212c22_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_3ef0ae97-ebe9-4f69-aee0-28e642776205_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_982d90b0-05da-4702-b259-f78f4edf2c77_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6da281fc-34e8-454a-a40d-1ddce50b80d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b480785f-07e7-4557-b8f0-2374b5f66e05_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dd094410-d7b8-4b9e-9934-25cc2edb002e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6f66c47b-f199-4bce-8bd8-6f6615ded44a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_c6097b23-4577-480e-a92e-b442a7e8e6a5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationEscrowAdjustment_095847d9-1789-4a36-b099-611fe1e81e7e_negatedTerseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationEscrowAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow adjustment</link:label>
    <link:label id="lab_bhg_BusinessCombinationEscrowAdjustment_label_en-US" xlink:label="lab_bhg_BusinessCombinationEscrowAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Adjustment</link:label>
    <link:label id="lab_bhg_BusinessCombinationEscrowAdjustment_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationEscrowAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationEscrowAdjustment" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationEscrowAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationEscrowAdjustment" xlink:to="lab_bhg_BusinessCombinationEscrowAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_f6910299-5ceb-4710-89cf-1cbc90e99ed6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a912c739-53ad-471a-a3b1-46514eff7e39_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8cdd780f-0c47-4c54-93e7-42c532075dde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche one</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4b8cd393-63e3-4733-b5f3-cf5d84205a44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b8c7edb4-98cd-49d8-82bd-9572a57152df_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_9c115073-1bda-4471-b654-3209e9ab906d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_553de313-1911-425a-bffe-8c549bcc3ccb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e9b87ee0-1ab8-448c-bd39-100933567e77_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from IPO</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_dd816ff5-672a-4bbf-83df-a4061603ec7f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_0a202135-5086-4eea-a4c6-d25966b4ce8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_00a80c33-0e09-4447-b0b1-5efdeb493801_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET LOSS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_1137b8cf-080e-46cc-90dc-d311401c8590_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3782aca4-a8a6-437e-96ef-39395ac2fe78_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4940eccb-da70-4271-b4e7-75b335d1ed4e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_44a29198-122d-4262-abfc-25d7a7005a6d_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Other non-current assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f1c33792-1c17-4c75-8bf2-87f007b0fe11_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1f49b787-e838-4b8f-b710-5d6a62374e3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnearnedPremiums_54722386-66fc-4b93-b275-e9cd5cf00a30_terseLabel_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_UnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnearnedPremiums" xlink:to="lab_us-gaap_UnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_07e7676a-83ab-4a81-8896-2d2d31d673b3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c236160e-26c6-4627-94c4-03a966be21f8_totalLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0b716eec-4ea1-4c7f-a0c5-58df690af45b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ReacquiredContractsMember_8630017e-0b55-4ed2-811d-f2ea576a2b93_terseLabel_en-US" xlink:label="lab_bhg_ReacquiredContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquired contract</link:label>
    <link:label id="lab_bhg_ReacquiredContractsMember_label_en-US" xlink:label="lab_bhg_ReacquiredContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquired Contracts [Member]</link:label>
    <link:label id="lab_bhg_ReacquiredContractsMember_documentation_en-US" xlink:label="lab_bhg_ReacquiredContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquired Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ReacquiredContractsMember" xlink:to="lab_bhg_ReacquiredContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_9e0251d1-8488-474f-a392-de9adf029765_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 10 years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_e97fae1b-4261-4f54-810f-26bd916f201b_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDICAL COSTS PAYABLE</link:label>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:to="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_57a8cedd-8fe9-4a07-9fc5-609839c70c4c_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Medical costs payable</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liability For Claims And Claims Adjustment Expense</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liability For Claims And Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_96e6e492-32b9-47bd-b7f9-7ebefd7108ad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, 12 months or greater, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_33dda6a4-0ed7-42c7-811d-70753213ee8a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_b5905292-c9d3-45d7-a2b6-1104bb3b2e18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_25003532-d6de-48bc-a976-458321db0bcb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_afb93d64-cc0f-4a59-b6d3-0a9eaefe363c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1e1ed70b-ee11-44bb-ae0e-629e5efbb302_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency obligations</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember_f86b8185-f10e-479a-805d-d28cb2eb122f_terseLabel_en-US" xlink:label="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMA</link:label>
    <link:label id="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember_label_en-US" xlink:label="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premier Medical Associates of Florida, LLC [Member]</link:label>
    <link:label id="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember_documentation_en-US" xlink:label="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premier Medical Associates of Florida, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:href="bhg-20210930.xsd#bhg_PremierMedicalAssociatesOfFloridaLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:to="lab_bhg_PremierMedicalAssociatesOfFloridaLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_fc5808a4-f8fc-472e-997b-398229e92cda_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance and sale of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c5d37fcf-876a-4afc-a635-c644056b25ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_eafee4e2-4eeb-44d9-b9f2-ff5c1a0836b8_terseLabel_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Amortized Cost</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_label_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Amortized Cost</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:to="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_79f5707e-1be2-48d7-b8ec-3908a0d4ffcf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_02fb6a2a-a297-4a6c-83fe-cadab328f70e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4b863f0c-ab93-4bdd-b225-a59e7893afca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_42f5d252-b2e6-435f-b482-2d66069be09b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fb63ec49-c5d7-4823-a8e8-68e1ff98ccf8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life (In Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_db7124c4-510b-465e-8647-0f137dc34842_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for IPO offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_87ddfb8c-c16e-4421-93a7-cb36674d126c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_0193bc6c-a761-4216-8a43-9831ad7ae4c2_terseLabel_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of common stock from escrow settlement (in shares)</link:label>
    <link:label id="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_label_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Returned During Period, Shares, Escrow Settlement</link:label>
    <link:label id="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_documentation_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Returned During Period, Shares, Escrow Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodSharesEscrowSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:to="lab_bhg_StockReturnedDuringPeriodSharesEscrowSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_44a61db3-c692-4882-9a10-fed75316d4ae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance and sale of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4c336e85-235c-438e-a31e-1b4ff80ea70f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0e57c112-9348-4e1f-aaba-87e7f792d684_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_9535d781-b56c-4797-9c95-51f68cd0e970_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_44d25f90-fcd2-4cea-a534-604cb78f8388_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ddd7f5b0-7e53-4978-831b-e338c4121aa6_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_334e3510-dda5-4d60-938b-84a8295579bf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 3,000,000,000 and 658,993,725 shares authorized in 2021 and 2020, respectively; 628,133,782 and 137,662,698 shares issued and outstanding in 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_60ab51d9-c03c-4e92-b0ad-5da52206acb7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, weighted average recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fff20565-ac32-4d59-9f69-7328e29f58e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_835e6718-2265-4e9f-b504-73a05799e1d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3e0c89c5-0119-43c3-9300-655471f3d249_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f672954e-736e-4fcf-a5d3-60c0995188bb_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_8f4b6d6d-5507-42bd-a25e-97973f5de11b_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU's</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_86abd5a3-fe2c-49eb-b8da-b7036caf56b7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_847cc4ae-a738-47a9-bb96-863d3c97f66a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_63159799-1171-46e2-8de6-6171c0757083_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_52c5c608-cfff-4d6c-af6c-639215038584_totalLabel_en-US" xlink:label="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total held to maturity</link:label>
    <link:label id="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_label_en-US" xlink:label="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held To Maturity, And Cash And Cash Equivalents, Fair Value</link:label>
    <link:label id="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_documentation_en-US" xlink:label="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held To Maturity, And Cash And Cash Equivalents, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:to="lab_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_611dd59a-d14e-4afe-8223-aa1bb0dda98a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_9b0848e0-099f-42eb-9a6d-ad4fde0dbd1d_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_label_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Unearned Premiums</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:to="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ebe9473a-8545-4484-8d33-b14b699536e6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c474a973-0878-4e19-b617-63948185dc85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_8dc66f35-7a06-45ef-be50-4006aa9076fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2685fa34-d716-4672-8013-4cc265011b9c_terseLabel_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Gross Unrealized Gains</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c0477a7d-5ceb-400a-bb62-46e87d8e2cd5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_87a4ebe9-57b5-44b5-8aa7-b2e089ccb1c2_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_600cc228-8fa6-4002-9c58-b2aca29a6c3a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b9c5fce4-1a9f-438a-936a-9b4ed1fc53d6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_dad68303-9b63-4364-8328-a2609bcbdb94_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_f71d6150-9837-4076-8d30-32cc1c0b0255_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_966b8849-858d-49dc-a334-b1dcc326f9e0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_0d3c93ba-2b8d-439d-9f79-5b29f616548b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_69263514-be7e-46cd-b029-e8f692b47438_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma, net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0901c2d0-3d78-4a94-aa32-494004d2e006_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0f879294-c465-4f6c-83ef-9870720e105a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ShortTermAndLongTermInvestmentsMember_9c6cb08f-2fbe-4afa-a301-4c660df1314c_terseLabel_en-US" xlink:label="lab_bhg_ShortTermAndLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term And Long-Term Investments</link:label>
    <link:label id="lab_bhg_ShortTermAndLongTermInvestmentsMember_label_en-US" xlink:label="lab_bhg_ShortTermAndLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term And Long-Term Investments [Member]</link:label>
    <link:label id="lab_bhg_ShortTermAndLongTermInvestmentsMember_documentation_en-US" xlink:label="lab_bhg_ShortTermAndLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term And Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShortTermAndLongTermInvestmentsMember" xlink:href="bhg-20210930.xsd#bhg_ShortTermAndLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ShortTermAndLongTermInvestmentsMember" xlink:to="lab_bhg_ShortTermAndLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_54a303ed-38e1-455e-88ea-560d73410c1f_terseLabel_en-US" xlink:label="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock (in shares)</link:label>
    <link:label id="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b919de4b-2342-431b-b681-7760d8dd0637_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6dc9f937-e771-4c49-8b37-9b4b1f7b8e9a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ProviderNetworkMember_5d7c3f02-f64c-4f7c-b6fe-3a77532c75b5_terseLabel_en-US" xlink:label="lab_bhg_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Network</link:label>
    <link:label id="lab_bhg_ProviderNetworkMember_label_en-US" xlink:label="lab_bhg_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Network [Member]</link:label>
    <link:label id="lab_bhg_ProviderNetworkMember_documentation_en-US" xlink:label="lab_bhg_ProviderNetworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Network</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ProviderNetworkMember" xlink:href="bhg-20210930.xsd#bhg_ProviderNetworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ProviderNetworkMember" xlink:to="lab_bhg_ProviderNetworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_93702d24-eb73-49d2-a0e7-8b3a444152cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Costs by Functional Classification</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Operating Cost and Expense, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_c7af99a6-becb-4e0e-9b28-aa1c5ee678cd_terseLabel_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider incentive payable</link:label>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_label_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid claims And Claims Adjustment Expense, Risk Sharing Amounts Payable</link:label>
    <link:label id="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_documentation_en-US" xlink:label="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid claims And Claims Adjustment Expense, Risk Sharing Amounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:to="lab_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_97b19fc7-7e6a-4d00-8f2c-63818c11f04b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_dd3581d2-8c01-48d2-806a-393949663b1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized investment holding (losses) gains arising during the year, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0f549c5f-0543-4f86-840c-dcdf246b124a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_09c9c400-96bf-4889-80aa-785d7ae49587_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d5db806b-2199-4570-969d-9208fc916653_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, $0.0001 par value; 100,000,000 and 166,307,087 shares authorized in 2021 and 2020, respectively; &#8212; and 164,244,893 shares issued and outstanding in 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_30ded1b0-7ff5-4877-8dcd-860668cf9835_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_78e14423-a5ab-4448-8a18-1bfa027b68c9_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9b2db96-001d-4a1d-8a33-7f0d43ede5be_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9dfe7c8f-6a39-4494-b692-d998b9dbb0cf_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_RiskAdjustmentPayableCurrent_200cc5cd-d154-49d2-a98e-b3bd1f90c1ea_terseLabel_en-US" xlink:label="lab_bhg_RiskAdjustmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment payable</link:label>
    <link:label id="lab_bhg_RiskAdjustmentPayableCurrent_label_en-US" xlink:label="lab_bhg_RiskAdjustmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Adjustment Payable, Current</link:label>
    <link:label id="lab_bhg_RiskAdjustmentPayableCurrent_documentation_en-US" xlink:label="lab_bhg_RiskAdjustmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Adjustment Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_RiskAdjustmentPayableCurrent" xlink:href="bhg-20210930.xsd#bhg_RiskAdjustmentPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_RiskAdjustmentPayableCurrent" xlink:to="lab_bhg_RiskAdjustmentPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_25dd5828-f42d-49c7-bb04-44a999733942_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5e573f8a-34eb-429b-80e8-b3b46260dac5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e6602a99-1ff4-4e04-86ff-a48e20427e3a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_deb1a370-3169-486e-96af-32909525b67a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_7c59823c-02a2-4749-b7eb-523ccfff1f1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_679f733c-2cb4-4a43-a5cd-fbee8e96cc6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_33c93ad5-45f0-477b-b0a1-b897ae001f0b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_6e0decfc-aa8f-4888-9993-236d2dbd2540_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, less than 12 months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_40882c3b-aea2-4aac-acb8-387fbc5cc7c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_838f4271-8a29-49ec-ac67-0f8cbd4bbf60_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_027fa18c-310c-41e5-998f-5cea9c5c5258_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND GEOGRAPHICAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_f9616b68-6037-464a-9a58-0c11fabce357_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5c32797e-c810-4d4f-9d60-02cf88095051_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1a6c3ad1-1667-40f9-be6b-72aa32e04411_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_NeueHealthMember_b4e0ecfb-a392-4505-87a2-36d604fd72e0_terseLabel_en-US" xlink:label="lab_bhg_NeueHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeueHealth</link:label>
    <link:label id="lab_bhg_NeueHealthMember_label_en-US" xlink:label="lab_bhg_NeueHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeueHealth [Member]</link:label>
    <link:label id="lab_bhg_NeueHealthMember_documentation_en-US" xlink:label="lab_bhg_NeueHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeueHealth</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NeueHealthMember" xlink:href="bhg-20210930.xsd#bhg_NeueHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_NeueHealthMember" xlink:to="lab_bhg_NeueHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_166b985a-2bd5-40d6-9220-3a186b3bd9a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6c041c27-8884-4cd3-99fc-0e76c8a964f3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e2bb4146-b03e-4c3b-8db0-c717681df550_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c167a889-fc2c-4a28-851c-23643b83620d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_739952f7-9418-4c7f-9220-c236389a9bde_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e06f0716-2837-4746-a272-e9f1117d2b59_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_6648b371-a865-4885-8710-8cefb705c3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7d8ef40f-7d30-444b-966b-4ade6a66e536_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1cd88efe-757e-4c3d-bdd6-177591747605_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e29c08d7-dc04-418c-a441-cb233ea207fb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_dc9a25eb-da54-420c-be80-419afa623c21_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_us-gaap_SeriesDPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_36ee98ac-3fd2-44fd-8d9b-27065b2210f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_994abfc7-282d-44b9-9f08-7427a196bb20_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical cost payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:to="lab_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_50fa85f1-3f45-49dd-b38e-ef1322395ca4_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost, Total investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_030e0c2c-8968-461f-9112-b1a4ebee198b_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Accounts receivable</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_a3007d37-a846-428b-9779-f9846ca67b93_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock issued for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4010950b-818c-44c4-88e8-7a3bb7052af6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_34e46b4d-66fc-4be9-b113-6c5460cdfae7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b52b7470-36cc-4336-907d-2e48d056e792_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_f4dc7615-5b1c-4054-b33b-10aabe3fb163_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustments for investment gains, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9e1a43d3-201c-49a0-bdf9-5f6b69daa4a0_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_ecf932d2-222e-458f-9761-7500283b7d8d_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_0ccd158f-5478-444b-8421-9d823c100c67_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Liability For Claims And Claims Adjustment Expense</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Liability For Claims And Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7165db39-51b8-4e9a-88fc-f396ae2ce5d4_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_163df162-650f-4c33-a0a5-26099bad84a0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a73d9773-c784-42ef-a1b9-5342028a8471_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8821343a-591d-4df0-8de7-871efa407b16_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3a6ff2ff-7696-4a99-a0ff-48c730dcc5d8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_71080872-3cab-4e96-ac12-8826dc63bfdf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_EquitySecuritiesFVNISharesPurchased_76cefc06-2ec0-444e-94bf-5582b8d8df6b_terseLabel_en-US" xlink:label="lab_bhg_EquitySecuritiesFVNISharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities purchased (in shares)</link:label>
    <link:label id="lab_bhg_EquitySecuritiesFVNISharesPurchased_label_en-US" xlink:label="lab_bhg_EquitySecuritiesFVNISharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Shares Purchased</link:label>
    <link:label id="lab_bhg_EquitySecuritiesFVNISharesPurchased_documentation_en-US" xlink:label="lab_bhg_EquitySecuritiesFVNISharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_EquitySecuritiesFVNISharesPurchased" xlink:href="bhg-20210930.xsd#bhg_EquitySecuritiesFVNISharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_EquitySecuritiesFVNISharesPurchased" xlink:to="lab_bhg_EquitySecuritiesFVNISharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c1ef96cc-5659-43e4-b3e6-b417e15186fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_d4e10f1a-246c-4164-b970-eec4d19c8d70_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f73c7151-3566-4b8f-86c5-e7bca58b0648_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_93699147-14b8-46c0-8edb-aa8c8161ee3d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_04299324-6f31-454e-87b4-d5a11c2ccc59_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_27ce3c7c-f80c-48f5-8019-c7bb65d66a3f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_51128ac3-5f26-4bec-8ee3-244c96221661_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b1dcd242-9aad-4c03-831e-5ff26473eeed_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a70cf4fe-c62a-4a8a-800f-c75ea66d9385_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_923d55a5-2267-41f2-8776-3f3d59c1345b_negatedLabel_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Gross Unrealized Losses</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_d36d751e-c83f-4637-9797-5d7dc69a7b84_terseLabel_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_label_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Short-Term investments</link:label>
    <link:label id="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:to="lab_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_d1f907b8-2ae5-4e16-b3b6-6dbf57d2aab0_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_TrueHealthNewMexicoMember_3a284645-46b9-4903-9360-a4b6b8aa8b6e_terseLabel_en-US" xlink:label="lab_bhg_TrueHealthNewMexicoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THNM</link:label>
    <link:label id="lab_bhg_TrueHealthNewMexicoMember_label_en-US" xlink:label="lab_bhg_TrueHealthNewMexicoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health New Mexico [Member]</link:label>
    <link:label id="lab_bhg_TrueHealthNewMexicoMember_documentation_en-US" xlink:label="lab_bhg_TrueHealthNewMexicoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health New Mexico</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TrueHealthNewMexicoMember" xlink:href="bhg-20210930.xsd#bhg_TrueHealthNewMexicoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_TrueHealthNewMexicoMember" xlink:to="lab_bhg_TrueHealthNewMexicoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_4585d9d8-ad69-4030-a584-a8245605e736_negatedTerseLabel_en-US" xlink:label="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock (in shares)</link:label>
    <link:label id="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:to="lab_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_bb8e02fc-5667-4552-8a37-3f18499bc968_terseLabel_en-US" xlink:label="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO net proceeds requirement</link:label>
    <link:label id="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_label_en-US" xlink:label="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Required IPO Net Proceeds To Extend Maturity Date</link:label>
    <link:label id="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_documentation_en-US" xlink:label="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Required IPO Net Proceeds To Extend Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:href="bhg-20210930.xsd#bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:to="lab_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ea1a0b65-abbc-4351-8a7e-ba75af1a94de_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_32f15a4e-8058-4671-98fe-8624eed8624b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_bb2f7a7c-6b50-430e-950e-15bc5787aaf1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_9659f6d4-6cf5-4b37-8d29-836adf78c8f8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_82ab7865-c75c-4603-89bd-18f67962c1b7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b7b108df-02bf-4ad3-af3a-e5989b189b11_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_45ffc931-0e03-4fc3-8d3b-2fbb492a2287_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_4e198d23-5363-4635-9bfe-c477affc4f78_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_b7cb50c5-20c6-4214-a5f4-f91069b540ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_181434db-69dd-4b29-b196-dafc4c717d66_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option grants expiration</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a9515c91-340e-4a63-8a68-71c1fea44098_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU's</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_4ef7bf47-cebe-4528-ac71-ad16195b3a49_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fc8a001a-6af4-48d7-8b71-6ff4b25493a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5b61fb20-da92-4233-8a2a-1a99da762728_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d60bdd33-0b0f-44b9-a8cc-143c98046ed8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cebdedef-3cd5-4b98-b50f-255e300bed72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7609d848-4d28-4273-a518-0661c5759281_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_c83fa3b4-4cc7-4f87-ae6d-4fcd6021fc33_terseLabel_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities in unrealized loss position</link:label>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Unrealized Loss Position, Number Of Positions</link:label>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_documentation_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Unrealized Loss Position, Number Of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:to="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_8e5d159e-40b6-4872-9701-7ad001107e10_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHORT-TERM BORROWINGS</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock" xlink:to="lab_us-gaap_ShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3eff3f4a-9e03-4167-be3e-e50a81d33e5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Contingent Consideration Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a7a095c5-a0f8-486f-addc-76033c9eec28_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_18ae7621-2e4f-42c8-8f4d-c6f4f9724f83_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d8434b25-4b31-4540-824e-037b1df08324_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56990d31-c39a-43a7-a07d-588f7a6b8ec3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4580e462-5939-4b9c-be0d-4d9aa2e4928d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f8f10074-6793-4cb5-9621-c146a9714df1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $5,701 and $2,602, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a3d1974b-6196-4d59-9976-f98c6458b52c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_6f98a1fa-1206-4d4e-b826-ad22940e5f26_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_f6a00e95-4b9d-4393-aa40-42b8683a036f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_691f7734-1817-4904-91ac-38bdaeaf87e8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_07bbad64-4d22-4fee-a349-b41867171990_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fac054de-7629-40de-be35-90432d7970f1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c779c2db-e865-4f04-abaa-f6cd1a56fbad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_80314041-f787-44ee-85d0-12653ad490e4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_335e534b-6c4c-4541-8dba-dda9f68f7598_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reportable Segment Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_76f704bd-fd4b-45c8-9eb1-a51da43138d2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_75deb9df-a433-4510-aa14-febcc9fb1c9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_95ebcb77-19da-4d57-95db-4b37fb80c6a2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_8c8892e2-5642-4276-80f1-a9195c63dd49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncome" xlink:to="lab_us-gaap_OtherNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a3fde901-61ab-4904-9e4e-606c9763ab48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_b0513a6c-c4c6-4ef9-a3c3-34cb27c9076c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_19c405af-f2b3-40e2-9d53-f2a929ef9276_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d624d100-4698-4102-b804-b41cb7654c04_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_890d2379-6018-4054-9ef6-38518cd67451_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_089fe02c-fc84-46fa-ae4c-b3c2161b6ccd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, other than options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_659ad183-8900-444f-98b2-cf4a0eb07d44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of stock options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_586af412-ca35-4c27-9aef-3e878f0698ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_51f028e0-9659-425d-bfd7-f8c9290d1482_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and selling expense</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_65dedba7-411a-47d2-9fcc-619a84d9e858_terseLabel_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments</link:label>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_label_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Number Of Investments</link:label>
    <link:label id="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_documentation_en-US" xlink:label="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Held-To-Maturity, Number Of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:to="lab_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_efe98916-100a-4547-9afb-365b1646a260_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2d270ca8-8cce-43ab-964e-795f7f9b78bf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_3f684588-fafe-4e4a-9627-4b9961c6172b_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value, Total investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f56c0f59-8de8-4299-89a1-843a5129cd3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_51715ab0-821c-4e18-a2c3-57cfe0dd9001_terseLabel_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capitalization ratio</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_label_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Debt To Capitalization Ratio</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_documentation_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Debt To Capitalization Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:to="lab_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_9081ca39-e254-434d-aed8-f600d641ccc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_29be2bed-3750-45ba-9847-1b281945b54d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_327bf053-f630-4701-8250-d6d69bccadb1_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_861115c8-8d11-46de-aece-37180b9ada85_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0c4b0bc2-18a4-4c03-ba75-3fdfd6a18bbb_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e8db1286-6ac9-4e2e-826f-0a0cc9c3192d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales, paydown, and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ae0393ab-6f50-4ad3-9f63-9269f3dbf9c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fcdd1e31-c169-430f-97cf-c021f20015bf_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_61e6faba-6eb2-4834-8d95-45cf71a69d5c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_a955f7bd-6235-4b57-a882-769f0bdc7541_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f1505413-3937-4779-9e97-53a3dcbd259d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_9d5a24f4-6781-401d-9368-3719d597cc85_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_88747e14-ec32-428a-9fc1-02387ad7f4e0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f58e8e05-b8f3-4845-baa2-be35b5f53afb_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_39af0dc5-23f4-49a5-818c-498aabe6311d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired claims liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseShortTermBorrowings_feff02e6-9bbe-4d10-abbe-10ac93f39296_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other costs</link:label>
    <link:label id="lab_us-gaap_InterestExpenseShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Short-term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseShortTermBorrowings" xlink:to="lab_us-gaap_InterestExpenseShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_07af8e07-8685-4a52-b3a8-9e3b11e2e2e0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_68b4ed86-68c5-4291-b8e2-d8daf0db4d0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9d188b1b-06b7-4aa7-873e-ffc228369a29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e5320eae-8f74-4d44-abb1-cfca87a23d10_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6b3db522-9124-46ae-8c52-aad68bcaa9df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9afd597c-564f-4e13-9453-6bc4e2425838_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_288fb8f8-7a43-40cc-af04-adf254c33e17_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0b40560d-ce3e-496a-b4c7-6736a1025968_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b4bb5ce1-2171-4a55-b9ae-02f9a26ed748_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_177c669a-7278-40c5-bedd-8f1fea55e056_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f83c7831-efb4-451e-8880-f06f399e93a5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c3980bcd-cf29-422e-bacc-86ad57086240_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Bright Health Group, Inc. common shareholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_bd1f6603-fe3e-4c83-b709-c3a29b8fa5f0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement adjustment</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d4ad0efc-a4bc-4929-89cd-61577607a71d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Bright Health Group, Inc. common shareholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_d44156ae-3855-45e4-8ada-cc972955c56a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b97eb6d6-a51e-4762-bd6d-d0b51d74c0f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_4c325dd1-955e-461a-8b6c-1a86e82a5258_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium revenue</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_e6a696f2-ac6c-43d6-a07c-98477926741e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium revenue</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_864e6c44-08c2-4e3a-a3d2-b9bc1234c82c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_2aa8178e-02ef-44a9-8b93-327476615452_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc674322-b73c-46c9-ac79-7d914673b202_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_e64273e6-ddc9-4678-aef4-eff829d603f7_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_d0ba4088-0459-443d-a634-fd66d328012e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7472787-b579-4d90-9ed2-a0275ea3f559_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_250aa690-5df7-4168-9c07-506a2a48ac4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: reclassification adjustments for investment gains, net of tax of $0 and $0, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_77f6495d-dd81-472e-b872-ffc4074ddfd5_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock (as converted to common stock)</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_afc2fb92-c381-4517-921d-efdc80c29864_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d6009563-8d8b-431b-b4fe-f34c06ea27cd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5979ba07-18c9-4a0b-b6d6-56f2cd3304fd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_b6e89e3f-f706-4f2b-a20d-3c85d11e25be_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_aa472ded-af93-4602-8333-4f911ed224e8_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f6f17d0-f824-423f-a7b8-c672a60dd7cc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f857f225-327a-4bfd-a986-edaaa804db48_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7db1872c-322c-4d1b-81be-bb413b730e39_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4bc1aaaa-9869-4e55-b360-544aaadbd9a3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_e52f515c-2c89-4cab-b8ae-b0b5161c9291_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_8d610e67-09c1-4dab-b11b-1bafcd8c75cc_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_7ab55f58-f79e-42c2-846f-cfbada4ada7c_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_6a16f367-3eca-4f70-9b6c-757cf2e28c12_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CentrumMedicalHoldingsLLCMember_87f0bfce-bf0b-4981-9404-82c0ee7e2de8_terseLabel_en-US" xlink:label="lab_bhg_CentrumMedicalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centrum</link:label>
    <link:label id="lab_bhg_CentrumMedicalHoldingsLLCMember_label_en-US" xlink:label="lab_bhg_CentrumMedicalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centrum Medical Holdings, LLC [Member]</link:label>
    <link:label id="lab_bhg_CentrumMedicalHoldingsLLCMember_documentation_en-US" xlink:label="lab_bhg_CentrumMedicalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centrum Medical Holdings, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CentrumMedicalHoldingsLLCMember" xlink:to="lab_bhg_CentrumMedicalHoldingsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c9b997d9-5cb3-4d13-85a9-71db4faaf0d0_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_16a0a15d-f583-406a-8c7d-3c55ea6ae049_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_NumberOfHealthCenters_aeecf61b-61f5-447a-80dc-930c46321662_terseLabel_en-US" xlink:label="lab_bhg_NumberOfHealthCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of health centers</link:label>
    <link:label id="lab_bhg_NumberOfHealthCenters_label_en-US" xlink:label="lab_bhg_NumberOfHealthCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Centers</link:label>
    <link:label id="lab_bhg_NumberOfHealthCenters_documentation_en-US" xlink:label="lab_bhg_NumberOfHealthCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NumberOfHealthCenters" xlink:href="bhg-20210930.xsd#bhg_NumberOfHealthCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_NumberOfHealthCenters" xlink:to="lab_bhg_NumberOfHealthCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_09fca331-8ce0-4c29-9c6a-e37e491b7e5b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Bright Health Group, Inc. common shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_15f4dc78-7251-41a3-8b1b-340c1173decf_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_e1b74b6f-be37-4e23-ae2f-916f16f53bd9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3e29349-aa49-44e6-8433-96a9f678a274_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_83967ab1-3d7d-4209-b27f-f5079479fe0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8ef2a560-0692-4c53-8c76-a8c610d5265a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable_032cf0e0-bf6c-4216-8deb-3cf86f7b720b_terseLabel_en-US" xlink:label="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment payable</link:label>
    <link:label id="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable_label_en-US" xlink:label="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Risk Adjustment Payable</link:label>
    <link:label id="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable_documentation_en-US" xlink:label="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Risk Adjustment Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:href="bhg-20210930.xsd#bhg_IncreaseDecreaseInRiskAdjustmentPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:to="lab_bhg_IncreaseDecreaseInRiskAdjustmentPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e1f6cd3b-e617-4134-a48c-8921c462fcf8_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c088776a-d5d7-4a8a-a950-02a5591c6505_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued, conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_9b6c38a0-24ab-4159-91dd-6bd795f32cfc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_089871ee-8a53-46d3-8a29-e887e9e0aee2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_b0d77fa1-2806-453c-83cd-9e9698c5d9d5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_8dd4bfb3-d5fd-495c-9735-0538a5311946_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate obligations</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_54a6526d-890a-4b21-8926-bafb5a547a5f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_39f9bcbd-5e18-4a7a-b38a-a3d496f07075_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ae3cc029-f3f5-4992-8692-909464cd28cc_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_814530c8-25c7-4cf0-b6bf-a88709a0c80f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019999aa-42e9-4195-a760-b345633b3c06_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b9437586-e219-4d30-894c-8247f52677c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6269e1ca-ee8b-43ab-9246-f9285d11068f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_97e80348-5b20-4a69-a983-1e77bb1d7d00_terseLabel_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting tranches</link:label>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="bhg-20210930.xsd#bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c115b837-fa00-4bcc-b2b5-7b4121e2cc63_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (October-December)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_51f8be51-8583-4933-9003-b3366b5ba9e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c6f2cd8a-cefd-4e17-a778-25d3ea3cce39_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b60039cb-2fcb-4762-b598-a6ecd55eef44_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a985ad0b-fd40-4e7e-858a-fb3710b2c561_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_cd70b997-62fa-4195-a5b4-7e02eaab6c30_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29bd5a07-e7b7-4631-a15d-270bcc8c2e56_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1123f52b-4e27-4021-a103-69742386c5b4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_6b11b9c6-e45e-4a40-8d9b-0a11f3491597_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through 10 years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_45c7b9a9-c376-429f-b78f-0ab3b9bc8934_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_0d2dca3a-6a84-4f32-9dae-af9bb5860152_terseLabel_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capitalization ratio after qualified IPO</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_label_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Ratio After Qualified IPO</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_documentation_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Ratio After Qualified IPO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:to="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_ebd8ab28-3b1f-4e98-b257-42a768506630_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_9c0a1617-af1d-45a8-a831-c7b516569f54_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of preferred stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_ControllingInterestHolderMember_82e06fd2-7eb3-4a57-8a06-d3a5067243e2_terseLabel_en-US" xlink:label="lab_bhg_ControllingInterestHolderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling Interest Holder</link:label>
    <link:label id="lab_bhg_ControllingInterestHolderMember_label_en-US" xlink:label="lab_bhg_ControllingInterestHolderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling Interest Holder [Member]</link:label>
    <link:label id="lab_bhg_ControllingInterestHolderMember_documentation_en-US" xlink:label="lab_bhg_ControllingInterestHolderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling Interest Holder</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ControllingInterestHolderMember" xlink:href="bhg-20210930.xsd#bhg_ControllingInterestHolderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_ControllingInterestHolderMember" xlink:to="lab_bhg_ControllingInterestHolderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c480e688-7c2b-42e6-b423-b1bdb393a380_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_03976487-e174-4034-8528-fb092888027e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in unrealized (loss) gain on available-for-sale securities in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_c17f95b1-9f4e-4bdf-9b8e-780793cf977c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Held-to-maturity Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e5f445c7-1d9f-4764-82b5-7d10b70de8ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_a253e5f3-c0f9-4f18-81ba-6982a67bfac1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_18f08b68-ed74-4cfa-9e94-3dd8c8fbc975_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_6e429ef9-8803-4508-9e9d-eec3a824c759_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_bb81b0c0-bcd5-4cab-919a-693dc98e7644_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_52425955-dd70-4743-bf95-197191b44501_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_94b17ef6-3937-4806-8359-57deb5f5dd34_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_cd1f6f49-2b9b-426a-bfb7-4d21879448fe_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_c07a3f68-ca14-4f4c-a9e9-296717a623ed_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c05006db-aa04-465d-9609-fc3f0fede845_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f956c99a-593c-421f-a1af-bf056cb6fb69_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fa666c25-a89c-46f9-b9e0-d7827e5aef57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3c4b9430-b918-4d35-b1a8-f1964223fbe7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_6d6cc052-1af9-41ff-89d5-3917e16b0903_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_cd0aeea6-8c80-4611-b1ae-79bed538c672_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma, revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_90afced2-f74a-4baa-b048-3ccea4276268_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_e70ac407-57da-43b8-9b2f-c9e472e4809a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_16b0e779-9dcf-4609-9ba6-9b0973d4b043_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ab6ee47a-b80f-4bad-bbbf-b18133caaa67_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e5162862-4712-41fd-a6f7-cfd68ed214f1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_9307387a-9ec9-453f-958d-f0405e982167_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_2009ccf0-f7c5-41e5-9de8-2c8e6b91de71_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_UniversalCareIncBrandNewDayMember_c0aae596-a22d-404e-9f79-b853cb8b3aff_terseLabel_en-US" xlink:label="lab_bhg_UniversalCareIncBrandNewDayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BND</link:label>
    <link:label id="lab_bhg_UniversalCareIncBrandNewDayMember_label_en-US" xlink:label="lab_bhg_UniversalCareIncBrandNewDayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Universal Care, Inc. (Brand New Day) [Member]</link:label>
    <link:label id="lab_bhg_UniversalCareIncBrandNewDayMember_documentation_en-US" xlink:label="lab_bhg_UniversalCareIncBrandNewDayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Universal Care, Inc. (Brand New Day)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_UniversalCareIncBrandNewDayMember" xlink:href="bhg-20210930.xsd#bhg_UniversalCareIncBrandNewDayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_UniversalCareIncBrandNewDayMember" xlink:to="lab_bhg_UniversalCareIncBrandNewDayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_815e228f-f596-4411-9d1f-c82116eb1561_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b3130d88-7b87-4558-bb27-0e0fb65419ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_0de0e7cb-96b3-4217-a387-d6f37efe0793_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b242e938-3ec1-40ee-bd56-540bbd849499_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_01857b83-a94c-4979-a804-6f7c06cf83a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_f346a7ed-9f7e-4607-86e3-af98ebca2dfa_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_de0c9aff-9cba-41bb-80a7-3dc7a98ac46e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e00e479b-0d74-45ce-b83a-8973fb127f1a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9d187a8c-0b36-4ce3-b809-386fd20a9503_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_aeb0abe9-e7af-4ef5-82ba-b63f1818f236_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4de940a3-1a27-425d-bd0a-8bbe5c31e3ea_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_db1ac5ed-4647-4a2c-a96e-b33e65209a79_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_94c24934-0d36-481b-bad2-310801d62f9e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_00248d23-4531-4044-b266-614b573f0990_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and fringe benefits</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_894e81b6-48d7-4fa3-af8e-d587d4162c74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_b7b75f40-9a89-4320-b191-224bb0d64fbb_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_84d3adac-a4a2-4b96-a78a-b08c98cf7ce5_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_89f5d888-d5fc-4f9e-9385-b39e0c766bc6_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains, Total investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Held-to-Maturity, Cumulative Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6e55e84f-44e7-420e-b932-46ee159a5e3a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3c809ce-202a-4dc8-80b9-20190feb5c33_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents&#8201;&#8211;&#8201;beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b2d70aa-d292-49b4-b8ed-c2f467bdc1c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents&#8201;&#8211;&#8201;end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b9358c22-4514-4531-8c3e-e39a77cc0748_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a442607a-138c-4cf3-ae29-b3bb761b3b48_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesRealizedGainLoss_77d9e41d-c3e7-4016-999c-7145285ade5c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gains on fixed maturity securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_5f549ff8-e526-4aaa-81f7-fb5f3e5ce0ea_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_243b4e26-be29-4263-930f-7ef76bf9c593_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_InvestmentIncomeLoss_d9820d18-7fc8-4717-981d-1b8b3ea044f6_terseLabel_en-US" xlink:label="lab_bhg_InvestmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_bhg_InvestmentIncomeLoss_label_en-US" xlink:label="lab_bhg_InvestmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income (Loss)</link:label>
    <link:label id="lab_bhg_InvestmentIncomeLoss_documentation_en-US" xlink:label="lab_bhg_InvestmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income and realized gains and losses on debt securities, as well as unrealized gains and losses on equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_InvestmentIncomeLoss" xlink:to="lab_bhg_InvestmentIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_10959569-1e3f-40fa-8e50-894a87893905_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a8bf2fdb-6326-49ad-8ef0-0e42c874a63b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b5383798-0a90-4656-8ff6-15cf2e35ed1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1635e2b7-1e30-43a5-9590-a58691e29695_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_9727a50d-2474-44b5-be18-216ad03e8675_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_us-gaap_SeriesEPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2968d0a5-6391-4a75-aad0-f39ddfeb4b6e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_33d6a1de-496e-486b-b58b-8ada4adb20f1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_94272583-af8c-4f70-9cbc-8ad7a88a6b45_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_bd1af664-d9e9-4f7d-be26-d44ce02a8653_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f9249b26-b042-40c9-820f-267c71e4b4c7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9b3d4200-0af9-423e-bb53-6d2a42677e7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CentralHealthPlanOfCaliforniaIncMember_812389b5-e447-4115-9512-5a078ee9f95e_terseLabel_en-US" xlink:label="lab_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHP</link:label>
    <link:label id="lab_bhg_CentralHealthPlanOfCaliforniaIncMember_label_en-US" xlink:label="lab_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Central Health Plan Of California, Inc. [Member]</link:label>
    <link:label id="lab_bhg_CentralHealthPlanOfCaliforniaIncMember_documentation_en-US" xlink:label="lab_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Central Health Plan Of California, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:to="lab_bhg_CentralHealthPlanOfCaliforniaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd2117ce-c193-48f7-a942-4bbc97e0dbac_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9815a946-92d5-49f9-aedb-e3cbeeb42f32_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_b82c7d4b-3f31-4100-915b-d229cc2cf7bf_terseLabel_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capitalization ration before qualified IPO</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_label_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Ratio Before Qualified IPO</link:label>
    <link:label id="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_documentation_en-US" xlink:label="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Ratio Before Qualified IPO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:to="lab_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_72ee8ac3-1049-4cc2-832b-7241b2700aac_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0c9ed4f9-5d13-40fd-87ab-1eda87be257c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f6318950-a837-4356-bb43-40f35c6363aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_30eba2fa-fa0a-4d0f-9083-a1ae29a9758e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_01f67ec4-e6db-48ac-9758-7f2482444b25_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_15ed4b7b-c662-44f5-a6a1-457ccfabb35f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0b877210-f0c6-4044-b62e-344f7b864bc9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_6561620a-d33c-4c02-bea7-6df59bbcea48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0ebda30d-b736-45c3-af57-2735a21cda4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1252ad32-2fcb-4290-a141-103a30f10718_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6e6e7ada-9c4e-4a15-a0f5-952d02ffac33_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_3e1bb2e4-0da6-4767-a7f4-86a6937e8fe6_terseLabel_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Carrying Value</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_label_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities</link:label>
    <link:label id="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_documentation_en-US" xlink:label="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:to="lab_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_ab8f5157-78d8-4942-8a65-4f62f4322fef_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34c27dcf-df9f-47c1-b1b6-9d0c8f7e2387_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b852bef9-e8cf-402f-903e-9eb004a14d89_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdb2d846-22a9-4cd6-b734-0c42b79f3dab_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquired assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d51e3d5d-dbab-42ee-b78d-3b16aa9d6f8c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_71ef9a69-036a-42d5-ad4a-e08ccecfe2a2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1a3a3430-19d2-4ab2-8c4e-302966d76915_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_3fd832be-e922-49a0-b799-95753f32c50f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_779f89e1-da2e-47b1-9bf2-1a4ceed572d6_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_3b9cecb6-76b2-4152-b920-6794ec941ec1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5836ebf6-7d1c-4c0e-919d-cfa1b3d01efe_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_21dd2797-b9d2-4281-be12-20aa963ecaba_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_013843aa-56a1-4ed0-9a84-f9c5a45971ec_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d3d73a5a-397e-417e-97b6-cda7b90dd393_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_2effcfaa-d3ea-4d88-9659-ce03debf4a09_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1dff32e0-1e98-4481-9191-ea740eb9de9d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_c313f915-d691-4c61-8270-6f279314cca2_totalLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Total assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f3b7b684-dc38-4177-94bd-f87d3459af06_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_3eb67267-e41b-4860-bddd-05dfa6452e58_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_be5a3d65-538e-4e7f-a36e-f27e92dc7ca8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued and Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_acb3891b-a5ac-4164-b725-d626f17abe5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_9e303852-2d9e-4ea0-bfec-67feffc508a9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses, Total investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Held-to-Maturity, Cumulative Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fac566f1-9f0d-45be-b654-7807d159ae8f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_THNMAndZipnosisMember_a49cdadb-09b6-4b4e-a554-000e9333b8a9_terseLabel_en-US" xlink:label="lab_bhg_THNMAndZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THNM And Zipnosis</link:label>
    <link:label id="lab_bhg_THNMAndZipnosisMember_label_en-US" xlink:label="lab_bhg_THNMAndZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THNM And Zipnosis [Member]</link:label>
    <link:label id="lab_bhg_THNMAndZipnosisMember_documentation_en-US" xlink:label="lab_bhg_THNMAndZipnosisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THNM And Zipnosis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_THNMAndZipnosisMember" xlink:href="bhg-20210930.xsd#bhg_THNMAndZipnosisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_THNMAndZipnosisMember" xlink:to="lab_bhg_THNMAndZipnosisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement_c2e23dcb-5eba-432c-bab4-b68222d702e6_negatedTerseLabel_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of common stock from escrow settlement</link:label>
    <link:label id="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement_label_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Returned During Period, Value, Escrow Settlement</link:label>
    <link:label id="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement_documentation_en-US" xlink:label="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Returned During Period, Value, Escrow Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodValueEscrowSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:to="lab_bhg_StockReturnedDuringPeriodValueEscrowSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_cccf054b-e8b3-493c-bf72-726d25a8afc8_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_33b6c348-8e85-4cc4-b317-dfbe9cfb0808_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 10 years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_1d3b96c1-00d1-43eb-93ac-268e20dc02cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, less than 12 months, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_9a8d6f9b-bf38-42b7-975c-3d8b4b2cf382_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable, increase (decrease) to prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_3f1f71d8-8907-4f54-9698-e9ace12f4e3e_totalLabel_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments, Total liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_label_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:label id="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_documentation_en-US" xlink:label="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:to="lab_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2c0ecb12-4b4d-4452-9a12-de9254be0c49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8657c684-54ad-4c82-a8ac-38d58f3d56be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3566cba0-beb2-452f-8464-daa02fe3196e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_3125779f-d183-4ea3-80ba-bd1fafeca50d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_333ec11a-ffe6-4057-8683-541a513039fb_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_be802ace-5cbf-493c-b41f-1ae86331e863_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_29365937-1e10-4ce8-8f5d-16e628689753_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, 12 months or greater, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f872bf2-ba36-45e0-9c84-ac76e7b5089a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_aeff3ea2-d3e0-4a42-9adf-f1add404c90a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a91969f6-144b-44ae-9665-064ae44f7140_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bhg-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2bfd60c-7535-4e31-837d-21d32ad03321,g:973e8e09-839a-4bd8-8a2b-aa863a54e0b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CoverPage" xlink:type="simple" xlink:href="bhg-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bfc95050-b59b-4d19-81ff-9a24bcdee869" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentType_bfc95050-b59b-4d19-81ff-9a24bcdee869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_0949130c-868f-4d52-a286-77934d28d8d1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentQuarterlyReport_0949130c-868f-4d52-a286-77934d28d8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6a246d5a-2979-4f1b-a879-92fb7ececef9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentPeriodEndDate_6a246d5a-2979-4f1b-a879-92fb7ececef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9987f2e8-1a12-4252-ae45-88480dcbe846" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentTransitionReport_9987f2e8-1a12-4252-ae45-88480dcbe846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_afdb7a99-edad-4529-aa97-a9b55157a01c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityFileNumber_afdb7a99-edad-4529-aa97-a9b55157a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_02ceca8c-1f72-4851-bf59-05b9a23f0e39" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityRegistrantName_02ceca8c-1f72-4851-bf59-05b9a23f0e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3979dced-adfb-4535-82bd-4c6dec1540a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3979dced-adfb-4535-82bd-4c6dec1540a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_de8adfb4-c6cd-4259-b0a8-c356b93ab4a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityTaxIdentificationNumber_de8adfb4-c6cd-4259-b0a8-c356b93ab4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bbf63c1a-7d61-48e8-8f46-61c9b1b538c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityAddressAddressLine1_bbf63c1a-7d61-48e8-8f46-61c9b1b538c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_099a0d33-7c81-4d39-8e41-3a82db7d88ee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityAddressCityOrTown_099a0d33-7c81-4d39-8e41-3a82db7d88ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_36d166fd-fd7e-4a1d-81b9-4181f16e9585" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityAddressStateOrProvince_36d166fd-fd7e-4a1d-81b9-4181f16e9585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1a205cc-4c7e-4301-a46c-46d709d20894" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityAddressPostalZipCode_c1a205cc-4c7e-4301-a46c-46d709d20894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_14676c60-28c1-4a5b-a9a0-1d19999e9cda" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_CityAreaCode_14676c60-28c1-4a5b-a9a0-1d19999e9cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_451483cf-2b3d-4f31-9813-a9c6ff86aaab" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_LocalPhoneNumber_451483cf-2b3d-4f31-9813-a9c6ff86aaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3d524fba-9c65-43e3-934c-4b129dc24d37" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_Security12bTitle_3d524fba-9c65-43e3-934c-4b129dc24d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_de15db0d-1032-42d8-a926-2166aa6bd425" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_TradingSymbol_de15db0d-1032-42d8-a926-2166aa6bd425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c80dc936-ac26-4637-9075-b27c069e10c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_SecurityExchangeName_c80dc936-ac26-4637-9075-b27c069e10c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c6605d60-88e7-47fd-83bf-3c8550dead1e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityCurrentReportingStatus_c6605d60-88e7-47fd-83bf-3c8550dead1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_529e8268-c142-4ccb-8a71-d842f46aa612" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityInteractiveDataCurrent_529e8268-c142-4ccb-8a71-d842f46aa612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_fda5efd0-0a8b-4826-a6d5-0b4bedb9a51e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityFilerCategory_fda5efd0-0a8b-4826-a6d5-0b4bedb9a51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_44349889-c01f-41b1-8b85-6644a2a29762" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntitySmallBusiness_44349889-c01f-41b1-8b85-6644a2a29762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_66b77bc7-b00d-46ae-8099-41780f54624c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityEmergingGrowthCompany_66b77bc7-b00d-46ae-8099-41780f54624c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a9823595-de6c-413c-bb73-7586bbb136a2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityShellCompany_a9823595-de6c-413c-bb73-7586bbb136a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2223dd1d-bb90-44b6-9a5b-be7badb09fe9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2223dd1d-bb90-44b6-9a5b-be7badb09fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6634a72b-bc8d-42b4-90f9-1f088a7e6a84" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_EntityCentralIndexKey_6634a72b-bc8d-42b4-90f9-1f088a7e6a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cf105196-52b0-47f8-9feb-79e11c25042b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_AmendmentFlag_cf105196-52b0-47f8-9feb-79e11c25042b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_82755102-972b-4905-a2aa-03bb179fad88" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentFiscalYearFocus_82755102-972b-4905-a2aa-03bb179fad88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bedd37ae-72da-49a4-a54d-c598af9052fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_CurrentFiscalYearEndDate_bedd37ae-72da-49a4-a54d-c598af9052fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f3a2802b-829a-4401-a2db-363d6fb7a29a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69803aa3-3f3f-4ca8-af64-bad6a4a0c9cb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f3a2802b-829a-4401-a2db-363d6fb7a29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a3b3b141-cdfc-4639-a1ea-5ad61829db2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0a556e3a-7469-4e98-bf0a-eb872633520e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a3b3b141-cdfc-4639-a1ea-5ad61829db2c" xlink:to="loc_us-gaap_AssetsAbstract_0a556e3a-7469-4e98-bf0a-eb872633520e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a556e3a-7469-4e98-bf0a-eb872633520e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cd688c1-40cb-49b9-acae-d5393dc91019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cd688c1-40cb-49b9-acae-d5393dc91019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_649a1faa-106e-4614-a7a8-f833e0b27fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:to="loc_us-gaap_ShortTermInvestments_649a1faa-106e-4614-a7a8-f833e0b27fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a536927d-99c6-47b6-a8c5-8600e44b829a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a536927d-99c6-47b6-a8c5-8600e44b829a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e9047bf-37b9-4aea-9820-1ab2a3d80395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e9047bf-37b9-4aea-9820-1ab2a3d80395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d62e47d3-5f2b-4a6c-b9df-82567681d93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e4d3ba6-0bb0-49db-b875-332e9010413b" xlink:to="loc_us-gaap_AssetsCurrent_d62e47d3-5f2b-4a6c-b9df-82567681d93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a556e3a-7469-4e98-bf0a-eb872633520e" xlink:to="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_7e4351f5-dc1a-4542-9458-57ef00882e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_LongTermInvestments_7e4351f5-dc1a-4542-9458-57ef00882e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e53fd1e1-7e3e-4f70-b5f3-f5bd8f44012e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e53fd1e1-7e3e-4f70-b5f3-f5bd8f44012e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_44ef577c-932b-401d-9b93-3cc5254ad439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_Goodwill_44ef577c-932b-401d-9b93-3cc5254ad439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_98c1a26a-64a4-4bb2-9599-601f4e9a1090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_98c1a26a-64a4-4bb2-9599-601f4e9a1090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cc394cf7-13d7-4105-83aa-584d58f1638c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cc394cf7-13d7-4105-83aa-584d58f1638c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_d6cfcb15-5005-4416-becd-baa440d9a406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_307367b4-7877-4c24-bc3d-e70dfe2a5fdd" xlink:to="loc_us-gaap_AssetsNoncurrent_d6cfcb15-5005-4416-becd-baa440d9a406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4a1c3a27-d457-4d9d-938a-369e1547d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a556e3a-7469-4e98-bf0a-eb872633520e" xlink:to="loc_us-gaap_Assets_4a1c3a27-d457-4d9d-938a-369e1547d9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a3b3b141-cdfc-4639-a1ea-5ad61829db2c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f3a7a79b-4e26-4f36-ba23-6a058d2d3e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f3a7a79b-4e26-4f36-ba23-6a058d2d3e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_82bf1412-01ce-4c50-a298-cb88101f99f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_us-gaap_AccountsPayableCurrent_82bf1412-01ce-4c50-a298-cb88101f99f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_991958ff-8c3a-4f00-aadf-53cf1576966d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnearnedPremiums"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_us-gaap_UnearnedPremiums_991958ff-8c3a-4f00-aadf-53cf1576966d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_RiskAdjustmentPayableCurrent_7625bc9d-0fad-4128-aac7-c167d9430a57" xlink:href="bhg-20210930.xsd#bhg_RiskAdjustmentPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_bhg_RiskAdjustmentPayableCurrent_7625bc9d-0fad-4128-aac7-c167d9430a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_54f96bcf-b007-45ec-969a-4dd9f3b25f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_54f96bcf-b007-45ec-969a-4dd9f3b25f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8626404a-c696-4ee0-9249-eb410733d225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_38f769cc-c692-41f0-9d14-be6676626f28" xlink:to="loc_us-gaap_LiabilitiesCurrent_8626404a-c696-4ee0-9249-eb410733d225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2dbb781e-ac9a-4488-b057-4f470ef3c3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2dbb781e-ac9a-4488-b057-4f470ef3c3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c4b83533-cd5c-4703-ab6d-fe68da29af18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_Liabilities_c4b83533-cd5c-4703-ab6d-fe68da29af18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_22139073-ed6f-4694-8c67-729bea7f6f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_CommitmentsAndContingencies_22139073-ed6f-4694-8c67-729bea7f6f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3da13bac-072b-4b12-aa3c-7f5c88f9ad34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3da13bac-072b-4b12-aa3c-7f5c88f9ad34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_aeb99970-23b4-41c8-b32c-d7ea6ade39e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_aeb99970-23b4-41c8-b32c-d7ea6ade39e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fdc406d7-d1e5-4b4f-813f-9b0a23a6650d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:to="loc_us-gaap_CommonStockValue_fdc406d7-d1e5-4b4f-813f-9b0a23a6650d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_457b8afb-7d32-4663-b3f9-da93d45f2c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_457b8afb-7d32-4663-b3f9-da93d45f2c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a5cf162-ae3f-4c28-b425-03d511ab1923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a5cf162-ae3f-4c28-b425-03d511ab1923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_27a847b1-0c67-4857-900b-7fd222602c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_27a847b1-0c67-4857-900b-7fd222602c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7889c6d5-58e8-4950-98b0-f1de132912cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2ae3bc17-069d-4faf-8f25-41540ee0368a" xlink:to="loc_us-gaap_StockholdersEquity_7889c6d5-58e8-4950-98b0-f1de132912cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e875b9f-a5a5-4fcf-b0cc-e3e25b94ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45608935-dfba-4928-b0b1-42b3970203ca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e875b9f-a5a5-4fcf-b0cc-e3e25b94ef3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c29a0c67-a5d3-457c-a2bc-43fc72604c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c29a0c67-a5d3-457c-a2bc-43fc72604c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_416bf5fb-eabe-4ea6-af6e-21c69aa02cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_416bf5fb-eabe-4ea6-af6e-21c69aa02cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_af249f9f-d04a-459a-9fc1-c6cdb8c5a7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_af249f9f-d04a-459a-9fc1-c6cdb8c5a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_446fc778-7144-41cf-898e-508f53488b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_446fc778-7144-41cf-898e-508f53488b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b8f2a213-b809-4878-a464-b439aabae0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b8f2a213-b809-4878-a464-b439aabae0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e7b5d51a-dc4a-4688-aa5f-81ea440c0d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e7b5d51a-dc4a-4688-aa5f-81ea440c0d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bb1388a5-9e63-43a9-bb14-42007fd80341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bb1388a5-9e63-43a9-bb14-42007fd80341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_90b6b2ee-0c71-47fd-bdce-6ef393fd2f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_CommonStockSharesIssued_90b6b2ee-0c71-47fd-bdce-6ef393fd2f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a4b43985-fd67-4a82-bf00-2adb7f49922f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e18a497d-03b7-4d31-831b-1bfac61b78b8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a4b43985-fd67-4a82-bf00-2adb7f49922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_7cf362eb-6f1f-47dc-be52-4d261d2e1d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:to="loc_us-gaap_PremiumsEarnedNet_7cf362eb-6f1f-47dc-be52-4d261d2e1d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f029823-31e9-4143-8def-477a8669bbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f029823-31e9-4143-8def-477a8669bbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_3aef1181-4ec0-468f-9db4-1ef68a9a3509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_3aef1181-4ec0-468f-9db4-1ef68a9a3509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_aedd63fb-328d-4e82-b2b9-0d31bbfc8f65" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:to="loc_bhg_InvestmentIncomeLoss_aedd63fb-328d-4e82-b2b9-0d31bbfc8f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_895a3368-368f-41ce-81e9-d3ed7fc65326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_89aca7b1-7adf-4459-89dd-f0c99c2f01c4" xlink:to="loc_us-gaap_Revenues_895a3368-368f-41ce-81e9-d3ed7fc65326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_8e156ccb-886b-48fb-8941-4643a18edf32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_8e156ccb-886b-48fb-8941-4643a18edf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_820aa624-843d-424f-8f97-35223c7c34c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_820aa624-843d-424f-8f97-35223c7c34c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_83f3b9e6-2d24-404e-a1aa-256b088c8bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_83f3b9e6-2d24-404e-a1aa-256b088c8bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_81bcb6e9-4911-4ab0-9efc-0189abae7e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_28b887cb-5ad1-477f-8ef3-8b81c818861d" xlink:to="loc_us-gaap_OperatingExpenses_81bcb6e9-4911-4ab0-9efc-0189abae7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a16526c7-9449-4d80-ae5a-804bb10fce2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_OperatingIncomeLoss_a16526c7-9449-4d80-ae5a-804bb10fce2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f3f4c8a7-7e74-4c6e-9da4-148505f0c4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_InterestExpense_f3f4c8a7-7e74-4c6e-9da4-148505f0c4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_dc60b1fe-5723-4b69-a01a-0c166ab68de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_OtherNonoperatingIncome_dc60b1fe-5723-4b69-a01a-0c166ab68de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50bc5903-46a9-47fd-991c-02afd993d472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50bc5903-46a9-47fd-991c-02afd993d472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47a332f6-4bf2-43cd-9271-30e6bb8e74f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47a332f6-4bf2-43cd-9271-30e6bb8e74f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eb88a163-c708-4f67-8be3-828f45cd78b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_ProfitLoss_eb88a163-c708-4f67-8be3-828f45cd78b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_28099485-6384-41e4-9549-85217cae04a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_28099485-6384-41e4-9549-85217cae04a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20050b56-0dfa-4553-bd8d-3817b7992cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_NetIncomeLoss_20050b56-0dfa-4553-bd8d-3817b7992cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_973b179b-4eee-4e0b-8d0b-b5979a1e7e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_EarningsPerShareBasic_973b179b-4eee-4e0b-8d0b-b5979a1e7e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f09747cd-8329-49c7-9da8-01fd9886757b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f09747cd-8329-49c7-9da8-01fd9886757b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3167af99-6bc9-4526-9bd1-363c19bdf1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3167af99-6bc9-4526-9bd1-363c19bdf1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35a6f850-894a-4de9-84fe-16c8aff33f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_637f9127-1518-458f-b845-261a4c3e1dcc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35a6f850-894a-4de9-84fe-16c8aff33f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f9260e2a-952f-40ba-a8ec-1bcfb6cae240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:to="loc_us-gaap_ProfitLoss_f9260e2a-952f-40ba-a8ec-1bcfb6cae240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_737486be-40ab-4b41-b280-e256ee7ead0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_737486be-40ab-4b41-b280-e256ee7ead0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7f1a44fb-d9eb-4bca-b228-de4d79651761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_737486be-40ab-4b41-b280-e256ee7ead0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7f1a44fb-d9eb-4bca-b228-de4d79651761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ad0a2e23-9f20-40d1-ba7f-651eff6c7ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_737486be-40ab-4b41-b280-e256ee7ead0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ad0a2e23-9f20-40d1-ba7f-651eff6c7ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62a1da9c-346a-40a4-9425-0892ed078165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_737486be-40ab-4b41-b280-e256ee7ead0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62a1da9c-346a-40a4-9425-0892ed078165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_63b5e379-691e-48d7-821f-9a20ef88ac07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_63b5e379-691e-48d7-821f-9a20ef88ac07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0cc75542-364c-48b1-8f04-a9b519ff4408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0cc75542-364c-48b1-8f04-a9b519ff4408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d2ef1eee-81c5-4b2e-a02f-8e4e10dfdbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9feb2c99-8651-40b2-82e5-7b03425a9a6d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d2ef1eee-81c5-4b2e-a02f-8e4e10dfdbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9c28a8ac-2410-4867-b418-9921c3241b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_e9c4573b-0101-4459-9fcd-6319216e3b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9c28a8ac-2410-4867-b418-9921c3241b09" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_e9c4573b-0101-4459-9fcd-6319216e3b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_fa41c883-993c-4962-ae5f-06451f1da4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9c28a8ac-2410-4867-b418-9921c3241b09" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_fa41c883-993c-4962-ae5f-06451f1da4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_91b65bdb-830d-4cb8-970b-b69042d01b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_91b65bdb-830d-4cb8-970b-b69042d01b95" xlink:to="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94fc974c-92a0-4d40-accc-84021b771bf2" xlink:to="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_13be7c83-48d3-47dc-bf43-9563011d8200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_CommonStockMember_13be7c83-48d3-47dc-bf43-9563011d8200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3cccfd2b-be80-4390-9288-6066c332274f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3cccfd2b-be80-4390-9288-6066c332274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f6e39c2d-85de-452c-8ed1-79ab2a559a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_RetainedEarningsMember_f6e39c2d-85de-452c-8ed1-79ab2a559a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af5cbd66-c640-4594-bff2-b4dd5d263769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17010f44-ebdb-4525-955c-c6ef62c2779b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af5cbd66-c640-4594-bff2-b4dd5d263769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f4899d88-4eeb-448f-88c5-c05cfe145a32" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_242d37b2-9e15-4014-a6e3-d591234a86a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_44ca0a4f-ba1b-46a8-85b6-d53e815d3e53" xlink:to="loc_us-gaap_IPOMember_242d37b2-9e15-4014-a6e3-d591234a86a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a223512c-dc56-49f0-84f6-ca5135b86ce2" xlink:to="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b1418afd-b2b9-4f67-953a-7f6d8c51d876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b1418afd-b2b9-4f67-953a-7f6d8c51d876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fa1535a9-0892-44d8-888b-da3a67454f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fa1535a9-0892-44d8-888b-da3a67454f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_b3ea16a5-378f-457f-8575-2929906475a6" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_b3ea16a5-378f-457f-8575-2929906475a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a49f305c-5ef1-4ea2-9bed-94cedcdb978d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a49f305c-5ef1-4ea2-9bed-94cedcdb978d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_464f25eb-573f-4b80-ae08-d289420ab11c" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities_464f25eb-573f-4b80-ae08-d289420ab11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_bfaf20ec-ead0-41e5-b7ae-76f108f4bca1" xlink:href="bhg-20210930.xsd#bhg_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_bhg_TemporaryEquityValueConversionOfConvertibleSecurities_bfaf20ec-ead0-41e5-b7ae-76f108f4bca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_91b2c13a-b0b9-46d0-8812-2b1ddc329a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_91b2c13a-b0b9-46d0-8812-2b1ddc329a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_89dcf60c-b6d8-49f1-9ea0-a94d7f8fc64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dbda7d88-0b68-42d5-bd0a-8610d24f0c22" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_89dcf60c-b6d8-49f1-9ea0-a94d7f8fc64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83ea1674-a103-4bdb-aac4-139e7dbd2c74" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_23b3a92d-df5a-490a-b373-a8a6abb2f214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_23b3a92d-df5a-490a-b373-a8a6abb2f214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9a36ee31-3233-475d-b3ee-b5eee38d0500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockholdersEquity_9a36ee31-3233-475d-b3ee-b5eee38d0500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9afa5710-bc74-4115-82b5-8def7e71fa44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_NetIncomeLoss_9afa5710-bc74-4115-82b5-8def7e71fa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_bb923fc4-d0a1-4985-ba8a-ecb3f73b52ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_bb923fc4-d0a1-4985-ba8a-ecb3f73b52ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d84c0025-73fe-44b3-a23b-04a61a9242ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d84c0025-73fe-44b3-a23b-04a61a9242ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_af96cb18-7f3d-43d5-a8ae-896fdc0e8786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_af96cb18-7f3d-43d5-a8ae-896fdc0e8786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ccf537bf-e5f6-404c-bfaa-e77c4cee3078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ccf537bf-e5f6-404c-bfaa-e77c4cee3078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_e0b4cd95-44d1-48bf-9b05-56495ada64c8" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodSharesEscrowSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_bhg_StockReturnedDuringPeriodSharesEscrowSettlement_e0b4cd95-44d1-48bf-9b05-56495ada64c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement_1b05d008-80db-4caa-8203-a4f3ca60225d" xlink:href="bhg-20210930.xsd#bhg_StockReturnedDuringPeriodValueEscrowSettlement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_bhg_StockReturnedDuringPeriodValueEscrowSettlement_1b05d008-80db-4caa-8203-a4f3ca60225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0c104c4e-580e-46e1-980c-a1f371a13a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0c104c4e-580e-46e1-980c-a1f371a13a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f95cb96e-ecc7-4a39-aa81-d85684cb90a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f95cb96e-ecc7-4a39-aa81-d85684cb90a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9040b6e8-d592-4ae1-8053-cbeeb9883144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9040b6e8-d592-4ae1-8053-cbeeb9883144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_775ce976-6161-4536-8f1c-71379611f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5ea0f09c-f94c-4103-a6ba-aed81e59815e" xlink:to="loc_us-gaap_StockholdersEquity_775ce976-6161-4536-8f1c-71379611f64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bhg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_debccc1e-3509-4d1f-8efe-0f8b85c00a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_debccc1e-3509-4d1f-8efe-0f8b85c00a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8f03811a-1b61-47a6-8e50-6e377b78ab91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_debccc1e-3509-4d1f-8efe-0f8b85c00a0d" xlink:to="loc_us-gaap_NetIncomeLoss_8f03811a-1b61-47a6-8e50-6e377b78ab91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_debccc1e-3509-4d1f-8efe-0f8b85c00a0d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_202a352d-b8a4-46d3-a91a-306f8dfa30a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_202a352d-b8a4-46d3-a91a-306f8dfa30a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_483667c8-70f9-4e84-9a3b-ab3514fbda0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_ShareBasedCompensation_483667c8-70f9-4e84-9a3b-ab3514fbda0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_de1b3271-5524-4623-825b-9fef93786f43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_de1b3271-5524-4623-825b-9fef93786f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0a37da0d-e72c-4ea6-9d7a-0cd6a2b19bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0a37da0d-e72c-4ea6-9d7a-0cd6a2b19bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_be60ef3f-12dc-4537-b73f-ee1223e82a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_be60ef3f-12dc-4537-b73f-ee1223e82a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_54210c9d-66be-43da-bf12-800bcb8c2a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_54210c9d-66be-43da-bf12-800bcb8c2a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_744f119e-5a23-4604-8628-a9447fffea25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_744f119e-5a23-4604-8628-a9447fffea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_4b899403-374e-424f-9dfb-5611ffaa57ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_4b899403-374e-424f-9dfb-5611ffaa57ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable_173900cb-cfba-4041-87f1-2990c8d3161d" xlink:href="bhg-20210930.xsd#bhg_IncreaseDecreaseInRiskAdjustmentPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_bhg_IncreaseDecreaseInRiskAdjustmentPayable_173900cb-cfba-4041-87f1-2990c8d3161d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_301ef35b-8b1d-4195-a38c-9bbe8728cf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_301ef35b-8b1d-4195-a38c-9bbe8728cf3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_56a2777d-439c-4f4e-9e52-aeb6ec695205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiums"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9329990b-d671-4dee-8b76-c56f682056da" xlink:to="loc_us-gaap_IncreaseDecreaseInUnearnedPremiums_56a2777d-439c-4f4e-9e52-aeb6ec695205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4dff65d7-a753-483b-89c5-cf63078a4c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18db5185-85a7-4cd0-af48-6a494be9bfc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4dff65d7-a753-483b-89c5-cf63078a4c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_32e6209c-eaef-47ec-81e9-fd0c3e0bb321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_32e6209c-eaef-47ec-81e9-fd0c3e0bb321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_dc6cd196-306b-468d-a6a9-3f4ad255efff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_dc6cd196-306b-468d-a6a9-3f4ad255efff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f4ac269a-57f9-4a42-8259-a7f7e1d6adf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f4ac269a-57f9-4a42-8259-a7f7e1d6adf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8e49b8fb-f770-4c7a-b29f-235767a2c0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8e49b8fb-f770-4c7a-b29f-235767a2c0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2c47897e-44a2-44a6-952e-1826e286a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d80b0cc9-2a94-48cb-a317-64a861b832f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2c47897e-44a2-44a6-952e-1826e286a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_204f3b5c-39c1-4324-82be-c49f0571de27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_204f3b5c-39c1-4324-82be-c49f0571de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9c135d08-69c2-4dc8-89ac-5363b99d08fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9c135d08-69c2-4dc8-89ac-5363b99d08fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_599cc976-6f76-483e-a8b5-18368e5006b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_599cc976-6f76-483e-a8b5-18368e5006b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_0bc0a2ed-1bce-4fbd-a86e-90b88c4b3727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_0bc0a2ed-1bce-4fbd-a86e-90b88c4b3727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_740df5d2-7186-41ce-8fe0-8d312a00b873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_740df5d2-7186-41ce-8fe0-8d312a00b873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_c4e742fb-eb26-4c94-9277-c01badf35616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_c4e742fb-eb26-4c94-9277-c01badf35616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_83595aa4-5fd2-4899-8287-412818f9b7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_83595aa4-5fd2-4899-8287-412818f9b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d70a982f-ec2b-4fb6-8244-8fc69a2dc86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60ba7da8-cf14-45ef-9db8-127f1dff36eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d70a982f-ec2b-4fb6-8244-8fc69a2dc86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_43079c03-d9e7-4fb3-9921-715ef676692b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_43079c03-d9e7-4fb3-9921-715ef676692b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_753449bd-73e6-4a67-b66c-47f0daa2d70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_753449bd-73e6-4a67-b66c-47f0daa2d70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7444249c-6ab8-49c7-a2e9-7cc8ef9c306f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7444249c-6ab8-49c7-a2e9-7cc8ef9c306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_57858346-11f6-43ab-a7b7-a49c71f858be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_57858346-11f6-43ab-a7b7-a49c71f858be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_656a31da-a610-472d-9cba-1a14b89f17f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_57858346-11f6-43ab-a7b7-a49c71f858be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_656a31da-a610-472d-9cba-1a14b89f17f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_9eec06f7-aee4-4b2d-a057-59b813599df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_57858346-11f6-43ab-a7b7-a49c71f858be" xlink:to="loc_us-gaap_InterestPaidNet_9eec06f7-aee4-4b2d-a057-59b813599df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_359358b2-78c7-49c4-8c17-9400172dacfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_26718750-3ca3-4d01-ba0f-a31bc5088c1d" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_359358b2-78c7-49c4-8c17-9400172dacfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_ef9aa0c2-79bb-47b7-8c67-b0fdb21dc780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_359358b2-78c7-49c4-8c17-9400172dacfa" xlink:to="loc_us-gaap_StockIssued1_ef9aa0c2-79bb-47b7-8c67-b0fdb21dc780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_efece84d-f643-4bf3-9907-8b51fc14c0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_359358b2-78c7-49c4-8c17-9400172dacfa" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_efece84d-f643-4bf3-9907-8b51fc14c0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4450b489-02e1-47ff-8817-c64e47a791e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0b5f9877-fc12-41ce-be1c-fb0c3fe72442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4450b489-02e1-47ff-8817-c64e47a791e7" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0b5f9877-fc12-41ce-be1c-fb0c3fe72442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies" xlink:type="simple" xlink:href="bhg-20210930.xsd#OrganizationConsolidationandPresentationofFinancialStatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bd1d3b5-ddd4-4fc2-898a-2e05e2fac16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8ec6f6bd-aac8-43a6-a68a-44ca7511dbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bd1d3b5-ddd4-4fc2-898a-2e05e2fac16a" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8ec6f6bd-aac8-43a6-a68a-44ca7511dbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_790b5e0b-5328-42b2-8c75-2bc7099a80ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bd1d3b5-ddd4-4fc2-898a-2e05e2fac16a" xlink:to="loc_us-gaap_UseOfEstimates_790b5e0b-5328-42b2-8c75-2bc7099a80ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_06a59c49-9702-4690-91b2-0c4a476630f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bd1d3b5-ddd4-4fc2-898a-2e05e2fac16a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_06a59c49-9702-4690-91b2-0c4a476630f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATIONTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6a90d433-5c4b-4763-9015-a2853675df72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_da7c6cf4-3f0f-4bd4-b237-3fda0623cf43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6a90d433-5c4b-4763-9015-a2853675df72" xlink:to="loc_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_da7c6cf4-3f0f-4bd4-b237-3fda0623cf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_526f5190-2999-4954-995f-d817d42ceaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_526f5190-2999-4954-995f-d817d42ceaa4" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ab68d5d6-169b-4189-9ee7-ba02facd1ef6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_20dc7635-9fca-4ff3-901d-8aca7d8d16a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ebbe3561-b5cd-495c-9b8b-2389962692ae" xlink:to="loc_us-gaap_IPOMember_20dc7635-9fca-4ff3-901d-8aca7d8d16a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0273d9e-0a4f-493a-8d63-482c22711441" xlink:to="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f1a1ff45-958d-4a91-8023-12f5fc2fcf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f1a1ff45-958d-4a91-8023-12f5fc2fcf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0c9af9ce-4e38-41c1-8c91-3b1217689808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0c9af9ce-4e38-41c1-8c91-3b1217689808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_b3359d66-2d8d-4157-a2fd-a30d3477ba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_b3359d66-2d8d-4157-a2fd-a30d3477ba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_bf3efaac-f9c6-4786-860a-af678d95b264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_bf3efaac-f9c6-4786-860a-af678d95b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_d99da406-b619-4350-a820-b9480071a941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_11835cd9-9729-451f-8a93-4b3f0a61b83f" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_d99da406-b619-4350-a820-b9480071a941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_929224dd-21ff-4501-a9b4-833e134e1499" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_8dba2c99-3496-4a49-9444-304349e64b7a" xlink:href="bhg-20210930.xsd#bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_3cf39a84-099a-41fd-bbc3-82812ec9f64b" xlink:to="loc_bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember_8dba2c99-3496-4a49-9444-304349e64b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d850f9bf-e68a-494e-b003-8c51ce0e2935" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_137216ca-ec36-4c42-9f0d-e6f9c43f7817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_137216ca-ec36-4c42-9f0d-e6f9c43f7817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f1e2d3fe-bd36-4418-a7de-1b915c7fc1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f1e2d3fe-bd36-4418-a7de-1b915c7fc1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_399d1c67-95fa-47e8-88b0-2e463ae73041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_399d1c67-95fa-47e8-88b0-2e463ae73041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1a9fd3c-ee90-4376-908b-7fa52d7383ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1a9fd3c-ee90-4376-908b-7fa52d7383ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ad21974-6509-41d2-a1e3-4ad14d91ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ad21974-6509-41d2-a1e3-4ad14d91ebe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_a9796f75-a2a9-433c-8a20-fc6b8fc59024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_DeferredOfferingCosts_a9796f75-a2a9-433c-8a20-fc6b8fc59024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3dc654cb-19d2-4f6d-878e-216f58eb0e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3dc654cb-19d2-4f6d-878e-216f58eb0e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_b035c3d1-8315-4c58-85a0-4f91f7a3010a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_b035c3d1-8315-4c58-85a0-4f91f7a3010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9aec8afa-6634-4666-9303-cfb8ba76a323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9aec8afa-6634-4666-9303-cfb8ba76a323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_RiskAdjustmentPayableCurrent_81d35e0c-c508-4a52-a439-a702287baf52" xlink:href="bhg-20210930.xsd#bhg_RiskAdjustmentPayableCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_bhg_RiskAdjustmentPayableCurrent_81d35e0c-c508-4a52-a439-a702287baf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_d0f7dd12-ab07-47c9-902b-6d93e9101fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8a5cdbba-32f9-4300-9268-f68d0b839cab" xlink:to="loc_us-gaap_PremiumsEarnedNet_d0f7dd12-ab07-47c9-902b-6d93e9101fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_dc3bc0e0-4641-49c3-923d-378946c2e508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:to="loc_us-gaap_LaborAndRelatedExpense_dc3bc0e0-4641-49c3-923d-378946c2e508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_02043767-f97d-4e1a-8f3c-e3bdea297307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:to="loc_us-gaap_ProfessionalFees_02043767-f97d-4e1a-8f3c-e3bdea297307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_ee26b0e2-2c1f-449f-b2df-f0d21f48ec0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:to="loc_us-gaap_SellingAndMarketingExpense_ee26b0e2-2c1f-449f-b2df-f0d21f48ec0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_5c0ccf7b-15b4-4efa-bc38-b5abfd817192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_5c0ccf7b-15b4-4efa-bc38-b5abfd817192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1c1f9c63-cc54-4645-b832-2937a91bbefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_024a9ad3-8d64-48ac-8ae0-c909cab55042" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1c1f9c63-cc54-4645-b832-2937a91bbefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d319646-9384-43a8-9095-25063716b456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e27aa87e-a500-4ee9-9e8c-67e4a794ab47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d319646-9384-43a8-9095-25063716b456" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e27aa87e-a500-4ee9-9e8c-67e4a794ab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b07939b4-683d-4357-91af-fb96516b1348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f0424c42-fbeb-430f-a2d0-a956ec1b9d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b07939b4-683d-4357-91af-fb96516b1348" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f0424c42-fbeb-430f-a2d0-a956ec1b9d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6e925794-6ab7-4fd1-91dd-f6d58ea72012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b07939b4-683d-4357-91af-fb96516b1348" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6e925794-6ab7-4fd1-91dd-f6d58ea72012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_90983702-eb24-463b-af28-ca5dc17389df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_90983702-eb24-463b-af28-ca5dc17389df" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c70473ca-039f-48aa-a856-108acd97accd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_6d931190-921f-4ac6-8a41-e9a7e944431f" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_6d931190-921f-4ac6-8a41-e9a7e944431f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_29d3411d-ffd1-48a7-8c3e-e49008250a1b" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_29d3411d-ffd1-48a7-8c3e-e49008250a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TrueHealthNewMexicoMember_3891b777-7ef7-4c5b-b902-35f7f4f51d97" xlink:href="bhg-20210930.xsd#bhg_TrueHealthNewMexicoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_TrueHealthNewMexicoMember_3891b777-7ef7-4c5b-b902-35f7f4f51d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ZipnosisMember_2320fe09-0595-423a-8a54-97c042c0a032" xlink:href="bhg-20210930.xsd#bhg_ZipnosisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_ZipnosisMember_2320fe09-0595-423a-8a54-97c042c0a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember_2a3d9c6e-1b5c-4c18-8021-0a3ae45f27c0" xlink:href="bhg-20210930.xsd#bhg_PremierMedicalAssociatesOfFloridaLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_PremierMedicalAssociatesOfFloridaLLCMember_2a3d9c6e-1b5c-4c18-8021-0a3ae45f27c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_UniversalCareIncBrandNewDayMember_134f8b5d-9b9e-4987-9079-909bc6aaa3d1" xlink:href="bhg-20210930.xsd#bhg_UniversalCareIncBrandNewDayMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ce2037c-2d5a-4e95-8b38-96588fa61150" xlink:to="loc_bhg_UniversalCareIncBrandNewDayMember_134f8b5d-9b9e-4987-9079-909bc6aaa3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a46371be-c8ad-4bcb-b1df-1ced295a92d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_7f659267-0e80-4806-81b8-911ac3272845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_TradeNamesMember_7f659267-0e80-4806-81b8-911ac3272845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3ffd0348-5ede-4382-9c54-6f0624b5cee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3ffd0348-5ede-4382-9c54-6f0624b5cee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_5697ac25-6429-4c94-bb06-553bfeed1a84" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_bhg_ReacquiredContractsMember_5697ac25-6429-4c94-bb06-553bfeed1a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ProviderNetworkMember_bc264707-89a4-4352-a1b1-461e4259cdbd" xlink:href="bhg-20210930.xsd#bhg_ProviderNetworkMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_bhg_ProviderNetworkMember_bc264707-89a4-4352-a1b1-461e4259cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_41ad8b3c-bf1c-4005-af7c-824107680a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37c00c78-e7bf-4372-a1a8-977a99040880" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_41ad8b3c-bf1c-4005-af7c-824107680a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_75387a1d-043e-491e-9f08-67079d068308" xlink:to="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f5995c0e-b294-4995-b0f8-77d5d8508e03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:to="loc_srt_MinimumMember_f5995c0e-b294-4995-b0f8-77d5d8508e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98e492e3-2991-4417-9f4b-88ba8dfdd996" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a1e3f184-6649-4d5d-b551-10a715b2b1cd" xlink:to="loc_srt_MaximumMember_98e492e3-2991-4417-9f4b-88ba8dfdd996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_76418d09-b1fa-4c5c-88ac-55b003a69839" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_87d35f24-458e-4320-a5eb-c00830983113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_87d35f24-458e-4320-a5eb-c00830983113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ae2cfcd4-e0c6-4e8f-8dea-c50af3a49f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ae2cfcd4-e0c6-4e8f-8dea-c50af3a49f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6bdc7417-3df9-4461-9828-f60b699ac090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6bdc7417-3df9-4461-9828-f60b699ac090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d663ef45-af63-4c86-9c83-dd9ffe74ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d663ef45-af63-4c86-9c83-dd9ffe74ecc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1dcd7be8-1f2a-48af-9c28-8c59dc7009a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1dcd7be8-1f2a-48af-9c28-8c59dc7009a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NumberOfHealthCenters_df2393eb-a021-4047-95fa-9941cdf6701a" xlink:href="bhg-20210930.xsd#bhg_NumberOfHealthCenters"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_NumberOfHealthCenters_df2393eb-a021-4047-95fa-9941cdf6701a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e11d1ee2-a920-4750-bee8-18f61641fa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e11d1ee2-a920-4750-bee8-18f61641fa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a9fa81f9-827c-4993-9b79-47996035c543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a9fa81f9-827c-4993-9b79-47996035c543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment_e4570fa3-04e6-407f-8ca1-f12f683239b9" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationTangibleNetEquityAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_BusinessCombinationTangibleNetEquityAdjustment_e4570fa3-04e6-407f-8ca1-f12f683239b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationEscrowAdjustment_2f204f8a-f3eb-458c-a3e2-2510d4aa1b71" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationEscrowAdjustment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_bhg_BusinessCombinationEscrowAdjustment_2f204f8a-f3eb-458c-a3e2-2510d4aa1b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_721fa298-ec1f-4657-a198-6a17e2736f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_721fa298-ec1f-4657-a198-6a17e2736f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e2af2b63-caf7-4971-8b7a-ac79e9896383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e2af2b63-caf7-4971-8b7a-ac79e9896383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_225f074b-0ba0-4750-8410-277354197ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_806e9d26-191c-4677-8462-7b502fca12a7" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_225f074b-0ba0-4750-8410-277354197ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6177dd8d-d1ac-4020-9a25-adebd8bc180e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6177dd8d-d1ac-4020-9a25-adebd8bc180e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b3c96dfa-96a5-4124-b34f-a9b531893efb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_2b6bd0ac-6f28-44b8-9be8-6d4c4b06ea73" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_2b6bd0ac-6f28-44b8-9be8-6d4c4b06ea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_5992e80f-ba86-403d-9efc-a3982c564cdc" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_5992e80f-ba86-403d-9efc-a3982c564cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_TrueHealthNewMexicoMember_3d263fc9-2f31-4bde-9119-84bd18b3a572" xlink:href="bhg-20210930.xsd#bhg_TrueHealthNewMexicoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_TrueHealthNewMexicoMember_3d263fc9-2f31-4bde-9119-84bd18b3a572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ZipnosisMember_7853b6cb-c2cc-4f41-9d91-072a5d55f01b" xlink:href="bhg-20210930.xsd#bhg_ZipnosisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_ZipnosisMember_7853b6cb-c2cc-4f41-9d91-072a5d55f01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_UniversalCareIncBrandNewDayMember_b0743c4b-8837-4737-bd46-863d8df3d1d8" xlink:href="bhg-20210930.xsd#bhg_UniversalCareIncBrandNewDayMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b9329bca-7545-484d-991f-e7b3a1a8770b" xlink:to="loc_bhg_UniversalCareIncBrandNewDayMember_b0743c4b-8837-4737-bd46-863d8df3d1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0858ff19-c410-47d9-aab4-f5eef3d5b3e3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_50396c3a-96d3-4ebd-be79-7793cff68389" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_718fa3ff-ac6e-49ea-9eb0-85646667ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_718fa3ff-ac6e-49ea-9eb0-85646667ca14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_720f1b7e-6a89-45bc-98cf-fd3b1cee4195" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable_720f1b7e-6a89-45bc-98cf-fd3b1cee4195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_092494ef-ce54-469c-b0f2-c81de290d699" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments_092494ef-ce54-469c-b0f2-c81de290d699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_40ee9a86-719a-4b6f-a0d4-d670916856fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_40ee9a86-719a-4b6f-a0d4-d670916856fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_f1cc8688-29bd-4b72-bf74-e86409063796" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets_f1cc8688-29bd-4b72-bf74-e86409063796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50642b85-c5ad-45f7-ac1e-16b2fcb795c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50642b85-c5ad-45f7-ac1e-16b2fcb795c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_95671a19-1556-4115-aef6-df0bfc8532c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_95671a19-1556-4115-aef6-df0bfc8532c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6740b92b-f5a6-4d96-87c7-ff7414b32275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6740b92b-f5a6-4d96-87c7-ff7414b32275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_62f75756-7b3a-4a29-a87a-370ffb18e396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_62f75756-7b3a-4a29-a87a-370ffb18e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_9197b412-6249-4a45-9269-2843a47fcba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_9197b412-6249-4a45-9269-2843a47fcba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b0e62083-dd5e-46cb-9463-9b670f09f4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b0e62083-dd5e-46cb-9463-9b670f09f4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_6832599b-4b4b-4684-8487-3ca6d0b3f4ae" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets_6832599b-4b4b-4684-8487-3ca6d0b3f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f6c715b2-914b-441f-9336-c6d4fb03d413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f6c715b2-914b-441f-9336-c6d4fb03d413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_2a1e4fd4-03de-4ba5-8af6-f3f054945fce" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_2a1e4fd4-03de-4ba5-8af6-f3f054945fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_9ba92f2c-ff21-48e5-a1f0-d398c5f81ffc" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense_9ba92f2c-ff21-48e5-a1f0-d398c5f81ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_031684b0-eae0-4382-967a-db1a2b629639" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense_031684b0-eae0-4382-967a-db1a2b629639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1c6b50a4-0bce-4b9a-bb24-9f6cecff96d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1c6b50a4-0bce-4b9a-bb24-9f6cecff96d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_d14327ff-9ce9-4fa3-8e1f-84486f8196a0" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums_d14327ff-9ce9-4fa3-8e1f-84486f8196a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e3780ce3-66d3-4612-8413-4eda2255bead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e3780ce3-66d3-4612-8413-4eda2255bead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_2f8ba4a6-3928-40a3-afc3-9b6c7929afb0" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities_2f8ba4a6-3928-40a3-afc3-9b6c7929afb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c04ab06d-4838-46d8-987e-b0a7288138c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c04ab06d-4838-46d8-987e-b0a7288138c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4ae4294b-dd97-4099-b088-42d902a2d594" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4ae4294b-dd97-4099-b088-42d902a2d594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ebe69615-e1dc-4f7a-9ff1-2615d44e7da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ebe69615-e1dc-4f7a-9ff1-2615d44e7da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_b43aa41d-a678-4712-abba-fed24c687968" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_b43aa41d-a678-4712-abba-fed24c687968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eec5ca10-d89c-4d10-9809-85c26e536a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eec5ca10-d89c-4d10-9809-85c26e536a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_03e52ca7-c511-49d3-927f-949743a7361f" xlink:href="bhg-20210930.xsd#bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired_03e52ca7-c511-49d3-927f-949743a7361f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c44c938b-8dec-4849-a336-685192ffd10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_Goodwill_c44c938b-8dec-4849-a336-685192ffd10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6be1e459-70b3-4e5f-b866-8f483bb3a911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6be1e459-70b3-4e5f-b866-8f483bb3a911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d136178b-4b3a-41f1-98b6-b29cdd99e2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d136178b-4b3a-41f1-98b6-b29cdd99e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea6e42ad-638f-4159-92bd-a3e6cacf04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ea6e42ad-638f-4159-92bd-a3e6cacf04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7e3e3716-481c-4afa-ad66-0104c9035415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7e3e3716-481c-4afa-ad66-0104c9035415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_235f075d-9f7f-438c-8992-5655187909ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_cba581c5-c2e2-4a48-8e33-e84b53aadf04" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_235f075d-9f7f-438c-8992-5655187909ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e28de1c3-f461-4c6e-986c-9aa570d229ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e28de1c3-f461-4c6e-986c-9aa570d229ed" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a14ca8c3-0040-48b4-a2cc-3090615aa6e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_0d377a40-757f-4b42-8ae5-66579fcc7878" xlink:href="bhg-20210930.xsd#bhg_CentralHealthPlanOfCaliforniaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_CentralHealthPlanOfCaliforniaIncMember_0d377a40-757f-4b42-8ae5-66579fcc7878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_THNMAndZipnosisMember_109d3ec2-1071-4abc-8ac2-89b1779ac577" xlink:href="bhg-20210930.xsd#bhg_THNMAndZipnosisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_THNMAndZipnosisMember_109d3ec2-1071-4abc-8ac2-89b1779ac577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_90ba0a9c-a9a9-4d32-8d41-8fae4cf3f6c3" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c253aafd-4cef-4995-9bb8-cf5b361895fe" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_90ba0a9c-a9a9-4d32-8d41-8fae4cf3f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_cba29d8a-9e85-4904-b6fd-4978afb912ce" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0250d8e1-3c07-475f-9b12-d118374cfc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0250d8e1-3c07-475f-9b12-d118374cfc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2c010375-a3ab-4d71-bf0f-f5f4ccddf672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_eb24ec01-efbc-4458-8a3c-05f4ef72e5e2" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2c010375-a3ab-4d71-bf0f-f5f4ccddf672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTS" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8b214b89-b3f1-42fb-9669-3d6cfb26cfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9cac321c-d4f8-4db5-bd28-fb4af2bb26b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8b214b89-b3f1-42fb-9669-3d6cfb26cfa9" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9cac321c-d4f8-4db5-bd28-fb4af2bb26b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_26f57980-f0a0-40d5-af33-c9ca6064bdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_b13b6369-22a4-4280-8a6a-a4895bf42374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_26f57980-f0a0-40d5-af33-c9ca6064bdee" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_b13b6369-22a4-4280-8a6a-a4895bf42374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesTextBlock_80a1a496-d447-45d8-aaa5-547d601530d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_26f57980-f0a0-40d5-af33-c9ca6064bdee" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesTextBlock_80a1a496-d447-45d8-aaa5-547d601530d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_35984ced-d296-4423-98a0-f69961ca634b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_26f57980-f0a0-40d5-af33-c9ca6064bdee" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_35984ced-d296-4423-98a0-f69961ca634b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_66805691-2cbb-4cb8-b38d-f7ba49bba99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_26f57980-f0a0-40d5-af33-c9ca6064bdee" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_66805691-2cbb-4cb8-b38d-f7ba49bba99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1ad9461-1ffd-43a2-a5f1-310e9ddb67bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b7008590-bfbb-4bfe-87a1-610b0156d82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b7008590-bfbb-4bfe-87a1-610b0156d82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d95a93df-f7a3-46e7-933e-6b215355e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d95a93df-f7a3-46e7-933e-6b215355e75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_8d4ced04-01c4-46d6-b6fa-dc396ec6334e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_8d4ced04-01c4-46d6-b6fa-dc396ec6334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_67ceff7d-b99d-4aa0-bbf0-8235967e9fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_67ceff7d-b99d-4aa0-bbf0-8235967e9fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_f1ee484c-4507-4259-80cd-5a7777b53e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_CertificatesOfDepositMember_f1ee484c-4507-4259-80cd-5a7777b53e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_1397dbd8-d504-4b67-83c5-8d53355763ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_1397dbd8-d504-4b67-83c5-8d53355763ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_4d58451a-e63c-4d9b-95e4-dd28c9f270c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4655246f-7ca0-4d12-9cbf-c9a0c5c28a09" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_4d58451a-e63c-4d9b-95e4-dd28c9f270c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1c833c9e-5867-4f20-9945-da5be4eea6cf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_f944fd01-8777-41d5-bb57-98301de7f186" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost_f944fd01-8777-41d5-bb57-98301de7f186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5fa2963d-cb99-4855-8dd5-6a7e076be4fb" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5fa2963d-cb99-4855-8dd5-6a7e076be4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4b5a7c-eef3-4cdb-a3a3-042caefaa3e8" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4b5a7c-eef3-4cdb-a3a3-042caefaa3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_8eb91c42-2347-4aa9-ad0d-73d71fa4f8fa" xlink:href="bhg-20210930.xsd#bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities_8eb91c42-2347-4aa9-ad0d-73d71fa4f8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a1f7e12-bd35-4687-96f3-32482b9ac7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a1f7e12-bd35-4687-96f3-32482b9ac7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8ea50541-954e-433a-a65e-75bc4473af0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8ea50541-954e-433a-a65e-75bc4473af0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5b1b1103-23d9-49a6-98bb-5b0e5d5ddd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5b1b1103-23d9-49a6-98bb-5b0e5d5ddd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_548c103d-d1d5-4157-b306-f32b0229eda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_661bd0b6-9ab6-4ef7-8ef8-fc07e309b8d7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_548c103d-d1d5-4157-b306-f32b0229eda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f6fc266-9436-4797-86f7-de7a6a795fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f6fc266-9436-4797-86f7-de7a6a795fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_775f2198-e7f6-4376-91b6-f27f874280a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_8758f813-736c-47fd-9da8-cd58b6656d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_3b8827bf-e374-42e6-b656-0628940db084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f44457a8-b5c1-43e7-94f1-a63ec0911839" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShortTermAndLongTermInvestmentsMember_664e5fd9-2cc9-4558-a1b8-251186816893" xlink:href="bhg-20210930.xsd#bhg_ShortTermAndLongTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d4bf7512-a3d9-4268-90ca-6f9df67ab53c" xlink:to="loc_bhg_ShortTermAndLongTermInvestmentsMember_664e5fd9-2cc9-4558-a1b8-251186816893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_03356859-cd3a-4520-b391-899dbe4b812c" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_493d61a9-46bc-4634-9306-ca20f8f5974b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_493d61a9-46bc-4634-9306-ca20f8f5974b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_e3f6b25a-bc17-48b3-872d-7b512c6b20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_e3f6b25a-bc17-48b3-872d-7b512c6b20d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_4d15341e-b223-489c-b785-d53ffff24c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_3d464d51-4a60-496b-ab1e-51ce8f380210" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_4d15341e-b223-489c-b785-d53ffff24c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_fa45fef5-4cf0-409d-a81f-2b5c99a419aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_fa45fef5-4cf0-409d-a81f-2b5c99a419aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_7e90b87c-ba0c-485a-a312-253e3126f34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain_7e90b87c-ba0c-485a-a312-253e3126f34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_5248ec5f-01d7-474a-aaa0-869c231b85fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss_5248ec5f-01d7-474a-aaa0-869c231b85fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_74588a66-a959-4526-aa9e-9b027677ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_db15637b-f23b-4995-a012-f2f8af7bb13d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue_74588a66-a959-4526-aa9e-9b027677ab88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5aa34575-213e-49f2-b67e-5c85ba130106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5aa34575-213e-49f2-b67e-5c85ba130106" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_97b96bf1-5fd1-417e-baff-527134dc2b86" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_141661ea-3bde-4e92-ac1c-6d150098f4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_141661ea-3bde-4e92-ac1c-6d150098f4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_71adfd52-aed7-4d46-8e54-dc99d5f79848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_71adfd52-aed7-4d46-8e54-dc99d5f79848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4bf6c135-d7c7-4146-a44b-44a1ce1ef59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_4bf6c135-d7c7-4146-a44b-44a1ce1ef59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_6d380b58-0282-4b1a-9216-287db32b7d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_6d380b58-0282-4b1a-9216-287db32b7d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_fe783adc-0dbf-4061-9c45-96d557fedcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_fe783adc-0dbf-4061-9c45-96d557fedcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_0adda21d-e67a-4ae8-87a2-c46b154b413f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdfb9e0a-d3c0-439e-97c2-856e42f227e9" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_0adda21d-e67a-4ae8-87a2-c46b154b413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6145ebb3-52e3-47ab-95cc-a59f04a15a4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_33d08e91-4512-407b-88a4-56842e60d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_33d08e91-4512-407b-88a4-56842e60d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShortTermAndLongTermInvestmentsMember_f247c5cc-fc8a-4153-a157-6f60c8c773b8" xlink:href="bhg-20210930.xsd#bhg_ShortTermAndLongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e32ac9-f216-48fb-ba95-ef2293fad726" xlink:to="loc_bhg_ShortTermAndLongTermInvestmentsMember_f247c5cc-fc8a-4153-a157-6f60c8c773b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c0fe238b-bec6-42a7-bc68-8afdf79d00b2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_bed725ab-8596-4d3f-971b-455c9e454d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_bed725ab-8596-4d3f-971b-455c9e454d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_50306641-dbed-466c-80f1-c9d0ccf2f884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_50306641-dbed-466c-80f1-c9d0ccf2f884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7100ca73-5de6-4341-9e23-03578548ba6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7100ca73-5de6-4341-9e23-03578548ba6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_74e7ffba-ff22-4ca2-aaef-517a2ed988b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_74e7ffba-ff22-4ca2-aaef-517a2ed988b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_42e81caa-1e65-4610-b49d-b7f641469d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_42e81caa-1e65-4610-b49d-b7f641469d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f1d74d47-6282-46ed-be17-19197f095fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_58ccfc13-5838-4455-89de-5623778b56be" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f1d74d47-6282-46ed-be17-19197f095fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6195114b-02a7-4a58-88ea-ca7979245c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6195114b-02a7-4a58-88ea-ca7979245c50" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b0397bce-eb88-4025-8980-ac94ec675fb4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_30f1bc81-17b8-4c56-977f-e461dd2a2f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3ad0f440-eaf1-421e-a96b-69442dd9ae1b" xlink:to="loc_us-gaap_DebtSecuritiesMember_30f1bc81-17b8-4c56-977f-e461dd2a2f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6accd9e0-b017-476f-bd39-c53117d98d1c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_cddc5bf0-7399-4917-bb7e-32ff20f6ff77" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions_cddc5bf0-7399-4917-bb7e-32ff20f6ff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_1a8b530f-2777-45c3-8cc8-fb51ba498027" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments_1a8b530f-2777-45c3-8cc8-fb51ba498027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_9ab10281-704e-4d9c-912b-861070ab717c" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_InvestmentIncomeLoss_9ab10281-704e-4d9c-912b-861070ab717c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesRealizedGainLoss_03987a9d-d1f9-4cdf-941a-2cc1e29ec1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_DebtSecuritiesRealizedGainLoss_03987a9d-d1f9-4cdf-941a-2cc1e29ec1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_EquitySecuritiesFVNISharesPurchased_b71f7a57-4e9d-4913-9921-9e5e5eda67db" xlink:href="bhg-20210930.xsd#bhg_EquitySecuritiesFVNISharesPurchased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_bhg_EquitySecuritiesFVNISharesPurchased_b71f7a57-4e9d-4913-9921-9e5e5eda67db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_6284fc2f-2007-42ca-b4cb-6f6ad86ac07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_6284fc2f-2007-42ca-b4cb-6f6ad86ac07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7fa37f5b-f816-4989-9337-e661e061aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7fa37f5b-f816-4989-9337-e661e061aca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_418ce551-a312-4e77-894b-5dc366cb6ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_08eb10e8-33f1-4297-a30c-b6be753e7dae" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_418ce551-a312-4e77-894b-5dc366cb6ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_883ba66d-d2f8-444c-9e44-10267cb451fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_883ba66d-d2f8-444c-9e44-10267cb451fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_7b5f819c-585c-4692-adf8-4d6a99cbd1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_7b5f819c-585c-4692-adf8-4d6a99cbd1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bb3c3c7e-f166-469f-87fa-7090509934d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bb3c3c7e-f166-469f-87fa-7090509934d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c99e6fb1-e7fd-4fed-8f90-3a3fca8e561d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c99e6fb1-e7fd-4fed-8f90-3a3fca8e561d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4a5e90dd-d33b-4019-96c8-91b46e19dfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4a5e90dd-d33b-4019-96c8-91b46e19dfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a9234884-9fa8-4b7e-8af5-6695356b91bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_869109fa-8e18-4bd2-afb6-a93b9ebfb5c4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a9234884-9fa8-4b7e-8af5-6695356b91bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_883ba66d-d2f8-444c-9e44-10267cb451fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d29d21c4-bafe-4069-bcfe-e6b8d7452279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d29d21c4-bafe-4069-bcfe-e6b8d7452279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_13228553-2f0b-473a-a98c-baf63a31d411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_13228553-2f0b-473a-a98c-baf63a31d411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bfe652c7-dd30-4435-8896-978c3e331678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bfe652c7-dd30-4435-8896-978c3e331678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e0a5a755-b0e0-4cbd-9d75-937f7a3ecfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e0a5a755-b0e0-4cbd-9d75-937f7a3ecfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_95d04440-6167-4512-838e-237573197783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_ca79a0d9-9609-4c64-8589-c0f7803fd6ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_95d04440-6167-4512-838e-237573197783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8e50a865-867a-4197-8924-030bc0a9bc21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f7b63a99-c19e-49a8-a4a2-4067325b84e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8e50a865-867a-4197-8924-030bc0a9bc21" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f7b63a99-c19e-49a8-a4a2-4067325b84e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4ebe585a-430a-4104-b7c0-619478abc48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b842766f-062f-489b-b5c3-9137fb2b76be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ebe585a-430a-4104-b7c0-619478abc48d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b842766f-062f-489b-b5c3-9137fb2b76be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_6954bf87-9709-4acd-9ea2-f6f0aa0b11b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ebe585a-430a-4104-b7c0-619478abc48d" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_6954bf87-9709-4acd-9ea2-f6f0aa0b11b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a29d49b9-b082-44f9-a5e9-bac56ba0c99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ebe585a-430a-4104-b7c0-619478abc48d" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a29d49b9-b082-44f9-a5e9-bac56ba0c99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b385a67f-080e-4a25-8923-9f8e63dae82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b385a67f-080e-4a25-8923-9f8e63dae82b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10a240a6-6498-4154-8b49-ec92a8b4547e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_60443a75-ae9a-445d-a1fd-418fcc60461d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9f824a4-a3bc-428f-a94d-e22248b632ce" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_60443a75-ae9a-445d-a1fd-418fcc60461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d50ec95-2593-4e6e-8399-90f11abc523d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6e1ab09c-ae54-48d8-8950-9714b2339989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6e1ab09c-ae54-48d8-8950-9714b2339989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d4e9d9e0-649f-4ab0-b0e9-c128ca4d51f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d4e9d9e0-649f-4ab0-b0e9-c128ca4d51f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2fcd2a6f-e3b7-41d1-9a4b-8b29e937eb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e922d43-b330-4bda-99c9-ec7c46327ad9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2fcd2a6f-e3b7-41d1-9a4b-8b29e937eb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3129dd0c-3b02-448f-8669-a56cdadc8715" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1f38b5d4-9903-49bf-979a-47a7e802ffde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1f38b5d4-9903-49bf-979a-47a7e802ffde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8098fb34-8f30-44ca-a1ae-d92515d93b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8098fb34-8f30-44ca-a1ae-d92515d93b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_749e9feb-1cb5-40ee-a88c-78ad1cc74f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_749e9feb-1cb5-40ee-a88c-78ad1cc74f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_1da32e01-85fd-43e3-bf6f-09b23654cbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_1da32e01-85fd-43e3-bf6f-09b23654cbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1fc45918-4ba5-4b73-9439-383491de3ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1fc45918-4ba5-4b73-9439-383491de3ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_4705f7be-4928-4472-a7c6-93ac3e9a1ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_4705f7be-4928-4472-a7c6-93ac3e9a1ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dd7f895f-fcab-42ab-9042-f6de8ed73ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_33585db4-66e3-4111-9806-c2a5508f2f16" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dd7f895f-fcab-42ab-9042-f6de8ed73ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8613f41e-c9bd-4d54-8ac9-3085859696d0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc381515-7452-4bad-b671-3a21632e1674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc381515-7452-4bad-b671-3a21632e1674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49fe9514-2523-4637-be84-67d01d4b7ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49fe9514-2523-4637-be84-67d01d4b7ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_802b355d-8058-4d58-b232-123d5de67116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_802b355d-8058-4d58-b232-123d5de67116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bf42eb83-4d68-41fe-827d-9b11188ac055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bf42eb83-4d68-41fe-827d-9b11188ac055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd646c4e-d012-45d2-b3f0-e2050786bf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_152411bf-d32b-41d6-9419-d3dbba1c0001" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd646c4e-d012-45d2-b3f0-e2050786bf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_722e675b-6451-4921-ba3b-5f8a7d4ec1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_722e675b-6451-4921-ba3b-5f8a7d4ec1d1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b4de6ada-6b73-4806-94dd-de6e68f3c68f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c9fff374-a337-4044-90b6-586b4f3b7347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c9fff374-a337-4044-90b6-586b4f3b7347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_96a0c874-8aa9-48c8-b6b3-9c0e84ac783a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_96a0c874-8aa9-48c8-b6b3-9c0e84ac783a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_67e5990f-bca6-4097-b712-f80b43404f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43668bd2-f204-4eb2-b335-7c00eafad677" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_67e5990f-bca6-4097-b712-f80b43404f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_12bd7909-797c-4dc4-826b-c1c22307c9f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5f715f5b-45f5-4cb6-b68b-8cb0e180c8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_5f715f5b-45f5-4cb6-b68b-8cb0e180c8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_a8c5c027-146e-489a-bfea-7171df98fd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54fc3560-5240-4ff4-8626-9d43ac479b17" xlink:to="loc_us-gaap_CertificatesOfDepositMember_a8c5c027-146e-489a-bfea-7171df98fd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a52613e-075c-49c6-bf9d-8201c4728aa4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_96b54611-da4b-439a-8c67-3133fbc946c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_96b54611-da4b-439a-8c67-3133fbc946c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_420ac0e5-51da-49f1-a7ba-ca721b68e03f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_420ac0e5-51da-49f1-a7ba-ca721b68e03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_db94cbfb-08c5-417f-97a3-a49806bccaf5" xlink:href="bhg-20210930.xsd#bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95878a88-5cd0-4ba7-ba00-408b6b82e367" xlink:to="loc_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue_db94cbfb-08c5-417f-97a3-a49806bccaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5e726c60-d36b-4106-9376-8ccf9d525d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5e726c60-d36b-4106-9376-8ccf9d525d41" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_21f721bd-6a9f-4916-bd70-aa25c12cd651" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ContingentConsiderationLiabilityMember_f187441d-132d-46b3-a424-5d4e9707c422" xlink:href="bhg-20210930.xsd#bhg_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_13fd9fac-fc7e-429a-a252-0bc9dbb1f797" xlink:to="loc_bhg_ContingentConsiderationLiabilityMember_f187441d-132d-46b3-a424-5d4e9707c422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d504769a-cf12-43a5-9749-c9fb31947116" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cf64ed8-6665-4658-acb5-a976ab58c5e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83a9e5c9-5895-4c8f-8134-060114c341f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_83a9e5c9-5895-4c8f-8134-060114c341f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_122bbac2-0a60-4645-a084-1c44af9801b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_122bbac2-0a60-4645-a084-1c44af9801b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f34651af-bd37-4d79-8726-4fcc2c5cc0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_dea4f519-3683-43de-ae1e-6b4506c1037a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f34651af-bd37-4d79-8726-4fcc2c5cc0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_38e2fd2d-4703-4641-b165-5d7958bc76da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f980e0b8-6ad5-42be-ad9c-8118ba3a77b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_38e2fd2d-4703-4641-b165-5d7958bc76da" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f980e0b8-6ad5-42be-ad9c-8118ba3a77b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f7cc718-06c9-4048-8c8e-b14dcbfc93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_188aac54-bd75-42bf-967b-d623484a8608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f7cc718-06c9-4048-8c8e-b14dcbfc93a6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_188aac54-bd75-42bf-967b-d623484a8608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5caab3c3-42a3-44b1-9405-5d8719bb35b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f7cc718-06c9-4048-8c8e-b14dcbfc93a6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5caab3c3-42a3-44b1-9405-5d8719bb35b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_a60174ad-ea3d-4f8a-ba2c-f55f689a41cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f7cc718-06c9-4048-8c8e-b14dcbfc93a6" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_a60174ad-ea3d-4f8a-ba2c-f55f689a41cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f46d2412-481a-4b05-af42-62deeec42146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f7cc718-06c9-4048-8c8e-b14dcbfc93a6" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f46d2412-481a-4b05-af42-62deeec42146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff48a5fa-a11b-4406-8646-c16cc276ee57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff48a5fa-a11b-4406-8646-c16cc276ee57" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cdb980fb-7072-44f0-a9b3-7de2ec21da16" xlink:to="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BrightHealthCareMember_0f6a6aa6-5dde-4e3f-8fdc-e1935512d18e" xlink:href="bhg-20210930.xsd#bhg_BrightHealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:to="loc_bhg_BrightHealthCareMember_0f6a6aa6-5dde-4e3f-8fdc-e1935512d18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NeueHealthMember_047de5e6-1b8c-4f09-9f59-2317210287d2" xlink:href="bhg-20210930.xsd#bhg_NeueHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc0abf21-4ac9-4158-8243-d8533bf92b11" xlink:to="loc_bhg_NeueHealthMember_047de5e6-1b8c-4f09-9f59-2317210287d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fd6c118d-a573-4e18-b86e-8ec692943b7e" xlink:to="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_99e755b7-c8ef-4f23-a534-989b2b2035d2" xlink:to="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_7036a7de-2a6d-42c9-a4fa-918868528e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillGross_7036a7de-2a6d-42c9-a4fa-918868528e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a4edf6a2-9e3a-4764-bdbe-bc9da700f26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a4edf6a2-9e3a-4764-bdbe-bc9da700f26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1b319736-cbab-4580-8a27-2af8b082f9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1b319736-cbab-4580-8a27-2af8b082f9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_47b407ed-820e-4c31-b407-853ca6537301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillGross_47b407ed-820e-4c31-b407-853ca6537301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_36f18eda-db03-43a5-81a2-6c7288ea86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_36f18eda-db03-43a5-81a2-6c7288ea86fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_364a8372-e659-4d88-9858-40de35053ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_dfdf5a4b-0771-4759-ab98-99137ef720ec" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_364a8372-e659-4d88-9858-40de35053ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df6f150b-f521-4569-a95a-5f51d3b3ea97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df6f150b-f521-4569-a95a-5f51d3b3ea97" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63778909-fa00-4406-9974-ce9f8c5f1dc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_55069ae7-586d-4fa6-9d8d-836d71f17740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_55069ae7-586d-4fa6-9d8d-836d71f17740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_53fb8f0a-3bc4-452a-a66c-7802937d575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_TradeNamesMember_53fb8f0a-3bc4-452a-a66c-7802937d575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_31755e01-c132-40b7-8b6a-6a977dc3307e" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_bhg_ReacquiredContractsMember_31755e01-c132-40b7-8b6a-6a977dc3307e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d5a96782-77a8-43a8-9c6f-51ff4bb14bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d5a96782-77a8-43a8-9c6f-51ff4bb14bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_7e80e70d-add7-4355-9b46-d2c5010bf23e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6fbfef0b-c97f-40d0-85ef-fa371dcbfa4a" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_7e80e70d-add7-4355-9b46-d2c5010bf23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_03678327-7214-4bef-b3ed-229ccfd6ef0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_de114207-396f-486a-975a-8f031106c37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_de114207-396f-486a-975a-8f031106c37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca625490-3655-4395-b5b2-e5a2767ba94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3167a19d-81d4-43e5-94ca-4aaa540c3969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca625490-3655-4395-b5b2-e5a2767ba94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b3255822-e95c-49b9-8c67-4af4d51eae1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b3255822-e95c-49b9-8c67-4af4d51eae1d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_84698143-baea-4260-864b-46388f84631f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9279ec43-bc5f-454e-b395-eb416cb20e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9279ec43-bc5f-454e-b395-eb416cb20e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3c8d8093-76dc-45ca-8d01-371243345c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_TradeNamesMember_3c8d8093-76dc-45ca-8d01-371243345c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ReacquiredContractsMember_92420b15-8670-413a-908b-91aa445074f6" xlink:href="bhg-20210930.xsd#bhg_ReacquiredContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_bhg_ReacquiredContractsMember_92420b15-8670-413a-908b-91aa445074f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_928c0117-76fe-44ff-ad76-f96dc762bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_928c0117-76fe-44ff-ad76-f96dc762bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f464f97c-52ef-47bd-81ba-d8b4d082e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7896947-98f5-4ee8-9c02-2a234035c0c0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f464f97c-52ef-47bd-81ba-d8b4d082e78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5a76b1b1-b3de-4e19-870d-898018608a7c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_bdfa11ea-2d0e-426e-8f80-17a40839ae8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_bdfa11ea-2d0e-426e-8f80-17a40839ae8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b5ddb361-5b16-46cd-a216-a03325e4358f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e067ee3-fd9c-4931-87b7-1ea5940b3318" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b5ddb361-5b16-46cd-a216-a03325e4358f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6917099b-87b3-4fbd-9c6d-84c022a2e6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6917099b-87b3-4fbd-9c6d-84c022a2e6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3df4d9c0-b7f9-4b86-8741-1a7cc6da6e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3df4d9c0-b7f9-4b86-8741-1a7cc6da6e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c11885d9-b4d7-4616-9c21-1d0278533660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c11885d9-b4d7-4616-9c21-1d0278533660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_485907d3-a6af-471e-803a-84676c011c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_485907d3-a6af-471e-803a-84676c011c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_13469b87-d794-4801-a0fd-9b0d4413eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_13469b87-d794-4801-a0fd-9b0d4413eb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba6d82bc-8df4-466b-bbec-53615888ce02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba6d82bc-8df4-466b-bbec-53615888ce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fdb329d7-eb8d-49e5-8070-80a8cc7ad3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e889d3d-828a-40a9-bbb8-7ab8b11762ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fdb329d7-eb8d-49e5-8070-80a8cc7ad3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLE"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_aae5cbd3-450b-4a31-9ee9-2f4469cf7f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock_094f83fb-9be7-4315-9d0f-6bdf3f418175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_aae5cbd3-450b-4a31-9ee9-2f4469cf7f4b" xlink:to="loc_us-gaap_InsuranceDisclosureTextBlock_094f83fb-9be7-4315-9d0f-6bdf3f418175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a9c8605b-e8c2-44d7-b460-bc302858d8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8e2988f9-f9d4-4719-9e46-69c0c4a57df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a9c8605b-e8c2-44d7-b460-bc302858d8d1" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8e2988f9-f9d4-4719-9e46-69c0c4a57df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_d7b27576-3210-4fc6-8bcb-7da1cc4b0000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d7b27576-3210-4fc6-8bcb-7da1cc4b0000" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_13bf021b-63b7-4a02-95a8-00200e42d873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_13bf021b-63b7-4a02-95a8-00200e42d873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_37ba673f-4064-4a3d-993c-f835c89e7e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_37ba673f-4064-4a3d-993c-f835c89e7e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_c65486f0-181b-44f2-bcf5-4dce0ba3b853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_37ba673f-4064-4a3d-993c-f835c89e7e82" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_c65486f0-181b-44f2-bcf5-4dce0ba3b853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_e60721fc-44ba-4eb6-b455-0faa3cfdf927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_37ba673f-4064-4a3d-993c-f835c89e7e82" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_e60721fc-44ba-4eb6-b455-0faa3cfdf927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64d07330-96e6-4afc-a1e9-12742a10441c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_37ba673f-4064-4a3d-993c-f835c89e7e82" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64d07330-96e6-4afc-a1e9-12742a10441c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a501d6c1-9203-4644-8b16-bea67b16c390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a501d6c1-9203-4644-8b16-bea67b16c390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_5447eef9-70dd-4b59-adb6-6e3c17ab98ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a501d6c1-9203-4644-8b16-bea67b16c390" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_5447eef9-70dd-4b59-adb6-6e3c17ab98ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3641559a-0321-41ce-a24b-d110cebce318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a501d6c1-9203-4644-8b16-bea67b16c390" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3641559a-0321-41ce-a24b-d110cebce318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_0c27ecf5-b530-4a4a-8417-17fdf596578c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a501d6c1-9203-4644-8b16-bea67b16c390" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_0c27ecf5-b530-4a4a-8417-17fdf596578c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_61f78cb2-22fb-4060-88f9-f2f2495df257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_61f78cb2-22fb-4060-88f9-f2f2495df257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ac78f126-47bf-442f-bf92-89c15464bafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_8b531baa-5411-4ed2-9de1-a5067de5daf7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ac78f126-47bf-442f-bf92-89c15464bafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_7d60fff9-5856-4b06-9e15-b98c92df2d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_35fd7906-a675-4ee8-b258-d1ce275015b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7d60fff9-5856-4b06-9e15-b98c92df2d1d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_35fd7906-a675-4ee8-b258-d1ce275015b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_67de59cc-6581-472d-99fa-0b391b98e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_67de59cc-6581-472d-99fa-0b391b98e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_caa416e0-f1b9-4c41-acb6-86f053fa95c3" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:to="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable_caa416e0-f1b9-4c41-acb6-86f053fa95c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_cf70150d-70ce-4026-980b-776593c7ab5e" xlink:href="bhg-20210930.xsd#bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:to="loc_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability_cf70150d-70ce-4026-980b-776593c7ab5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_eeb0fce8-0349-4d5c-a0ae-e479bd879f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_eeb0fce8-0349-4d5c-a0ae-e479bd879f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_31700407-c033-481c-aebd-d33d36d0b214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_230498c5-8e6f-4670-a4f4-40fe9ba45ecd" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_31700407-c033-481c-aebd-d33d36d0b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHORTTERMBORROWINGS"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9cf92e4e-0ff0-453f-b087-e68ee5b25dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_c7ef80e6-7c7a-41f2-b9a4-6f9c199feaae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9cf92e4e-0ff0-453f-b087-e68ee5b25dda" xlink:to="loc_us-gaap_ShortTermDebtTextBlock_c7ef80e6-7c7a-41f2-b9a4-6f9c199feaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHORTTERMBORROWINGSDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cb6ee642-7c13-4f9d-b7c1-6bb19a454461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cb6ee642-7c13-4f9d-b7c1-6bb19a454461" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:to="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6f080be0-d97b-4706-9f41-f4a1760cdb01" xlink:to="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c750532c-7105-4335-818a-9b926e5ff867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fdee7158-aaf8-451e-a61b-ea8cc9487cfc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c750532c-7105-4335-818a-9b926e5ff867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e6c8ac97-a477-4401-b346-29bf3522429d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_13127ea8-a360-433d-b763-e998d2630a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_f05a757b-f8eb-4dfa-ac73-1e0a0dc1bd55" xlink:to="loc_us-gaap_LineOfCreditMember_13127ea8-a360-433d-b763-e998d2630a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_538ca3dc-c9db-47a2-9613-b688369a1566" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c8e2f0b9-f8a9-45d2-ae1e-91187f2d5f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c8e2f0b9-f8a9-45d2-ae1e-91187f2d5f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_0f1bf1d2-6ea6-437f-9908-413a82b7b14a" xlink:href="bhg-20210930.xsd#bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate_0f1bf1d2-6ea6-437f-9908-413a82b7b14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_bc0474d4-1b75-4a64-a6ae-fe61ffa0bf7b" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO_bc0474d4-1b75-4a64-a6ae-fe61ffa0bf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_cf4dd80e-c6d6-4d3e-93c5-fca5dc5be3f6" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO_cf4dd80e-c6d6-4d3e-93c5-fca5dc5be3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_2a917b2e-a6ae-41c5-be4d-8dc3d7e78ddd" xlink:href="bhg-20210930.xsd#bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio_2a917b2e-a6ae-41c5-be4d-8dc3d7e78ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_320b7693-1da0-4973-b13a-561ff2842442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_320b7693-1da0-4973-b13a-561ff2842442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseShortTermBorrowings_21f8a44a-f7d5-466a-b7e5-02cc9c720713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseShortTermBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_197fbc6f-a6c4-4c63-8131-6b90213da67f" xlink:to="loc_us-gaap_InterestExpenseShortTermBorrowings_21f8a44a-f7d5-466a-b7e5-02cc9c720713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_499d4f9c-82a7-4a43-9a76-9d1e0d48a5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_aaa5ba26-a913-4767-be7a-66b00d39eede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_499d4f9c-82a7-4a43-9a76-9d1e0d48a5eb" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_aaa5ba26-a913-4767-be7a-66b00d39eede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513aa4d2-7360-48d9-b11e-0a96a889b044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6c1607b9-d5bc-45fd-9c74-2d8c23142b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513aa4d2-7360-48d9-b11e-0a96a889b044" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6c1607b9-d5bc-45fd-9c74-2d8c23142b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_07d1499f-09da-4842-977e-78545547c213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513aa4d2-7360-48d9-b11e-0a96a889b044" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_07d1499f-09da-4842-977e-78545547c213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f3f9a28b-3792-4890-afec-647b796ddeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513aa4d2-7360-48d9-b11e-0a96a889b044" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f3f9a28b-3792-4890-afec-647b796ddeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_b8544976-1ec4-4e1e-bf4f-772b78ed6cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513aa4d2-7360-48d9-b11e-0a96a889b044" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_b8544976-1ec4-4e1e-bf4f-772b78ed6cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bff32c84-b177-45c1-977c-56e5b4bed061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bff32c84-b177-45c1-977c-56e5b4bed061" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:to="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_43525e04-a838-4a10-8d10-791d97667e1f" xlink:to="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b43e8576-c1d0-40b0-8dd2-7cc8a7199395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b43e8576-c1d0-40b0-8dd2-7cc8a7199395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1e81418-32cc-4872-b078-894ad747f211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_61c66e46-d7e3-4d2d-9a5d-a216e728d6dd" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1e81418-32cc-4872-b078-894ad747f211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:to="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4c1c8582-6ff0-43b6-ba8a-213d5679e5fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a4363440-2f72-45cc-b491-1a3913218d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a4363440-2f72-45cc-b491-1a3913218d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e3bc1cd8-c09f-4b09-9fda-c019cd609df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e3bc1cd8-c09f-4b09-9fda-c019cd609df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3ecb20ee-0ac0-46b4-a01a-a40ac9213b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53086d05-c08f-4d82-a2f2-8e715b08ba19" xlink:to="loc_us-gaap_PerformanceSharesMember_3ecb20ee-0ac0-46b4-a01a-a40ac9213b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b0b0341-d363-4805-9325-d1c87aecec45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_da183675-d06b-46e0-b233-f2d4648568f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_da183675-d06b-46e0-b233-f2d4648568f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8c74d60c-ca83-4f8b-a9e5-c807da9ea3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8c74d60c-ca83-4f8b-a9e5-c807da9ea3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c9a06930-022b-44ad-bd26-00a4ba66a10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c9a06930-022b-44ad-bd26-00a4ba66a10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0a046da8-0ae1-432b-9d3a-dff11c28069b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0a046da8-0ae1-432b-9d3a-dff11c28069b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d7113f17-8a19-43ab-b11d-99e6f51c8321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d7113f17-8a19-43ab-b11d-99e6f51c8321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_edc04bd0-692f-4bbd-942c-4a97767aa38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_edc04bd0-692f-4bbd-942c-4a97767aa38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22bac9d9-0f0e-444e-801a-4ca2f9be3163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_22bac9d9-0f0e-444e-801a-4ca2f9be3163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_41729bcc-3362-4c4a-b98d-1824fa795600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_41729bcc-3362-4c4a-b98d-1824fa795600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd0b42aa-83c1-4549-bda7-e3d30358efed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bd0b42aa-83c1-4549-bda7-e3d30358efed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e9ad72fc-9601-43dc-902f-f26848874090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e9ad72fc-9601-43dc-902f-f26848874090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dfdbb2f2-3997-4e26-a701-4a5a06cc2eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dfdbb2f2-3997-4e26-a701-4a5a06cc2eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_3dbc30c9-f61a-4d89-86b1-fa8da73f2175" xlink:href="bhg-20210930.xsd#bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_3dbc30c9-f61a-4d89-86b1-fa8da73f2175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_c40b5bd7-4712-40d6-b557-746e8534e958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6d84174-06f2-4ef9-a7b4-d99f00c7f111" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_c40b5bd7-4712-40d6-b557-746e8534e958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ba018ad-a1cc-4299-b7da-53ba57758b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ba018ad-a1cc-4299-b7da-53ba57758b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc4272d7-ddb6-45fe-8878-c90a3c0c61fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc4272d7-ddb6-45fe-8878-c90a3c0c61fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_44589009-8035-499b-afba-5790dbb5b19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_44589009-8035-499b-afba-5790dbb5b19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_53e3bcbf-5ba8-42db-b2e4-198f62bb8c87" xlink:href="bhg-20210930.xsd#bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:to="loc_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_53e3bcbf-5ba8-42db-b2e4-198f62bb8c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_03be3053-8bc1-420a-9603-471b9be113ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b2521a-9c0c-4161-b504-532bf377eb55" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_03be3053-8bc1-420a-9603-471b9be113ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8b64dad-23d6-4545-b335-e0f2efbf0f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8b64dad-23d6-4545-b335-e0f2efbf0f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d9641408-2e9c-4d0f-9b85-a78bc93e09ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d9641408-2e9c-4d0f-9b85-a78bc93e09ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a6a13250-76e1-40b0-88a7-d954d8d78659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a6a13250-76e1-40b0-88a7-d954d8d78659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4efa4dc1-07da-42aa-a3d2-aa6bfce1c4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4efa4dc1-07da-42aa-a3d2-aa6bfce1c4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9cad12b3-52e4-420c-b704-8a0089ea7f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9cad12b3-52e4-420c-b704-8a0089ea7f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_26790062-e256-450b-bc99-35df51f0d011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_26790062-e256-450b-bc99-35df51f0d011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f73f5d74-050c-419d-b94f-5f83c1745e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a322b726-d9c0-4bf8-bda4-19c32b373634" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f73f5d74-050c-419d-b94f-5f83c1745e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8b64dad-23d6-4545-b335-e0f2efbf0f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4c5801f4-9709-4540-abf5-006ec531dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4c5801f4-9709-4540-abf5-006ec531dbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9db0fe31-522d-4b32-b686-81fa97bcb507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9db0fe31-522d-4b32-b686-81fa97bcb507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3aeca6b9-1b36-4d98-a734-dfebc6f145c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3aeca6b9-1b36-4d98-a734-dfebc6f145c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1a499e62-e5a9-4b1e-89a1-75c66b9fc9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1a499e62-e5a9-4b1e-89a1-75c66b9fc9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7e50535e-e9b8-4e25-a8ae-027edf0feca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7e50535e-e9b8-4e25-a8ae-027edf0feca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13e9f9d4-7346-405e-8a82-d4ba976d457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_928f3fff-5606-40c3-bc2c-3181a2ee6955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13e9f9d4-7346-405e-8a82-d4ba976d457c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8d1963fd-a2f6-4469-bfe1-065833344aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8b64dad-23d6-4545-b335-e0f2efbf0f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8d1963fd-a2f6-4469-bfe1-065833344aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_afd35753-62ec-45b5-8ff3-c412aff98303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8d1963fd-a2f6-4469-bfe1-065833344aa8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_afd35753-62ec-45b5-8ff3-c412aff98303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1aef14b1-9da1-4c9b-9f34-e764ef4f500d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8d1963fd-a2f6-4469-bfe1-065833344aa8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1aef14b1-9da1-4c9b-9f34-e764ef4f500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febaf87a-990a-42ca-8c4a-ab4d2c846bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8b64dad-23d6-4545-b335-e0f2efbf0f8c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febaf87a-990a-42ca-8c4a-ab4d2c846bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8005811a-5fa3-49e3-b8c9-cd4da78eec32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8005811a-5fa3-49e3-b8c9-cd4da78eec32" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:to="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ef46bb39-c9bf-4b85-a802-c712aac7dad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fdbe7e11-50d8-4925-94e5-973e33c4940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fdbe7e11-50d8-4925-94e5-973e33c4940f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c190c3bc-f5e1-4415-9b48-9cb18aac2829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ef68623-2bdf-46b6-99eb-573674ef95b3" xlink:to="loc_us-gaap_PerformanceSharesMember_c190c3bc-f5e1-4415-9b48-9cb18aac2829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d372936-bb31-4435-8285-8cd5c91dc84e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c424ec55-44a6-4611-9cbb-02e390cc4378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c424ec55-44a6-4611-9cbb-02e390cc4378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_595cc71a-eae5-4b1b-b5a5-0b592cbac402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_595cc71a-eae5-4b1b-b5a5-0b592cbac402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1a3ebc4b-7888-4c8f-a02c-bdbf62b1a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1a3ebc4b-7888-4c8f-a02c-bdbf62b1a43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04ed4962-92c4-4902-85d5-539950725b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9e5fe426-a756-4f24-9408-145c524ed3f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_04ed4962-92c4-4902-85d5-539950725b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3e5a24-a9f6-4aa5-a007-633aa1fd5e51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b946dfb6-0848-4ddf-9caa-a380ff48fa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b946dfb6-0848-4ddf-9caa-a380ff48fa3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5ded8c85-06da-4836-9a08-d7dd83a924ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5ded8c85-06da-4836-9a08-d7dd83a924ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d54debc1-55e3-4bc1-9ca6-05fb10140e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d54debc1-55e3-4bc1-9ca6-05fb10140e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce48be07-a4fe-4b1f-9841-9b1f9c8b9dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ec7ba56f-8b75-4b65-940b-1a8666f294bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce48be07-a4fe-4b1f-9841-9b1f9c8b9dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHARE" xlink:type="simple" xlink:href="bhg-20210930.xsd#NETLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/NETLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_95730f06-ed92-4309-9f2c-35e6152344b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_70010b72-f9ba-4ded-8cf1-e2265d8f62ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_95730f06-ed92-4309-9f2c-35e6152344b0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_70010b72-f9ba-4ded-8cf1-e2265d8f62ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables" xlink:type="simple" xlink:href="bhg-20210930.xsd#NETLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_78b15071-612d-426e-9977-e52d0f4ec2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4e74b204-9d95-42f4-940f-f2df174bf10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78b15071-612d-426e-9977-e52d0f4ec2d9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4e74b204-9d95-42f4-940f-f2df174bf10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9d72337a-5d30-4ec6-9e50-cea0da31b0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78b15071-612d-426e-9977-e52d0f4ec2d9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9d72337a-5d30-4ec6-9e50-cea0da31b0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#NETLOSSPERSHAREScheduleofNetLossPershareDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ef6fcba-2256-447f-9302-579cd8734864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7ef6fcba-2256-447f-9302-579cd8734864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_839bf6c7-95d4-4303-9f6e-ea27cc7ec3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_839bf6c7-95d4-4303-9f6e-ea27cc7ec3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11221fac-1839-4ec7-a6a8-39fbd42591c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11221fac-1839-4ec7-a6a8-39fbd42591c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e413c9c-bc4f-4787-8e7a-babc257fe57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e413c9c-bc4f-4787-8e7a-babc257fe57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7a1e850e-cb4b-4775-b013-9707657d0358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_EarningsPerShareBasic_7a1e850e-cb4b-4775-b013-9707657d0358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c4a4ad90-b666-47e0-a6a1-50347672372f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ba607f9-49e9-41a7-b203-cb60a7d26c7a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c4a4ad90-b666-47e0-a6a1-50347672372f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6229ff9a-f3f1-46ae-988a-27131c5ceb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6229ff9a-f3f1-46ae-988a-27131c5ceb25" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c681a3ae-a00e-436b-912e-ed28c105a090" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_2c385cbe-a62d-437a-83c5-c88e96b814f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_2c385cbe-a62d-437a-83c5-c88e96b814f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_53a41ed7-04f7-4bbf-bc98-f29dbcfbb19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f51fd2d8-34d4-42b2-b73b-c0aac84bba96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_53a41ed7-04f7-4bbf-bc98-f29dbcfbb19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33629264-50b7-4289-a7fe-1f373fa2ced8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_346cc9e2-62b4-424f-b782-1b50989f39b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5b201f9-0b8f-481e-8963-f10b60e2f24e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_346cc9e2-62b4-424f-b782-1b50989f39b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bhg-20210930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a84e4959-4488-4f7d-ae9e-c6163748b7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fc46a68d-bf54-448f-9bc2-c3461f39be74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a84e4959-4488-4f7d-ae9e-c6163748b7e0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fc46a68d-bf54-448f-9bc2-c3461f39be74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION" xlink:type="simple" xlink:href="bhg-20210930.xsd#SEGMENTANDGEOGRAPHICALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_346a9362-62ed-4b60-afc7-cdba7a6e43f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2fe74f34-1b58-4750-ab2d-bbf852930f80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_346a9362-62ed-4b60-afc7-cdba7a6e43f2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2fe74f34-1b58-4750-ab2d-bbf852930f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#SEGMENTANDGEOGRAPHICALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6e608cfb-a286-4c59-b98e-ad5f68d49fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_99d4ef7f-6085-471e-a0d0-000ca147c939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6e608cfb-a286-4c59-b98e-ad5f68d49fc4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_99d4ef7f-6085-471e-a0d0-000ca147c939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ed775a0a-24fc-4276-93c0-48280909e672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8636db9b-ec2d-4767-8aa2-4605fbbadd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ed775a0a-24fc-4276-93c0-48280909e672" xlink:to="loc_us-gaap_NumberOfReportableSegments_8636db9b-ec2d-4767-8aa2-4605fbbadd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_efa3fb3d-e756-4564-ae10-a0f98247e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_efa3fb3d-e756-4564-ae10-a0f98247e3e5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:to="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_899378f4-02b7-46f5-af58-a6cafaa9df93" xlink:to="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4665c153-da49-40ae-98b0-fb40dd4583c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:to="loc_us-gaap_OperatingSegmentsMember_4665c153-da49-40ae-98b0-fb40dd4583c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_fd9f952c-77df-4238-be7d-2bac7c2e6ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab891649-25ad-4706-8bc8-e9bb2ba777c7" xlink:to="loc_us-gaap_IntersegmentEliminationMember_fd9f952c-77df-4238-be7d-2bac7c2e6ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70a6cd56-40aa-45d5-a6b1-ba1f99249f81" xlink:to="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_BrightHealthCareMember_c7448346-d407-457d-8530-e00eb46a8b14" xlink:href="bhg-20210930.xsd#bhg_BrightHealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:to="loc_bhg_BrightHealthCareMember_c7448346-d407-457d-8530-e00eb46a8b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_NeueHealthMember_8a2b400e-ac4a-4620-85d0-ba82bbc1cbed" xlink:href="bhg-20210930.xsd#bhg_NeueHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_202332dc-c514-4723-8486-9c61dd982cb0" xlink:to="loc_bhg_NeueHealthMember_8a2b400e-ac4a-4620-85d0-ba82bbc1cbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fd513014-f581-4026-a692-e2d2eb704ab3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_4d57865d-4fe4-4b42-943c-07957567517b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_PremiumsEarnedNet_4d57865d-4fe4-4b42-943c-07957567517b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6867ab-ca96-4bdd-b75c-8289e022a443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6867ab-ca96-4bdd-b75c-8289e022a443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_InvestmentIncomeLoss_b1c9abd5-0343-4f5b-8965-c839accd8d53" xlink:href="bhg-20210930.xsd#bhg_InvestmentIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_bhg_InvestmentIncomeLoss_b1c9abd5-0343-4f5b-8965-c839accd8d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d73de6bc-8b6a-4459-bf1f-01d0ff8896ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_Revenues_d73de6bc-8b6a-4459-bf1f-01d0ff8896ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d422a1d9-ccf4-45ad-baf0-9e9abd4bec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_OperatingIncomeLoss_d422a1d9-ccf4-45ad-baf0-9e9abd4bec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_264a72f4-801f-456c-a472-06d9d2225b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d93d181-803c-49ce-bdde-a93e2997c7a0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_264a72f4-801f-456c-a472-06d9d2225b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bhg-20210930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33f0f48e-78d4-4beb-a891-e69c88b21c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_efc86413-b2c3-4923-ad0b-6fe26a6faf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33f0f48e-78d4-4beb-a891-e69c88b21c3f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_efc86413-b2c3-4923-ad0b-6fe26a6faf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f18c3d2b-9b72-45bd-8811-058b0c173ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_81534c35-271d-48f5-b1dc-9c92bed5cac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f18c3d2b-9b72-45bd-8811-058b0c173ab7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_81534c35-271d-48f5-b1dc-9c92bed5cac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="bhg-20210930.xsd#REDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_8943921e-31e4-48b0-9768-a530f27c0268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_312455ca-1b45-43f0-9df9-323bcd93f593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_8943921e-31e4-48b0-9768-a530f27c0268" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_312455ca-1b45-43f0-9df9-323bcd93f593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="simple" xlink:href="bhg-20210930.xsd#REDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_dc1a49fb-0127-4ce1-a74b-627a4f125bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_62f47ad8-36ba-42df-8205-8234da6c4878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_dc1a49fb-0127-4ce1-a74b-627a4f125bc5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_62f47ad8-36ba-42df-8205-8234da6c4878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_904fe210-007d-4e16-8c58-a72f30938906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_904fe210-007d-4e16-8c58-a72f30938906" xlink:to="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:to="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_569d5449-f47e-46e4-9b64-a8826efeafba" xlink:to="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_ControllingInterestHolderMember_a04bea7a-539e-40f5-9d5b-7099fe049ca5" xlink:href="bhg-20210930.xsd#bhg_ControllingInterestHolderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5c7917c7-b762-4283-8d47-7c2b81ef7b43" xlink:to="loc_bhg_ControllingInterestHolderMember_a04bea7a-539e-40f5-9d5b-7099fe049ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:to="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_52ea8277-f08d-48d2-a9f4-52c95b890976" xlink:to="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bhg_CentrumMedicalHoldingsLLCMember_c09396ce-b91c-4694-a479-e355175bc614" xlink:href="bhg-20210930.xsd#bhg_CentrumMedicalHoldingsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_10a8f94e-892d-49e8-a6a4-4e2589f103fe" xlink:to="loc_bhg_CentrumMedicalHoldingsLLCMember_c09396ce-b91c-4694-a479-e355175bc614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e3f91641-16e3-411b-a20e-4225e092e8ac" xlink:to="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_77653ca2-d2d5-4e0e-aa86-13d6ce8d196c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_5c1abef0-af56-412e-9ab7-40ffad19d5ca" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_77653ca2-d2d5-4e0e-aa86-13d6ce8d196c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="bhg-20210930.xsd#REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_46d04071-d8d9-4344-ada4-b0543707e0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_46d04071-d8d9-4344-ada4-b0543707e0f6" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_75d3b780-672a-45b1-977a-e7ac9e296384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_75d3b780-672a-45b1-977a-e7ac9e296384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d05e1e3a-c025-494f-8d9b-c879b66f411d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_d05e1e3a-c025-494f-8d9b-c879b66f411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fda8e863-8290-48f2-8509-933a30fc2912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_fda8e863-8290-48f2-8509-933a30fc2912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_5ec53649-e5c6-451a-8b87-38e6f53848e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_5ec53649-e5c6-451a-8b87-38e6f53848e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_cbfd170f-c975-46b2-bd74-49b95fc9a7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_ea2a97a6-bb07-48bf-8d7c-a1b3fde4e9e5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_cbfd170f-c975-46b2-bd74-49b95fc9a7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bhg-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bhg="http://www.brighthealthgroup.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bhg-20210930.xsd" xlink:type="simple"/>
    <context id="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c3a276f58cf46b487a48d33d62cf375_I20211104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2021-11-04</instant>
        </period>
    </context>
    <context id="i28f7521b4a234009aa828e733e8f9a3c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if890322e1050423c9f21ff3c2b864535_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8393f93f84a6414b91b167951bef057f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6f868825a854ad29b00d7c27d6e2c83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4871efe74704f978b993ba51fc2ad6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i411ffa67bd024b8fba87e9c64077fcf2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0137f0a50f174a078570affe987b9897_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a1a3fb2febf422abccd9d03e715acf0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idd11786a418e4ce4b107cb2441a2f8de_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib168a2810cb14711aa2a509c2b7bec5b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i30e3312456d94b45b58360f1365cce93_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i73597c3d3a334263ab2aa9d6b4f46f20_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i896eec808e0343cfbae2f717934e71b4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i59037bc717a449289317ac0d87adea87_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63e4858120f3454984bb4f44d0b45435_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c76927d0c87485f81b0c99ec31fe573_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie5496876444a4be489375b4c022ef150_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0da7eda6089f40dc80394423712bac8c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3747e34d1b8945a2b35ae65a0c95b283_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib1632e2cf7834f558bc296dd7d180324_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib9381960dce441ae877f25e0db8e3933_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib20155a3f7a940acb68c19efd45e42d9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f7a6f0ef29542f884edade6bd7d8ef0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i253d2d1e76de471f92bb9665c552586f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib665d31bf9d7437591781fd1d77c6b99_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie46639bd73344ddebb19d877ee0b947c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i649e794681cf4cca99c2536e968dc812_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17ef0d69fb47479bb3350e333c9f7181_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie606262a9d784da09df56adafa6c1538_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6c91a02c94204c438991d1c1f55dd5d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie882f1e05dbb484bb99d78576ac4d175_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ac918bc38544218819b0a101da9f295_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie4e64ca59c864ed9a6e56e45243b353f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4aa6030d8ef4580b4eb924a05e135f7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icc061278f0da4aa9a0f13da8c2ab475d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ice6dc6d47370425b9fce3a98c5650ffc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i544c254ae4234f02a8ea8433f7111c6b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9545d10c15f3484799e95f2fa94df37a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iad985bb842b24424b5f51535a74e0d20_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie1467d7e2eba4616ad00ffd76e8ea421_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i715014b57d1441db9f72b2c4fc26c971_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib18c4a2f0ce64d00b414ff7d7e5d76d7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iab3b38cf004a47bfb5f9ff6a8663bb04_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia97167ac64ec4bb6b360504ece6d65a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1d60eac239514d1986be1ece58c50aff_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i439d50f322e748c2a9db9431eb49add8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idbdb64c5b993489fa19ab055445e7cb5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if3d52ed33ef14b8d95901deef872bce1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1ee8a98ff3284e9a89cb462c1a5975cb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if9ed5988a89248598fb835a3d6eb8fb1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i217634c8da0246ab92821d26990e7ab8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1208c83ea17943c393f48af48a7323f6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3e9df45a4ef406badd359c74e03a99e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8ffb20b6c43f4e73b4c1baaed88a2476_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fb28b0bad874df383fc182d52bcd000_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1e7b09a7c5084223a5134c48364d9483_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2d75a8b417104e2e99acca850c6fd16f_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-28</startDate>
            <endDate>2021-06-28</endDate>
        </period>
    </context>
    <context id="ia8f1c51b74e14129bd0f91602963e036_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i3eb69ad6e15b4395bf5d632879271c37_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i8955d418b9e348a09575068e6bd96030_D20210628-20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-06-28</startDate>
            <endDate>2021-06-28</endDate>
        </period>
    </context>
    <context id="ia21467a131f241a8b54be2659b98dd34_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i122e578042ed4e84b1d841704471a4a9_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i1b79375e653b4c6ab22e579ba0de8468_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="iffd914077e9f404a9da2a417b56c4672_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i837392de0aa64e87bfdcc482e5eb4682_I20210628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-28</instant>
        </period>
    </context>
    <context id="i5759a0d876be449aac313ca0615a3807_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">bhg:ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if396eed261f24ec59dcf755f4bcd3906_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">bhg:ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic898e99881d641128dfcfc367e765db9_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i107c6a9c6a5f4b72b6a388858fbcfaf8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42f62b97d0d14e2a80908c5ba5ce1ce7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i437f51b176c14704a8d187469131515e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i6a20a27e64cb4a15b3a57eea10b70269_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="id8c4c3b025d849189363e133e0b11e87_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ifacffe1d832f42b7bdf2a5102beadd9c_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic41d330372d542e286128a811bcd3408_D20200701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i906967f82f324f7e83d7e378327d6632_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i36358997c9554e299250c29d1edc21ce_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i6b87a30e39784613942ef3b1ffe359c9_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ic68b8f77cc0c4feb964ea6ff561a07fc_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:CentralHealthPlanOfCaliforniaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idd0973903cab4deeb08dfc70ef9dd0e8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0e7e862b6f944cf1a7a7807ff6aa4abf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23ea924109b24362b4aa90947da7cb3d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia24617e1d9eb4076b54c7d7e70276339_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7786594de6244ae6a5a8034a5ce9da7e_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9f0afeba703f4eecbfd79b0b0ac66c51_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if9c829a59ac144c2a6c38f54d48e9328_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:TrueHealthNewMexicoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib88d85b6051d4282a78fa46340280420_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5d4bddbfcfe456aa8f422cf2a237786_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3914765d423b4a628de3214723906cf7_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:ZipnosisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4d081fc23d14e75a64545999d205679_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i88b028119331454b86c135bc40e6d46f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:THNMAndZipnosisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iabcc40d305134dce85d3cf3faaea6c2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:PremierMedicalAssociatesOfFloridaLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f1e0f30291346f1bd501e797f389c07_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:PremierMedicalAssociatesOfFloridaLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i9ecbee92cb12427db0c1287be74eabff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i02d119c5e70e49299a5a771390922e80_D20200430-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bhg:UniversalCareIncBrandNewDayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ProviderNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="if157b21998ca4b74bcf79e7477729fc8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49f9b0edbc5d4e6eb845493d5559b678_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i999a85020f9f4f10a9aa47b8f908b339_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i876397b0696242c1a07ad1299e40876b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iba93dbe931f244d8966ac1d962a2fea4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62e383ba4c874ed1a61aa4f77bf40523_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1821e67a709400081ca8ffa683a8944_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93edb636370844a0929f4e4375a579b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54b616b4492d4f57b6587e8013fa8e17_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48170a5de4b440f692e33f62a6d27726_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i60813677512b434bacaebec6e08f0443_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95f63630eb2b4c619abf10dae7347361_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55715dc78ffb471b9a34ab8fc2be9773_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bd1d1e14a644d769d623a268712ab39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bhg:ShortTermAndLongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcc35cb44c3a44e4988de9c09f1145a2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ae3dff21f514bee8dcfb24fbbee065c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i783a66cb5f2448f3acd95db34f27a159_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2d4a304ce1df419a88d9585aceafdead_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i01db93ebd12c41889a5bbe280eed1eae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idcf21177884c41bc92c0b8c908d78a52_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8ea779896ada4159a7f60019e9927bf8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5121369128bf46f1b28d027064b97268_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib4c3c88b8b464936985a142c13ba59a1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i063bcb9e20df488faba4c86ff6b2d2d7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6321a1eae6741258bc2ebec56ccdd2b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2ba12124710a41d09f79459538d7f774_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i112615aabc29458c80feb79df5325cfe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i39a7e8b71f6b44ef93ee44e051b98fa8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iff31328bf070411aa7d0bb0ec25452ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42079981bc19457ea93081a70515a67d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i98131e51113d4be280910ddde875e482_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaa4d5d4769ec49aaba6b4e6a10a70938_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8c32f01079e74ada8aa45c870e22b903_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4b929d612cbd4848b4301f794170eb0f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2d8e5514c7c84b5f9a6699e445d92f2f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i698a8a675a8841d99a8e4be9969c21ca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0a1a14e6cf3d416f975eed2bfba93422_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8342f62d3a84412587f448f9c68dd462_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8df04854b56f4e59a9948d081a560768_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if9068fd2eb5c468fa8aebe290cd9eda3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i673e75bed3d843009499b44448ad15e0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4b8d872078b641849ec57b4e0288f932_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if899da5bf1bd41409a4b68a13470cbf1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ieddace9853a649deacee98a11a13ee5b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id5ff1faea03c41699fda03aeeb1f558b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if5492bc70b174482b6c39dce60f8004f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i063b0bab67784b50bd90eab8e6ad0e9e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2d6a5781117748b8957106e1ea54500b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i36ccdb626bf0477288751a9c0cd4833c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabca06f9fbf9459aa74bd97191815ac5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8214960907014dcdb3065f18a818a891_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb1d5009fb76492bba7eb7f3ef9c1bbd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8868207423f4dc1886e5e83a2c9ffec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53d031fe827d4ae9bb2cf648e3ce20cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i519d21ea4f4f4131b47e685212e69fed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b475d1c4f864fecb3191e434e9a05c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia41095a8fe9f4f45b4e41448fef3fe52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfa2422a2e3c425fbdb4444361bec7c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i353f273f34ba4a6e86802cad11918d1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42019d07c89a4eaaa3ce1cbaa7ce9040_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e872c51cbe14f019f7cc9f67921a34b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if69d42f4ef924ebf801a45ca4af8b600_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8bd31902240473494b2cbd44c479592_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibba8cbf1ad1841b888da8acba5f7f620_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fcfc92e884043cda965149401c427a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia40fa98b862c45d08dfdaee06d40d302_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6394f5129932421ab1a4974a1a1a6b00_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf297a460c204ec2b1885acfc0c94a10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b5c730df6314669bb5151635d49120b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie38fe77be60140f48090522f63c9a39a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74044123d230403ea1b8d392ee592a83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6d7fe7922944855967728940bb7a2db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ec41e2a7ebf48839293841bdf908142_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b04c47b17f04e9080c84e6237ce8133_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib84d8e18b6b5493c8c2f73fae745b71f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i987b1607278642e6bdb251b05e65b8ff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia43a6f4851ae408aa78991f992f90d3d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i44343e4888bb4fdd8ef28262ba0a829f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3bb05d51535c4c5fb8505b007c999ba9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3ebad86f24bb445b8b965a4431d284e5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib3a78bf8567442f181de5c4cac29fe31_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i603837f5d76a430db5a4b8b5127fbac9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8b82a503cd044fe590aa67341061d910_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i59812274cf5a4c7396e08ab5b517c05c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if38815aebdb74f77a02060f060d0869d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7434d9096c64a1bb923b544c8f1389d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b4c1482377444818d26fe58a951011d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad3ed3d5f5ef4a70bf392309669bd29c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id470f6c918dd495a836d00f9b203e39e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1946250bcb8b4f35ae19d843abace6b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c97e7f2726740aab3e591c631f1086c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ec66f7f13b74426818220faa08b44bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0d8836b93dd4f33b7d7aadeba06f167_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1192b7a40dd4bf8901438bfe5d81d4c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i06271373575042ab95c33d25a8ca9392_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic724acf3709143ae92b0205c01aff95b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bhg:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia5706b49442c42cc92ff686adc9c2f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc51d73723524b38a531dfff6500d1bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5e079ad5fea45d1896564cab3657124_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2347919b5a0f402dbe70c10597badc81_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a5e9f871cd340148867c6e71fdf972e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5263022fb5924aec8717109210e85b4e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia7f4e995deff4436ac164dccfef41665_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d60d46058494a0c9b1c382560f26baf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idac76b89cd7144e9aae00bd7925215e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc5b9d2a29e04e838afb62706696b06b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32dc3e4609c14b56bb221bfee7c43e94_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bhg:ReacquiredContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i239b6a8206b34281a2d7bdb5f1c2ecb9_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="ia89038a50c124021864f208e24672ab8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8d71d04cf62a46bc8ec80068d333d865_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1cb0c464b5b74f17a7e2b16b4ca83666_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica442b5ba7794e58b4b714aa57dcfb75_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic04162a13ce44bbcbac57b063ee86f28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab3ef9a574ff42738e7c366e77b92366_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic52eea78557244659324ce8e6c2bb202_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie498ad30294744b1ac90b3f7364ad523_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i043ba02e46a04d3d9c3801cac0f40005_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a06652cd21144e68f470720d0b26e59_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1803b1c56bb045a9a7e1425efd488b53_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2fc0670e71004cc7a5aaf2b1e4d07c2e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i096b128e354942a2943cc883c2a582eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib7f653fc2a4d47c4a01311be6348f994_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i820545dd461745cb9b88d3b536970633_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbe36d5030b44213aa037bd2cd8a869f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1edb8fe9719f4576984692641eb7fb92_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id37b7a5485404128a642a44330167703_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie1ec0bf0ed7741758e2d7b0b6a2cd127_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:BrightHealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bhg:NeueHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29660353a02b48e987417294a4c7d8ee_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001671284</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">bhg:CentrumMedicalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">bhg:ControllingInterestHolderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="healthcenter">
        <measure>bhg:healthCenter</measure>
    </unit>
    <unit id="investment">
        <measure>bhg:investment</measure>
    </unit>
    <unit id="vestingtranche">
        <measure>bhg:vestingTranche</measure>
    </unit>
    <unit id="segment">
        <measure>bhg:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV8yLTEtMS0xLTA_f678998e-4f9a-4d75-8a2b-301bbfa0a9b8">0001671284</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV8zLTEtMS0xLTA_e9d987bc-be11-44e6-a28e-eb1ad72be302">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV80LTEtMS0xLTA_11322794-45ac-4bb7-b494-815c72d4d640">2021</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV81LTEtMS0xLTA_fdfe1a15-9180-4b02-99fd-d7d2809713f1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80L2ZyYWc6YmFhZWI3ZTc3MjM2NGQ3NjgzMWI0YWIxYzI4MjgyYjQvdGFibGU6NDZjNzNiYmEwMzIyNDFiMmExZjZlMDdjMjYzZTE4MzkvdGFibGVyYW5nZTo0NmM3M2JiYTAzMjI0MWIyYTFmNmUwN2MyNjNlMTgzOV82LTEtMS0xLTA_e14cd8b0-ae7c-44d5-bc83-aa512e770ad8">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_20fcd581-8099-4149-a9b3-a33d8739be45">http://fasb.org/us-gaap/2021-01-31#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_a0d2339f-d88e-46c2-a091-0b6fdb8cc411">http://fasb.org/us-gaap/2021-01-31#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_b6886748-2b1d-491d-a844-5aaa0be8f223">http://fasb.org/us-gaap/2021-01-31#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0wLTEtMS0w_c9024cd6-16f8-4b26-b6df-f343d19c9d24">http://fasb.org/us-gaap/2021-01-31#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <dei:DocumentType
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA4_935de9f1-6e2c-42e1-9e08-8a0bcb80aab2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6MzM1MDg1ZDc0ZDZkNDg2NGJhM2NiOTM5OGQzY2VhNmUvdGFibGVyYW5nZTozMzUwODVkNzRkNmQ0ODY0YmEzY2I5Mzk4ZDNjZWE2ZV8wLTAtMS0xLTA_91c20a62-15b4-472b-9737-a6710f3191a3">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xMzU_8db6b377-f08b-49b6-9021-1166e2027d36">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6MmY2NDJiMDQ4ZjE2NGFjM2EyODRmYzUzY2JlMjk5YjEvdGFibGVyYW5nZToyZjY0MmIwNDhmMTY0YWMzYTI4NGZjNTNjYmUyOTliMV8wLTAtMS0xLTA_8527df41-87e9-4fc1-83a0-a18738dcf7e7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA0_79a1a663-aa62-4763-a780-21a9bba07b15">001-40537</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEw_89d1a4d8-647f-41bc-a101-a50789bbeac2">BRIGHT HEALTH GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8wLTAtMS0xLTA_7bf637f9-5d46-4869-8ffc-ccc295ddd5ae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8wLTEtMS0xLTA_8d6ac5ff-d60a-4e31-99c9-face29932909">47-4991296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF81_d0576bb7-94ef-4ba8-ae94-7fcd420702a4">8000 Norman Center Drive, Suite 1200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF85_90b90c02-3bce-4638-b69d-0122d74b9a05">Minneapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTM2YzI1ZTBjNzU0OWI0YTdkYzk5MGZkYjAxNzZlZF8xMw_74f034e1-17f1-4d85-8272-eeea068a934b">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZjJlNGE3ZDg0MjU3NDE0ODgzYjYwMzAwMmRmOTA2MjUvdGFibGVyYW5nZTpmMmU0YTdkODQyNTc0MTQ4ODNiNjAzMDAyZGY5MDYyNV8zLTEtMS0xLTA_d9d15483-4c63-4b0a-be80-d41e0afb12c0">55437</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEx_fbe7ebff-58ff-4dee-bd72-de907aac3215">612</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA1_3f1b67b0-8338-4c39-986b-cf90a0da42c2">238-1321</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTAtMS0xLTA_73d9d79c-68af-4bfa-a5a1-79bb31fe3719">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTItMS0xLTA_fbaea789-7b18-44a5-81d5-6cf346efcd4d">BHG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6ZWQzY2M2MTNhMGEyNDU5OWI3NzlhOGM1YWZmNWY5NTcvdGFibGVyYW5nZTplZDNjYzYxM2EwYTI0NTk5Yjc3OWE4YzVhZmY1Zjk1N18xLTQtMS0xLTA_db458478-2fdf-42d9-96b2-aaeee70abe9e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xMDk5NTExNjI5ODAy_586fb65c-42bf-48d8-a1ee-1d6171e66393">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDA3_51bae1d8-5f6a-4f4c-ab15-71660a5a8b24">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8xLTAtMS0xLTA_667808d2-e00c-426d-bc95-90a07c596bba">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8xLTMtMS0xLTA_6edb7b3e-ddc1-4512-9178-12833602d5eb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGFibGU6Mzc2MGI2ZjEyZDE4NGIwYWExNmNjNzIzNDVmZDdkMWYvdGFibGVyYW5nZTozNzYwYjZmMTJkMTg0YjBhYTE2Y2M3MjM0NWZkN2QxZl8yLTEtMS0xLTA_21b4a7dc-002a-4830-99bd-7b4eedd18610">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8yMDEy_820328a5-8d73-4b83-9c6d-647e2949e604">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8c3a276f58cf46b487a48d33d62cf375_I20211104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xL2ZyYWc6NDhmNDAyM2Q3ZTQ4NDM5YTljYzljMjdkMjU0NDlmODEvdGV4dHJlZ2lvbjo0OGY0MDIzZDdlNDg0MzlhOWNjOWMyN2QyNTQ0OWY4MV8xOTM0_1a32f493-59cb-4a35-8da7-01f13e334189"
      unitRef="shares">628315180</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNC0xLTEtMS0w_1b0ff1e7-1962-40de-a463-628a6cc44630"
      unitRef="usd">956189000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNC0zLTEtMS0w_7ff72dea-b7b3-453f-a888-e384da439230"
      unitRef="usd">488371000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNS0xLTEtMS0w_7b6d7c1d-6a6c-4ec2-a413-c1f055e0c874"
      unitRef="usd">331719000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNS0zLTEtMS0w_98525ea5-afe5-4d10-b6b3-9fdd865ccad6"
      unitRef="usd">499928000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0wLTEtMS0wL3RleHRyZWdpb246NmE1OTBhY2Q4MGQ2NDdkYTkyMTFhZmFjOThmYzNiNzVfNDY_2158b21a-3af9-4457-b89d-d2b35166fe0d"
      unitRef="usd">5701000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0wLTEtMS0wL3RleHRyZWdpb246NmE1OTBhY2Q4MGQ2NDdkYTkyMTFhZmFjOThmYzNiNzVfNTM_3a98ee64-c222-40ca-a04b-fc8ed9af581f"
      unitRef="usd">2602000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0xLTEtMS0w_c7d0a51e-68e0-43a5-bc8b-02f0462c9ea6"
      unitRef="usd">99216000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNi0zLTEtMS0w_e9cb5416-8278-4ac5-b523-6c654b708ad2"
      unitRef="usd">60522000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNy0xLTEtMS0w_1d81f186-3fb2-4e65-8636-07740b37dff8"
      unitRef="usd">240545000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfNy0zLTEtMS0w_c8b70fe0-bc84-492c-82e5-05c1b5bcdaf2"
      unitRef="usd">130986000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfOC0xLTEtMS0w_d871878b-d6bc-4533-a94d-b055ec3c47a7"
      unitRef="usd">1627669000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfOC0zLTEtMS0w_439ec089-faa3-4b19-9777-34d5fad21907"
      unitRef="usd">1179807000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTAtMS0xLTEtMA_c71fc472-ce06-4f94-8e46-d3cd852e138b"
      unitRef="usd">681923000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTAtMy0xLTEtMA_54e8afce-0215-49f8-875f-aa7f59e8ebd3"
      unitRef="usd">175176000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTEtMS0xLTEtMA_6c7ee1d8-d0f5-414d-ba80-a2713ac52795"
      unitRef="usd">30932000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTEtMy0xLTEtMA_7be5ade0-1f12-4bca-a6bc-8621efb0715c"
      unitRef="usd">12264000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTItMS0xLTEtMA_a31fa781-00b4-4ba9-b615-1dd9cde68bba"
      unitRef="usd">842301000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTItMy0xLTEtMA_74ccd4fc-ce95-4743-a7db-f84a4e690190"
      unitRef="usd">263035000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTMtMS0xLTEtMA_dff4361f-bcdf-4d7b-98e8-5fc87eb2a615"
      unitRef="usd">351519000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTMtMy0xLTEtMA_26cf9409-a4cb-4404-8b68-731e7dbd6f53"
      unitRef="usd">152211000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTQtMS0xLTEtMA_aa59f171-91ca-45a1-837c-cafe6998673a"
      unitRef="usd">40751000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTQtMy0xLTEtMA_eb322103-97b0-46ed-94c4-8d8a2e4f2e85"
      unitRef="usd">28309000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTUtMS0xLTEtMA_ca73b916-ce77-4466-8b25-9d5eee163f0e"
      unitRef="usd">1947426000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTUtMy0xLTEtMA_41ea3093-62a8-4cbd-b1f9-c6245b5b200b"
      unitRef="usd">630995000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTYtMS0xLTEtMA_052c8b95-844d-4bf4-bfa0-076bc60c5c0f"
      unitRef="usd">3575095000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTYtMy0xLTEtMA_9c6080da-a1fa-40b9-b677-0d8e721f8616"
      unitRef="usd">1810802000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTktMS0xLTEtMA_ef0887f6-f77c-4d58-a7fe-c5927289f8d4"
      unitRef="usd">685045000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMTktMy0xLTEtMA_b758101e-5b28-4df3-bfc7-584333c8d539"
      unitRef="usd">249777000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjAtMS0xLTEtMA_e998353a-6a67-48eb-be85-57e23d918d6b"
      unitRef="usd">95161000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjAtMy0xLTEtMA_f57a35fb-c6b2-48a0-985f-2fb35590eb0e"
      unitRef="usd">57252000</us-gaap:AccountsPayableCurrent>
    <us-gaap:UnearnedPremiums
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjEtMS0xLTEtMA_ca8bc902-739d-4266-bbf7-e14027a2822f"
      unitRef="usd">34917000</us-gaap:UnearnedPremiums>
    <us-gaap:UnearnedPremiums
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjEtMy0xLTEtMA_76deb62d-fe6e-4055-97b6-80dc352e6158"
      unitRef="usd">34628000</us-gaap:UnearnedPremiums>
    <bhg:RiskAdjustmentPayableCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjItMS0xLTEtMA_3ba2b01a-c199-4752-8245-93c7a4b994eb"
      unitRef="usd">548352000</bhg:RiskAdjustmentPayableCurrent>
    <bhg:RiskAdjustmentPayableCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjItMy0xLTEtMA_7d305c8d-3052-458d-9dd1-6e9576516114"
      unitRef="usd">187777000</bhg:RiskAdjustmentPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjMtMS0xLTEtMA_bbdf18d1-4428-42bb-8821-2c0abbfeea03"
      unitRef="usd">88133000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjMtMy0xLTEtMA_28dd6489-c7ac-4587-8c42-2c51aa7b65a9"
      unitRef="usd">35847000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjQtMS0xLTEtMA_36cc15ac-7d4e-4e9f-9834-2fed1e0e3fd9"
      unitRef="usd">1451608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjQtMy0xLTEtMA_3f0a73ae-6828-44d2-90ef-534f4eaa4029"
      unitRef="usd">565281000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjUtMS0xLTEtMA_08dd5e18-f327-425b-85e6-4456e8ae86d3"
      unitRef="usd">56254000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjUtMy0xLTEtMA_9b44af78-d49b-4425-adff-332b6466905f"
      unitRef="usd">28578000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjYtMS0xLTEtMA_ae9374a0-916a-4a76-bfc4-2f8c4b856f3d"
      unitRef="usd">1507862000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjYtMy0xLTEtMA_1c2ff6d5-d2c6-49f2-aa1b-cb4e8df0fb00"
      unitRef="usd">593859000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjctMS0xLTEtMA_da033e98-6965-4c78-9655-f649fb3401a7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjctMy0xLTEtMA_7d5a864a-105b-4db4-8b4d-d0761e78fc2c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjgtMS0xLTEtMA_b01a9df3-1273-4b1c-a25a-fb43814018cb"
      unitRef="usd">130029000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjgtMy0xLTEtMA_94716611-e55f-4994-abea-7b641ca95944"
      unitRef="usd">39600000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzMy_a1ffd200-9d22-43b9-a46b-094edfaf3a83"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzMy_a4ec96b4-0e8a-496e-9838-046c5833394a"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzQ2_fb0b7800-7c59-4509-98c0-2120fe40f8c2"
      unitRef="shares">100000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzUz_22d6919d-a2d5-4912-9c71-01f9e365d83f"
      unitRef="shares">166307087</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzEwNg_6a216446-fe12-4f0f-be78-82f82d077a32"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzEwNg_d4552f62-9647-44b2-8fcf-c501f1da58a3"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzExMw_e0e40049-284d-4988-b3a6-049e9ef5b739"
      unitRef="shares">164244893</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjZhOTZjZDAzYTNiYjRjODA5YjZiMzJlOWUxYzU5ZGJmXzExMw_ff9ae91e-392d-491e-9186-60ad7c47c9c0"
      unitRef="shares">164244893</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMS0xLTEtMA_9f62b27f-a259-4a41-9645-afa634a389bf"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMjktMy0xLTEtMA_3b968852-9428-4191-b108-7d95dda47354"
      unitRef="usd">1681015000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzE5_2ff76094-bbf3-473d-bbfe-79db23a5aecd"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzE5_3a35a252-9ba4-4b8f-bf32-a8862c4c7d45"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzMz_78fdfc21-f77f-452a-8097-ee0bd8fe7a4f"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzQw_eed1e4c9-bd15-4ab4-8355-66cd1000e5bc"
      unitRef="shares">658993725</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzkz_adb046de-e667-49b8-ba17-67d4279f49d7"
      unitRef="shares">628133782</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzkz_f4d1f09f-aa15-4b0b-a820-704fd0fbcbbf"
      unitRef="shares">628133782</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzEwMA_3bc0329f-5116-4dbf-ab7b-f4d641887b0c"
      unitRef="shares">137662698</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjdlODkzNDg1NTM5ZjRiMDQ4M2I4MzIwM2JjM2NjMTZjXzEwMA_cdc73177-dc1a-47f8-b696-ec7198783ae5"
      unitRef="shares">137662698</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMS0xLTEtMA_177204ec-fee9-4f0c-8373-1e1a94c692b2"
      unitRef="usd">63000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzEtMy0xLTEtMA_a47d16c1-83db-4cb7-9f77-a74371ea5ca3"
      unitRef="usd">14000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzItMS0xLTEtMA_61456a0b-4a6b-4572-828b-0386e21e038e"
      unitRef="usd">2823244000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzItMy0xLTEtMA_1d51bad1-3e84-4ebb-bcbf-a162769b864e"
      unitRef="usd">9877000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzMtMS0xLTEtMA_25a34ef7-b499-49ee-b9e5-34e34d74e6b7"
      unitRef="usd">-886333000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzMtMy0xLTEtMA_9fc345f1-4689-439b-b5d2-3b44cb3154ad"
      unitRef="usd">-515989000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzQtMS0xLTEtMA_3a4a27d1-2546-4c92-85ef-58616b36ed25"
      unitRef="usd">230000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzQtMy0xLTEtMA_290e47b7-a0ae-4b4b-8c43-0af2ecb3631c"
      unitRef="usd">2426000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzUtMS0xLTEtMA_1b05494f-1a20-44c4-bc47-bb6c5460c284"
      unitRef="usd">1937204000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzUtMy0xLTEtMA_b5cdf807-f808-49d1-802f-fa0453b4b14b"
      unitRef="usd">-503672000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzYtMS0xLTEtMA_af4b928f-795f-4e4a-a50b-5fc637460ae9"
      unitRef="usd">3575095000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8xOS9mcmFnOmI4ODMyN2Q1MWFkYzQyYWFiNTdhOGM0ZWY3MTY5YjZlL3RhYmxlOmJlNTEyMWZiZGM1NTQ1MzdhMWZiZmRiMmYwZjRjM2QwL3RhYmxlcmFuZ2U6YmU1MTIxZmJkYzU1NDUzN2ExZmJmZGIyZjBmNGMzZDBfMzYtMy0xLTEtMA_f5bd0a36-61a9-4f4b-9689-0eb16e611568"
      unitRef="usd">1810802000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy0xLTEtMS0w_c7798e10-b376-4a05-becb-63e5084c9c38"
      unitRef="usd">1020233000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy0zLTEtMS0w_abb99cc3-23b9-4b21-8d50-de3304ea6639"
      unitRef="usd">345426000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy01LTEtMS0w_1e0aed5c-b431-476d-9dd8-d96a7b072e34"
      unitRef="usd">2922950000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMy03LTEtMS0w_32c62f59-320d-4568-bbe7-05bc571a24b7"
      unitRef="usd">827135000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0xLTEtMS0w_992676d3-6b0b-491b-888d-18cd8dc5d912"
      unitRef="usd">11079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC0zLTEtMS0w_9c49c068-3321-4cb9-900c-f88b6479fa4e"
      unitRef="usd">4920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC01LTEtMS0w_02072bb6-6de9-4e1b-8013-484b00715101"
      unitRef="usd">31602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNC03LTEtMS0w_a5e39362-e3c4-4360-9c66-bcdc00cce80b"
      unitRef="usd">13344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bhg:InvestmentIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS0xLTEtMS0w_19c65c49-dfa2-4012-b047-8a49b0b6181c"
      unitRef="usd">47345000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS0zLTEtMS0w_cfd6368c-adaf-4679-8040-f2dc56711fe2"
      unitRef="usd">1774000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS01LTEtMS0w_395bae77-6b7c-44d0-bb5f-4860e5125dfd"
      unitRef="usd">112503000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNS03LTEtMS0w_e0e5822f-241b-4f6f-be43-3b7f5be64feb"
      unitRef="usd">7063000</bhg:InvestmentIncomeLoss>
    <us-gaap:Revenues
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi0xLTEtMS0w_07eda825-494f-4713-a7da-1eb3682fb48a"
      unitRef="usd">1078657000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi0zLTEtMS0w_7f0c7c8d-7417-4ab1-b4ff-178ffb13252c"
      unitRef="usd">352120000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi01LTEtMS0w_f9943f6a-2b38-4e97-a86e-cce312e5a2a8"
      unitRef="usd">3067055000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfNi03LTEtMS0w_2fca7333-ea69-4199-bd4b-64f7346a8b20"
      unitRef="usd">847542000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC0xLTEtMS0w_954eda2e-4938-4ee8-899b-7b58fb628baf"
      unitRef="usd">1050943000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC0zLTEtMS0w_a188073e-347a-4288-b0c6-33df887e3bf7"
      unitRef="usd">311319000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC01LTEtMS0w_88005777-c07e-4be4-bac2-832a2eed2243"
      unitRef="usd">2640143000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOC03LTEtMS0w_afdb4079-6a17-46ce-b2d9-dd51cba4b438"
      unitRef="usd">675114000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS0xLTEtMS0w_5b8bfd2c-d00d-41d5-bc48-3d1eab7f5c3d"
      unitRef="usd">309790000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS0zLTEtMS0w_899e5a31-607e-48d1-a7b4-72a57db1d687"
      unitRef="usd">97379000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS01LTEtMS0w_f2dfad5b-80f8-4900-a3ee-006ec1ce2a68"
      unitRef="usd">779090000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfOS03LTEtMS0w_3bbd102c-0442-40dc-b6ee-98be5ba7c2de"
      unitRef="usd">260650000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtMS0xLTEtMA_e9382d54-5eb4-4579-b4aa-346b8c19c016"
      unitRef="usd">14205000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtMy0xLTEtMA_bddf0f66-020f-4f69-950e-9e4236798ef0"
      unitRef="usd">2678000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtNS0xLTEtMA_593fcfa2-a92c-4f9b-a20c-30368bf4be89"
      unitRef="usd">25981000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTAtNy0xLTEtMA_49c8d267-0be1-41cf-bff4-fc3862e06860"
      unitRef="usd">5550000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtMS0xLTEtMA_32fc2ad4-e509-4ebe-a491-712c52d1b077"
      unitRef="usd">1374938000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtMy0xLTEtMA_c42b761e-e7cb-4ad1-b663-eaf0126e9ae9"
      unitRef="usd">411376000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtNS0xLTEtMA_31aeef63-da1e-4214-b3b0-d152e293f791"
      unitRef="usd">3445214000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTEtNy0xLTEtMA_9c8381d0-41ee-490e-9300-5b621cd31c1f"
      unitRef="usd">941314000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItMS0xLTEtMA_be9741d7-cb87-40ce-92c7-7baf6928063e"
      unitRef="usd">-296281000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItMy0xLTEtMA_eeace158-050f-435b-8d4c-de5ee714260b"
      unitRef="usd">-59256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItNS0xLTEtMA_faf77327-75a0-4414-b7a3-e9f0831feda8"
      unitRef="usd">-378159000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTItNy0xLTEtMA_54672f40-b889-4bc6-afc9-ff7f278a0804"
      unitRef="usd">-93772000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtMS0xLTEtMA_08d6817d-9d87-49d6-9842-56c673a7a245"
      unitRef="usd">1594000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtMy0xLTEtMA_3e1cd0ab-48f5-47fe-be42-8c5c66f984d4"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtNS0xLTEtMA_376a9a49-ed0a-43a7-b1b0-b22dba359305"
      unitRef="usd">6282000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTMtNy0xLTEtMA_daa003e9-1c03-40d5-be9a-717e13685fd5"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncome
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMS0xLTEtNDI2Mw_1fbef73b-4148-4061-b8dc-ad17c9ab841a"
      unitRef="usd">1226000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMy0xLTEtNDI2Mw_b5c8470e-5f14-41e7-8bc2-b4e48eadbdea"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNS0xLTEtNDI2Mw_7eef9cfe-4e7c-4760-aa8c-37a596373a4a"
      unitRef="usd">1226000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNy0xLTEtNDI2Mw_fc5bcf4c-b0c2-492f-b041-26932e685445"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMS0xLTEtMA_7712f6e9-528d-4bfc-9570-1d20cab4a084"
      unitRef="usd">-296649000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtMy0xLTEtMA_ee4d4da8-7631-47fa-8368-3f690782cae7"
      unitRef="usd">-59256000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNS0xLTEtMA_9991ff3e-e746-4d85-ad40-43b25a5d4611"
      unitRef="usd">-383215000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTQtNy0xLTEtMA_d77e1192-ca71-45e5-b742-986401a3b751"
      unitRef="usd">-93772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtMS0xLTEtMA_9d2a8c5b-1f61-44f0-80a2-30563b3e3a42"
      unitRef="usd">73000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtMy0xLTEtMA_818d0454-65b1-4e01-b088-de0b76a83c1e"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtNS0xLTEtMA_bba3ddf7-092e-424a-9435-f9ff37858623"
      unitRef="usd">-18225000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTUtNy0xLTEtMA_9b45469a-8e6b-44ce-a47c-89367000acfa"
      unitRef="usd">-9162000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtMS0xLTEtMA_72b30769-913a-48d1-9cb2-f3571200cd16"
      unitRef="usd">-296722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtMy0xLTEtMA_7df64348-e821-49c8-b0e5-4a781c413fdd"
      unitRef="usd">-59256000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtNS0xLTEtMA_5c2d21ce-a2dd-4a46-bceb-3dc0608ef21b"
      unitRef="usd">-364990000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTYtNy0xLTEtMA_7069c192-199c-4785-8c01-4bcb58bad40f"
      unitRef="usd">-84610000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctMS0xLTEtMA_e8061af5-d702-46d0-917e-fd988a074a8c"
      unitRef="usd">3942000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctMy0xLTEtMA_7b8a2f3d-bc4c-4ced-a936-688a1c7afc9c"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctNS0xLTEtMA_4a3d5f9a-22a3-45e7-859f-433a4de35d65"
      unitRef="usd">5354000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTctNy0xLTEtMA_5f3e0c75-e3e7-402a-a966-f521c5d752e2"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtMS0xLTEtMA_b7be0adb-9f32-4624-82cf-fdb669364fc1"
      unitRef="usd">-300664000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtMy0xLTEtMA_baaf684e-ddab-492d-abab-7ab8aec45969"
      unitRef="usd">-59256000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtNS0xLTEtMA_8181e3f2-30a6-44fa-93ba-3fdc5995d4b7"
      unitRef="usd">-370344000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTgtNy0xLTEtMA_ce2262c7-3a93-484c-b529-922556b1ba89"
      unitRef="usd">-84610000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMS0xLTEtMA_aac3ab39-1705-41b0-9572-0e271ca70e35"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMS0xLTEtMA_ad20cdb9-7ab4-4673-aaa1-1f5b0dd5648d"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMy0xLTEtMA_0a5e24de-ef13-4f90-ba23-8552a21627b7"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktMy0xLTEtMA_3eda63a8-3beb-4dcf-98be-778feb77d912"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNS0xLTEtMA_2f7eedea-9607-4ff7-b9e3-447759c04b3a"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNS0xLTEtMA_a613000f-3f36-42ac-9596-75e578799c38"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNy0xLTEtMA_4909bbe2-0ca8-4633-9209-53ecf538a6b5"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMTktNy0xLTEtMA_a1e88855-2769-4a56-a429-926aeaddec88"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMS0xLTEtMA_a1e49d9d-c6d9-4e5f-a504-0c62735c5036"
      unitRef="shares">630378</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMS0xLTEtMA_fe826953-6e32-4cc6-b55e-55bc7747d4b8"
      unitRef="shares">630378</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMy0xLTEtMA_28008c6e-353c-4f23-bec2-eb390cc2564d"
      unitRef="shares">136337</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtMy0xLTEtMA_a0fea8b9-ddc1-43b6-96b0-ca8973b38f49"
      unitRef="shares">136337</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNS0xLTEtMA_aa239402-2c7a-4fda-b13e-4b6184d42efa"
      unitRef="shares">312294</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNS0xLTEtMA_ca308be1-9bdd-4408-9fac-a44a098e2e06"
      unitRef="shares">312294</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNy0xLTEtMA_53545a93-d311-4ae0-aef9-a06f6ba175ca"
      unitRef="shares">135926</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yMi9mcmFnOjRjYjE1MTFjNWYwNjQzMWY5NTBlNTY5N2Q5ZjIzYjhkL3RhYmxlOjI0ZjhmYjM4NWZkMzQ5MGRhZGVjY2Y1NDkyNjNjOGY1L3RhYmxlcmFuZ2U6MjRmOGZiMzg1ZmQzNDkwZGFkZWNjZjU0OTI2M2M4ZjVfMjAtNy0xLTEtMA_61647438-4c25-4f03-a32e-c0b1b50ad007"
      unitRef="shares">135926</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi0xLTEtMS0w_ada715cf-1c53-4010-9874-7664b9c93a8f"
      unitRef="usd">-296722000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi0zLTEtMS0w_2cb73325-7848-40b3-a462-62473e78db3b"
      unitRef="usd">-59256000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi01LTEtMS0w_5e8e57d4-bbd1-4913-be5c-bd8ceefe0362"
      unitRef="usd">-364990000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfMi03LTEtMS0w_84c75df7-0f61-4ff5-a055-6fd92b701e7c"
      unitRef="usd">-84610000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfODg_1ec579ab-5502-4210-808a-0a60d678110d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfODg_857b3e8b-a91c-4c57-a633-dbb543ccbbed"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfOTU_969a50d2-abb8-489d-8e00-81f38fc84fac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0wLTEtMS0wL3RleHRyZWdpb246NDk0OTYwNjQwM2UyNDA0NDhiZDM4ZjVhNDc3MDU4MGJfOTU_ffdd43ec-8c41-458c-a7d5-3d5ea2c91517"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0xLTEtMS0w_a8327ceb-72e4-482a-8861-709daa035f5a"
      unitRef="usd">-143000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC0zLTEtMS0w_64d1285f-24b4-40d3-b50f-7f869d0c3aaf"
      unitRef="usd">-958000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC01LTEtMS0w_242680cc-7ee0-4a24-a727-f9ba3537f7ba"
      unitRef="usd">-1808000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNC03LTEtMS0w_5cfe8c21-6528-40f1-b70e-adaba62513ec"
      unitRef="usd">2326000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfODQ_5490daf4-5922-4e32-ad97-a1572b14f532"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfODQ_c8a69801-6d25-42b3-83a9-0722beafe28a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfOTE_b7d9ae40-b52d-4ee3-9a6c-aa4c44050707"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0wLTEtMS0wL3RleHRyZWdpb246Y2IyZmQ4MjI3MDRkNDVhYmIwMzI5YmRlNTA4MTQ1NzlfOTE_d62c6ee8-ec63-4ad0-8386-df06e94fbebd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0xLTEtMS0w_7d1c6907-dce8-4bd3-91af-c6936a96327d"
      unitRef="usd">160000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS0zLTEtMS0w_a83f8e4e-9db2-401e-9f23-eb3fb60a14d8"
      unitRef="usd">119000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS01LTEtMS0w_fda19eb7-124f-41bf-ad7a-30f5a9e19325"
      unitRef="usd">388000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNS03LTEtMS0w_d7c21a13-f51d-4e37-92c2-194e9a269427"
      unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi0xLTEtMS0w_9a98ac3f-ecc1-4244-bf99-66e286dd957e"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi0zLTEtMS0w_db5ecf01-b31c-4c71-9775-b0d7939605ea"
      unitRef="usd">-1077000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi01LTEtMS0w_3464ecab-7829-4066-b33e-2d287fa20a2c"
      unitRef="usd">-2196000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNi03LTEtMS0w_860411d7-791f-43ac-9e40-ac367046df36"
      unitRef="usd">2258000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy0xLTEtMS0w_d0981608-54de-4ec6-aaa8-588387aa3b56"
      unitRef="usd">-297025000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy0zLTEtMS0w_5ef6e0f5-2e92-4e72-8600-67e8740814cb"
      unitRef="usd">-60333000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy01LTEtMS0w_c510312f-4187-4a10-86c5-bdf21a84a342"
      unitRef="usd">-367186000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfNy03LTEtMS0w_78cf56fa-cdec-44c1-ad68-81ed61d20329"
      unitRef="usd">-82352000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC0xLTEtMS0w_f2d3ff3c-23c7-40ad-a4e2-262007b67c0b"
      unitRef="usd">3942000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC0zLTEtMS0w_0c37d675-472e-4975-b4c3-b759cc309757"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC01LTEtMS0w_39ab8e49-ec67-4652-b8d4-4a5fc1d8deda"
      unitRef="usd">5354000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOC03LTEtMS0w_0aab2d61-dc92-418e-9777-847e5ce11619"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS0xLTEtMS0w_a6a53d58-9269-433a-8ac9-ba15d74a98ae"
      unitRef="usd">-300967000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS0zLTEtMS0w_12d23d06-4e7b-4fa0-a47b-baf898e462f3"
      unitRef="usd">-60333000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS01LTEtMS0w_0e132ec4-8ab2-499a-bc7d-1f37874c81af"
      unitRef="usd">-372540000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yNS9mcmFnOjdkNTg0ZjEwNWIxZTQzNmI5N2JkNzY1ZjRlYzBkNWE3L3RhYmxlOjI5ODM3ZDgzNWNkNjRiZDRiNjkzMDI0YjA4NzVmODI3L3RhYmxlcmFuZ2U6Mjk4MzdkODM1Y2Q2NGJkNGI2OTMwMjRiMDg3NWY4MjdfOS03LTEtMS0w_1c601869-95ca-41cd-8c96-9675e42dd42a"
      unitRef="usd">-82352000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xLTEtMS0w_4475b077-f707-4f08-84a7-5e5d2786ba51"
      unitRef="shares">164245000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0zLTEtMS0w_5c4819c1-8c67-4744-ae78-aca8842dbc0b"
      unitRef="usd">1681015000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8393f93f84a6414b91b167951bef057f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi02LTEtMS0w_a5d2c439-3737-43d6-be10-80126fbfe82e"
      unitRef="shares">137663000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8393f93f84a6414b91b167951bef057f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi04LTEtMS0w_fd7a8852-ffe3-44a5-a337-f4288034ab12"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie6f868825a854ad29b00d7c27d6e2c83_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xMC0xLTEtMA_2844f652-0c18-49ac-8e6a-5e365463bd1b"
      unitRef="usd">9877000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4871efe74704f978b993ba51fc2ad6d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xMi0xLTEtMA_375b5867-e1de-4cff-a530-074e58fc920c"
      unitRef="usd">-515989000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i411ffa67bd024b8fba87e9c64077fcf2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xNC0xLTEtMA_2abf39a3-7876-4b25-b166-e45ff80d7f5e"
      unitRef="usd">2426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMi0xNi0xLTEtMA_4722b5b0-65ad-4842-b09b-7c0cc0c49437"
      unitRef="usd">-503672000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0137f0a50f174a078570affe987b9897_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMy0xMi0xLTEtMA_60bed3eb-f2d7-4471-b771-ec85e318e99d"
      unitRef="usd">-25162000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMy0xNi0xLTEtMA_85bd7640-1792-422c-9c62-3dbe145f8314"
      unitRef="usd">-25162000</us-gaap:NetIncomeLoss>
    <bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNC0xLTEtMS0w_3f6c3f7e-ff9c-4f94-b4d3-491b2232b17a"
      unitRef="shares">1420000</bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNC0zLTEtMS0w_9d6f5b59-0ea6-41e9-90e9-bf6c28c5e046"
      unitRef="usd">55137000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5a1a3fb2febf422abccd9d03e715acf0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS02LTEtMS0w_c001c112-5043-4809-b056-fbe8738b37c4"
      unitRef="shares">4661000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS0xMC0xLTEtMA_6c5d3856-6b93-4687-b5e9-70dd2a6c420c"
      unitRef="usd">4893000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNS0xNi0xLTEtMA_cbbb4290-0caa-44a9-bb2d-4f25fb205149"
      unitRef="usd">4893000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7acd5276173244c7b179bbb14e476f8e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNi0xMC0xLTEtMA_f8a8eacf-8a36-4a25-b596-451ec2f97e6d"
      unitRef="usd">5176000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNi0xNi0xLTEtMA_db1ca29e-930f-4220-b971-b9f3262825c2"
      unitRef="usd">5176000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idd11786a418e4ce4b107cb2441a2f8de_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNy0xNC0xLTEtMA_dc65baa4-c0c1-4cda-a2bf-42419167fdd1"
      unitRef="usd">-1042000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfNy0xNi0xLTEtMA_480d8284-57f7-42c2-aedc-83be6fa443cc"
      unitRef="usd">-1042000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xLTEtMS0w_7facd64e-ed25-485a-b92d-99e4440d9c0e"
      unitRef="shares">165665000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0zLTEtMS0w_46edea63-cc07-48bc-a484-edcdb9f86fac"
      unitRef="usd">1736152000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i30e3312456d94b45b58360f1365cce93_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC02LTEtMS0w_2047dd24-f3c4-41aa-bb09-2da6b3b58e8e"
      unitRef="shares">142324000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i30e3312456d94b45b58360f1365cce93_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC04LTEtMS0w_309c1fe7-6c05-4097-96ce-1ee3bda186cc"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73597c3d3a334263ab2aa9d6b4f46f20_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xMC0xLTEtMA_da7c0db4-9ede-4345-9873-d81b7668dcd7"
      unitRef="usd">19946000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i896eec808e0343cfbae2f717934e71b4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xMi0xLTEtMA_3ebe8cd3-24a9-4b74-b6ab-6cb8583e057b"
      unitRef="usd">-541151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59037bc717a449289317ac0d87adea87_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xNC0xLTEtMA_fe5275f7-a772-4e72-b397-bad2345a8f2e"
      unitRef="usd">1384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfOC0xNi0xLTEtMA_a7776c1b-b4da-4ad9-b8c5-b16f525d6b38"
      unitRef="usd">-519807000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i63e4858120f3454984bb4f44d0b45435_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTAtMTItMS0xLTA_f778e27c-1384-4092-8216-56812045233a"
      unitRef="usd">-44518000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTAtMTYtMS0xLTA_a2bfd734-0811-4baa-8855-d6e0ca324151"
      unitRef="usd">-44518000</us-gaap:NetIncomeLoss>
    <bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTEtMS0xLTEtMA_158471c0-fc49-4040-8195-6657033101e4"
      unitRef="shares">2067000</bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTEtMy0xLTEtMA_cfb5f77f-bf8f-4cc7-8d73-6db03706a403"
      unitRef="usd">79807000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <bhg:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMS0xLTEtMA_0153c4d6-fcf5-4c47-9fa3-293fe3e4c69e"
      unitRef="shares">167732000</bhg:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <bhg:TemporaryEquityValueConversionOfConvertibleSecurities
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMy0xLTEtMA_1e9d8a46-e847-431d-9f94-3c4d5659c8e3"
      unitRef="usd">1815959000</bhg:TemporaryEquityValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItNi0xLTEtMA_111aff56-7cf9-4aa3-b48f-344d99e89c95"
      unitRef="shares">427897000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItOC0xLTEtMA_bf660ecb-2c13-4d54-bbe4-52f3d0dd43f1"
      unitRef="usd">43000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMTAtMS0xLTA_799288f1-dea1-4c8a-93ed-db39ba5d23f5"
      unitRef="usd">1815916000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTItMTYtMS0xLTA_568c135c-6590-4e3b-a1d7-9afa859b547e"
      unitRef="usd">1815959000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtNi0xLTEtMA_284a103a-9bc8-4c04-8bbe-f420d762cf32"
      unitRef="shares">4120000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i01ba2fb3493545a8baaeba51887f7ef9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtOC0xLTEtMA_f1b773b4-4a48-4a63-baf7-ac73d865fc1e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtMTAtMS0xLTA_0665b48c-565d-4e35-8247-2fb44c4e4b0f"
      unitRef="usd">4722000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTMtMTYtMS0xLTA_457c6b56-5d77-435a-a21c-41b564f07444"
      unitRef="usd">4723000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtNi0xLTEtMA_10f6324e-5c58-4714-a67d-d43260877b40"
      unitRef="shares">51350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifb8db942ad8b4cbfaeb110a8e870bfe4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtOC0xLTEtMA_d71e4583-1989-4c66-8da9-5e1149da25e6"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9c76927d0c87485f81b0c99ec31fe573_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtMTAtMS0xLTA_fd387ab3-1708-4de7-937c-356b776587c7"
      unitRef="usd">880637000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie5496876444a4be489375b4c022ef150_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTQtMTYtMS0xLTA_22e60191-e2e8-4dab-81a4-78ba2ff51d40"
      unitRef="usd">880642000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3b53c9e93ea446b0bdda459b09495424_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTUtMTAtMS0xLTA_6d5c1ba0-2ef0-4cd1-a6ad-898b6f8b7a7b"
      unitRef="usd">13878000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTUtMTYtMS0xLTA_51697592-7d33-4169-bdd7-54f980e91f13"
      unitRef="usd">13878000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0da7eda6089f40dc80394423712bac8c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTYtMTQtMS0xLTA_2b7bf60b-74ee-48d4-8305-afe9334cec25"
      unitRef="usd">-851000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTYtMTYtMS0xLTA_86d913b7-84b1-4d4b-9c2b-db8c1fa9cc49"
      unitRef="usd">-851000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMS0xLTEtMA_eaa28c60-872d-4667-a0a0-2b58a48b3649"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMy0xLTEtMA_079bb022-9d2d-4406-ba5a-ea6e9ea302a4"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib1632e2cf7834f558bc296dd7d180324_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctNi0xLTEtMA_ccac810e-0125-4c54-b4c4-585faff2103b"
      unitRef="shares">625691000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib1632e2cf7834f558bc296dd7d180324_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctOC0xLTEtMA_dbe5423a-d834-4e02-97d3-b01f6535e901"
      unitRef="usd">63000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9381960dce441ae877f25e0db8e3933_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTAtMS0xLTA_70fc8d73-e726-4f9e-9bf1-bcb840fe48bf"
      unitRef="usd">2735099000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib20155a3f7a940acb68c19efd45e42d9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTItMS0xLTA_f03ee7dd-976b-4bd5-bce7-76a514003078"
      unitRef="usd">-585669000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f7a6f0ef29542f884edade6bd7d8ef0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTQtMS0xLTA_2c9fb4ab-ee89-4de9-8842-4e2bb4a4972b"
      unitRef="usd">533000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTctMTYtMS0xLTA_fc24b667-975c-4081-8a85-119586076ff2"
      unitRef="usd">2150026000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i253d2d1e76de471f92bb9665c552586f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTktMTItMS0xLTM0_106217ea-9756-4104-920f-cd92b903a4a5"
      unitRef="usd">-300664000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMTktMTYtMS0xLTM0_25b2cc3e-b65c-49e2-903f-752270221d9e"
      unitRef="usd">-300664000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItNi0xLTEtMzQ_d319058e-f00f-4a55-b418-b4b161af236f"
      unitRef="shares">4965000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTAtMS0xLTM0_ec6c983e-b893-4838-a4a7-f2980516428a"
      unitRef="usd">75965000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTYtMS0xLTM0_8d19f43b-5de7-44e6-b01d-bae283bf0c46"
      unitRef="usd">75965000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <bhg:StockReturnedDuringPeriodSharesEscrowSettlement
      contextRef="i5db2aa6ddadf4702a682c7cb0843aede_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItNi0xLTEtMTk1MDM_f975a6b1-67c3-45d8-8009-ab4167dba6d3"
      unitRef="shares">-2522000</bhg:StockReturnedDuringPeriodSharesEscrowSettlement>
    <bhg:StockReturnedDuringPeriodValueEscrowSettlement
      contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTAtMS0xLTE5NTAz_7f58ccdf-9a71-4434-be8b-acf43004a10e"
      unitRef="usd">12000000</bhg:StockReturnedDuringPeriodValueEscrowSettlement>
    <bhg:StockReturnedDuringPeriodValueEscrowSettlement
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjItMTYtMS0xLTE5NTAz_b83d3335-a1ed-44ea-9d31-5170ba6c3599"
      unitRef="usd">12000000</bhg:StockReturnedDuringPeriodValueEscrowSettlement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9f0043f3b6ab4c8cbf3a37cad687f068_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjQtMTAtMS0xLTM0_a61eb33a-ce88-4165-ad94-8c5fdc5cf606"
      unitRef="usd">24180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjQtMTYtMS0xLTM0_29134cb8-9551-4990-adc4-d5b0a721f734"
      unitRef="usd">24180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib665d31bf9d7437591781fd1d77c6b99_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjUtMTQtMS0xLTM0_25a598d1-9a96-4408-9a04-476357d26107"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjUtMTYtMS0xLTM0_ed2491bb-5fba-489c-bed2-043dcf94fcd2"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMS0xLTEtMzQ_725a07d5-39d2-40b1-b232-1e9ff6c734a5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMy0xLTEtMzQ_44083351-a6d6-44ac-ae04-2f488525da55"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie46639bd73344ddebb19d877ee0b947c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtNi0xLTEtMzQ_e8caf6f4-41e4-4719-9118-ab4cae669ec2"
      unitRef="shares">628134000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie46639bd73344ddebb19d877ee0b947c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtOC0xLTEtMzQ_deffabb0-8a99-47bb-8ac5-822da8dd9220"
      unitRef="usd">63000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i649e794681cf4cca99c2536e968dc812_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTAtMS0xLTM0_7f7b66c6-522a-40f0-847b-26bf9e0f06c7"
      unitRef="usd">2823244000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i17ef0d69fb47479bb3350e333c9f7181_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTItMS0xLTM0_673d596f-8b79-4a2f-8f63-f3a38cf232e1"
      unitRef="usd">-886333000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie606262a9d784da09df56adafa6c1538_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTQtMS0xLTM0_53411568-18cf-457c-90a3-230ba01b17d9"
      unitRef="usd">230000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOmFlMDM0MGU4MDkzYTQxZDhiODgwZGNiYTVkZGIwN2YzL3RhYmxlcmFuZ2U6YWUwMzQwZTgwOTNhNDFkOGI4ODBkY2JhNWRkYjA3ZjNfMjYtMTYtMS0xLTM0_577ce409-821a-4eab-83e0-1404855c1831"
      unitRef="usd">1937204000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xLTEtMS0w_77050885-1b4c-4101-bb5f-599adc9f8f7d"
      unitRef="shares">119222000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0zLTEtMS0w_ace55c25-c433-4124-813c-9b53ca6bd5c8"
      unitRef="usd">871990000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi02LTEtMS0w_a07a1a3b-8ec3-4ac2-9d70-3cab636a6a99"
      unitRef="shares">135509000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i47f7ed1d8aa24b0b88950034ff6d247d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi04LTEtMS0w_09cd96f4-4dd4-4fd1-8bf3-82a3432b61c1"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie882f1e05dbb484bb99d78576ac4d175_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xMC0xLTEtMA_8b4aa729-d821-4768-86a5-318fde22d549"
      unitRef="usd">3184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ac918bc38544218819b0a101da9f295_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xMi0xLTEtMA_221ed5b7-288b-4f38-ba14-24b40fa04202"
      unitRef="usd">-267547000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4e64ca59c864ed9a6e56e45243b353f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xNC0xLTEtMA_2267141c-33cd-4354-868e-d532d13e4d4c"
      unitRef="usd">982000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMi0xNi0xLTEtMA_2389b285-fa7c-4c72-9281-fff617238023"
      unitRef="usd">-263367000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="id4aa6030d8ef4580b4eb924a05e135f7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMy0xMi0xLTEtMA_421dbca6-156d-4b11-9db3-ff49c0daceed"
      unitRef="usd">-7280000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMy0xNi0xLTEtMA_ed1f0b8f-f6e9-4cec-8df6-f29b562a9415"
      unitRef="usd">-7280000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="icc061278f0da4aa9a0f13da8c2ab475d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS02LTEtMS0w_1a701978-721a-463a-94f6-4df3320415cf"
      unitRef="shares">183000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS0xMC0xLTEtMA_039b0406-2486-4f33-b144-d42d9efc30b1"
      unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNS0xNi0xLTEtMA_016ec1f2-fcb0-4046-9f8c-1b8ac8f024a8"
      unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib932014c338f4e6fa63b32bada81670c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNi0xMC0xLTEtMA_1815a57d-8c17-4665-8edd-47d1b9392649"
      unitRef="usd">943000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNi0xNi0xLTEtMA_73f537a7-004f-4958-8523-c63a7cea3822"
      unitRef="usd">943000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ice6dc6d47370425b9fce3a98c5650ffc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNy0xNC0xLTEtMA_965ddb0b-7ef8-431f-b7bc-a4e8b0c71a44"
      unitRef="usd">951000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idca5df77de9e47b99f476652cd4da52e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfNy0xNi0xLTEtMA_d49e72bb-7376-4b05-a7fd-91e336ff8d9d"
      unitRef="usd">951000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xLTEtMS0w_f5f9f221-7368-4dba-852c-482f65ed8f54"
      unitRef="shares">119222000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0zLTEtMS0w_121e384f-cc61-46c3-804b-c9d218a46bfc"
      unitRef="usd">871990000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9545d10c15f3484799e95f2fa94df37a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC02LTEtMS0w_8fa0c9f4-8601-45bd-9cd4-c6fccc25bdec"
      unitRef="shares">135692000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9545d10c15f3484799e95f2fa94df37a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC04LTEtMS0w_6f88f04c-0c4c-452f-96ca-fcb66e358a70"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iad985bb842b24424b5f51535a74e0d20_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xMC0xLTEtMA_ebeb0c8a-e4a9-4aa0-b610-af91b90c040c"
      unitRef="usd">4140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1467d7e2eba4616ad00ffd76e8ea421_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xMi0xLTEtMA_9b5484d1-8183-4993-b7cd-f544e8a29b99"
      unitRef="usd">-274827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i715014b57d1441db9f72b2c4fc26c971_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xNC0xLTEtMA_7c5f2480-2aad-44f2-801c-8ff957619224"
      unitRef="usd">1933000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i544c254ae4234f02a8ea8433f7111c6b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfOC0xNi0xLTEtMA_de893070-e91d-4796-95c3-bc6006a95e22"
      unitRef="usd">-268740000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ib18c4a2f0ce64d00b414ff7d7e5d76d7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTAtMTItMS0xLTA_24082b03-0073-4bb8-b94d-7c35b327e5e5"
      unitRef="usd">-18074000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTAtMTYtMS0xLTA_d882a518-57ca-40f2-a9d0-2c08cbeed81d"
      unitRef="usd">-18074000</us-gaap:NetIncomeLoss>
    <bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTEtMS0xLTEtMA_35429a30-d0b6-4c6f-aba0-dd577d6005fb"
      unitRef="shares">19661000</bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTEtMy0xLTEtMA_49d05bc7-8cf9-4a17-9f88-62f3a4dfcac3"
      unitRef="usd">291200000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="iab3b38cf004a47bfb5f9ff6a8663bb04_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItNi0xLTEtMA_18b3ca66-d2a9-4346-8775-c1857fcc71d7"
      unitRef="shares">246000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItMTAtMS0xLTA_dae5a6db-b4ad-47c2-af4c-00e969e3443b"
      unitRef="usd">118000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTItMTYtMS0xLTA_1f3661b4-6aae-4f55-b368-45b64850cfa4"
      unitRef="usd">118000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia4e960facc184c639fd3109edc0b4859_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTMtMTAtMS0xLTA_cd83b1be-c134-4ca6-a0ff-4ccb8059b378"
      unitRef="usd">1250000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTMtMTYtMS0xLTA_92886c85-c2f1-4efc-b652-be02a9ddc108"
      unitRef="usd">1250000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia97167ac64ec4bb6b360504ece6d65a6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTQtMTQtMS0xLTA_82491d38-108e-4bfb-bca3-59904657bf3b"
      unitRef="usd">2384000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i54745e29b9fb45a09c3e2b30acc04116_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTQtMTYtMS0xLTA_7f794942-245c-45ad-b6bd-7b89a0541a85"
      unitRef="usd">2384000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMS0xLTEtMA_a4d00140-48e5-4e63-a209-8274978000c0"
      unitRef="shares">138883000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMy0xLTEtMA_400fcb58-534f-4a46-a92a-51afe9635360"
      unitRef="usd">1163190000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i439d50f322e748c2a9db9431eb49add8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtNi0xLTEtMA_61e7dcd2-72fc-414c-8a54-37fd15caae1c"
      unitRef="shares">135938000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i439d50f322e748c2a9db9431eb49add8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtOC0xLTEtMA_24050008-aaa1-4610-8ae4-c5f9032f4629"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbdb64c5b993489fa19ab055445e7cb5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTAtMS0xLTA_85e49611-5b82-493a-a936-e35b090a1c30"
      unitRef="usd">5508000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3d52ed33ef14b8d95901deef872bce1_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTItMS0xLTA_e9b33ff7-eac3-4d89-b886-5e2cd69bf41b"
      unitRef="usd">-292901000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1ee8a98ff3284e9a89cb462c1a5975cb_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTQtMS0xLTA_ca293984-fe2f-47a0-94ca-21a35beec912"
      unitRef="usd">4317000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1d60eac239514d1986be1ece58c50aff_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTUtMTYtMS0xLTA_ac7d2e5e-47fe-4fb8-814d-f706aee4e13a"
      unitRef="usd">-283062000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if9ed5988a89248598fb835a3d6eb8fb1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTYtMTItMS0xLTExNQ_714a9275-0785-46a0-8a2f-24af9ec1b179"
      unitRef="usd">-59256000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTYtMTYtMS0xLTExNQ_321f8b5f-91fe-4b4b-9f87-21cb8e338485"
      unitRef="usd">-59256000</us-gaap:NetIncomeLoss>
    <bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTctMS0xLTEtMTE1_eff6e9a0-14f4-4782-98d7-c854eb146f30"
      unitRef="shares">23296000</bhg:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTctMy0xLTEtMTE1_c0d842d3-19eb-49fa-831a-648071c24acd"
      unitRef="usd">475640000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i217634c8da0246ab92821d26990e7ab8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtNi0xLTEtMTE1_79f2685e-e671-4081-8952-6c876b9f8038"
      unitRef="shares">882000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtMTAtMS0xLTExNQ_0bb10c77-98d2-4832-998a-fdaae900b9cf"
      unitRef="usd">743000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTgtMTYtMS0xLTExNQ_6902a456-e0fb-4d35-9c28-5a2cb4a4a5bf"
      unitRef="usd">743000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id5978bcd41074dd3b869b4cac84faf9a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTktMTAtMS0xLTExNQ_0701cdae-43a5-44e8-bfaa-3922dff346ac"
      unitRef="usd">1529000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMTktMTYtMS0xLTExNQ_e9ccffee-c4a6-43d6-83e5-093ce622d258"
      unitRef="usd">1529000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1208c83ea17943c393f48af48a7323f6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjAtMTQtMS0xLTExNQ_9c9cd2ab-e2e8-4199-8b97-bb03c5988776"
      unitRef="usd">-1077000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjAtMTYtMS0xLTExNQ_aa120371-ba97-4a06-a62c-91052bf48c00"
      unitRef="usd">-1077000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMS0xLTEtMTE1_c8648b3b-fdc4-4087-aec2-4c4ed388d6d6"
      unitRef="shares">162179000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMy0xLTEtMTE1_9d0d6785-ed4f-4cab-bb45-57dfc54262d5"
      unitRef="usd">1638830000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtNi0xLTEtMTE1_1a3170e5-b016-429e-badf-6abf631237e9"
      unitRef="shares">136820000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie7bbe257f09a4c43a7b1d0150fd5222d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtOC0xLTEtMTE1_90e9fff9-ee3b-459c-833d-fa3d1b566bf3"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ffb20b6c43f4e73b4c1baaed88a2476_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTAtMS0xLTExNQ_29d43dba-ba1a-4e34-bcea-89cb4edcbfb7"
      unitRef="usd">7780000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fb28b0bad874df383fc182d52bcd000_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTItMS0xLTExNQ_25b9c16e-dfd6-44fb-808c-659b9fb80da9"
      unitRef="usd">-352157000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e7b09a7c5084223a5134c48364d9483_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTQtMS0xLTExNQ_785cea7e-e36b-46c5-b0a2-49865764666d"
      unitRef="usd">3240000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8yOC9mcmFnOjhiNzA4ZWZlY2Y4MjQ3ZGViYzQwZWE3OGEyZWZhOWEwL3RhYmxlOjgxODA5YWE2OGFjMjRiMWJiYjNhODRhNjE1Yjg0M2Q4L3RhYmxlcmFuZ2U6ODE4MDlhYTY4YWMyNGIxYmJiM2E4NGE2MTViODQzZDhfMjEtMTYtMS0xLTExNQ_85970654-701d-41a5-b8c6-66e6e5561ba7"
      unitRef="usd">-341123000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMy0xLTEtMS0w_13dce82c-948e-4556-8971-9043780816e1"
      unitRef="usd">-370344000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMy0zLTEtMS0w_a4c05e3d-06dc-4430-9a27-d044da0bb4b6"
      unitRef="usd">-84610000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNS0xLTEtMS0w_1c8255cf-70ed-4129-a8f9-a9c590c370d1"
      unitRef="usd">25981000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNS0zLTEtMS0w_bc8391ae-89a0-4a00-987a-b79d45013df6"
      unitRef="usd">5550000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNi0xLTEtMS0w_4a57a2e8-420a-4175-901c-27a6d797cb70"
      unitRef="usd">43234000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNi0zLTEtMS0w_81f7af3b-065b-43ff-a0ac-d24c377c367c"
      unitRef="usd">3722000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNy0xLTEtMS0w_74d1eeb3-76fb-4753-82ff-c8246a22b296"
      unitRef="usd">-17946000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNy0zLTEtMS0w_4005c66a-b4de-4e49-9076-011d2e9b5477"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOC0xLTEtMS0w_df51f6e3-7145-4002-a7b4-384ded0ed736"
      unitRef="usd">109012000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOC0zLTEtMS0w_92c9d5e9-4024-447a-9b35-94376f38fe38"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOS0xLTEtMS0w_62197662-9875-4162-bd03-857b1f76a28b"
      unitRef="usd">-14555000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfOS0zLTEtMS0w_29878fd9-fb07-4d16-b85b-fe1b6578923b"
      unitRef="usd">-1022000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTEtMS0xLTEtMA_a63826ca-4498-4c75-ab76-daa4fb11ffb7"
      unitRef="usd">18683000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTEtMy0xLTEtMA_64d8288f-862a-4d45-a188-4dc6080e9fba"
      unitRef="usd">-27508000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTItMS0xLTEtMA_1c5f169a-0fa2-43ef-b5cd-9e8050366c41"
      unitRef="usd">86836000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTItMy0xLTEtMA_607e09c8-ba1f-4bb6-89a2-65c548258a61"
      unitRef="usd">24980000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTMtMS0xLTEtMA_c6fb4930-a219-446e-b22f-fd97635538c8"
      unitRef="usd">342531000</us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve>
    <us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTMtMy0xLTEtMA_729a6cdd-91a4-45d1-b643-f0aefa815dc8"
      unitRef="usd">35458000</us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve>
    <bhg:IncreaseDecreaseInRiskAdjustmentPayable
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTQtMS0xLTEtMA_82eee0e6-ae31-4eba-9142-e4357af5afd2"
      unitRef="usd">359257000</bhg:IncreaseDecreaseInRiskAdjustmentPayable>
    <bhg:IncreaseDecreaseInRiskAdjustmentPayable
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTQtMy0xLTEtMA_53b6180d-ba29-4555-9f86-b75cb69b38f6"
      unitRef="usd">68186000</bhg:IncreaseDecreaseInRiskAdjustmentPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTUtMS0xLTEtMA_fa8bf980-530a-4f4c-a681-9a69775f3ee0"
      unitRef="usd">53853000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTUtMy0xLTEtMA_1b4fb938-6d08-4f97-a09c-51fc33c2c104"
      unitRef="usd">-22015000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInUnearnedPremiums
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTYtMS0xLTEtMA_8d911c33-ad14-4f65-870c-16bb33d4ae96"
      unitRef="usd">-3476000</us-gaap:IncreaseDecreaseInUnearnedPremiums>
    <us-gaap:IncreaseDecreaseInUnearnedPremiums
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTYtMy0xLTEtMA_9d0edee8-6555-41a1-874c-c4ad012af3e7"
      unitRef="usd">1498000</us-gaap:IncreaseDecreaseInUnearnedPremiums>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTctMS0xLTEtMA_a2e7ea62-7d6a-479a-ab51-6c7deffb0f42"
      unitRef="usd">233114000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTctMy0xLTEtMA_c72cc86a-f505-4bc7-a9b8-7566e29a3206"
      unitRef="usd">11339000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTktMS0xLTEtMA_df3320a7-d26b-488e-9239-3c4ea67b7032"
      unitRef="usd">736838000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMTktMy0xLTEtMA_823abf5e-5064-426b-aa72-005073ae0650"
      unitRef="usd">702672000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjAtMS0xLTEtMA_e2485174-4180-40a2-9388-1fea916f7f59"
      unitRef="usd">536110000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjAtMy0xLTEtMA_5a1ac7c6-43d0-42c2-99cc-b9f78c58a87f"
      unitRef="usd">349113000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjEtMS0xLTEtMA_1512b9a6-6949-4905-b267-f0e1e571aca7"
      unitRef="usd">20682000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjEtMy0xLTEtMA_9a938933-dfc9-4fec-b4aa-e4eb8a8be739"
      unitRef="usd">1181000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjItMS0xLTEtMA_6eb81685-6052-4b79-8577-64bb3d85d2e0"
      unitRef="usd">431718000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjItMy0xLTEtMA_48209369-4a91-47fe-9f50-b7c98a9bc012"
      unitRef="usd">174090000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjMtMS0xLTEtMA_153d330c-8d11-4c00-b687-c412a9e0d34f"
      unitRef="usd">-653128000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjMtMy0xLTEtMA_e297b26f-83da-46b9-a78d-398bc469b92b"
      unitRef="usd">-528830000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjUtMS0xLTEtMA_bb36ddcc-66a7-4a90-aa0d-a5bb9975b0c3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjUtMy0xLTEtMA_031798a8-e375-48ee-88c1-70569daf8a95"
      unitRef="usd">686840000</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjYtMS0xLTEtMA_12f3329e-7023-418b-a8ef-6fa18fa147c5"
      unitRef="usd">10581000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjYtMy0xLTEtMA_1948dcf5-3fc9-4055-8be2-bf49a70955e6"
      unitRef="usd">874000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjctMS0xLTEtMA_513bbc1f-affa-4ef0-a946-a7d86d86185f"
      unitRef="usd">200000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjctMy0xLTEtMA_13ac0763-14d8-4ca5-ac5d-dece959c1c6f"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjgtMS0xLTEtMA_8456ba5e-0e65-4ccc-86c1-dacb5f04b390"
      unitRef="usd">200000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjgtMy0xLTEtMA_772c1aea-3898-45d6-825a-21ade6717a5d"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjktMS0xLTEtMA_ab75ee20-828a-4c94-8a6e-d7707df2169c"
      unitRef="usd">3391000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMjktMy0xLTEtMA_d1ee9448-0384-467a-aee8-9854301e0ba1"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzAtMS0xLTEtMA_bcf1c563-dc10-4247-9fdc-07bd430398f1"
      unitRef="usd">887328000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzAtMy0xLTEtMA_c3e18c8f-f0fc-4dd5-898a-d7c7e3df232b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzEtMS0xLTEtMA_c69e8dfe-cca3-41ba-b861-939c67c63319"
      unitRef="usd">6686000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzEtMy0xLTEtMA_e95a163b-5c83-4e33-ab34-055b8684e618"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzItMS0xLTEtMA_3169a830-2135-482f-a6ff-d65a154751d9"
      unitRef="usd">887832000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzItMy0xLTEtMA_1d1cabf5-29f2-46ed-94cb-406a97288c81"
      unitRef="usd">687714000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzMtMS0xLTEtMA_189068e0-ef9e-4cbc-88d9-1af4e1db46c5"
      unitRef="usd">467818000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzMtMy0xLTEtMA_83d83b74-0442-4fe8-addf-530440f83aac"
      unitRef="usd">170223000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzQtMS0xLTEtMA_fe284fa2-e0d4-4246-8c22-3c2b6f8d41a3"
      unitRef="usd">488371000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzQtMy0xLTEtMA_1c2a9960-e880-4bc8-8f85-77b70788262e"
      unitRef="usd">522910000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzUtMS0xLTEtMA_a4a96b33-21dc-4515-8dec-4ddf9873c13f"
      unitRef="usd">956189000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzUtMy0xLTEtMA_0841eb24-f28e-4f1f-bc15-9c98847987a5"
      unitRef="usd">693133000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzctMS0xLTEtMA_693b4a4a-b2ed-4f22-8244-3bc69161da1d"
      unitRef="usd">-2196000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzctMy0xLTEtMA_b0068be7-0096-4d8d-aab9-77d01a0dd1a9"
      unitRef="usd">2258000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:InterestPaidNet
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzgtMS0xLTEtMA_09061390-de89-4c51-b849-8f38696a58d2"
      unitRef="usd">3865000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfMzgtMy0xLTEtMA_9b4d4eb4-4e74-440f-86a3-5c694603668b"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:StockIssued1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDAtMS0xLTEtMA_c18e7fb1-f188-4355-9633-22104b086297"
      unitRef="usd">134944000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDAtMy0xLTEtMA_4aba2f8a-2cf0-43a9-9d0f-bccde11dcf7a"
      unitRef="usd">80000000</us-gaap:StockIssued1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDEtMS0xLTEtMA_719179a7-120d-471c-8f5d-61f358a79b90"
      unitRef="usd">1815916000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zMS9mcmFnOmUzMWNhNGVkOGJhNzRkMzk5MjMwNWRkMDVjYzE5NDA5L3RhYmxlOmZkNzE4OTMzMjRhYjRhMDI4MGRhMGQ4M2I0YzRmNjRiL3RhYmxlcmFuZ2U6ZmQ3MTg5MzMyNGFiNGEwMjgwZGEwZDgzYjRjNGY2NGJfNDEtMy0xLTEtMA_feafd902-bf17-4700-86c6-9efd66608c5d"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE3Mg_82ef1e59-276e-47b0-a9be-183282729844">ORGANIZATION AND BASIS OF PRESENTATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bright Health Group, Inc. and subsidiaries (collectively, &#x201c;Bright Health,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; or the &#x201c;Company&#x201d;) was founded in 2015 to transform healthcare. Our mission of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Making Healthcare Right.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Together.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;is built upon the belief that by connecting and aligning the local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, reduce systemic waste, lower costs, and optimize clinical outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Split:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On June&#160;2, 2021, we effected a stock split of the Company&#x2019;s common stock on a 1-for-3 basis (the &#x201c;Stock Split&#x201d;). In connection with the Stock Split, the conversion rate for the Company&#x2019;s preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was increased in proportion to the Stock Split. Accordingly, all common stock share and per share amounts for all periods presented in these financial statements have been retroactively adjusted to reflect this Stock Split. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Initial Public Offering:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On June&#160;28, 2021, we completed our initial public offering (&#x201c;IPO&#x201d;) in which we issued and sold &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,350,000 shares of common stock, par value $0.0001 per share, at an offering price of $18.00 per share. We received net proceeds of $887.3 million from the sale of our common stock, after deducting underwriting discounts and commissions of $37.0 million. We used a portion of the net proceeds from our IPO to repay in full our outstanding borrowings under our revolving credit facility, as well as to fund the acquisition of Centrum Medical Holdings, LLC (&#x201c;Centrum&#x201d;). Refer to Note 2, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 7, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Common Stock is traded on the New York Stock Exchange (the &#x201c;NYSE&#x201d;) under the symbol &#x201c;BHG&#x201d;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incurred $6.7&#160;million of deferred offering costs consisting primarily of accounting, legal and other fees related to our IPO, which were recorded against IPO proceeds within additional paid-in capital upon closing of our IPO.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Conversion of Preferred Stock into Common Stock: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;28, 2021, the Company issued 427,897,381 shares of common stock upon conversion (the &#x201c;Conversion&#x201d;) of all outstanding shares of its Series A Convertible Preferred Stock, par value $0.0001 per share, Series B Convertible Preferred Stock, par value $0.0001 per share, Series C Convertible Preferred Stock, par value $0.0001 per share, Series D Convertible Preferred Stock, par value $0.0001 per share, and Series E Convertible Preferred Stock, par value $0.0001 per share (collectively, the &#x201c;Preferred Stock&#x201d;), pursuant to its eighth amended and restated certificate of incorporation. Conversion of the preferred stock into shares of common stock occurred automatically immediately prior to the closing of our IPO. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our audited consolidated financial statements, unless the information contained in those disclosures materially changed or is required by GAAP. As such, the condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes thereto as of and for the year ended December&#160;31, 2020 included in the prospectus dated June 23, 2021 (File No.333-256286) (the &#x201c;Prospectus&#x201d;), as filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. The accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for fair presentation of the interim financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Our most significant estimates include medical costs payable, risk adjustment revenue and associated payables and receivables, valuation and impairment of goodwill and other intangible assets, valuation and impairment of investments and estimates of share-based compensation. Actual results could differ from these estimate&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $134.0&#160;million as a result of updated data inputs used to calculate Individual and Family Plan (&#x201c;IFP&#x201d;) members&#x2019; expected full year risk scores, which resulted in an increase in risk adjustment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payable in the Condensed Consolidated Balance Sheets and a reduction in premium revenue in the Condensed Consolidated Statements of Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our operating costs, by functional classification for the three and nine months ended September&#160;30, 2021 and 2020, are as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and fringe benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;143,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and selling expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;183,636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78,802&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;217,739&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;309,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;779,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued and Adopted Accounting Pronouncements:&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no accounting pronouncements that were recently issued and not yet adopted or adopted since our audited consolidated financial statements that had, or are expected to have, a material impact on our consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="i2d75a8b417104e2e99acca850c6fd16f_D20210602-20210602"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNjA0_27178124-a48e-43a3-8bf6-ead085cf0c1f"
      unitRef="number">3</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTE2NA_a24cd11c-3aaa-4969-86fc-410ef0447062"
      unitRef="shares">51350000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia8f1c51b74e14129bd0f91602963e036_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTIwMQ_635bbff4-7e85-4ace-84e3-a3f5980ccd8f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i3eb69ad6e15b4395bf5d632879271c37_I20210628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTIzOQ_f4d9f4fb-9c86-47e6-b9dc-84ee4b21893b"
      unitRef="usdPerShare">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTI4MQ_c3ef0712-f243-4834-90a8-fa7f6627fec3"
      unitRef="usd">887300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i692caf09aca8497ea71bd3ad17d7476b_D20210628-20210628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTM3Nw_e2263d8e-b301-410e-8fb0-9113708b48b3"
      unitRef="usd">37000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i3eb69ad6e15b4395bf5d632879271c37_I20210628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMTgwOQ_8c068719-19c7-4938-849c-54fcea979c41"
      unitRef="usd">6700000</us-gaap:DeferredOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i8955d418b9e348a09575068e6bd96030_D20210628-20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjA5Mg_d5c98b8f-cea7-49d5-a5bd-108f14b86f9e"
      unitRef="shares">427897381</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="ia21467a131f241a8b54be2659b98dd34_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjIyOA_12b18de4-a989-486d-b62c-5db5c695e794"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i122e578042ed4e84b1d841704471a4a9_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjI4NA_88ce0548-84dd-4cc2-8280-cb6cf367eb25"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i1b79375e653b4c6ab22e579ba0de8468_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjM0MA_c88ad710-d12f-4862-8983-b4adfa03cb59"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="iffd914077e9f404a9da2a417b56c4672_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjM5Ng_6c1eea27-149a-4be9-86a5-d40ca0d90fbc"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i837392de0aa64e87bfdcc482e5eb4682_I20210628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMjQ1Ng_7e8156f8-bbad-430b-bec3-8fb16896449e"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2Nw_3630325c-b2c6-4cfb-93e9-191a8d3f8a50">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our audited consolidated financial statements, unless the information contained in those disclosures materially changed or is required by GAAP. As such, the condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes thereto as of and for the year ended December&#160;31, 2020 included in the prospectus dated June 23, 2021 (File No.333-256286) (the &#x201c;Prospectus&#x201d;), as filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. The accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for fair presentation of the interim financial statements.&lt;/span&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2OA_f7ddd0de-5fb9-4aab-b8b7-aa7a3a577823">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Our most significant estimates include medical costs payable, risk adjustment revenue and associated payables and receivables, valuation and impairment of goodwill and other intangible assets, valuation and impairment of investments and estimates of share-based compensation. Actual results could differ from these estimate&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $134.0&#160;million as a result of updated data inputs used to calculate Individual and Family Plan (&#x201c;IFP&#x201d;) members&#x2019; expected full year risk scores, which resulted in an increase in risk adjustment &lt;/span&gt;payable in the Condensed Consolidated Balance Sheets and a reduction in premium revenue in the Condensed Consolidated Statements of Income (Loss).</us-gaap:UseOfEstimates>
    <bhg:RiskAdjustmentPayableCurrent
      contextRef="i5759a0d876be449aac313ca0615a3807_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMzI5ODUzNDg4OTkwMg_b2af109b-1b20-49ed-a83d-f3c92303b310"
      unitRef="usd">134000000</bhg:RiskAdjustmentPayableCurrent>
    <us-gaap:PremiumsEarnedNet
      contextRef="if396eed261f24ec59dcf755f4bcd3906_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfMzI5ODUzNDg4OTkwMg_fc85ae02-0bc0-47e4-a645-4c2717130656"
      unitRef="usd">-134000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE3MQ_c4eb35d3-eda5-4403-aa1f-ad83917c6f01">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our operating costs, by functional classification for the three and nine months ended September&#160;30, 2021 and 2020, are as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and fringe benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;143,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and selling expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;183,636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78,802&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;217,739&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;309,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;779,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock>
    <us-gaap:LaborAndRelatedExpense
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi0xLTEtMS0w_751e4777-13ae-42c8-8748-559f4e571f40"
      unitRef="usd">100062000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi0zLTEtMS0w_2ba4de35-a5aa-4c70-b608-7a0388a99a47"
      unitRef="usd">35588000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi01LTEtMS0w_8ab901db-1917-4281-9c14-eade34b62c6a"
      unitRef="usd">234467000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMi03LTEtMS0w_e947fbe7-0149-482e-8a4b-59815c2ee571"
      unitRef="usd">92589000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy0xLTEtMS0w_235e0bf2-3840-4370-b0e6-bda36a6a1952"
      unitRef="usd">61483000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy0zLTEtMS0w_6cd96d67-6506-492a-afb5-fd0ae7a5f2c9"
      unitRef="usd">20745000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy01LTEtMS0w_3cc94820-01a9-4df2-9039-3cfa79bf38a9"
      unitRef="usd">143248000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfMy03LTEtMS0w_e747442f-a9ec-40b1-addc-c40b1740829c"
      unitRef="usd">53381000</us-gaap:ProfessionalFees>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC0xLTEtMS0w_7006e803-0bdd-4345-b59b-6bd234f5a731"
      unitRef="usd">69443000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC0zLTEtMS0w_3c42d053-a516-49b4-9f27-f95e86512a5d"
      unitRef="usd">15941000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC01LTEtMS0w_a92a8ad4-d627-4a5c-b9a4-a21919750dbf"
      unitRef="usd">183636000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNC03LTEtMS0w_cf194595-fe5e-42b3-bc84-fe91b5996cb9"
      unitRef="usd">39056000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS0xLTEtMS0w_80462aba-c069-4312-b915-fe0fa7afdddd"
      unitRef="usd">78802000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS0zLTEtMS0w_506cd38e-493b-4099-aae5-0edf4e5e88e0"
      unitRef="usd">25105000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS01LTEtMS0w_5b2a08cf-37bd-4b0a-8fed-02c91cfc0bb2"
      unitRef="usd">217739000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNS03LTEtMS0w_3af3b10c-c9bb-48e2-a8b3-337b38ec246f"
      unitRef="usd">75624000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi0xLTEtMS0w_4abe31d2-08b5-4d9f-966b-7da9186236ab"
      unitRef="usd">309790000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi0zLTEtMS0w_4c9abd31-fc2c-4472-b759-3871eaba64ab"
      unitRef="usd">97379000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi01LTEtMS0w_d04a8d1a-9041-4fe5-aa81-5bc99ec48c56"
      unitRef="usd">779090000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RhYmxlOjJlNmVhMjQ4ZmQwOTRjNDNhZmRjYWI3Y2Y4YWJlNzVhL3RhYmxlcmFuZ2U6MmU2ZWEyNDhmZDA5NGM0M2FmZGNhYjdjZjhhYmU3NWFfNi03LTEtMS0w_8a15a02c-6734-4af1-9342-b419edbb87cd"
      unitRef="usd">260650000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV8zNy9mcmFnOjU2ZjcyMzY1NjQ4ZDQ5YmNhYjZjOWJhNjk1YTIwNWJmL3RleHRyZWdpb246NTZmNzIzNjU2NDhkNDliY2FiNmM5YmE2OTVhMjA1YmZfNTE2OQ_97cff50c-9915-423c-9c5d-b8fa8f8f66ef">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued and Adopted Accounting Pronouncements:&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no accounting pronouncements that were recently issued and not yet adopted or adopted since our audited consolidated financial statements that had, or are expected to have, a material impact on our consolidated financial position, results of operations, or cash flows.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMjE_b80a2819-c1fe-4b1e-bb22-1801296d46b5">BUSINESS COMBINATIONS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centrum Acquisition: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;1, 2021, we acquired 75% of the outstanding equity interests of Centrum for cash consideration of $222.4 million and $75.0 million of common stock, for total purchase consideration of $296.2 million, net of $1.2 million of cash acquired. Centrum is a value-based primary care focused, multi-specialty medical group based in Florida. Centrum operates 17 health centers in Florida, serving Commercial, Medicare, and Medicaid consumers across multiple payors, with secured expansion locations in Texas and North Carolina. Centrum is included in our NeueHealth reportable segment. Transaction costs of $1.0 million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total preliminary purchase consideration for the Centrum acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill, which is predominantly attributable to the incremental financial benefits achievable through Bright Health Group&#x2019;s integrated care delivery model, whereby Bright HealthCare members are cared for under value-based arrangements with Centrum. This model brings together the financing, distribution, and delivery of high-quality healthcare and provides the opportunity to enhance overall margin potential for the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the Centrum acquisition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:105%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary fair values of acquired assets and liabilities assumed represent management&#x2019;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. The Company is in process of identifying any additional intangible assets that would reduce the goodwill recognized. The fair values of certain assets and liabilities have changed from previous disclosure. We obtained additional information to estimate the fair value of the right-of-use lease asset and liability included within other assets and other liabilities. We also updated the fair value of intangible assets based on the methodologies described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our preliminary estimate of intangible assets related to the Centrum acquisition consists of trade names with a 15-year useful life, customer relationships with 2- to 15-year useful lives, and a reacquired contract between Bright HealthCare and Centrum with a useful life of 4.5 years. The value of the trade name was determined using the relief of royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements. The fair value of noncontrolling interest was determined using a market approach and included a discount to account for the lack of marketability of the noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition of Centrum would not have had a material impact on our revenue or net loss had it been included in the consolidated results of the Company for the nine months ended September 30, 2021 or the three and nine months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Central Health Plan&#160;Acquisition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On April&#160;1, 2021, we acquired all of the outstanding shares of Central Health Plan of California, Inc. (&#x201c;CHP&#x201d;) for cash consideration of $276.0 million and $79.8 million in Series&#160;E preferred stock, for total purchase consideration of $271.7 million, net of $84.1 million of cash acquired. CHP is an insurance provider of Medicare Advantage (&#x201c;MA&#x201d;) HMO services. CHP is included in our Bright HealthCare reportable segment. Transaction costs &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of $0.2 million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September&#160;30, 2021, out of $1.4 million of total transaction cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s we have incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total preliminary purchase consideration for the CHP acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for CHP is attributable to synergies from leveraging CHP&#x2019;s clinical model and California consumer expertise to continue to expand our MA business in the California market. The goodwill is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the CHP acquisition&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary fair values of acquired assets and liabilities assumed represent management&#x2019;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our preliminary estimate of intangible assets related to the CHP acquisition consists of customer relationships with a 10-year useful life, trade names with a 15-year useful life and the provider network with a 7-year useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro&#160;forma financial information presents our revenue and net loss as if CHP had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and the three and nine months ended September&#160;30, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pro Forma Consolidated Statements of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,195,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;True Health New Mexico and Zipnosis Acquisitions:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On March&#160;31, 2021 we acquired all of the outstanding equity interests of True Health New Mexico, Inc. (&#x201c;THNM&#x201d;) for cash consideration of $27.5 million, net of cash acquired of $24.1 million, for total purchase consideration of $3.4 million. THNM is a physician-led health insurance company offering policies available through the commercial market for individual on- and off-exchange and employer-sponsored health coverage. THNM is included in our Bright HealthCare reportable segment. In addition, on March&#160;31, 2021, we acquired Zipnosis, Inc. (&#x201c;Zipnosis&#x201d;), which is a telehealth platform that offers virtual care to health systems around the U.S., for aggregate consideration of $73.0 million, including $55.1 million in Series&#160;E preferred stock and adjusted for $0.5 million of tangible net equity adjustments. We acquired $3.2 million of cash as part of the Zipnosis acquisition, for net total purchase consideration of $69.8 million. Zipnosis is included in our NeueHealth reportable segment. Transaction costs of $0.5 million incurred in connection with these acquisitions are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total preliminary purchase consideration for the THNM and Zipnosis acquisitions is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for THNM is attributable to synergies from leveraging THNM&#x2019;s strong local clinical model of care and the ability to enter into a new state of strategic interest for future growth and expansion. The goodwill from the Zipnosis acquisition is attributable to benefits from the ability to enhance our proprietary technology platform, DocSquad, and Zipnosis&#x2019; attractive virtual care capabilities to enhance Bright Health&#x2019;s consumer and provider connectivity. The goodwill from the THNM and Zipnosis acquisitions is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the THNM and Zipnosis acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;THNM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zipnosis&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary fair values of acquired assets and liabilities assumed represent management&#x2019;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our preliminary estimate of intangible assets related to the THNM acquisition consists of customer relationships with 10-to 14-year useful lives, trade names with a 15-year useful life and the provider network with a 7-year useful life. For the Zipnosis acquisition, our preliminary estimate of intangible assets consists of customer relationships with a 15-year useful life, trade names with a 5-year useful life and developed technology with a 7-year useful life. For these acquisitions the value of the trade names and developed technology was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro&#160;forma financial information presents our revenue and net loss as if THNM and Zipnosis had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and three and nine months ended September&#160;30, 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pro Forma Consolidated Statements of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,114,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(372,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PMA Acquisition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On December&#160;31, 2020, we acquired a 62% controlling interest in Premier Medical Associates of Florida, LLC (&#x201c;PMA&#x201d;) in exchange for $74.2 million. PMA provides care services to Medicare and Medicaid patients in Florida through a network of primary care providers and population health-focused specialists. The acquisition of PMA is expected to enhance our clinical capabilities to better serve enrollees as part of our Florida market expansion. The total purchase consideration for the PMA acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The purchase price allocation is preliminary and subject to change, including the valuation of property, equipment and capitalized software and intangible assets, among other items. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BND Acquisition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On April&#160;30, 2020, we acquired all of the outstanding shares of Universal Care, Inc. (d.b.a. Brand New Day) (&#x201c;BND&#x201d;). BND is a leader in providing healthcare services in California and serves Medicare eligible seniors and special needs populations through their extensive network of primary care providers and specialists. BND combines analytics and evidence-based clinical programs with aligned provider relationships to provide high quality, affordable care for complex and vulnerable populations. The total consideration included $206.9 million in cash and $80.0 million in Bright Health Series&#160;D preferred stock. We have since applied indemnity escrow adjustments of $44.0 million to the acquisition price, bringing total consideration to $210.1 million, net of cash acquired of $32.8 million. Transaction costs of $3.8 million incurred in connection with the acquisition are included in operating costs in the Consolidated Statements of Income (Loss) for the year ended December&#160;31, 2020. If BND had been included in the consolidated results of the Company for the nine months ended September&#160;30, 2020, our pro&#160;forma revenue would have been $1.0 billion, and our pro forma net loss would have been $(100.9) million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase consideration for the BND acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The goodwill is attributable to synergies from leveraging BND&#x2019;s strong clinical model of care to drive growth in our MA business outside of California. The goodwill from the BND acquisition is not deductible for tax purposes. The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the BND acquisition, as well as measurement adjustments made in the nine&#160;months ended September&#160;30, 2021 to the amounts initially recorded in 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized as of &lt;br/&gt;Acquisition Date&lt;br/&gt;(as previously reported)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Measurement &lt;br/&gt;Period &lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized as of &lt;br/&gt;Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other currents assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The measurement period adjustments above primarily resulted from completing valuations for certain intangible assets. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the acquisition date is immaterial to the consolidated financial statements. We recognized intangible assets related to the BND acquisition, which consist of $25.6 million for the BND trade name with an estimated useful life of 15 years, customer relationships valued at $46.9 million with a 12-year useful life, and $2.0 million of other intangibles related to the provider network with a 10-year useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNzc_30c91311-5a2b-449f-a760-801d44b24b69"
      unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTUz_7a410543-3fb7-4f02-9e5c-6102edc1b31f"
      unitRef="usd">222400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTY4_dec0fe50-5052-4a74-847a-419af4a4493b"
      unitRef="usd">75000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjMy_0ab7fbd2-3ac6-40dd-8826-80c1794cb6ef"
      unitRef="usd">296200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjUx_55ce50bd-2894-4767-9740-dbc70dbe22b9"
      unitRef="usd">1200000</us-gaap:CashAcquiredFromAcquisition>
    <bhg:NumberOfHealthCenters
      contextRef="i478dde417c3f4d2d895cbacfc27124f7_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNDQy_7d7a7ce2-f4a2-4ac7-a667-79684ab35294"
      unitRef="healthcenter">17</bhg:NumberOfHealthCenters>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i107c6a9c6a5f4b72b6a388858fbcfaf8_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjkw_74740334-60d8-4531-8c01-5b627ab86a8f"
      unitRef="usd">1000000.0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i42f62b97d0d14e2a80908c5ba5ce1ce7_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjkw_788d13b1-415a-4423-ad89-1a374c766da5"
      unitRef="usd">1000000.0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTA_fa45499f-bf89-4f50-af52-4ac1846f77b5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the Centrum acquisition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:105%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the CHP acquisition&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the THNM and Zipnosis acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;THNM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zipnosis&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the BND acquisition, as well as measurement adjustments made in the nine&#160;months ended September&#160;30, 2021 to the amounts initially recorded in 2020&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized as of &lt;br/&gt;Acquisition Date&lt;br/&gt;(as previously reported)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Measurement &lt;br/&gt;Period &lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized as of &lt;br/&gt;Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other currents assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identified assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMC0xLTEtMS0w_3ffa90f2-040b-4d99-92ad-8b1dd3916746"
      unitRef="usd">1874000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMS0xLTEtMS0w_ba977207-3413-460a-8e90-d701505c7c5c"
      unitRef="usd">627000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMi0xLTEtMS0w_6954410a-1580-4f8b-b827-ba33dbdf44f9"
      unitRef="usd">2557000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMy0xLTEtMS0w_5a4c7b31-06b0-4aa2-93e8-f27a656b97dc"
      unitRef="usd">102370000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNC0xLTEtMS0w_06d4b018-9bd9-4070-8a55-f702a292ac52"
      unitRef="usd">8917000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNS0xLTEtMS0w_47a2f2a1-a17c-44e4-bbb4-16f03a20ebe1"
      unitRef="usd">116345000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNi0xLTEtMS0yMDM4Nw_157799f5-cd7f-4973-afc0-6c76d949cd7e"
      unitRef="usd">19000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfNy0xLTEtMS0w_634679b3-cf40-4f1b-bc4b-454d94bdba88"
      unitRef="usd">359000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfOC0xLTEtMS0w_7054e98f-a016-4d06-8af8-2a8f109f54b1"
      unitRef="usd">861000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfOS0xLTEtMS0w_adde30d0-dfe0-46d4-8aa8-1368a2f52a84"
      unitRef="usd">11636000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTAtMS0xLTEtMA_a892def0-cb1d-44a1-8a5a-e55722168a5a"
      unitRef="usd">12875000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTEtMS0xLTEtMA_4bce3801-3808-4797-9772-d10e948b6436"
      unitRef="usd">103470000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTItMS0xLTEtMA_faedb5c4-8474-439e-b211-2716e707ac4d"
      unitRef="usd">277831000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTMtMS0xLTEtMA_1c8b8ef8-886f-4097-b59d-01e9ba58815f"
      unitRef="usd">85075000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="ic898e99881d641128dfcfc367e765db9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjFiMTYxMDJkMTFlZDRmMWNiYTYyNGUxNTQ3MGEzNTk2L3RhYmxlcmFuZ2U6MWIxNjEwMmQxMWVkNGYxY2JhNjI0ZTE1NDcwYTM1OTZfMTQtMS0xLTEtMA_4657a8fe-0de0-4564-9f4d-e52a25ba017f"
      unitRef="usd">296226000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i437f51b176c14704a8d187469131515e_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI3MQ_90fafed6-f7dc-466e-ba4d-4d4a8501df1c">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6a20a27e64cb4a15b3a57eea10b70269_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI4MQ_33d45df1-ff1a-4bba-842a-7b7bfbf11b53">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id8c4c3b025d849189363e133e0b11e87_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNDI5OQ_8e19ca58-aa6d-4494-a2d7-aaeeded230e8">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifacffe1d832f42b7bdf2a5102beadd9c_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI5ODUzNDkwNTE4MA_fe52c3b5-6563-49ad-9259-242342592247">P4Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzE5NA_158859be-a2fd-42cc-ae35-2803c8d12fc4"
      unitRef="usd">276000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzIwMQ_306fa0a2-8ccc-46f4-abed-c6e75e1ea82f"
      unitRef="usd">79800000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI2OQ_94469042-1fa4-4068-81b8-8956ffe2a903"
      unitRef="usd">271700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ibfe6134300944a47a86bd7ef89503c2c_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzI4MA_94fb9007-ca65-4f93-985f-e8e52128c35b"
      unitRef="usd">84100000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzQ1NQ_c6bffa1c-e0b4-4108-a6c2-2cf8355f147e"
      unitRef="usd">200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic41d330372d542e286128a811bcd3408_D20200701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMzYyNw_34cc9316-1d43-44f9-b239-22c28b190c21"
      unitRef="usd">1400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMC0xLTEtMS0w_fbb0fa98-c7b8-4bad-af17-80beac92db63"
      unitRef="usd">16361000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMS0xLTEtMS0w_5af65ec7-0451-4bd8-b9b1-861201074180"
      unitRef="usd">19041000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMi0xLTEtMS0w_04ca1d24-3726-4954-b031-20b324b0a9b0"
      unitRef="usd">25520000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMy0xLTEtMS0w_3f002b2a-c526-4339-9d5d-4e9f0c4d067d"
      unitRef="usd">370000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNC0xLTEtMS0w_e34fc267-5078-4002-8f7b-535949f2929d"
      unitRef="usd">102000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNS0xLTEtMS0w_8f039dc8-2a42-4c2c-82d3-60dd3b221470"
      unitRef="usd">163292000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNi0xLTEtMS0w_f07e62dc-698d-4b75-bcdd-77d018ba8082"
      unitRef="usd">79450000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfNy0xLTEtMS0w_68da8408-cb49-44cc-b0eb-ee66c5860965"
      unitRef="usd">2371000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfOC0xLTEtMS0w_e814d530-ff35-4b21-8015-12361847e5ca"
      unitRef="usd">17212000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfOS0xLTEtMS0w_7befabbb-b107-4d4b-b244-0aad61bd51c1"
      unitRef="usd">28622000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTAtMS0xLTEtMA_900dd331-f6b0-4542-867a-96293a588469"
      unitRef="usd">127655000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTEtMS0xLTEtMA_4f6abbf2-e3e7-4fb5-b3b6-0bd348c684d2"
      unitRef="usd">35637000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTItMS0xLTEtMA_f153de26-d9e0-47fa-8987-25810ede284c"
      unitRef="usd">236037000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i906967f82f324f7e83d7e378327d6632_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjg1Mzc1ZWExMjY2NDQxNDZiMzU5YmRmNTE2YTRiMjhkL3RhYmxlcmFuZ2U6ODUzNzVlYTEyNjY0NDE0NmIzNTliZGY1MTZhNGIyOGRfMTMtMS0xLTEtMA_f4ed06fc-9f76-4101-b1a3-c07e1faa05d7"
      unitRef="usd">271674000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i36358997c9554e299250c29d1edc21ce_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTU_493f4843-420b-4bad-b839-f9f6596c4421">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6b87a30e39784613942ef3b1ffe359c9_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTY_1e74c042-b254-4673-a94e-6ae2991cb48b">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic68b8f77cc0c4feb964ea6ff561a07fc_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDM_75df13d9-7462-4718-b345-d9efafa6f061">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTc_1ff217de-85be-4cb9-bf82-4efecff2b6df">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro&#160;forma financial information presents our revenue and net loss as if CHP had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and the three and nine months ended September&#160;30, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pro Forma Consolidated Statements of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,195,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro&#160;forma financial information presents our revenue and net loss as if THNM and Zipnosis had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and three and nine months ended September&#160;30, 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pro Forma Consolidated Statements of Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,114,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(372,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC0xLTEtMS0w_13f4405d-3ba5-49ac-bf43-585d0070f621"
      unitRef="usd">502378000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC0zLTEtMS0w_32ec7da6-c683-485e-961e-928078c81983"
      unitRef="usd">3195925000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNC01LTEtMS0w_220d89b4-b7e7-4979-ad7d-08634de302be"
      unitRef="usd">1263016000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS0xLTEtMS0w_2ad846db-07af-41c0-9274-54bfdec552de"
      unitRef="usd">-49157000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ic90f6c79ac5b476680c86973349e1760_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS0zLTEtMS0w_e72531de-cda1-4318-8060-44e10fff3afe"
      unitRef="usd">-358935000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="idd5cefbd5fb649d19b11baad2e5387af_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmEzZTJiOTFiOWU5YTQ3ZGNhM2I3MjM4MDE2MzdjYzNmL3RhYmxlcmFuZ2U6YTNlMmI5MWI5ZTlhNDdkY2EzYjcyMzgwMTYzN2NjM2ZfNS01LTEtMS0w_1db468c7-1e01-4465-83da-bfa977e02184"
      unitRef="usd">-70971000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjA3Nw_85ce01cb-5c9f-44dc-9e95-405b5cecf362"
      unitRef="usd">27500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjEwNQ_b883c748-5a18-4954-b2b9-0e0b3c0f09f2"
      unitRef="usd">24100000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibe6c671414324d66bd976d6751ac7aa9_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjE0NQ_c66fcbe0-2200-494c-8835-dc3c3a7e11f0"
      unitRef="usd">3400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjU4OQ_2450b375-627f-40e8-b3e3-82923be27e39"
      unitRef="usd">73000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjYwMw_d41fcf46-9f0a-411c-b3ca-8bf34defc574"
      unitRef="usd">55100000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <bhg:BusinessCombinationTangibleNetEquityAdjustment
      contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMjE5OTAyMzI3NjY1Mw_3866a03c-63a2-41d7-b3f3-8052aefb4620"
      unitRef="usd">500000</bhg:BusinessCombinationTangibleNetEquityAdjustment>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjY0Nw_80542684-5fcd-4bbc-bb16-1388993172a0"
      unitRef="usd">3200000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib758e0347e6f4280b80b0904a33db612_D20210331-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjczNQ_fa9aa802-c7f7-4049-ae17-15e4f0119f4a"
      unitRef="usd">69800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="idd0973903cab4deeb08dfc70ef9dd0e8_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjgxOQ_8712f7f3-fef2-4165-8aa4-c5c6e5d5aaf4"
      unitRef="usd">500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0e7e862b6f944cf1a7a7807ff6aa4abf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfNjgxOQ_bff74120-beb6-4975-99aa-e8eda98faf2c"
      unitRef="usd">500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMS0xLTEtMS0w_b631c8e6-d954-4dea-8491-21ca74033962"
      unitRef="usd">714000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMS0zLTEtMS0w_7de52ead-f015-4a52-8c8b-ab8c4b67450a"
      unitRef="usd">1062000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMi0xLTEtMS0w_d9d09805-1a8e-46ac-ab3d-d74ff7661451"
      unitRef="usd">4677000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMi0zLTEtMS0w_4456ad66-0f3e-4d2a-b080-f5b713cb385d"
      unitRef="usd">0</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMy0xLTEtMS0w_06c75007-2b23-4394-8005-560bd05b62c4"
      unitRef="usd">8337000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMy0zLTEtMS0w_a394e7ac-4509-470b-a981-1923cb269d2c"
      unitRef="usd">141000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNC0xLTEtMS0w_edd8687b-f597-4731-8de6-3e9fca80e594"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNC0zLTEtMS0w_808861c6-3b84-4676-9966-dda973eab51b"
      unitRef="usd">232000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNS0xLTEtMS0w_d04852c2-5062-4e5b-8a15-9bc7024ff45d"
      unitRef="usd">7300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNS0zLTEtMS0w_c08add9c-39b8-46ba-be94-68782449111e"
      unitRef="usd">8970000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNi0xLTEtMS0w_b7d90633-537f-4ae0-bf15-6fdedd7e3c5e"
      unitRef="usd">13081000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNi0zLTEtMS0w_0fff8c28-e8e1-47b5-8c38-57b1a1071239"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNy0xLTEtMS0w_d0d050b8-49d8-4041-a3f1-942bf2bb6caa"
      unitRef="usd">1324000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfNy0zLTEtMS0w_ff65fbdf-3843-415e-b83e-cb1486bb0943"
      unitRef="usd">766000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOC0xLTEtMS0w_d3da9ea3-a216-4ccf-9687-b823b1b3cc9a"
      unitRef="usd">35433000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOC0zLTEtMS0w_d90576e5-80f8-4152-9207-7b09eec69eb1"
      unitRef="usd">11171000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOS0xLTEtMS0w_e225e50f-7df8-41c1-a7bc-e06b5e1f1432"
      unitRef="usd">13268000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfOS0zLTEtMS0w_0e7f2fcf-a82f-491d-8ff8-82e04c20a5c1"
      unitRef="usd">0</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTAtMS0xLTEtMA_a2d3f781-276c-4505-bc1e-b755efcdc5eb"
      unitRef="usd">14663000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTAtMy0xLTEtMA_4e683c89-7e85-4d07-91b4-2c0aa00fa1ca"
      unitRef="usd">136000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTEtMS0xLTEtMA_52fae9ef-de02-4bec-a8cb-09651d38f3c2"
      unitRef="usd">3645000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTEtMy0xLTEtMA_0e6fd782-b810-4acc-bd5f-b1dadd7c82c9"
      unitRef="usd">120000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTItMS0xLTEtMA_318133cc-d26f-4070-aa6a-a9cd3567b5cc"
      unitRef="usd">2682000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTItMy0xLTEtMA_1ac43013-a761-4b1f-8320-1bd60bbf5307"
      unitRef="usd">665000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTMtMS0xLTEtMA_7137a724-faef-4c84-a80f-7f8270836128"
      unitRef="usd">2499000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTMtMy0xLTEtMA_28be34e3-24de-4f44-95f2-ecff19d96d1c"
      unitRef="usd">2730000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTQtMS0xLTEtMA_be4e6fb4-b696-4630-bb39-ebefa576a2f3"
      unitRef="usd">36757000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTQtMy0xLTEtMA_e7529ed0-ce15-4f25-88f8-f158dd7e6cf1"
      unitRef="usd">3651000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTUtMS0xLTEtMA_ab08b527-1cab-449c-823c-5412ae193ff2"
      unitRef="usd">-1324000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTUtMy0xLTEtMA_a56594cf-28a2-4aae-9538-81126208b394"
      unitRef="usd">7520000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTYtMS0xLTEtMA_40eb46c7-13b7-43e1-8bfe-f18cc8008352"
      unitRef="usd">4739000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTYtMy0xLTEtMA_15015785-9865-4ddd-99b8-3898ee430c1e"
      unitRef="usd">62277000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i23ea924109b24362b4aa90947da7cb3d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTctMS0xLTEtMA_62b76945-5596-4dcb-8316-3368417b5fab"
      unitRef="usd">3415000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i2ff7d600f0fb419da2a1a8454585cb8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjQxOTE1NDMyMDJkMzRiZDJiZjI4ZDg2ZmNmMGUxZWM5L3RhYmxlcmFuZ2U6NDE5MTU0MzIwMmQzNGJkMmJmMjhkODZmY2YwZTFlYzlfMTctMy0xLTEtMA_3334633c-93e3-406a-ab0a-89d9336f99f7"
      unitRef="usd">69797000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia24617e1d9eb4076b54c7d7e70276339_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfODM5Mw_f82849ea-bafa-440c-a119-b653fde3007f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7786594de6244ae6a5a8034a5ce9da7e_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDc_a39f9c93-f7b8-4a24-af93-4774f243ad79">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9f0afeba703f4eecbfd79b0b0ac66c51_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTk_a3f8817a-04a7-4e57-9e0b-5ad68bf2d3e9">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if9c829a59ac144c2a6c38f54d48e9328_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDg_14ff9cec-72b1-40da-9d4c-ab3850aef60e">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib88d85b6051d4282a78fa46340280420_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTM_8eaad204-cc8f-4610-a9d8-d97d92cce7f3">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id5d4bddbfcfe456aa8f422cf2a237786_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDU_e919231a-edaf-469d-850e-b4bd33df593e">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3914765d423b4a628de3214723906cf7_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMjA_fb7384f8-3262-479d-a00d-b2ff6d4a4cd5">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie4d081fc23d14e75a64545999d205679_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC0xLTEtMS0w_b238d08c-7f3a-4353-be0e-62affac78cee"
      unitRef="usd">384797000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC0zLTEtMS0w_5b08c176-63e8-4669-b85f-d6ca82d5f7dc"
      unitRef="usd">3114954000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i88b028119331454b86c135bc40e6d46f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNC01LTEtMS0w_fe455ac4-5075-4718-8960-745c9d2454dd"
      unitRef="usd">943286000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie4d081fc23d14e75a64545999d205679_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS0xLTEtMS0w_104a4939-b3af-49a3-8b4b-3be9f7f6cf0f"
      unitRef="usd">-57035000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i426819431e3b4e08b28e288a4617e66c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS0zLTEtMS0w_692eaa46-a5a4-432c-8c1c-f3f8c12c279b"
      unitRef="usd">-372315000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i88b028119331454b86c135bc40e6d46f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOjM0ZGNjNWNkNjM3ZjRmMjY5OWM1ODRhYmM4MGM2MGNkL3RhYmxlcmFuZ2U6MzRkY2M1Y2Q2MzdmNGYyNjk5YzU4NGFiYzgwYzYwY2RfNS01LTEtMS0w_7f4dfd99-d573-474b-a147-cc1c632a6f49"
      unitRef="usd">-85988000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iabcc40d305134dce85d3cf3faaea6c2c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfOTI4Mw_5c09806c-d59f-4d1b-aad4-ca76ea0ccf9a"
      unitRef="number">0.62</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3f1e0f30291346f1bd501e797f389c07_D20201231-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfOTM3Nw_74c20ddc-9ef0-4d67-a027-2be2179ce356"
      unitRef="usd">74200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA4NTQ_3642fdbc-992c-40cc-85db-d8c62da0b98a"
      unitRef="usd">206900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA4Njk_38b8fc10-376a-4c6b-b895-0c3d26d4bcda"
      unitRef="usd">80000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <bhg:BusinessCombinationEscrowAdjustment
      contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTA5Njk_9cd8d5d4-4129-4afb-8097-cb3167961f95"
      unitRef="usd">-44000000</bhg:BusinessCombinationEscrowAdjustment>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEwMzA_55711c84-ebfa-4647-9347-0c0b9a8320e4"
      unitRef="usd">210100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ie57ed1835bb3404ba61a94c67b23e5e6_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEwNTg_30c42261-b993-47aa-be7e-1ebdd6ddcd1e"
      unitRef="usd">32800000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i9ecbee92cb12427db0c1287be74eabff_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTEyMDI_57a8140e-e042-46c6-85a3-5af23255a8c2"
      unitRef="usd">3800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTE0OTM_d2b89d85-531a-44b0-971c-87556a1265c7"
      unitRef="usd">1000000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i943b5e1ee7de4e178f8f790e72971179_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTE1NjI_26a67c4a-501f-4364-9d2d-c97a898d8807"
      unitRef="usd">-100900000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS0xLTEtMS0w_e20621ea-5ea6-42d2-b962-f64a34c43c69"
      unitRef="usd">74128000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS0zLTEtMS0w_0530fd3b-4ede-41ca-a086-95d20bff9760"
      unitRef="usd">0</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMS01LTEtMS0w_d7d06615-c731-42df-ad32-7a895f78f2c1"
      unitRef="usd">74128000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi0xLTEtMS0w_d933cb2b-dd18-4648-96b1-fdd02096631e"
      unitRef="usd">30583000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi0zLTEtMS0w_7f609542-5acf-4e25-8691-ca8918a11b87"
      unitRef="usd">0</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMi01LTEtMS0w_df4c5f1b-cfcd-4dd7-aad4-9ad0b4325447"
      unitRef="usd">30583000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy0xLTEtMS0w_bba5041f-edee-4f0d-9a47-141d4ea57d29"
      unitRef="usd">4375000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy0zLTEtMS0w_753c61c4-e24f-4a63-a078-159ea55b6b7e"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMy01LTEtMS0w_e753e30e-f688-41ae-aac5-dd7469ce4943"
      unitRef="usd">4375000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC0xLTEtMS0w_1a8ea41e-8931-4e55-aea7-b197ea1c9fa4"
      unitRef="usd">72600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC0zLTEtMS0w_c41d77eb-b5fc-447a-a381-67912a2beede"
      unitRef="usd">1900000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNC01LTEtMS0w_655f986c-c554-4254-8437-dd10b987c7b3"
      unitRef="usd">74500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS0xLTEtMS0w_128c14f4-5f8a-420d-a125-5e17abb6220a"
      unitRef="usd">2906000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS0zLTEtMS0w_dbc72335-ed29-4a42-aa70-20d3c0e9b060"
      unitRef="usd">0</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNS01LTEtMS0w_b6d04310-c57e-42b1-a6ef-20c02aecfe4d"
      unitRef="usd">2906000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi0xLTEtMS0w_33b444a0-28ee-4da1-8e71-04e24fce3093"
      unitRef="usd">184592000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi0zLTEtMS0w_c599e8c2-7227-4a9a-b492-405093328dd5"
      unitRef="usd">1900000</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNi01LTEtMS0w_e72c046c-c6a2-48e9-838b-28e1aa382182"
      unitRef="usd">186492000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy0xLTEtMS0w_3b50d57d-d62a-4b62-98ef-829a2b3e5d62"
      unitRef="usd">119408000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy0zLTEtMS0w_e485db4f-a392-4371-96d9-17494b8992f8"
      unitRef="usd">0</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense>
    <bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfNy01LTEtMS0w_d8572d42-4bc4-4cc1-abc1-1192268a701e"
      unitRef="usd">119408000</bhg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC0xLTEtMS0w_c5be1a9a-f36f-4138-b1e3-fdbbd99001d9"
      unitRef="usd">51744000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC0zLTEtMS0w_74a7f158-2e6f-4991-a48b-145dce0b9453"
      unitRef="usd">174000</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOC01LTEtMS0w_832b326c-17a0-49ac-907c-b1950d9c2146"
      unitRef="usd">51918000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS0xLTEtMS0w_6b6d12ee-0d83-430d-87b4-d63b414eaa6a"
      unitRef="usd">1236000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS0zLTEtMS0w_46d51f30-748b-4eac-b22d-64db6144cb60"
      unitRef="usd">108000</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfOS01LTEtMS0w_12bb9982-6e28-459d-be86-804ca4d59331"
      unitRef="usd">1344000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtMS0xLTEtMA_1d0a6851-a2c4-4ab2-94a5-73eee3aaaf55"
      unitRef="usd">172388000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtMy0xLTEtMA_744744a5-a93e-4840-a77a-731e97ea2810"
      unitRef="usd">282000</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTAtNS0xLTEtMA_936a8838-4435-4b68-b98b-d523b42bfba4"
      unitRef="usd">172670000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtMS0xLTEtMA_04c338ac-6d27-4edc-973f-0af96b33895f"
      unitRef="usd">12204000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtMy0xLTEtMA_de701ede-3889-475a-964f-efa189421954"
      unitRef="usd">1618000</bhg:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTEtNS0xLTEtMA_60dd9f7c-30d4-4581-93d4-586b321ba9f9"
      unitRef="usd">13822000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItMS0xLTEtMA_fda4360e-7b7a-4bae-9ec4-61d9b62555bf"
      unitRef="usd">197886000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItMy0xLTEtMA_73d126cc-8596-4e38-8698-de6ee204c9e0"
      unitRef="usd">-1618000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTItNS0xLTEtMA_21c972a2-dc55-48b4-bd5e-1a97d7295e97"
      unitRef="usd">196268000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8e858b6d039b409fbb49d9118bf7ce2c_I20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtMS0xLTEtMA_2fd1f57b-ec4c-41b0-9376-56cb6c8566f7"
      unitRef="usd">210090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i1ea7492e573e4f1cb2308ceade00585c_D20200501-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtMy0xLTEtMA_7acd0d02-d2d7-44ef-8d2c-b501592b5b83"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ifd2507a77d0846f39ac1e4e71b0bcf2d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RhYmxlOmU0MDU0MGYwNTE4NDRhNjdiYTY2NWFmMTRlM2Q2MDEwL3RhYmxlcmFuZ2U6ZTQwNTQwZjA1MTg0NGE2N2JhNjY1YWYxNGUzZDYwMTBfMTMtNS0xLTEtMA_7e69e759-18cf-4be6-b983-c61cabd19d41"
      unitRef="usd">210090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI3NzI_e2ee9baa-702a-4829-9bbd-7e0df6dd24ba"
      unitRef="usd">25600000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9c57ea06d8bf4266b64ea919b64e8b70_D20200430-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI4MzE_9279d56b-c4e1-40f6-ac8a-5dc8231780f0">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI4Njg_93fcbf9e-5f69-4438-afe7-8d8dfbfe4464"
      unitRef="usd">46900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1080ea82861c4245ac9de2ba050d2298_D20200430-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMTQ_5839e013-aa89-482d-a3b4-0a8b0ce73e2a">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i02d119c5e70e49299a5a771390922e80_D20200430-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTI5MDM_732f9ec9-aab4-47f2-9834-f35de862a4cb"
      unitRef="usd">2000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i02d119c5e70e49299a5a771390922e80_D20200430-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80MC9mcmFnOjliMDg5ZWM0NTNlNjRlMDdiZWEwYTMyMGM3NGRkNWM4L3RleHRyZWdpb246OWIwODllYzQ1M2U2NGUwN2JlYTBhMzIwYzc0ZGQ1YzhfMTMyMDQ_44b2b1ac-dd88-4dce-961f-ad34ca9c6d6c">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNg_81dc440a-d7b5-47b3-a955-f9414df5618a">INVESTMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fixed Maturity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale securities are reported at fair value as of September&#160;30, 2021 and December&#160;31, 2020. Held-to-maturity securities are reported at amortized cost as of September&#160;30, 2021 and December&#160;31, 2020. The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;283&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;290,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,437&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,876&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;725&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale investments, including those that are cash equivalents, with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position at September&#160;30, 2021 and December&#160;31, 2020 were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, we had &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; investment positions out of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,859&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that were in an unrealized loss position. As of December&#160;31, 2020, we had 117 investment positions out of 1,917 that were in an unrealized loss position. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. At each reporting period, we evaluate securities for impairment when the fair value of the investment is less than its amortized cost. We evaluated the underlying credit quality and credit ratings of the issuers, noting no significant deterioration since purchase. As of September&#160;30, 2021, we did not have the intent to sell any of the securities in an unrealized loss position. Therefore, we believe these losses to be temporary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the maturity of available-for-sale securities, by contractual maturity, reflected at amortized cost and fair value were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through 10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment income in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021 and 2020, was $3.5 million, and $7.1 million, respectively, related to our fixed maturity securities. Realized gains (losses) from our fixed maturity securities of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.1 million are included within total investment income, and reclassified out of accumulated other comprehensive income, for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;On April 1, 2021 we completed the purchase of 1.6 million shares of equity securities for aggregate cash consideration of $40.1 million. As of September&#160;30, 2021, the equity securities had a carrying value of $149.1 million, which is included in short-term investments in the Condensed Consolidated Balance Sheet. We recognized an unrealized gain of $46.3 million and $109.0 million in investment income in the Condensed Consolidated Statements of Income (Loss) for the three and nine&#160;months ended September&#160;30, 2021, respectively.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:HeldToMaturitySecuritiesTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNw_15c455d6-b94b-4b2d-b4af-2094e975a224">The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;283&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;290,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,437&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,876&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;725&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNw_da41689e-1e28-42d4-8d48-c311338ea27c">The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271,984&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;283&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;290,917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,437&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,876&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,745&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;725&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,136,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized &lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross &lt;br/&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held-to-maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi0xLTEtMS0w_fd94cc42-3b92-4cb0-90c9-c05ed9b33890"
      unitRef="usd">271984000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi0zLTEtMS0w_6d65ad89-609f-45d9-94b6-36906314dd05"
      unitRef="usd">1000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi01LTEtMS0w_22c69237-5964-4f0a-8dcd-c54a814e358a"
      unitRef="usd">1000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMi03LTEtMS0w_9aa05b49-b316-4aae-9dce-132eebbb82ae"
      unitRef="usd">271984000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC0xLTEtMS0w_4c54999f-7c6d-407a-9aa4-f69550d60d8f"
      unitRef="usd">501343000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC0zLTEtMS0w_38e9150f-bc79-477a-a06a-712c75910cd5"
      unitRef="usd">283000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC01LTEtMS0w_17525d79-072d-494e-b32e-5e0e294c5fbd"
      unitRef="usd">376000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNC03LTEtMS0w_ff0a8554-4c37-4e09-97e2-56c8ca2db8d5"
      unitRef="usd">501250000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS0xLTEtMS0w_3d7d06f7-5ae5-4f03-b8d5-7a2655ba97d2"
      unitRef="usd">290917000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS0zLTEtMS0w_a812565a-453f-4105-a0d5-5f860522e4b4"
      unitRef="usd">384000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS01LTEtMS0w_bac4081a-ac66-42f0-8915-646d5bce9ab4"
      unitRef="usd">106000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49f9b0edbc5d4e6eb845493d5559b678_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNS03LTEtMS0w_100cfa56-d4bc-4ee2-b1dc-2a0313dbe9c1"
      unitRef="usd">291195000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi0xLTEtMS0w_5abbb522-344a-4d49-a8c4-5c7d60be6b17"
      unitRef="usd">15437000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi0zLTEtMS0w_f0742d68-2c3c-406f-af98-d22ea7364a06"
      unitRef="usd">51000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi01LTEtMS0w_9d71f5a6-9db0-4dca-855b-137fe97ef64f"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i999a85020f9f4f10a9aa47b8f908b339_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNi03LTEtMS0w_54d8358a-9f66-4968-b050-94acc71413ac"
      unitRef="usd">15485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i876397b0696242c1a07ad1299e40876b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy0xLTEtMS0w_29d9d29e-2ad1-433c-b1e6-429bb48caf63"
      unitRef="usd">5160000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i876397b0696242c1a07ad1299e40876b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy0zLTEtMS0w_5f2cc3ca-444e-4004-bfba-06be0d418b55"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i876397b0696242c1a07ad1299e40876b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy01LTEtMS0w_e2ea0df2-8580-4aba-9257-d728b86d746e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i876397b0696242c1a07ad1299e40876b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfNy03LTEtMS0w_b524e805-1185-4ff6-9524-03c3b50a0045"
      unitRef="usd">5165000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC0xLTEtMS0w_20f168f2-58c5-4cf7-9120-d10b401b4b15"
      unitRef="usd">26809000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC0zLTEtMS0w_01314aff-8c34-469b-a696-b967443334e9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC01LTEtMS0w_c8f12ebe-6e67-43ee-a295-aa0b8fffc3af"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOC03LTEtMS0w_96889d0a-9cb5-4cc1-b6f2-1f2d4490b442"
      unitRef="usd">26809000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS0xLTEtMS0w_bdc482a0-fe24-4799-a090-ce4ab1cfa5a9"
      unitRef="usd">2533000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS0zLTEtMS0w_2800df66-588a-44b6-9380-8938a4a364c4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS01LTEtMS0w_6a1cbf29-d22e-4775-97cf-2b2b19779c7f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a13bb5d1fe64ab2b1c85df4515c6d26_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfOS03LTEtMS0w_41b7c8ac-dcbf-4c5e-8bf5-08d565d8dcf8"
      unitRef="usd">2533000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtMS0xLTEtMA_eb43b856-7950-4928-87bf-76a651251be8"
      unitRef="usd">12876000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtMy0xLTEtMA_a513a1e8-2bc2-4c16-bdf6-14fc07f1f953"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtNS0xLTEtMA_b1508cdf-cb10-4e9c-b6b7-4b436ec232ce"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iba93dbe931f244d8966ac1d962a2fea4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTAtNy0xLTEtMA_1f6be2a7-7cf8-4f7e-9198-24275e9566ea"
      unitRef="usd">12869000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtMS0xLTEtMA_51a14961-d131-4228-8434-f428e26d9976"
      unitRef="usd">855075000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtMy0xLTEtMA_cc0d9546-3242-49bc-88fa-9430635d44fd"
      unitRef="usd">724000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtNS0xLTEtMA_037149e7-1759-4289-ad64-0ab030c0eeb7"
      unitRef="usd">493000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTEtNy0xLTEtMA_4f6d0aaa-96b4-448b-a8b1-6810514c7b59"
      unitRef="usd">855306000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtMS0xLTEtMA_98d79643-1a0d-4ec1-aebc-78ca3f992dde"
      unitRef="usd">7745000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtMy0xLTEtMA_54b9ddb7-d182-452b-848b-a98670aeaee1"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtNS0xLTEtMA_f6fd52d7-8f7b-4560-9f34-7665e3655bd7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTMtNy0xLTEtMA_19293abf-7a29-4d4a-8f28-cdbb165366f6"
      unitRef="usd">7745000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtMS0xLTEtMA_8a6f56e7-590a-4420-b9e5-ee7f84bffc8c"
      unitRef="usd">1447000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtMy0xLTEtMA_654e5309-316b-4660-a245-b9633452e5da"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtNS0xLTEtMA_f4041325-4c1f-46e2-8959-c5e684885f0f"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTQtNy0xLTEtMA_f18030cd-a526-4d48-836b-0db186acb45e"
      unitRef="usd">1447000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtMS0xLTEtMA_936d03ba-14be-4304-8d21-e5cc858f447a"
      unitRef="usd">9192000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtMy0xLTEtMA_0ec06250-48e7-407f-b6f1-4adcfc5dda07"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtNS0xLTEtMA_ad5a3fb1-e10d-4d91-97ec-6e535a40a53f"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTUtNy0xLTEtMA_4039cb90-683e-4363-81ae-fb1831620674"
      unitRef="usd">9192000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtMS0xLTEtMA_ead5dc37-1a88-49dd-b606-dda8d9758e84"
      unitRef="usd">1136251000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtMy0xLTEtMA_cf84bbeb-1269-4fd8-9312-07bfe3c65527"
      unitRef="usd">725000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtNS0xLTEtMA_fabf08fb-400f-4023-9163-b1311b122e6b"
      unitRef="usd">494000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjNjYjVhZjI3YTAxZjRjMzBiMmNlNTc4ODU5YWVhYWY0L3RhYmxlcmFuZ2U6M2NiNWFmMjdhMDFmNGMzMGIyY2U1Nzg4NTlhZWFhZjRfMTYtNy0xLTEtMA_bbf6fa41-75ee-4b4b-9c1e-03390b2250f1"
      unitRef="usd">1136482000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi0xLTEtMS0w_f5e485df-5146-4c4d-b549-a172016de0aa"
      unitRef="usd">153743000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi0zLTEtMS0w_a1038cb1-e20d-4f56-a288-fa65c6b35b71"
      unitRef="usd">0</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi01LTEtMS0w_6fbb0ee0-b53e-430a-938f-2f73956c5f3c"
      unitRef="usd">3000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMi03LTEtMS0w_6eb612b7-0526-405b-a256-c14cc7768b2d"
      unitRef="usd">153740000</bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC0xLTEtMS0w_3f4b3953-6b86-4462-ad42-46d7810d43e1"
      unitRef="usd">291834000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC0zLTEtMS0w_c50eaad1-a6dd-48da-8bc8-082259195412"
      unitRef="usd">1246000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC01LTEtMS0w_26db30d0-3540-404e-b029-3eeb27fd8e12"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNC03LTEtMS0w_a365add9-fa90-420f-b164-ae1aeffa48fe"
      unitRef="usd">293079000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS0xLTEtMS0w_54c2aed5-3050-438e-97a5-b5b526b7e3cf"
      unitRef="usd">280557000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS0zLTEtMS0w_14056ec8-b4aa-4b68-af3b-7da4b1a3d819"
      unitRef="usd">1104000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS01LTEtMS0w_d26926e8-6294-41ba-9376-2a0b2083d64e"
      unitRef="usd">30000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i62e383ba4c874ed1a61aa4f77bf40523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNS03LTEtMS0w_0221c200-1c56-4d09-a2f6-817756a4b4da"
      unitRef="usd">281631000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi0xLTEtMS0w_40a5f349-ffd1-4b24-9c2e-665c10f462f3"
      unitRef="usd">18459000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi0zLTEtMS0w_2b1f84c9-edff-4d29-b4ef-514a74a1f5b4"
      unitRef="usd">107000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi01LTEtMS0w_ffa2e059-3916-45ac-9456-c57bde3a76c1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1821e67a709400081ca8ffa683a8944_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNi03LTEtMS0w_661a96a5-9953-4a3e-926f-d4c1dc1e581f"
      unitRef="usd">18566000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy0xLTEtMS0w_680e3652-a366-4b55-be93-0c924682e1a8"
      unitRef="usd">14990000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy0zLTEtMS0w_2e2e7366-a391-49c2-ae0e-35bf389e0814"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy01LTEtMS0w_083f32d2-dc62-493b-8ac9-271d231e5be3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3ac4eb7321904e2aadc4d01b4edb45c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfNy03LTEtMS0w_630a37c9-2579-4d8c-8745-0494d7cbc95c"
      unitRef="usd">14991000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC0xLTEtMS0w_b22a8726-99d6-4bca-ae98-168dc4e70807"
      unitRef="usd">53504000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC0zLTEtMS0w_ae0ea7e9-a4a9-472a-8182-4355eb0f6cae"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC01LTEtMS0w_d626480a-7e22-4042-a369-b4e5c113615c"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOC03LTEtMS0w_a04bdec0-5c0d-468e-a8ca-3a3373270f25"
      unitRef="usd">53505000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i93edb636370844a0929f4e4375a579b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS0xLTEtMS0w_2a308c81-6c4c-4126-bb22-0220946de12e"
      unitRef="usd">5534000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i93edb636370844a0929f4e4375a579b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS0zLTEtMS0w_132dbf88-24b3-4d28-b74d-25c6d5bcbd55"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i93edb636370844a0929f4e4375a579b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS01LTEtMS0w_e9004648-8ab5-483d-9425-a2672e78759c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i93edb636370844a0929f4e4375a579b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfOS03LTEtMS0w_77805d9e-3559-4870-9836-fa4624025a20"
      unitRef="usd">5536000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtMS0xLTEtMA_5989a651-ff93-4128-a30b-156c7c05ca1f"
      unitRef="usd">664878000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtMy0xLTEtMA_828e7405-c3cd-4c64-9297-7d7406f3b318"
      unitRef="usd">2462000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtNS0xLTEtMA_02f195e3-1a01-423a-8c46-fdf5b72fa514"
      unitRef="usd">32000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTAtNy0xLTEtMA_634cdbb3-c576-4243-ad6c-35d8994bc2c7"
      unitRef="usd">667308000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItMS0xLTEtMA_f79b1f6d-98d2-4b02-901b-1458f42cbadf"
      unitRef="usd">6677000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItMy0xLTEtMA_a0982f12-934f-4edb-98df-cf6206345d1b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItNS0xLTEtMA_b146488a-9c0b-415a-876f-8bc784450f3a"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTItNy0xLTEtMA_e7820b09-e929-4ef6-a2e2-53be1e70b9e6"
      unitRef="usd">6677000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtMS0xLTEtMA_d02a9a16-16d3-4ceb-870a-8d36a96ddb65"
      unitRef="usd">1119000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtMy0xLTEtMA_18e99bdd-085f-4a02-9401-dc4071e12f27"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtNS0xLTEtMA_a904556a-7bde-4010-ab69-a0688613232b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTMtNy0xLTEtMA_55ec74c4-def0-4dbd-947e-fdc77d1358b7"
      unitRef="usd">1119000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtMS0xLTEtMA_66de834e-1a7d-4f3a-ba69-2d83533d8279"
      unitRef="usd">7796000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtMy0xLTEtMA_6a6ae2b4-406a-4b26-b5c6-14113d4d5d6d"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtNS0xLTEtMA_443b71b7-fda3-486f-9347-413a3c20b353"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTQtNy0xLTEtMA_41d11704-fa5b-4495-b628-c294859ef9a8"
      unitRef="usd">7796000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtMS0xLTEtMA_ada42ca6-f317-4caa-9cf7-abde8fea317e"
      unitRef="usd">826417000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtMy0xLTEtMA_a1377c5b-28ce-408f-b4dc-ae8c2eaea0af"
      unitRef="usd">2462000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtNS0xLTEtMA_ee01023a-9e7c-414e-a407-82737b65da8c"
      unitRef="usd">35000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjg2NWUzOWMxMTVlNDQ5OWQ4ZjM2MGZlNjQ3ZTg1YWI0L3RhYmxlcmFuZ2U6ODY1ZTM5YzExNWU0NDk5ZDhmMzYwZmU2NDdlODVhYjRfMTUtNy0xLTEtMA_ebf1d976-00cb-4d31-b2b4-0942be929fd2"
      unitRef="usd">828844000</us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxNA_7b72fca1-14a9-481c-be19-712ae6bc4d77">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale investments, including those that are cash equivalents, with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position at September&#160;30, 2021 and December&#160;31, 2020 were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,812&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;508,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description of Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xLTEtMS0yMTU5Mw_fcfbf7ca-55fe-4cc5-9755-2fe7059186d8"
      unitRef="usd">9643000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0zLTEtMS0yMTU5Mw_952dba22-4591-4f08-8095-9969e4e22644"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy01LTEtMS0yMTU5Mw_3a900b0f-ccb8-482f-a72e-c1965b48a293"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy03LTEtMS0yMTU5Mw_29d34333-d6f8-4d33-b6b9-a8b9da71e1ee"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy05LTEtMS0yMTU5Mw_f63a0c56-66db-4124-8c73-5b52061a5068"
      unitRef="usd">9643000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i54b616b4492d4f57b6587e8013fa8e17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xMS0xLTEtMjE1OTM_9cd74148-eb01-449f-90e8-74faa5959846"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xLTEtMS0w_291ea341-b327-481d-a605-f11b65252ec9"
      unitRef="usd">347735000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0zLTEtMS0w_99204cad-2079-417c-810e-e5f56333d1f2"
      unitRef="usd">376000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy01LTEtMS0w_5c6abad0-ef96-437b-b8b9-3c2ec87ef4c5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy03LTEtMS0w_402a8e76-5484-410d-ae13-939806380023"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy05LTEtMS0w_319d33ef-77bc-4fd5-8c64-460367fdc2ab"
      unitRef="usd">347735000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i62cd68bf7f334c1ea97f74de9ac08cc2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfMy0xMS0xLTEtMA_c7a2f3b3-bad8-4f45-96e2-5ed53f5240c8"
      unitRef="usd">376000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0xLTEtMS0w_9d56f03a-fad6-4250-9e48-ca4f47e8f17d"
      unitRef="usd">137456000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0zLTEtMS0w_47ebc460-7c03-4c0f-999b-933b2cf7d3ed"
      unitRef="usd">106000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC01LTEtMS0w_56137da1-1f5a-4680-bc57-ade286a39903"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC03LTEtMS0w_1a566d69-c801-4101-bf97-88b975108471"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC05LTEtMS0w_106a69b1-4464-4527-ba62-e1c2a6a337e1"
      unitRef="usd">137456000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i42da671896bf4e2fbd7ec0fe32a541f0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNC0xMS0xLTEtMA_27885750-a4c8-45e3-a419-e7955f83ae34"
      unitRef="usd">106000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0xLTEtMS0w_ceb68820-4069-43cf-aa1e-9652e64225a1"
      unitRef="usd">2812000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0zLTEtMS0w_c90a5b11-4a8b-4ca2-a096-b8e82ffb4556"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS01LTEtMS0w_6bd48e85-df6c-488f-81b6-b0aa80bfa16b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS03LTEtMS0w_3efcd72c-52d6-4a96-ab72-8ab5cae4cb31"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS05LTEtMS0w_2d6ecf7e-5a68-4c0b-80fa-81f139bd05da"
      unitRef="usd">2812000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i48170a5de4b440f692e33f62a6d27726_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNS0xMS0xLTEtMA_45d87775-996b-4e86-8f47-ea5c66e9b92e"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0xLTEtMS0xNzkzMw_b393eb9e-d666-449f-85bf-424535b0497b"
      unitRef="usd">10950000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0zLTEtMS0xNzkzMw_c9904620-9bb7-46bf-83c6-2bc40f00119f"
      unitRef="usd">8000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy01LTEtMS0xNzkzMw_95119808-c419-4e8d-9101-6c2ed3e79f7a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy03LTEtMS0xNzkzMw_a0034a67-cf55-4a70-8d60-9efca2b0f120"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy05LTEtMS0xNzkzMw_b2a868f1-65e0-4dac-9253-19777c2f44db"
      unitRef="usd">10950000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i60813677512b434bacaebec6e08f0443_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNy0xMS0xLTEtMTc5MzM_a0406218-f598-4396-a588-a72e30f50aaf"
      unitRef="usd">8000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0xLTEtMS0w_43e49949-9ccb-48d2-9233-3c3fe1bfbfbe"
      unitRef="usd">508596000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0zLTEtMS0w_0f650a1c-df27-4da4-8389-462d011705bc"
      unitRef="usd">494000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi01LTEtMS0w_974cbb05-f812-46b4-816e-0246db6ed608"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi03LTEtMS0w_5e308840-c498-46de-a405-d56e359f7d0f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi05LTEtMS0w_8d06d8ec-daf8-476a-8476-b94f98bc772e"
      unitRef="usd">508596000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOmJmZjJjNzgwMThlNDRlNWU4YjhkZmI3ZDVlOWM2NjVjL3RhYmxlcmFuZ2U6YmZmMmM3ODAxOGU0NGU1ZThiOGRmYjdkNWU5YzY2NWNfNi0xMS0xLTEtMA_bbe90bec-6278-477e-b2ed-64097ee9f5ff"
      unitRef="usd">494000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0xLTEtMS0w_df9afeea-91c0-44a6-ae4a-bf8cd7099359"
      unitRef="usd">25007000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0zLTEtMS0w_0be53ac2-b523-4ace-84d7-c1b8a82f323a"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy01LTEtMS0w_5a2a8b95-a8a5-4085-a4a5-0e446ad7f9c8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy03LTEtMS0w_383d4d15-f466-4d49-b188-264f162021ff"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy05LTEtMS0w_6ac50732-712e-4425-a64e-b11070e66b8d"
      unitRef="usd">25007000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie1a0abdf256d492cb848ed7a37fa43bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfMy0xMS0xLTEtMA_9a9cd305-5ddb-41c7-aa2a-e819e3d2113c"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0xLTEtMS0w_c1cca3cf-3550-4504-9fdb-4f1044148c93"
      unitRef="usd">12507000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0zLTEtMS0w_350b4833-10a6-4208-bde6-36f83f07b2eb"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC01LTEtMS0w_4c6a8d09-2c28-42c0-8738-78d0bd5c674d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC03LTEtMS0w_ffa9888c-f4fe-4cfd-baa5-91996465fe2b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC05LTEtMS0w_09a625a6-f3c9-4c44-b415-5c1bb5c047dc"
      unitRef="usd">12507000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i95f63630eb2b4c619abf10dae7347361_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNC0xMS0xLTEtMA_09eee942-e887-4b86-8fc5-8c4d4532ac38"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0xLTEtMS0w_7e90d08e-4087-4eff-8402-2e6e2eca2d93"
      unitRef="usd">121006000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0zLTEtMS0w_5fcccefd-9ba9-4955-bd4d-45c9f4b735aa"
      unitRef="usd">30000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS01LTEtMS0w_d0944aef-0ed7-4804-816e-242efd7c25f2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS03LTEtMS0w_ba505db6-0505-46a3-a442-dfd603318113"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS05LTEtMS0w_b6512414-907b-450e-8133-05406eee352b"
      unitRef="usd">121006000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i55715dc78ffb471b9a34ab8fc2be9773_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNS0xMS0xLTEtMA_e23f8040-5869-4835-9d87-b5c0e6dd4787"
      unitRef="usd">30000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0xLTEtMS0w_ad898831-1a1e-48b6-a73b-0cae84b2dbee"
      unitRef="usd">999000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0zLTEtMS0w_4a69b30a-9369-4ecd-80b1-34fcbce2cc39"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi01LTEtMS0w_363916a0-e7ca-444b-bcea-98ac9dad0314"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi03LTEtMS0w_1b47a112-ce49-4459-a4bb-b6f1d0bd9680"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi05LTEtMS0w_0a3199c2-c458-492d-bd45-1fa399e5f84b"
      unitRef="usd">999000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3bd1d1e14a644d769d623a268712ab39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNi0xMS0xLTEtMA_4577409e-306d-4a70-a1ac-7620265bfdab"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0xLTEtMS0w_cea27401-1814-4ed6-a7c2-98de597d5ec6"
      unitRef="usd">14003000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0zLTEtMS0w_44bb9b8d-7758-4000-9ba6-7b6c494808e6"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy01LTEtMS0w_f40d3656-f204-44e2-9852-498de62b779f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy03LTEtMS0w_f42a7674-db36-46b7-aa6e-6099fb439d43"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy05LTEtMS0w_f13bc3a1-9fee-4f77-ab05-bde10bccb7f6"
      unitRef="usd">14003000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5a28d14cd6e04b439e4e3afd0d704f69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfNy0xMS0xLTEtMA_f18bd9fe-10e9-49eb-9d6a-2d0eed492f9f"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0xLTEtMS0w_8a35b84f-3a29-4768-88af-2dc0a359f555"
      unitRef="usd">173522000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0zLTEtMS0w_26543038-8df6-4830-8c64-5a09c94dfe9e"
      unitRef="usd">35000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC01LTEtMS0w_08889603-985f-40c3-9b03-640328cb7452"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC03LTEtMS0w_9742cc41-8e47-4430-9afc-0b41b850915e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC05LTEtMS0w_ec4f43c9-cb4a-42de-b59f-9d0e858b2e6e"
      unitRef="usd">173522000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjFjNjMzNmNkY2NiYjRiNzlhMGZjMDBhNDNkZTVhZDQ0L3RhYmxlcmFuZ2U6MWM2MzM2Y2RjY2JiNGI3OWEwZmMwMGE0M2RlNWFkNDRfOC0xMS0xLTEtMA_b6a42ca3-ab27-4aba-880d-cdc4ab38422f"
      unitRef="usd">35000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjA1_01206786-83cd-40d1-86eb-dedd1b0aa5d7"
      unitRef="investment">744</bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions>
    <bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjM2_3c1fbbb2-90f7-4768-95f0-87ca869547b3"
      unitRef="investment">1859</bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments>
    <bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNjk4_404fb9dc-2f2a-44ad-9502-348c9b9cacee"
      unitRef="investment">117</bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions>
    <bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfNzI5_9a7dc90f-72b9-4e32-9598-2584a48f70bf"
      unitRef="investment">1917</bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjUxMw_25eafef3-7bea-4c5a-a748-c9151db19e0b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the maturity of available-for-sale securities, by contractual maturity, reflected at amortized cost and fair value were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through 10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMS0xLTEtMS0w_be046eba-ca11-4f01-8a08-48b869db9e66"
      unitRef="usd">203284000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMS0zLTEtMS0w_7884897c-8323-45cd-a5a2-49320f5e608f"
      unitRef="usd">203614000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMi0xLTEtMS0w_c23789df-332b-4176-943a-9e32a54f2c36"
      unitRef="usd">651705000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMi0zLTEtMS0w_8d79625f-cc46-4ef7-b745-1ac93ed62595"
      unitRef="usd">651606000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMy0xLTEtMS0w_a2f20c1b-aefc-4c96-b386-9a62c07f5164"
      unitRef="usd">86000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfMy0zLTEtMS0w_7c71bf54-de57-49bf-8c52-eb27e1511825"
      unitRef="usd">86000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNC0xLTEtMS0w_37807d1e-d890-452a-8978-b0d08766d596"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNC0zLTEtMS0w_1546126f-112e-4c6d-bcf9-ad46e2a906ec"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNS0xLTEtMS0w_c8acb43f-772e-45d6-b1c0-45f8ad64139a"
      unitRef="usd">855075000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RhYmxlOjBjOGI2ZDc0OGMzZDRlNGM4ZjMwNGQ0MWM1ZjQ3MGEwL3RhYmxlcmFuZ2U6MGM4YjZkNzQ4YzNkNGU0YzhmMzA0ZDQxYzVmNDcwYTBfNS0zLTEtMS0w_59872048-8bbd-4768-b380-7425c1e76cf0"
      unitRef="usd">855306000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <bhg:InvestmentIncomeLoss
      contextRef="idcc35cb44c3a44e4988de9c09f1145a2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTc2Mg_2320e388-55b8-4e40-a24e-2f52f72c44ab"
      unitRef="usd">3500000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i5ae3dff21f514bee8dcfb24fbbee065c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTc3MA_0362d44c-4238-45c3-95a9-f8ec42ad9a00"
      unitRef="usd">7100000</bhg:InvestmentIncomeLoss>
    <us-gaap:DebtSecuritiesRealizedGainLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTg5Mg_116f5c3a-2218-4a1b-b65e-099dc39b8759"
      unitRef="usd">400000</us-gaap:DebtSecuritiesRealizedGainLoss>
    <us-gaap:DebtSecuritiesRealizedGainLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMTg5OQ_7726977d-0368-4823-b9af-8a83eb9177ca"
      unitRef="usd">100000</us-gaap:DebtSecuritiesRealizedGainLoss>
    <bhg:EquitySecuritiesFVNISharesPurchased
      contextRef="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjEyNg_21c1e116-b041-4feb-ad82-c4e5f36d56b4"
      unitRef="shares">1600000</bhg:EquitySecuritiesFVNISharesPurchased>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="icf31d32f4f9546c58cbb9e54c72975a1_D20210401-20210401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjE5Mw_bf14c2ad-cfa5-4ed3-8068-20ffc3b6022a"
      unitRef="usd">40100000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjI1Mw_e7546457-2c7d-4a61-9adb-760aefbd2ae4"
      unitRef="usd">149100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjM4Mg_ffc20a0e-4df7-4921-a49b-84c0b162502a"
      unitRef="usd">46300000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80My9mcmFnOjFhZWY1MjkwOWMxMDQzODA4NDBkNzAxMzMzNTVhY2ExL3RleHRyZWdpb246MWFlZjUyOTA5YzEwNDM4MDg0MGQ3MDEzMzM1NWFjYTFfMjM4OQ_af015972-653e-4d08-ad00-3a92495bf029"
      unitRef="usd">109000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc1OA_d1faffa5-a467-48e6-aef7-a5add1639787">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices for similar assets or liabilities in active markets or quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are measured at fair value in the condensed consolidated financial statements or have fair values disclosed in the notes to the condensed consolidated financial statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, except for the equity securiti&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es, see note 5 of notes to the audited consolidated financial statements included in our Prospectus filed with the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the equity securities was determined based on the quoted market price of the underlying securities in an active market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth our fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for assets measured at fair value on a recurring basis&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;245,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;358,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;143,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288,961&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;473,599&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;740,578&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509,106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,249,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the Company&#x2019;s fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for certain financial instruments not measured at fair value on a recurring basis&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents, held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,965&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,965&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents, held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no transfers of assets or liabilities into or out of Level&#160;3 of the fair value hierarchy. The contingent consideration liability related to the acquisition of AssociatesMD Medical Group, Inc. is measured using Level&#160;3 inputs based on a formulaic multiple of forecasted 2023 EBITDA per the terms of the purchase agreement discounted back to net present value. The following table presents the changes in fair value of the contingent consideration liability for the nine&#160;months ended September&#160;30, 2021 and year ended December&#160;31, 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported on the Condensed Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value due to their short-term nature. These assets and liabilities are not included in the tables above.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc1OQ_07395cc7-4412-4430-8d4f-47283b3bcd9e">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth our fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for assets measured at fair value on a recurring basis&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;245,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;358,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;143,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288,961&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;473,599&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;855,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;740,578&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509,106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,249,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available for sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy0xLTEtMS0w_43716266-c572-49db-9551-9027fb95dd77"
      unitRef="usd">209727000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy0zLTEtMS0w_d697b242-edf0-4795-aacf-84c53391124a"
      unitRef="usd">35507000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy01LTEtMS0w_806694d2-6d23-4bb1-8333-51deca36880a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMy03LTEtMS0w_e101b8e0-74c9-4f49-bf83-56c86b01c3f7"
      unitRef="usd">245234000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8ea779896ada4159a7f60019e9927bf8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS0xLTEtMS0w_09d4c502-ae13-4ce4-bf96-0605f4956fb3"
      unitRef="usd">358202000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5121369128bf46f1b28d027064b97268_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS0zLTEtMS0w_fc5e3e2d-4f9d-4170-b5a1-144ba7bf8509"
      unitRef="usd">143048000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4c3c88b8b464936985a142c13ba59a1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS01LTEtMS0w_d7a31b01-d915-4bc7-873c-58a2e8b4134b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i063bcb9e20df488faba4c86ff6b2d2d7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNS03LTEtMS0w_a4dadce3-1476-49bc-8ace-b106dd5fb246"
      unitRef="usd">501250000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie6321a1eae6741258bc2ebec56ccdd2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi0xLTEtMS0w_757e871d-0e69-4f5d-9094-91ea82058d5b"
      unitRef="usd">2234000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ba12124710a41d09f79459538d7f774_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi0zLTEtMS0w_1428af79-9505-49bd-b732-2942cef4da64"
      unitRef="usd">288961000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i112615aabc29458c80feb79df5325cfe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi01LTEtMS0w_95b31d77-436a-46ca-94ae-4f213b12f616"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39a7e8b71f6b44ef93ee44e051b98fa8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNi03LTEtMS0w_63c3b525-f849-4e9a-9406-1a0d8a4a26d5"
      unitRef="usd">291195000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff31328bf070411aa7d0bb0ec25452ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy0xLTEtMS0w_defcbb00-53c1-4d89-b59b-51014d6f5282"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42079981bc19457ea93081a70515a67d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy0zLTEtMS0w_c281a420-f3a9-415c-9d9d-72d0f4261cb3"
      unitRef="usd">15485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i98131e51113d4be280910ddde875e482_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy01LTEtMS0w_661c97ad-b654-4367-bd2a-a17fbd95e434"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa4d5d4769ec49aaba6b4e6a10a70938_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfNy03LTEtMS0w_2dc8ca50-2a24-4d77-b2c5-d3bf5861487b"
      unitRef="usd">15485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c32f01079e74ada8aa45c870e22b903_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC0xLTEtMS0w_7dd6be67-f29a-4734-84ae-19fda58f7f38"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4b929d612cbd4848b4301f794170eb0f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC0zLTEtMS0w_d18eb323-cbbf-4602-915d-9e9612cb8823"
      unitRef="usd">5165000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d8e5514c7c84b5f9a6699e445d92f2f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC01LTEtMS0w_8ea79438-361d-41bf-a2f7-392d76aa0d91"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i698a8a675a8841d99a8e4be9969c21ca_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOC03LTEtMS0w_bbf7c353-f094-456e-85ca-b9b1ccd69108"
      unitRef="usd">5165000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0a1a14e6cf3d416f975eed2bfba93422_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS0xLTEtMS0w_e270f99e-dae7-4513-8990-6333a85c0a1e"
      unitRef="usd">18738000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8342f62d3a84412587f448f9c68dd462_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS0zLTEtMS0w_75f5c014-b629-461e-9b11-8e41c3ff6b96"
      unitRef="usd">8071000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8df04854b56f4e59a9948d081a560768_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS01LTEtMS0w_325cb66e-dc2f-4bef-828e-ce8b6d2a1013"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if9068fd2eb5c468fa8aebe290cd9eda3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfOS03LTEtMS0w_8a1966d6-82ab-4712-9e5c-fbcb39d0360f"
      unitRef="usd">26809000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i673e75bed3d843009499b44448ad15e0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtMS0xLTEtMA_cd4ef7f6-0a8d-401d-9170-29a798cc5308"
      unitRef="usd">2533000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4b8d872078b641849ec57b4e0288f932_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtMy0xLTEtMA_21e38c4e-3acf-4150-8cca-317182b1ce83"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if899da5bf1bd41409a4b68a13470cbf1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtNS0xLTEtMA_e542f316-7ca2-4044-8a06-78fe96a9b057"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieddace9853a649deacee98a11a13ee5b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTAtNy0xLTEtMA_dec44fa9-481f-4f59-abc6-3decde1efef8"
      unitRef="usd">2533000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5ff1faea03c41699fda03aeeb1f558b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtMS0xLTEtMA_0e1d6db9-37ef-41b8-9e03-7fab5e331f8b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5492bc70b174482b6c39dce60f8004f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtMy0xLTEtMA_37e745b1-e3cf-4b22-9f8b-219eb8bf35a6"
      unitRef="usd">12869000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i063b0bab67784b50bd90eab8e6ad0e9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtNS0xLTEtMA_19cd3180-176a-4d65-b185-caf1ccd535a3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d6a5781117748b8957106e1ea54500b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTEtNy0xLTEtMA_f2a8341f-9e6b-4a8c-80d4-f1df7d30ff92"
      unitRef="usd">12869000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItMS0xLTEtMA_ecd13da5-9e23-4a6f-a7e9-9c7b669cde1a"
      unitRef="usd">381707000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItMy0xLTEtMA_f974e6d6-2e9a-4412-afe6-fc261feb18d4"
      unitRef="usd">473599000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItNS0xLTEtMA_097654cf-609a-4bfd-beb2-08d2f7c96e92"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTItNy0xLTEtMA_40bacac0-f102-4e6c-8568-04eb3fa832da"
      unitRef="usd">855306000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtMS0xLTEtMA_2508e96e-a79e-4619-8e88-55f894c46d64"
      unitRef="usd">149144000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtMy0xLTEtMA_800d99a4-2356-4d4d-a85b-9cdadc054f89"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtNS0xLTEtMA_1d15a258-525e-44d6-920d-6df07e8dc3ea"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTMtNy0xLTEtMA_bf0d1fc8-5c3e-4548-acb4-1a92567bbc31"
      unitRef="usd">149144000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtMS0xLTEtMA_44f5384e-ae00-4ba9-8b65-be476d6a872f"
      unitRef="usd">740578000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtMy0xLTEtMA_fabc017d-a447-4b22-9f72-559cc00d4f71"
      unitRef="usd">509106000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtNS0xLTEtMA_01abf0a1-6d3c-455f-8f34-99619bb172bd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTQtNy0xLTEtMA_776b3829-2953-4d62-91ef-d6fca2d65f87"
      unitRef="usd">1249684000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i783a66cb5f2448f3acd95db34f27a159_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtMS0xLTEtMA_f73bde14-0272-436c-96bd-94192d6a38db"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2d4a304ce1df419a88d9585aceafdead_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtMy0xLTEtMA_3aa37110-c6eb-4e2b-b88a-5a4fc82dec13"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i01db93ebd12c41889a5bbe280eed1eae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtNS0xLTEtMA_fee8a1a8-e421-4668-a148-7aae5baf5d33"
      unitRef="usd">7079000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idcf21177884c41bc92c0b8c908d78a52_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjU1ZjQwYTE5Nzg1NTQxYjE5NDYxZmUzY2E1M2U1ODJlL3RhYmxlcmFuZ2U6NTVmNDBhMTk3ODU1NDFiMTk0NjFmZTNjYTUzZTU4MmVfMTYtNy0xLTEtMA_b774a2c1-f603-4a3f-87cc-442c58ae02a6"
      unitRef="usd">7079000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy0xLTEtMS0w_caebb803-3af3-4471-af96-f8960907aea8"
      unitRef="usd">149499000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy0zLTEtMS0w_f90b7609-82ff-46e6-9e8b-d5230f7a2f1a"
      unitRef="usd">4019000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy01LTEtMS0w_c8695c80-5539-4abf-9b7d-bfef5f20cf13"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8214960907014dcdb3065f18a818a891_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMy03LTEtMS0w_0ffa3047-a30c-476b-a9d9-4142d0b4c927"
      unitRef="usd">153518000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb1d5009fb76492bba7eb7f3ef9c1bbd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS0xLTEtMS0w_87e4b551-54fa-4c4f-b4b6-623a23468c3c"
      unitRef="usd">197886000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8868207423f4dc1886e5e83a2c9ffec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS0zLTEtMS0w_780e4156-aa6e-4819-af7e-4270f1496391"
      unitRef="usd">95193000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i53d031fe827d4ae9bb2cf648e3ce20cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS01LTEtMS0w_83d4dd90-0cd6-4d19-b76a-803502eb7e41"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i519d21ea4f4f4131b47e685212e69fed_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNS03LTEtMS0w_1b6f9b19-8180-4aa3-8a65-0c99bad8732f"
      unitRef="usd">293079000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5b475d1c4f864fecb3191e434e9a05c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi0xLTEtMS0w_f133b50e-a62e-43a0-804f-11a346fa86ce"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia41095a8fe9f4f45b4e41448fef3fe52_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi0zLTEtMS0w_ea49f920-06ac-426d-9b01-1bae53d4e2cf"
      unitRef="usd">281631000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icfa2422a2e3c425fbdb4444361bec7c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi01LTEtMS0w_037a5441-a724-4766-b261-84229ab5c701"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i353f273f34ba4a6e86802cad11918d1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNi03LTEtMS0w_4099e476-19fc-444b-a36d-a7bf3eedd2b7"
      unitRef="usd">281631000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42019d07c89a4eaaa3ce1cbaa7ce9040_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy0xLTEtMS0w_48df0122-7881-4eed-9769-4ca20f43de1f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e872c51cbe14f019f7cc9f67921a34b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy0zLTEtMS0w_4d3c974b-fa31-4dc2-83c0-6efb09e7a6b7"
      unitRef="usd">18566000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if69d42f4ef924ebf801a45ca4af8b600_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy01LTEtMS0w_e10d33bd-bcf7-448f-b2b1-8ba0ef66790f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia8bd31902240473494b2cbd44c479592_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfNy03LTEtMS0w_f15cbbb0-7782-4bfe-bfe6-481ca4e6e874"
      unitRef="usd">18566000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibba8cbf1ad1841b888da8acba5f7f620_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC0xLTEtMS0w_bd149bd1-6527-490f-9b43-79ad535d54fa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9fcfc92e884043cda965149401c427a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC0zLTEtMS0w_6a8ec128-2a20-4bcb-9437-2d76fce94842"
      unitRef="usd">14991000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia40fa98b862c45d08dfdaee06d40d302_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC01LTEtMS0w_81bfb47f-05b3-482c-83e4-780910f8c9bc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6394f5129932421ab1a4974a1a1a6b00_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOC03LTEtMS0w_ead40728-5aff-46f8-bad8-127d1abace98"
      unitRef="usd">14991000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf297a460c204ec2b1885acfc0c94a10_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS0xLTEtMS0w_79d1c133-8a7f-44b5-a038-c63d55c7d033"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b5c730df6314669bb5151635d49120b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS0zLTEtMS0w_a8acf426-2ef9-4951-a21c-348f69ada1ac"
      unitRef="usd">53505000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie38fe77be60140f48090522f63c9a39a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS01LTEtMS0w_a2eebe53-e61f-4ab6-9e6f-90268bfc4f4c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i74044123d230403ea1b8d392ee592a83_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfOS03LTEtMS0w_480c0c93-1110-4d19-932a-30ea0678649b"
      unitRef="usd">53505000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6d7fe7922944855967728940bb7a2db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtMS0xLTEtMA_a588c4fb-1edf-44a6-b9b9-78f5bd2a17ca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ec41e2a7ebf48839293841bdf908142_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtMy0xLTEtMA_ae726cb6-aaca-46ff-9539-4709fbc48397"
      unitRef="usd">5536000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b04c47b17f04e9080c84e6237ce8133_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtNS0xLTEtMA_e12f477a-9b4c-438a-816f-fcc6c6f01db8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib84d8e18b6b5493c8c2f73fae745b71f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTAtNy0xLTEtMA_afc3a00b-07a9-41f6-b257-a5f0edbc7367"
      unitRef="usd">5536000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtMS0xLTEtMA_e8648c8c-c80a-4b91-9e50-2b34f7baaecf"
      unitRef="usd">347385000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtMy0xLTEtMA_9a1450dd-2374-4f62-a59c-ab38cd1a6723"
      unitRef="usd">473441000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtNS0xLTEtMA_3325e7f0-76c2-4709-a83b-7ee8649964cd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8214960907014dcdb3065f18a818a891_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTEtNy0xLTEtMA_b3ff33f0-9b8c-4ee4-a099-2c3349a30794"
      unitRef="usd">820826000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i36ccdb626bf0477288751a9c0cd4833c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtMS0xLTEtMA_66060e07-2aa3-4494-be94-033619ad5059"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iabca06f9fbf9459aa74bd97191815ac5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtMy0xLTEtMA_78dd8f9e-c185-4d72-ba3b-eaab602a4db2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie15b93f00e4d41f3bc132790d33dfe0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtNS0xLTEtMA_b940cf9f-f63b-4479-9ea2-4a6ccf72153c"
      unitRef="usd">5716000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8214960907014dcdb3065f18a818a891_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmI5YzIyZmRhODllZjQwNTc5NWE2NTQ4MTE4MGZhMGE4L3RhYmxlcmFuZ2U6YjljMjJmZGE4OWVmNDA1Nzk1YTY1NDgxMTgwZmEwYThfMTMtNy0xLTEtMA_31a8f2c2-0e46-48af-a145-50681a1e4bc9"
      unitRef="usd">5716000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc2MA_ed4fe861-3da7-4fbb-82a3-b468704420d5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the Company&#x2019;s fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for certain financial instruments not measured at fair value on a recurring basis&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents, held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,768&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,965&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,965&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents, held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, held to maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total held to maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i987b1607278642e6bdb251b05e65b8ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi0xLTEtMS0w_925db249-c8c5-47b2-bbb7-7e3343615c89"
      unitRef="usd">26750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia43a6f4851ae408aa78991f992f90d3d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi0zLTEtMS0w_46208aee-45c0-4b7c-abd5-0841413fa2bc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi01LTEtMS0w_3c306262-c524-4d01-b3db-f399f2bddbf3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfMi03LTEtMS0w_11355ac3-36e7-42c2-b598-af94768922f4"
      unitRef="usd">26750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i44343e4888bb4fdd8ef28262ba0a829f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC0xLTEtMS0w_a9a30c45-f7ec-4c7f-bf4e-b99e348549be"
      unitRef="usd">7768000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i3bb05d51535c4c5fb8505b007c999ba9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC0zLTEtMS0w_0617db4d-467a-4eb3-baa6-2069a944a88a"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i3ebad86f24bb445b8b965a4431d284e5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC01LTEtMS0w_5a775ba2-b5af-49d5-b5c0-66dd0aa19099"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if157b21998ca4b74bcf79e7477729fc8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNC03LTEtMS0w_001ca7f9-7721-4540-8bfb-5cdf51751fe6"
      unitRef="usd">7768000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ib3a78bf8567442f181de5c4cac29fe31_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS0xLTEtMS0w_73f25c94-aba5-4f18-aa0c-6f561bffcd36"
      unitRef="usd">1447000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i603837f5d76a430db5a4b8b5127fbac9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS0zLTEtMS0w_70fd2cab-3dc6-4bc8-ac87-14993a561168"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i8b82a503cd044fe590aa67341061d910_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS01LTEtMS0w_55feed2d-8c1a-4fb7-b0ba-f0158de9f25f"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i93cb73d8cce94d1d9b6db48a9ecd1662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNS03LTEtMS0w_ccb6b637-78c6-49e5-bfbc-ed9099352821"
      unitRef="usd">1447000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i987b1607278642e6bdb251b05e65b8ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi0xLTEtMS0w_87294f2c-e130-4a06-8a21-dae474bd2812"
      unitRef="usd">35965000</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="ia43a6f4851ae408aa78991f992f90d3d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi0zLTEtMS0w_66d9c4de-c4ad-4f1a-ab7b-dd0d348f1f16"
      unitRef="usd">0</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i87ecf0ae2b034ea9baddb6bfd6535d77_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi01LTEtMS0w_fab09d0e-a1c9-4280-8916-aa9f2b732779"
      unitRef="usd">0</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOjA4M2E0MTVlZjkzYjRiOGRhYzQwZWZkNTQxMjIzMzYwL3RhYmxlcmFuZ2U6MDgzYTQxNWVmOTNiNGI4ZGFjNDBlZmQ1NDEyMjMzNjBfNi03LTEtMS0w_a64ae1d6-d549-4767-8640-24000bd62e3c"
      unitRef="usd">35965000</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i59812274cf5a4c7396e08ab5b517c05c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi0xLTEtMS0w_6661978d-2fd1-4b82-81d2-aaf58f4cc186"
      unitRef="usd">222000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi0zLTEtMS0w_20984ecd-fdac-4351-ab1e-5d6303291e30"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if38815aebdb74f77a02060f060d0869d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi01LTEtMS0w_24e63ed2-9215-43e0-a102-82ada1221829"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfMi03LTEtMS0w_2bd0b01a-c85a-4b3d-9e25-eb45e00b82b2"
      unitRef="usd">222000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="id7434d9096c64a1bb923b544c8f1389d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC0xLTEtMS0w_d2c6e90b-2abf-4d8f-a5fc-81f7c3d010e5"
      unitRef="usd">6732000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i2b4c1482377444818d26fe58a951011d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC0zLTEtMS0w_82d7ec42-b535-4900-9550-7d0dba356d94"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="iad3ed3d5f5ef4a70bf392309669bd29c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC01LTEtMS0w_8f85baff-81c3-4782-b26c-6b9f7fc620e7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i03fcf6d4d91d4ee79841e00a56b225e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNC03LTEtMS0w_13f13552-b0ff-478b-ab5e-17e0c3548e45"
      unitRef="usd">6732000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="id470f6c918dd495a836d00f9b203e39e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS0xLTEtMS0w_1f5d1834-f715-4d41-9aa9-fa33d00a5efe"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i1946250bcb8b4f35ae19d843abace6b1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS0zLTEtMS0w_361aa957-d516-49c1-b391-1f6113b4c74c"
      unitRef="usd">1119000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i5c97e7f2726740aab3e591c631f1086c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS01LTEtMS0w_64546121-d08c-486a-a26d-a3eb4f4f8511"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i39f9ad4a8d36493099acb3cd1b8ef23c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNS03LTEtMS0w_f36b0d14-10e5-48a9-aa9b-4095276eaba8"
      unitRef="usd">1119000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i59812274cf5a4c7396e08ab5b517c05c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi0xLTEtMS0w_2285eaba-056a-4dda-a01b-dcf572f37c8c"
      unitRef="usd">6954000</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i9e7c48fef71f48ef98534d5893dd5cbf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi0zLTEtMS0w_7fdf0e92-a437-4841-90d7-ceb4ef3949a3"
      unitRef="usd">1119000</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="if38815aebdb74f77a02060f060d0869d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi01LTEtMS0w_3ffed9fa-c845-4bea-8642-fc5c00e3a9dc"
      unitRef="usd">0</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmMwYzQ1MjRkNjBjNjRhYjE5NDNhNmIxYjg4MTI5Yzc4L3RhYmxlcmFuZ2U6YzBjNDUyNGQ2MGM2NGFiMTk0M2E2YjFiODgxMjljNzhfNi03LTEtMS0w_c3091063-d1ac-4199-85f4-d32bcee3d36b"
      unitRef="usd">8073000</bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RleHRyZWdpb246ZWQ4NGY0ZjU1ZDE1NDFiZDlhYTdmMmYzMmM5OTZhYTVfMjc2MQ_c71b04f5-de4a-47d9-b800-8968cc321e07">The following table presents the changes in fair value of the contingent consideration liability for the nine&#160;months ended September&#160;30, 2021 and year ended December&#160;31, 2020&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0ec66f7f13b74426818220faa08b44bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMS0xLTEtMS0w_c8f278eb-e5f6-42d6-b93a-3ac79a9ecd6b"
      unitRef="usd">5716000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia0d8836b93dd4f33b7d7aadeba06f167_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMS0zLTEtMS0w_378df671-4333-4317-b8ec-846a8fc5ac84"
      unitRef="usd">5716000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia1192b7a40dd4bf8901438bfe5d81d4c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMi0xLTEtMS0w_7748b9b3-64ee-4f2e-b8c0-b816bd033746"
      unitRef="usd">1363000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i06271373575042ab95c33d25a8ca9392_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMi0zLTEtMS0w_88a1db37-1669-49d9-85d3-6ab81c3557b9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic724acf3709143ae92b0205c01aff95b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMy0xLTEtMS0w_113da0f6-141d-4b29-a509-e51835a190da"
      unitRef="usd">7079000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0ec66f7f13b74426818220faa08b44bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80Ni9mcmFnOmVkODRmNGY1NWQxNTQxYmQ5YWE3ZjJmMzJjOTk2YWE1L3RhYmxlOmYzM2FmNDBjMzgyMTRkY2Q5OTAzODI5MDA0ZjY1MDU4L3RhYmxlcmFuZ2U6ZjMzYWY0MGMzODIxNGRjZDk5MDM4MjkwMDRmNjUwNThfMy0zLTEtMS0w_71635b64-6b4a-4db2-ab05-bad2d4bf7ae4"
      unitRef="usd">5716000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYx_b4759f26-7cbe-47a4-867b-d504cecd47be">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,776&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;340,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;437,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;405,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value and accumulated amortization for definite-lived intangible assets were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;380,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,633&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to definite-lived intangible assets acquired during the nine&#160;months ended September&#160;30, 2021&#160;were as follows &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,370&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;220,640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense relating to intangible assets for the three months ended September&#160;30, 2021 and 2020 was $13.3 million and $1.8 million, respectively, and amortization expense for the nine&#160;months ended September&#160;30, 2021 and 2020 was $23.2 million and $3.6 million, respectively. Estimated amortization expense relating to intangible assets for the remainder of 2021 and for each of the next five full&#160;years ending December&#160;31 is as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (October-December)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,050&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYy_b18a168c-01c0-48c0-88be-f5d2722b32fd">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,776&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;340,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;437,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;405,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="ia5706b49442c42cc92ff686adc9c2f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi0xLTEtMS0w_4d482d20-0c98-4bf2-8dad-87690abd5e4d"
      unitRef="usd">197886000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia5706b49442c42cc92ff686adc9c2f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi0zLTEtMS0w_2686fad7-e7d6-4432-a072-e1213984b9ae"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="idc51d73723524b38a531dfff6500d1bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi01LTEtMS0w_2885311e-11bb-461e-9e67-ec9e7fe1cf46"
      unitRef="usd">65149000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="idc51d73723524b38a531dfff6500d1bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMi03LTEtMS0w_87d890e6-dd25-42ac-b90b-af5b1c096a51"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMy0xLTEtMS0w_4e173899-165f-42ac-80a1-367f4100e010"
      unitRef="usd">240776000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfMy01LTEtMS0w_6d42c618-fbb6-45ed-ae66-8d3e9e0572fc"
      unitRef="usd">340108000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNC0xLTEtMS0w_17cd66d5-6747-447f-8555-fc2fa3a5ba61"
      unitRef="usd">-1618000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNC01LTEtMS0w_0ff3413e-12f6-4960-a31d-10c120f626e4"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillGross
      contextRef="ia5e079ad5fea45d1896564cab3657124_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS0xLTEtMS0w_bf80aace-f20d-409d-b167-b3ab6da6936e"
      unitRef="usd">437044000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia5e079ad5fea45d1896564cab3657124_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS0zLTEtMS0w_be7b624a-c8b6-4542-8ef9-f3545b30cf68"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i2347919b5a0f402dbe70c10597badc81_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS01LTEtMS0w_a143d19b-ebd2-45ef-9b45-5c205449e7c7"
      unitRef="usd">405257000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2347919b5a0f402dbe70c10597badc81_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOjI3N2M4MjFlNWE2YTQ2NjRhMjIyOGQ1OWZlZjlmODM1L3RhYmxlcmFuZ2U6Mjc3YzgyMWU1YTZhNDY2NGEyMjI4ZDU5ZmVmOWY4MzVfNS03LTEtMS0w_bbd1b2bc-85ed-4f93-a711-486d8607592a"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODYz_c2605254-411b-4c58-89fa-75d95c11b4ea">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value and accumulated amortization for definite-lived intangible assets were as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;380,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,633&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4a5e9f871cd340148867c6e71fdf972e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi0xLTEtMS0w_6619ce4d-a4bd-4904-8ea5-f917ad1d51cf"
      unitRef="usd">209321000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4a5e9f871cd340148867c6e71fdf972e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi0zLTEtMS0w_c955ab0b-3e34-4f8d-9d68-6eda1e0955f8"
      unitRef="usd">19257000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi01LTEtMS0w_c3ef689d-22eb-4924-993c-faeb91fbcc59"
      unitRef="usd">117451000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2396e45c41fd4a97b4d6d24b28ccfea6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMi03LTEtMS0w_ca020142-23df-4269-b93e-b57068ab4e58"
      unitRef="usd">3664000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5263022fb5924aec8717109210e85b4e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy0xLTEtMS0w_64ebb993-1133-48f7-8883-b606445becfa"
      unitRef="usd">99231000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5263022fb5924aec8717109210e85b4e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy0zLTEtMS0w_9d07120f-938e-4e9a-89ad-7836248bf595"
      unitRef="usd">5057000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia7f4e995deff4436ac164dccfef41665_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy01LTEtMS0w_89bd466e-18f0-485e-aae6-f9c1d6f516cb"
      unitRef="usd">38161000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia7f4e995deff4436ac164dccfef41665_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfMy03LTEtMS0w_e7fede40-61e6-4721-af16-d91c75aec52c"
      unitRef="usd">1604000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d60d46058494a0c9b1c382560f26baf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0xLTEtMS0yMjQzMA_ad88fc79-b1f3-4c75-b40b-a012ee318f14"
      unitRef="usd">59000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d60d46058494a0c9b1c382560f26baf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0zLTEtMS0yMjQzMA_58a41e15-2c64-488c-86e3-d1eb0321bc66"
      unitRef="usd">3278000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idac76b89cd7144e9aae00bd7925215e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC01LTEtMS0yMjQzMA_aebbedfd-1893-489e-b8c9-a5fee290ba64"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idac76b89cd7144e9aae00bd7925215e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC03LTEtMS0yMjQzMA_88b01b30-6061-4646-95b9-94aeb058c87a"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifc5b9d2a29e04e838afb62706696b06b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0xLTEtMS0w_395f1546-197e-4fd5-9abd-b0fe82bb43ab"
      unitRef="usd">6200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifc5b9d2a29e04e838afb62706696b06b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC0zLTEtMS0w_50f71744-4e26-414e-969f-2d5ce247da37"
      unitRef="usd">443000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC01LTEtMS0w_83bd54fa-333b-4092-8e3b-5ea5b2444342"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i053bb5bbe44043edab8f84a3fec9c1d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNC03LTEtMS0w_7d6741eb-330b-45ac-a470-1f7422460af8"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i32dc3e4609c14b56bb221bfee7c43e94_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS0xLTEtMS0w_07a6e122-c10b-49d7-90df-266ee9cc54d9"
      unitRef="usd">6400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i32dc3e4609c14b56bb221bfee7c43e94_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS0zLTEtMS0w_cf8e6747-f6db-4dc6-9630-282cfcfeb998"
      unitRef="usd">598000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS01LTEtMS0w_36bdb557-ed2e-4e05-8ea8-78c47062fc77"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ida8b9a579e4f4f4589c421b6c8ae93cf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNS03LTEtMS0w_e55148db-ad67-48f0-8270-ea3d366ced53"
      unitRef="usd">133000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi0xLTEtMS0w_9d213263-51ab-4351-b3ef-d99c825663fc"
      unitRef="usd">380152000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi0zLTEtMS0w_ab7736c0-45d5-47e3-8767-723659050c59"
      unitRef="usd">28633000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi01LTEtMS0w_c06c096a-ddc5-4802-a526-102cda799e79"
      unitRef="usd">157612000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmZiOGRhMzdhNzVhODQ0NzZhZmUwZmZkM2YyYWE1NTRkL3RhYmxlcmFuZ2U6ZmI4ZGEzN2E3NWE4NDQ3NmFmZTBmZmQzZjJhYTU1NGRfNi03LTEtMS0w_658965da-bab9-4057-8fac-8a122d1a7dea"
      unitRef="usd">5401000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODY0_0081e498-5158-4578-b4ef-357c088f6a3b">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to definite-lived intangible assets acquired during the nine&#160;months ended September&#160;30, 2021&#160;were as follows &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,370&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reacquired contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;220,640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMS0xLTEtMS0w_ae0c9a1c-e1cd-4d98-b352-559782a3100a"
      unitRef="usd">90670000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5bd537fa1a624af58ea31311dcb6b190_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMS0zLTEtMS0w_c0fd3527-1dcb-425e-95f4-392e10fe372a">P16Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMi0xLTEtMS0w_253918fc-719a-4197-8ae6-4e043b192cae"
      unitRef="usd">60370000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i71ccfdb00203492ea5777309e4c9e62d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMi0zLTEtMS0w_132e3dd2-5e49-4a76-bf03-b766795ed905">P14Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0xLTEtMS0yMjQ1NQ_3471c3d3-d7f0-4e81-ac9a-81e188be8671"
      unitRef="usd">59000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib6cf5f6b0165484289e32171c85a2085_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0zLTEtMS0yMjQ1NQ_03421972-aae0-437b-900e-cbf9afa2baa8">P4Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0xLTEtMS0w_0a516fdd-6f11-4350-9eb9-deb3d59a66b7"
      unitRef="usd">6200000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if5c5e952ae5e4bb19874731e3e79302d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfMy0zLTEtMS0w_1a11632b-1b8c-4163-ba37-040a972af215">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNC0xLTEtMS0w_afe6a061-8869-49c3-972f-f4a0c2c187aa"
      unitRef="usd">4400000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNC0zLTEtMS0w_17ef1f2d-9bda-4cfb-8796-a7a4ad226afa">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNS0xLTEtMS0w_1d4281fa-493e-45e7-a6c9-1e029469f6fe"
      unitRef="usd">220640000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmI5ZWE3NjBlODBkMTRhOTlhNWJmZjZkZWI1MWNjMjU1L3RhYmxlcmFuZ2U6YjllYTc2MGU4MGQxNGE5OWE1YmZmNmRlYjUxY2MyNTVfNS0zLTEtMS0w_7d02fa8f-89d1-4374-ba61-cbdd7f289faf">P9Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNTQ4_0e793b99-9a79-4de4-8752-85415af5ad69"
      unitRef="usd">13300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNTYz_4bfdcb77-0eb1-4fa0-ae82-02003d4ff674"
      unitRef="usd">1800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNjUy_c2e46d93-26fd-4dd0-aad9-40ea302579bb"
      unitRef="usd">23200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfNjY3_a6bc855f-3d4f-4006-9449-63c2208547f2"
      unitRef="usd">3600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RleHRyZWdpb246YTExMjEwOGJkZDFkNDBkNjliNmVlNDQ2MzZiZWE4Y2VfODY1_3087d401-04a5-4778-a74a-2d0e6330c7d7">Estimated amortization expense relating to intangible assets for the remainder of 2021 and for each of the next five full&#160;years ending December&#160;31 is as follows&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (October-December)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,050&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMC0xLTEtMS0w_e2851202-aa45-43cd-b8c6-f60c2f8cc918"
      unitRef="usd">10513000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMS0xLTEtMS0w_13ce2a17-ac5d-40cf-ad48-a50e468eafbc"
      unitRef="usd">42050000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMi0xLTEtMS0w_1f5ddf63-dbb7-476b-bb66-2d69c9d1f744"
      unitRef="usd">42029000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfMy0xLTEtMS0w_9d742bff-1f8c-4c57-8c74-96cb20a3568c"
      unitRef="usd">41890000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfNC0xLTEtMS0w_001cbd4c-accb-44bd-81e9-a6d77805e3a5"
      unitRef="usd">41890000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV80OS9mcmFnOmExMTIxMDhiZGQxZDQwZDY5YjZlZTQ0NjM2YmVhOGNlL3RhYmxlOmY1NzNkOGZjNDdmNTQ2NmE5MmFkMTZiYjcyMmUxZWFlL3RhYmxlcmFuZ2U6ZjU3M2Q4ZmM0N2Y1NDY2YTkyYWQxNmJiNzIyZTFlYWVfNS0xLTEtMS0w_d386dfa3-7063-48d8-8003-e61b40c1e2cf"
      unitRef="usd">26323000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InsuranceDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfNzkx_59691a29-7ab3-4e9d-baa5-f51f0b040331">MEDICAL COSTS PAYABLE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the nine&#160;months ended September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable - January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,647,719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,649,445&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,074,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232,312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,306,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired claims liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable - September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;Medical costs payable attributable to prior&#160;years increased by $1.7 million and&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt; decreased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;by &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt;$9.3 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"&gt; for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively. Medical costs payable estimates are adjusted as additional information becomes known regarding claims; there were no significant changes to estimation methodologies during the periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below details the components making up the medical costs payable as of September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims unpaid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider incentive payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69,274&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims adjustment expense liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred but not reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,870&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs payable are primarily related to the current year. The Company has recorded claims adjustment expense as a component of operating costs in the Condensed Consolidated Statements of Income (Loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:InsuranceDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfNzky_c7bc368a-7798-4c00-a7aa-b417c6a4ac19">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the nine&#160;months ended September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable - January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,647,719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,649,445&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,074,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232,312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,306,914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired claims liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable - September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below details the components making up the medical costs payable as of September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims unpaid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42,488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider incentive payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69,274&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims adjustment expense liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred but not reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,870&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;685,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMS0xLTEtMS0w_ebee9f3c-3c31-480d-804a-aad3c7b1b827"
      unitRef="usd">249777000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i6c91a02c94204c438991d1c1f55dd5d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMS0zLTEtMS0w_9e16e3c9-5aff-4dd1-b1d9-413bea7c507c"
      unitRef="usd">44804000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMy0xLTEtMS0w_5724daa7-a7cd-4876-aecd-9b9d491a50b8"
      unitRef="usd">2647719000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMy0zLTEtMS0w_503d73de-cba8-4d97-ae91-6abf588904f8"
      unitRef="usd">685637000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNC0xLTEtMS0w_ac207006-8e0a-4562-840c-e57fa089f6e3"
      unitRef="usd">1726000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNC0zLTEtMS0w_d99e5f25-a565-4f69-a4c7-2302104535db"
      unitRef="usd">-9297000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNS0xLTEtMS0w_c3dfd05a-b8f0-4c70-afd1-1b543528b9c8"
      unitRef="usd">2649445000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNS0zLTEtMS0w_c852be96-6b46-4f20-9eb7-d6129ff632b7"
      unitRef="usd">676340000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNy0xLTEtMS0w_a1fa8bf7-c17a-4d36-bc95-f97a4686da84"
      unitRef="usd">2074602000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfNy0zLTEtMS0w_ea1332c0-65fe-43b1-a52a-691d8b6e9978"
      unitRef="usd">610161000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOC0xLTEtMS0w_bb27e156-b437-4b30-a9f0-016a8063c9c3"
      unitRef="usd">232312000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOC0zLTEtMS0w_27ee2962-e591-444d-a052-e7a5e3adb4a5"
      unitRef="usd">29974000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOS0xLTEtMS0w_7bdd12b1-3fff-48be-b5d3-3fdb35e05cc4"
      unitRef="usd">2306914000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfOS0zLTEtMS0w_117cd026-cc6a-4a60-a4ec-aa82b8d0a80a"
      unitRef="usd">640135000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTEtMS0xLTEtMA_1e5df162-cecc-4098-b6d6-c01b4a99201f"
      unitRef="usd">92737000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTEtMy0xLTEtMA_61cb3482-9a7e-4d21-8e40-abfd9e5d91a2"
      unitRef="usd">118662000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTItMS0xLTEtMA_5669bfb7-9d06-47c4-a2c3-3169499a0ee9"
      unitRef="usd">685045000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjdiNzY3NjQ1Zjc3YzQ5YzBhOWIyNjg2YzY5ZTNlMDJhL3RhYmxlcmFuZ2U6N2I3Njc2NDVmNzdjNDljMGE5YjI2ODZjNjllM2UwMmFfMTItMy0xLTEtMA_d1c99c0b-2672-49de-bdfc-cb903e200a40"
      unitRef="usd">199671000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfMjI0_2e158d56-3e6c-464c-9dd2-8b7a64aad9e3"
      unitRef="usd">1700000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RleHRyZWdpb246NDEyZGNkYzM5OWJmNDY3NTljYzA2MDdlNDU5YzFhOGZfMjQ0_5de70e28-1cbd-470e-9a29-3f6425fdf4ad"
      unitRef="usd">-9300000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMS0xLTEtMS0w_860e0e60-91fb-4152-8153-c127d9f6fb98"
      unitRef="usd">42488000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMS0zLTEtMS0w_398316a0-f749-4dde-a7e0-6686e17e7233"
      unitRef="usd">25961000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount>
    <bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMi0xLTEtMS0w_f445a27d-88a7-437f-986c-de87cb7c2f2e"
      unitRef="usd">69274000</bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable>
    <bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMi0zLTEtMS0w_77af4614-1dd9-4220-8ff0-b14421a224f3"
      unitRef="usd">10391000</bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable>
    <bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMy0xLTEtMS0w_5d7e9e51-56a2-4f54-8400-fb080bc7464a"
      unitRef="usd">12413000</bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability>
    <bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfMy0zLTEtMS0w_57e2fb5f-18c3-4a71-8366-e9d38815d3ac"
      unitRef="usd">2572000</bhg:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNC0xLTEtMS0w_d97dc4ac-1154-4e71-8387-e5962e29b266"
      unitRef="usd">560870000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNC0zLTEtMS0w_2942bcd9-6d59-4352-8384-db82fbb28d10"
      unitRef="usd">160747000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNS0xLTEtMS0w_decfaa5e-38e3-40b3-a78a-ae74e161f047"
      unitRef="usd">685045000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81Mi9mcmFnOjQxMmRjZGMzOTliZjQ2NzU5Y2MwNjA3ZTQ1OWMxYThmL3RhYmxlOjE0NTA2MWQ3NDg4MjQ1ZjE4MWViNDQyNGE2ZGQxMDE3L3RhYmxlcmFuZ2U6MTQ1MDYxZDc0ODgyNDVmMTgxZWI0NDI0YTZkZDEwMTdfNS0zLTEtMS0w_bb91307e-3fbd-4183-918d-c249424c06d2"
      unitRef="usd">199671000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortTermDebtTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMTIyNg_9fafe0b6-f392-4c83-92d0-eb620a1dea6a">SHORT-TERM BORROWINGSOn March&#160;1, 2021, we entered into a $350.0 million revolving credit agreement with a syndicate of banks (the &#x201c;Credit Agreement&#x201d;). On August 2, 2021, the Credit Agreement was amended to change the definition of &#x201c;Qualified IPO&#x201d; by reducing the net proceeds required to be received by the Company from $1.0&#160;billion to $850.0 million. In addition, prior to such amendment, the Credit Agreement contained a covenant that required the Company to maintain a total debt to capitalization ratio of (a) 0.25 to 1.00 prior to a Qualified IPO, and (b) 0.30 to 1.00 after a Qualified IPO. The Amendment changed this covenant by removing the increase in the ratio after a Qualified IPO such that the Company is now required to maintain a total debt to capitalization ratio of 0.25 to 1.00. On August 4, 2021, we elected to extend the maturity date of the Credit Agreement from February 28, 2022 to February 28, 2024. During the second quarter of 2021, we utilized a portion of the net IPO proceeds to repay the $200.0 million principal balance of indebtedness outstanding under our revolving credit agreement originally entered into on March 1, 2021 and the associated interest and other costs of $3.2&#160;million. As of September&#160;30, 2021, we have no borrowings outstanding under the Credit Agreement.</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i239b6a8206b34281a2d7bdb5f1c2ecb9_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNjI_0c34c934-2e4f-4c6b-8741-177ce0becb82"
      unitRef="usd">350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate
      contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMzEz_77705990-041b-4cd1-8843-57415cc8dc2b"
      unitRef="usd">1000000000</bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate>
    <bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate
      contextRef="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMzE5_c16ff4fe-1e88-4117-8e29-825b64101bde"
      unitRef="usd">850000000.0</bhg:LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate>
    <bhg:DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO
      contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNDkz_6c1482ac-41c6-40b1-80be-9101583d182c"
      unitRef="number">0.25</bhg:DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO>
    <bhg:DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO
      contextRef="ib31a1c8050534f39b7e9c9a99b2f3743_D20210301-20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNTM2_03f2270c-fcdf-4417-8a0c-16141d33a3ba"
      unitRef="number">0.30</bhg:DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO>
    <bhg:DebtInstrumentCovenantTotalDebtToCapitalizationRatio
      contextRef="ie1bcc88ee69d48ebabf7827ec34d7648_D20210802-20210802"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfNzU0_643ca6b7-7a36-4c6a-9856-8cf14a551f86"
      unitRef="number">0.25</bhg:DebtInstrumentCovenantTotalDebtToCapitalizationRatio>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ia89038a50c124021864f208e24672ab8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfOTUw_cdcec9a5-52a0-43ac-b502-046a5f99abec"
      unitRef="usd">200000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:InterestExpenseShortTermBorrowings
      contextRef="ia89038a50c124021864f208e24672ab8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81NS9mcmFnOmI2Y2UyYzQ2Y2U3MTRlYzliMzFjMWZlM2Y3ODU4MjExL3RleHRyZWdpb246YjZjZTJjNDZjZTcxNGVjOWIzMWMxZmUzZjc4NTgyMTFfMTEyNA_6c182cfd-f276-4e5f-85ec-64f3cb153191"
      unitRef="usd">3200000</us-gaap:InterestExpenseShortTermBorrowings>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE1OQ_1a849814-5f19-4906-8c16-7af13a7b4b4b">SHARE-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2016 Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted its 2016 Stock Incentive Plan (the &#x201c;2016 Incentive Plan&#x201d;) in March 2016. The 2016 Incentive Plan allowed for the Company to grant stock options, restricted stock awards (&#x201c;RSAs&#x201d;), and restricted stock units (&#x201c;RSUs&#x201d;) to certain employees, consultants and non-employee directors. The 2016 Incentive Plan was initially adopted on March 25, 2016, and most recently amended in December 2020. Following the effectiveness of our 2021 Omnibus Plan (the &#x201c;2021 Incentive Plan&#x201d;), no further awards will be granted under the 2016 Incentive Plan. However, all outstanding awards granted under the 2016 Incentive Plan will continue to be governed by the existing terms of the 2016 Incentive Plan and the applicable award agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Incentive Plan was adopted by our Board of Directors on May 21, 2021 and approved by our stockholders on May 25, 2021 and June 5, 2021. The 2021 Incentive Plan allows the Company to grant stock options, RSAs, RSUs, stock appreciation rights, other equity based awards, and cash based incentive awards to certain employees, consultants and non-employee directors. There are 42.0 million shares of common stock authorized for issuance under the 2021 Incentive Plan. As of September&#160;30, 2021, a total of 26.8 million shares of common stock were available for future issuance under the 2021 Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized share-based compensation expense of $43.2 million and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Board of Directors or the Compensation Committee of the Board of Directors determines the exercise price, vesting periods and expiration date at the time of the grant. Stock options granted prior to the third quarter of 2021 generally vest 25% at one year from the grant date, then ratably over the next 36 months with continuous employee service. Stock options granted after the beginning of the third quarter of 2021 generally vest ratably over three years. Option grants generally expire 10 years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculated value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted-average assumptions for options granted during the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of our publicly traded industry peers. We use historical data to estimate option forfeitures within the valuation model. The expected lives of options granted represent the period of time that the awards granted are expected to be outstanding based on historical exercise patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity for the stock options for the nine&#160;months ended September&#160;30, 2021 is as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except exercise price and contractual life)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate &lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,573&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;445,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value of stock options granted during the nine months ended September&#160;30, 2021 was $10.86 per share. At September&#160;30, 2021, there was $150.7 million of unrecognized compensation expense related to stock options that is expected to be recognized over a weighted-average period of 3.4 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;RSUs represent the right to receive shares of our common stock at a specified date in the future and generally vest over a three-year period. The fair value of RSUs is determined based on the closing market price of our common stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes RSU award activity for the nine months ended September 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;in thousands, except weighted average grant date fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.01&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized share-based compensation expense related to RSUs of $0.2 million for the three and nine months ended September 30, 2021, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). As of September 30, 2021, there was $2.5 million of unrecognized compensation expense related to the RSU grants, which is expected to be recognized over a weighted-average period of 2.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-based Restricted Stock Units (&#x201c;PSUs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our IPO, our Board of Directors approved the grant of PSUs to members of our executive leadership team. The grant encompasses a total of 14.7&#160;million PSUs, separated into four equal tranches, each of which are eligible to vest based on the achievement of predetermined stock price goals and a minimum service period of 3 years. This grant is intended to retain and incentivize our executive leadership to lead the Company to sustained, long-term financial and operational performance. The fair value of the PSUs is determined using a Monte-Carlo simulation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes PSU award activity for the nine months ended September 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except weighted average grant date fair value)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested PSUs at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;PSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;PSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested PSUs at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We recognized share-based compensation expense related to the PSU grant of $10.0 million and $10.3 million for the three and nine months ended September 30, 2021, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). At September 30, 2021, there was $108.5 million of unrecognized compensation expense related to the PSU grant, which is expected to be recognized over a weighted-average period of 2.7 years.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTIwMw_51d6104c-3757-47da-83e7-33e6c71b4afc"
      unitRef="shares">42000000.0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTMxMw_f1380601-854a-4adc-aca5-12e9546f2f5f"
      unitRef="shares">26800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTQ5OA_27b35603-05ac-40fb-a679-cee2250bad85"
      unitRef="usd">43200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTUwNQ_41d75780-e963-4b54-aa83-166f36aef41f"
      unitRef="usd">3700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTg0OQ_eeb5db3e-5914-48eb-8994-f17f8543eaa7"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8f868e61bb1e46f782456a7f3bb91ef2_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTg1NQ_3d0c85f9-ea0c-4190-abd1-270bf7f583d6">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8d71d04cf62a46bc8ec80068d333d865_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTkwNg_7dd026b1-873a-473d-87b0-0ab4a9bc4041">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg5MDg4NQ_7ea83466-055f-4a1d-ad09-1fc8e010c317">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ib2b8edf4355b42a394c65cb67a5caa09_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMTk3NA_5ad67d31-e36a-41b5-8897-ff1533f33a21">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2MA_05657c18-0c7b-4cbe-aa3c-dc647bfd3381">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculated value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted-average assumptions for options granted during the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMS0xLTEtMS0w_1823d1d3-cef3-4b55-982b-b7283a89662a"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMi0xLTEtMS0w_004975ad-846e-4059-a0e5-af560dde253c"
      unitRef="number">0.333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfMy0xLTEtMS0w_ebdd71d2-4edd-479a-bf75-cd0cd665e0b1"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfNC0xLTEtMS0w_7fc56359-f534-49c5-84d2-fbaf46e6871a"
      unitRef="number">0.145</bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjYzMGIzZTA1YmM5ZjQ3MzJiOTJiZjg4YzU0ODdlMTQ5L3RhYmxlcmFuZ2U6NjMwYjNlMDViYzlmNDczMmI5MmJmODhjNTQ4N2UxNDlfNS0xLTEtMS0w_a9ce8b48-e4b0-4dad-bb3f-28e18ecd1922">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2MQ_883425e6-85ff-47c5-89f0-2ec363018844">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity for the stock options for the nine&#160;months ended September&#160;30, 2021 is as follows&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except exercise price and contractual life)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate &lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,573&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;445,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS0xLTEtMS0w_88285ebf-8d98-48bb-9d9e-79d5aa4c48c2"
      unitRef="shares">63925000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS0zLTEtMS0w_56067eee-40f3-4dd6-bcca-4c20455680ce"
      unitRef="usdPerShare">1.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i1cb0c464b5b74f17a7e2b16b4ca83666_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS01LTEtMS0w_57d71fe8-931b-498a-ae80-a22bd00c790e">P8Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMS03LTEtMS0w_b1f198b4-3f47-49b1-90bb-d5509e47dc2d"
      unitRef="usd">53573000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMi0xLTEtMS0w_b8fb0795-2a4b-4b42-bc9f-a9526f980d3c"
      unitRef="shares">20447000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMi0zLTEtMS0w_82c85e8f-9c8c-4544-85f7-30f33e6a52e4"
      unitRef="usdPerShare">2.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMy0xLTEtMS0w_17c079a7-a5e2-4d23-8b8f-4d7da6d95910"
      unitRef="shares">9373000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfMy0zLTEtMS0w_06347df1-b917-4d3b-a304-df62be6aa141"
      unitRef="usdPerShare">1.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNC0xLTEtMS0w_ad419884-6297-4621-9374-dee58fd7d8a2"
      unitRef="shares">4709000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNC0zLTEtMS0w_918087d5-fb53-4b25-acf7-98b35a143677"
      unitRef="usdPerShare">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNS0xLTEtMS0w_afe00fc1-c764-479a-8e9b-4208b96110d0"
      unitRef="shares">11000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNS0zLTEtMS0w_20866f90-8562-4a74-9b22-2bb1d2b44e6c"
      unitRef="usdPerShare">1.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi0xLTEtMS0w_43507012-b93d-4beb-8c68-af995288b34e"
      unitRef="shares">70279000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi0zLTEtMS0w_e23b7bd5-77ae-4876-b198-430a59fb9f38"
      unitRef="usdPerShare">1.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi01LTEtMS0w_8611e609-4e6f-48e6-9373-8e26838a785a">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOmE2ZjkwOGZkNTk3MTQ0NmY4NTliZGQ0MTMwMmUwZWVhL3RhYmxlcmFuZ2U6YTZmOTA4ZmQ1OTcxNDQ2Zjg1OWJkZDQxMzAyZTBlZWFfNi03LTEtMS0w_a667153c-d466-4f19-b343-0fec3ebe8894"
      unitRef="usd">445246000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMjkwNw_6386a480-df09-49e7-8fb3-e5d20eca2b30"
      unitRef="usdPerShare">10.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMjkzOA_7ab7f584-7cf4-4155-8bb9-409f31058887"
      unitRef="usd">150700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ica442b5ba7794e58b4b714aa57dcfb75_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzA3MQ_6255c7dd-81c7-419c-8660-3ce3fd29d9a1">P3Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg4ODU1Mw_2eefd16d-f628-403c-9627-45f148d975cb">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI5ODUzNDg4ODUzOA_68821993-4bca-4267-a3c3-1dae25617c45">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes RSU award activity for the nine months ended September 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;in thousands, except weighted average grant date fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.01&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic04162a13ce44bbcbac57b063ee86f28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMi0xLTEtMS00MTkz_01bddf23-4bfe-4d4d-b087-80984d8bcb25"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic04162a13ce44bbcbac57b063ee86f28_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMi0zLTEtMS00MTkz_017d322e-55ab-43f1-b1bb-4083838cb476"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMy0xLTEtMS00MTkz_6b4d6a7d-f72f-4976-894f-e042b8219658"
      unitRef="shares">364000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfMy0zLTEtMS00MTkz_0d5b74cd-2ea1-44c1-9aa6-39a32a4894a4"
      unitRef="usdPerShare">9.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNC0xLTEtMS00MTkz_c1bea6cc-dd7e-4d12-88c7-19da2d2edf7e"
      unitRef="shares">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNC0zLTEtMS00MTkz_90cd6770-9ae3-4ddb-b16a-6f39ab3c47b4"
      unitRef="usdPerShare">9.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNS0xLTEtMS00MTkz_8f95b8a7-b4ea-4dd1-84ae-625eb6995226"
      unitRef="shares">345000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjFmMmUxNjU4MDFjYzQ5MjliODQ5YWFhMzBlNWMxOTk4L3RhYmxlcmFuZ2U6MWYyZTE2NTgwMWNjNDkyOWI4NDlhYWEzMGU1YzE5OThfNS0zLTEtMS00MTkz_c7c92e35-f423-4570-82d2-f17b7a79635b"
      unitRef="usdPerShare">9.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic52eea78557244659324ce8e6c2bb202_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg0Ng_ac397302-84e1-4eb1-81c6-c997e7812991"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg0Ng_b440f649-ffa3-43b0-a391-65833dda2181"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="iab3ef9a574ff42738e7c366e77b92366_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg2Mg_d40cb9fb-3545-4942-ad27-43a15dda8875"
      unitRef="usd">2500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3b16a26184f542c1864a9c5d30920cc0_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzg3NQ_5d14900e-0939-4bf0-95d8-40e65d54c10d">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzI4Mw_4dea8784-ba6e-4605-b26c-2ef4f09c7a17"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzMwNw_b0baca40-ddba-44b1-b04c-8da845f2806b"
      unitRef="vestingtranche">4</bhg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDA4Ng_5bf590a7-4bd6-49e2-a4cc-0a24620ccb31">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfNDE2Mw_346cabbb-5e20-4b43-a63c-7915cfe67d4f">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes PSU award activity for the nine months ended September 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except weighted average grant date fair value)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested PSUs at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;PSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;PSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested PSUs at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie498ad30294744b1ac90b3f7364ad523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMi0xLTEtMS0w_7e57f4ed-50df-4d60-8915-506f253828e0"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie498ad30294744b1ac90b3f7364ad523_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMi0zLTEtMS0w_0ba03ee7-b5a5-431c-8662-902b80b5cd25"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMy0xLTEtMS0w_ba08099a-2ca5-4238-932c-21f8cd790416"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfMy0zLTEtMS0w_e753ff97-00a5-4697-be93-f98192e3a8b9"
      unitRef="usdPerShare">9.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNC0xLTEtMS0w_43a720ba-d7b7-4252-8042-51740f49f679"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNC0zLTEtMS0w_deb0eb6f-3093-4437-bfea-68f094726826"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNS0xLTEtMS0w_72856d61-0602-4f40-a93b-ea3c88c059b3"
      unitRef="shares">14700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RhYmxlOjIwOTI2MTVhZTBjZTRmZjZhYjk4NTc3MjIwZDRjMWNkL3RhYmxlcmFuZ2U6MjA5MjYxNWFlMGNlNGZmNmFiOTg1NzcyMjBkNGMxY2RfNS0zLTEtMS0w_0e92ca77-4f9d-42ff-8b07-5f7df83c33c9"
      unitRef="usdPerShare">9.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i043ba02e46a04d3d9c3801cac0f40005_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzk2OQ_a2921132-3569-47aa-aa04-8589239372a4"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwMzk4OA_bc6c58ae-bdf2-4721-b268-eb15719826ac"
      unitRef="usd">10300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i0dcae2bd3e4b48deb2eff47b7c3fde66_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDAwOA_33cb74b5-bc6f-4cb6-8a39-bf50094af0b0"
      unitRef="usd">108500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i203d535c01884ea0ae6700ffe287835b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV81OC9mcmFnOjBmNGFiOWM5MDU5MTQxZjQ5ODEwY2QwNmVjYWU2MDg5L3RleHRyZWdpb246MGY0YWI5YzkwNTkxNDFmNDk4MTBjZDA2ZWNhZTYwODlfMzg0ODI5MDcwNDAyNQ_1406a67f-6475-47c1-82ae-9ed106645f7e">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg3_c05b7896-95e3-4442-9163-ed07d303dff7">NET LOSS PER SHARE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine&#160;months ended September 30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Bright Health Group, Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(300,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(370,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;630,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the nine&#160;months ended September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (as converted to common stock)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg4_10076d33-f7d4-40d5-91e0-aa5544a650c2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine&#160;months ended September 30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Bright Health Group, Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(300,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(370,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;630,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0xLTEtMS0w_be378bf5-df61-4db3-9767-4e55d97227ce"
      unitRef="usd">-300664000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0xLTEtMS0w_c240808b-7cb4-4f85-9eb2-4abdc36895eb"
      unitRef="usd">-300664000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0zLTEtMS0w_17e33b4a-7002-45dc-9c2a-ab20fba58b4d"
      unitRef="usd">-59256000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi0zLTEtMS0w_a6fcad10-904f-4c4a-8e74-799d4a11cff8"
      unitRef="usd">-59256000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi01LTEtMS0w_ab372f2f-9f93-4930-a9b4-1c53bdea4ad2"
      unitRef="usd">-370344000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi01LTEtMS0w_f118e6dc-90e5-440d-8eba-36ce956dee08"
      unitRef="usd">-370344000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi03LTEtMS0w_8d3b51fe-8118-4ed8-9f3a-962046e8788f"
      unitRef="usd">-84610000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMi03LTEtMS0w_cd552a16-72f1-45e5-85a4-50ee414c3804"
      unitRef="usd">-84610000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0xLTEtMS0w_9fed6671-40dc-480b-9ede-466144ea2e5f"
      unitRef="shares">630378</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0xLTEtMS0w_ee1b2b88-b4a8-447b-a6a8-0cfbcef484d3"
      unitRef="shares">630378</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0zLTEtMS0w_dcf21e50-3e84-4077-9967-9f4b253a3e83"
      unitRef="shares">136337</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy0zLTEtMS0w_de8a6abb-5825-4ac2-9e5b-ce755c11f896"
      unitRef="shares">136337</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy01LTEtMS0w_11dfa6cb-f23e-4f93-a6ac-3818046bb839"
      unitRef="shares">312294</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy01LTEtMS0w_8253e7b7-dc2d-45e4-86c8-9fa298a6c3a3"
      unitRef="shares">312294</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy03LTEtMS0w_ab2be6ac-80e5-4ac2-ab13-f0f39f95d6fa"
      unitRef="shares">135926</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfMy03LTEtMS0w_fc9fd2be-599c-4b32-8d62-04f2d26e8b37"
      unitRef="shares">135926</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0xLTEtMS0w_3beb7439-9747-44ff-ae9b-5aee1f7d3641"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0xLTEtMS0w_f7e89b0a-1fd0-4231-b72b-297716d91b93"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0zLTEtMS0w_98a81166-a470-41bb-bcd0-7c083975bc4f"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC0zLTEtMS0w_e9685030-bb94-426a-b329-f2042759b42d"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC01LTEtMS0w_66990a6e-ac03-47f2-9ca8-c951bc8d4c48"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC01LTEtMS0w_c3ed9573-1948-420a-bccd-ec0eb6709eb0"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC03LTEtMS0w_b65c419e-de0c-4a74-94aa-2a439b456e81"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOmU1NzEzNjA1MzcyNzRiZmI5YzkyMjJjZGY2OTBmNWYwL3RhYmxlcmFuZ2U6ZTU3MTM2MDUzNzI3NGJmYjljOTIyMmNkZjY5MGY1ZjBfNC03LTEtMS0w_d19a12ab-e674-4bee-8587-bfdb6f707a7c"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RleHRyZWdpb246Y2FjY2Y1NWRjYjZjNGRkZWIzZTJkYzgyNTk2YzYxZDZfNDg5_2ac8ca1d-8c9b-439a-8fe3-7fa64de3b037">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the nine&#160;months ended September&#160;30&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (as converted to common stock)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4a06652cd21144e68f470720d0b26e59_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMi0xLTEtMS0w_51d776c9-d8e1-4e48-82cd-2ca8b2b0d0ad"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1803b1c56bb045a9a7e1425efd488b53_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMi0zLTEtMS0w_e49d8b1a-0c85-4ab7-96fe-9fb1b78fd107"
      unitRef="shares">411238000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2fc0670e71004cc7a5aaf2b1e4d07c2e_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMy0xLTEtMS0w_96f16785-0fc4-4920-904c-245e25951656"
      unitRef="shares">70279000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i096b128e354942a2943cc883c2a582eb_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfMy0zLTEtMS0w_a237c557-a8d9-46e7-a3bf-4c444691b7a4"
      unitRef="shares">58224000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfNC0xLTEtMS0w_e726733a-6840-4c5b-99fe-e83c9879b903"
      unitRef="shares">70279000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82MS9mcmFnOmNhY2NmNTVkY2I2YzRkZGViM2UyZGM4MjU5NmM2MWQ2L3RhYmxlOjRlMzBjMjc5ZTViYjQyZTI4YmUzMTM1ZmUzY2NmMTlmL3RhYmxlcmFuZ2U6NGUzMGMyNzllNWJiNDJlMjhiZTMxMzVmZTNjY2YxOWZfNC0zLTEtMS0w_020cf02b-dbc6-44e0-b418-e2bcfcb0661d"
      unitRef="shares">469462000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82NC9mcmFnOjU2MmE1OTlkMzY2YjQzOWM4ZWFhNTZmZDUyYTg2YWVjL3RleHRyZWdpb246NTYyYTU5OWQzNjZiNDM5YzhlYWE1NmZkNTJhODZhZWNfNDE0_23abb6be-d16d-441f-ab84-dc3e1c100738">COMMITMENTS AND CONTINGENCIES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal proceedings:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;In the normal course of business, we could be involved in various legal proceedings such as, but not limited to, the following: lawsuits alleging negligence in care or general liability, violation of regulatory bodies&#x2019; rules and regulations, or violation of federal and/or state laws. At September&#160;30, 2021 and December&#160;31, 2020, there were no material known contingent liabilities.&lt;/span&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTI4_db74de57-a8ad-461b-9e43-421a9bbf7be7">SEGMENTS AND GEOGRAPHIC INFORMATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our two reportable segments are Bright HealthCare and NeueHealth.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the reportable segment financial information for the three and nine&#160;months ended September&#160;30, 2021 and 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;994,586&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,647&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,020,233&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,258&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;995,612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,078,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;139,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;995,612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,078,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(303,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(296,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,860,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,922,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,573&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109,012&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;112,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,863,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;203,265&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,067,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182,392&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(182,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,863,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;385,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(182,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,067,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(443,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,291&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(378,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,981&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all periods presented, all of our long-lived assets were located in the United States, and all revenues were earned in the United States. We do not include asset information by reportable segment in the reporting provided to the chief operating decision maker.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTc_b5adb8ea-b1e7-44bf-baf1-cdc739902da3"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RleHRyZWdpb246NGI4ODAwNjU3ZGE5NDliY2E4OWE0NzBiMDljMzQ0YTFfNTI3_534eec34-4861-4499-b419-da8c895d0e69">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the reportable segment financial information for the three and nine&#160;months ended September&#160;30, 2021 and 2020&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;994,586&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,647&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,020,233&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,258&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;995,612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,078,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;139,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;995,612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,078,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(303,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(296,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,860,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,922,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,573&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,602&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109,012&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;112,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,863,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;203,265&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,067,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182,392&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(182,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,863,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;385,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(182,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,067,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(443,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,291&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(378,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,981&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Bright&lt;br/&gt;HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NeueHealth&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unaffiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Affiliated revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS0yLTEtMS0w_d46b55f3-a8b6-4c62-b132-f1e5c763de9e"
      unitRef="usd">994586000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS00LTEtMS0w_dd385604-61f1-4fa8-bcc5-3767a4710975"
      unitRef="usd">25647000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMS04LTEtMS0w_727dc2d9-eb82-4ed8-81fa-029796650ce3"
      unitRef="usd">1020233000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi0yLTEtMS0w_de2a264e-ccea-4073-a42d-b351188885cc"
      unitRef="usd">-61000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi00LTEtMS0w_959fcb50-93c8-4709-97d9-7bcba78af714"
      unitRef="usd">11140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMi04LTEtMS0w_68de158e-0515-448e-82ca-c90064001272"
      unitRef="usd">11079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bhg:InvestmentIncomeLoss
      contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy0yLTEtMS0w_82c5fd90-9032-4903-b8ae-68de50880ed1"
      unitRef="usd">1087000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy00LTEtMS0w_8e472aa2-d3c5-4221-918e-d2c34ff0a4a8"
      unitRef="usd">46258000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfMy04LTEtMS0w_92e835d5-f091-4fbd-946d-81554c0cb283"
      unitRef="usd">47345000</bhg:InvestmentIncomeLoss>
    <us-gaap:Revenues
      contextRef="i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC0yLTEtMS0w_2f59d6fc-93d1-4ad5-ac57-4883b15e6822"
      unitRef="usd">995612000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2cb24a9e9665486c938a7cbc9348bec0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC00LTEtMS0w_5e23791c-ee6f-4403-a2fe-dacdf2878ccd"
      unitRef="usd">83045000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNC04LTEtMS0w_8367a7e6-a9ca-4463-9d53-788499a09644"
      unitRef="usd">1078657000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib7f653fc2a4d47c4a01311be6348f994_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNS00LTEtMS0w_9c6fb966-538b-4733-8f74-44d3e190ee78"
      unitRef="usd">-139759000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i820545dd461745cb9b88d3b536970633_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNS02LTEtMS0w_2b53169e-1236-4482-b942-26f3a164ce72"
      unitRef="usd">-139759000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi0yLTEtMS0w_b2607bc0-5634-47bb-a858-7c52f2b86b13"
      unitRef="usd">995612000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi00LTEtMS0w_46893bc4-dcd6-4135-872a-9acd7da2da92"
      unitRef="usd">222804000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i820545dd461745cb9b88d3b536970633_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi02LTEtMS0w_a0cca743-b458-4336-bdda-44c76e230a35"
      unitRef="usd">-139759000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNi04LTEtMS0w_488e109a-1c97-4977-9116-011a07183b1f"
      unitRef="usd">1078657000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy0yLTEtMS0w_79fcc966-7eb9-4f61-94e2-36beba6a3cbe"
      unitRef="usd">-303271000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy00LTEtMS0w_88dce8b9-bd59-4aae-8c5c-1ce8644bb4af"
      unitRef="usd">6990000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfNy04LTEtMS0w_54eb5c80-ec98-4302-9c32-48e6e4eedc17"
      unitRef="usd">-296281000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id566fa33affc4d31afef5e770bd5bc23_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS0yLTEtMS0w_88ed7237-e0d1-4450-ad7d-1eed333af350"
      unitRef="usd">4584000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib6a13e9349a3462da2e829f76809f87d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS00LTEtMS0w_b98a8758-3b11-4975-9981-d34cf5741843"
      unitRef="usd">9621000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmI1NjhkYzIxNGFiMzQzZDhhODY3MGQ2NGQyZDY4NGUzL3RhYmxlcmFuZ2U6YjU2OGRjMjE0YWIzNDNkOGE4NjcwZDY0ZDJkNjg0ZTNfOS04LTEtMS0w_31c49c95-7188-41d1-9359-50f7f4bfddd8"
      unitRef="usd">14205000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS0yLTEtMS0w_50f9365e-5466-48a3-b91c-83094d0fcef7"
      unitRef="usd">343472000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS00LTEtMS0w_292e506a-7c7f-45f0-a0de-b5744ffd377c"
      unitRef="usd">1954000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMS04LTEtMS0w_8b939c19-3509-4bd3-a126-c2497fb18b37"
      unitRef="usd">345426000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi0yLTEtMS0w_b5d6d332-e17b-4a0d-a094-53f789452426"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi00LTEtMS0w_f122963f-ab3c-40df-a49e-902d3866e9a6"
      unitRef="usd">4920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMi04LTEtMS0w_4bd03362-7ba0-44e0-911b-d7b35fd5f733"
      unitRef="usd">4920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bhg:InvestmentIncomeLoss
      contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy0yLTEtMS0w_c583201f-cb23-4811-a570-b3e9e768bc7a"
      unitRef="usd">1774000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy00LTEtMS0w_46fba6da-6880-43fb-87ce-6f4a245debbc"
      unitRef="usd">0</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfMy04LTEtMS0w_05fd6d0d-2517-4aa3-a152-067329f99765"
      unitRef="usd">1774000</bhg:InvestmentIncomeLoss>
    <us-gaap:Revenues
      contextRef="i253e1d6aeb854ecf9c5d89444a32006c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC0yLTEtMS0w_910415e0-9656-4f41-9b2a-c7b18fa2fbce"
      unitRef="usd">345246000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie90952dacc2442f8ab06c72e6114295c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC00LTEtMS0w_9c540976-95cd-43a1-9197-5866cb5a00cb"
      unitRef="usd">6874000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNC04LTEtMS0w_57ddeb3a-34b2-41be-9176-fc374372ae97"
      unitRef="usd">352120000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifbe36d5030b44213aa037bd2cd8a869f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNS00LTEtMS0w_46e8b08a-6b25-4696-ab4a-d519935e79b4"
      unitRef="usd">-2727000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNS02LTEtMS0w_2eeeb83c-0565-4eaf-8200-fbdea3406dbf"
      unitRef="usd">-2727000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi0yLTEtMS0w_6ad75f97-7cd8-4cd9-bcfc-afe654942182"
      unitRef="usd">345246000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi00LTEtMS0w_66e35fa5-6a3a-4455-a0c1-2dd0f3ce0874"
      unitRef="usd">9601000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i040a7fd5986945e89fe0ddce13242aef_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi02LTEtMS0w_3864d91a-f164-4d2d-b0bb-8be1c560a2c3"
      unitRef="usd">-2727000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNi04LTEtMS0w_64eaf3bc-6273-4f07-9adb-398bda0201e8"
      unitRef="usd">352120000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy0yLTEtMS0w_e23aa623-af6a-417f-9e35-70dc36a26517"
      unitRef="usd">-57263000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy00LTEtMS0w_f159dd9c-7f8e-42f1-aa0e-54e0d6dcd983"
      unitRef="usd">-1993000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfNy04LTEtMS0w_786e0142-c892-454f-bda6-9fdd9f7ea15f"
      unitRef="usd">-59256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9bfdedcb13b04e1cabfdc1543db74c88_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS0yLTEtMS0w_5a3ab653-c220-4aac-bceb-3b7a1c8a4fb3"
      unitRef="usd">2274000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i136e63d37f9940afb60898aa7d0668cd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS00LTEtMS0w_52cc06cb-c42c-4257-9dcf-d25c8a5f9f18"
      unitRef="usd">404000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if890322e1050423c9f21ff3c2b864535_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmFlNGJiMTc5NzU1YjQyZjdiNjFiZWNiNzU3ZjYyYzM3L3RhYmxlcmFuZ2U6YWU0YmIxNzk3NTViNDJmN2I2MWJlY2I3NTdmNjJjMzdfOS04LTEtMS0w_a84032f3-c391-4b22-b1fd-bd78b28b523d"
      unitRef="usd">2678000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS0yLTEtMS0w_552db94f-64dc-4cb5-8ea5-97f99a070a5f"
      unitRef="usd">2860270000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS00LTEtMS0w_ffa79949-9f00-4c60-a87c-d422058e0a76"
      unitRef="usd">62680000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMS04LTEtMS0w_47dfcf54-1763-47ec-b0b5-6fc83b86ab6d"
      unitRef="usd">2922950000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi0yLTEtMS0w_17b0e373-3287-4e84-a026-900d846ce810"
      unitRef="usd">29000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi00LTEtMS0w_74318cc5-7e79-456e-bf92-93b81e8bc860"
      unitRef="usd">31573000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMi04LTEtMS0w_78b18684-6f7d-4c19-9c73-786e6d08a67a"
      unitRef="usd">31602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bhg:InvestmentIncomeLoss
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy0yLTEtMS0w_be8402c4-7831-49bd-9ee5-01c361dc0881"
      unitRef="usd">3491000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy00LTEtMS0w_446ff442-892c-4873-a137-8c190281e664"
      unitRef="usd">109012000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfMy04LTEtMS0w_6f905598-fda1-4998-bad4-be0e53adb69f"
      unitRef="usd">112503000</bhg:InvestmentIncomeLoss>
    <us-gaap:Revenues
      contextRef="i3ff2980a0a7a43c49a100da49bdd49ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC0yLTEtMS0w_4af8a4b4-2eee-4fe0-91e5-847fba5d1a8c"
      unitRef="usd">2863790000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72af7b82970b4c85ac61a866ee63f990_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC00LTEtMS0w_b8ec085e-d99e-4cfc-8a15-23ec1d43dbab"
      unitRef="usd">203265000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNC04LTEtMS0w_1f480a6b-ef14-4ce5-872d-0e07cd5115b3"
      unitRef="usd">3067055000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1edb8fe9719f4576984692641eb7fb92_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNS00LTEtMS0w_eb0e07fd-ef04-4c6d-9578-de52e114c891"
      unitRef="usd">-182392000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNS02LTEtMS0w_1a5963b7-f0b5-4685-9e58-c84a298d14ae"
      unitRef="usd">-182392000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi0yLTEtMS0w_b3e11d8f-30b2-4707-a047-fb2d4bb260ad"
      unitRef="usd">2863790000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi00LTEtMS0w_e763618b-5323-4859-b34d-19dac62c66af"
      unitRef="usd">385657000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58ee502020db4ce3ac72da12c2acea43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi02LTEtMS0w_d81dba8a-67fd-47be-a09e-c26a8b8bfa03"
      unitRef="usd">-182392000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNi04LTEtMS0w_656ed9db-1afb-48bb-ba53-f51c2a3f8665"
      unitRef="usd">3067055000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy0yLTEtMS0w_97a99c45-629a-4515-9a49-7f00173aea90"
      unitRef="usd">-443450000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy00LTEtMS0w_c4e7049e-f3a1-4191-91b5-0207c4ad03ca"
      unitRef="usd">65291000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfNy04LTEtMS0w_7953385b-8efa-4dbd-8525-d4c6db9b674b"
      unitRef="usd">-378159000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id37b7a5485404128a642a44330167703_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS0yLTEtMS0w_205c0c9b-2276-4425-9659-a97e1e9ef4fd"
      unitRef="usd">11524000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaaf7fc2eb5f14c759e6283bcb0c53c0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS00LTEtMS0w_c9d2d4d6-dd1f-46e1-a86c-49404baaae82"
      unitRef="usd">14457000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOjk2NzNkZTFiOGY5NjQ4ODliOGUwMDhlMTkzZTlkODE4L3RhYmxlcmFuZ2U6OTY3M2RlMWI4Zjk2NDg4OWI4ZTAwOGUxOTNlOWQ4MThfOS04LTEtMS0w_dcf98da9-5e60-429d-a2b3-cd96f5fd8190"
      unitRef="usd">25981000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS0yLTEtMS0w_7dee23cd-9d08-4238-924d-c48fe56666c8"
      unitRef="usd">821185000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS00LTEtMS0w_01430f10-85c6-4752-bb38-622a22f560ef"
      unitRef="usd">5950000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMS04LTEtMS0w_dca7afa3-9a30-4aad-9d24-a57a8d6be667"
      unitRef="usd">827135000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi0yLTEtMS0w_943c24ac-e271-4433-b8ac-f99fe9dc2801"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi00LTEtMS0w_31dbcb1d-ad82-40c4-ad41-87ae7ea0203d"
      unitRef="usd">13344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMi04LTEtMS0w_27ed585e-1656-4455-be7e-98f58bdd8287"
      unitRef="usd">13344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bhg:InvestmentIncomeLoss
      contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy0yLTEtMS0w_c3ada224-0629-40ba-bb87-c3e052d8f43e"
      unitRef="usd">7063000</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy00LTEtMS0w_9b11271c-ae0b-4a36-982c-01f7f8aacfc7"
      unitRef="usd">0</bhg:InvestmentIncomeLoss>
    <bhg:InvestmentIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfMy04LTEtMS0w_08f603e1-a2aa-4573-b07e-9c6187090a8b"
      unitRef="usd">7063000</bhg:InvestmentIncomeLoss>
    <us-gaap:Revenues
      contextRef="i6830aa7be62a4044b218a0cbb519d297_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC0yLTEtMS0w_4334924e-6bd1-4898-bb9b-8fb244b5ee87"
      unitRef="usd">828248000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfea120e80f74eb69082c0dfd4316ace_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC00LTEtMS0w_eecced60-6b6e-44fe-9406-1ed4a6348966"
      unitRef="usd">19294000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNC04LTEtMS0w_04769b59-98cc-4cbb-95ec-aa4f38bae9fc"
      unitRef="usd">847542000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1ec0bf0ed7741758e2d7b0b6a2cd127_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNS00LTEtMS0w_be0e5679-137e-4f16-bf66-49062f3f072b"
      unitRef="usd">-8176000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNS02LTEtMS0w_16b1e009-6807-443c-9f16-706be585a8d9"
      unitRef="usd">-8176000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi0yLTEtMS0w_2cc7a0c1-49ae-4fdf-b0a1-299acec9b9ad"
      unitRef="usd">828248000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi00LTEtMS0w_0b747850-f001-4476-9f5e-ff03dff391e1"
      unitRef="usd">27470000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i902d90b17f064bc1ab3af1abc00cad6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi02LTEtMS0w_933e200e-a6ff-4c39-bbe9-76fa56a15a72"
      unitRef="usd">-8176000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNi04LTEtMS0w_c5ebff26-87ad-41d2-bb3a-78d3ae7010b7"
      unitRef="usd">847542000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy0yLTEtMS0w_fb2c524d-5a0f-4004-880c-d8b029ca0446"
      unitRef="usd">-88427000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy00LTEtMS0w_1787ebb6-efdf-4310-84d5-a1b90ce1219c"
      unitRef="usd">-5345000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfNy04LTEtMS0w_b392cbc6-b702-4dc2-b7fb-d6477d05759e"
      unitRef="usd">-93772000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i90d1772be7b44496a00eaf90733c5d28_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS0yLTEtMS0w_6bfe3484-f555-4724-a68c-9885d68ba7f1"
      unitRef="usd">4131000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i22fc6e63146046bda462ed353e35e16e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS00LTEtMS0w_75cdc431-8099-4f8d-856f-c0ecbcd7fb28"
      unitRef="usd">1419000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1b1636c0dcb6463a895cce9d615ac7e6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV82Ny9mcmFnOjRiODgwMDY1N2RhOTQ5YmNhODlhNDcwYjA5YzM0NGExL3RhYmxlOmJiN2MxYmI1MmQ3OTRmNDk5YmE5Y2ViYzZkMzg1ZDRlL3RhYmxlcmFuZ2U6YmI3YzFiYjUyZDc5NGY0OTliYTljZWJjNmQzODVkNGVfOS04LTEtMS0w_db35ffab-88b1-4574-8388-c06226657cdd"
      unitRef="usd">5550000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfMTU0Nw_6dff9069-8ef0-4fb7-a314-42786eb73c7b">INCOME TAXES&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) was an expense of $0.1 million and a benefit of $18.2 million for the three and nine&#160;months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The impact from income taxes varies from the federal statutory rate of 21.0% due to changes in the valuation allowance for deferred tax assets and adjustments for permanent differences. For the three months ended September&#160;30, 2021, the expense largely relates to amortization of originating goodwill from asset acquisitions. For the nine&#160;months ended September&#160;30, 2021, the overall tax benefit is primarily due to the release of valuation allowance in connection with new deferred tax liabilities recorded on identifiable intangibles as part of business combination accounting for the BND, Zipnosis, THNM, and CHP stock acquisitions. The Centrum acquisition was treated as an asset acquisition, and accordingly, no deferred tax assets or liabilities were recorded as part of business-combination accounting.&lt;/span&gt;We assess whether sufficient future taxable income will be generated to permit the use of deferred tax assets. This assessment includes consideration of the cumulative losses incurred over the three-year period ended September&#160;30, 2021. Such objective evidence limits the ability to consider other subjective evidence, such as the Company&#x2019;s projections for future earnings. On the basis of this evaluation, we have recorded a valuation allowance for deferred tax assets to the extent that they cannot be supported by reversals of existing cumulative temporary differences. Any federal tax benefit generated from losses in 2021 is expected to require an offsetting adjustment to the valuation allowance for deferred tax assets, and thus have no net effect on the income tax provision.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfNTI_1e337a04-05aa-4ee3-ba96-33835f8ff829"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83MC9mcmFnOjBjODAwODdkNGRiMjRkMDVhN2VmYzkwNTU2MGE0YWVlL3RleHRyZWdpb246MGM4MDA4N2Q0ZGIyNGQwNWE3ZWZjOTA1NTYwYTRhZWVfNTk_1f362860-e579-4cb8-a88d-b2dacc146108"
      unitRef="usd">-18200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMjgy_5aaddeda-9e9e-4770-9055-28a354851a58">REDEEMABLE NONCONTROLLING INTEREST&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Centrum acquisition on July 1, 2021, we entered into put/call agreements with respect to the equity interests in Centrum held by the controlling interest holder. The call options allow for the Company to purchase the 25% noncontrolling interest equity over time beginning on September 30, 2022, or under certain other accelerating events as defined in the agreement, solely at the Company&#x2019;s discretion. The put options allow the noncontrolling interest holder the ability to cause the Company to purchase their noncontrolling equity interest on consistent terms with the call options. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the nature of the put option&#x2019;s redemption features, which are outside the control of the Company, the noncontrolling interests are classified as redeemable in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021. The put option redemption feature that is outside the control of the Company is settled based on EBITDA, which is an other than &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fair value settlement amount. As such, we will make a measurement adjustment when the put option redemption price exceeds the carrying amount as calculated under ASC 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was no redeemable noncontrolling interest during the three and nine&#160;months ended September&#160;30, 2020. The following table provides details of our redeemable noncontrolling interest activity for the three and nine&#160;months e&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nded September&#160;30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;329&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,012&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;85,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i29660353a02b48e987417294a4c7d8ee_I20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMzI5ODUzNDg4NTU2MQ_d6f38227-ab5a-40af-b2ce-10da0c4f9757"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib3e9df45a4ef406badd359c74e03a99e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfNjE_635862f9-d06b-4609-a4f2-4694dd8ebd00"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RleHRyZWdpb246ZTE2YmQxMmFjOTY0NGM0ZjlhMmI4OGJiNjJhZGNhOGNfMjgz_1f78a7f1-5ce0-4477-84b6-5186a69c0fb3">The following table provides details of our redeemable noncontrolling interest activity for the three and nine&#160;months e&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nded September&#160;30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;329&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41,012&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;85,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMS0xLTEtMS0w_49d86db2-1ef2-4fdd-bc87-d819a281be73"
      unitRef="usd">39600000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMi0xLTEtMS0w_3f8cceac-3de4-420d-b047-8df05de87fb8"
      unitRef="usd">288000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ic8205e32653f4af7b0d29140221fba44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMy0xLTEtMS0w_7c77c5de-4448-46a4-9bf9-abe18215ec92"
      unitRef="usd">329000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib168a2810cb14711aa2a509c2b7bec5b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNC0xLTEtMS0w_cb6a114d-9673-4d88-ba9e-d59aee3cb02a"
      unitRef="usd">40217000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNS0xLTEtMS0w_1e958b0f-17dc-41c2-9cfd-97748f64a71e"
      unitRef="usd">640000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="if76bd54aa57443eaabf411ccff850bf5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNi0xLTEtMS0w_fff3f942-8b35-4f98-a573-5b682be44f10"
      unitRef="usd">155000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i3747e34d1b8945a2b35ae65a0c95b283_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfNy0xLTEtMS0w_2a65ce0c-f38e-44ee-a202-8159415f20b2"
      unitRef="usd">41012000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOC0xLTEtMS0xOTE0Nw_9dbb7770-57c7-48fc-a53f-a0c755a6f38a"
      unitRef="usd">85075000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOC0xLTEtMS0yMjU_888f9d5f-64a0-4d18-b468-02312face3d9"
      unitRef="usd">-4577000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfOS0xLTEtMS0yMjU_4eb8caf6-39b7-42eb-9f42-cd32067cb9a9"
      unitRef="usd">8519000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i28f7521b4a234009aa828e733e8f9a3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUwYWJmZWViMmVkODRjNThiYTVkNzJlZmVjMWFmNjZlL3NlYzplMGFiZmVlYjJlZDg0YzU4YmE1ZDcyZWZlYzFhZjY2ZV83My9mcmFnOmUxNmJkMTJhYzk2NDRjNGY5YTJiODhiYjYyYWRjYThjL3RhYmxlOmVmMjNhNDdmMDZiZDRiMTc4YmZhNjZlMTNiNjZkODdkL3RhYmxlcmFuZ2U6ZWYyM2E0N2YwNmJkNGIxNzhiZmE2NmUxM2I2NmQ4N2RfMTAtMS0xLTEtMjI1_acbcfb93-2785-4c12-8927-e5eb65f867b9"
      unitRef="usd">130029000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770071666136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRIGHT HEALTH GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-4991296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8000 Norman Center Drive, Suite 1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minneapolis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-1321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,315,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001671284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769976001704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 956,189,000<span></span>
</td>
<td class="nump">$ 488,371,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">331,719,000<span></span>
</td>
<td class="nump">499,928,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $5,701 and $2,602, respectively</a></td>
<td class="nump">99,216,000<span></span>
</td>
<td class="nump">60,522,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">240,545,000<span></span>
</td>
<td class="nump">130,986,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,627,669,000<span></span>
</td>
<td class="nump">1,179,807,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">681,923,000<span></span>
</td>
<td class="nump">175,176,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and capitalized software, net</a></td>
<td class="nump">30,932,000<span></span>
</td>
<td class="nump">12,264,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">842,301,000<span></span>
</td>
<td class="nump">263,035,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">351,519,000<span></span>
</td>
<td class="nump">152,211,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">40,751,000<span></span>
</td>
<td class="nump">28,309,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">1,947,426,000<span></span>
</td>
<td class="nump">630,995,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,575,095,000<span></span>
</td>
<td class="nump">1,810,802,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="nump">685,045,000<span></span>
</td>
<td class="nump">249,777,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">95,161,000<span></span>
</td>
<td class="nump">57,252,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned revenue</a></td>
<td class="nump">34,917,000<span></span>
</td>
<td class="nump">34,628,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_RiskAdjustmentPayableCurrent', window );">Risk adjustment payable</a></td>
<td class="nump">548,352,000<span></span>
</td>
<td class="nump">187,777,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">88,133,000<span></span>
</td>
<td class="nump">35,847,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,451,608,000<span></span>
</td>
<td class="nump">565,281,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">56,254,000<span></span>
</td>
<td class="nump">28,578,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,507,862,000<span></span>
</td>
<td class="nump">593,859,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">130,029,000<span></span>
</td>
<td class="nump">39,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable preferred stock, $0.0001 par value; 100,000,000 and 166,307,087 shares authorized in 2021 and 2020, respectively; &#8212; and 164,244,893 shares issued and outstanding in 2021 and 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,681,015,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 3,000,000,000 and 658,993,725 shares authorized in 2021 and 2020, respectively; 628,133,782 and 137,662,698 shares issued and outstanding in 2021 and 2020, respectively</a></td>
<td class="nump">63,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,823,244,000<span></span>
</td>
<td class="nump">9,877,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(886,333,000)<span></span>
</td>
<td class="num">(515,989,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">230,000<span></span>
</td>
<td class="nump">2,426,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity (deficit)</a></td>
<td class="nump">1,937,204,000<span></span>
</td>
<td class="num">(503,672,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 3,575,095,000<span></span>
</td>
<td class="nump">$ 1,810,802,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_RiskAdjustmentPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk Adjustment Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_RiskAdjustmentPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979650504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss</a></td>
<td class="nump">$ 5,701<span></span>
</td>
<td class="nump">$ 2,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">166,307,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">164,244,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">164,244,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,000,000,000<span></span>
</td>
<td class="nump">658,993,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">628,133,782<span></span>
</td>
<td class="nump">137,662,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">628,133,782<span></span>
</td>
<td class="nump">137,662,698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770072502648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 1,020,233<span></span>
</td>
<td class="nump">$ 345,426<span></span>
</td>
<td class="nump">$ 2,922,950<span></span>
</td>
<td class="nump">$ 827,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="nump">$ 11,079<span></span>
</td>
<td class="nump">$ 4,920<span></span>
</td>
<td class="nump">$ 31,602<span></span>
</td>
<td class="nump">$ 13,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue, Product and Service [Extensible Enumeration]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="nump">$ 47,345<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
<td class="nump">$ 112,503<span></span>
</td>
<td class="nump">$ 7,063<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,078,657<span></span>
</td>
<td class="nump">352,120<span></span>
</td>
<td class="nump">3,067,055<span></span>
</td>
<td class="nump">847,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Medical costs</a></td>
<td class="nump">1,050,943<span></span>
</td>
<td class="nump">311,319<span></span>
</td>
<td class="nump">2,640,143<span></span>
</td>
<td class="nump">675,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">309,790<span></span>
</td>
<td class="nump">97,379<span></span>
</td>
<td class="nump">779,090<span></span>
</td>
<td class="nump">260,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">14,205<span></span>
</td>
<td class="nump">2,678<span></span>
</td>
<td class="nump">25,981<span></span>
</td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,374,938<span></span>
</td>
<td class="nump">411,376<span></span>
</td>
<td class="nump">3,445,214<span></span>
</td>
<td class="nump">941,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(296,281)<span></span>
</td>
<td class="num">(59,256)<span></span>
</td>
<td class="num">(378,159)<span></span>
</td>
<td class="num">(93,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,282<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other income</a></td>
<td class="num">(1,226)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,226)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(296,649)<span></span>
</td>
<td class="num">(59,256)<span></span>
</td>
<td class="num">(383,215)<span></span>
</td>
<td class="num">(93,772)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,225)<span></span>
</td>
<td class="num">(9,162)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(296,722)<span></span>
</td>
<td class="num">(59,256)<span></span>
</td>
<td class="num">(364,990)<span></span>
</td>
<td class="num">(84,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(3,942)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,354)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Bright Health Group, Inc. common shareholders</a></td>
<td class="num">$ (300,664)<span></span>
</td>
<td class="num">$ (59,256)<span></span>
</td>
<td class="num">$ (370,344)<span></span>
</td>
<td class="num">$ (84,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">630,378<span></span>
</td>
<td class="nump">136,337<span></span>
</td>
<td class="nump">312,294<span></span>
</td>
<td class="nump">135,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">630,378<span></span>
</td>
<td class="nump">136,337<span></span>
</td>
<td class="nump">312,294<span></span>
</td>
<td class="nump">135,926<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_InvestmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest income and realized gains and losses on debt securities, as well as unrealized gains and losses on equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_InvestmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979309096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (296,722)<span></span>
</td>
<td class="num">$ (59,256)<span></span>
</td>
<td class="num">$ (364,990)<span></span>
</td>
<td class="num">$ (84,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized investment holding (losses) gains arising during the year, net of tax of $0 and $0, respectively</a></td>
<td class="num">(143)<span></span>
</td>
<td class="num">(958)<span></span>
</td>
<td class="num">(1,808)<span></span>
</td>
<td class="nump">2,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Less: reclassification adjustments for investment gains, net of tax of $0 and $0, respectively</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">388<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
<td class="num">(2,196)<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(297,025)<span></span>
</td>
<td class="num">(60,333)<span></span>
</td>
<td class="num">(367,186)<span></span>
</td>
<td class="num">(82,352)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interests</a></td>
<td class="num">(3,942)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,354)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Bright Health Group, Inc. common shareholders</a></td>
<td class="num">$ (300,967)<span></span>
</td>
<td class="num">$ (60,333)<span></span>
</td>
<td class="num">$ (372,540)<span></span>
</td>
<td class="num">$ (82,352)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979183176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized investment holding (losses) gains arising during the year, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Reclassification adjustments for investment gains, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769969053176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>IPO</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>IPO</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>IPO</div>
</th>
<th class="th"><div>Retained Earnings (Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">119,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 871,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">119,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">$ 871,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(263,367)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (267,547)<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(7,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,692,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="num">$ (268,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(274,827)<span></span>
</td>
<td class="nump">1,933<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">119,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 871,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">162,179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 1,638,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(263,367)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(267,547)<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(84,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">$ (341,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(352,157)<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">119,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 871,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">19,661,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 291,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="nump">138,883,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">$ 1,163,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,692,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="num">(268,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(274,827)<span></span>
</td>
<td class="nump">1,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">2,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,384<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="num">$ (283,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(292,901)<span></span>
</td>
<td class="nump">4,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">23,296,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 475,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">162,179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 1,638,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(59,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">$ (341,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(352,157)<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">164,244,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,681,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">1,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 55,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">165,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,736,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">137,662,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">$ (503,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(515,989)<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(25,162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,661,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">4,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="num">$ (519,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(541,151)<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">164,244,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,681,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">137,662,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">$ (503,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(515,989)<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(370,344)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (2,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">628,133,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 1,937,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,823,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(886,333)<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">165,665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,736,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 79,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="num">(167,732,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_TemporaryEquityValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="num">$ (1,815,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="num">(519,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(541,151)<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(44,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">1,815,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,815,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,120,000<span></span>
</td>
<td class="nump">51,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">4,723<span></span>
</td>
<td class="nump">$ 880,642<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">4,722<span></span>
</td>
<td class="nump">$ 880,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">13,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(851)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 2,150,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,735,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(585,669)<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(300,664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance and sale of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,965,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="nump">75,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_StockReturnedDuringPeriodSharesEscrowSettlement', window );">Return of common stock from escrow settlement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,522,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_StockReturnedDuringPeriodValueEscrowSettlement', window );">Return of common stock from escrow settlement</a></td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">24,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">628,133,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 1,937,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,823,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (886,333)<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_StockReturnedDuringPeriodSharesEscrowSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Returned During Period, Shares, Escrow Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_StockReturnedDuringPeriodSharesEscrowSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_StockReturnedDuringPeriodValueEscrowSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Returned During Period, Value, Escrow Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_StockReturnedDuringPeriodValueEscrowSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_TemporaryEquityValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Value Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_TemporaryEquityValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984171784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (370,344)<span></span>
</td>
<td class="num">$ (84,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">25,981<span></span>
</td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">43,234<span></span>
</td>
<td class="nump">3,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(17,946)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain on equity securities</a></td>
<td class="num">(109,012)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">14,555<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquired assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(18,683)<span></span>
</td>
<td class="nump">27,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(86,836)<span></span>
</td>
<td class="num">(24,980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve', window );">Medical cost payable</a></td>
<td class="nump">342,531<span></span>
</td>
<td class="nump">35,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_IncreaseDecreaseInRiskAdjustmentPayable', window );">Risk adjustment payable</a></td>
<td class="nump">359,257<span></span>
</td>
<td class="nump">68,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">53,853<span></span>
</td>
<td class="num">(22,015)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnearnedPremiums', window );">Unearned revenue</a></td>
<td class="num">(3,476)<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">233,114<span></span>
</td>
<td class="nump">11,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(736,838)<span></span>
</td>
<td class="num">(702,672)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sales, paydown, and maturities of investments</a></td>
<td class="nump">536,110<span></span>
</td>
<td class="nump">349,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(20,682)<span></span>
</td>
<td class="num">(1,181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(431,718)<span></span>
</td>
<td class="num">(174,090)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(653,128)<span></span>
</td>
<td class="num">(528,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">686,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">10,581<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments for debt issuance costs</a></td>
<td class="num">(3,391)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from IPO</a></td>
<td class="nump">887,328<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for IPO offering costs</a></td>
<td class="num">(6,686)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">887,832<span></span>
</td>
<td class="nump">687,714<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">467,818<span></span>
</td>
<td class="nump">170,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents&#8201;&#8211;&#8201;beginning of year</a></td>
<td class="nump">488,371<span></span>
</td>
<td class="nump">522,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents&#8201;&#8211;&#8201;end of period</a></td>
<td class="nump">956,189<span></span>
</td>
<td class="nump">693,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Changes in unrealized (loss) gain on available-for-sale securities in OCI</a></td>
<td class="num">(2,196)<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">3,865<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Redeemable convertible preferred stock issued for acquisitions</a></td>
<td class="nump">134,944<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</a></td>
<td class="nump">$ 1,815,916<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_IncreaseDecreaseInRiskAdjustmentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Risk Adjustment Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_IncreaseDecreaseInRiskAdjustmentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInUnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stock that is classified as callable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979683512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td>
<td class="text">ORGANIZATION AND BASIS OF PRESENTATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bright Health Group, Inc. and subsidiaries (collectively, &#8220;Bright Health,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or the &#8220;Company&#8221;) was founded in 2015 to transform healthcare. Our mission of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Making Healthcare Right.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Together.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is built upon the belief that by connecting and aligning the local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, reduce systemic waste, lower costs, and optimize clinical outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Split:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On June&#160;2, 2021, we effected a stock split of the Company&#8217;s common stock on a 1-for-3 basis (the &#8220;Stock Split&#8221;). In connection with the Stock Split, the conversion rate for the Company&#8217;s preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was increased in proportion to the Stock Split. Accordingly, all common stock share and per share amounts for all periods presented in these financial statements have been retroactively adjusted to reflect this Stock Split. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On June&#160;28, 2021, we completed our initial public offering (&#8220;IPO&#8221;) in which we issued and sold </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,350,000 shares of common stock, par value $0.0001 per share, at an offering price of $18.00 per share. We received net proceeds of $887.3 million from the sale of our common stock, after deducting underwriting discounts and commissions of $37.0 million. We used a portion of the net proceeds from our IPO to repay in full our outstanding borrowings under our revolving credit facility, as well as to fund the acquisition of Centrum Medical Holdings, LLC (&#8220;Centrum&#8221;). Refer to Note 2, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 7, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Borrowings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Common Stock is traded on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;BHG&#8221;. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $6.7&#160;million of deferred offering costs consisting primarily of accounting, legal and other fees related to our IPO, which were recorded against IPO proceeds within additional paid-in capital upon closing of our IPO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion of Preferred Stock into Common Stock: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;28, 2021, the Company issued 427,897,381 shares of common stock upon conversion (the &#8220;Conversion&#8221;) of all outstanding shares of its Series A Convertible Preferred Stock, par value $0.0001 per share, Series B Convertible Preferred Stock, par value $0.0001 per share, Series C Convertible Preferred Stock, par value $0.0001 per share, Series D Convertible Preferred Stock, par value $0.0001 per share, and Series E Convertible Preferred Stock, par value $0.0001 per share (collectively, the &#8220;Preferred Stock&#8221;), pursuant to its eighth amended and restated certificate of incorporation. Conversion of the preferred stock into shares of common stock occurred automatically immediately prior to the closing of our IPO. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our audited consolidated financial statements, unless the information contained in those disclosures materially changed or is required by GAAP. As such, the condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes thereto as of and for the year ended December&#160;31, 2020 included in the prospectus dated June 23, 2021 (File No.333-256286) (the &#8220;Prospectus&#8221;), as filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. The accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for fair presentation of the interim financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Our most significant estimates include medical costs payable, risk adjustment revenue and associated payables and receivables, valuation and impairment of goodwill and other intangible assets, valuation and impairment of investments and estimates of share-based compensation. Actual results could differ from these estimate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. </span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $134.0&#160;million as a result of updated data inputs used to calculate Individual and Family Plan (&#8220;IFP&#8221;) members&#8217; expected full year risk scores, which resulted in an increase in risk adjustment </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payable in the Condensed Consolidated Balance Sheets and a reduction in premium revenue in the Condensed Consolidated Statements of Income (Loss).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our operating costs, by functional classification for the three and nine months ended September&#160;30, 2021 and 2020, are as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and fringe benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100,062</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,483</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">143,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and selling expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">183,636</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78,802</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">217,739</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">309,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">779,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Pronouncements:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting pronouncements that were recently issued and not yet adopted or adopted since our audited consolidated financial statements that had, or are expected to have, a material impact on our consolidated financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975782072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATIONS</a></td>
<td class="text">BUSINESS COMBINATIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centrum Acquisition: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2021, we acquired 75% of the outstanding equity interests of Centrum for cash consideration of $222.4 million and $75.0 million of common stock, for total purchase consideration of $296.2 million, net of $1.2 million of cash acquired. Centrum is a value-based primary care focused, multi-specialty medical group based in Florida. Centrum operates 17 health centers in Florida, serving Commercial, Medicare, and Medicaid consumers across multiple payors, with secured expansion locations in Texas and North Carolina. Centrum is included in our NeueHealth reportable segment. Transaction costs of $1.0 million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September 30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the Centrum acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill, which is predominantly attributable to the incremental financial benefits achievable through Bright Health Group&#8217;s integrated care delivery model, whereby Bright HealthCare members are cared for under value-based arrangements with Centrum. This model brings together the financing, distribution, and delivery of high-quality healthcare and provides the opportunity to enhance overall margin potential for the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the Centrum acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:105%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. The Company is in process of identifying any additional intangible assets that would reduce the goodwill recognized. The fair values of certain assets and liabilities have changed from previous disclosure. We obtained additional information to estimate the fair value of the right-of-use lease asset and liability included within other assets and other liabilities. We also updated the fair value of intangible assets based on the methodologies described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the Centrum acquisition consists of trade names with a 15-year useful life, customer relationships with 2- to 15-year useful lives, and a reacquired contract between Bright HealthCare and Centrum with a useful life of 4.5 years. The value of the trade name was determined using the relief of royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements. The fair value of noncontrolling interest was determined using a market approach and included a discount to account for the lack of marketability of the noncontrolling interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Centrum would not have had a material impact on our revenue or net loss had it been included in the consolidated results of the Company for the nine months ended September 30, 2021 or the three and nine months ended September 30, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Central Health Plan&#160;Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On April&#160;1, 2021, we acquired all of the outstanding shares of Central Health Plan of California, Inc. (&#8220;CHP&#8221;) for cash consideration of $276.0 million and $79.8 million in Series&#160;E preferred stock, for total purchase consideration of $271.7 million, net of $84.1 million of cash acquired. CHP is an insurance provider of Medicare Advantage (&#8220;MA&#8221;) HMO services. CHP is included in our Bright HealthCare reportable segment. Transaction costs </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $0.2 million incurred in connection with the acquisition are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine months ended September&#160;30, 2021, out of $1.4 million of total transaction cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s we have incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the CHP acquisition is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for CHP is attributable to synergies from leveraging CHP&#8217;s clinical model and California consumer expertise to continue to expand our MA business in the California market. The goodwill is not deductible for tax purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the CHP acquisition&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the CHP acquisition consists of customer relationships with a 10-year useful life, trade names with a 15-year useful life and the provider network with a 7-year useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if CHP had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and the three and nine months ended September&#160;30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,195,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">True Health New Mexico and Zipnosis Acquisitions:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On March&#160;31, 2021 we acquired all of the outstanding equity interests of True Health New Mexico, Inc. (&#8220;THNM&#8221;) for cash consideration of $27.5 million, net of cash acquired of $24.1 million, for total purchase consideration of $3.4 million. THNM is a physician-led health insurance company offering policies available through the commercial market for individual on- and off-exchange and employer-sponsored health coverage. THNM is included in our Bright HealthCare reportable segment. In addition, on March&#160;31, 2021, we acquired Zipnosis, Inc. (&#8220;Zipnosis&#8221;), which is a telehealth platform that offers virtual care to health systems around the U.S., for aggregate consideration of $73.0 million, including $55.1 million in Series&#160;E preferred stock and adjusted for $0.5 million of tangible net equity adjustments. We acquired $3.2 million of cash as part of the Zipnosis acquisition, for net total purchase consideration of $69.8 million. Zipnosis is included in our NeueHealth reportable segment. Transaction costs of $0.5 million incurred in connection with these acquisitions are included in operating costs in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total preliminary purchase consideration for the THNM and Zipnosis acquisitions is allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired is recorded as goodwill. The goodwill for THNM is attributable to synergies from leveraging THNM&#8217;s strong local clinical model of care and the ability to enter into a new state of strategic interest for future growth and expansion. The goodwill from the Zipnosis acquisition is attributable to benefits from the ability to enhance our proprietary technology platform, DocSquad, and Zipnosis&#8217; attractive virtual care capabilities to enhance Bright Health&#8217;s consumer and provider connectivity. The goodwill from the THNM and Zipnosis acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the THNM and Zipnosis acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THNM</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zipnosis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,651&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary fair values of acquired assets and liabilities assumed represent management&#8217;s estimate of fair value and are subject to change if additional information, such as post-close working capital adjustments, becomes available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preliminary estimate of intangible assets related to the THNM acquisition consists of customer relationships with 10-to 14-year useful lives, trade names with a 15-year useful life and the provider network with a 7-year useful life. For the Zipnosis acquisition, our preliminary estimate of intangible assets consists of customer relationships with a 15-year useful life, trade names with a 5-year useful life and developed technology with a 7-year useful life. For these acquisitions the value of the trade names and developed technology was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level 3 fair value measurements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if THNM and Zipnosis had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and three and nine months ended September&#160;30, 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,114,954</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(372,315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PMA Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December&#160;31, 2020, we acquired a 62% controlling interest in Premier Medical Associates of Florida, LLC (&#8220;PMA&#8221;) in exchange for $74.2 million. PMA provides care services to Medicare and Medicaid patients in Florida through a network of primary care providers and population health-focused specialists. The acquisition of PMA is expected to enhance our clinical capabilities to better serve enrollees as part of our Florida market expansion. The total purchase consideration for the PMA acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The purchase price allocation is preliminary and subject to change, including the valuation of property, equipment and capitalized software and intangible assets, among other items. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BND Acquisition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On April&#160;30, 2020, we acquired all of the outstanding shares of Universal Care, Inc. (d.b.a. Brand New Day) (&#8220;BND&#8221;). BND is a leader in providing healthcare services in California and serves Medicare eligible seniors and special needs populations through their extensive network of primary care providers and specialists. BND combines analytics and evidence-based clinical programs with aligned provider relationships to provide high quality, affordable care for complex and vulnerable populations. The total consideration included $206.9 million in cash and $80.0 million in Bright Health Series&#160;D preferred stock. We have since applied indemnity escrow adjustments of $44.0 million to the acquisition price, bringing total consideration to $210.1 million, net of cash acquired of $32.8 million. Transaction costs of $3.8 million incurred in connection with the acquisition are included in operating costs in the Consolidated Statements of Income (Loss) for the year ended December&#160;31, 2020. If BND had been included in the consolidated results of the Company for the nine months ended September&#160;30, 2020, our pro&#160;forma revenue would have been $1.0 billion, and our pro forma net loss would have been $(100.9) million. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase consideration for the BND acquisition was allocated to tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The excess of the purchase price over the net assets acquired was recorded as goodwill. The goodwill is attributable to synergies from leveraging BND&#8217;s strong clinical model of care to drive growth in our MA business outside of California. The goodwill from the BND acquisition is not deductible for tax purposes. The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the BND acquisition, as well as measurement adjustments made in the nine&#160;months ended September&#160;30, 2021 to the amounts initially recorded in 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized as of <br/>Acquisition Date<br/>(as previously reported)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Measurement <br/>Period <br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized as of <br/>Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other currents assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurement period adjustments above primarily resulted from completing valuations for certain intangible assets. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the acquisition date is immaterial to the consolidated financial statements. We recognized intangible assets related to the BND acquisition, which consist of $25.6 million for the BND trade name with an estimated useful life of 15 years, customer relationships valued at $46.9 million with a 12-year useful life, and $2.0 million of other intangibles related to the provider network with a 10-year useful life. The value of the trade name was determined using the relief from royalty method and the excess earnings method was used to value the customer relationships; both methods are considered Level&#160;3 fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975374280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fixed Maturity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale securities are reported at fair value as of September&#160;30, 2021 and December&#160;31, 2020. Held-to-maturity securities are reported at amortized cost as of September&#160;30, 2021 and December&#160;31, 2020. The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,343</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">283</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">290,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,437</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,160</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,876</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,844&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale investments, including those that are cash equivalents, with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position at September&#160;30, 2021 and December&#160;31, 2020 were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> investment positions out of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,859</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that were in an unrealized loss position. As of December&#160;31, 2020, we had 117 investment positions out of 1,917 that were in an unrealized loss position. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. At each reporting period, we evaluate securities for impairment when the fair value of the investment is less than its amortized cost. We evaluated the underlying credit quality and credit ratings of the issuers, noting no significant deterioration since purchase. As of September&#160;30, 2021, we did not have the intent to sell any of the securities in an unrealized loss position. Therefore, we believe these losses to be temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the maturity of available-for-sale securities, by contractual maturity, reflected at amortized cost and fair value were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 10 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,306&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income in the Condensed Consolidated Statements of Income (Loss) for the nine&#160;months ended September&#160;30, 2021 and 2020, was $3.5 million, and $7.1 million, respectively, related to our fixed maturity securities. Realized gains (losses) from our fixed maturity securities of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.1 million are included within total investment income, and reclassified out of accumulated other comprehensive income, for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Securities</span></div>On April 1, 2021 we completed the purchase of 1.6 million shares of equity securities for aggregate cash consideration of $40.1 million. As of September&#160;30, 2021, the equity securities had a carrying value of $149.1 million, which is included in short-term investments in the Condensed Consolidated Balance Sheet. We recognized an unrealized gain of $46.3 million and $109.0 million in investment income in the Condensed Consolidated Statements of Income (Loss) for the three and nine&#160;months ended September&#160;30, 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769973959752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of fair value measurement:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices for similar assets or liabilities in active markets or quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value in the condensed consolidated financial statements or have fair values disclosed in the notes to the condensed consolidated financial statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, except for the equity securiti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es, see note 5 of notes to the audited consolidated financial statements included in our Prospectus filed with the SEC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the equity securities was determined based on the quoted market price of the underlying securities in an active market.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for assets measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,727</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,507</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">245,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">358,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">143,048</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288,961</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,738</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available for sale:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">473,599</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">740,578</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509,106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,249,684</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the Company&#8217;s fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for certain financial instruments not measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,768</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,768</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,965</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,965</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no transfers of assets or liabilities into or out of Level&#160;3 of the fair value hierarchy. The contingent consideration liability related to the acquisition of AssociatesMD Medical Group, Inc. is measured using Level&#160;3 inputs based on a formulaic multiple of forecasted 2023 EBITDA per the terms of the purchase agreement discounted back to net present value. The following table presents the changes in fair value of the contingent consideration liability for the nine&#160;months ended September&#160;30, 2021 and year ended December&#160;31, 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported on the Condensed Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value due to their short-term nature. These assets and liabilities are not included in the tables above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975427176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,776</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">340,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">437,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value and accumulated amortization for definite-lived intangible assets were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">380,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,633</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to definite-lived intangible assets acquired during the nine&#160;months ended September&#160;30, 2021&#160;were as follows </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,370</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.8</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense relating to intangible assets for the three months ended September&#160;30, 2021 and 2020 was $13.3 million and $1.8 million, respectively, and amortization expense for the nine&#160;months ended September&#160;30, 2021 and 2020 was $23.2 million and $3.6 million, respectively. Estimated amortization expense relating to intangible assets for the remainder of 2021 and for each of the next five full&#160;years ending December&#160;31 is as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (October-December)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975807416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICAL COSTS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">MEDICAL COSTS PAYABLE</a></td>
<td class="text">MEDICAL COSTS PAYABLE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,647,719</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,726</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,649,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,074,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232,312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,306,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired claims liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,737</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Medical costs payable attributable to prior&#160;years increased by $1.7 million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> decreased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$9.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively. Medical costs payable estimates are adjusted as additional information becomes known regarding claims; there were no significant changes to estimation methodologies during the periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below details the components making up the medical costs payable as of September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims unpaid</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider incentive payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims adjustment expense liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred but not reported</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,870</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable are primarily related to the current year. The Company has recorded claims adjustment expense as a component of operating costs in the Condensed Consolidated Statements of Income (Loss).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770073207768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM BORROWINGS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">SHORT-TERM BORROWINGS</a></td>
<td class="text">SHORT-TERM BORROWINGSOn March&#160;1, 2021, we entered into a $350.0 million revolving credit agreement with a syndicate of banks (the &#8220;Credit Agreement&#8221;). On August 2, 2021, the Credit Agreement was amended to change the definition of &#8220;Qualified IPO&#8221; by reducing the net proceeds required to be received by the Company from $1.0&#160;billion to $850.0 million. In addition, prior to such amendment, the Credit Agreement contained a covenant that required the Company to maintain a total debt to capitalization ratio of (a) 0.25 to 1.00 prior to a Qualified IPO, and (b) 0.30 to 1.00 after a Qualified IPO. The Amendment changed this covenant by removing the increase in the ratio after a Qualified IPO such that the Company is now required to maintain a total debt to capitalization ratio of 0.25 to 1.00. On August 4, 2021, we elected to extend the maturity date of the Credit Agreement from February 28, 2022 to February 28, 2024. During the second quarter of 2021, we utilized a portion of the net IPO proceeds to repay the $200.0 million principal balance of indebtedness outstanding under our revolving credit agreement originally entered into on March 1, 2021 and the associated interest and other costs of $3.2&#160;million. As of September&#160;30, 2021, we have no borrowings outstanding under the Credit Agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769974085512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted its 2016 Stock Incentive Plan (the &#8220;2016 Incentive Plan&#8221;) in March 2016. The 2016 Incentive Plan allowed for the Company to grant stock options, restricted stock awards (&#8220;RSAs&#8221;), and restricted stock units (&#8220;RSUs&#8221;) to certain employees, consultants and non-employee directors. The 2016 Incentive Plan was initially adopted on March 25, 2016, and most recently amended in December 2020. Following the effectiveness of our 2021 Omnibus Plan (the &#8220;2021 Incentive Plan&#8221;), no further awards will be granted under the 2016 Incentive Plan. However, all outstanding awards granted under the 2016 Incentive Plan will continue to be governed by the existing terms of the 2016 Incentive Plan and the applicable award agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Incentive Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Incentive Plan was adopted by our Board of Directors on May 21, 2021 and approved by our stockholders on May 25, 2021 and June 5, 2021. The 2021 Incentive Plan allows the Company to grant stock options, RSAs, RSUs, stock appreciation rights, other equity based awards, and cash based incentive awards to certain employees, consultants and non-employee directors. There are 42.0 million shares of common stock authorized for issuance under the 2021 Incentive Plan. As of September&#160;30, 2021, a total of 26.8 million shares of common stock were available for future issuance under the 2021 Incentive Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense of $43.2 million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the nine&#160;months ended September&#160;30, 2021 and 2020, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors or the Compensation Committee of the Board of Directors determines the exercise price, vesting periods and expiration date at the time of the grant. Stock options granted prior to the third quarter of 2021 generally vest 25% at one year from the grant date, then ratably over the next 36 months with continuous employee service. Stock options granted after the beginning of the third quarter of 2021 generally vest ratably over three years. Option grants generally expire 10 years from the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculated value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted-average assumptions for options granted during the nine months ended September&#160;30, 2021:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of our publicly traded industry peers. We use historical data to estimate option forfeitures within the valuation model. The expected lives of options granted represent the period of time that the awards granted are expected to be outstanding based on historical exercise patterns.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity for the stock options for the nine&#160;months ended September&#160;30, 2021 is as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except exercise price and contractual life)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate <br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">445,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted during the nine months ended September&#160;30, 2021 was $10.86 per share. At September&#160;30, 2021, there was $150.7 million of unrecognized compensation expense related to stock options that is expected to be recognized over a weighted-average period of 3.4 years.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">RSUs represent the right to receive shares of our common stock at a specified date in the future and generally vest over a three-year period. The fair value of RSUs is determined based on the closing market price of our common stock on the date of grant. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes RSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in thousands, except weighted average grant date fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense related to RSUs of $0.2 million for the three and nine months ended September 30, 2021, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). As of September 30, 2021, there was $2.5 million of unrecognized compensation expense related to the RSU grants, which is expected to be recognized over a weighted-average period of 2.7 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Restricted Stock Units (&#8220;PSUs&#8221;)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our IPO, our Board of Directors approved the grant of PSUs to members of our executive leadership team. The grant encompasses a total of 14.7&#160;million PSUs, separated into four equal tranches, each of which are eligible to vest based on the achievement of predetermined stock price goals and a minimum service period of 3 years. This grant is intended to retain and incentivize our executive leadership to lead the Company to sustained, long-term financial and operational performance. The fair value of the PSUs is determined using a Monte-Carlo simulation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except weighted average grant date fair value)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of PSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>We recognized share-based compensation expense related to the PSU grant of $10.0 million and $10.3 million for the three and nine months ended September 30, 2021, respectively, which is included in operating costs in the Condensed Consolidated Statements of Income (Loss). At September 30, 2021, there was $108.5 million of unrecognized compensation expense related to the PSU grant, which is expected to be recognized over a weighted-average period of 2.7 years.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770073207768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text">NET LOSS PER SHARE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine&#160;months ended September 30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except for per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(300,664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(370,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">630,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312,294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (as converted to common stock)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975185128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal proceedings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In the normal course of business, we could be involved in various legal proceedings such as, but not limited to, the following: lawsuits alleging negligence in care or general liability, violation of regulatory bodies&#8217; rules and regulations, or violation of federal and/or state laws. At September&#160;30, 2021 and December&#160;31, 2020, there were no material known contingent liabilities.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975791464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHICAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHICAL INFORMATION</a></td>
<td class="text">SEGMENTS AND GEOGRAPHIC INFORMATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our two reportable segments are Bright HealthCare and NeueHealth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the reportable segment financial information for the three and nine&#160;months ended September&#160;30, 2021 and 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">994,586</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,647</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,020,233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,140</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,258</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">995,612</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,078,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">995,612</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,759)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,078,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(303,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,727)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,860,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,922,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,491</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109,012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,863,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">203,265</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,067,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,392</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(182,392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,863,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">385,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(182,392)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,067,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(378,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,457</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,981</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,176)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,427)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods presented, all of our long-lived assets were located in the United States, and all revenues were earned in the United States. We do not include asset information by reportable segment in the reporting provided to the chief operating decision maker.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769973795912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) was an expense of $0.1 million and a benefit of $18.2 million for the three and nine&#160;months ended September&#160;30, 2021, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The impact from income taxes varies from the federal statutory rate of 21.0% due to changes in the valuation allowance for deferred tax assets and adjustments for permanent differences. For the three months ended September&#160;30, 2021, the expense largely relates to amortization of originating goodwill from asset acquisitions. For the nine&#160;months ended September&#160;30, 2021, the overall tax benefit is primarily due to the release of valuation allowance in connection with new deferred tax liabilities recorded on identifiable intangibles as part of business combination accounting for the BND, Zipnosis, THNM, and CHP stock acquisitions. The Centrum acquisition was treated as an asset acquisition, and accordingly, no deferred tax assets or liabilities were recorded as part of business-combination accounting.</span>We assess whether sufficient future taxable income will be generated to permit the use of deferred tax assets. This assessment includes consideration of the cumulative losses incurred over the three-year period ended September&#160;30, 2021. Such objective evidence limits the ability to consider other subjective evidence, such as the Company&#8217;s projections for future earnings. On the basis of this evaluation, we have recorded a valuation allowance for deferred tax assets to the extent that they cannot be supported by reversals of existing cumulative temporary differences. Any federal tax benefit generated from losses in 2021 is expected to require an offsetting adjustment to the valuation allowance for deferred tax assets, and thus have no net effect on the income tax provision.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769973942888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">REDEEMABLE NONCONTROLLING INTEREST<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Centrum acquisition on July 1, 2021, we entered into put/call agreements with respect to the equity interests in Centrum held by the controlling interest holder. The call options allow for the Company to purchase the 25% noncontrolling interest equity over time beginning on September 30, 2022, or under certain other accelerating events as defined in the agreement, solely at the Company&#8217;s discretion. The put options allow the noncontrolling interest holder the ability to cause the Company to purchase their noncontrolling equity interest on consistent terms with the call options. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the nature of the put option&#8217;s redemption features, which are outside the control of the Company, the noncontrolling interests are classified as redeemable in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021. The put option redemption feature that is outside the control of the Company is settled based on EBITDA, which is an other than </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value settlement amount. As such, we will make a measurement adjustment when the put option redemption price exceeds the carrying amount as calculated under ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was no redeemable noncontrolling interest during the three and nine&#160;months ended September&#160;30, 2020. The following table provides details of our redeemable noncontrolling interest activity for the three and nine&#160;months e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nded September&#160;30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,600</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,217</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,519</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770069518920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Consolidation and Presentation of Financial Statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our audited consolidated financial statements, unless the information contained in those disclosures materially changed or is required by GAAP. As such, the condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes thereto as of and for the year ended December&#160;31, 2020 included in the prospectus dated June 23, 2021 (File No.333-256286) (the &#8220;Prospectus&#8221;), as filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. The accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for fair presentation of the interim financial statements.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Our most significant estimates include medical costs payable, risk adjustment revenue and associated payables and receivables, valuation and impairment of goodwill and other intangible assets, valuation and impairment of investments and estimates of share-based compensation. Actual results could differ from these estimate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. </span><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021, we recognized a change in estimate for risk adjustment of $134.0&#160;million as a result of updated data inputs used to calculate Individual and Family Plan (&#8220;IFP&#8221;) members&#8217; expected full year risk scores, which resulted in an increase in risk adjustment </span>payable in the Condensed Consolidated Balance Sheets and a reduction in premium revenue in the Condensed Consolidated Statements of Income (Loss).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Adopted Accounting Pronouncements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Pronouncements:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting pronouncements that were recently issued and not yet adopted or adopted since our audited consolidated financial statements that had, or are expected to have, a material impact on our consolidated financial position, results of operations, or cash flows.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769973963464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock', window );">Schedule of Operating Costs by Functional Classification</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our operating costs, by functional classification for the three and nine months ended September&#160;30, 2021 and 2020, are as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and fringe benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100,062</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,483</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">143,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and selling expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">183,636</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78,802</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">217,739</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">309,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">779,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975282920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the Centrum acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:105%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the CHP acquisition&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the THNM and Zipnosis acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THNM</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zipnosis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,651&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table discloses the preliminary estimated fair values of assets and liabilities acquired by the Company in the BND acquisition, as well as measurement adjustments made in the nine&#160;months ended September&#160;30, 2021 to the amounts initially recorded in 2020&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized as of <br/>Acquisition Date<br/>(as previously reported)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Measurement <br/>Period <br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized as of <br/>Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other currents assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identified assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if CHP had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and the three and nine months ended September&#160;30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,195,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro&#160;forma financial information presents our revenue and net loss as if THNM and Zipnosis had been included in the consolidated results of the Company for the nine&#160;months ended September&#160;30, 2021 and three and nine months ended September&#160;30, 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Consolidated Statements of Income (Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,114,954</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(372,315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769977515480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities, Available-for-sale</a></td>
<td class="text">The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,343</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">283</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">290,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,437</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,160</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,876</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,844&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesTextBlock', window );">Schedule of Debt Securities, Held-to-maturity</a></td>
<td class="text">The following is a summary of our investment securities as of September&#160;30, 2021 and December&#160;31, 2020&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,984</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,343</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">283</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">290,917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,437</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,160</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,876</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,136,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized <br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross <br/>Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for sale:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held-to-maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,844&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Available-for-sale Investment With Gross Unrealized Losses</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale investments, including those that are cash equivalents, with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position at September&#160;30, 2021 and December&#160;31, 2020 were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,812</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">508,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total bonds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,522&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Available-for-sale Securities by Contractual Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the maturity of available-for-sale securities, by contractual maturity, reflected at amortized cost and fair value were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 10 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,306&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769977675672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for assets measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,727</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,507</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">245,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">358,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">143,048</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288,961</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,485</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,738</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,533</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,869</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available for sale:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">473,599</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">740,578</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509,106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,249,684</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available for sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the Company&#8217;s fair value measurements as of September&#160;30, 2021 and December&#160;31, 2020, for certain financial instruments not measured at fair value on a recurring basis&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,768</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,768</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,965</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,965</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents, held to maturity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, held to maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total held to maturity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value of Contingent Consideration Liability</a></td>
<td class="text">The following table presents the changes in fair value of the contingent consideration liability for the nine&#160;months ended September&#160;30, 2021 and year ended December&#160;31, 2020&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2E<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498357-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975926392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Impairment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,776</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">340,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">437,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">405,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value and accumulated amortization for definite-lived intangible assets were as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">380,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,633</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Finite-Lived Intangible Assets by Major Class</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to definite-lived intangible assets acquired during the nine&#160;months ended September&#160;30, 2021&#160;were as follows </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Useful Life<br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,370</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reacquired contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">220,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.8</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text">Estimated amortization expense relating to intangible assets for the remainder of 2021 and for each of the next five full&#160;years ending December&#160;31 is as follows&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (October-December)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975328568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICAL COSTS PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,647,719</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,726</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,649,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,074,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232,312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,306,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired claims liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,737</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable - September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below details the components making up the medical costs payable as of September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims unpaid</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider incentive payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims adjustment expense liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred but not reported</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,870</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">685,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979162744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculated value of each option award is estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted-average assumptions for options granted during the nine months ended September&#160;30, 2021:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity for the stock options for the nine&#160;months ended September&#160;30, 2021 is as follows&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except exercise price and contractual life)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate <br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,373)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">445,246</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-based Payment Arrangement, Restricted Stock Unit, Activity</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes RSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in thousands, except weighted average grant date fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;RSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Share-based Payment Arrangement, Performance Shares, Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes PSU award activity for the nine months ended September 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except weighted average grant date fair value)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of PSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;PSUs canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested PSUs at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769974021128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Loss Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine&#160;months ended September 30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands, except for per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Bright Health Group, Inc. common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(300,664)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(370,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,610)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">630,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312,294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the nine&#160;months ended September&#160;30&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (as converted to common stock)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770069795464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Reportable Segment Financial Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the reportable segment financial information for the three and nine&#160;months ended September&#160;30, 2021 and 2020&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">994,586</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,647</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,020,233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,140</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,258</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">995,612</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,045</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,078,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">995,612</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,759)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,078,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(303,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(296,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,727)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,860,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,922,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,573</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,602</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,491</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109,012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,863,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">203,265</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,067,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,392</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(182,392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,863,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">385,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(182,392)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,067,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,291</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(378,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,457</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,981</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bright<br/>HealthCare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NeueHealth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unaffiliated revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliated revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,176)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,427)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769974009208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NONCONTROLLING INTEREST (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">The following table provides details of our redeemable noncontrolling interest activity for the three and nine&#160;months e<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nded September&#160;30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,600</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,217</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,519</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769976391912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 02, 2021</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts and commissions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,686<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued, conversion of convertible securities (in shares) | shares</a></td>
<td class="nump">427,897,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_RiskAdjustmentPayableCurrent', window );">Risk adjustment payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,020,233)<span></span>
</td>
<td class="num">$ (345,426)<span></span>
</td>
<td class="num">(2,922,950)<span></span>
</td>
<td class="num">$ (827,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember', window );">Updated Risk Score Data</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_RiskAdjustmentPayableCurrent', window );">Risk adjustment payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares) | shares</a></td>
<td class="nump">51,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share of common stock (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of stock | $</a></td>
<td class="nump">$ 887,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts and commissions | $</a></td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs | $</a></td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_RiskAdjustmentPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk Adjustment Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_RiskAdjustmentPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979435048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Compensation and fringe benefits</a></td>
<td class="nump">$ 100,062<span></span>
</td>
<td class="nump">$ 35,588<span></span>
</td>
<td class="nump">$ 234,467<span></span>
</td>
<td class="nump">$ 92,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">61,483<span></span>
</td>
<td class="nump">20,745<span></span>
</td>
<td class="nump">143,248<span></span>
</td>
<td class="nump">53,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Marketing and selling expense</a></td>
<td class="nump">69,443<span></span>
</td>
<td class="nump">15,941<span></span>
</td>
<td class="nump">183,636<span></span>
</td>
<td class="nump">39,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="nump">78,802<span></span>
</td>
<td class="nump">25,105<span></span>
</td>
<td class="nump">217,739<span></span>
</td>
<td class="nump">75,624<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">$ 309,790<span></span>
</td>
<td class="nump">$ 97,379<span></span>
</td>
<td class="nump">$ 779,090<span></span>
</td>
<td class="nump">$ 260,650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769967140760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($) </div>
<div>healthCenter</div>
</th>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember', window );">Reacquired contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Voting interest acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business, gross</a></td>
<td class="nump">$ 222,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity interest issued</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">296,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_NumberOfHealthCenters', window );">Number of health centers | healthCenter</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum | Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum | Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum | Reacquired contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity interest issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma, revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 502,378<span></span>
</td>
<td class="nump">3,195,925<span></span>
</td>
<td class="nump">$ 1,263,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma, net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (49,157)<span></span>
</td>
<td class="num">(358,935)<span></span>
</td>
<td class="num">(70,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP | Provider Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM | Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM | Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM | Provider Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember', window );">Zipnosis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity interest issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationTangibleNetEquityAdjustment', window );">Tangible net equity adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember', window );">Zipnosis | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember', window );">Zipnosis | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember', window );">Zipnosis | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_PremierMedicalAssociatesOfFloridaLLCMember', window );">PMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Voting interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember', window );">BND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity interest issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationEscrowAdjustment', window );">Escrow adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma, revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma, net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember', window );">BND | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember', window );">BND | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember', window );">BND | Provider Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationEscrowAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationEscrowAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationTangibleNetEquityAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Tangible Net Equity Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationTangibleNetEquityAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_NumberOfHealthCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Health Centers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_NumberOfHealthCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ProviderNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ProviderNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_PremierMedicalAssociatesOfFloridaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_PremierMedicalAssociatesOfFloridaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769976252456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">17 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 842,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember', window );">Centrum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identified assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85,075)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identified assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember', window );">THNM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identified assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember', window );">Zipnosis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identified assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember', window );">BND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">74,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable', window );">Measurement Period Adjustments, Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="nump">30,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets', window );">Measurement Period Adjustments, Prepaid and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">4,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Measurement Period Adjustments, Property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">74,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Measurement Period Adjustments, Intangible assets</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">2,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets', window );">Measurement Period Adjustments, Other non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">186,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,592<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets', window );">Measurement Period Adjustments, Total assets</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="nump">119,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense', window );">Measurement Period Adjustments, Medical costs payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="nump">51,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities', window );">Measurement Period Adjustments, Other current liabilities</a></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="nump">1,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities', window );">Measurement Period Adjustments, Other liabilities</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">172,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,388<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities', window );">Measurement Period Adjustments, Total liabilities</a></td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identified assets acquired</a></td>
<td class="nump">13,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,204<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired', window );">Measurement Period Adjustments, Net identified assets acquired</a></td>
<td class="nump">1,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">196,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement Period Adjustments, Goodwill</a></td>
<td class="num">(1,618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="nump">210,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,090<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Measurement Period Adjustments, Total purchase consideration</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liability For Claims And Claims Adjustment Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identified Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid And Other Currents Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Liability For Claims And Claims Adjustment Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Unearned Premiums</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets (as defined) recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -URI http://asc.fasb.org/topic&amp;trid=2134543<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_CentrumMedicalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_TrueHealthNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_ZipnosisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_UniversalCareIncBrandNewDayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769974053656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember', window );">CHP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems', window );"><strong>Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 502,378<span></span>
</td>
<td class="nump">$ 3,195,925<span></span>
</td>
<td class="nump">$ 1,263,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(49,157)<span></span>
</td>
<td class="num">(358,935)<span></span>
</td>
<td class="num">(70,971)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bhg_THNMAndZipnosisMember', window );">THNM And Zipnosis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems', window );"><strong>Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">384,797<span></span>
</td>
<td class="nump">3,114,954<span></span>
</td>
<td class="nump">943,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (57,035)<span></span>
</td>
<td class="num">$ (372,315)<span></span>
</td>
<td class="num">$ (85,988)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_CentralHealthPlanOfCaliforniaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bhg_THNMAndZipnosisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bhg_THNMAndZipnosisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769976946616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investment Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost', window );">Cash equivalents, Amortized Cost</a></td>
<td class="nump">$ 271,984<span></span>
</td>
<td class="nump">$ 153,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash equivalents, Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities', window );">Cash equivalents, Carrying Value</a></td>
<td class="nump">271,984<span></span>
</td>
<td class="nump">153,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">855,075<span></span>
</td>
<td class="nump">664,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">2,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">855,306<span></span>
</td>
<td class="nump">667,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Debt Securities, Held-to-maturity, Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">9,192<span></span>
</td>
<td class="nump">7,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost, Total investments</a></td>
<td class="nump">1,136,251<span></span>
</td>
<td class="nump">826,417<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain', window );">Gross Unrealized Gains, Total investments</a></td>
<td class="nump">725<span></span>
</td>
<td class="nump">2,462<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss', window );">Gross Unrealized Losses, Total investments</a></td>
<td class="num">(494)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue', window );">Carrying Value, Total investments</a></td>
<td class="nump">1,136,482<span></span>
</td>
<td class="nump">828,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">501,343<span></span>
</td>
<td class="nump">291,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">501,250<span></span>
</td>
<td class="nump">293,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Debt Securities, Held-to-maturity, Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">7,745<span></span>
</td>
<td class="nump">6,677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">290,917<span></span>
</td>
<td class="nump">280,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">1,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">291,195<span></span>
</td>
<td class="nump">281,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">15,437<span></span>
</td>
<td class="nump">18,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">15,485<span></span>
</td>
<td class="nump">18,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">5,160<span></span>
</td>
<td class="nump">14,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">5,165<span></span>
</td>
<td class="nump">14,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">26,809<span></span>
</td>
<td class="nump">53,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">26,809<span></span>
</td>
<td class="nump">53,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Debt Securities, Held-to-maturity, Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,876<span></span>
</td>
<td class="nump">5,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">$ 12,869<span></span>
</td>
<td class="nump">$ 5,536<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative unrecognized loss on investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769967092952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">$ 508,596<span></span>
</td>
<td class="nump">$ 173,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(494)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">508,596<span></span>
</td>
<td class="nump">173,522<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">(494)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">9,643<span></span>
</td>
<td class="nump">25,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">9,643<span></span>
</td>
<td class="nump">25,007<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency obligations | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">347,735<span></span>
</td>
<td class="nump">12,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">347,735<span></span>
</td>
<td class="nump">12,507<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate obligations | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">137,456<span></span>
</td>
<td class="nump">121,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">137,456<span></span>
</td>
<td class="nump">121,006<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and municipal obligations | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">2,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">2,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember', window );">Commercial paper | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,003<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | Short-Term And Long-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Available-for-sale securities, less than 12 months, Fair Value</a></td>
<td class="nump">10,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Available-for-sale securities, less than 12 months, Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Available-for-sale securities, 12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Available-for-sale securities, 12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Available-for-sale securities, Fair Value</a></td>
<td class="nump">10,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Available-for-sale securities, Unrealized Losses</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bhg_ShortTermAndLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bhg_ShortTermAndLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770072726824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Narrative (Details)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>investment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>investment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>investment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions', window );">Number of securities in unrealized loss position | investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments', window );">Number of investments | investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,345<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
<td class="nump">$ 112,503<span></span>
</td>
<td class="nump">$ 7,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLoss', window );">Realized gains on fixed maturity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_EquitySecuritiesFVNISharesPurchased', window );">Equity securities purchased (in shares) | shares</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Payments to acquire equity securities</a></td>
<td class="nump">$ 40,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity security market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain on equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">$ 7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held-To-Maturity, Number Of Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Held-To-Maturity, Unrealized Loss Position, Number Of Positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_EquitySecuritiesFVNISharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_EquitySecuritiesFVNISharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_InvestmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest income and realized gains and losses on debt securities, as well as unrealized gains and losses on equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_InvestmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769977625032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less</a></td>
<td class="nump">$ 203,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">651,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through 10 years</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after 10 years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">855,075<span></span>
</td>
<td class="nump">$ 664,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">203,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">651,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through 10 years</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after 10 years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Carrying Value</a></td>
<td class="nump">$ 855,306<span></span>
</td>
<td class="nump">$ 667,308<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769972563608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 26,750<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">855,306<span></span>
</td>
<td class="nump">667,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">501,250<span></span>
</td>
<td class="nump">293,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">291,195<span></span>
</td>
<td class="nump">281,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">15,485<span></span>
</td>
<td class="nump">18,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">5,165<span></span>
</td>
<td class="nump">14,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">26,809<span></span>
</td>
<td class="nump">53,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">12,869<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">26,750<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">245,234<span></span>
</td>
<td class="nump">153,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">855,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">149,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">1,249,684<span></span>
</td>
<td class="nump">820,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">7,079<span></span>
</td>
<td class="nump">5,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">501,250<span></span>
</td>
<td class="nump">293,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">291,195<span></span>
</td>
<td class="nump">281,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">15,485<span></span>
</td>
<td class="nump">18,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">5,165<span></span>
</td>
<td class="nump">14,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">26,809<span></span>
</td>
<td class="nump">53,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">12,869<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">209,727<span></span>
</td>
<td class="nump">149,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">381,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">149,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">740,578<span></span>
</td>
<td class="nump">347,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">358,202<span></span>
</td>
<td class="nump">197,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">18,738<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">35,507<span></span>
</td>
<td class="nump">4,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">473,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">509,106<span></span>
</td>
<td class="nump">473,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">143,048<span></span>
</td>
<td class="nump">95,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">288,961<span></span>
</td>
<td class="nump">281,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">15,485<span></span>
</td>
<td class="nump">18,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">5,165<span></span>
</td>
<td class="nump">14,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">8,071<span></span>
</td>
<td class="nump">53,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">12,869<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">7,079<span></span>
</td>
<td class="nump">5,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | State and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984221304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 26,750<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue', window );">Total held to maturity</a></td>
<td class="nump">35,965<span></span>
</td>
<td class="nump">8,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">7,768<span></span>
</td>
<td class="nump">6,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">26,750<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue', window );">Total held to maturity</a></td>
<td class="nump">35,965<span></span>
</td>
<td class="nump">6,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">7,768<span></span>
</td>
<td class="nump">6,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue', window );">Total held to maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue', window );">Total held to maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | U.S. government and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held to maturity</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Held To Maturity, And Cash And Cash Equivalents, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979292648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details) - Contingent Consideration Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 5,716<span></span>
</td>
<td class="nump">$ 5,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">1,363<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 7,079<span></span>
</td>
<td class="nump">$ 5,716<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=bhg_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=bhg_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975568952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember', window );">Bright HealthCare</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Gross Carrying Amount, Beginning balance</a></td>
<td class="nump">$ 197,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Gross Carrying Amount, Acquisitions</a></td>
<td class="nump">240,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase adjustments</a></td>
<td class="num">(1,618)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Gross Carrying Amount, Ending balance</a></td>
<td class="nump">437,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative Impairment, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative Impairment, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember', window );">NeueHealth</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Gross Carrying Amount, Beginning balance</a></td>
<td class="nump">65,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Gross Carrying Amount, Acquisitions</a></td>
<td class="nump">340,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Gross Carrying Amount, Ending balance</a></td>
<td class="nump">405,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative Impairment, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative Impairment, Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984290504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 380,152<span></span>
</td>
<td class="nump">$ 157,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">28,633<span></span>
</td>
<td class="nump">5,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">209,321<span></span>
</td>
<td class="nump">117,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">19,257<span></span>
</td>
<td class="nump">3,664<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">99,231<span></span>
</td>
<td class="nump">38,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">5,057<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember', window );">Reacquired contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">59,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">443<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">6,400<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979173784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 220,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 90,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 60,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember', window );">Reacquired contract</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 59,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 6,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Fair Value</a></td>
<td class="nump">$ 4,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhg_ReacquiredContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984127960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 23,200<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2021 (October-December)</a></td>
<td class="nump">10,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">42,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">42,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">41,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">41,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">$ 26,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770084674760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Beginning balance</a></td>
<td class="nump">$ 249,777<span></span>
</td>
<td class="nump">$ 44,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">2,647,719<span></span>
</td>
<td class="nump">685,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior year</a></td>
<td class="nump">1,726<span></span>
</td>
<td class="num">(9,297)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">2,649,445<span></span>
</td>
<td class="nump">676,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">2,074,602<span></span>
</td>
<td class="nump">610,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior year</a></td>
<td class="nump">232,312<span></span>
</td>
<td class="nump">29,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="nump">2,306,914<span></span>
</td>
<td class="nump">640,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquired claims liabilities</a></td>
<td class="nump">92,737<span></span>
</td>
<td class="nump">118,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Ending balance</a></td>
<td class="nump">$ 685,045<span></span>
</td>
<td class="nump">$ 199,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769973967112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICAL COSTS PAYABLE - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease', window );">Medical costs payable, increase (decrease) to prior years</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="num">$ (9.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769972746648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount', window );">Claims unpaid</a></td>
<td class="nump">$ 42,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable', window );">Provider incentive payable</a></td>
<td class="nump">69,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability', window );">Claims adjustment expense liability</a></td>
<td class="nump">12,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Incurred but not reported</a></td>
<td class="nump">560,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total medical costs payable</a></td>
<td class="nump">$ 685,045<span></span>
</td>
<td class="nump">$ 249,777<span></span>
</td>
<td class="nump">$ 199,671<span></span>
</td>
<td class="nump">$ 44,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Adjustment Expense Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid claims And Claims Adjustment Expense, Risk Sharing Amounts Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984166952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM BORROWINGS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate', window );">IPO net proceeds requirement</a></td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO', window );">Debt to capitalization ration before qualified IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO', window );">Debt to capitalization ratio after qualified IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio', window );">Debt to capitalization ratio</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseShortTermBorrowings', window );">Interest and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Ratio After Qualified IPO</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Ratio Before Qualified IPO</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Total Debt To Capitalization Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Required IPO Net Proceeds To Extend Maturity Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate interest expense incurred on short-term borrowings including commercial paper and Federal funds purchased and securities sold under agreements to repurchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769977615464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>vestingTranche </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares) | shares</a></td>
<td class="nump">42,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares) | shares</a></td>
<td class="nump">26,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of stock options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 150.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option grants expiration</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense, other than options</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">364,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense, other than options</a></td>
<td class="nump">$ 108.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting tranches | vestingTranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche one | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche two | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769977912664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">33.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">14.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life in years</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770071690488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">63,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">20,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(9,373)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(4,709)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">70,279<span></span>
</td>
<td class="nump">63,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">1.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share)</a></td>
<td class="nump">1.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Beginning balance</a></td>
<td class="nump">$ 53,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Ending balance</a></td>
<td class="nump">$ 445,246<span></span>
</td>
<td class="nump">$ 53,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Life (In Years)</a></td>
<td class="text">8 years 6 months<span></span>
</td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769984054520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">364,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled (in shares) | shares</a></td>
<td class="num">(19,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">345,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">9.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">9.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSU's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">14,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">14,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">9.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979400600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Net Loss Per share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to Bright Health Group, Inc. common shareholders, basic</a></td>
<td class="num">$ (300,664)<span></span>
</td>
<td class="num">$ (59,256)<span></span>
</td>
<td class="num">$ (370,344)<span></span>
</td>
<td class="num">$ (84,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to Bright Health Group, Inc. common shareholders, diluted</a></td>
<td class="num">$ (300,664)<span></span>
</td>
<td class="num">$ (59,256)<span></span>
</td>
<td class="num">$ (370,344)<span></span>
</td>
<td class="num">$ (84,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)</a></td>
<td class="nump">630,378<span></span>
</td>
<td class="nump">136,337<span></span>
</td>
<td class="nump">312,294<span></span>
</td>
<td class="nump">135,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)</a></td>
<td class="nump">630,378<span></span>
</td>
<td class="nump">136,337<span></span>
</td>
<td class="nump">312,294<span></span>
</td>
<td class="nump">135,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770068960232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">70,279,000<span></span>
</td>
<td class="nump">469,462,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock (as converted to common stock)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">411,238,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of net loss per share (in shares)</a></td>
<td class="nump">70,279,000<span></span>
</td>
<td class="nump">58,224,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769978867800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769978575592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">$ 1,020,233<span></span>
</td>
<td class="nump">$ 345,426<span></span>
</td>
<td class="nump">$ 2,922,950<span></span>
</td>
<td class="nump">$ 827,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="nump">11,079<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
<td class="nump">31,602<span></span>
</td>
<td class="nump">13,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="nump">47,345<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
<td class="nump">112,503<span></span>
</td>
<td class="nump">7,063<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,078,657<span></span>
</td>
<td class="nump">352,120<span></span>
</td>
<td class="nump">3,067,055<span></span>
</td>
<td class="nump">847,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(296,281)<span></span>
</td>
<td class="num">(59,256)<span></span>
</td>
<td class="num">(378,159)<span></span>
</td>
<td class="num">(93,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">14,205<span></span>
</td>
<td class="nump">2,678<span></span>
</td>
<td class="nump">25,981<span></span>
</td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember', window );">Bright HealthCare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">994,586<span></span>
</td>
<td class="nump">343,472<span></span>
</td>
<td class="nump">2,860,270<span></span>
</td>
<td class="nump">821,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">7,063<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">995,612<span></span>
</td>
<td class="nump">345,246<span></span>
</td>
<td class="nump">2,863,790<span></span>
</td>
<td class="nump">828,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember', window );">NeueHealth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premium revenue</a></td>
<td class="nump">25,647<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
<td class="nump">62,680<span></span>
</td>
<td class="nump">5,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenue</a></td>
<td class="nump">11,140<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
<td class="nump">31,573<span></span>
</td>
<td class="nump">13,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bhg_InvestmentIncomeLoss', window );">Investment income</a></td>
<td class="nump">46,258<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">109,012<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">83,045<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
<td class="nump">203,265<span></span>
</td>
<td class="nump">19,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Bright HealthCare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">995,612<span></span>
</td>
<td class="nump">345,246<span></span>
</td>
<td class="nump">2,863,790<span></span>
</td>
<td class="nump">828,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(303,271)<span></span>
</td>
<td class="num">(57,263)<span></span>
</td>
<td class="num">(443,450)<span></span>
</td>
<td class="num">(88,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,584<span></span>
</td>
<td class="nump">2,274<span></span>
</td>
<td class="nump">11,524<span></span>
</td>
<td class="nump">4,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | NeueHealth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">222,804<span></span>
</td>
<td class="nump">9,601<span></span>
</td>
<td class="nump">385,657<span></span>
</td>
<td class="nump">27,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">6,990<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
<td class="nump">65,291<span></span>
</td>
<td class="num">(5,345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">9,621<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="nump">14,457<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="num">(139,759)<span></span>
</td>
<td class="num">(2,727)<span></span>
</td>
<td class="num">(182,392)<span></span>
</td>
<td class="num">(8,176)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | NeueHealth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="num">$ (139,759)<span></span>
</td>
<td class="num">$ (2,727)<span></span>
</td>
<td class="num">$ (182,392)<span></span>
</td>
<td class="num">$ (8,176)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bhg_InvestmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest income and realized gains and losses on debt securities, as well as unrealized gains and losses on equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bhg_InvestmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bhg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bhg_BrightHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bhg_NeueHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769979170952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (18,225)<span></span>
</td>
<td class="num">$ (9,162)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139769975814104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=bhg_ControllingInterestHolderMember', window );">Controlling Interest Holder | Centrum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=bhg_ControllingInterestHolderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=bhg_ControllingInterestHolderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=bhg_CentrumMedicalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=bhg_CentrumMedicalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139770068961720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">$ 41,012<span></span>
</td>
<td class="nump">$ 40,217<span></span>
</td>
<td class="nump">$ 39,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition</a></td>
<td class="nump">85,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Earnings (Loss) attributable to noncontrolling interest</a></td>
<td class="num">(4,577)<span></span>
</td>
<td class="nump">640<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Measurement adjustment</a></td>
<td class="nump">8,519<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">$ 130,029<span></span>
</td>
<td class="nump">$ 41,012<span></span>
</td>
<td class="nump">$ 40,217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-THNVC<:CU(I6;:7<Y% .MH ?I]*D#F;&_V29/M2[.(_4$L#!!0    ( &5
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MSAB5*$LA7LK)?3RP<*F(<AKI,@2!GPT=4\[+2*#CWSJHU>0L'7?'K]&_&GB
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M0_[9W= [**N'C[3#H:G?#7L]+W"[[0@._OV.P^=#?*P%ZLA[LMS0\;P@=-\
MM)@Z7N#[KM\+CQ#LO*6=\PG.:( Z_(<P#DV/8=@[]X[RTO<GD6N6*<3I"GSQ
M=0!!9'6/JB9:Y.8JLA0:+C9FF,#=D\K2 )ZOA-"OD_)VT]QFA[\ 4$L#!!0
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M NC?GX10NY-J@.[=W=4_4$L#!!0    ( &5 ;U-"$YFV,00  ,L-   8
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M6Y0K /R_8$R^=U2 ^OTV^ =02P,$%     @ 94!O4\L0&:/C @  ]@<  !@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6RE5=MNVD 0_961E0>0TIAKVD:
M1+"C((6+,$D?JCXL]H#=V%ZZNX:D7]_9M7%)Q"5J7]B=\9PY,X?53&?+Q;,,
M$16\)'$JNU:HU/K&MJ4?8L+D%5]C2E^67"1,D2E6MEP+9($!);'=J-6N[81%
MJ=7K&-]4]#H\4W&4XE2 S)*$B==;C/FV:]6MG6,6K4*E'7:OLV8K]% ]KJ>"
M++O,$D0)IC+B*0A<=JU^_<9MZW@3\!3A5N[=07>RX/Q9&\.@:]5T01BCKW0&
M1L<&!QC'.A&5\:O(:964&KA_WV6_,[U3+PLF<<#C;U&@PJ[UQ8( ERR+U8QO
M[['HQQ3H\UB:7]@6L34+_$PJGA1@JB")TOQD+X4.>P#*<QC0* "-]X#6$4"S
M #0_RM J *V/,K0+@&G=SGLWPCE,L5Y'\"T('4W9],6H;]"D5Y3J=^(I05\C
MPJG>8#)VW+'G.D W;_(P=/IS,KPY'2-W//=@<D>?1M.9>T]QPR<7AF.R7:@\
M3#RO"I5I?T9Q]^Y\..@_5.$3/'H.5"ZJ< %1"O.09Y*E@>S8BLK5I+9?E':;
ME]8X4EH31CQ5H00W#3 X@'=.X[^>P-LD4ZE58Z?5;>-D0@_75]"L74*CUJ@?
MJ&?P<7CM4#O_Q^[^,_L;,9KEPVF:?,UC^1132 -# 5_"@"<TI4(]/C8(P]3G
M"<+W_D(J09/@QPFZ5DG7,G2M(W2/*4W!./J- ;VJ#4IEJ$,>!U&Z@DK,I419
MA15-1@E,1%*[@TSH0X4(K\C$)2CV<N@=YM37AEH/UDV/%-KL_[-G(YRS$>ZI
MB#>:M$M-VB<UF:$?,RFC9>2S?.H&/[-<&0FT0O:5,L(<%:!]5H"S$<[9"/=4
M1"Z O3?($A0KLT$D^#Q+5?XT2V^YI/IF-K_SW]9O!O4#?H>66KZ#_J;/-^*(
MB95^.S$NB:IV]9FJ%?F6R0W%UV:,+KBBH6RN(2UF%#J OB\Y5SM#$Y2KOO<'
M4$L#!!0    ( &5 ;U.(GR&0=0P  ,Y4   8    >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&ULQ9QM4^LV%L>_BH?IS/;.;(KU+'6XS  ))=U[@06Z.SL[^\(W
M,9=,DYC:YM)^^Y5#B&SI2+;ST+Z!!([DOV5)OW..)9V\9OFOQ5.:EM'OB_FR
M^'CT5);//QX?%Y.G=)$4/V3/Z5+_YS'+%TFIO^9?CXOG/$VFJT*+^3&.8WZ\
M2&;+H].3U=]N\].3[*6<SY;I;1X5+XM%DO]QGLZSUX]'Z.C]#W>SKT]E]8?C
MTY/GY&MZGY:_/-_F^MOQII;I;)$NBUFVC/+T\>/1&?IQC)"H2JQ,_C5+7XO:
MYZBZER]9]FOU93S]>!17DM)Y.BFK.A+]ZUMZD<[G555:R&_K6H\V%ZT*UC^_
MUWZYNGM]-U^2(KW(YO^>3<NGCT?R*)JFC\G+O+S+7J_2]1VQJKY)-B]6/Z/7
MM6U\%$U>BC);K MK!8O9\NUW\ONZ)6H%$/$4P.L"N&L!LBY NA:@ZP+4+L ]
M!=BZ +,*8.$IP-<%N%6 ^%I)K L(^PK24T"N"TBK /7=@UH74*ON\/;\5@]_
MF)3)Z4F>O49Y9:UKJSZL>M"JM'[FLV75V^_+7/]WILN5IQ<WU\/1]?UH&.E/
M]S>?QL.S!_WE_D'_^CRZ?KB/;BZCBZNSZY]&]]'X.KH;#4>CSV?GGT;1[=WH
M<G1WM[*^N?A'=':M/UV=W8VN;CX-1W?W?XM&__QE_/"?Z/OAZ')\,7[X$ VB
M7^Z'T????8B^BV;+Z.$I>RF2Y;0X.2[UO52*CB=KW>=ONK%']T-6)G.@V$6X
MV/CV!B@T#!>ZR!8+/2[ORVSR*U!ZU+TT?/G+< 5GT^FLFAB2>72;S*:#\3*Z
M2)YG\/W_M&U=L+2K<'5W::DGU'0:C9)\.5M^+?2S3A]GDUGY :ALW*)M,GE9
MO,R34M=W4SZE>:2;3D_A3]7<^BV-QLM)MDBC[S]E16%5?ZQ[_:;KXTW7QZOK
M4<_USM.OLV6E6L^6\V0YT57K/ED\)7E:?(B2,AJFDQ\B@OX>X1@IJ(N^U<]6
M]5=8^7:*D,)8DR8^.?X&2",;::2GM"YRWNKD-3E2(*4\6NA&"PUJ&2VG@3;Z
MG.3OHG ,B:)]VXAM=+$^NKIH8;T:B&^$\,/VHR%WVX@P%BMO&XF--'& ?B0<
M.0/,">%B(^9-MG":$]&FR:5K0I"TC*Y<(WT]P:AUO;%KIR2&&TAN&DBN"A$?
M#Y83[2,6:35OO7WZ4(%I-5D_9?-IFA<:8[^]S,H_HO_>9?-YI%VLUR2?_B\P
M :G-Q57PZ5QK9W:N)S/H&2CW&0@L8ZOEVJP:LE!L?((X*&Q<%"]OO64YC8ID
MGD;98S1YXUA1-4V]AX,\C=T>+8FW.Z.:MX)V4P9Z$@@87U9'#=LTU1K H#!A
M[JL6&E2^^+02J2.4(JGH"XIT8:*HHS)LU)1I8(/"M'F#[:0!V]D:MG,7MFN]
MQ)7"D#5B6XR:>@V0T"&)-$0 D@CCRH\D9)B$]@XEY%))3W]24&NP#P%#9[Y=
MV]3OC2*[IBO :H %E=B><0%#I(BOPQE@H@,3\QP!R R[%<@P$QT"FLBE4\BY
M0(902.[0V^_39ZTK#G0OZ;84QTCXG0MD^(7" '-[>[L<Y79B3J2& RP&&VCA
M,+1V=\,P0*VP'X8-N' 87-MU*NQ2"7;%UH;!N0&H#'#&X$L"WAA@Z'7'<"TF
MPW^^0X8-"G$8A2&7#+LP&TC*D:]O&)[A,,^VXB]V*88QDQXM!F"X%\!ZSC9#
M# "#<%E-R[YF,M3 86IL,=NL:VRPE5"$,+''CVOHCA^7.4(X+CE@-2 ,(^:,
M']>08.IK)4,OW)=>?2-V[,9_+6S%!F8X##-P&FQ7)'NQ%1N 816<;>[2:9HN
MDB\ZCKC-T\<TS[6G#N3YFDD<@R32,8[20<KSIOXN$=0Y 5BDN)YLO*DE@R+2
M,89R58%*7+1@A;!7AYGJ23@Z"D\U/[\LPV.; -DW[4@$PDQ22[^%,>!.->UR
MW.P;TIX-\G528O! PGC8>40/2>^(AQA@D# PMAO1!(I H*"'= AZ@,J H >\
M)!3T (;^H(<8?!'^YWLVQ'"!A+D0\FP(D/%#,A:V;]ANUQ1GL$#"6-@YX43<
M* =3[N_>AA D'.)LE7 B;EX.(6GWVK!1,U=OD$/#R.F3<J( 8S"SQLUEFU53
MJ*$0#5-H*Z>7NC$')G8(,VZS:BHVO**'Y-600KQBBDAO+Z6&5W3OO*(NKP98
MPY-C:P8&#)T9F+JAD8Z;K1Y_!5@-L,(JMM.&@"$E2'A:J?8BB^[?VZ.&A#1,
MPAV\/>HB!Q.L_!,8-=BAX:BII[='W4"("L9]<0DU_*%A_NR8QJ) 4!).8U%#
M']HKP]9)CAN1!--8U "'AD.2@[@)S/"#A?D1<A.82X(!4YAQ:YRWVS7%&6:P
M'=_^M+D)S"6#E(%7T88-+,R&K=P$YA)!.*]\6HR:>@TP6!@8?=P$YL[&B&%E
MZVRQ:@HU<S8[0&Z,N?'. ,7"=O1;S9J::PL3#II#8[US:,S0@.T]A\:ZYM
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MI6A$B!UEW*.,7S'HAM4U0.05@&2H27\PJR?&QN)S'"5^.,)HBCG,F/0 DTF
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MT1BJ*1?&X!P.J /3X&FJZ5WS@%$'@-".<!0&5N06.J%Q8#BK*38GQ,.! _E
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M_Y%8+,3;$F8EQ>D[Z.NI-BIT+>$S8J-A2!(,"8 (>BUDW2,)5H66Q@1K6>2
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MD58"FI=M6>;T8'>L6^Q2*3QQZLT"5B+3 6"663N-9LXX@\RRX>9=M3"N+MJ
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M3K&DTG8'JOAEP[*OH-*!:X8TB:)^?W_.S?[#W6H]V)"FL\7^T!MZ^WV6BM*
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MPR8>-OF_X?L/,/!4,=@H@77#Y18L+00#4ZF= 8L[:U4W2C)I#:A-MU)1N67
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M9N,!Z.XET4VL:OSM72B+;P$_K/#QQ;0[@/L;I>QQXA3TS[G9WU!+ P04
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M49,Y\2]_K*0H4+D;'+ZI%*(#I*PBU'WQT18?J'0&ZRWA)B%<\(:49:=)5_N
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MK.B# Y55H/-2$F<."WO!\ FS_!=02P,$%     @ 94!O4]%5S]W? @  (P8
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M+E!4>:-8S2:.6G#!6]C"(J8:T2).VW I&W9RJ@7'L\7=:K5\6-VN'S8P7]_
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M10],\]YI%E;/_1MCI"V^6#PYPR>B-.X [D^TMNN%,] ^.D_^!5!+ P04
M" !E0&]3+PL!794#   0"   &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6R=5MMNXS80_96!T (MX%JVG&W3A6T@=K+(/B0;;-(+6O2!ED86&XK4DE2<
M].M[2,E:IW7215\L7N8,SQS.##W?&7OO*F9/C[72;I%4WC=OT]3E%=?"C4W#
M&CNEL;7PF-IMZAK+HHB@6J799/)]6@NID^4\KMW8Y=RT7DG--Y9<6]?"/JU8
MF=TBF2;[A8]R6_FPD"[GC=CR+?N?FAN+63IX*63-VDFCR7*Y2,ZF;U<GP3X:
M_"QYYP[&%"+9&',?)N^+13()A%AQ[H,'@<\#KUFIX @T/O4^D^'( #P<[[V_
MB[$CEHUPO#;J%UGX:I&<)E1P*5KE/YK=)??QO G^<J-<_*5=9SN;)92WSINZ
M!X-!+77W%8^]#@> T\D+@*P'9)%W=U!D>2Z\6,ZMV9$-UO 6!C'4B 8YJ<.E
MW'J+70F<7[Z_7G^XNJ"[LU\O;N>IA\>PGN8]>M6ALQ?0/]*5T;YR=*$++I[C
M4S 9Z&1[.JOL58>WW(QI-AE1-LFFK_B;#>'-HK_92^'IW-1,=^*1SJ7+E7&M
M9?K];..\14+\\<H1)\,1)_&(D_^IX)>CJ6?KP98?47:.Z9L-:RZE_Y9VPI'0
MPX8IZ:O)>(J<4"JFMRY(4&\==Z>GXVS81OF2K^"[LLS16(,)U=WU<;@^@OB>
MZPW;X09&J#O7<*P<]32F.WB0=0/EJ+2F)CD09D</PDI\XD8XJN2"K5#DO/"M
M-_:)K/"1>#8=3[ZFH@724%X)O05.ZHAZ$*H57<$J= RA<X[D46EL+5@&=81S
M[%T7<_$GJ@1M O-@US!J56-*A2P!83AP8WKW+/[_##N8[I56PFX1/:10X.\"
M9U$;Z^5?'4\$9*S<2HVIWM+6F&('U3LA(E/TGD^M=#*8'W#YLAL(EN8A**EB
M[/LKEHX:*]%));CU6@9;T&31)<@Q+2%S;K3NF^).^HHT>N<S>944&ZE %]%:
MSHT-W& M"^@J2^RJX,CCXB2&N AP$3:FW:9U",LYG%)OHB:Q]^:FU5&>?2*N
MKL]'])MLM''2C>CN\OIJ%"]T?7F#E#'Y_3]4"[FWQOFVK0]W8EUXO$<>'+L2
M^9?FG>- PA;@H)Y&I,W1C *YP^!WR)_/"AR)\KOC48Z/]97TH$O7C)P*;U'0
M"9BN80^KPW-WUG7YS^;=6WF%E)3:D>(2T,GXAS<)V>[]Z2;>-+'G;XS'"Q*'
M%9YLML$ ^Z4Q?C\)!PQ_ I9_ U!+ P04    " !E0&]3UT3_<]0$  #A"P
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M."!4&#NV(.AGC6-4B@U1&-^V-ANU2U;<7^^L_^*Q$Y:%L#C6ZD^9N/2BT6]
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M)1'CW1KL8LZ"D$:8QU^4JIYD71.>IC0+&?DJ*H'<[=QJ55MB0VH0X-9?ME8
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MW6E?I73U!.YS@MWI=M(#.'GASNQHKGE^A#VHZ1.;W+Y/MD(6 QK';OA?,BW
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M7;8O_':B16U?U3.AX8UNASFC8)4Y /MS(?1J8@1T?[.,_@%02P,$%     @
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M#^P+TC.KD))##/?K)%S9]_2' @,,"R941ZVVV*[MQ<R+M^R!*WQG0*OYHJV
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M>+SD [Q;:7K-9,GAK^766(UE\?<GL.D(FWK8]",WL5NJON&@=G GV%8TPKX
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MPY)>3JBL .T7DG)F-[$']&^QQ=]02P,$%     @ 94!O4\,G3C/Q!   0 T
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M;'-?;R;.+,(=^<DXN'&'X1P^<;3U&^#]U!BWGGB ]J-I\!]02P,$%     @
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M'=GV)LKKP0[*,[OG]-#6HWU3X1 -$!HXUI8&5#CTD MMIWK?T#)3C]6L7ZL
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M9^"+B_/EV-[6R'485UQ EHM;(FUO:Q<Z7 "7.YQ1<H%';J]&:::1J[;YL=B
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MVR]UL6[?W+LMZKI8M1\7*M4C:!KHO]\51?WTI7&P>X/U[/]02P,$%     @
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M>2=G8D0X8!2_Y(@A^2.?U]PRP\6^I(87!%,8YY0BO :CY(^PMM@^./AU*SC
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M&2_K /7[G1#RZ:!^BW#[UNC%_U!+ P04    " !E0&]38EW%B5(&  #9+
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MD2YEP?F;'MRO1H:E%1%&EDI38/C;D0EA3#.!CA\%J5'FU,#J]2?[;58\%+/
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MBC"&@[YM9<!,%<ST84_\L%^B/AL!S!PA!&F#@QE'A#&,\&TK?<\7N.JZ'S
M,Y78$TOT"^?+>8 1*P0:I 4.1C01Z.LS-]LV?"M!?TVK>V8T?!16.Z*)G3LW
M -R33!QD*FP;&;1O@[S4/[\^S%?8MN97:+#-#4:D$7HRC8<X"N#(+#I2!*ZR
M[A@!&-E&Z DW]ESV8W@+8,0C(<Q\)!@!2>A)2 Z] /MO;?IK6ATT2-Z3D.R7
M]&!3P8A40IB92C!"E="3JASZ]HH!C!^>K 0C6@D]V<I^!5]A)<3F6SZ"O.D)
M1C 3>I*90[4<\&TP/)T)1CP3CLEGMJ[&X1:"D=Z$,..;8.0WH2? .52\?MO=
M7]/JH,'ZGO#F /$.]PZ,\";$89KM1L(3>B*> S5T1#8M#;TUK0X:M._)=/9K
M>)QI8(0U@85IM!MA3F"C&.UL^-2>F2]J>HUU'@\Q#8R\); P#7(CH EL%(-\
MTXKP7E2^FI<.3HSW;C9O/;W*RH=\444S=:^W(6^:QRC+E_>(OGRHB^7Z59RW
M15T7\_6/CRK3ZYRF0/_]OBCJ[8?F[9Z[U[F>_Q]02P,$%     @ 94!O4[HY
MB(5B!   =QD  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULS9E;;^(X
M%,>_BH7F84::);'-=01(]*:IU%85E.[#:A\,,6!-$C.V U-I/_S:(8VY!#<S
M\)"7DLO_G/S/.>8'-;T-%S_DDE(%?D5A+/NUI5*K;YXG9TL:$5GG*QKK.W,N
M(J+TJ5AX<B4H"=*@*/20[[>\B+"X-NBEUY[%H,<3%;*8/@L@DR@BXNV*AGS3
MK\':^X416RR5N> ->BNRH&.J)JMGH<^\/$O (AI+QF,@Z+Q?&\)OUPW?!*2*
M5T8W<N<8F%*FG/\P)_=!O^8;1S2D,V52$/VRIM<T#$TF[>-GEK26/],$[AZ_
M9[]+B]?%3(FDUSS\FP5JV:]U:B"@<Y*$:L0WWVE64-/DF_%0IG_!)M/Z-3!+
MI.)1%JP=1"S>OI)?62-V F#C1 #* E#9 )P%X+30K;.TK!NBR* G^ 8(H];9
MS$':FS1:5\-B,\:Q$OHNTW%J<#>\'X'7X</D%CS>#L>3T>WC[=/+&/P%QGK%
M!$E( 9^#.\($>"5A0L$C)3(15$]2I7=83.(9(R&XCZ42B;DNP1-7[\( F&&!
M$9TE0K!X :Z(9!)\OJ&*L%!^T4^:C&_ YT]?P"? 8O"RY(DD<2![GM+U&9?>
M+*OE:EL+.E'+F*[J /M? ?(1+ B_=H??T)D.AVFXOQ_NZ:[FK45Y:U&:#Y]J
M;=ZTKV H)=5]T76!!T:F+&2*4;G7(]LAHWKBL3AHV3\/^@'@7M%(_NNPAW-[
M.+77.&'OFL@EH#\3MB:A&5I1O[<96FD& X3U +7:3=V<]6Y;"U0(Y9H]<XW<
M7,-I[H4KO:26- R XGJ]JT0P]59D<9NGN?-PW.RVF@<6CU4=OXV+/39SCTVG
MQTE]7 <+OJ8B3M\-9FR:?/'L#?!IR!;$<$HZ)M7*']2JXD)JY_;:SCY\+S&E
M]E'_V^U6YV!(QZ)6&Y]82)W<7,>]RJE0;,YF1.DN:5X%=,4E4XZRNWGF;A6G
M GU+=O_LN60I=GL.&XWVP6"*5!!VBR<#=SYZH-/@ UW3$$!7L9:UL)*PA9:V
M\'S<9BF:'_"V2'8*N- 2%UX*N; <<PMDK6ZS<<*GI2YT8S=;-> _<#: H24P
MK"2"H64P/!_"L!2%"U2G,0PMAZ$;Q'9LOX]D:)D,*PEE9*&,SH<R*@7E I5?
M/"1DB8S*$!FY*MWY]EM)(B-+9'0^D=$Q:@]I[)3L6[,L1I=B,3J&[)'!8\GI
M3V]D.8S*<!A=@L/(<AA5DL/(<AB=SV%T3-BCF;DD^]8L@5$9 J,_(C"R!$:5
M)#"V!,;G$QB[V)K]T_L[WXFQ)3 N0V#LJM02&%>2P'AG!^("6Q ?$]@IV;=F
M"8PO16#\,8&=DGV#%K^X#'[Q)?"++7YQ)?&++7[Q^?C%'^/7*=FW9O&+R^ 7
M_Q%^L<4OKB1^&Q:_C?/QFZ5H.2;DE&RM>3N[XN8GB4<B%BR6(*1S'>/7VWJ\
M8KO+OSU1?)5NE$^Y4CQ*#Y>4!%08@;X_YUR]GYB]]_RWEL'_4$L#!!0    (
M &5 ;U-S^Q$0X0(  $ '   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM
M;(55VT[C,!#]%2OB 226I E-%]16Z@TM$EVAEK(/JWUPDVECX=A=VVGA[W?L
MI*$+;7A)?)ES?.;B<7<GU8O.  QYS;G0/2\S9G/K^SK)(*?Z2FY X,Y*JIP:
MG*JUKS<*:.I .??#((C]G#+A];MN[5'UN[(PG EX5$07>4[5VQ"XW/6\EK=?
MF+%U9NR"W^]NZ!KF8!:;1X4SOV9)60Y",RF(@E7/&[1N1[&U=P;/#';Z8$RL
M)TLI7^SD/NUY@14$'!)C&2C^MC "SBT1ROA;<7KUD19X.-ZSWSG?T9<EU3"2
M_!=+3=;SOGLDA14MN)G)W0^H_&E;OD1R[;YD5]D&'DD*;61>@5%!SD3YIZ]5
M' X R',<$%: \",@/@&(*D#D'"V5.;?&U-!^5\D=4=8:V>S Q<:AT1LF;!;G
M1N$N0YSIWPWN9^1Y\+"8D.ED,%_,)M/)SZ<Y^4;F6#!IP8'(%1EE5*R!,$'N
M*%/DF?*B7)?",-P1Q@XU2T%1EYWS,1C*N+Y HI-&#XPN&6?F#8T6\S$Y/[L@
M9_:0ITP6FHI4=WV#/EJE?E+Y,RS]"4_X<T.F>%RFR42DD![!CYKQK;"!P,?@
MUA$.]Q$>AHV,<]A<D2BX)&$0MHX):H:/(4%XR\&#!CE1G?#(\46G$EXG\+).
M  --ID!UH2 EF)@9)(52F#,RI)KI2[(0<JE!;>D2Z^%>; IC;:1($.UR>4E&
ME"<%+Q/[>R8Y)WC-=E2E?QI$7]>BKYWHZQ.BA[!F0EA!2\JI2.!88904L:.P
MS6O;;W=:<=??'@;["Z/_U+5K=>U&=>^W8V6#N]W?CN2]\)/#PC\FOCRA?:"K
M%<71!_&?C8+CRN-:>=RH'&O\BZ#&G^+5"3HW'W1]-CH25/^@2>6@UJYW:XQ,
M(4S9K^K5^GD8N*[HOYN7;\N4*JP'33BL$!I<=3 DJNS7Y<3(C6MY2VFP@;IA
MAD\<*&N ^RLIS7YB#Z@?S?X_4$L#!!0    ( &5 ;U,.VM0V60,  * +   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;+6677/:.A"&_\J.IQ?M3!I;
MQF#3 68@I"DS:9H):7O1Z85B"ZQ6EJ@DA_;?5[*-S3E@)Z7GW. O[:M'*^W+
MCK9"?E<I(1I^9HRKL9-JO7GCNBI.28;5N=@0;KZLA,RP-H]R[:J-)#@I@C+F
M^IXW<#-,N3,9%>]NY60D<LTH)[<25)YE6/Z:$2:V8P<YNQ=W=)UJ^\*=C#9X
M399$?]S<2O/DUBH)S0A75'"09#5VINC-#$4VH!CQB9*MVKL'NY0'(;[;AT4R
M=CQ+1!B)M97 YO)(+@AC5LEP_*A$G7I.&[A_OU-_6RS>+.8!*W(AV&>:Z'3L
M1 XD9(5SIN_$]AVI%M2W>K%@JOB%;3DV'#H0YTJ+K HV!!GEY17_K!*Q%^"C
ME@"_"O +[G*B@G*.-9Z,I-B"M*.-FKTIEEI$&SC*[:XLM31?J8G3DZL/'^:?
M%]?7,+V9P^+F?GISM9A=7\)TN;R\7\)K6)ISD.2,@%C!E1#)EC(&+^=$8\K4
M*W@!E,-]*G*%>:)&KC9,5MF-J_EGY?Q^R_Q#>"^X3A5<\H0D_XQWS5KJ!?F[
M!<W\3L$EV9Q#SSL#W_/1Q^4<7KYXU2';J_/4*V2#%MF9M-L+[PAF.KW DG1H
M!K5F4&CVVG*_2^>7.V%^S2G;8IE\[5#NU\K]3MHK*90"@RE_4;Z&:29RKL]@
M1M:4<_OF 3/,8W)LOTKE0:%L:_IQ@H9A% U&[N,1HD%--#B%:!K_R*FBMD"/
M'IY2M+\'XP=>&+; A#5,V U3)?X,;G,9IZ:H 2??3+$9N]%'.<(#CM=H@*+C
M&%&-$9V2$U,)3VQ1=$ 3]$(O"([C#&N<82?.19[E#%N3A$6VP53:;#SST P/
MB+SC,,AKC,D[!>?I[%2ZSX'9<TG4"7-#<E+6?D=U(K^1\__CRD>-4:%NI_J;
MVJ^D]U,WZ*-@V)*^QNA0\']4?Z6ZC],+/.2UU!UJ[!$]X8]_; "5X',.56.)
MZ"1/?,8)/[3%P.O[_;"%J/%%U&V,?V,!Z- CVS+4&"3J=LC3/2 Z^!?[-XR[
MUS1E1*Z+UE!!;#>A[)_JMW7[.2V;KF9XV;N^Q](D2 $C*Q/JG8<F";)L!\L'
M+39%"_8@M&GHBMO4M-!$V@'F^TH(O7NP$]1-^>0W4$L#!!0    ( &5 ;U.0
M!"F%S0,  *0/   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;+U7VX[:
M.A3]%2OJ0RN=3FSG E2 Q$#;@T1G1L/T]*'J@R<88C6QJ>T,,_WZXUPF">2B
M>4"\0)SLO;V\O+RT/3X(^5N%E&KP'$=<3:Q0Z_TGVU9!2&.BKL2><O-E*V1,
MM!G*G:WVDI)-EA1'-H;0MV/"N#4=9^_NY'0L$ATQ3N\D4$D<$_ER32-QF%C(
M>GUQSW:A3E_8T_&>[.B:ZN_[.VE&=EEEPV+*%1,<2+J=6#/T:8[=-"&+^(_1
M@ZH]@W0ICT+\3@?+S<2"*2(:T4"G)8CY>Z)S&D5I)8/C3U'4*N=,$^O/K]6_
M9(LWBWDDBLY%](-M=#BQAA;8T"U)(GTO#O_28D%>6B\0D<I^P:&(A18($J5%
M7"0;!#'C^3]Y+HBH)2"W(P$7"?BM"4Z1X&0+S9%ERUH03:9C*0Y IM&F6OJ0
M<9-EF]4PGF[C6DOSE9D\/?UZ>[OXL5RMP.QF 98W#[.;K\OKU6<P6Z\_/ZS!
M1[ VPMDD$05B"Q9TRSC3]&-DJ-^ )=>$[]BC^3A3BFH%WB^H)BQ2'TSB]_4"
MO'_W ;P#C(.'4"2*\(T:V]J@3N>V@P+A=8X0=R!<T_T5<. _ $.,6M+G_>D+
M&IATE*7#XW3;<%42ADO"<%;/Z:CW)6=@U<' SY6)!TM-8_6K9S:GG,W)9G.[
MMD<*I<"<2/G"^ [,8I%PW<9A7L;/RJ1']VGJ#"'R\-A^JG/5#$/>P$=5V!%*
MMT3I]J*<!4$2)Q'1AA(#46KVEZ2'M UH7LFK(<!#WW%.<#:C/!>B=I1>B=+K
M13G/3A.5QGVB#)X*V5[U;))?%O8O((E!.=O@/)(8-)F&(P>C$ZJ;80@-7*^#
M[&&)<G@V20R;"$;8&YS@;$8YON^VHQR5*$>]*!\DV5# 24S[=(!@9:;P DI
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M56:/H;E&4YD&F.];(?3K(+VHE1?SZ?]02P,$%     @ 94!O4QF28$V8 P
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ME4AK8)YOA-#'B7U!T_[._@-02P,$%     @ 94!O4^=*8X-? @  0 4  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULC53;;MLP#/T5PMA#"[2Q8V?M
M6C@&<NFP LT6-.N&8=B#8C.Q4%GR)*5I_WZ4['A9D13+0RQ1/(<\(JETJ_2C
M*1$M/%="FF%06EM?AZ')2ZR8Z:D:)9VLE*Z8I:U>AZ;6R H/JD081]%%6#$N
M@RSUMKG.4K6Q@DN<:S";JF+Z98Q";8=!/]@9[OFZM,X09FG-UKA ^U#/->W"
MCJ7@%4K#E02-JV$PZE]/!L[?.WSCN#5[:W!*EDH]NLUM,0PBEQ *S*UC8/1Y
MP@D*X8@HC=\M9]"%=,#]]8[]H]=.6I;,X$2)[[RPY3#X$$"!*[81]EYM/V&K
MY[WCRY4P_A^VC>\%.><;8U75@BF#BLOFRY[;>]@#$,]A0-P"XM> P1% T@(2
M+[3)S,N:,LNR5*LM:.=-;&[A[\:C20V7KHH+J^F4$\YFLYOI[61T!Y,OBZ\+
MF(]^C,9W-W .GYG6S-TPG$S1,B[,*5D?%E,X>7<*[X!+F'$AJ!(F#2TEXNC"
MO TZ;H+&1X)>P4Q)6QJXD046_^)#$M"IB'<JQO&;A NL>Y!$9Q!'<?] /I/_
MAT=OI)-TEYIXON0(WZTT&\UDCO!SM#164Z_^>H-VT-$./.W@6*VPX#D3D"MC
M#=3LA2T%GE$I<II?0Y4JL%F=@E50:ZXTO"#3!RO4A.HW?>%F_2GK]R[3\&G_
MV@XXG5_UDFC_U^\PC:APKQDKU&L_HX:2WDC;5+2S=L_ R'?_*_N8GH=FFO_2
M-&_+C.DUEP8$KH@RZEW2<.EF7IN-5;5O^:6R-$!^6=(3A]HYT/E**;O;N #=
MHYG] 5!+ P04    " !E0&]3%N-S$_\"  !;"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6R-5EUOVC 4_2M6M(=6VIH/\@$5(-' M$JMADJ[:9KV
M8)(+>'7LS':@_?>SDS0"$A OQ';..3[W^N::X8Z+5[D!4.@MHTR.K(U2^:UM
MRV0#&98W/ >FWZRXR+#24[&V92X IR4IH[;G.*&=8<*L\;!<FXOQD!>*$@9S
M@62195B\WP'ENY'E6A\+3V2]46;!'@]SO(8%J)=\+O3,;E12D@&3A#,D8#6R
M)N[M+#+X$O"#P$[NC9&)9,GYJYG<IR/+,8: 0J*, M:/+<1 J1'2-O[5FE:S
MI2'NCS_4OY:QZUB66$+,Z4^2JLW(ZELHA14NJ'KBNV]0QQ,8O8136?ZB78UU
M+)044O&L)FL'&6'5$[_5>=@CN/X)@E<3O$L)O9K0NY3@UP3_4D)0$\K0[2KV
M,G%3K/!X*/@."8/6:F909K]DZWP19NIDH81^2S1/C1]GT_MX\H#B[XOG!9I/
M?DWN'F;H"XIYEG,&3$G$5^@14I)@JE>E7ICC=[RD@*ZFH#"A\EKC7Q93=/7I
M&GU"A*'G#2\D9JD<VDI[-#O92>WGKO+CG?"S@/P&]9S/R',\MX,>GZ=/(=%T
MMZ0['?3IY;MWT6<7[^X.#NFV/I?F<+SF<+Q2KW="[Y[)0F"6 /H]64HE]%?U
MYXQLKY'ME;+^"=F88I))5+ <D[3KB"IZ6-)-H]F.?<_O]X?V=C^5;907#$*W
M01UX\QMO_EEO<\&W) 6ARRC1U:>;",JK<NLR6FD%>Q;"@1?Y1T;;*-?I#4X8
M#1JCP25)Q.E?_9'JQJD0O.GF+0%1@I>$$O7>Y3AH>_%\MW?DN(WR@LCK-APV
MAL.SAN]94@@!*5H6"C&N=)?/N5#060%ART 0.OW(.?+9AKFA$_E1M].H<1J=
M=?K,E>XU6=USDK+GG"F"J%6'83]P_.#0:]R&>?X@BJ*CD-HP=S ((_<0-FO#
M?+_O^$>!VWN-V5R[CUBL"9.(PDKSG)M(ITY45UDU43PO>_62*]WYR^%&W_X@
M#$"_7W&N/B:F_3?_)\;_ 5!+ P04    " !E0&]34B%G)R0#  "["@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6RU5EMOVC 4_BM6M(=.VLB%:RM
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MS26^+D%H YSW.5>;CGXL%._5_E]02P,$%     @ 94!O4ZP36@UK!0  ?AD
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M#DW^=&G'5%!N@7T^E](\7[@$Y> [_ U02P,$%     @ 94!O4[6T''&W P
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M7F\ BT'6Y_FZHT51'5A70L/QMVIF< 4BTAC ^XT0>M\Q =I+U?0O4$L#!!0
M   ( &5 ;U-)&]Y9!0,  *L)   9    >&PO=V]R:W-H965T<R]S:&5E=#4X
M+GAM;,U6VV[B,!#]%2M/6VFW">%> 1)0JE9JNXCLY6&U#R:9$*N)G;4=Z/[]
MCIV00KEL'WD!7V:.SYF9>#S8"/FB$@!-7K.4JZ&3:)W?N*X*$\BHNA8Y<-R)
MA<RHQJE<N2J70"/KE*6N[WD=-Z.,.Z.!79O+T4 4.F4<YI*H(LNH_#N!5&R&
M3L/9+BS8*M%FP1T-<KJ" /3W?"YQYM8H$<N *R8XD1 /G7'C9MKPC(.U^,%@
MHW;&Q$A9"O%B)@_1T/$,(T@AU :"XM\:II"F!@EY_*E G?I,X[@[WJ+?6?$H
M9DD53$7ZDT4Z&3H]AT00TR+5"[&YATI0V^"%(E7VEVPJ6\\A8:&TR"IG9) Q
M7O[3URH0.PZ(<]S!KQS\]PZM$P[-RJ%IA9;,K*Q;JNEH(,6&2&.-:&9@8V.]
M40WC)HV!EKC+T$^/GF??R./7("#SV8($]^/%C'PA 19+5*1 1$S&7+.(I86)
M-@D@+"33#!29O89I$4%$[J3(R#,6W*-0BLQ!DB"A$LBG6]"4I>H* 95940-7
M(V-SKAM6["8E._\$NSYY$EPG>!K'H_;]751:R_6W<B?^6<  \FO2]#X3W_,;
M1_A,/^[NG:'3K*/?M'C-$WC_#6YL@CL565YH:LL>,S*CDC.^VHWUKT<$)@\:
M,O7[#*U63:ME:;4^0DN]T8(]6N$^+8XED)H2R)&6*DN \2KU5\=R7Y)H6Q+F
MNEF/NI[?[7L>AG:]FY1#PU:GW^KXNY9[0MNUT/99H0N( *_%)99Z*/@:I&9F
MC!=B#%*B4/S^PA?RB:KM/JYI8:1GJ-KN7IT)>*?FT;FD.NC6M+J74 ?=@_2^
M+X!#BU:CX3=[)PN@5ROLG548V/R*W)!7)K-Y(<,$V\)>BL^$LE\?U+^D##>\
MM_O?NX0<5RP^\+$?L6SW?+]UF&MWI^UE(%?V-6"^U(+KLB74J_6+8VS[[+OU
MB7F)V';Z!E,^8YZH7#&LC!1BA/2NNTA+EB^#<J)%;IOK4FALU7:8X&L*I#'
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MJD,;<X3;C[+5TNP2@]-QEBR2Y/EAMDI0ND[GZW27K5>K9?H%+=-=DB7;'?J
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MHN+<QO=NVE4,&A6#[FJQY!>;?'"V,5W?<;Q3_N=F+6=AWF)U=!8J#?9!,RA
M;$U3E23F)5/5]=BL-GU[8MK5R?H4^WG5?G^ZJ7X&\/;" RY)#AMTZ5SW,:NB
M:K#51/&=:3EKKK"!F6&*_R0@M %^WW"NWB8Z0/.7,_X?4$L#!!0    ( &5
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MP9Z2),FR, )86$&28 @\C3B"*0 -&)(D[CVX]SZ*U^^I>/-?OM%O4$L#!!0
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M9 M=G-X_&]T:6?J0A7QD"UT=HY_JW<2$+.0C6PC ;*1N8D(6\M'7= !,>WL
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M1KWS=^I=Q\]#J=>>KS4^_SNI'L_WENOC+\NODY-7Y8)SNJVHSW\!4$L#!!0
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M<' N>&UL4$L! A0#%     @ 94!O4Z^4"B;O    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 94!O4YE<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !E0&]3BA@G3$8%  !P%0  &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 94!O4_1P,G7%
M!@  (!L  !@              ("!B@T  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( &5 ;U/5^ PU5 ,  -D*   8              "
M@844  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !E0&]3
MJO[\(6 &  #'&P  &               @($/&   >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ 94!O4T(3F;8Q!   RPT  !@
M     ("!I1X  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M &5 ;U/+$!FCXP(  /8'   8              " @0PC  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !E0&]3B)\AD'4,  #.5   &
M            @($E)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ 94!O4XXP2INS!P  V1X  !@              ("!T#(  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &5 ;U.Y98YPQPL  &4=
M   8              " @;DZ  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !E0&]33  -"2<2  ""0@  &0              @(&V1@
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &5 ;U/74OC/
M;0@  $X8   9              " @119  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ 94!O4RU*Q[E "   B1<  !D
M ("!N&$  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !E
M0&]3A$N+WO0$  #<"P  &0              @($O:@  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &5 ;U,H=O!1:P0  -H)   9
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M970Q."YX;6Q02P$"% ,4    " !E0&]3)\0%:6$%  " #@  &0
M    @(%VB0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M &5 ;U,O"P%=E0,  ! (   9              " @0Z/  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ 94!O4]=$_W/4!   X0L  !D
M             ("!VI(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !E0&]3+K;H$G<&  !U$   &0              @('EEP  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &5 ;U/V8_<?5@,
M ,T&   9              " @9.>  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ 94!O4]S&]AZ)!@  ^!(  !D              ("!
M(*(  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !E0&]3
MG>=2 L,&  !J&@  &0              @('@J   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( &5 ;U/X>1+(IP4  '(1   9
M      " @=JO  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ 94!O4[LA=JD4!0  V@P  !D              ("!N+4  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !E0&]3LDM0E+(#  #:!P
M&0              @($#NP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( &5 ;U,/!4>WP00  .P,   9              " @>R^  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 94!O4RL.R&0#
M!   EPD  !D              ("!Y,,  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !E0&]3PR=.,_$$  ! #0  &0
M@($>R   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &5
M;U/K 4R@_ (  ,<&   9              " @4;-  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ 94!O4XY*J*%+!0  :QD  !D
M         ("!>=   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " !E0&]3J.K(-90#  #&"@  &0              @('[U0  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &5 ;U,#U^:R=@D  ')
M   9              " @<;9  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ 94!O4PY0G,3'"0  S3H  !D              ("!<^,
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !E0&]3ENT>
MQ"T#  "Q"0  &0              @(%Q[0  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( &5 ;U,&J^^'.P<  $$J   9
M  " @=7P  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M94!O4V)=Q8E2!@  V2P  !D              ("!1_@  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " !E0&]3W6DF_<,#  !##0  &0
M            @('0_@  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( &5 ;U.['%A?&0,  "P*   9              " @<H" 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 94!O4_V4+VA""@
MVE4  !D              ("!&@8! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " !E0&]3NCF(A6($  !W&0  &0              @(&3
M$ $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( &5 ;U-S
M^Q$0X0(  $ '   9              " @2P5 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ 94!O4P[:U#99 P  H L  !D
M     ("!1!@! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M" !E0&]3D 0IA<T#  "D#P  &0              @('4&P$ >&PO=V]R:W-H
M965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( &5 ;U,9DF!-F ,  , .   9
M              " @=@? 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L!
M A0#%     @ 94!O4YLDQR U P  >0H  !D              ("!IR,! 'AL
M+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !E0&]3:AU+>IL#
M   *"P  &0              @($3)P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y
M+GAM;%!+ 0(4 Q0    ( &5 ;U/G2F.#7P(  $ %   9              "
M@>4J 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 94!O
M4Q;C<Q/_ @  6P@  !D              ("!>RT! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " !E0&]34B%G)R0#  "["@  &0
M        @(&Q, $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( &5 ;U.L$UH-:P4  'X9   9              " @0PT 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 94!O4X3;:RB> @  XP8
M !D              ("!KCD! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " !E0&]3**I/U?(#  !-#@  &0              @(&#/ $
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( &5 ;U, @X4V
MA0,   0/   9              " @:Q  0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ 94!O4[6T''&W P  8 T  !D
M ("!:$0! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !E
M0&]321O>604#  "K"0  &0              @(%62 $ >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( &5 ;U,94H>V) (  &L$   9
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M970V,RYX;6Q02P$"% ,4    " !E0&]3,UJ1+3(#  #R$P  #0
M    @ 'A7 $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &5 ;U.7BKL<P
M !,"   +              "  3Y@ 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M &5 ;U.LQ<0@Z00   LJ   /              "  2=A 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " !E0&]3)V75I0P"  "$)0  &@
M@ $]9@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !E
M0&]3[M7M&.8!  #U)   $P              @ &!: $ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     1P!' &@3  "8:@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>306</ContextCount>
  <ElementCount>413</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS</Role>
      <ShortName>BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111103 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128106 - Disclosure - MEDICAL COSTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE</Role>
      <ShortName>MEDICAL COSTS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2133107 - Disclosure - SHORT-TERM BORROWINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS</Role>
      <ShortName>SHORT-TERM BORROWINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/NETLOSSPERSHARE</Role>
      <ShortName>NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2145110 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHICAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150112 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Organization, Consolidation and Presentation of Financial Statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies</Role>
      <ShortName>Organization, Consolidation and Presentation of Financial Statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - BUSINESS COMBINATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables</Role>
      <ShortName>BUSINESS COMBINATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/INVESTMENTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - MEDICAL COSTS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables</Role>
      <ShortName>MEDICAL COSTS PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2342308 - Disclosure - NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables</Role>
      <ShortName>NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/NETLOSSPERSHARE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2347309 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2353310 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables</Role>
      <ShortName>REDEEMABLE NONCONTROLLING INTEREST (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - INVESTMENTS - Schedule of Investment Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investment Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - INVESTMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails</Role>
      <ShortName>INVESTMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails</Role>
      <ShortName>MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - MEDICAL COSTS PAYABLE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails</Role>
      <ShortName>MEDICAL COSTS PAYABLE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails</Role>
      <ShortName>MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - SHORT-TERM BORROWINGS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails</Role>
      <ShortName>SHORT-TERM BORROWINGS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - NET LOSS PER SHARE - Schedule of Net Loss Per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Net Loss Per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2448427 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2449428 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.brighthealthgroup.com/role/INCOMETAXES</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails</Role>
      <ShortName>REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bhg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bhg-20210930.htm">bhg-20210930.htm</File>
    <File>bhg-20210930.xsd</File>
    <File>bhg-20210930_cal.xml</File>
    <File>bhg-20210930_def.xml</File>
    <File>bhg-20210930_lab.xml</File>
    <File>bhg-20210930_pre.xml</File>
    <File>exhibit311_111521.htm</File>
    <File>exhibit312_111521.htm</File>
    <File>exhibit321_111521.htm</File>
    <File>exhibit322_111521.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bhg-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 306,
   "dts": {
    "calculationLink": {
     "local": [
      "bhg-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bhg-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bhg-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bhg-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhg-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bhg-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 522,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 4,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 9
   },
   "keyCustom": 39,
   "keyStandard": 374,
   "memberCustom": 15,
   "memberStandard": 39,
   "nsprefix": "bhg",
   "nsuri": "http://www.brighthealthgroup.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.brighthealthgroup.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - BUSINESS COMBINATIONS",
     "role": "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS",
     "shortName": "BUSINESS COMBINATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111103 - Disclosure - INVESTMENTS",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTS",
     "shortName": "INVESTMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128106 - Disclosure - MEDICAL COSTS PAYABLE",
     "role": "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE",
     "shortName": "MEDICAL COSTS PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133107 - Disclosure - SHORT-TERM BORROWINGS",
     "role": "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS",
     "shortName": "SHORT-TERM BORROWINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - NET LOSS PER SHARE",
     "role": "http://www.brighthealthgroup.com/role/NETLOSSPERSHARE",
     "shortName": "NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145110 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION",
     "role": "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHICAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150112 - Disclosure - INCOME TAXES",
     "role": "http://www.brighthealthgroup.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Organization, Consolidation and Presentation of Financial Statements (Policies)",
     "role": "http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies",
     "shortName": "Organization, Consolidation and Presentation of Financial Statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Tables)",
     "role": "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - BUSINESS COMBINATIONS (Tables)",
     "role": "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables",
     "shortName": "BUSINESS COMBINATIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - INVESTMENTS (Tables)",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTSTables",
     "shortName": "INVESTMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - MEDICAL COSTS PAYABLE (Tables)",
     "role": "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables",
     "shortName": "MEDICAL COSTS PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342308 - Disclosure - NET LOSS PER SHARE (Tables)",
     "role": "http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables",
     "shortName": "NET LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347309 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)",
     "role": "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables",
     "shortName": "SEGMENT AND GEOGRAPHICAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353310 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "role": "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia8f1c51b74e14129bd0f91602963e036_I20210628",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia8f1c51b74e14129bd0f91602963e036_I20210628",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details)",
     "role": "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION - Schedule of Operating Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
     "shortName": "BUSINESS COMBINATIONS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ic898e99881d641128dfcfc367e765db9_I20210701",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details)",
     "role": "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
     "shortName": "BUSINESS COMBINATIONS - Schedule of Business Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ic898e99881d641128dfcfc367e765db9_I20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i2085512a64a1494c94ac42e04f4fd266_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details)",
     "role": "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails",
     "shortName": "BUSINESS COMBINATIONS - Schedule of Pro Forma Revenue and Net Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ie4d081fc23d14e75a64545999d205679_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - INVESTMENTS - Schedule of Investment Securities (Details)",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
     "shortName": "INVESTMENTS - Schedule of Investment Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bhg:CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details)",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails",
     "shortName": "INVESTMENTS - Schedule of Investments in Continuous Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unitRef": "investment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - INVESTMENTS - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
     "shortName": "INVESTMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "bhg:DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "investment",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details)",
     "role": "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails",
     "shortName": "INVESTMENTS - Schedule Of Available-for-sale Securities Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details)",
     "role": "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement for Assets on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "idcf21177884c41bc92c0b8c908d78a52_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details)",
     "role": "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement of Financial Instruments Not Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "bhg:DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i0ec66f7f13b74426818220faa08b44bb_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details)",
     "role": "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Change in Fair Value of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia0d8836b93dd4f33b7d7aadeba06f167_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia5706b49442c42cc92ff686adc9c2f6a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia5706b49442c42cc92ff686adc9c2f6a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details)",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Definite-lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-lived Assets Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i144475c6674948ebafa8c944ee1cbaf4_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details)",
     "role": "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Asset Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details)",
     "role": "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails",
     "shortName": "MEDICAL COSTS PAYABLE - Change in Medical Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - MEDICAL COSTS PAYABLE - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails",
     "shortName": "MEDICAL COSTS PAYABLE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details)",
     "role": "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails",
     "shortName": "MEDICAL COSTS PAYABLE - Components of Medical Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfShortTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - SHORT-TERM BORROWINGS (Details)",
     "role": "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails",
     "shortName": "SHORT-TERM BORROWINGS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i239b6a8206b34281a2d7bdb5f1c2ecb9_I20210301",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i28f7521b4a234009aa828e733e8f9a3c_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Schedule of Stock Option Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i4a55b31ca8db41dbbc3e1f00d13d9254_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ic04162a13ce44bbcbac57b063ee86f28_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)",
     "role": "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Schedule of RSU and PSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ic04162a13ce44bbcbac57b063ee86f28_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - NET LOSS PER SHARE - Schedule of Net Loss Per share (Details)",
     "role": "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Net Loss Per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details)",
     "role": "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded From Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448427 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL)",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449428 - Disclosure - SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details)",
     "role": "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails",
     "shortName": "SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i1218a13a52bf45438ed1cd1d3a1f0cd8_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.brighthealthgroup.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i29660353a02b48e987417294a4c7d8ee_I20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)",
     "role": "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i29660353a02b48e987417294a4c7d8ee_I20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i3747e34d1b8945a2b35ae65a0c95b283_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details)",
     "role": "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST - Schedule of Redeemable Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "ia9e6f4ea16de4bcabb82df7811b8def5_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i6c91a02c94204c438991d1c1f55dd5d7_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT)",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "id4aa6030d8ef4580b4eb924a05e135f7_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION",
     "role": "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bhg-20210930.htm",
      "contextRef": "i317212dc5c6a4127ba4ef151563b562f_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 56,
   "tag": {
    "bhg_BrightHealthCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bright HealthCare",
        "label": "Bright HealthCare [Member]",
        "terseLabel": "Bright HealthCare"
       }
      }
     },
     "localname": "BrightHealthCareMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_BusinessCombinationEscrowAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Escrow Adjustment",
        "label": "Business Combination, Escrow Adjustment",
        "negatedTerseLabel": "Escrow adjustment"
       }
      }
     },
     "localname": "BusinessCombinationEscrowAdjustment",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable",
        "terseLabel": "Measurement Period Adjustments, Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivable",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "totalLabel": "Measurement Period Adjustments, Total assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "totalLabel": "Measurement Period Adjustments, Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liability For Claims And Claims Adjustment Expense",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liability For Claims And Claims Adjustment Expense",
        "terseLabel": "Measurement Period Adjustments, Medical costs payable"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identified Assets Acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identified Assets Acquired",
        "totalLabel": "Measurement Period Adjustments, Net identified assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiedAssetsAcquired",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Liabilities",
        "terseLabel": "Measurement Period Adjustments, Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentLiabilities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "terseLabel": "Measurement Period Adjustments, Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Assets",
        "terseLabel": "Measurement Period Adjustments, Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentAssets",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid And Other Currents Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid And Other Currents Assets",
        "terseLabel": "Measurement Period Adjustments, Prepaid and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidAndOtherCurrentsAssets",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Short-Term investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Short-Term investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsShortTermInvestments",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Liability For Claims And Claims Adjustment Expense",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Liability For Claims And Claims Adjustment Expense",
        "terseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Unearned Premiums",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Unearned Premiums",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedPremiums",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_BusinessCombinationTangibleNetEquityAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Tangible Net Equity Adjustment",
        "label": "Business Combination, Tangible Net Equity Adjustment",
        "terseLabel": "Tangible net equity adjustment"
       }
      }
     },
     "localname": "BusinessCombinationTangibleNetEquityAdjustment",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities",
        "label": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities",
        "terseLabel": "Cash equivalents, Carrying Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecurities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Cash equivalents, Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Cash equivalents, Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Amortized Cost",
        "label": "Cash, Cash Equivalents, Available-For-Sale And Held-To-Maturity Securities, Amortized Cost",
        "terseLabel": "Cash equivalents, Amortized Cost"
       }
      }
     },
     "localname": "CashCashEquivalentsAvailableForSaleAndHeldToMaturitySecuritiesAmortizedCost",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_CentralHealthPlanOfCaliforniaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Central Health Plan Of California, Inc.",
        "label": "Central Health Plan Of California, Inc. [Member]",
        "terseLabel": "CHP"
       }
      }
     },
     "localname": "CentralHealthPlanOfCaliforniaIncMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_CentrumMedicalHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Centrum Medical Holdings, LLC",
        "label": "Centrum Medical Holdings, LLC [Member]",
        "terseLabel": "Centrum"
       }
      }
     },
     "localname": "CentrumMedicalHoldingsLLCMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails",
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Risk Adjustment Estimate, Updated Risk Score Data",
        "label": "Change In Risk Adjustment Estimate, Updated Risk Score Data [Member]",
        "terseLabel": "Updated Risk Score Data"
       }
      }
     },
     "localname": "ChangeInRiskAdjustmentEstimateUpdatedRiskScoreDataMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Liability",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ControllingInterestHolderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Controlling Interest Holder",
        "label": "Controlling Interest Holder [Member]",
        "terseLabel": "Controlling Interest Holder"
       }
      }
     },
     "localname": "ControllingInterestHolderMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Ratio After Qualified IPO",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Ratio After Qualified IPO",
        "terseLabel": "Debt to capitalization ratio after qualified IPO"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationRatioAfterQualifiedIPO",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bhg_DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Ratio Before Qualified IPO",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Ratio Before Qualified IPO",
        "terseLabel": "Debt to capitalization ration before qualified IPO"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationRatioBeforeQualifiedIPO",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bhg_DebtInstrumentCovenantTotalDebtToCapitalizationRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Total Debt To Capitalization Ratio",
        "label": "Debt Instrument, Covenant, Total Debt To Capitalization Ratio",
        "terseLabel": "Debt to capitalization ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTotalDebtToCapitalizationRatio",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held-To-Maturity, Number Of Investments",
        "label": "Debt Securities, Available-For-Sale And Held-To-Maturity, Number Of Investments",
        "terseLabel": "Number of investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityNumberOfInvestments",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bhg_DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Held-To-Maturity, Unrealized Loss Position, Number Of Positions",
        "label": "Debt Securities, Available-For-Sale And Held-To-Maturity, Unrealized Loss Position, Number Of Positions",
        "terseLabel": "Number of securities in unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Held To Maturity, And Cash And Cash Equivalents, Fair Value",
        "label": "Debt Securities, Held To Maturity, And Cash And Cash Equivalents, Fair Value",
        "totalLabel": "Total held to maturity"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_EquitySecuritiesFVNISharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Shares Purchased",
        "label": "Equity Securities, FV-NI, Shares Purchased",
        "terseLabel": "Equity securities purchased (in shares)"
       }
      }
     },
     "localname": "EquitySecuritiesFVNISharesPurchased",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bhg_IncreaseDecreaseInRiskAdjustmentPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Risk Adjustment Payable",
        "label": "Increase (Decrease) In Risk Adjustment Payable",
        "terseLabel": "Risk adjustment payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInRiskAdjustmentPayable",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_InvestmentIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest income and realized gains and losses on debt securities, as well as unrealized gains and losses on equity securities.",
        "label": "Investment Income (Loss)",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeLoss",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Adjustment Expense Liability",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Adjustment Expense Liability",
        "terseLabel": "Claims adjustment expense liability"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsAdjustmentExpenseLiability",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid claims And Claims Adjustment Expense, Risk Sharing Amounts Payable",
        "label": "Liability For Unpaid claims And Claims Adjustment Expense, Risk Sharing Amounts Payable",
        "terseLabel": "Provider incentive payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRiskSharingAmountsPayable",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Required IPO Net Proceeds To Extend Maturity Date",
        "label": "Line Of Credit Facility, Covenant, Required IPO Net Proceeds To Extend Maturity Date",
        "terseLabel": "IPO net proceeds requirement"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantRequiredIPONetProceedsToExtendMaturityDate",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_NeueHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NeueHealth",
        "label": "NeueHealth [Member]",
        "terseLabel": "NeueHealth"
       }
      }
     },
     "localname": "NeueHealthMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_NumberOfHealthCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Health Centers",
        "label": "Number Of Health Centers",
        "terseLabel": "Number of health centers"
       }
      }
     },
     "localname": "NumberOfHealthCenters",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bhg_PremierMedicalAssociatesOfFloridaLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premier Medical Associates of Florida, LLC",
        "label": "Premier Medical Associates of Florida, LLC [Member]",
        "terseLabel": "PMA"
       }
      }
     },
     "localname": "PremierMedicalAssociatesOfFloridaLLCMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ProviderNetworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Network",
        "label": "Provider Network [Member]",
        "terseLabel": "Provider Network"
       }
      }
     },
     "localname": "ProviderNetworkMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ReacquiredContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reacquired Contracts",
        "label": "Reacquired Contracts [Member]",
        "terseLabel": "Reacquired contract"
       }
      }
     },
     "localname": "ReacquiredContractsMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_RiskAdjustmentPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Adjustment Payable, Current",
        "label": "Risk Adjustment Payable, Current",
        "terseLabel": "Risk adjustment payable"
       }
      }
     },
     "localname": "RiskAdjustmentPayableCurrent",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bhg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Tranches",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Tranches",
        "terseLabel": "Number of vesting tranches"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bhg_ShortTermAndLongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term And Long-Term Investments",
        "label": "Short-Term And Long-Term Investments [Member]",
        "terseLabel": "Short-Term And Long-Term Investments"
       }
      }
     },
     "localname": "ShortTermAndLongTermInvestmentsMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_StockReturnedDuringPeriodSharesEscrowSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Returned During Period, Shares, Escrow Settlement",
        "label": "Stock Returned During Period, Shares, Escrow Settlement",
        "terseLabel": "Return of common stock from escrow settlement (in shares)"
       }
      }
     },
     "localname": "StockReturnedDuringPeriodSharesEscrowSettlement",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "bhg_StockReturnedDuringPeriodValueEscrowSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Returned During Period, Value, Escrow Settlement",
        "label": "Stock Returned During Period, Value, Escrow Settlement",
        "negatedTerseLabel": "Return of common stock from escrow settlement"
       }
      }
     },
     "localname": "StockReturnedDuringPeriodValueEscrowSettlement",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_THNMAndZipnosisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "THNM And Zipnosis",
        "label": "THNM And Zipnosis [Member]",
        "terseLabel": "THNM And Zipnosis"
       }
      }
     },
     "localname": "THNMAndZipnosisMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_TemporaryEquitySharesConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Shares, Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesConversionOfConvertibleSecurities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "bhg_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of preferred stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "bhg_TemporaryEquityValueConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Value Conversion Of Convertible Securities",
        "label": "Temporary Equity, Value Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "TemporaryEquityValueConversionOfConvertibleSecurities",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bhg_TrueHealthNewMexicoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health New Mexico",
        "label": "True Health New Mexico [Member]",
        "terseLabel": "THNM"
       }
      }
     },
     "localname": "TrueHealthNewMexicoMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_UniversalCareIncBrandNewDayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Universal Care, Inc. (Brand New Day)",
        "label": "Universal Care, Inc. (Brand New Day) [Member]",
        "terseLabel": "BND"
       }
      }
     },
     "localname": "UniversalCareIncBrandNewDayMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bhg_ZipnosisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zipnosis",
        "label": "Zipnosis [Member]",
        "terseLabel": "Zipnosis"
       }
      }
     },
     "localname": "ZipnosisMember",
     "nsuri": "http://www.brighthealthgroup.com/20210930",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r116",
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r297",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r116",
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r297",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r302",
      "r316",
      "r338",
      "r340",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r500",
      "r558",
      "r559",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r302",
      "r316",
      "r338",
      "r340",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r500",
      "r558",
      "r559",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r302",
      "r316",
      "r328",
      "r338",
      "r340",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r500",
      "r558",
      "r559",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r302",
      "r316",
      "r328",
      "r338",
      "r340",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r500",
      "r558",
      "r559",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r24",
      "r201",
      "r202"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $5,701 and $2,602, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r54",
      "r56",
      "r57",
      "r535",
      "r564",
      "r565"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r53",
      "r57",
      "r66",
      "r67",
      "r68",
      "r118",
      "r119",
      "r120",
      "r430",
      "r560",
      "r561",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-Average Useful Life (in years)",
        "verboseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r374",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r371",
      "r372",
      "r373",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r341",
      "r343",
      "r377",
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r343",
      "r368",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r31",
      "r203",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r102",
      "r266",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r112",
      "r178",
      "r185",
      "r192",
      "r239",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r424",
      "r432",
      "r455",
      "r467",
      "r469",
      "r507",
      "r533"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r50",
      "r112",
      "r239",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r424",
      "r432",
      "r455",
      "r467",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r112",
      "r239",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r424",
      "r432",
      "r455",
      "r467"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r207",
      "r247"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through 10 years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r211",
      "r215",
      "r527"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through 10 years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r211",
      "r214",
      "r526"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after 10 years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r211",
      "r216",
      "r528"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after 10 years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r211",
      "r213",
      "r525"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r205",
      "r208",
      "r247",
      "r511"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available for sale",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleOfAvailableforsaleSecuritiesMaturitiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r344",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r337",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r337",
      "r339",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Date of Acquisition [Abstract]",
        "terseLabel": "Business Acquisition, Date of Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Voting interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]",
        "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]",
        "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net Loss",
        "verboseLabel": "Pro forma, net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue",
        "verboseLabel": "Pro forma, revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofProFormaRevenueandNetLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r413",
      "r414",
      "r416"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Equity interest issued"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r412",
      "r415",
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "totalLabel": "Measurement Period Adjustments, Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Measurement Period Adjustments, Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "bhg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Measurement Period Adjustments, Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets": {
     "auth_ref": [
      "r405",
      "r406",
      "r456"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial assets (as defined) recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net identified assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "terseLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r3",
      "r117",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r34",
      "r104"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r97",
      "r104",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents\u2009\u2013\u2009end of period",
        "periodStartLabel": "Cash and cash equivalents\u2009\u2013\u2009beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r457"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r126",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r126",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r110",
      "r112",
      "r134",
      "r135",
      "r140",
      "r143",
      "r145",
      "r154",
      "r155",
      "r156",
      "r239",
      "r287",
      "r292",
      "r293",
      "r294",
      "r300",
      "r301",
      "r314",
      "r315",
      "r317",
      "r318",
      "r455",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r329",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.",
        "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r285",
      "r512",
      "r539"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r286",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r118",
      "r119",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 3,000,000,000 and 658,993,725 shares authorized in 2021 and 2020, respectively; 628,133,782 and 137,662,698 shares issued and outstanding in 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r77",
      "r519",
      "r545"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Bright Health Group, Inc. common shareholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r76",
      "r422",
      "r423",
      "r435",
      "r518",
      "r544"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r75",
      "r421",
      "r435",
      "r517",
      "r543"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r329",
      "r336",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate obligations"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r212",
      "r220"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "totalLabel": "Amortized Cost, Total investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain": {
     "auth_ref": [
      "r209",
      "r224"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, Cumulative Unrecognized Gain",
        "totalLabel": "Gross Unrealized Gains, Total investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss": {
     "auth_ref": [
      "r210",
      "r225"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative unrecognized loss on investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, Cumulative Unrecognized Loss",
        "negatedTotalLabel": "Gross Unrealized Losses, Total investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue": {
     "auth_ref": [
      "r208",
      "r223"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value",
        "totalLabel": "Carrying Value, Total investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r231",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Available-for-sale securities, 12 months or greater, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r231",
      "r252"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Available-for-sale securities, 12 months or greater, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r231",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Available-for-sale securities, less than 12 months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r231",
      "r252"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Available-for-sale securities, less than 12 months, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r229",
      "r249",
      "r255"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Available-for-sale securities, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r230",
      "r250"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Available-for-sale securities, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r228",
      "r251",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Investment With Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r205",
      "r220",
      "r221",
      "r511"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Realized Gain (Loss)",
        "terseLabel": "Realized gains on fixed maturity securities"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r113",
      "r384",
      "r389",
      "r390",
      "r391"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r49",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r102",
      "r173"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r78",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r131",
      "r134",
      "r143",
      "r144",
      "r145",
      "r149",
      "r150",
      "r441",
      "r442",
      "r520",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)",
        "verboseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r78",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r134",
      "r143",
      "r144",
      "r145",
      "r149",
      "r150",
      "r441",
      "r442",
      "r520",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)",
        "verboseLabel": "Diluted loss per share attributable to Bright Health Groups, Inc. common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation expense, weighted average recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense, other than options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options to purchase common stock",
        "verboseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r66",
      "r67",
      "r68",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r153",
      "r240",
      "r320",
      "r322",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r440",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r560",
      "r561",
      "r562",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity security market value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Unrealized gain on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r238",
      "r547"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedLabel": "Unrealized gain on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r444",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r450",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r443",
      "r444",
      "r446",
      "r447",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r303",
      "r329",
      "r330",
      "r335",
      "r336",
      "r444",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r329",
      "r330",
      "r335",
      "r336",
      "r444",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r444",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r448",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r448",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r450",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r222",
      "r226",
      "r235",
      "r236",
      "r237",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r251",
      "r253",
      "r254",
      "r255",
      "r305",
      "r319",
      "r439",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2021 (October-December)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r267",
      "r270",
      "r273",
      "r276",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r273",
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r267",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r257",
      "r258",
      "r469",
      "r506"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Gross Carrying Amount, Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r259",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Gross Carrying Amount, Ending balance",
        "periodStartLabel": "Gross Carrying Amount, Beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r259",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "periodEndLabel": "Cumulative Impairment, Ending balance",
        "periodStartLabel": "Cumulative Impairment, Beginning balance"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r261",
      "r397"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Measurement Period Adjustments, Goodwill",
        "verboseLabel": "Goodwill, Purchase adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r218",
      "r224"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r219",
      "r225"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r217",
      "r223",
      "r511"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "bhg_DebtSecuritiesHeldToMaturityAndCashAndCashEquivalentsFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "verboseLabel": "Held to maturity"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesTextBlock": {
     "auth_ref": [
      "r222",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities, Held-to-maturity"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r504",
      "r514",
      "r523",
      "r548"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r381",
      "r382",
      "r383",
      "r387",
      "r392",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r129",
      "r130",
      "r176",
      "r380",
      "r388",
      "r393",
      "r549"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve",
        "terseLabel": "Medical cost payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquired assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Preferred Stock"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInUnearnedPremiums": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.",
        "label": "Increase (Decrease) in Unearned Premiums",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnearnedPremiums",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.",
        "label": "Insurance Disclosure [Text Block]",
        "terseLabel": "MEDICAL COSTS PAYABLE"
       }
      }
     },
     "localname": "InsuranceDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r265",
      "r271"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r172",
      "r465",
      "r466",
      "r522"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseShortTermBorrowings": {
     "auth_ref": [
      "r521",
      "r581",
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate interest expense incurred on short-term borrowings including commercial paper and Federal funds purchased and securities sold under agreements to repurchase.",
        "label": "Interest Expense, Short-term Borrowings",
        "terseLabel": "Interest and other costs"
       }
      }
     },
     "localname": "InterestExpenseShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r94",
      "r98",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r233",
      "r505",
      "r529",
      "r572",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Compensation and fringe benefits"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r112",
      "r186",
      "r239",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r425",
      "r432",
      "r433",
      "r455",
      "r467",
      "r468"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r112",
      "r239",
      "r455",
      "r469",
      "r508",
      "r537"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r112",
      "r239",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r425",
      "r432",
      "r433",
      "r455",
      "r467",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r552",
      "r555"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Medical costs payable",
        "totalLabel": "Total medical costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails",
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquired claims liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Paid related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "terseLabel": "Incurred but not reported"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Incurred related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)",
        "terseLabel": "Medical costs payable, increase (decrease) to prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount",
        "terseLabel": "Claims unpaid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEComponentsofMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r38",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Measurement adjustment"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r48",
      "r81",
      "r420",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r206",
      "r329",
      "r330",
      "r336",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage Backed Securities [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r100",
      "r103"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r60",
      "r63",
      "r68",
      "r73",
      "r103",
      "r112",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r129",
      "r130",
      "r141",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r239",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r442",
      "r455",
      "r515",
      "r541"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss attributable to Bright Health Group, Inc. common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r63",
      "r68",
      "r129",
      "r130",
      "r427",
      "r434"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Earnings (Loss) attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r131",
      "r132",
      "r142",
      "r145",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "verboseLabel": "Net loss attributable to Bright Health Group, Inc. common shareholders, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r133",
      "r136",
      "r137",
      "r138",
      "r139",
      "r142",
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net loss attributable to Bright Health Group, Inc. common shareholders, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r323",
      "r407",
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "verboseLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "Other assets:"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r51",
      "r52",
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Changes in unrealized (loss) gain on available-for-sale securities in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r66",
      "r67",
      "r69",
      "r74",
      "r320",
      "r458",
      "r463",
      "r464",
      "r516",
      "r542"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r54",
      "r58",
      "r59",
      "r232"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "terseLabel": "Less: reclassification adjustments for investment gains, net of tax of $0 and $0, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r55",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Reclassification adjustments for investment gains, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r51",
      "r54"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "verboseLabel": "Unrealized investment holding (losses) gains arising during the year, net of tax of $0 and $0, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r52",
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized investment holding (losses) gains arising during the year, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "verboseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r228",
      "r248",
      "r329",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r41",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r99",
      "r554"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments for debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments for IPO offering costs",
        "terseLabel": "Underwriting discounts and commissions"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r86",
      "r417"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire business, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "auth_ref": [
      "r95",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "terseLabel": "Payments to acquire equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSU's"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Medical costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r513",
      "r540",
      "r551",
      "r567"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "negatedTerseLabel": "Premium revenue",
        "terseLabel": "Premium revenue"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r32",
      "r33"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from IPO"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stock that is classified as callable.",
        "label": "Proceeds from Issuance of Redeemable Preferred Stock",
        "terseLabel": "Proceeds from issuance of preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemablePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Proceeds from sales, paydown, and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r570",
      "r571"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r60",
      "r63",
      "r68",
      "r96",
      "r112",
      "r121",
      "r129",
      "r130",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r239",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r421",
      "r426",
      "r428",
      "r434",
      "r435",
      "r442",
      "r455",
      "r523"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r278",
      "r469",
      "r530",
      "r538"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, equipment and capitalized software, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock (as converted to common stock)"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/REDEEMABLENONCONTROLLINGINTERESTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Repayments of short-term borrowings",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSU's"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r322",
      "r374",
      "r469",
      "r536",
      "r563",
      "r565"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r240",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r440",
      "r560",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r183",
      "r189",
      "r190",
      "r196",
      "r197",
      "r199",
      "r325",
      "r326",
      "r501"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Service revenue",
        "verboseLabel": "Service revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue, Product and Service [Extensible Enumeration]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r71",
      "r112",
      "r169",
      "r170",
      "r183",
      "r189",
      "r190",
      "r196",
      "r197",
      "r199",
      "r239",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r300",
      "r301",
      "r455",
      "r523"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Proceeds from sale of stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedFromNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSScheduleofBusinessAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r267",
      "r272",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r267",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Held-to-maturity Securities [Line Items]",
        "terseLabel": "Debt Securities, Held-to-maturity, Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": {
     "auth_ref": [
      "r222",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity [Table]",
        "terseLabel": "Debt Securities, Held-to-maturity [Table]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.",
        "label": "Schedule of Other Operating Cost and Expense, by Component [Table Text Block]",
        "terseLabel": "Schedule of Operating Costs by Functional Classification"
       }
      }
     },
     "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Reportable Segment Financial Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r344",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Restricted Stock Unit, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r349",
      "r358",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement, Option, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r199",
      "r280",
      "r281",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r167",
      "r168",
      "r178",
      "r182",
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND GEOGRAPHICAL INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Marketing and selling expense"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Operating costs",
        "totalLabel": "Operating costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONScheduleofOperatingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D Preferred Stock"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series E preferred stock or outstanding series E preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series E Preferred Stock [Member]",
        "terseLabel": "Series E Preferred Stock"
       }
      }
     },
     "localname": "SeriesEPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of stock options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r351",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r342",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofRSUandPSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche one"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Tranche two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.",
        "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Performance Shares, Activity"
       }
      }
     },
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Option grants expiration"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r363",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Life (In Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "Short-term Debt [Text Block]",
        "terseLabel": "SHORT-TERM BORROWINGS"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHORTTERMBORROWINGSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r19",
      "r509",
      "r510",
      "r532"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r199",
      "r263",
      "r279",
      "r280",
      "r281",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.brighthealthgroup.com/role/SEGMENTANDGEOGRAPHICALINFORMATIONScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r110",
      "r112",
      "r134",
      "r135",
      "r140",
      "r143",
      "r145",
      "r154",
      "r155",
      "r156",
      "r239",
      "r287",
      "r292",
      "r293",
      "r294",
      "r300",
      "r301",
      "r314",
      "r315",
      "r317",
      "r318",
      "r320",
      "r455",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r47",
      "r66",
      "r67",
      "r68",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r153",
      "r240",
      "r320",
      "r322",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r440",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r560",
      "r561",
      "r562",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Shareholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r153",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Redeemable convertible preferred stock issued for acquisitions"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r46",
      "r304",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Common stock issued, conversion of convertible securities (in shares)",
        "verboseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r320",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance and sale of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r320",
      "r322",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r47",
      "r320",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r320",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance and sale of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r112",
      "r204",
      "r239",
      "r455",
      "r469"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Stock split, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/MEDICALCOSTSPAYABLEChangeinMedicalCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r287",
      "r292",
      "r293",
      "r294",
      "r300",
      "r301"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable preferred stock, $0.0001 par value; 100,000,000 and 166,307,087 shares authorized in 2021 and 2020, respectively; \u2014 and 164,244,893 shares issued and outstanding in 2021 and 2020, respectively"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r10",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value (in dollars per share)",
        "verboseLabel": "Redeemable preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://www.brighthealthgroup.com/role/ORGANIZATIONANDBASISOFPRESENTATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Redeemable preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Redeemable preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofDefinitelivedIntangibleAssetsDetails",
      "http://www.brighthealthgroup.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFinitelivedAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r222",
      "r226",
      "r235",
      "r236",
      "r237",
      "r305",
      "r319",
      "r439",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSNarrativeDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government and agency obligations"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementofFinancialInstrumentsNotMeasuredonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r329",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "State and municipal obligations"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueMeasurementforAssetsonaRecurringBasisDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentSecuritiesDetails",
      "http://www.brighthealthgroup.com/role/INVESTMENTSScheduleofInvestmentsinContinuousLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnearnedPremiums": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.",
        "label": "Unearned Premiums",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "UnearnedPremiums",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/OrganizationConsolidationandPresentationofFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r133",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r131",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.brighthealthgroup.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS",
      "http://www.brighthealthgroup.com/role/NETLOSSPERSHAREScheduleofNetLossPershareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e777-108305"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498357-110258"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "http://asc.fasb.org/topic&trid=2134543"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r576": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r577": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r578": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r579": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r580": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r581": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r582": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r583": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r584": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r585": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r586": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r587": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r588": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r589": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3444-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001671284-21-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001671284-21-000023-xbrl.zip
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MROG(-,F0WDXH;9)70>F@G32DV:29Y%[DXEJ@RO[H5J"Q4GL;99(@I1)&0A
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MJ!)S/$<AR]),J\&4/)7W/@FFC?7K,BZ^]T>[M=%/"X)R*</@2AC')WLQD9%
MYH)P*)R#2?J+@JYU&9=9+)1+&9YQ+I#TY-R3(:?^&)R)7.H0%4.3E%F;&0T+
M[Y6+G\  (1)L2;)20CE%=#K)F&4&0(I>Q70P@'&QNA[[BPC^.<0>7?U\_13Y
M\4'L4$N-=O*3[F#827#;E4I8DXOY#!3(S)%ER80GI$SF(6G&T7J;I?.1G>]
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MP>K4ZQW0LA6F+TJ7T=J AG'2K<HQS[00Q.;H07JHZ;LJC%DIJ;PJ]+6*E4K
M,@G)%),(/+@DO4#47H"3-7U7A;ZKPIA@DB6+YX7P2CFMO2G+MKUB(5@0J?;7
M*[+"?Z6D[JJ0E^(CQ5&4U7[DJAT9.B_+^$#*GCFNZM32721O55:JB\#*V&?@
M-E.@3X1ET2DT0MJ(CLO:5]]%\E9%: :GDD/N@@E:>1E=%-G*#&B5+CNAU^1=
M#?*N"E^\(T-GF!76&270A!2$YH%I-#JX7*T2?BNJJ^:X?ZR28$A1:0ZHF .P
MSGN>O1>Y5%*IUI[>*RHDYKB/BL68&2 )"JD0?("4R"[G9+34R=J[@5952NHI
M)95$BE9<""HG\J)9.&%$  9.^-H2SGT&W*HL$)YCF;U GC-I3OT[JJAS<)KI
MP)B-WE/W]W>#0W>Q"L<<.83D)YS)0I$=(M'N@C<:R#KQ1%BCOAL<NHLE+^;'
MH2!)&8;LM+%*B<P=3U@L$D1R9"BKM9E&!7Q9I3>_8M))FTF0&@HO6 ID;,CH
M:"YL#A!KGU5SY4-$$YP S61,3*F,VC, 8Z7BS/#D>14V2JN'O!?$%>T=%\*J
MF,F@1"N]0>8@:+(L-C)=K2)Y*YI9FF,>$&V<U(&Q/"L*?<LV1BIIYV5*.H9J
MY8U7-+,TQ]6GTI6RVQA2L"I;"W1QPS+]GY@SOEHES5;4$LX/K605]27/O(E&
M 0_!"QFT4M%E+MU=0>LN9I;F.2BM(E=.2&O+OK3<)6%(@#GPFC/.[PB'[F)F
M:8X+OI(L6QSKK#$KL"QD29:(S)+Q(0E_1Q397<PLS=&7*<NRB:5855*EE* T
MB;'L@V 2I:_6-@X5\&55GL+*O3)"LQ"#"RI+TJO<EPW6(4!$$ZJU8T,%?%:5
MN:*CMVBSL,)8Q0""1.UY-))G3B%-%7Q3G5E:$%<81F.RI> IE.$-0VI8")8!
M&-D9%:HU-?Y9!T*G2P_WN NCT12D<'3X\#&]<:=_.)$.].V$4_%P<7I%L *6
M'&F$4/)(Y ,(L60!$H:RFQBU;,&*^QJK[\:*^_EAQ;D7P8)BA%7(SC.NI L4
M9B;'DXI_;TZR^_1O<^73_*L(&@$S'&^2^3]/M)?_+JYS<>RB0=.E4R_GY&='
MOL=R&F&YM%);S92 X'64,@F2\1$\!8,3A-D,X=J$_A#"[.8(?V1O?P#A:(6"
MF*5EGCHO('5HNKR.C$/.7E=K8]C5 ?9V9O-JRTQ0GC1,I/^B%SD;9R!%'T4V
M%5C3/*EA5[[S^^FHT\?1Z/GT$I>P^GW8.3P:_X'0+?4_AE@1W9*BYLE**Z06
M*D@'6O*4"1_-6.)5T)@WP*:-%"1,D*D(*C)GX1T#!J129%0>.,$!RH>2C8)0
M(86R$EUG^8K$"L@V..$M"RJ6@CJ&@S,&T<CL/5LO1&^SPRT?2]#(K(>D,X+2
MB3MOM%$1@C2:6ENMOO98B4YY*UI#2&4]]T$#RXJ)%-"RR)GV-I#><!68$;HZ
M_FR.:TZHR_CL+(])*HJVG3,V&K0\I^RMP-5'Y4FGWQGCL\X;3-M]:H;#3NCB
MQFB$X]'O9RTX'@PO:?>+3.CI:#SHX7 7N],1L:/.256F5HLRD4WIJ @C!=1]
M5#*))*)P,9+=J\(><-6 ;(YC"\)()D0.VE-PC)'ZFZ5.11T+7=D";4U[V=X0
M$K:A5YE5"V"S0N]UPIS+GEX0N5&I=*NLN#%5*+>\PCC-<:YH,BPIP[137@&+
M/O HG="&96$"5&&EY+?@5)3%+D+\]VEGB*GDGH80;[ELZ?PZ58)H37 ^)LM5
MV:@4D+&0K!=:<(UJS3K5,L":X[S>J(-/ H1'IM!)!SD889DQW@1FJI"]_1X+
MN%E&GP<GF/8P'O4'W<'AV6Z)LJK2QYB6(>@04)5] C!!<-DID!FCCSRM6Q];
M+FQSS":*%"62(R.05- F!"%XR%B60DCT%<A7?!=LDV(U'Y]>D9Z6P 4/VGJ<
M[.:NR:\IPLQ$!^AEK,(RE6I -L]-TY.6-I>R^Q1]9>T0))><IQA,X)7*\*YR
MY+S\]*_E%*JEP(@\4GF!U$VME8RZ:O1H1%IWH&\SCEL^NF1CL\ZD0KG1RBGA
M/$K!"7.G03"GUQ7=A044RX<XZZC1:P%(<6$@V^RLLI*C1$MHKG\'7J">73[8
M7"EE=33&*J\<!LC@HE<*)UM+9[7N8"](4BT?:"%],. $,T&2V>8@D@TIZ,RC
MP!AF]3TD6UG)_/QH,!SOX;!7*FSNG9W@522?=?JXDQ^3=9[?=/KIU9Y G,PG
MNWJ_77PSZ+[I] ^OGG3;$92\Q)P?*@W$@9PVTTQ+E8D;%GWTX'T065HES_N]
MG/7[FA<KQXN/;8J\N4VY?.H/V!3D(4;G$,LNV,5YA&R=L!BE2M8H=TXBQT1S
M]D--HM4FD6LR<4,273[U1Z8+.<_*Q$H6N5!T86=4ID@"A3)60)B12,TLD5E=
M!5*3:,H,=7-+9.:C;EQVQJ'A%*Z@,L4**6W 9AF"YYC%QS)VA4FT\1:&Z5/R
M;/5.NH,SQ.?C07R]<U)22//BT$L<E7GT5^_W_ B&^#N,2K#;.Z&O3+)6TX<;
M0I^:9J>_6E-1YT6E9'EB*F8C0)D0'9),8L8E*65RYI,,QPI3Z3N!W7L[F!>U
MYD;F2E(IB. P926U#DJ ]"H:'8.QH", \^=4LA4(KE<)2+OX+$D,+"JC@BZ%
MMK@%BR)P$U0LE2^,6<*"N6]MM^4L0P.E!#4:6.L5:A=4L%P!:)MB#K9*V>)5
MZ@"+SQY)8CL(PYW*6HE81#KXJ)-D7K 8JS1Z]QD@=\E7#CMQC&D"Y8M^9SS:
M??YB'<&,3'$2-UQ&+'428H"H;2 A@U@*CKO5'SU?-H:W4R,A2,QE5H/*60DK
M'=I(SJ5L=^L%_;#Z\U!6");YS36)6B""=5I;H9317@H5D8+-*$*@.U5?Q"W-
M]"U>R DF4]F5@W'G% (#-):QG%$XZZ2NTLK1SX#Y)P[S8-BC0 XGD=ZZ#&:=
M$BLG&+Z9!K7C::QZ@4YONO/;9*#^_)3S<'9VP=D9L\_EBM>GM95W0-)&>&7)
M07*(G@69K231D[2HP,Z/R^/&[51Z2K%LGY4DJJ!<PB#*TA ;R#_FA!7VC(L%
M9(XSG94,P 0J TPEF7R4CO$(L:PJ94Q7WR<NP8PNWALJ8,9H$9/@95&(<=2I
MF!4LL2 ,:E\E;TA72)WNZ;CS!C]44]UZ%[NG"=.3X:!7LIVGXTFR<R=OP;!/
M'F)$,$_SH6?77^!CH900>Q"Z^'C0?U/J^-&/?PXQXW!X+I[6Q-M>S7XY1O%_
M+#/CF=+@P2)70F-.RKF@Y4?9KYHF2Z?)-R7[YJ:M<V2DIM%RQE2,%C1 %F5
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ME[/A-UWS^:#S[B&UR.!T&'$T_7B$D";/DSIO'OU&?YQ+5P9EKY1 ]L2IJ%T
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MD[OF\6:]:I/4C;M1S!L!J8^UM1P.S'F0;<5AP=FM<#9U9+P*V H2D=01(\[
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M[=4WKT@">XPB'[%$/!F.=.02!>:#%C02IMW*FM2D:2BKG:%6>TPMASE6,+4
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M'H1&5J6(O#!446V2#CQO- 87[X%:MRTQF2S2D5L.,ED.=ZV0R7V2R=2I<TJ
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M,U'-F>=: ;(_.DR#)@H^2(<HE9W/J=7M#VN5QVIS>SU,K@RRK@Q2JSPJ_U6
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MI6PR29A2L1SG":W&V5SAZC<MXC>=G(MD2\ZB#Z )4SH2Z1DC+GJ!?I-T@49
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MI4JE2J5*I>4</;H4E;,6K..EL:3-W@H%(NKD\36;%@.:TV) MYR %EJ-LS+
M&LM:*);U?N[X\?5?>[]^,$R"XT81:JPB4D-)&N.9< E(WL \,VYC4[DV5Y?G
M2BT<S:IB7,&V4NEV8&M+$B=/K#11X"*XS%G.(G!OM51"5;!=2;!]/P^V DEF
MO<K$L7)VX*4G+EM#. O>)B&L+.76JP2VSZE;X/S$W^-!RFDP2&67G]W0W\6J
MG98 3#? (W_X\5*%=9TXNGS,"K.RZX/7[ ,RL$X.C4(FLR326$Z<C88$JV3R
M3.I<$G"Y:'-7QXX^%3&_%^/C#IT4ZN2O^Q#SDSDQ#S1:R:,@S"5/I,M K&!
MM+34L(#.8(@;F]*HMI9WKJ=>83FOK4IKX[Y*I4JE2J5*I4JE2J5*I2=/I>>4
M;S4?X0I-_Y@[A+?6-NI>ST8JE6K^U5HPP6*1:,Z,%C+8")1+#=YQ9*'(M7,T
M&?#V!E&J&\V<KQ'FNX2>/LZZ;970DW&9:ZL22=HP(JEEQ#K%B0[6:.^RI<)N
M;%I[N9;FZ4##DY3=)P?@3Y)*BS304<Y8'Z)DU,@8A;?:>1D@6)DA.U@6O-;
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M(]5=;9HJOZNK^Q\V\E/E]V[R.XOYB! <>B(4?1) GR2B%8! [(@(&8SS65A
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MNQ27878/ 3.I_NI6#J=LLX(,^LS\*C$[Z<7BQ)X-AB.P<+KP*Z/H)]G$B=_
M\LI5%(O>P%?NH?S+>_&;'94W[@R&\/47=C@ "\HN"7FW[WN34$EI]D9UXB16
MDE ,XPE<EZD&_-)AIJ;;1:E@:E$MPYQ7A4>01B^M@?^)Q)VB3EJFM18Z.9]L
MTC\[IK^.2EQ R+IA1DY+V%S^W/G\Y?0@%XC$C'$D<="("T:0]CB?J$NJK-/2
MZK32,1VG20+"JH #X9%:C0W67C@+L$Q\O(!"S4K>UDIJ'0AS!+BN ,++*4,6
M=  BEBGNE93!BJSW+HN+N$H1 @Q,,FO,, "KW(_5\I<PDTUK.U^(TK^]!!O+
MB0_YK7P)$-.0CTY#?C7W</\S]YH#=.SV@8''XK>_ >5^K_@W7-K/7>^!E^>N
M]S%WO2^6.MZ77I[MXG;<>0_K9KORC&-JAPQCKWL,NP&8QQ4VR732IJ"^N%29
MQ?1*I5 =18QM_["; 3UKA6Y__N=H%,>CN=,L?]SK6M?MP7W@N>!ST$>A)C2#
M<H&[PWPRD8\YNE^!$5GXN^1+^=M3C\SB6/+R@P(YRH<C'K;Y]#NSQP*&E0]>
MOL9:"/+QS+EQP?,,H\_GMR'_RN%@$$Y!@D$?'G7]4?X8)BP,\H25)SYV/!YV
MW:128OGYCTK1'98"F+O(S(Y;IGVYX;>.NO%K=<$1L+C#H^+/\MBWJ-7BZTSM
M_K__TI2H/T:E@^EP6,YOR0P#K!<\ 3#! ;S, P/SW9TMW^-%_N9Q*<^C<COE
M2T.YDA,0]^$2\;1#T+F']98I-V2]TGDRX8G+'RI<;B\^@F<\C&41EORD]=/U
M#UM%R $->29*LR8O[VR@L Q',#;T?Q,0?:"P-?',P\K?.QD.OH*PC2H/VTFF
M!%DIG.7IC/TCVZ_7#.2L ()\"+O_9#"&$>99G<GFX!BVT=GV\M:[]%1JNM?J
M#<$%[)CI6=BS858",.P_3KMA?#0-+5FXJC[RQ_-+K /LF8ROOF1AU]=L^V$V
MO3DW.0O_'@VG@SFQAR 7PVB_()M@K,]L[]2>C;;^M?1((/_3>YO\X^<?_<H'
M3.G.'K *HPAY]Y:+_:R4]/PM&)-=F[$41\/,;O[KYT>?"G"ZA(GL6<[$J)^3
M_NS5ZJ7:'57<"5X.8;LCP:/7.M2Y!-Y:63%O7T=1/NC(.X-L0@,07<$U_IK!
M^YQU/.!#7>^,[;</_3KPX/?+$.'2X\>?'B>>.WYTUN"@ C<^)B[R19$HXH2W
M*L$_XLZ#B?[Q1S%,>O%-NN2H;/3GV<)?&WU\OO?\(%DNN#$)N00DGR>! ?I+
MG[<GFLNDU,7C<Q:8(B:I0"WG*1$7J* J")^X$E1>C$"Z'DP]&"O&HF;%:0!T
M]C3;&A6G"U6414U/%MERA*$>5S$U"]04L'K**<]3W"G'!+*V0%EFULPE[/J.
M#[[+.S[K D_M^FM,SV_E2 <3N&L8_7XW8SL/RY>/Y-EU52 (4NU?FK*W,C(3
MQMFS)Z/X;/KB#UCFDYX]>];ME[]67O1'?;.:\F6>>"XPLY3<ZN,Y!=K&%0VJ
MBQ/4OUQ_O%U^="[,M/I,RVVBK_X8;Y,K/_O1;0G9EO1ZM]V$9AEUY&%IYL5N
M:8;=I%CG$\T7>)IQ_[\6>[-BN/\E3L;W8 <<]N&9PF[(=FOJ9K%[7JJ)Z<';
M\W[X>ZXLGE?ND!?99=8?5]]\/Q/8M6EC]*N4I4X6^*O;WMO_UG[YGR_MO;_@
MM]X?MS]V8&S[9T!;OG7VWK'VZU??.WM?Z(5D@8^[WSJ?7YVVC]]]:W^$9WF]
M_VV?YECK7?QI[Q7IO/3Y=\F;O4^IO=@RA*4$S#11A#EVN1J"08;:@+0C(3!#
MI.)R:X>TM+IQL9NFM.^*S9?CB>V&BC<-2A>3K\2_)E1/ML;O ^+:/4%7O;9U
MJA-\ORSE57W68-DJ6+98%AAL;*4H5HAQPA"7N01@-!@%6&B!A5=@/V_M2'KQ
M%/G1E^U:<R3+!U;CLQ+)<ICH2?8+/=E&;)M'RZ8+_+9G^V4QPND:-UBV"I8M
M5JF21G!. ,&(T!CQI!URFBKD+&/!A<1YRKVE6T+<&,T:7K;21MX]?XC;\+ G
M V3SM:V^7-*RO2/;?UV?>S> M@J@G2T FK#<*\<(PM(!H%E+D6%1HT25E4+F
ML"8@9P33%E,WSDIO"-HO=)&Y 9HUM&P=T:Q<ULZ@[Q=-SP;!5D"PI>ZZ6 ;N
M,-'(N& 0AX5&V@J!DL+44D.M%W1K1[?,)6'*3X^2E7]W<Q  ;"5]\2AH#>I#
MWYR>W:!&4@-U]PEU#;:MCFV+KC.N+$W4$F2)RJ4T(T?..8Z(3)A9BJ.+!-@9
MD2W&;ZL5SCU4!7KBO*U=YSZ=V+/R&*SA;G=U(I#3MN[@-&#A@^G+L[\&PQ<]
MVST>P87UBY##@+(_;<UJHST.G)N[U<[:+]N\<WI A%+&)(%\4 EQHQBRR6,D
MO9+!< -O1T"[VRH:O,XT;IWV\RP4I<:SQK'V" \X%S^HU_-MM9P-:JV"6HN^
M,\FX5,8QY!//AP'$(>>Y0UQP@"L7G-5Z:X>)&P-6XS?[!;_9-"IC(;:U(6*/
M&[G*A6WP:@6\>K/H*5-8\&AT0A83B7C $FF;-*)6)X*!>'$'UJ26I"%8#X!7
M-\6IAF&MHP=L[N=O<.PF.+;H%0,)CPP'C$**P+MDX(!C5B/"I+8T"<"S7)6$
MM"23&T"]'H'+_Y8X6./W?R2HM_!. W.KA&;L/1_/8F>?'UAM:(@)(^](0)Q;
MDH\V+8I"*$J)S'\ T-&6OJ0:Z(TZ!JR+]_\73CVI6C,([,0Q2'ZU?\IR'4NE
M/!JN]V10#Q:Z0;N5T.[5(MIQYR/3F"#X1R.N3"YCJ"@*!$?#M9.<Y9PGS%I\
M(T+1UAK4II&7C4OM0>&K"8#])=S97<2=9&-PPI=UDSGBS$3D*"&(*B*CPLIZ
MGALS*=72;!-<8VN-.^]CB/&XK)4 JY WW'!0]BV;5;C?,$+UV[I!TH^K5[Y)
M?\-G.78?AE^W@N@L+>2TT/M?MCO\WURLI,&VE;"MO8AMQ&NG8])(:YD0Q\"I
MG# !81*-LP(D0:2M'2U:^!(+\O>&3=VKE^SRNI8/TD/S:98+:=J+KH,VN(Y]
M/>6UEWL7X7Z7ZXQ&5:RD*MXMF=]2**M31#CD4Q4A.3*)!Q0%M50XBXFJ&D6T
M*+WQL<IF]R=]J%+*BV7ASA>#FU4\OJ(J7%WX>!CA)J,<5P,CLE4UWED-X&FI
MN7S#^?W+>^4JNJ.)^QS].->I!#W7/XQ%%WX85C)+4&X'V:^ I2S-.YKXHUS:
M^&0P&J.RM%UQ.AA^*:MKVY-NF4@R"\ =M0H7<P%M&.A7V^WE1:U*+,^JUY7E
MN$^&@VG%Y=HC>Y9OF+^P-([S]:"K'IJ#22]/0)CX6);"FU9=+DLQ5XA6_>BY
MN?4@AA9^_8JIS6TQZPD)11H.CO,Z?>T.)J-I5;_)$)[F(TRKR_?)BW3II)65
MB*=+,%X:Q[3&=+DOT""A"<QG+V:R48YJ:5!G\ZKFN<QRKFR^D(FX4/AFX2G*
M\8&"&!23DZKFZ,4!7)S7Q3+:Q7$<'PT";(?#/"LACORPZW(=PM@;G%ZK!NOC
MW)EO)L-+"S9>/F7#JOS_M(CW9>482_I8MZ08#VV(I4ZN:V;;'[8 Y4PE01Q1
MTA.N,+<Z$*VXS WI!!'QTHXJ"W0 YL _"Y,A;-4 *'&>#<S:]W2!EL2_NU\O
MYG9_+*<FAN>YE/9A_#"*:=+[NYOBX]3HOU[U]/NN>//RP_?.RR^GG9>[K/WN
MP.!D4PP2)14\XE+FRNB@H7F =1*8A$1RKK9 9]$.SRNS8E+.).S9%%N%!XD'
MN!Q6XI1+S1YU3VH)^9%\R%Q=EZHHN7?<$N&8%2I&2[!3F$IS7?G((VR$X[:$
M@X-P,!:X  E *1&+N',6:4XM4DZYY!(A3C"@;^?% F4@^=&*!^VY9PY3$30W
M1!LF622,1>P(B?KR'DL-(MS]HHLW[PYT),9;H9&U,@<(&(XL#0K^C!'4-V4X
MZFL@PM<XJGHA6,"#&1,L[:O<G]O%\6F,_4M:-^1KIAJHUBX+,)/USX]$*UF?
M4B1!,YHX!3D-B5I!,'41"([Q#9C<OUSMO>+Y2 2,/MCT DDA&>+&!F2H,(AR
MRCB\H)2KK1V^+2[(5%Z+4<6"EXCGG(<4IS:S.S#8CTLNFQT$AQ4Y!0X44[YB
M.#BKN\AE2EB*V7C>+P5^HE\V^:@_SC?,7>@RE%4_FK]\N8K[HP K\*B^LNXY
M4GO;X 9_QZ^Q5[!%WGH,)'E2]4D9G6?W>:A7G$)<_I0V=P;YDNGV"9@B-ELX
M9?^9FFW;DO#GY)S\*+;*TYGU#NF!%9U_L;K%E*K7\WO%,)XP;=X[UU9GH:]Q
M9:GU!^/*MCJRH9QYF)+< J$+%B&@VJ#J\P:F5NSGI1R6C79ZN<M<OJ";<2_V
MEQH\E6*UV%<!IGC2&\\Z^$R-S57:-Q7U=\='PU@!ZC6NPD^CZ=,/>JO#.M5]
M.'+UNLJ[M-AL_2%[K1=O^L7SDV&W]X-NZ[D+T"7=N$='@#CS'MS+3UF^#2L
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M5#G+8\I]H"5S0M)T:5N)RZVJA<KZ;X>#O_+VV9TSJSWXR3][ _]E$R5^SQ^
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M+O(H0=,A)XU$7#*,G&,&11>3%4I:FMC6#I,M)6ZK25231?54,..Q4:4&,VZ
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MW1"')<M>E:O53JGJ>9XQ6(8PF.164:5CZ@9.X;4+)OKO!YF:IX/D:WRV-E4
MC?EX*XK!+Q(Y6&DE#1=(B'RV%KQ#FA&)&).:$^5$LB[[R3FYK=RMV]AW#^QM
M:E"W0=W'PY\;U%T3U)W3<<88EXQY9%ADB..<>N*P1=H$ \B;C$DY(MVTE+DQ
M'5\#V"UI_+_&6<;@_T/WZT[Y4'DK=/N34B)W_@?>GC[$PMUSL:QN.JNW\L[_
MN.&_=F:/7M[I.M?=(P30DL(?Q>)D&'O=8]APP[,BV>ZP^&I[$_B)09J=8,Y.
M-/MA,38LOYTW63&,<)-1SNR#$=G#F*N&E>6LU!^C(L(# @3$?,/Y_<M[V6$L
M1A/W.?IQ,1X48$?T#V/1A1^&M<RS#?9%MU]!"/S5@B_[(_C5XF0P&B/?&X#9
M<3H8?H%U+[P]Z995OV=URT:MP@%^Y.FR7VVWEY=U>_4U>2QK^68R7%K+Q7GO
MGN^]"TO6@\]"GO8Q",'>OSOM:KE'Y<17UEPN%0I7>W@NF,9A=1%\.CKJGHR*
MT^[XJ*B52 ?D8-CURUK#4BZ)BB28Z#A6T@GN55!18:H 5<S!RZG60'/UL: P
M8";\LS 9GD4[/*\LINC_5Q>T5OR[^_5BQ\F/Y>S$\!SV/ CEAU%,D][?W10?
MIQ[HQ7^_AWN%$S!\Y)N/NZ=O7O;@ON](FWZ@G=<?3COT/[W]O3^/,L[O?_?X
MT^MW9/_[47KSLBW:IP=)4\U-M,C99!'GV"-+B$%."I9"9!BKM+5#9J<O]9+N
M -C^<)65TOED)T1).;=16F$U9MP*'X$HJ'C=58:-' !#FH7^Y85NYWN]] >6
MF62\82BIW)8&MB&R"?[D2O$$5K,-*B?!<Y0WUOGE+B;E] '.?XV H..A#;%<
MDGK#VQ\*@TG8INBLPBSQ&+U+\%L. V?P4GI!&F&X5V'8^P+"D+0FRB+,K<K]
MHQ4R$3LD;)#:)1I8S,(@?B(,J=+8XY(P#+YF1U_1C^.L?:\C%R"/FAHKC/6$
M<T^M]$PGP0/7T3"J&[FX7Y X/" \P:)$CQ1U!*A]L,@$#CK!,2VPC4GBN+6C
M?BH6V\5?@V$I%Y^Z)_T!D(9%'M$J!BO1DNO2CA]+F],Z:.$D%B1PJJE5.EDP
M9#BF&G.*&VF[7Q1J'^AH;:"8(^]U0D +,;*Y75HP*A@*II_*H?'70*&5-5(0
M@;L07/(I<B&MU8E3ZA.UE&7JTLC"_2+/AX-HB*&,6!2#S;)@ @+$B<C!.C$6
MDC ,D.>:"BG$K[$W.,F63/1'?;"U#L^N(Q;,$*XDR 9ECEM)-3!@"F]19K#T
M235B<:]B\?GY07**:9XT8E12X*H@%A;C@!Q-209NN0]B)84TBHN::%3JJ,KW
M ,HE_[&()%?+DAW!![FG>S=75\P^RL/RZJS38BK2<'!<# =GMC<^*X[C^&@0
M9DPI?O-Q-"IR>2^X:C3].-\2!EP:W]6 \I<O5W=_%&X PEQ=.2H])M.#5KC!
MWWG$!5OTJQQ'.YH,2Q?,Z)RWXX>^K-J7P,7)^(^3035GSZJA?(U_G';#^&CJ
M-UZXJG;3X?DEUHT&O<GXZDL6'"8>!AF'#^0O(?3<["S\>S2<CN8$MB9RPVB_
M@ T%@WUF>Z?V;+3UKZ5G MF8WMSD7S__[%<^84IW]H25[S-$/ZB.Y)]-^B T
M^5LP)KLV8RF.AAF0_ZL;L74I1D=CT-P+[:P(BL84/;%)RGB@MG;VL@\O;]\7
M&<O[N;N?O=HU=VR'A[ PI;,8+Q]0W9'DT7-SH2Z5O#]+5W3Q[PB8<52\'@XF
M)ZUBM^^OY9Q\T)%W!F.X&< 6S'_(32%"?E5ZX4MOXJQ%>O'/&-XXKI;HP1[J
MO&A>_E"_?>C;20 U'7Z_#!'.@6:EG,%PQ@EK$8-AG&.N5> \1FY8"![LJ.K\
M#*X!_9X) ^?!BVQ662RYX<K1(*ED*JK<492$K2M^QV*EG R"2L*X9M@DS$,@
M3(-1HY655T+KPY\KI$&O-SC-VO)D.*C.@DK^5*29D"SX]HOZ!&%4&HQU#>-2
MD?;CN.@-1OFT(1\-5)YJ>']F;A[94+@88<;ZOC<)((;=?J51%T43;C_I589E
M_NS%X!CFY2Q3NO)O4-"Q&N0Q/-T1*.U^OM,_\03$V,5A]1G#K2+3P5K##V,]
M1+BXN,9U>/E([(Y6IKSCLWP8TO776*O?RMD:3."N8?3['8_MAR-Y=ETD!ZDN
M#^GF+*0\%81Q]NS)*#Z;OO@C=$<G/7OVK-LO?ZV\Z(_Z9C5U$1>CZLIM5'T\
MU^3;N-+F=91?_<OUQ]OE1^>..*O/!-EF6ESY,=XF5W[VH]L2O8T%_:7;_O@S
MX."W/UBZS8U\3(,UU[KM3\(^?QJ73<2%[UX23%,IQP<*';F@,LM=\'8XR%86
M@/F2^I\K_0RSP&C GBE^^QO >SEG;V/G[3*J<1L3<O&KUYZ/XVX(O?A \[%7
MJM!VI3E?9<UY9<[1"K-A'JET=#*-6)R,H@P]F'&) FC$'8G-M>-JUGP*E^:J
MI%RW(5!/;YXRB;W&S/S\<3=KSO JV^])U#Y]?_-N,IM:TB?R@#5)GK) .!CZ
M5N: 66-,H%A(584_8:QP><2 L6'X%J)GGR^XO(&FE2RM7L0G$@G;QI]>=SYW
M/G:^=#ZWV:?/[X_;G_?%FX]M N.$[[0Y7$?;KSM?SD?"MK^__[)/VV2?OJ/M
M[^&X\WK_K//YB\AC[<#X][\?GNY_WS_=I^]3Y\5"IU]'F8;%]$@E9A%G@B$7
M<422VI2L5QHD?6L'K)';#X1]$AD&CRR'X'+\_]4<@L>2)7#Y4Z\ >)Q*30QG
M)#+'(]:.ZDBUMF44J)2^/E,EN#Y3;0!OS0!OWK)8.$ [HB22+&K$I33(:9%0
MD-YJ&D12P>=T*T)XRXB+-7H>R(U82NP3AMN&=OT<A;1VF&I"#&,$")?3TA,F
MG.<XRL!EJFD7:6C7FJ(0F:%0CM@2UG,DL!*(*Z*1-A(CQ84'%@VK&\+6#FB<
M%M4W[C=Z+SBP";V^<C7$[//=L/)!J]0]O 73\"8%$"\#*UBURF&?EZZ!K%4@
MZY\%2Y%@;KEA0)=8#FXTEB'MN$/,19-4DC[AM+4C5 NSBXGJUZ]LN'[%AFZ\
MHQ^QO7?9(ZX+6%UQ$'6_9ET#5FL$5G,K3QH:+:PCLL)RQ!GU"*P^CQ)+\/_4
M4V5R40U%6^R2LAJ/&:T:+G*;]E*SO==H>\_-)Y5X2,$8%(3*V9] 0RSA"GG8
MXY)1*Q,W6SM:M(S6Z[&[GW !ALMC3]^VGQ<+.^#90X;?%6_ZQ<OH%\,6276&
MWBI.XT(QB.)*=($][W*OK.4R ,X#F 2&!6$\^*A%8!Y4C+712D^KXC&8T.7B
M,?0:@/$V#O,YL3V,;]+_#D!$#G?SJ7$<S:O#S- #T<<)'[^>]K^WR]NG!\)C
MH['T  (&#))   1LX,A;):/%WB=C<T7%"P#P_\I5' YZO1S#VZTG-L?6EHWJ
MX[!HQY!W<O%\-!KXKAU714/^ FGM!MLJ_O[[1?%;+@-"\1\@Y^4K\L?O^0[Q
M6UWK(X??_O<*RHHE$G%BF!J0)9F("P*3J(Q*3!N/J[2M4I;094*%Q$TK$KU8
MK'*X-X3MEN(0Y(S,!$UNG)S!?4#9<$]Q"!Z9F##(F53(8JH0=9$297QD0F[M
M*+Y]4=(* +,>O-@N,AS6Z>6CPI?E8>+P:]=720>5O VKF.OJCVXH3F IRI!#
MD*M:]G)H]F!RF', ISGJ()@G0UCCX5EUWVD2>Y7Y=3(XF51)5\51F96!TL"7
M*5JCDYA#U7-.\G:1P]H7BZ3 3?.(NR,0:/A>74\E]D&V?2P#V3ULGG*/>'LR
MKYL#7W)Q#!NJ?+P(5^1M%LN*.O \PW&^<[Y\^CPP[B]QG'\%!*Z<J3R4\0\*
M<,X"V_, %\><D\]LKS?PL_(OLQ3L?K@D(WL.^U<4_W$VS].@#+GOYM#]/&4Y
M:6RIFI"=1=XO#B:'C5;/4J?*U=^9/1.L69Y)( U5E#Y,POEQY0<:YLRB4!8J
M*@[K>F#5?<_=J7[R,K]BM)27GA_O0BVB5IU3,,WYRP]CITL/(G0"9.:L5408
MRDF.>RWO4E<BRE7+BM$@C4^G(GMA<EN%/1[ K0=E@^'N.!Y/A>P8"-:X>JZJ
M_EF1'PFDILR>J.YMJY3&Q22*?LRSF!\G/\+@^*07QU5VH86KSG*V!/QWX,8V
M)S.V"C<9%_U!D4L!Y0D&SC'HQR)G6!9EMMOE"_84:BA=D9G5>;E6=.PY2&UO
M.87D'!<#H:CWS& R'H%\E;(Z.@*9*W?3AS[LQ.$(<.(%O%6EF16_A6VW;;>+
M/X=9+/-X7]JSWV?*&F9AJJSA.S EN:9#T8LV%_WH]FOLS+]3@>4R4,,77L!:
M@E#VN[;:5AGD1G/XADU7[8)1['<'-0370 LB',-H 9!',S"O\ 5$)0+.?8W7
MA/8E ,\/XTME7J;\PI8 6Z3Z7LS7 &RC"L]FP UW.QS:XVFM@2RD\/&L!LIR
M;0K8=?4GQ1$L9?%_$[@@(X1-,!^AS%DIQYC1N=J?W\I?_SKI]0&Y\^<+C[X(
M\\OH/DMU6H4\1:& J&@P[AWCF#LKB37<2^4HBR+*VM+G#*/IBQN0I[?VK$P%
MV!O47'S*IN+H]7#1KM\TPM3>>\X[>^\.F.0T!0>,R5"/.%!Q!*:10T%[28/%
MSFB;HT[E]L7>!%/*E'>;MZ.C4HC65Q96(-*O0%;&9S,[;A=81MF0)[_(^V.S
MQ>;SEP.FG4Z>8,24M B6S"&GC4#8LT!EX,X'$!N-MR_VT5F4FN4DY'] 1\51
MI6E>9EY4+0;HO('_LEU\!#RS +FPBIE$G9STNF6:98C'(&*YJ(\?#DX7:R]F
M5+YG>5S%"^F.#B\3RE?E<SR?/<8F"YO(PF9\T+F"#N*$&L1M<DACHY!WC$AE
M)$E&;.UP_B-AJTM,+M+(DHP#_1P"B2BY]24J#BY[$H"VN9Z!]MZKT_;WYP="
M*$*\YBBZ7'E2<H4,@W^P!QUG-:,X<E!T!&]?['$ZE:)6:?OEJF"EMIORW_M'
MF16$Y 4,=58(:#@X7K L-EHF.GN'!PQ[3JDDR)FR,J6UR$45$8DN!!F"#[G1
M"Z/;%T\FYNZB<I?5J^X'H]6UCHG>Q0CTRQ'*J0H.>T*U@I'P:%TZ?_9U^^[$
M!9%X7U7D?9&?8Y/%XZS]<O= **L)QQ%%S"E AI? C2U#PB;*J!!6>PKB\0/I
MR";2I.0PW;*:<3]6TE":<>?U43;)%JM'9,>.'9=EI4NQJ@M*7#?9>>9\*STI
M546(RT]6MHO=5%JEMU;$XEIU**9E&9?J<DR+;IP.)KU0\;UR1"MM*,Z<B"1&
M%2*/1.FDDS(X*FI !\P"VZX\3-9W%GQK-F\GX3=[[8- P3H(6B"12^YQ[C""
MI0!34PDA+:%2>+6U0RXC<&ZJ>K-Q60M,M3SSHBP7A&65T(.;2LLBZ;]I=,$&
M(BWI?-X]H-)*Y;E% I.$.),<F4 #\@8@V.B@-<[R@?$E7HC?YZJXJ33W@TIS
MK*DTMP9C:2K--97F'E^EN6M4CKN>(#Y\1;AKG5=G,KS!Y]73O\HSM_%XV'63
MJM09//GHK!]A>6%T9='97BPK!V<KI3ZQ*_OMC,;#?*8\.\ Z'H38JSPGP_(V
M89@?]G X. 5,R,8.,+OV\\+5E*D\2,PG6!G\9@=YYT97#N"RY8)A]P=C(&EA
M I.:!UXNK/V6YPA4=QQM%U>4.M3$P2-@[CT&RX]J&;'7#.,HK7>.G"^IF+SW
M44A&!"'<2&>-2$08E12G6#!SO@IA-8VA.RK[!HWJ5@87"].'"UV0KFA^-%U0
M=[9DC-5VV[F):>6E/HTP=7:T6*-WR6=^G.L1U]>O6)!PZF2M P=RV6D Q][9
M7-3@OHLE""\PM!J0+EV;G\[UN;7Q-G"FJ/")!RYD=(0E9SF/P3.IL;L[$'H"
MQ0\OKLS/RR%>NFK76(7'4T;1; OU:_4.?UCLCVQ+<KUB?VM0F?"Q#99>;\$>
ML/K=@R9A/2_!NI@WN:Q91QDLM>"Y*%Z"6BK?_,V606M?NX!8);:?#(87B@EN
MV"RV%Y1I.4EOX3Z#NG;>_"CWZG3D#9BCYS4MN)ZH%3-9J\C)BM4JGT3=L^?>
MST(P8_=KUGAW5/YGS7)A;[=_\F.I?73SJB-1"^UDP,PXCDURCIM@"-$N*1^G
M22X7#I3OI4/RI9V17^3#L?ZX^N;[F9 _D72[XP^X_1+^]WK_M+/WBG=>OC_J
M? XPMGW:@3&U]^ >.9WNY:O3\^EVG_;>P37O3C]]?D[:>X>X\_H5[=#_P/7[
M9/_C_K?.ZP_?/[W</VWO_9G:BZG_D6))2;1(1"L1IX$B9R1%27++N.?,2Y,S
M(%J$7CRV7,=B)4V-N 8G;QLG87\H;F@4BD6>B'>48>US:#G&N9E\?>0GKEDC
M+G6_Q8"^Q^'@)Y%];W-8]JAL*;T[3YC8K=PDM;(O\P>G61-SYCBE G.0;#!R
M-8R<5QS @N$4F$,\AH@X\199K"4R(E#L4C)*XES!35-"_VA L@')C03)%*C
MRBH5L.8RL=PU-_*HB,/.)QI*,GE;]3,;,KD^0#FOW1!@[:4D GG%2":3"=G
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MSQL#)(9KAP@7P4?L#!?Y_%DU&_X);_A'=RC4J/Y;@8&Y+:,9=8Q*CXBR&&#
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MF\-=84CQ:W<P&=6#'A7=!)?%I<&?QF%<O,R.BD']K0P+HVZ): %&4G3A!L>
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M9Q]R !6<-LQZS1EXZ9BS!)#6H-%":A$RP:*0*^Z<QA,+A(O-/;>,H-(8H1Z
MR9=C,$$M%(KLR$"+DG0L85A(Q3 !)7);1/%:G==]O.%(PY';J/WST$#2:)^;
M ,G&3"L)0G,74V$Q"-)*LH\LF& 9D+9B<I1*QOQDS;7J/XLCQWTW,AKC<EMB
M/-,'1#$A2[3,QN(8%)N9%Y[4 Y!69Z^-R3@U+DP+V+F_@!UI>T:Z;([W<33
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MGC[Q2O_*HS38'P](BJO\?7EZ(8MT&[Q]NT=_[O$H\Q[?KKY9'7P<TY!VMFF
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MM]IE!]5[(Y19D7H92GS?AMP_L(>YH7Y#_5[5[[LBL#^?,B+#O_(\)=*HV>M
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MVF.#$?U.+Q"^#+;QTWAR%)K_9;#_93=W10CIZQ_IFS28?7K7Z1.&.S2=PW1
MZ#*+Y1]LX5]Y$'(FP=P9X)'8C0_./'!PI*(,Z%YO\B[!4\B3J?*G^,J@2D[W
M[!<YSE\2W24^^)SI#7&/;('JQ-L[J37>T<)U=WPZW*?7B)=8RG_0%-"2'-!=
MT][_WO'8OCF2IY<]E&G3=WKL3*'L%&<:YPAW]_+3HQ]^3,.]W1%^>3K<Z9[6
M?>G'PYL=:J%5=3VE-W=2-KT\4\I6^50Q.XS".'SRX>75[M(I*^#PFE\UYN++
M?%5<_-5OW5:L&N&O==MO7U,.VF#;8-M@:;!27^JVWXG.^G[5X3F>\P1!\&T6
MX*QI\D <VQD-N4/*X]-R<'10GF!+;CII_O2<?9\VZ?F$_3N3OK&Y10\6<K!.
M']^Z..GP44_4\?0,2 U\1?K:_C<ZT9^1K>O$4R_?''9!EM<1R'ZY/,Y_N1=D
M44V&NYW>3M; +Q>'DEYKFRS&"E=#_)]A\L-:9XW?K7PLW^S-R(UN#O_=&9^W
M <?+-U5MHSW$1FN3V+;@O6W!ZY8"N=8,]2Z"XODIAO)N<H/Z%DUR_EZY?#3)
MU5Z^+_$BY[_U%>)%- 0C3 #P,D'1-3#+V>RX4 5=%K:+%SGTMMQ1O,CS8SK[
M?!=--32KG2GDU(Q:CBB2;1K7I__[M/'UX^?US:W1QHO?1AM_T+,^;?WY?OL7
M]?[%[R.ZE]SX]/NGTU$D[[;?;Z]OKRMZQM^O7[WE&Z_>BO?T7J]?_;;][E/Z
MD^ZCWWU])S?^V"C'P<UO^)?US;=Z_?.'$DLH-B+3NF0&,6KFK=9,EFRY]L*9
MY)ZL^14#ZDP<R0/Q[=VN[F.FXRW5L&^0O.R0?)4PZ.MC\EW"[ESYB.4)C;X_
M%/YZ"H6]EBF@E P(<AD4[ICCGJ#8&Y\A2VD GJR)1](NMP'@L@/@O>ND%Q?(
MN1DN'N'AZ\F_QSL?\Z0!X=6 4)P"0H6>\\ +BS$X!DX6AE9F%H4W.H!#Z;]1
M.*<II V/&QXW/)[A<=-3;P3/ZA0\2Y\4**58,L75O!/%@@F>H0L^8>WMD'.#
MYP;/#9X7&YYO1.&>C\P->J\&O?HT46L4\J@-,R;5QIX2F(M6,1VTY$:@YJ81
MM0UX&_ N-U%[/K@V-?=F3K'C^FJ?7HK7F^L??$P6!#B6 Q>U!F=AGF?'+!1$
M[;5W8!: C[VETIL] :;SSY>WJV]6!Q_'-*2=&B79)33AQ[P3OPS&@8;7Y3!>
MKP/*(C1QNK'":&1,QH5BBU(0149OBX64/4;N8I3-Y[_X\':H2E;[G198@6!!
M25MS.A-#PS4K0M!Q);7,T3]94V!7[#FU>!9(C6QMXWJL*5T?<II+N[<@\_48
M9+R7'"(F)KGU9*G:R)S@F65=M%%*)5$D@8P]6[[\RL6^FGPOK4;1/+;]E'-Q
M+.>U.$? Q%DNWC!0-K#@@F<JDAI!IF^!J)?"&=# IH%-<T?V 'O4,?8 E^BR
M-4R# ](Q.!DR62CFE7?<*,>Y7(XXD88]RXX]S=?VX+BBCW%%"9^4RH59&R*#
MDC1ST1#"&*Z,+2E*#(T@:;BR# 1)<R7=J2OIV8=H4185%",KR1&8@&;>9,ET
M3EH5+8%'UR,BY+J)LHOD+7H^GNS6DJSYQLZA<UY^09#H*@7$94)CA?,F%,BR
MA&1SY"4KB1I$X<TYM-B M?%\SCGDDS:%*Z1=EPP#J3GS&1R+2-!ELRO"IB=K
M0MD5T&<A:X%TG_-QZR$CB98<<:[4]N7:D-.<0[T%F9ESB( D1+*FF(U<,:"5
M9=[[P+Q20<9BD\H59/A-=*(FW\NN433G4#_E?,XY9$A12+5Z>-'(P#C.0M26
M8<K2&53>\^4@:!O8-+!ISJ$>8,_,.210&Y.,9]'5Z-W:)2(4;YFKS2BTX ZL
M:-C3L&<!L*<YAQX<5V;.(;)*T/A0$P*J2TA+RP(:R;*($DFG43:+1I T7%D&
M@J0YA^Z":YUS#DGKG+::,X3H"$RRHI^$9]EZK8M3F!7TB AY#*E$70NW+H%H
MF^0O#G=QU'*(+@5)3EB..F4( +P8+[-2Q="AF*2UTC0WT8)#UYLY-U',P3@G
M.0-.)A:H6!BBR,P;+;,!*362%B17G)"+K .U )D^ZT#7!ISF).HMQ,R<1-'3
MX@9!AA:ZP""B9,B]8<%E)TL)H+5YLG:VSD7+'^JM=-^[-M%<1/V4\IF+R(0$
M)-":I6(B ^<*<R*0E'-$QT-!8<)2T+0-;!K8-!=1#[!GYB)2N<1D961:UE@W
M).4"@Y7,8= 1,\2@EL-%U+!GV;&GN8@>'%=F+B)"DQR+S4RC<36\+3#'"Y)B
M4X3R(7&=L)$C#546GQQI#J*[8%GG'$2@D[/6=DU  H/L#',%+,NHHS'9!UK7
MWI @CR%WZ/7^UC=Z-2^G8_HJ28O<"65HPPH90 '- N:0H\G<%0Z@FA-HP>%I
M5DCN[XVO?WY=__PA**]R\)DE8\RT3*;3H3"0H)4.'+P-U8>]XC5?9'6GQ</T
M6-VY/NXT7U!OD>;K*:2)WG,PDC,?@F5@"&2<BH;)$$G%Y5P(7YZLN7[$RC09
M[Z5JT3Q"_91U<4K6O29I=MRQ6./AR/!)S-<8?A-E3BI;7RPN!3?;(*=!3O,+
M]0"!U"D$0LX5H+$L%JT9H.7,)5/+(92(,O B)&\(U!!H 1"H>8<>'%WT:=9$
MHC.ND$*C,V>0,#(OM6+"6VNC+ "IL28-7):!-6E.HKM@88^=1)M1TUA(70%N
MI'"L:.\8J!K,HIWK.B<K7C1'[ \Y<E>)1-WOPYV4=T@<W&Z_7$>;XWT<#<)X
M)YW)(OK>>Q]VB)H._ZFB64_C Y*P:9>HQ]EB[C:GIM^0?@5$EZY8+44 E(IV
MH4=TTF6K5';%HXK-_[;@R#^<2\("E<%[\,S'&!BX)$F'5(JIJ$H6H=#_\I,U
MS=V*]@N=BGZ+HO[ $4H-Z!O0WX[N?GVD;Q[/WF+[+/N-%T,JNX@LE=JD+R$P
MIYQG8&3B0EBN0WRR!AYN'OK58+7!ZE+#ZKWKS\W)W$]XG:4=>@LQA-KTU E9
M0TD(7H7)C$LP*9B<#'=+X=QI&-\POF'\ F-\TZAO!/FS;$^=%7<..(M0"7*3
M,D.@$R!IDY7VQ29>&N0WR&^0WR"_A5'T%,YG2;8N<9-<CBQA(3BW!IFC?UGP
M4+P+T5K9R.\&YPW.%P7.^T=^M\"5NW!?SF4WAY ]#X3A1MJ*X3:S(,FJ,L"]
MS=D77<H2D-Q=M,L/^W5GT7_3\*^U?](_1T/>QLG'X<[TV;S#R^Z3QV\T'1J]
MS0AW]_+3HQ]^3,.]W1%^>3K<Z62I^]*/AS<[?$U]-@*F&_GT\H^?AVE_JTK?
M*I\J5(<1.8=//KR\VETZ-<^'U_RJ,1=?YJOBXJ]^Z[9BU0A_K=M^^YIRT ;;
M!ML&2X.5^E*W_4ZDWG>#;-6<OG@"@K^-L_,(&S.=_)->Z2HO<LS;(4\&2JP,
M2-7@)XZCF\Z9/SUEWS^7>CY?-4Q@4.,$!D(.IOSFA34TSFR8;[S](YK"XXD;
MC">#5Z28[G^C#DF;PXLC<*\CJHM@4[[(>W$RW.U,IW$9_++S5][;WZ9%N!U1
M6XP5_AF'DW^&R0]KO^/H(-^M?"S?[,T,WFX.JWF;+[-['N%4M8W6-EK;:+V?
MO>]OM.L6K;O6#/6NG-USW-L:Y/\>#/_"T7FJPNW,0M](^?/GXO*D_-5>OB^T
M^_EO?076/0OD&%*1VB3P,@8'+B>+RA8$%5+'NG,AE6C)1;?*SG_Z^=/&)_K[
M]L:?[^3&\-VGWX8;7T=;ZZ_>?UI_\=/6QHN-/]_3=]Z_^)6?9N?7_UB7=$_Y
M3OY&(_F_X<:K7]3K/UY^?K^]_GG]U4N^+BO3__.?&R]^*^M?YI*+4O%8<D;F
M1>0,  W##,A"<3%9[KW2_LF:U"N<VS/T_/62Q/OAQ/Q.^GA#Q&5'Q*LX(J\/
MB2T+I[<@.)>%$[)6&"4+6BH&&#-SD"R+(CATLBBI\&;EEQOT->CKSUO?NS+8
M,F7Z"8&S3!F-$EWPFJ%#S8 [^@GH)YX!#"9;?/Q&IDQ3!!L:-C3L&QHV_?!&
MX#C70<RI!$EH5J#6OJ>E9T$XQZ2!(DR-02S?R"EIX-C L8'CO?"&RYQ]<7_
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MU\HE6ZR%AB0]1I(9]T,FMD-:.N8UUU712BQ8)9GT9'OG0FJ8 4(2YU:\.=N
MH&%)PY);P!(A9.W]AJ2,$(:XZ'C)P?I4M)(ZEAO'^348N1L8F7$_7@<EDK4,
ME$$&)B+S@)E4$RE4$+(889:"^VDPTE\841Y)+0Y6%!, <O$J9_HOUR)X5["Y
MH_J,)3/NQZBH@I::%0=DW&1?L80;)I GAX#2)$TJB1<KPI]M!?TXL>11A@)U
M9>NZ *!M0H4XW,51BP&Z#%"6HH2J3GMN.0B!:!,/@><H-6B9F[[52XR<3\1-
MN41:,<ZTBH)!<IX%[0/3@@M(IFCIY%+H6\W7UE\8 <FM]TZ$*,ALLQD),)Q
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M)C.MI$AT"D0AR\8$!N@B<SP!*R(5FQ0OQ<NFE=Q[P(]P/:-[-L?[.!IT)_^
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M5<T6'!NK&%@QL"E/WK1]@(J!#X"!,R8HF#.9!TYP82LRXBZ3DNY!)%6&.9;
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M%BP!;B@QEBGB7#E/K@77^E%E"U8\KWA>\?P!CJI74']H4)^%^)T"EUA4)$I
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MI"BBS#)E<)KZ+' QQI5961^Y_<Z&;K7A7V+#LY"@R49ZES,NNT$0T :MF:M
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M#A0D3X8GIU*D/%@J9#E+?U\@.KGC;]TQ8G:X :S^ P=HO#<XPKO&T;E,^J\
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MFZ+S81,Z&V]$Y^#EP>[V\X/=@S<GN_O_W=O9?L\ZK]Y>E(-4Z,:$!)$X\)&
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MQ=-$E'A2&]!_HJW4S>>Z^5PWGQ\']Y[^NECUW 9/7=YNM;S-;RT[EIWQ69/
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M9N2X?O/'+V0E*!(P!ZM(+9?.Z^@UQE('QEC04MQ65JJ(JDC*#"4%/K/[586
MJ<P'*Q2SB"L6X)7#"/QN;HWS'/-<!"<OR<@XPJV.1H[=FO[1\&PCK9$WH<#$
M76>DZKKX+$$N@C_>RT9P;-QN9;+.">)-\N>HTS$DSH1PG%IFN)?".ZFL\-9B
M,Y8_=2X76;#J*23P9 /N^?FD#?>!>W' +16M9EQ*A(5(B%L2D W8()( -P C
M/"-@LD80'=;(-;PHELMC![66L^&4U%1>57P24<DCFYF+LW[F#=92\MJ$9.L;
M:Z]^%39(%1A!D4F *>($TMHHE!(1C"7&+"6YX\@EF*JD9&+03@\^U [TS.H(
M'Y-+P^_%<-2-X\W42SA2P>LX*OO7=NMX='4X/#JH_U9E1UYQ[2IMK7[%0@KE
MB4;8JWS@V45D+?,H>,F52^"*:'*Q%G5N@U,(:OQ1S;SS'=:[$N=H_=[8Q(YK
MNSI@BF&D!W9<<W=)^!M'PZHNK?%7U_IO",2LW\W[R?5-OI]*$MCY$+OU6;6C
MX?A ;CHKPJM'&P&FP0Y#T)7/39Q*7I46OVCWP^2\4,Z6-VZ3*']SVV0>K$K%
MO31)1%=D3[ Z77LXC&].7_P1.L/#KOWYIM.KYKBZZ(_QS<;9:W&94+42@_KM
M23)W&=<)W3'!Z[EV]V09G[6[O_B>ELM$7_\V7B;7OG?3;0E9EO1VM_T%+^U+
M;D!/SI&*O8:^4+D+&DK9;SH[S@1>Q?UZ9CZ\(?("T<Q>F0)[8($#FUD4\<YV
M!MGJQRF+GY?Z':STZ0FPC]-$%XN:#!MS&&Z?M-YOG.QLK9+M@Y: S[/6R=^=
MS:V_.SO[NQR^%V^NA6XN>;C(8=C>;QUO[[>[K;5_.]LG77 9_$GK8$.T#OX^
MV%S;@V?\P-OT,[@3W?.]VHFF+)# D(^IVIL6R&CJD%-4Y^H!*6EUS/R5-VJ?
M.S+M_WD8QB]@&YM<3%(=^/C>SSOT]^[UMPA-)%X\BI\NYK]G:UEP_,XX/MT>
M&6-NE+ !:2XCXE@89'$4R"8A<0B1"N:75AA;7NAN?[?M6_'2X'H!7?(SN(:
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MJTJ!CAD"7ET2=+Y=Q@=F02>T#V>VIOB4=[ GYZ@?;.#$:,V1I ;LB:0$&:;
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MAMN$'<X*HF?-"G5FAI^ %.HQ^0(**=33">S/]H>OA&-II4I(<B4 T3U!F@+
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M$,"613I%AE2RDH?('&;JIN8L<]L7^WRSENDSI*?'2E/CL)_;KW5LM_NS<2I
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MS3Z?=@T3_L=Z_>H3A+U1'LN7SFCO[=$09B8.ZA.&,+.KPV&$_X4M^Z, [5V
MMC.=78O44LDC ABRB&/%D.4T(,<$(1K^([Q?6I'D 93XA9YE?AVDITW=%,U^
M=,V>)'>,,,D[@9%A7B.N<.Y@#1Z5<MY9I6U2A(,+19J$XT7VGPJ\E/Q%$9'Y
M$I&Y#=&+!7IT"S0)XB4L(!$Z(BR(0)S#*TV]1=Y@+$&Q"56TLD!XL9ET"A'9
MG69WH_<]#BOZB=Q]!]3N,6I_[L(8]+(!]FD*7]S>[IO)PFY4Z_J__>&PH.==
MT//G5&0.4"E2,)FSE5'$X2=RVD:4455@K3&L8Y4"U2]A;W:.=I *=#QM=J!
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M^R\HYY#50B/E!4W4:>D(*[N[)3T^=T#CI"4L&L:-95S28&G4U"0E-39)JU"
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M4Z.H^LM3]1):OEBEGX263$L>#+$H$<D1#S0@AYU#VH%[)B2VU+.'AY9%WQ=
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MB8W0;_3Z%0=W]RC$^NO@MUI?,RZXGW#'0U"]//EG9VG&]ZO?R44JAX/^]TZ
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M@U<8+ !ZZ*^56]@.[OB\Y.(AJ/L ?KB+$!5;W+@:IB2U&JR,(.*ZZ'4<^[>
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M!@N*;"'3I7YAG%%FO7C6DSD?*G$1S^VR,(HLC$F7A7$$>WE!61CP27(E4$4
M!H*8PJO* K!&X4?.K#;*#E2/E3#>J.X9RU-6/-X>P2%$'%KQ2Y(7HRYOA<-!
M^K, W/Q%=*' ^>&+)VZDW>E^4'T/BN5,8J,T$[@'D5)E,DR:X: 2H$1W4Y12
M3X6:T5NUCZN@QX905/@ME29>%20*Y\C"YP4^_.9$0B7]B&_"]_$9G>M=$6X4
MT0'$#WXM( \<NG1YC3E'+B$QEK&'5[QPOP>+?"&*<[@',T=,%57JRQBTPY7X
MB@CISH,96C9DH:8\UR)/Y9Y3AIH\('XXDVOP8V 0'74$D*8"9<N"2"K0"MU@
MT0 ^:;O504>UGT1$Z@W!*5 OD#7V85[X?948,]J)[YG':XOP$SBBG*>VP!Y+
MTBI=B%H:(LJ4Y(927'M?V]+:Y4F0 2<,R6!JO#[IOZ+V7_B[<F<G3GGW+E5O
M,BX"S$6'[9;]5TJ/EIK*7,U7+FKI1,AK^1+"RPUE5DJ!HXQC4?X3X^129F)A
M?PPTPU'A1W 2N8 @XUGB<I%:2A/:+85I@?WMZL^+S"4BU3RE6LE;Q@N?55DE
M7?>R$9Z2F25#R;SA!CIHU;*)ZJ6[:8J+@74C-8@T)X<Q;HJ"'&N&%BGG9>VT
MVMXM2/P>3XB4M8(GC3F/2I0"Y/S>>-FL6J>J5\P_?DF5T/-)0W);&A3()QPA
MHF*TI V@GS5[&QZL0*XPJXGE23S$:!5VDJP697"J:JN +3O.N)2I)JHVR(PE
M@85IG0&&#-V(Q7F*@I!7C8CB[479PRJ+XU 6B2PY5@14Y2";.&'H#U4,M''Y
M=T0F"%4E4)/BTF_4:,E7JVW)*E\WY[DKKY8X(DK.U6119<.%YZ3.&5KJ&8KK
M>EG4W] $IXD-N-Z<DIE$9H[HQX57!4("-*A 9/I1AW.$Y2S KCFKDP;EKMV#
ME*+E!MF#X%&;)E#'#Z1*B@E)O XB8)X9'X*E0!M4Q@PI!B-P28P$AHZC)8LI
M?9NG ,G&=&6# S6IB_]0OQ]B,1@W3Y#,J/^!2%9.YQ0 +,B(DL1D7A9FBLM>
M!'K9'X+_3R*L:LKE3/2<%3EA1)!"H^=-E7C:-.)4KR!_+G,$AJ$I$T7LQ'WR
M&TGQ7):4\M:O<'>-G6"?+P ^/W>5X9\R<(_1*36J*4*=:MN#BGPO'/%%HZ,F
M)W[]*5F6Z/./* $WZ<ZO9K^+/(HBSLIYD8@)G/2M["@4/U4CSR=]],WA]EJ(
MG1KY)(0R9;"CI7ZU/0I/B75<J$F$*Y%,T?8V83C_JLSR$6UDGBT:;AM'/"]K
M8)8O!4>Q_[Y4;:C14QL(:C&Z"GZ6?82HT4= \<@9^NW1!O&+I3+W.[;@](-,
M]N\N,B[0?2#CF"5F"YXI4@^YB2*S0/RR[EHX,&?,1R>E5E915A@PZ-NADOE1
MB(5^]3 B?4');4AY@R6N2^*'/HF^2Y^2.&-EUZRS,G63\ E[M!<%,.=GK7DN
MHM13^COY+^G:!52277RVP)>6\$91C$#9:)4\%;@$JELHSNR6+(A++5X?R-/A
MI#_6#]SK*"9W_$DC_H,9 N4%[H<1' 6UKY^/"+%(W2(__7E!*"H9%#0J[-D"
M>40Z,SP@S![$2N'PWVHA+*GQDH#\J)J?Y-=K2_;;=[C&@S"=:0%PP9*Q+IPO
M\< VNG#^$>SE9$8C;1NSIW2H((Y*@BRDNR+T,(XA91G2I\Q+0A=,'M* D$HU
MAN0,BLR3;2>#.&F5754F\7Y+)K'](72ED(&K%N478'.XJ)(_+QEMJ?C(0BEE
M0 HY!BE%E=*PZ'-M7*]V(%CW#Q'TI=?0PX10)&\S[J4<(R.639+ CQ-N&Z3D
M/E(SR<B%Q3V4(AXLOBJX,06AW(;FMUF<\7E+Y;"6PJZN21O1O0=W=XMSBFSC
M!P*=/?JA@$Z$H5^Z''3-8UG#>F=+>@G^8>@R]DW^;5U13-7)/LW1*^$L>UDZ
MCV(OOAB3I_W,V)!>%O3*/W&R:0T'D10GM,)$E%53CZD-S<[J81+)Q:A!15H.
M)N"SSM(E=GT61#F3Z:)Q*$OV,EZ8AHR(&RC%%HI,"]'SFP]_8*#[^WK1T1L6
MO)W'(=(-;TPVK^VGKWW!/Y9=K46EILHRW95L%%L:7C+?M,Q?51Z+2F<X1;W3
M2H4=ALI7)/@H14L$2A:B,Z"L RQ#7[B<_%R1Q/H/Y?+DYBD/)]T(5)G34P&>
MDIL:-T \E2:B8.IEMD5:'C]58H=%KW!JO#!E8J)-97H$;]E1%BP\7]+\)V\)
MC6*,1&[:VOQ1AG126;1=B736Z5KM_UYKWEY)HVIHWG[BX-[1-RNXU/,7 K6#
M*IZM!AE 6LI:/$#PL#(.T,S^6]D[E3RF!1\MNGE[<;$T#[[+=$3$^E"4UA2^
M+Q[AD-Q'Q![XVR+X$=RXHFQ(;2_&F[=SIDB\5:D5$-/^B :Y<B[\:U4()"Q8
M3#'?D59$WDDEBK/ XV%4/T_*E#'FGS@EW=$10&D2F=9PJQ"4M>:290,)$;9J
M0Z'&FI:F=E^5<1XD7; :7W9[6FMW6RYUTC>S(X^[* )OPK]\TH??Q=\7U$\N
M3"-48=/R;Y3O(!(5KFGX $VDBRG-H>(^;C9?BX^@9)V!%1AS5A*D5;/;9],,
M4Y[E3%.A]]#@/(55438C]6)4_WC-\V+0"$^6<<(S*8LO7R>N#_8FV(UL)1/R
M9SEV_>&Y8:)S':U:[J"BM18@P#?RJ!TB! FL'\4F%<5:)TY3&RGH8Y$Y<XZI
MVR=]T!V9QZ6:LW[2!]\\=+22FB^F#2&!5F1^JM15BK)OJ>+(S"9=+,$KSJN.
M?6P8F2]E%[<B=)"B%Z=T@JDF76E!-MB-E:)(=6.D:!4662T9=!ZG-.D;$[[F
MJS0 ,U+6>F2BSD(<#XZ@%"[>LV3TKE35:JGH!Y#:R.A6:W!%4*"D]^M%C*XH
MN>1&J@R=5/,%B,&+>_2K=XC#NA/*D*D:L@5[%]HEKVUICM\J'0$2=EUV&_RT
M%MDIBU'4O@*UED"\:W\Q3WT)M[YPO579.(?GG"9K':2*)Q,VI0ZCI1^W2-U!
M@U]X$6A':J68['A3UN6B#A]$5//3U]X3UNH:]Y[J"LY4L'KMYI1A1;5$CGI5
M<149/JM$4?5!<0\)D2.HW33]EFOBZ)G@'EIIWE9\U+QL2'9/5'/U!042]?R=
MMD4.H8)X=.&3$D^A;%]B@P<Z#WI.^-(]&>D3LI)^4G?'BW'EU2U =/(>M9Z;
MN6D&QCD&N-%A3;F4"_<;NP<S*"PB@D^U^IHG1Q+6$V3+[&RR@81.HAI'"NS+
M@:GW\TP]G0"YX[V7%P$UNPCH$>SE614T[ZA*/B<M>G.1<*6LH2'^2B6=H@2X
M6OXBQUPW:2*%+UAM:%IUJ8FZN5K##/)4N2&6[TEEB NI,M&$^EJ02"E*B,H%
M=-2YN%D-RAN+_*J&H*IVRG!'G%9"]04S1D,\*TIR)<D?MC]+4/KE'K6R4@IN
MQ"HSUY/50F7A.]<]:K4!967UVBU@ ]K2]R@DY +L9O1"-4XQ46>4BO!L$3UN
M=2X5IWQ7=)/DA5QHE%-;=GGSW)"6(Q6F2?R-MTH4P\U%7TML!I#1U'J]XK5=
MRR@"F0Q&.1=,[T2^0)&'B% $;9WWI:-!,B4(A=(:XT ?C@EE'+G\HA(LKP0;
M2%$148RX!G-J\R^JT5'M$-)2:$&I#'@4F(V!#?C\-,]X299XU6V.O+>/FSUI
MWK(C6WV/_GOLV5>D92XPP%.=+G62@-C(9->.[2K'5BUX7WV0S'+$4BPV11_6
MLG"Y<3-$E"O%L^R6AELH#K+*!VAAT':#C/5",JUP<&ET36T41$$QT2,/EJN!
MO,543):M%&ADZ,'3(G=!/@3IP:Y,.I6E6<6ZQ'Z>M^>-&-3%Z;NM=_;9DVOZ
MJ_M=^\#%A?;F%RZM?SQI.-P15:)38]H\DZ<6.LJ/DJ35YF5H>))$*TQZ.<B9
M!Q)YQD>1)X_K2M)$=W:@UB 3KU \.>BD$LP%^WJCK9RNEPL>-.>Y#77@2'#:
M3_D4SJ)]%#T1=MOZT:'&QTC[2QXQS;+E<.<F%?DSNQ:J(-S;%W0J<0=%A/VJ
M%]J7GEDH<H$ TY*#J1B:@]T?4 \NRD.H[77L?=-NJ9C "\GO4M:5BF(,BN)\
M*8,[_\==+-\!\0J5Z[Q0ZRK>627=1?D2G^.#$H%VQ-6;JW]]^: D-6:!A^IB
MNEI,XU 351>__/DW476!;W& .1Q@_+,7GSYJ7A@+38X_,%:2"M54'BJ\&IBZ
M+::.MX"%^H?RUMWPTVMSW(=GE[@U?)[/$Y2SF/BMB84 ''DQ";*\@#(X_'H\
M'O5M#; II$96$9$IA=JI^T"UN5W1CU/0\FM[U#?4EPEVMW ]:HJMZ*17%-M(
MW1OVO4!/)N]L6MYVX0!#* I\H2ZRGS[J-.#7'([TD6WJ8UN%&'<W4E/OC#KW
M\%P<R:$$@C$R%"-4^&6*G6.-]/%DI-MCL^4"0%MP>0*Q>GF\7V ([ Y[X+PV
M^V-*VB5S$,T.^"IC"]%VO;8-[M_/L(]#@G:IB/61J:%>?%1IN8WNT!Z.C>!Z
M%.*7;,Q:),9.P0JE!DESQK)G47S=FM<EFG3Z2!QEPA5O:E\B,;\G;'2%O[RV
M#$/!62"J")OFA 7<**:-863F<T^ @DV<-0B[* [Y7#)>?.8"^0E.""HC:)_4
MKTK-Y(2O45\KS:PQ Z4A>!$W+RW'(M;UVNY;<M]][:S "DI*1E=]$R!4(,QD
M?J!BQ)+K"YL(@+'IJH-J ,NN8C C+7W?\R=V+:F26OZYHN4?<D0&Y_I@L+L!
M1X\&%!3)@OR24#R*YF=*IL$R3Y949/!\2?8+P\82":$U2H6<Y$"]$A+E9R,J
MFD>'BFX:$&E^XME]PI-W2&2L#W:4?4Y [>\7BE >N6 0B]:V/MH ?E6&E"&F
M5"IXFTQ@,!6 X_6R>/EVT#B[_ X\#?P_O;K;6S^V7AT'<K<T _GXCXOW/7.B
M_7V)0'R^5$RJM3PL?-]GB\!3W2R4M4#:G-2K%SCR$?M0QO H2,6;((EE,;60
M22)KOG \AC&UIB'\D\TSZJ78J6S$XXJ9(*+Y%*X'G\@I4T3)Z98M7A5W*&?>
M3.1$\$B0/!NF=+FBU0V9'Q'1S)=RM*@[36+7KWX$>#YZ2<NJ**I:+U2X-$^N
MR[PTVF5M'GB*]KDR (7WK/6!26*W/I =U.,ZQC0W]@WA#12>44636E2 I00W
M<>"7QP%S/\; N@QHJ,YI#ONRTJ!^O7P/"X8#5"CC@<;NG'\&B//)3&6EF'+6
M/!(Q:VP,GA8![**%D S3$&+PN@;T[H-\]"B\@OD?H 1CV@2<3Y>#5VCPW*(8
M?.YFM O:X90QBL6PZSAB)7+1-6'B33GFA6?NX\19ST,M8B^YQ"\O!&YU(? C
MV,NS"H'?9042X9>=@7W!Y@M_91$6X(6A@K7) !R]36U7?=Y;E)5,CYIH8"<V
M'UDT^;+0V*)0&1]^*5E8FJ?H2Q4&%0N%)X.8?1$2YLY2-U2[5'L4 ;FM'D &
MY1IG=-0F.E6[//\GA]^X#8*UJWWM"V8TD5M$;QSX,:>LY"Q/Q&!>ZB(=8:?'
M4&V1TM8N70 UB&2A"8:*1625"U6U+Y$<"U8,;W-%/P<<4)K1*%20]ZMG$FUI
M\;\?Y91JCD24K%?#(5,7_@[>V([\9VJ7[T)5R!*:@(OX>!L76IR+VDY&W7"*
M(>R_PIG T.#]%>,$:\E=4)H M7B_S]2]K<R^+=ODP^+%]SSYE[6=ZZ) 79D<
M]3Y(*<I]+@HQJ8$(Q;:)"HK)4>_/BXXZ-,8+U3"/1]LEKOHNHG)E&YKP;Q)P
M\B68_D2:-H@JW""URR%%%G@.BRJSVEIIUZQIA<40PM9KPI^^@"HXAY-F-655
MY2YM!^%G4.H8Q3&L 1RCNG&7"A:RC;O_BG/U?!H4C)B@JJ$4=6JZ.?DV G$X
MZ ]_*$M":I^1[:@1L6CI8ET,(<#KQ,A .8PT<PC[WQ;FO\:'M-Y%V &D]R[]
M"2C4(DP;Q7RIS<@$91W(=> 8F&5"(P\#Z9.W)]4_UEL>B/95/,VFDFU2;;>/
M3LH!7%OA7<7%7YMV&6"HKLQ'G-ZC(\,N)W:LAA-;CWABTW(4AS(=V;+[X[8C
M/U_1]E%4.8.9F%*9IF*=5ZQ*8%*D_9/=QAVGU#$@=#$;+:9L;H7_BQFRJ&K!
M=G75E+QF1<<RL/E([5A3![FNUF#?!]&,B2:W>&O8]!X#FP&?(U(*-LKP7RYI
MXC1-!N&\!?L=D+)#+=;IJUSCZ6MG83:GCOZ$V\4X>-[]E^:9EM9J:8"2,D9_
M*YDPQW4_3\HDG.I,#4J2%_IJ@*Z];U%\&Q66+Z:^186:6LZK#](D7Q9+KDW!
M4>;9RTYP4[:*!=/%3X3,%XVX1'.#Q\3L+1V" ]4A>!BO7Q&-:/'ZG18%_Y-5
M^K53:80T@F2PD29H"J+@32BHCIMC$ _6DF.F*'HH9D"(7RB9$9^@T< \2B[;
MAJH3NY$ET,3=4*V1XEHDL8IJ;A<AN\@$J!6F\\+V7A;WBK4+9?276&D!P63?
M(^IWS17<]0& %Z!7 FN_QJ7+#-@O?/*%5"5_"3Z64TB5E%W9%QSM3U07;ZL@
M3T'R5WJT"YN)%[L6Q:@$PYL ;IV 'V/Z#(T&0:OS&Z-0)^(%]@C&$'/&]6C\
M5"2Z2Q;%3U4-#$%'0S4!6CYO>TR:_]O[H?82-=CHNA>R6?;6'C9&!_B?,'@6
M96][YGB9'0C]S?[3*']-K.1=!5*FT1\@&&H$B=W*(CX@OB(A^=#I0VJNE!UC
MFN^TVH[5B4T@)3#WA(\+QX@ ,!4^^F56:WS?U(< 9 ZQ"5GQ-;)XRDRE9S&L
MM*XXZF@/6,YHW0IH,CX,8;H4)7_T-=-TZ&N79](+3?99V=N6"VIQN')(N-0D
MTU(:HW9+^NP7,7S[0SF>_A-7=>!]-&R(1)7A];!!89,-C5']\)DZQ6JC9276
M, W%O%+>:S.-E$Q]RO.O1#U4S!1 H-V[HG<;K&+:I@:JR?H@CT_D(%KQ!K?G
M-*0@+20"A_Z(WW71D^2.#EIMF/#XL?63XF_6,?(W&=T2+;!$"BKC>G\Q/?:0
MO$VRMH]KPI(H2KK&9)-G\2-0& 4011NP0HYC9L@U+Z0I3=B:D<D5%M4WD];Z
MGZWW>P;&2497Z3%1! 3IZ*+_&6<CMWSS@DW- SZ5I_BBS,D A2I$[RQWM?&G
MQ00SKH=\5=E:.T<+.=-5]Z1\6G ,86+PU%$ 8;"@*48>PD]FS&$:8Q,30:=X
MD0:(;U_S!$<^D"R5RJ=T^]\*Q,/3W? 5BBEL5+O+0I$AN72YV<BGIU0_*R<:
M%04.2O!3F<4@&T2N3X<!/8[&.]WBP&%?E98N*=IIQD=R9S*_4G'=TT5'<=3C
M_B]Y8V6;))W75ROF<A&8*!WVU1!%+')SJ.%I!L?-6"H+LVE^D"QG0R];Z6*+
M9[.493)-MX[?&!0NA])C'$ T5!5#ZFYQM&?9]D[@A;PI3EX\#:A&)N28KA,"
M[^U'"O(4N H3_L<FG18>P+FA!>7BYGD0;27FKQ;\IZ:B\&.O2UFQL%JOY2H.
M %+6A3W-.V&1?_0FQHBP*$#?(+MQBBR%9G!X%SP)?[1DT*I"X2+]%.]<Z4Y?
M.'<1-1I93!%Y$C.!TI+^X"YQKQ5\)BDGLA:;R4W,$1,O^TCH*18$8K[0XPOC
MEQ=NM[MP^Q'L9>_A]I/2,NUCU#(E+T*^[@=8!X&A/]'71PC^TL Y%DN:]Y"F
M!JY5ZQE38M=[^A4#%U"2%[J&:,%&\N:V%(HX%)1F*(ND!YIV+?N5DH;E"5-,
MQMH*M2>5VI@J!,@OR/7!<I-MK58K5K$T)/V*SG3+C[]POXG9>O6YI15]F.(+
M,H^]3&^72H1:CX.FKZS7$3 6.Q MBN2TVXB[U[G#$S8@XM;5 3 8E>7^Q^+1
M^K#WTDGYE7UWTZ:XMQ#F?;(Q0)>_H5YR&4;/27^"VXP4?<L::%C(&M_$Q25)
M=0!V >P@I-H0[![PK3@D&>W%?@.QGG*I5*7@:K.<9JVKURJ=E4I/)X2:F">(
M ;,B@D ),FJ7 C&Z6ZY'7H$U[TXMV%UHYUH23W'"Z#)8,AK8S6,>M?&_1=D$
MUQ+%=$3R'E2- 7X_PO6$ U4#C,>468%B[I5V'7-@< 4K\BLY/WK13YB[:TML
M%X-R:%JX+"].R[M]*<Z'YDB)<ZQB@<97\R) UN2I/Q9AT#QQ%!D?QAHH5;:'
M;KQJIP]=>Q][7\"24*94\;X5G)1[V/>#^%X<BNIWM3Q($@_5'$EO#<4H"\9<
MLFS^LC"=)?EAS)9(%P.[RG+$UN#/:D"$)^2E%9N/TJ$CLMY8LN!6:-G'!$C.
MOP7L3@LV)_:EAJV*KXHXD4JGHECYEA6M!$3ZD+I57K8L+5BE:"?&4(WHIB*&
MI):34SF;X(Z/*>\7$S)Q*N0(>LO4"'3]%I*R6 1#M1J&A,,29F(E6R3(Y\CV
MUWP,8-*2RT4"G4>+7K@K='!TW.B\T()F.:'V$05U%!6.*MG4",^TUOX^7"DA
M1T].R*T[4/J:XB(1$E26C1>X7[@XE#GB?ITP*WL3(<UUFBJ_>Q%5$A!))2LR
M<$NIOA#.#OC?MV[B5WB&K*,63IQB&G.I.M><DU)):U";+TKMY$OI.^$ZT7OA
MHXEY'RC*1D(E3O!N5$E0T13@BXG_ +&+H1/JZ&J.<$78BT(R(8V-P(:"%86O
M/:@B<SW(R\174]H#N455LC(!FML$ /*U&U%!7K47O)B/R1/ZLXPC4;8 <D$T
M7'@3)V"GWP/2 KDO4U'D5*W[O/?EZA-M_SW]2XYEU,O>\BR;HW,7PWD(0'2'
M)EB233F7'LBB/"$MEEIV47#"DQ/"91<M.JN</I(55A(21_UFD,&73CE4NJ\9
M5SCE1%:"&3RF2S.(1GE(!Y7:T+3((B#)C%[8A+Z-W^%"INQR2K->RP"+Z.<.
MP@#]S'$B(G\]\0<N:8,0 W"$]I0_4#"F,H5BK109-\R-**D$ /ZA,";7AVB=
M'8$D(*^LSLND*7U!.(0E )LLI]]8G%P'KNB-*CL:T+A-.I_D(K,@P0Q5X(=
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M:D&F_35.UX+-#\]=;HTK'AT,7N_I\,<23&T^]1MK,M1'EK4F9!_G]">4H?8
M7#Z^&/F;P42W!L/G>:L=5WKV7,D>.OID8CQ/_'VY7&GLZ$/SV&[U !55!RIB
MI<X'S-<^_'+Q]?W9$U5/->WEL:NG'ISE=L)\O^F(Q\(&VG1.9Z!/S/'V?*#+
ML7QR_='1C;%SRC?4\833X@D30Q\-1J>,<<^=)XQ-W1P?AFLWYUR?4*O$DTS(
MWBY?K2D?^]7/7QC3Q'BV#7VBQ-0V3"J);RG))<&^:!XU\Z/&GJ*-W@(;I/$Y
M"B*OV4TH_T!ML21&80*(O)P/Z AHO@B8#Y1:0MW9:">8_2&'>& /L3"F5W?,
M@=BR=]?$?+6VXO[NJ#F-ZX&]NLR"(EK30?9TJAW3U5ILG#O.UMZ$[)%RUO9>
M3/!/3">;81BY!@%,%XI8IH4Q-;B5S<=D%V\YREDO6M>[WVED"3;M\X)R$JJ[
MB('[_%<T/W/E1V0'0&6\DM+16.F!!@Q"$AREH[E\SHZ8MI3.W:3(4<*>>_
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MS:<TESU.D4QX"^?Z<F$ 8LX/,B[DW&A5X&FYN'P<]AW<M&OK]:['?/R+>%>
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M3/+T%@\)1WM4<\PH_SE/Y&Z6[C7K3>%ROO7<&6SVK1O>NJOTU4]571L4;16
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ML/+9RN4+4B)MH" F:<AP\J&*2FUB%HL<I0ZY\611'/7H=-JG3^]5.ZUF^Y7
M;D5,\=&1!;M:QAS_W]**0&OO;@,_FPLGF?H6]]:]-<I7W&D*2E+6_LK:'.>G
M]_418.U)%1;J?\Z+N<U+]YKUIH#IWWKN##;[U@UOW57ZZJ?*F19!U%,!6#][
MZPEGL[V=D#M:?096/Q4,OP4<9@D^!7MRCV8O&E#][$^O_B=@ACN=,3:UF#]V
MO,%XZ@[\D<5FS#/=V7#(?A^!""$*0/D('P3D2?_W)_?GIFO<A>,>G,1W88"&
MR@#MR8X,4&5\ [OZ\A8<IM_./IZ3/,3PW@^[*::E-!S;CR$+=[.77<VQ'T,4
M/A=)>"]X5BC+NA=EZ?BFN2-9'5(E!Z6!7[TYV.Z\/O#C!)$YSX)0=*+@7A2$
M=J-2C[X4TNKY.MP<+.FE:M+01R[/M&42^SE\=!%\K^OG>)V_)+AM!,)[=T5'
M0/>.JKGS<VWEC9<^?7+Z-/CT%8N"(@A\4[ \VA2X[L6OGYZSH5#M<U8WZ\=#
MU1>!AKU1]2H^KM-G\VZ<D=$W:S[.<<7[O->(&"&_Q'L_IV@++;AAM50N5W<Z
M<ANX=#7"8W'M\)R5P#4+Q 2D3E:Z2EST=WP!\35E !>EOKL>V*&M?OGPB3X%
M#%0)/T[S% "72@M:KH_G@J7*#C53%K%9D(G]M4;[V&(9QBO&&LDTG0.H>M/U
M#]"B?>T"/N7[1.9ZN6\)36(U<_=&=;TWPDWE%I(%^#%PYHR_[HI;(\J'>P$$
MDO=/C.P9D_S&QD,UDK-JY&\:9G^X-_+?96>COE/=V6CR=*R@/'HU_%'@:>L7
M&]E Y9B"?BF":]5]PR,UH%N-DG 9BF10KD^D !+?C:X#1'0W!:F7<N+ ,R.P
M.&W B1*FW>)_1+%*&["W/")6+*G1D*=LIQ'X_#48S9@V-.Z;@VI^5(G]E'Q3
M.ALHU0BH('27*7LK__'.#])EZ*[>!A'A,KWT3GQ!>"@:>GO1!_G/I<'>-[C1
M+I+AQ9?%SWWZJ989Q7]S[/[$FK3^#&*I];=-RYI6WS*<>RV[^3=[?+]5N\T>
M;+.CK9:]HY3CR"HV:,6W009?\[;(^KQB.?LS<\-LOD7ZYPZS%%[2H\\$05K*
MJUYS,13GL*Z?MA?W3+8Y,/=/'U7>\U?2*2ZYUO*!= A2*BN*Q&,0QZD"Z I5
MK5W@<U?MV[:%=X>FE(U0^9*!H4=.#U :^>1E[0TVL/B1M,;20/+=S-UJ*M!]
MP'*$Z((J]Z,<=YN)/<\'9L;CRM]G!)D.FQZ*38(AUP+3-L'CH/!\7.6L^]X)
MJZ4;E=#22ME&DAZGE7#P1Y^B$^L1]GS_)*M7FJ=8[W+Z8VL#\M V-DU'/):J
MRI:&"H.A/CFI,;K'-UOCE#'^H8UOCAGCF\]FZI/!KEWX.YSKN.R## C+U,?V
M*4U&[#"^X[(/.=L N&PWCNFIH?Z%)3>!Q]I4\ZV:AYS"8(X677:B#P:GQ&2[
MT2U/?#\C?>B,NDLZEDMJ)N.!HX^-24?&'8:T#E+#&5V[:A>/>$LOU/%W$=TP
MD9?.X[,O;*"T,]2M03=/NAM#N^%^QI9IO>NNZ5BNJ:V+\$0W3*NCY Y%CI:2
MG\*#8=I'IV/P08^/X+\XT8%:;?YC"VRB$YQ*>Q(C+5X 6K6T'M>'QCTGV787
M>QP7VS+9<3S0AX-1QR\ZM'I4O\M(=T;W]+MTTV$>"OV/VT^_?@R]OEOC>-9X
MH>',2K/&EQ;,'.(,SRX,TH5!'ME'T5W34QOOIJF;HRXOH4.1XZ7D%QK1K+5J
M>FGQ3$N?F*?D5.RB($^=*P^2:W+ -,[NEK::]>?H(]ONZ+C#D+;[L4W=GMQS
MRNBI!#./4+W8V KNA?DS)OK0VC17Z-AX5&<#/?'].,:N57G=%3VU3]+1G5.,
M*G88\F0&@^Z8D^?MQC#'1Z9E\)2I>/OHX&ZCHT\I;-WF@!WHXU-T=!Q'-L1^
M)I*?$EJU.D<&DWMV$NAN]CANMB5]RC)T>WA*$9L.K8X*K5J\,!:(H<$QWNR^
M_#/'1-1EK*?27'0_>6S'UH#BH2U7=CO\L9!A\ZE/K>'5*:7&/D_J>6C[EM.D
MGI;VY2:0C[TGMMEA;\?[]\O[![HU.<$P1$<^'?,_@E._&>BV,S@RYO\2:C]D
M)OPY#HK_C/%C[<WE^>?VX2&[V=8V@-Z/<QQD=?S&=5M-O],_):U^MTNX!VT<
MXA)^V&M%TC/&Z3TT(3A5S&H&18=9CYN-,^B?8/N34T7ICEEVS/)PS)+TXY]H
MXNC/&Z><UJ[X- <#UZ93U&>!#P;E\-D]#0#>O /+'/0G:SO8ZZ#?96U#U6-7
MA_]N^#PL&>8^:Q(;K9;?4]UZ"E=KC_I6=="P.3+4T<])X]Z?;(O*F&,::8Q7
MH$[XQKEWGR[/:.OG."<]7^AXY[<L#/&_8<MQ<NU&@5>]7; &L25C"&NG?>W1
M1WZ+0XPL..4RYGM]2V/9X8/E5&*<[JJ\)68:&^4K[A3L_CQK?V5M!MC3<T^+
M)Z)68:'^Y[R8^;5TKUEO"K?PK>?.8+-OW?#67:6O?JIR5V"M*@#K9V\]X6RV
MMQ-R'N\S+TXH$?TMD"U+\"G8DWLT>]& .\W^].I_ F:XTQEC4XOY8\<;C*?N
MP!]9;,8\TYT-A^SWT:N?O](0;B"@<_@@($_ZOS^Y/S==XS&*K%K7]KK(,DMY
MP8?$@PP;[6U\_>;-V+;*4&DS3F4S>Q5DZ=K>-. S<[ZHG%H?5&;3)\"D(MQZ
M>8X >0M]/UII$<MNX^0;[ <8KNME:]^X#> #<9YHOY">I_&I:>>P=WCT&IOA
MZF+Z/'S8FX,V!9]  80;PF73? '_P/]!8-&F;AJDQ.3G;JILRX>/ 3!@X]]8
MADF<@%%%W4A4@4.QJN#Y7ULD";S]GGD"^*;.Y][C>O\.EE&,VX G+MT$-B]^
MAKL)TYA#(Y@"MRXN:,7<I!>#EMO#?VVZECW(H*,AU;46R-HM7.)K9UB2A5 ]
MC$FKHMF@<6%:RCJAH,JBJ@T"1?((0!_"KGWMV@TBND4&MY^MX"J\/ $D@!,3
M0B1,DI/9U\JA?YH?P!;B3)O'(6(7DH<\6 J?27 _.ZN(1O_Y7GRE%0VH9$#^
MK\VA7;]V"[BUM?VU-[+'^JT+]D+?;.)L->90T0=);\3U\I#F*N-N:CIFA7-4
M%$ZI;8)F?PLX VLC'[QQPQPT'^)9;I*XT35-;08V='G^F<B!7/$_T#?0S_0#
MGW?^,# 0DP, $!0B8).5^[C/!YXSMM;Z&M2%N-D?582X-;;[@[UI%)LW,ZQK
M%)9A/IU&L:X^( (K5,8Y;KEE_ J+TK*D<\HB-@LR<38R[!8QX"A;+,-XQ1B2
M%(XOS[,4J,>#)8!L?3@;J+2$N&F^7,8)46<AUSG%58A165\0L5Z*\39R?LZB
M>&-Q;0W))JU,^;$0:Y?=F':#:K!7-+^'MZ>1#BJ'$G5&B+BOQ_UQ3?^Q^H[J
M>5$%&A='R! (G4$?!R$2H 'GIBG+%-4%@<.E7U;A_AP(9//!EO*H% &DX@I:
M?D0&'_A_>G6W(3H9O5)>>O*H I'%7P. G8^Z(#$%=QE@==AGQKE/N@U(*MZ7
M4V$'_^38DZ:DI(0%%! O6+(@FPA_<:=!B'\';+X&U@V2"5[T07VF?PAD0E[L
MIG.RQQA88Z!4)ZA3(4AG>98C%C(&&*9]A"61$#PTE3B]K+0<]L%MP'0.!-/#
M#="[81Q=\_\EK,"$>V.O67R=N$O ='I,&E3Q;,824=+'K4&]KJVA:$':$(=!
MA2A9QG2J90[_2M$^!-C,W1OXCR#-X@3U)B#I64ZDCS 1M8-H.1+K4DW)D@<
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M\DI56$9<8RJ$.60LI6F,SG:9S0$*IZ*#<9T7O49VZ??O:^]+(S0%D02/_P>
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M6P7!V9-,',DGRB6W5TW/9-^\B"EJ$=I >J8G* PQQP$4@ABSRH>V]4Z494<
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ML,BT0L2%6*]<0'G(1'[AI 8^<F>58<QWG$RY@D>>3RPQ62V]4'+U;MCK9EQ
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MPC,I"[-[_$093>NLBE)61:<^JV+K.@FF\'^#?#3\W_\'4$L#!!0    ( &5
M;U.XHG8VHA$  .B\   0    8FAG+3(P,C$P.3,P+GAS9.U=;9.B2!+^OK^B
MSB^W%W%.B]*OL3T7MM+=Q-GHJCVS>U\N2BAM;A!<"OKE?OUE%2 H6 *MW=[B
MQNR,8E5F5CY/966] +_\XW5NH6?B4M.QKVO2ET8-$5MW#-.>7=<>Q[?UB]H_
MOO[TTR]_J==_NQGV4-?1_3FQ/=1Q"?:(@5Y,[PE]-PC]@::N,T??'?>'^8SK
M]:^\4L=9O+GF[,E#S4936O_5O=*;DZEQUM#KYZ>MT[I,6E+]HG5NU)N2T6IB
MH]%J-:6_SZXNSUOD@C0NX<=+7)<GQD7] C<G=8POSEKX5":-R2D7^DJOJ/Y$
MYAA!PVQZ]4JO:T^>M[@Z.7EY>?GRTOKBN+.39J,AG?SVT!OQHK6PK&7:/U9*
MOTY<*RK?.F$_3S E4?')TVRE](2W\XE@RWN:N8Z_^*([\Q/6[,9EJQ'58C)-
M@1;3IAZV]:46PW/KWMN"T.PZ\/,)^YGI:=0;$CBNAK#GN>;$]\BMX\Z[9(I]
MR[NN^?8?/K;,J4D, -DB#,:5 HF?/>S.B*?A.:$+K),B[?SZ$T(,!G.^<%P/
MV2D94TPGW';J>KP:,[L%9@? ]1P=>YR-K#R%"KRQJ5HGQ/(H^U:/97QYI4;M
M)+\%/JW/,%Z4L")9,[ DO%+<F@0OI<O+RY-71K1L.S(9P\O7V<>ZU"RF=A/U
M\NN&;_6HWBYLB#M9,1NB>N^T(;,[;6+$MIK\.\UI!A=$B?YEYCR?&,3DS-K"
MQO7B[ /GWZI.;-N.Q^NS*^&UQ<*TITYP 2XQ_UU%3AR2:12M4C$Q@ZG\GROL
MZJYC;:'UR<)U%L3U3$*3\90+>'+)]+H&4;4>Q9)_6WCR!0R)2J3DKQ*!_7P"
M58C5BQL2U6587-<H^-\B@6L.N-T+EQ1M-U2A$- YS/_OS=>Q5;3Y4$7WK3]%
MZPTR+=IZJ&+:9HG&L]IC^!V9QG6MXT B., S,(Y=?QRJ.<9]KC^N&8F/%,26
M?6U T@5_4#U.(NN(UT2LZB\GZQ761/F4&'W[*_^\SO:P<EA$4'&-)[GKK7HX
MLUIX,7*IR-%]K:MH(Z4+'T;]GMIMCY7N3;O7UCK*Z%Y1QJ/B"&P7*8!&XM T
M 8\1^)1$V$0R45(H"J6B0.P1MH2/!^VAHHWOE;'::??V@.&J?#&@+#J4 13]
MO*+E;U4'>#2&OQ_ (:/^K:IU^@]*KS_:40?=(%L,;*O1D/,!&XM'_5L4*$ _
M,Q5'5!.>![<,ALH]E%&_*?N$>),B,=YRHW%:!N\5;4?T"X*RAU!>6*N8%Z>-
MQMF.>7&,_0+$[MO:G3)2M:'2592']DU/ 3?>*L,A*]?O_+.M=4?WX+[[?J^K
M#$?*KX_J^/>N<JMVU/$>"/0N<\3,.FLTSDLQ*[ ).(5BJ]#2+,3M0F 82EKV
M5Q38AGX.K3O2+HES>W1_V^M_W\=PM!0MIL-YHW%1B@X@'W$%%0*T/[QK:^J_
MVF.UKP'3;]HC%5P-?6 $;N%7"P.90Z0 P*;4D*1@VFU2W7*H[Q+XDA3*NR07
MRV!+"JX2<.X,V^9_N14=QZ:.91K\"[:-0:)ESO36A&NZB:UECZ #**V;A!;'
M=B=:1? W&_ G#7]"[]_1BF8$JE%2-W*F:*D]#@,4LH70@"I%[.V]<8PG5ADJ
MY!4L0KO5:+7*=G;T<Z#@B&;2*QIV73#RF72)ATUK'[BF5(@0EANR7!KA.EKJ
M@G0KT':$.^DB=B3 \"WB3/L+PCQESSH.]>C^T-^F44R&4YFOVY8C0Z2:1?BE
M<L2U5Y(>-X\PH5)&(Y@2WZA:@$YAQ#.%B!.T,RD-8B0&)>54'(N2(ZM E'@L
M/6_EQ*6*0V>65]\]6.82*HZ(%S+?^,@!6M5'PRQGQZ/1C4]-FU#:UO_P3<IU
MEAX%RVL28WTI\[V07%@G![M((TJJ/'(@A<S ==@103PDS\3V"<P,->+U'+HG
M(FQ5)V2#U)#Y3DEA-H!:Q/6B4#&? H-JQ'17DA:J]DT9C?E27F&,DW6%>0_\
MEP[5B=K5]'?))"<M09C;2&RI0.#[*F8TB>;',4FUGPGUV(+7B.B^:[)C7&6C
M7V$%XGC7DOD.X$8(5Z-<K ?%BJH>W+)@@-2@X]@P%?8=G[(18. $&<*>8-^J
M3\P"6>:[=8590)%IHUAQ,-9%JJO.BW=/9$2RQ'B>RGR[38!GM6<M&;VI/VT_
M@QO8@#5U7(HM$D>X!^SM/FH74RC&^PRF,3G[;W^*EGKKH+C.-">C>:R[DM2X
M;:O#;^W>H_*@M$>/0Z5<_IHM19S)GDOIB2B3@[@@E)14=3Q*YK<B6>),]Z*5
M&YLJ9KV9CHWSE%MLNM^PY9,'@IGS6.H H:=-*?&H8\-<':*/:]JS&TS-TC%V
M+T:(X^ZE+#7RTF(UAV+6(&X.2MB#P" 46(38+CI:&H6X5<>(G _7Q%$'U::>
MRV\5H9KCA66,SR1=>>.$9&PV9"FUI_LN,JZ<V4B8BL#6J*!QY&E.GG:>L#TC
MIKVD!%SB,Z<9-)F=GC$-OGM:?HZX<P/$?)-D*;6SE8]O@25L[IA@'KN^- >M
MV%-).MWU^]WO:J_7UKJJ-FYK=^I-#UPZ*G-KETB6,"EM-J7T>G@DC9\+B.6A
M0. 1(N:%DAGJ=HG"/+79:A6%JXKIJL#+<;B\<QSCQ;2LLM&XE!)QQ)5E*;7>
MO@7=U< ;J3L&U$V = .-Q#*?B:%"6^V9"=TCR,GW2H5<FL7\.)6EU"RU$#\B
M&^K<"!1;$4U*CKS9@-YMC%W@JD=*IK[5@PO[I4T>Q6+6G,E2T3%C;?J0Y$Q(
ME, *Q,TXLF83>&O=O#UW7"\\4:^\+HA-2^\=[%B]F$'GLI3:1"S$H/5 @Y*F
MH-"62M+H0>FRVR@[_1&[=?]W=C=<82YDR1!G_1=2>E<XE(*X&!3*J382)9/\
MS9+$R?UE*R<J5<SI,YP:+7@\$,,$&_F9] %^8ZXI&U;+:1%&SU9#EE*;[]FP
MUA,K)Z&Z\*1]J/ 8(@-/O7OK/8],,:J2+*6VX#>A6NW-^*P^Y<P7CLW6FIWI
MGGMO/DUBK-E.4.X>O%3($I]C+XY8,+KO#\=C9?APTQ\.^]]5[:[X,F>6#&&B
MTVI)Z8-/7$J=B4&QG&HC4;;#"42)>Y0L-U,;JYFX5+2OM(?*39L_E^%AH&BC
M<@\%V"!&W&-.I?31,BZHSB6AI*C*0U)R@B 4)IPCM,Y:60$M&YXJ3A.R7?ON
M?#&G6''0.Y>;J0W\C=A5/6O,]GB\MC7R'/U'?\&TL?UE;FV;4G_.+Y5>D]V1
M6C$1+N1F:F==0(3D2AK7CP(#T-("E##AR!8Q;&T=^I3IO7T 0]95B5EQ*3=3
MNW]E6!%I/1(A YWAZ)$]-F?TN&\:;%0D)('<D)NI+;Z<) "-P7-YX-]*<T!3
MQOQ!B<J0>ZXPM.OUA0FS+$GIL_D@ 3$1"&0$\%77_25SY&PIPN08XF=Z[I*&
MHHII\9HWXS 5WCP]("Y]PF[I_+BH?'$0!"13.]89.*Z&O^6]V* +<67'X)=$
MHFU[IF%:/IM1Q+<#*:^ZY1O$N'6=>8S5:"]<*&V!F"VRW$QMFVUE2]*6Y-U1
MD36(F;/*J5%E.05)QX,:W&K6UMBS0L>J=J=H'54I\\C1S;+$ ^VIE+X9(R&-
M'T18D5<AA$;*'7,"N.!.Z=\-VX-[MCFA:K?]X4/)Q<.M$L5HG4GINQ5"F1RI
MI%24$'L$+?9%V>7%G'+%R=1Y*YW7Y@&PBNG55H^_?P&RL ;QH'DA-]/KR'G0
MK?RZY#8@$BM!9,;NIU+M*7MP$-._-_3S*!43XE)NIO=]\A%B924J4(\2^BM)
MD^"=">/V;R52I&1=X2![VI#2MVB%;VO@U:OI\/(/<4B)$/:94TEN9CR6(79_
M)9D?O]9!ZVLL'Q_V>Q"J[E1MK,!LL/A[+K8*%/>1II2^J2;QZHE5F2@2>@1L
MZ=^266A.L<(D])0=X"D.7A53T&WN?G<&6EB!.';*<JL,LE5//[>AD-B (@8A
M<]8/-,?6'=L#.2!OIMH> 1=X^^)!<0O$1#F56ZF%A%Q$6=D;6YJ"5FU!D3%_
M=C;]<K+Z2N?@^\IKG]E+G\.7OG.N39YF_^:+GC<8Y+.#K<2FP8D'Z(+VC)>\
M>8N+#/ ;N]1^P:ZA^?,)<?O3;^!;\/,8*@ >0#<\H9Z+=>^Z-L46>\LM>]$U
MS*MVKL@V+?X4K.N:Y_KL;;H3US*O%L0U'6/,7WAK^,'S!VJ(^F"5Z?GLVQWC
M^W4M*&YZ9%Y#P?MQPRM F!EQ5?B!28G?H;WNNAO>A^YY'^J Y0^$&9IT0&!7
MT/Y-I7?>"L-SZ^P3O3*<.3;M[0WI8/K$_E?^\,UG;+&SS<M'C-TZ[@@NM6WC
MGEC&V F?+O86+ZFW==V?,Z83 VRB]-%VH9'F?^$K:+]A#T<C8_RZD1@?I'V[
MGX-WV'O13Q-LL3?:7]=TEQBF5XA#<\>&8..^;?=]ETR\1&NV-3QN7O(AD5$7
MB;YO[H7[4E? N_OHB@6;%34@\2#,77DL4_0G>Z=GXHEI@7%@]*.]P*;1L; Y
MIV!\^,'XCQ\8&]ZJN>'R4M!&;^U#U8'VW.CY\3"<34R;1^B!ZSR;%#ZP)T,M
MU\=4-IQC"R*5X_/GXZB0H+ WL7LD;O; )<Q;X*<^I&5NQW=='@GYW=@;W?VA
M-A09J=: ,,AD;SCPLW%# MW/)D;79P^Q&G";^&.)%*J[SLN(>%Y0;7-^4E#,
MH7JC;)JU?*I4XJ@I=.(I 0M=,H0!=O>I71Z=>\R/0(C.EM*W)TC\KDW5'IKT
M1R)2@2[H7>1Q8;#T@_TXTB'=Z&(/BW/!\O(.(%L<D_G"<8&,+&&#5(SU&Q7P
M6^TU''"JD1?^T^8(5E+:GG)_?JR(EHK]0Z([,YNE2JH!1<VIB9=/?^%O&(&Q
M"")K-*ZQ7(*1GAB/-L$LYD#TG9O^O%"PWZ'22HRRX:\4_$9@L@'-_:"A-4OQ
M@8X@Q5,X'JF@YT#;VW/>S/!&V!VFB0(=!\K<'M"G/^UP%;=8Y\WM.,_$!DN&
M).B;ZJ"O$<B[')T0@XX=Y=4CMA'-);JB07=7XM_!PH_N^*6C79C)!B5'3X[K
MC8D[SS/[^V KRE-YGQ&!#Q+$#>]U!_L=W03NT/[TUG)<T\"]7D><\!21< @I
M#B@.5NH@Y7@@KZ;NB-LGJ'  S=GM4 81)2)^],BRB/8?-)@*+3C04?6=JYS!
MX[38!(MNGL+N5,=AAJ+W-7%/GCM49XWOM0<P^U_FPG:H2;>$L.S"?[KPQ9>V
M-,=>&8T_*'!MT'V@(>O1-I\)>[$-VZZ"YMRX_&6,+UW\)J92CHH'0*L.?'']
M>9B3W#N6 :C1K:G,UFH'T+0]L#:1SGYD9UE1>ZA3E7P!MAJ1-0QMGT27+.V'
MRAJ-1',&,6_2Y0Z .9WT:1\6"MD43Q@\MU4[@*9ET#+8_8FY5H32Z;J'2D@^
MLL&0QKDV (W]:0=;)G1#V\30Y7*,BSEJ'P#";$L_?AU.M&@V=CQLL9_&3@<O
M3(^=>P@6?-C?PO,!Q87M:?]BX4/"5?"TQ.JLAJW PD0H_"<Q'UKNU>4\*5%<
M[&%.HC:\8F>Y@KT]X.6I?0"]8FTGCH,"1K-,'A3UI\%GCSWD.\>,NJ2T YT*
M1:=ZPN-[A(U=F]N^H?2GGU?<_5IVXH?DELZVS9R/7&XO;>*!;BN%^^3+/G/[
M35.#[?&![^I/[(C%1O?FJOO)6^OK!P)XM9W%H=SB/MD+V5G%QH2B/840\ZO/
M\BV3;_L53%>*"/[4U&7UQ$RX!1SV](UM%E<ZT'Z^KV/1["#OYQW*7M-^F"G?
MQJ. 0?1X_Y'"37(.[U33.Q9D]I40?)A)ASI/CT\,\#82UJ<V.C"[\*$VK>#H
M%$22?8Q[69(_=>#+Z CC\)5+&O&"Y*;< I50S*$293]QX>-6J_\O5JC!<!BW
MV4O$@G_7#RQO.^67N_Z!SOIW? 3T(W>:#WQK>7GZC<W<'7NV=A!.O*:6L_(!
M+*EQ  WB0FA]<=P?V\[(918^@&8,"0X76OC^#5B^!2%!A0]M#K\'FNI/9(Z_
M_O0_4$L#!!0    ( &5 ;U,"G5LEER@  +FX 0 4    8FAG+3(P,C$P.3,P
M7V-A;"YX;6SE?5ES6SFRYGO_"D_=U\DV]J6CNV_(LMRE"%MR6*[N>^>%@25A
M<8HB/23ELN^OGP2I?;&Y'%!'[@J7+%$T3R;R0^++1"+QU__\>C9Z\06GL^%D
M_+=?^)_9+R]PG"9Y./[TMU]^^_@&W"__^?<__>FO_PO@OUY]>/OB]22=G^%X
M_F)_BF&.^<4?P_GIBW]EG/W^HDPG9R_^-9G^/OP2 /Z^^$?[D\_?IL-/I_,7
M@@E^][?3OR012S8L@=52@T+)P4F;0? L1<A,2L'_]Z>_>"O1(?/T2Q] Q>S
M!1$A!&=DT I9U(L/'0W'O_^E?HEAAB](N?%L\>/??CF=SS__Y>7+/_[XX\]?
MXW3TY\GTTTO!F'QY^>Y?+M[^]=[[_Y"+=W/O_<O%;Z_>.AL^]$;Z6/[RO]Z]
M/4FG>!9@.)[-PSC5!\R&?YDM7GP[26&^&/,?RO7BT7?4G^#R;5!? BY \C]_
MG>5?_OZG%R^6PS&=C/ #EA?U[]\^'-YZ9%P8YQ3#:'[Z:3HY__SG-#E[6=_Y
M<O_XZ/7!T<G!:_KFY/CMX>N]CP>O7^V]W3O:/SCY]>#@XPDIM'C _-MG_-LO
ML^'9YQ%>OG8ZQ?*W7^+I)ZB&9UZR*M5_K/"A+Z\E3V&4SD>+@7I+/U]\=)6N
ME1+X=8[CC,OANQ1C-$FWWC2JQIM,+__E*$0<+5X=G,_@4PB?!V^'(0Y'P_D0
M9P-FDTQ&,'#)2U!"(P3&%6213,@A"^?+[5&KJLU(MX6U2YC%A<DO/OME'<^7
M.)K/+E]9C# P?F'Y_WA B.6@=J+/_OET2@Y@X+0)BJ,#1.9 )4.3,V,"F;3R
M3C#/E&ZMUH4LM[6[ 9J]:7HQF6:<DFO[Y<4?6&%RX>66@H5INH>FVW/LXATO
M9^=G9XO/A.$<SR[_?75YW5A^/NETQ)>&)>&WM?PQS:OI#6&.)N-T(0\7Q><B
M&6C/29X<#/B</:2D=2I,ZJ1S$P0\+M,J2!#/# D=6: S1)S,)^GWT\F(!G-V
M\/_.A_-O X=6IA@L!%<$*)\UA!0$9*Z<43+[Q%43)-R795OM]G(>5N.&T?LP
MS(?C_?!Y. ^C <<2?+8<,!:R8%8>HA8.BF8R\R*#]:*)BH\(U">?MR4B[@*^
M"Q-TAO:]1(2W#BWFQ43<GYQ]GN(ICF?#+WA(5/D,WTYFLR.<'Y>/X>M :LE0
M.%)7(S'52E*C\ :,]UDH$YQP;5;[-07MDZ?L&C\-3=89KC[@/ S'F _"=$S!
MUNR&T*^Q#--P/HA&8]%($9%#PGM(%/1(;8 EED6Q4<<0FT#IQ[*M@A[Y/-'3
ML6$Z PRA^&PR7BC[SS ZQX'*)MB<(]@8+2F9$@2#%#IKQWRAKT'9)O"X*\DJ
M8%#/$PQ;#7IW:]!LAO.K, !-2"4["2@BN2MA+;CJKB*WQ1#^$*UIL\+<%&-;
MG=Y/\3.M[@=?/Y-?QKWQTE7?UC0&]"5("2PSLISD"9S*I:[_(=BB')8V:^D*
MPO6)?VV.C[MX[]HJ7=*PR?EX/ON "8=?0APA+=^7$DF*@&5R#HR+C"9EX!"3
M#>!#X24(K7)*K3C7HU+UB6!U!Y#.[-!=.'HZF<X_XO3L</P%9_.:G)X-K"BE
MU$<'4@I400$Q)P3%8RFQJIC:^,B'I.D36>H."5N/>W?,*,Q.R575O^J2_R6,
MJBQ[\_TPG7XC"K=<N:TQ)NHDP?-*VIQDX)52(+@3QK+(LPUMZ-(JXO6)0W6'
MD>XMTQEH'LBO"E(G.4F0+97;25<@L(P@I&;DNXIQC5(\/\IHKZY=//TT^#"<
M_;Z7_^_Y<DZ^#]^JE[ZRID!TOGKG4NA+0 7>: TV16Y"5LKD.TOEO2V<'SVC
M3\QH2RM?XKG386V6FK\21GH1M4B@<]&@4K;@7<F0G+?.8W;9MLG&/B)0GYA0
M1X#HT@2=N[1O;R;3_5$8GLVJ[UU^<P7<"VH_\$X+S6EI3ED64!6L41@RJ<O)
MR&1M3K*ILUM%RCXQIXZ1T\Q8G<'IMS&&Z1@SQ81GP_.SV4#%(%RQ$8IDQ 28
M))KG(P(6[1G7F2G3!C)W)>D36>H8%EL->N?1]IU5CD64Q,4\6!2U"D<Q<"40
M%51<"E.(KH5F>QL/R+,*#/3SA$$'!FC!E,E%/9!@C4I*3** TXP4Y031&#P'
M+ZSP+'A2E+7FS0]*MJWF'_'L\V0:IM^6'W<9M>R=5=OLS>?383R?5_M\G+P/
M2P,9IWPQ;+GDJYHEBUD5L)$'[3U!*[0),M<6M:<L?7N$W9U*;8W8Z?;.<)E%
MJ41@,IZ3D#A.M7HD>\F3]@@YF@C*.F*3TC(0T4C/C1<HVQ#Z[PC54U+?/7ZZ
M,DR'.\<9\6R1>IV,$\E#8T7O_70XGN,49_.'<#Y(C"4LI8!DLN98!$E:T:TI
M%A$N11>D;[27O+ZT/:7]W6.KN2E;%GW9R+)!3F0D2P4*K0925D*2MJ8[>*"P
MY$F*OGH3$'0/F"W-T((3#F*(V54H,A,UZ>,)CS%FT(1#KXUAI='NVZ/US;T)
M!;H'P*8#WW$MPD QG26+'HK6@IP0+Q!32"0 ]][9H@5O5 ZY>'XW6MRHI T\
MTH@9!3232!^= SA%RSE+,B)SM>RZ95'%>A7,NZTK6,O6]P+9;0:Z40%-9$8Z
MI2/84NOH55+@C$J 4>A@22*5VM35K5U LMOZ@ X,O<D0=VSE&UC+0>:<"@-T
MBARMKKD8$0(MDLIHAMIGW2A?]=U)O>%.SSWU"KH0;'90K"%S)1I?QQV"Q<1H
M0:%Q#FU\\(/B],]Q;8B$!_=XMAK\SA#^?CKYC-/YM_>C,)X3N:B$XG,-38]P
M/D":M#(D!HY11*ITE6CA7JV*1FATLK0)\;XG5?^\7$>HZ,P4G8&#@L8P_C2D
M8/)"49P??$VC\WJ6]Q^32?YC.!J1RMQ%90L(SC-Q1OHN.$TN'F-A(DD931N>
MLXIT?8K[.P5+YZ;I##173R>MM'-D-U[HF<0$"OA,ZG&"K$"67&JTN;>.\7=;
M =61\3<:XNXB]<GXT]TJ/2:M1^^)@Q/=!D5+%L1H,P3MK8CH7>!M=BD>$*9/
MD7NG9M]VX.\@X*\O[P[06_JYS2'_DX_T]=W!T<>3XS>'1_O'[P[>'I]T=MK_
MD4]O?^Q_%;4Z.O__ ;_@^!QG V19L%@\2!=$W;Y7$&0)($(6FMDL \<F4^U2
M@NUW&Q:?\X8F2]W[F(8T_]=P?KI_/IM/SG!ZM8S5N4-_<CU0QX31V=5R!5D4
MJ* 9>$<AH&9")^E,4J'-?M4&PO8I;-D(-??W%-H:K,-@9EGB<K H>*FTV=A:
MT5*JLM(3 RH<8M 9N+'16!U+;K0NW1.E3V%+)ZC8;K"WMGDMH+U>"*_/X YH
M<562T>+*G/>U>M92I$0KK$@V9VZ]26&5>N2'/KM/T<16-NQD\+K,093A?/%\
MHSP7+#.P11"=$:Z $X9B%VU4Y"0)CZY5QN%"ANV#YLO1O'28P_$Y><=C"NX7
MAIV]PC*97AP;)U^)LX.OY%0)/\-QF'X[)+//'MZ\'7BN-0]U/.JF'+G613Y
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M!RZB(I9'GMPKFR$:HS4+ILA&S9X>%:E/F<1&*'H@2=B!>3KL0ODY?%N<:J9
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M6=@ -;WT*C=3RX%Q(:0.8"+62^ 2#6N(&K1A3NDLG&?]/T7>M],^/_M$V!1
M/>6=C_5P':CB@Z]W4?O%#2PI6_ 8'*#/Y /H=UX^A^3=8_KU)QK^WF&VHC*3
M.7*P7BHR@F/@,D7[/'H41B8NPX8G\W=Q"OF'*_'./=!33Y1V 7)7*.K,35TV
MSWA_/DVG88;7XE\+35$*>4Z7$@T>_46BD3MP%*S7#O'$+41"%]N$NBN)U_<%
MM2]P;F?SI^:0EQH]2DM"MA@5BV"2$$1+; &GT0#7OOBL@XB\S2URC11J,,XW
MNH ?E[?TN]I;AS/V'J>I>JX)P7,\I[DP6F!U>8?$FS"<_C.,SFO%DK!%U>/3
MUDH*.90!;S6'PKD*W!.2;)O;:SM7I>^KX\XGQ H\?8?@Z7SI&X@<HK,A0RJ\
MYN BQ2Q)>W"&F2*20]OH[M%U.HCUO.R_*> VLM13KTF/CH1F13*SP+G(H*+0
M$ N!0ZCBC",MS-W3UCW,9]Q;@YYE^?VNW>3.<+.;&U4.C_YY</+QW<'1QQNW
MBEQW'KN^-GWSBU36?D2G]Z=LIV!'UZ:\QGCC27M?Z$$5-6\FTY,PJA<B_(JC
M_''R+LSK6[[MGY\ME/Z"]:+Z2[S5J^H',BE$3Y QTE*$Z6K["LT]< Q:<NL#
MPS;)HLY4V-:7WWWT'<%26CZ9'E9O]:M/#Z/+9[]"BMWP8_@Z\"))$UT&'[6A
M<?0!0O$1HLJQ%)TU\C:;,IV(WZ=]F*?!]EU/O7M4=$9.;H_/@T+?'*I?)Z-<
M+_>M(^9=$$G( J5P1V$]%^"L,2!S<B(FX[-H<W1_<YG[1)3[ =T=V;^3\K1Z
MA6#]OU:&?J$QJI5!/QJV]:=A5E9E4VJ9-H61*H4$T7D'SL406& IZU4.0.Q$
MV#Y1Z*?%<S_QT9F;7G-P]\XFTWD5?7%)>IGC=&\TFOP1QJG^DWV*$H;SM_7:
M81,I&L;((>E2&Y)1?!)19QIJXY"78@*V\>&-%&K,[VY*\2K,AK-!D<E30)=I
MV"P%>#I14"5X;4N9F;04[]E&EXVO*^DS9FU-T+PFA]O.\HW\P(;#)$SR0@IR
MJ%X&(%^;(&16 &5,43CZ-N@=3/HN9OBSHG [P?'.$=(':G=3KT$H3.I$;%3H
M5.J=C@)"U!IJ:S3O9.&6K7*RID.1GC%-:XK9I[3\4U&SAWGO8@B+I(#*60W:
MTV*BG$"(10DH6")S(2:>=^&7MU#AJ=)K]=G7##U$DUUT#D*J-+UD#[[>+^:"
MTIY3R(JB39JR$_&?,5'K"-M=I=<V1\43I]>6:W V%%M:":;$VH^T6(HS50:+
MDN>27;T<ID?IM6?.S1I!=T?V[P,'6W$::E>45QA(+:RM4I@ +SF"D=IX+,EE
MNTJ?C)T(^XQY6\=X[B<^GHK#71<>&6>8R,% 65SZ0407?+ <C.;2"V],SKW8
M$7VD.&U[AG9S"_NF1 -,P3G)&!3/:JF-]A"0!UIS4^31Y5JIO!,2]IB$SYAG
M;8:_']&J3DS9@Y5HX'3P@8L 46=9+Q:HU8#90BF:%>&#+,(T7V*>,1?:#EX[
M-F"_4JO$T'AF&B';%"C(\!GJ+=90ZM5GNAX4QS:5';M*K?:4[G3C$7<.@5Z4
MV<V&X_U)/;YQ/CF?517>3Y:5V,VJ[G[XQ%T6X:VG_DYJ\FYSXTMY!HKK4!*!
MRB5BQ<I[MSQ;$S6SW L"EF]39[Z)M&TI^;7%'GXZ%^_H':>SX^G;R?@33@?%
M62<I@ #,RH.*MMZ6K@68R+BMO3N\>(K<ZKIZ/!_2V@&&O^^>=PJ)'46:/]+A
MZF3,A2Z#*"5*3T(S5NO+M9#$E+RB:#D[&E+'/&]3?M"M'L^'+/<.UEM!8D>P
M?ECR&QFA!7'*%$H6&24$YBC,M-Y"\"A &JU%DMQ'W9_E[8[P_5KM[HZL=\)D
MCQI88:I><N8A6N%!>A[JSJR7H<WQZZ9J/?>U<!O\MUT:M\%/3U?*>X-M;5(^
M)- B+)+@@E2B8>=%FE*"DF8G-5 =J_7<U]'^3(DN\?-D4?YQN5*[3*:S6SG>
MB[Q&UX?KUGMDZSA_BP'H*-!?.<G.Z+^BBZO77M2T4>80>'4?(BK'2DRHVSBD
MS?9+NAZ):VLL<FL?<?S?&*:SZ[R>],S)G"VDE!TH05[ 6Z-)JV U8\E(VZ92
M?3NY^T12FF!QO5VE3LW<&=582^8WPR_X\91<SZ?3^^)K=(K'&,!:-*"P2 H!
MO01,"8-RUN'=KNY/@=+OJ= G"M$_P'9F_*?![O'X4OJJR!WQF8W%UX:+.1/!
M5]YX<%Q%6'85"YY)NYM3R1NKT*<-K/YAMS/C[QR[_QK.3X=CDK\*?6.K3V,4
M.A;(7"$H%@2-8?#U *KD+$:57)N64=O)W8=[!'J)T@[,W R:/SP.EE,T,G )
M:G&1:3V]'TUR(*)D2IGHI94[ >-Z!P%WO^#</K+A!#<YJ@R)$>E3I4;XFB&4
ME#T:8:3G3SN'5U*CSRR_4^1VO0!M#H:G(5"7I.^VW)X)57@NY UY[?)4;_].
MJ;:O%L:PH'T0NYG[Z\O>9[K?'^1N;_;>Q*JW5<!D>$#%@4O4%&Z'!*'H !3)
MF.*+"B+BTR/W1VKTF??W!\2=@N%I8X [\["(P.M]/%D(DCNF4$O^%!3A4"85
M;7!M&B)N+WN?8X%>(+<CL^]F"^;-WN&'?^Z]_>W@W<'>R6\?#N[4'%Z%-.\P
MS,ZG6*L/RV2Z;-\X&8</=0RFP_&GQ?!NOBW31(Q.MVK:#U17VS>+1U[)\WHX
M2Z-)%6G G2U2* >.U4M!8I(0*18%BE$Y4C#L;&K$^1X3:5M/7 OVZ_7FM^OV
M']0=A<K.(#"=*"(7OD"0-H.UA$'MF=.\399[91%[%9!U@J&[#K2-M7:TK-](
M+!E?DF:F@"$V72^P0W!$.(!S+V1T(DC3_W-B.XN0FD"IB:TZ0U)%]\W306^^
M' WW+^[)'>?:&7[YPR"E7+1F$9S4%(Y%A1!S-J DBT$F$UK=0[ZJA+T*4YH@
MJ8FM>LO=Z-7A.(S3L-[+,IM/SQ?'28XF\XOWY*?E=)N+]]1<KZ.!W9(#UH.,
MWST1MEQ]O[,(#XI22B3+@/E8H&Z4@$LV D-GE"A"VI4N>=].BMWQ0E12Y&(<
MV.5%>:*ZCJP@"0S:\90T;[.6/RM>N&-<;4X<US%G\XXY-Y0O*:&1%FI[%%"H
M#43O(B!Q$Z]8,)JWR5G^4+0^4,4G1E>WYMO-TO_NX/7A_M[;_>.3CR?O]_Y[
M[]7;@_W3,/Z$P_$[S$-Z7,TWS=Z';Y4D;[Z&;_:<3A?C#E3M*+-R>4?)-PHZ
M?AM_#L.\/PK#LUD%YO*;J[OD#KY^QO$,#Y?L\>+7?% 8^:<B':"L]YF@,>!4
M26"EU(K;S)-M<ZIE:]&W]9$GYY\);?7S;]T(2.*\GTX^XW3^C>;V.9G_&]&G
M\VD]H_X;F6SZ!\U%G,XN&'G-J/Y(\ $S21>."IQQ#%16]29HK<%Q)XRV3A;=
MYH#A[G3L R=XFEEQUWGW%%>=<8LM]7L_'4ZF*VE'*F@O/0(OM0<$9@ION?(@
M@BV")5ZR:%/5LBL-^\!T?HHYTP93G<T8(@*+V)O4J<>>L I8O[DO7A;::>X]
M8"@DGBBU9T^0@)$DL]G$5JQ\91&W'8OU<;9\^7U]Y[5KY .>R,-Q;H$OXJK:
MIR:ZE,!SI<C_*2W1]X2X/*Q!GU;,-@B].\N?Q/:=S>)MI+]R4.0G4R8GJ6G<
MA"1P*4%1FU=U0&L-;G(H+;;9\^Q(@3ZM6OW'[::6?[J@?7+V>3*N@SHIS0/W
MU9[5/'C?0.4& ?P/R4NT5B6N.$1M#2@E C&L8$ S+-*JPK3*S3W'>J1VO8V"
M]2?:A^'L]Y/34+<P]LXFY^,KHPVLS$5%[Z"XVOF960U>JWK47&B10XDH[ \0
MV[%(?5KPF^'N9@/+IS+G$R[YET'1J_/YT63^ 3]/IG/,AZ^./ES\@X56 RT\
M,1BI(,1,@3N76-.W"#*+((K"D!MUN&RE49](07-L]PH>3PCV2_EOR5ZD#SYR
M"274ZV-$ED#,QD,P%'IK':RT;7*=W<C?I_*2'@-Y:]-WTN)Z4V)^[^6K#Z+0
M$K'HI,#96N>7I%GJ4 ]GRF)"/:G9A#;\2+(^%;GWE#UT:MP5 ["+U^N7&&;X
M]S_]?U!+ P04    " !E0&]3JR?.:Z=4  #BT0, %    &)H9RTR,#(Q,#DS
M,%]D968N>&UL[+U;5YO)DB9\W[^BIN9VHBO/A[VZ>A:V<9779V,/4'O/](U6
MY,E6;Y#<DG"5^]=_D0(,%@)T>%,2PKM74R#)>B,RGLR,<_S;__[K_.RG+WDT
M[@\'O_[,_Y7]_%,>Q&'J#S[^^O,?IZ_!_?R___U?_N7?_@? _WUQ_/:G5\-X
M<9X'DY]>CC).<OKIS_[DTT__2'G\SY_*:'C^TS^&HW_VOR# OT__T<OAYZ^C
M_L=/DY\$$WSVW='?H@@E&1;!:JE!9<G!29M \"0%)B:EX/_KX]^\E=EEYNE-
MCZ!"<N!0!$!T1J)6F04]_=*S_N"??ZL_ H[S3\3<8#S]\]>?/TTFG__VRR]_
M_OGGO_X51F?_.AQ]_$4P)G^Y_O3/5Q__Z\[G_Y333W/O_2_3=[]]=-R?]T'Z
M6O[+_WWW]B1^RN<(_<%X@H-X\P!Z?)I\^X>WJ=&_7+Y)'QWW_S:>_ONWPXB3
MJ7@>9>&G>S]1_X+KCT%]";@ R?_UKW'Z^=__Y:>?+E<.1W$T/,O'N?QT]>L?
MQV_N4MH?3'Y)_?-?KC[S"YZ=$<73;YA\_9Q__7G</_]\EJ]?^S3*Y5[JKUFN
M1.E*SO^LW_;+VC1](D)&\2)DH%?SH *\0QKG??OZ-'_[+DBYX,79I$.*[WYW
MI_0.S['?Y0+?^>H.J)U^$9SG\Y!'79+ZW??>HO.:R%D*ZU>&Z:GX*>/9Y-/'
MT?#B\[_&X?DO4SI?OC]Z=7AT<OB*?CEY__;-JX/3PU<GI_3SW>'1Z<G[UR]_
M/SCZ[?#DS='QX:O#PW<'+]X>?C@^?'UX?%P_]_[E_W=P].KD]X/CP]_?OWUU
M>'QR^'_^>'/Z_UX=OG[S\LWIXXR'3Q^AGM;,2S9EL#%!MU:,H-D?].MI]Y;^
MO**J+LHNKEW^:Y('*:>??^JG7W_N6Y4C]T*@SDR%R()!SU7QR(6S49A>8]KJ
M*EZOX]DP?D?J6;U#AM] ?X8AGTU?[5V,X2/BY][)A*[S>K/3PN<W].NXYV1&
M;JP"Y'1=T*5;[]NH@$N?;0I)1*ON;IGQ]18L. [337/UB%\JIG[)9Y/Q]2M3
ME 'C5_?0_[R?EDN,K,[=FT$D?66<7^7+_[X9G.;SS\,1CKX>_M=%?_+U>'AV
M]GHX^A-'J4>LH4W. 8G0@1))0T@,P1G.DE"%12&:\+T,E=^OR,V^.1A=K\W5
ML;?BN5B5N4X1,AEN2"27F"#F?OYI.$IY].O/;%WXS%!V\@E'>?S^8E+UNJHJ
M]P)7W&%)$$3PH(JQX+5$L,4D%S5/SIHFD'F,LLW#I)U<APV%<A<TO&/0O,31
MZ"N1=7 ^O!A,#B:343]<3#"<Y=/A!R)],.D5Y&0%H0?FO "EJI7C7("$$FF7
M:56TW02*'B?U^<"J8['=Q9E8%6>DIMW9 Y-A_.>;\?@BIU<7(Z+Z0Q[UA^ER
M:QSE/Z=OC7MA>FRC!FE= :5M :>M!N&%]\PHJ]$\HA*N_/ ]1,YF!'$7.;+K
M:VT^T7_'LXM\0S,J7R33$70N'%1& 3[D!%[%G&(*WKJTD:MN$6KW$&T;$]Y=
MP*DNCZKI5G@Y'%PY']^7R]\G?3I:3W(D'B9]HE@9583. ;25M$6"8X"9.4C"
M>248!L[C"F?58D_?0_AL2!1WP:,[!,\4U8\3' H6P7*$C(F!XIG6QV(&:PIG
MKI"1CGQY["SV\.<!G0:"N(L<T]Q\\SR(R,DT"*Q:"H:(=(X+$(&G%*7PR.(.
MF&^;L$&<3['4@$P@(PGHNN#@,]).]RK9XDHT"G?1!NG")S2]0S\-SPAUX[M;
M1M,R%.8C%+HM"<1, IJ = 8F1XCVCNLY'N0F;J$'"=U#SU!W@FE@Y[\<GI\/
M+TF\>[((&21ZD2 5C;2=Z(@-TA*!#@V&((K@;7RH#U&U"W=3AR(=-I)' ZS<
MY;KG49I<X]Y22-HI5B>B*&<(.M/++C'-6",O^RPM^XV+-=>^0\_--45'>4(+
M,#S/;X?C,1%34%O.(-#92+QQ#4X$^D&"L-GR@JK-4?$=&?N-@=57O('[Y4$G
MT0)*=?!"%KI326\G6]X[4JKI&(,<@RQ6!BVPC=*Z'MW[#; -RK1#_\PCU"]H
MY26G(F-"@Y4E@U*!UHWN6V *#:=+5XG0QG18B^QGB<<&$NW0X[/09KKEU"S>
MQ, =V"(3*)ET5><R.&]*BBP[Z]H$7Y].Q&-+!]YJ,FK@ 5K,.QYCT=*& ED7
M XK18H2"=/I:&U4DC9!9M_$#['GC: T)W8617<<%/27P.$\N1H-Y4#\<T]+^
M>9(GD[.I*Z2765 Q>5T#PG25.R+:!Z9!&^4U)C0JSH!IKO-YR<?N)TA:K_]=
MJ+@F4)FB^0ZEG,A*C#EP+ 50D?#L1%T6561$PX30:1VDS'WJ,P3*^JM_%R=^
MW9OI(/WGQ7A2*1F?#@]2F@H!SSY@/[T9O,3/_0F>31%>$_?3R^'YYSP83^L!
MCC,MV;@_(85M]*4?\R63QSD./UZ*<LIOCT5.QZ3*H!TC'<YD#MZQ",B+M!RY
M1-E&*V_-V7XB>"=Q,<<3NG9.Y?O)ISRJ=(_RIYKI_R7?>&:.\N1].<6_>L7K
M&+S)9 !'"PJEKR4_')+3AFR3X!GJ)N!=A+K]!F#G\ID#HK:Q%\\4"R8[2+KF
MY2$AW#$M(8:<@W=.\D8.U<5C+YU$$*S5,7MKP'!#FHZ6!ESA$2R7UAO.BU%M
M,K(>BR"L485P6B.]/11":BXBI*A-#48S<(H4_XB:2QV<B;E-)O[W='2XT6]5
MRC6/HZZQF/-"7S]=UCW]+9X-Z<;Y]>?)Z"+?O#@<3/)?D\-+I>K7G\?YXUTM
M<PT\7"4%T'$T'-0[\>"O_KCG58G>TLGF!3)023' &".Q15(-UO)0&L-C'ED=
MHN6!&L8'T+."N.]#SMK+WB"&.D/3J^G5N1!1O9FJRDXQ,9>L+E6$^VI#'T#"
M^N(;MEK[C0&#6\9940IR/3R5%AJ\UA&BR<6(**SUX:D#XKOBV^WC89DE;YN0
M\VZJ4/>X#-E&1Q>H2S7.GZK;4$FBRDC&>2*#OTV.Q1U2-F\S=""B^Q-L5EC?
M!N5Y]YC'5\1) G-)(D#(CO M/2.D.P>&&1.E%,*JTL@!\@!9^P"$[M:]P2EP
MG"?$7TZ'.!J0W36^HJJ8+'T4"9Q.N?)+!UU.'*S'(%#K6J[=! WSZ=D'&'2P
MT@V2JPYBO#B_.*M-:NYS95P1BD7'D RIQH;N/J6]HM.K" @J)9V$D=;X-@?$
MHB3N TK:R*-%6M9%&/=3'T=?3_ LOR_3BVZJ*17EO*]%$RIG8E^Y LY%#9'I
M6#)7&F4C>_,^DO;!UNQDN1L<(+?(.<)S^O5TA(,QQKJ^5_MA$0J;&IV/T[@E
M"[0;H<Y"I8U$6N1Y/TZI4A$9J@(!.5%JT-%%&0PD+;/C.LFLY5YAYC$C=5N0
M6480#:#RYL/[JWM/*)&D#0)\YAH4XPJ0=*@:ON!"*G0&V\0KOI&PA=*ACN4S
M6TJTTN+>:Z+^VR\S"_.6_ER[W]?[X]\.CM[\Q\'IF_='!T>O7AR<O#EY__K#
M\>')X='I]-4C'(UP0GK2JZIJGXV_)W2A'EXK/*3+OESK\CC3:TNA2CI+QI-1
MRJ,-*2G!N5/"H6 1>RL\KX'6>"N.@SJF$!"D*)Z,85:-8>.@&)=8<&0H81LO
MY,-T=7G/7=1]1G],(YZ7F7QO!K>V<X]+*[B)-9M=DI88%6W&PA)D4WQ4LEC'
MV[2W68;*+1R!W2'GH=NO4_$T<.+=\BI^P-'[T=3$N,S9^I!'4[)[A6<ZQ4N&
MD"J)BCM FS+PX+F.MD1>VD2Z%R!NKX#3M3#:JM@?1I=I3I=T25(6>9PV^RH(
MRN;:CBDP$%D9B=E*IGCK8^8[BO8*&9TL>UMK_>60+ [ZUJMLN)CIDD_OOSOK
M(D=?DHR0LZ^^:6O ,Q? %M0B6>DD-DJ968;,?05.QP)JX /\@%^GJ9=7!-?K
MLG;P?CD<3\8]C4EP;Q48S6@5>!* G$P)A8FKY'D.N4U2XD-4[156.EO^!C62
MKW+)HQ'AM=!_^X./ET2AM]X4JP$%5FX)N=42@1)-<"5JST0;VWTN.7L%AO47
M?-.EB8\75LH4C58Q /<$7U5, F==!E+ BW8YL&P:IFP^H=KMEA?2YD38OJ?5
MO5IZ8%)'F>I8C>KWBKIZSVJ>3_&\6)2,LXWT<WH69E,+H718QGA_WO;1<)(O
M\]4_G_4G-^ _KBH:[WG,T2&I]<9(!<H8TL8DDQ!+< &M02D:Q2J6I'2OT-14
M3!V7/![WQ_^\*5DB_:W&A5]>C"Y[RO$D=681HF:.]#1-&INJI2*6">%LP*)G
MXN9S"QP?>L9>"+[3A6Q0J_AAE,_[%^?CFNB3TU&>]!(K-B5.9 1FR>B/GLPT
M$< D+[/GC)?0YF"X0\I> *";A6Y1K7?#[/O1Y5GT+D\^#=,;.H+&DYQO+<&+
MKW<_?/VQRW21Y#0KOE;Q&U>;L*D,H4ZDJDWY8V99>-G&@.Z2BXT5!36\8+8E
MU)TI+[HWYP #K9].!KCQ 11WM-]RMA"0B8(Q\5P:]939N52OK8%DX42Q982U
MG62?12C\D2BVNE"7S_I912+;P4X.(4MM. 0ZZ6G/Z B>]'D0TGEOA/$"V_0=
M?G*)8HTALXP@VB:*L12MD1I\B72*EB))&>0)',;:U#UQ@XT&E.UTHMA2\KD_
M46R)Q6V0!O$ML_KE&8['WZ&;"2N3SS!-AE->(KAD:LV5B$)8SE6KN/9])/U0
M23H15H-H^&UZKB^\!2AJJH+<I6G+U='K"6TV8Z:;%6]1#GN7,LZ=I#.2KD<K
MR&C4O-#QYFM_"5D8&DYV8YN2R$UA8-&"Z-806&:A6VB7>=3/XX,/HZL0ZNV:
MW<*1EZ)J!9>CVQ)][8XCZECPHDL4)1;1!@,/$+5YM6)=F<U>"!TM> O%8DK:
MB[FDL>BQ^)A!9>E(<8Y$6B3Z9.""6^.\8XT:G]Y/U)Y@8?T%;W8NO)Q+6I!2
M^UI]*5*%*=<64)0$*%F2RMJ C<KE'R!J3["P_H*W2)R<DO9J/FE%DGJ"M7]<
M-*"L,^ ,0\!BK$M>!V$:30"_GZ@]P<+Z"]ZB]'E*VN%<TI+W"14S$ RO@0;-
M )U@$+QRC%F.OI7Y>3]1>X*%]1>\09[CRT\X^)C?# YBK!/8^H./A^-)_YP4
MYQ=?3^D[+GL'"2^$2@D$J3;$.TD/?5#@I,Q<JLR5;],Z81'JGKU[HG,1-CAR
M[J>Q4GC=8&P!&MOZ+A:@<CO>C.YEO#"(UA10"U?'(K3*6*1'IX!Y3SN*DZH5
M0J0=)1P7.?IB5)M2S.V!Z!%WR&Y@:!FY=(B=FG1U3=_WR5?7-/[Q.=44SOKF
M21R.\BN<X-4=[5) $;T'J3SI:ZA("U!*@62*7LE$L9W)KIV;V;;J\[>@_W0N
MR>&&Q;#AXOX7?YR\.3H\.7GY_MV+-T?3RO.3#LKY%_K:+@OXE^=CIF1?JF*-
MMCD3$XH5[@M/.8J,-L=26.@M](3U[H<7%^/^((_'!_&R1?[E<EQG4C&3?1(&
MN.<1E+$6G#(";-!,E(A<8)OR](>H6O=&G//='TB3I6V%'TD)_?NP;N$W@TD>
MD<YY^2DR0WK.)JF+4'3.NTRV!YD=6">_1\:<9-Y)SMOD=:Y&[^;/P<Z0-'M5
M;D!@#9S+UP5[I\,KBJ[9R./?1G74)F812TP*,JN.C5Q[^*2,-9$9BZ0#NS2:
MT?8897L$G4Z%T$ [OR;GY? \] ?3XM_O*H&G&1V7?I!K2_@*YI=56@>#-*T$
MK6:Q"2E:Q2W(5-->E:G32T1->V7!D-81F6_3T;=#)O8(>ML2;0-_^!*L\%XR
M1N8:T\-2@\31&?"U#W)*OI1L58ZQC8-\&2J?)\Z6$TX+SQ:./UW?SZ]IB6XM
M1H^GF&S(#G@19"$Y+$0:8=Q%[0G]C'ELU)#\?J+V""9=+7V';O5JWU[W8/I]
M:F"]S/4,'/=2$=)+TM6PBDPQ==5"Q7O%8RK&,KZ(#V'NE^^!3+M9N 8M .:<
M1;>8/L[35L>7S0HRYXGG+  ]*>;*:@8A5PBZ8KA1==!\&Y?CXC3N 5(:"Z9!
M$?^W,ZHN=GY;V^"08H2#C[77P $I[I/Q/W)UR9"&](6NN(_YCW$N%V=O^R7W
MT!=TG%0D)RPMD?<2?+"D,5GO32TPUZJ-C;X.U7L$LXT)K^-!QG.VQ^D5U4?Y
M:D3,C?>UEY6VK* $IG(=N6S):*2%@<)%,4[2$1S\ M?3<D_= Y@T7NJ.Z_?G
M4'HY*?<6>:((IHI#*/725=I%0$EGI]"<)87(@^6K(6'V4?LK_K46M4%)_QR^
MQQ]&P]?#T3D>YR]Y<)%[5M ]*+R#''DA]FN"&J<_#7*;A96F^#;EV@L0MP=(
M:26*%FT 'J*13K2;";&]++"(0'9WQ&+I@K,<7+ (&*W/WGDCW<8B"/-)?";0
M65TL+0;V7BI+9_.4I6M]BO>$T(59%8 %O-+*G>(,A+52*^XMQC;IZ(M0MT>P
MZ5P8<Q"S?GYR_)331<V8FX?R%U]O_769,6?);G.)>0B\-J*-.H)S&$'KFCB'
MQCO9)B=Q64HWU4&D&7Z:BF97>H3,86V:#Q4M4U9&!"9]J7Y$.D2=IG5DQ%&J
MVR*V:>%X#T%;RW9M"H+'+[JEA=$PLGF;K,L#]#HE:A$"FV:P/DKB=M)7.Q'H
M B!97QI;@0V/63!I(XBD::]DKTE=DPZ\T<X5-)SKMF'N#</ED435[:!E&2%T
MG9A*%]CHXOQ=3OV(9[\/SU(=L/GV[<NKQ,?:_HWSZ635:@]B-.!0<<@>;:XI
MD)+/%.O-SS]]^#$[H?*N(Y1AFQ7M,)'J&VE$TS3(]>$,:^MA/.N7X6C01[+A
MKAN4^"05YPE*2;R"G32V*#-DY1ES0C/D85&9/_JTO1-]M^O;\78_)7WVDKRC
M_.>[_%<_#J^'*3M?9[%;L+G:[5$'")X)D+K8HHKF=,HM(/1['[!/<NYF%3M,
M+:I$_4?_\V X[E\/1Q92L)))"6::V%*B]IE K<#;R)2(#-GL*-FY\OS^6_=)
MB&NL5X>Y/)62:3/6/+JZ,0[&XV'LXR2/WY?79\-1/^'-Y2%0)A]-G8%$5HV*
MW-46#Z1?H<2L=!%$[0)27?R)^R3Q1NO<<0[/'X-^;;J-9R]Q5,=6OQCA(-$Y
M\PJ_7A''I2HNZ 0^^ S*.PN>V=JOUX=H$(GV1<)DCSYHGV3?[:HV2/9Y(,C_
MXNL[_,_A:%H9?ME#2!EI><@0'290(=(MPU,!6IPDO$9/B]/0?;T0D<_"6]1*
M: VRCA\@]8;0VOCPNK?8 N0V]2<M2?!VO$O- + XT#J37@/_T[)DT\'.6+0.
ML@VE#F6KD[>03G=KT7NFF'-MO%$[ ;9'?%.[BK5EA-8 8Z<C3+F2<ZW)VV*T
M%\8"RXZ1><T,.!Z('LXQ2F&%4VUNQUE*-J\_-17=["BB==:]Q7C?B_%D>)Y'
MT_3;>M=_ZG^^)DV6DIA4#G1.M7C1"?"1C#M3F!&*5/R<&W61N9^H_49'5]+H
MV/]UG/$J[^#EL/KJXN2:*&VJ%U]H,*HV68I>00@$8:UE*#DG8EPM8%3=^X#]
M%'=W:]JQ-^S#:/BE%FT=Y<F?P]&W[F=1&&69!>=1U8Y7E<7 01F>E= ^II 6
M$/+<+]]? :^_E@V*WU[E+_EL^#FGTQP_#89GPX]?CVLN_#7V%,?D@HP02DT[
M8:Q6Z5FR[83BS!K'4+1I8?\(8?L)DQ92Z="O-AY->L>U]<M4.;9:.HL\ 5.R
M>GIX!E^8 T-H]HD9)Q=K1DO?>@L6]-<L)+Y[[%X[1%9?X Z/AF]$7"ND"Y"Q
MC MC<7EWO]4?=TFL(8)9(:ZQ?AWJ:[/DU!G<A3O2$XTB;2+I!$%K#IRAY3J(
MP!?+A]L-,=YC['<OQ666K6/IO:.5.J^I$)?MR;7W.K(,09 BJ.@/"*PXL)9H
M<IJYS!9*V%](?M\]>G-W[EJ+/^QBY3JTK*>$X%^W"/$N*R^R!.$]:7JUAX8O
M*M#]$-"EDI+W"S7964R$MQ_]!$6X\LK=NPLWUT#N6FD8SE4:NNTJM]BS6K>:
M6X'CF?YSVFLT7#B?(A),@N,NBDQ*K<VV>)OG]I];[+$-F])I)KV)$L&;)$'E
M0/#.UM/9XF4LM2K4M7&-;;@IW2N<D I\.[ <QE-G12\&U(Y'#20M47L[.G!9
M2LA.!2T14V%M6^PL0N5.Q.)70\T"^;#="*>!4WE.@>UQCL./@_Y_DS6=\F#2
M+WV\4]1T,$AOZ>7^&3&3Q_3>Q7E.5S.V+S])WY+[7^J_)"V/NX*R%,":<:)\
MIF7-@8'3IHY8MQ'YQGH\=<[=3@"W(WP]W@9DN^#HV%D^A[^I*[ :,'CV9E!J
M]6=]]4T5*9[=M.R=UH.2-C#)-X7H5^_>8JYG!2L\V P&71UL$")X%PN4)$FK
MREGQV;KO1>O].Z5S#R&\<^+MV/W?;&N>?!J.)J=Y='XY1&':#K/'O*AS$PK$
MK,D^,SY6^TQ =#QEX5DRLT,J%L5Q.Z*?#ZAW1/ -8B#-F/TPRI^QGP[_^IP'
MXTR??T^&U.CRO9YB.7MT!BROS=>#H;N))07)6.:YH8NI;*S76'MV]W"?/!WX
M=)Q:W>V-=\7E-7M7*S"^8K/P&)UQ#H0/-0/+"@C%*A*,4<PS(^VLJVP#NLV#
M).\ATG=9Z)MI&+GRAJ8U^IQ'DZ^UC&U"GZB]Q#Y/&TII9I0(C@2A:VZA+I9L
M$YZ!FR!*#-;KV&9.VT;8V\-=L+OP:-#QLNOM?A^;7AO+D7O@6AM0G&O 7 R0
M $*)3DNQN5W0@L'GM0^V#I$.6W"VV.ZSB4/3R^_T$PY^&P[3G_VSLYZQB@4O
M A2-Q&SR!IR-%@K=?UP%*81MV\-O(VP^KUVQ(W#IL!-IFR/@AMUQSXABM:7]
M;H,D\P:%!W0605I62N DCL5"Y%N^%VZQ]+PPOP48-.RZVL5F?DU?,(C]:<5T
M-7(\]S8H+L"(FA"!2H,7QH-P2J*RI./A[H>K9IAZ7AC?"A1:=HOM@K?I'74T
M',3;GJQ>8-D(-IWIHC,H$P-X96HO=4,[F?FB"NX\V.>R]@/R&X)%EUUNNW=H
M7?/WG0.W5YO!:^\#J*#HAW$*G'(69$236)!%X6.I7ALB=0]AO(M";M%XM\MM
M>NV -7&:E F>5Y84+^"E-!!-4B4PF53CL:+=\;*'P-X1P<_!\EK]FSI.I+AD
M2"#/JB0%1#O=,+3:X+ 8*+(PK;S2)6[^!-Y;9.Z$&.?@LNMPY[KQW5MO7/_Z
M]?6TA+!_/J9_>/7+S6CURQ!PSP?THH@(I=1):BYK0%X8).E=U,7Q4N)V,F16
MY.CY[(&G )DY.V?E8&KW1\%2;#/)21$+##)F=M4<P5B$%#B*8(0WL\,%-G#N
M_]@93P42<W9"BY!JAX?"=>+H!_PZS1KET03-D&[,$.N-Z1%"$ H\J7@YEN+-
M;'?#'53A'V5S#W?)[L-ESN;H>M#ARIS^,<@X&M3$BGS>OS@?]Q)74MA2AP=G
M#ZI.[7.9S!JGE#-T_7DS.\&YN<HT2^,>@GBGQ#H'KRTBGQWNSJFCJ9>E=2QF
M"69:'6:XJ!.=:IU80B&T#AG;3JYIR-P>8GY7H3$'_BL'1AOY5.^RV1/%!51H
M0'KA0#':X%CB-#00K1<>2UCQW.Z>V#T$\VX*>DYYTTX%/V\"7'=V;&0* S.)
M3'!);)KDP#N;(3"TPCDN7=Q80DL#_O9P"^PP0.;L@UV+A=[>X@JS$EX%2,E;
MVN+>$U>.F!3),X$B:;](4\BV5.XA@G=,M'-0NU/!S]M\Y9"--UQ#YBF2?6&1
M3.'"0=!K2:EL$^Z^^V2_T;U+$)@#[1V*A=[F*BA:3L43H+&T32U9#A@"0LE)
MJ&B<]<9M_"S>;Z#NCD#GP'3ET&@3]2A/>CE''9$S2,[3MDOTFW?,@]-1F*RE
M099W_N0E1O80R+L@\CD0WJ$8)7%SS?]U3LTU]STFLQ81+43-.2B?R,85MH!7
MWM(>MM(L- -T8P3O(8!W5^!S8+UVP/%;E5!4*GKI KB4:7\YY0%K5I=QFGM1
MQV>RV.1(?0;U7BLM\AQIMZA3O,7K^_*6WJNU8YRQ#WD4*W:'!.C!A);U;(KN
M21[E\>0U]D=_Q[.+W#,A\ZRT!\M"=2WK L$9 ZXH)T.0Z/G&;*#U6-EC_&U7
M['. O'9H[7I'?;@8Q4\XSC<'\,VQ6P. ='Q:5[.N:V48)\/,NV!J;]]8V\!F
M$4O3,^U!\O88<-V+9PZ(ME6Y=\W<_:HJFJP$)C#2%>*+MHD7@8POF4W$2.LV
MFTZP7>OD,8;V&*B[ ($YW<JV%;!ZD*]Z2\R_%WHVRRPM-Z32U%DC6! PT77
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M^9 B,"%\3N@V@L/[*'Q.4.M$2G?1M':'O)DM,$/UZ=4<+"=E]!FT,Z2@%L'
M>Z4AH2;K/6<TC=J*+4#<IK+(-H><KB6R*^E@K_L#',1^;28RKE&F.LCV,N$
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MT"Q"[H^H8#, K!FI645Z.P ZM,X;KRQX5V>:Y%P]0DR 0#+TF-21Q391G)T
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MDFGI@]HJ /_",MWFX%N1?UR'=AM5ZX8@[_+C_,V[*?SYV_]02P,$%     @
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M6"L*U;R$1E7]NY7PP$@_ HVZW_0GTXJ0]"=T)L"=CG*G<OTQ>*\_&376-RB
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M(ZR;==[QHBI/.E$3*=Y],QV9S>+<"YVN*@>:(XI;9T50+$C$35'B&"N(2)Q
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M0U5>ZP&F&T4<_*Q>G@0+IW9H]@WM(P=K\U(_%(WRX--P'PH'7WYH#T=?H<&
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M4(*A]K-RB&(40Q))"E-$TSC-,AZ%;FBR5ZZA>5R5:.";EBUT<Y+]9K+CQ0N
M'Y@Q.S<L&:T^,KJ9Y5UCOTJ]2_8N.0KWA;N8[)=MX/U,C@)Z?F>3X[?O[! ]
ME_)1WW[R*JML -- Y5;=T]_U_Z8OIHCZEWE9>6[+93EA+\LJ47=N(GL]IVA
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MQVG!,%<P,J424,XY))'@4*1QC**8XXQ$+A1Q?+BA\<1*6L@J<<%B+:\;7YP
MV8XT_$$7F#FN38J:-@^=3OZI05O)#6K!WZ3:>\]7M0/)*Z.<&+)76K%3?YM;
M+*_R?IKWZDD///EG?8;X=Y,.)/\A:?E1/XGCM, )Y11!BJD.6])"0I)+!5.2
MDHSR1,G"K3YX)S&&1DCZ$<R\'>4]!K\=)84'-3!5'3WN:S(JGR6ODB=;VHR
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MM6V8IOW%=Y^T@;X? =.]<*Y,-PSM-VZ9Z\!"D<=J]WXP]EL0_TR9^JV9[P?
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M?U7="EDV&6$ZVIWS"5W*Q:WZ.)V7$T$_?;INWCJ%<X9CG$$5FRY&!:$01YF
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M,2$@2Y(,THS( I.4*NZT?71DK*$18R4;2#N>^=F#I1W'>4(H,'^U*R/6@HY
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M>>7[Q5HO-+_*;[-R;1KWF4/0::QP05)-01R:SK>FNBK.I ($%W&1QC*)<ZN
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M-[22HNU-:<KB-^F_1MJR?'Z4XJ-^WNL,RC9G;XH*HHI,LW'*F5Y#4FB"CK@
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M2 :J@&#Q<CC5.CBF\HGZ!GNW#%;3X)BPW3H&1Z^YM,GJ[BG@]GSPXZ9)CO9
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M:6.;68'0&#"A",@58H@(2B&-78(=.\\>6X!B'9#8>_NEBYH=O?;$(C K?K0
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M+K==9X'W_L?3;%7=L]FFF_)$*F+J4.0H)P!FTF3$2@083 J9Y E&BO6HJ15
M5*N/;?CB6Y6D?9@_I%6'\?W[&NFOY_5W--T>W(S'W3]AB%$Y^H?D_$NY^">
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MF<4QDZ)(/<P_A\8>VTS2R!>MOQ\OM'LQWA?- Y>B.""C;YAZ^U5,HA9A+7R
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M"VZL*ZR4'Y8K)6=K[7V7MTU1A7_(V;>'M2:N%[V<_R;?_Y K/BOEE]6,RZG
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MQ2;-1$(*R  R!=RAR D@I$! $<R1]JA9GO)>I?(.C3:VN;$IW+85LM?:_C3
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M>:VW,(.RWZ60[7+DQ<^[3O36W?.Z7.L757/'J:(.7Y?SN7ZOS8U3E2,>JYP
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MT.KI&WLF$)6E7)=3!AG+N4Q FA2)B=#) 2-4@CA5A*9(B@)BI\R4ZK%.%#)
MODG=&9!6LCEFF]0PV;&!N_*!/_DWIS5V3_9XI:#?%([ZT<,F9KQ29R_=XO5O
M^WUFG0^V.D<HWSRO'Y8KDZ<Q38J"(T0H*-("&T=<?WM2"(!5HJ3^$J6>]UUF
M]A-CC6U.O^G,W)/F2#:B&W'[']2>PMON(_:$8N ONSME3^KCT3+:2NKOD[>
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MW7ZC,U,P=Z&I8*FB-?UA_O,O<16B^R_Q1#^K?)+FC9%SQZ5DN-?#CI)'8?3
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MT]RDQ%, F=*R$8R %)12'$/!(':K81S,3,-4,/['KHD6E0(F4NB E9[+33C
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M-\%B<L-VB%_^#F/JN%0?%.Z#42%L:SZ42O<GZ56=G!E-,ZA'! AXK A *L$
M)XR"G."4Y@53U*V,F46;4Z/V,POD:BNCKECE.!FVP=^.S#VC&IB9?0!ZH39H
M+T0!I3^/MWM%9<]>(/J%._LOO4S$HDH87I=-\=P/IF1NIW+NI^5BU=;TVNT@
M[%:."58Q9CD&4IB-6ZXH()(@ (7 '"O&29$-$:>XR*JIT=I6JJ#C554\.ZH<
M>UTZN^M;=^=O^$Z GYZVH\?1^R\P@8[7=8.E([Q '402XC++KB+UX 7,4Q(.
M?FX^4(:9KK]]F"__T*UP_6.M9F=:6HA&)TG_S#?E<YTN7*[Y?&F*.FXCUG.)
M4B+US!3C& *4Q=@PO0!2<DAQBGB1N4DU7VC0U$C^UZ?OW^?5 H/.HW5GTW&Q
M7 #C842WWCAF#US<=W;</6:/!*9MXTID?*E(N4)_ZTYUAK9U*-IY%.U<"I+5
MX M?OV*\EQHUKF"O)P@/1'U]W3>L;L[?R\VW<G&_J JQO]+OGS&&$Q;S&# N
M,CT1-T5O$V)V#Z#@!,LB1TZ9&I>;-#6"-DHY58!$K9*C.RB:RYZ:&*%ZRHZ,
MQ\7_NML0=>##?BT3-T6<2@M'PS"^!,[Y'KB*]DV/69,4O3D/XU"U&XL[#YQ3
MZSGZ\E&NOLAY-8-??RN_KYL _BQ%:4:R# A1Q  5" *F2 824B0D84A/H)UV
M<WO:FAK1MJ9&KVQUG/+V0$L02PJI<@ )+ #"<0XPS C("B%9IC(A()H]RQ5;
MC@QNM\T1X%V%@==RL> 'LM#K@*./8H#J[!9P^)VV][0W[HS\O.,'DVV+2P8J
MZ[_6_JDC!4R&H10S+A*5*T1 RHC)-\FI)F0CF2_2!!<$(:R<0HQ[VIH:(7<2
M9_<2E;=UI\K*\.&5>?J0MR,43W@&)I1]W;"V-D]46^I1K?X\''[%YWO:&U=+
M_KSC!]+P%I<,(Y2/R^=J2^]N\;%<+,URHTVIZX8!\;B@4.48<)H8<2_$ 252
M,PW)BZ2@>0KU6^! +5:M3HUDJESM;U6BX?I_MJIZ;S:;5<F>-A7W;);59MRQ
M[$_+2)\+^LB.A+PC'YB.Q@#=F;J<0/1*8G8MCTIG3F#L$YO;Q8,58;[+U>;E
MLWZP-F\6PCQ$WYLT <UL61SG@@%*8\UL>28 R6,"%(<J5GI:@9'3\7Y?8U,C
MM-;6FTBV5E;[3UN90C.)6JJ-[@-Y$RVD8UWD7MSMV,H7FH%):@=D96@%XM;4
MF^A3#W)#]%O.0N);K>5T@V-KLYQU_8@2R_EK!N:&ZAM3<X;2%(!?SQ3)<DX(
M!1F!7*_ $@5H0I5>AL7Z%RQ7+">SS5*_6W9D<M""$X-LVPFX6#!M1,O6S$@V
M=CHF7QX :<<.%\$3F!*VMD7OSV'BGM%XRF^_J8D'K8R;8WC*R8-DP9-?O"#E
MNU- Q$PNZZHB,T7S/.=I!B@F^OW.%0&,R!B( J>%S*A4F5/-CM--36VJ4%D:
MS7>F#DBO/HZIY:ON!:G0[WP%TJNZ2CL[/2<T]V+A/T7Y>'/C)QWWNGTTC;C_
MBLL2@Y>F E^YD;^4SU+HA8M^&,IMG:(/3QL3/U&?QE7;P U!5;'-#_+'YNW<
MJ!U"CAA!,-94DF" !,P 2R@&*B$Y2E.HF'0B%9_&38V&NJFNM7>@<B_:^=<4
M0KN):A>CKH_M6#PLS]A+;]O1W;7Z,/1FCI_N:Q(Z(N-B5/D8()_9)_1!$IZ]
M&'B5C&B?T)Y*F?;:QK!18E^3R#%8]=3E$WJ?CPEX!0@K/8>$U]?K9&.COBKG
M7-Y_[,]^?^#6Z7)>\I=Z^_VM7$A5;DQUXMLY+1_7=_5L2OPLZ7SS[5:W.LM%
MSGF<I2"A)L,S40I@(C( 25+()&<QB:'3;JI;^U.;KGR4HN1T'O'E>N.X8G)%
MWG(_-1R>H;=8.Y9'K>G51FMM?-1:7VVW&LT9XX3';==AR/G=B76T8=S-V6$
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MV=5<SSP@E'F6QH065A% H0V=&NVT5D?L:1,MEIMHU1CNFA ;J%_MYNE3Z*W
MS+=UT4@+1[63K:!W1]M[YVB['WX3O>IC[6W4NAO]9!S^4W/M31.GX#.S-VRW
M>$X,#F3LR'G%82$_3$L.W-XE4>9OC@9"$\131" "L3!;_3AA>GTJ4OT\Q#A.
M1)XJXA:^<+JMJ;%]$S?]QD>4^7%P+?=5_$ 6>H_C!%K!HLQ[ 0D097Z\O2M$
MF?<Z?CS*O/^2@;-3RI8KS5Q?9"6!U!ZHQW&*L$BA42XRT>4( 9;F.<@3Q+("
MJIB0V&EN>;29J7'%JUT],\-0JW)A#I^:4A..$\3CT%I.[RX&+/3DS!A8@=28
MZ#\8H1\#OS.AXTV-.X_I=?=@%M+_[0NJV[Y646L&.4R0U-,&,WD0>K&IJ EG
MQA*(#!<")7G*"^1<W/982U/CA,K0 ?5LCZ)H]^Y[P2;PZU\?6U1JC?=L7GZM
M.',=8)IP%@S_Y6R/MC9^-=L^IX\6L^V]8&")M]52#WR5&BDK6)$I% -",0$(
MIC%@"4E FB+&8I$CQ9B+HN'NUDZO_ B:AI_D)IKW!>F?@PHC :F@'%!$4X"8
M$9,JL"E7A#G!7!5<9DZ%[H9!-48%D4NALF/$80 $ID#CNU[9+Q]EH\Y?;3O-
MGZJ$E\^F>J@Y&]YL5B5[VE0E:3?+_2"F-LS%8RFZ ZC\5IG;W7[< G(';AW4
MACO\1@@U;CWE^EG.Q</R(]V8K[S<UO*QY7,E,,N77Q>MZ+^>-*E,8(SU+$EQ
M/6DB$A"(,\ @D3$O\ISQW(4RO5DV-<:MD\?V:EZL;Z):7;:L3FFK$UR?(MPN
M/6E'4U?IG]#'C_V"W,:Q:A5H7 .;)6B=NXEV[D5=_ZJ^'4N7>P#F(ZISNU@W
M(8WN :"Z*74/:>"R$I^WRT=6+JI%S)?M_>^$IIQ2E71;&KRJ2K>20AO8G@(8
M\]?KIT?9_626RRR3&"F D#3Q'+$$C$ ]%\RE3#)",PFI"_,'LG-JXT#-]_.=
M@<,J7?KN33OVGT ?!1X+MA4U.R[>1#LGHZZ74>UFU/I9C1(=OZ+&U9ONA_Z+
M<0;JC2 %/'W;>I6BGX$ /U4H-%1SP\:36[K^9OXWH8?/>B334]8O>NZZ*OE&
M"O.+:L>V^T'GFS,).8X)E^8YH0 )C@&.&='_3$BL),LXA.ZJ'!?9Y,(^XZEX
M&",K/N'F![DS]W_\=ZS!^M_FKZ3^2_^+;<4]EBIZD=1Q._>R/H4L%45,*1 I
MT>,_80@P+ 7@J4)YP01/>.PJ!C)RCX87#W'K3ZF_J'NR-F[,OK2;!XS6.X%'
M>V.97L69'ND8:,;[UO9HVV_[GW4N\#>D>P'6Z\!]F46C#L]>P-L?A/W<=&"\
M$S4Z#U4DQ*<G<]2A_U%I9MWI05U/ 18/*[I84UYIYNO%5X9YJ@DX2U =U( Y
ME$!"0HN"\[A V"D RJ'QR>W95P8;!EW7:F]E97,E\5Q_XJKK[-(3=AP:"M_
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M*_S&#P:Q=-P0PY!@'T0A!FW,7<ZCT>G^H <D.O^'I*OW"_&.;N0LR:1 K&"
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MX*4B:Q6XH,!:D/^S7U1Q]XF;J;_C'.9>(AQ9_1^66,M23KZ>AL6,WN$Z!9:
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MV^KM^5F]VE$CZXD00J;$$_'@&2@5#/B:3 W9DFP"\R4/433S& V;@:3C[.3
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M?/Q<.2&?;9*U+(EG#C9+<OV+K7T5BX2B0W*EYMI%FP3B8U2-:VZ&AM!@\N\
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M"%'=]+ >$X];:>9ICF':X B@R7"FK9_;QW'(00<Y;0;]*!S2+@Y"<8JYG+%
M7K0#[P6/DMX,C3HY'?AL9.A$3UW>V4>EK0S$'?&W[L+B2TQ@)"?IF5QOX#Z)
M5.#H6<"6J&V=\ML6"9UG+G9*X509%%0\.B=)"9(<*[^>X*L+,*,T+Q1%JT8E
M02VX>6)'0PV6P\&P\!-4>_SMZ,U?7YR\>O/^Q?,7+WX[>O;Z!6W^+U^\?U\_
M]_;XOQ^]>7[R-]KZ__;V]?,7[T]>_(_?7WWX7\]?O'QU_.I#$X]H+X(.[2H-
M)[WA?:A'!KAZ'HP.*8"3+(&*@=:;K37"QC,E$N/!M\GL;D3>_O.C+Q_RH4;3
M$Q1":BXBI*@-+>C":OF6@8B:2QV<B;G-U;S;='3CI0R$B^_G1N\L]0[<BF_4
M7TBD;BJ+.?VZ.OISNIIX5:*W*H(72)M44@PPQD@<D>:#M3PTNMWY*%F=(&H'
M?3\$G;V%WP&2[O#P?'%*OOB$6W*OBU*0Z_)26FCP6D>()A<CHK#6-[K.<!\Y
MG2!G?W7?O=&PM^P[ -#Q]:23WW(M39YP&;*-Y)(J5\?_KIO%%T4>JC:2<9X<
MD=$J2WJ;E'&!,X!Z'YXJLX.L.P#+44KK&3LX>X?3]&I^C)^G9SB[9$;2PBE)
MT :>':TEZ1FM*N? ,&.BE$)8U690T:-DC1N@#@^BX730 :#>YS.21TY7E\,N
MN2@F2PK5$SB=<I4/&>2<.%B/0:#6'GD;#^A^>L8]%!\>0@-(O0/L',5X?GH^
MJ\>'#Z5F+AG#HF-(AMQ#0_N[TEZ1E2T"@DI))V&D-6U2]QN3..ZI= ,CU40W
M'8#NY#RLIFF*RZ^7V;RZF:\]R:*<]XE,K<JUCE6Y LY%#9'I6#)7&ANUN7Z0
MI$Y2LP-$;(,(O0?T7)/_!D_IY8<ESE<8UQUJ+U:=4A$9J@(!>:AMJAR9XV @
M:9D=UTEFW:9?WH]I&SF.&P8$=Z$UK$8ZP-BK=V\O3:M0(DD;!/C,-2C&%2!M
M\42XYT(J= ;;3.+[1L+(B!E8MW=;A.TDZ X0\LTROR8G<-TM;^)D1FXLT<UK
M<[RZX2-&!5SZ;%-((MHV4/F>EDXJ4 ?,,^XFY@Z <K>:_-7\0R8?<4DV^,)E
M?+^8S5XNEG_@,DV(?+35"K-@R!2+I"$DAN ,9TFHPJ)HUI-P8RH[247NB(CO
M>Q2V44\'T+O#R?=M$@)7W&&=ZUW'<JW;[7DM$6PQB39_GIQMT]'B1Y2-/G:V
M$286#16T,^ ^KPN+:%TMAYGV>(>K8UPNO];IE:>+\_G9[:KI=VM]3 IR+37Z
M]447<CX3>1#.!4@HD=:U5D6WN?BQ-:FCC]8:!9@#JW!TI-:)A7?77O5P7ZU6
MYSG=++>[6))O\A_K/ZTF8;W5H 9IZQ0[7<=?:*M!>.$],\IJO&,Q[YT$N=/#
M1Y_NT!9[AU%*A]OR_4S^'6?G^9I')+]94BP..I<Z1Q4I4 HY@5<QIYB"MZY-
M5YE=J!U]L,0XV_?@BAQY%NZ][LGQ8OZ%OIUT^;9<O#ZK<WZO*S(GRJ@B= Z@
MK:3E&-;S69B#))Q7@F'@/.Y@(S=[^NBC*0YO)!NH9?RK:/<PNEY(/^8S%"R"
MY0CU/G9MVDQBM9C!FL*9*[4Y!M\>?IL]?/1!$@='7P.EC ^^C>,SSX.(G *R
MP&I\9H@WY[@ $7A*40J/C>;&#1) MQPFT4D O8V"]@Q+7LS32.&S\RD6PR($
M0V$7^1<<?$8R[UXE6UR)1K5IV]TF?&XYO*+7\'D;%7:"T^^E^7V9^DV!:N*G
M,!^A^'H5OJ9JT=2.A3DYV@^\X[K-_<4M">WDQ+]5>GLX)7402M\H!OW>]@L9
M)'J1(!6-M*9H\09IB2&'!D,01? VYW&/4=5;9GM .#Q<J+N?;D9/%UZOS;NR
MFGB4)F=)$!"RUA[K1'SD#$%G>MLEIAO5>7]/2V^IZ7;(VE,/W>#I]@09CP6U
MY0Q"K+-*.=?@1* ?*1>;+2^HVIBK[0?U'##)W Y%NTN_@XWOT<SX!N%X\$(6
M\B'(H^5D?ATYMV1Z(<<@BY5!"VP3M^Y'=V]YY<8F[C#Z[:(?[&.Y\Q^SFYR*
MC D-5I8,2@62M*C],10:3FZ&$J%- +P7V;VEJ@^.Y@;:[=TTWS@'*M[$P!W8
M(A,HF71U?C,X;TJ*+#OKVM3>#'C8?,!,]DBF=C=]]8O".X>1,18M;2B0=1W'
MRU2].HFT3U@;523/F=DV#2B'.T8^8!)[' .YF[9&/CI>,_0^GYTOY_<MJQ<K
MTL0?)_GL;+9.=DTR"RHFKVOE$*]],@OXP#1HH[S&A$;%.T"\]]!NR\?VEHX>
M'F"M==$KS-8KYSO..+&1&'/@6+V-%VGM.%'%J(J,:)@0.NV#LGN?.OH@Y7%!
MMK\F^CD/ONY(MOJP>. .^7I1!9+TNH=:GJ_6JGZ?2=*KZ1GYM<LOTY@O9/,^
MQ\7'^?I;UF*:L,C)JJL,VC%R=4WFX!V+@+Q(RY%+E&T"F=:<C3__^6![>5<@
MZ< 3W6CR0?$Z!F\RY!@M*)0>$!V'Y+2A\"]XAIT/KF@ZB/I@X!U<65UDEQX]
MBO),L6"RJS<-!7%#R\DQ+2&&G(-W3O)&>??]CPE_BM.<P93325W$/:=3UNJ8
MO35@N"&/6DL#KO (EDOK#>?%J%8C07<Z)6PZI'K,8\)M%#$HG,;K%GMT\K>7
MK]_^H\TTX&]??N@NKO=S-7Q'UF-<?7HY6_RQ^M9P4QC+G=4,*$Z1H!*K8\-8
M 90\1,V<B[SY>-_OJ!K@)+I^Y[OEXLN4Y/?LZ^_DFKZ:OR4HDQ[G'X_BV?3+
M14OR*SFD'&*,/(/4S),<>!TT43*PXH+3D3%D;>2P/:V=7%C>%TWW'&"W5%H'
MH</M(WI7F'2<(_!0C;=%,MZ91&>RM#98A\&W:?F^?8%$,S"UUOFC-1+;** #
M]-P*Q&L4/8_36;[%TH?%MM+D+@7-G0:GD6*?F!A@40X,*J]"]J'<352WR- ,
MQ,VX)6,'QO+H<.A@23S/].0X7:N87L_R6M?S='1:A_3]^_K]"0$0I18)@D-5
M[TR0S^UIU4MFBDL%)<,V34@VH6Y<\SL^AA:-%=H!2-=9@&=WDZ,3Y:0Q-CJP
MK-#:STZ!1QD @]1<E9"0M>G'?3\]X]K.[H X@-(Z@-[SR\=>2/$#_OGBS\I+
M?I;GN4SK_L.#%):#UJ*N)"'!"1W EUR\M,X4U::QX \(&[=JMSLP#JG&#E!Y
M>;GQ6T7<RR]OIM?SPZX&ATT82DOK*4&V(M;. @9\L@@L)H,B<!)9F[L(F]$W
M;O%N=QAMH-1]#\J'.^ZKTW!)EA>RO5Q\DY -RT46X"+%FGRU$&HK@IRY$#([
M@:K-!OX@2>-6X'8'R6%4UT^YQO>'#=\D=WD.?SU&20KO/0N0#&T+*M4INL$:
MB-H4XP33)K4IO-B<QG$K<KL#:R/E=K#=?\_948SUYGB=D)BG7]9-5;42G$6?
MP)B0:SDR0BA<@&,LQ. B17QMDJ&;4-?;)==AD/%# .ZIIJX-Y]76<+ZL*CA:
MK?+9:F*5*IS[#!K)A5:&*7!&N-JU0-E22D;1IFIG0P)[NQ)[(!SNKZR>H?AZ
MBF$Z(]_YY6)Y/,/IZ:K.J[UX\6V3NG1<WI/&EU_R1 7GO6(2I%6T#(4JY$67
M +J>^1=$;1O==QR$_-[NY!X(QJT5/7+M^O<,OY^N_GG-V3O\NMY"N)6>L1@@
MEH#UU@<'9PN'VMLRNB2YN5MP<&_1^H:/Z^V*[:!8:R7VKIW&2X9H[:SWA6\"
MO5I>]8JE9)S".QU(A#R!XEX#2A?!AY"=%2X6V::88R^R>[M >V W<VC%=HGB
MW^<9ZY62=\M\.CT_74VT06&MK5<P?015R,S[K.O$]V!R-%Z3. \$U;NT]79G
M]D!XW$M%'8!N\SJ$B4JE&)TLH-5UWJBDA>7KE*1BZN5+5+%1I[W-:1SWTFQW
M::)&RMT=M@M:B"UA^VK^):\>*I]Q++ 8/0@*^HA#\FY0<@NFCE?BP4E1VMC.
M[6GMI O?@6HVAU):!]:4O)*KNV_Q_YY/E_F"M_5[$RFR$;6</V,NH&R.X'CV
M4!*+,K,0I&B3M7R,JBXK.@=#Q**1>OI)$9'H8LYI]9)D6\?5_89G]4SU:\T6
M+&:SO)Y5MWI;;G*:HHF)>U-KH.K,.I< #7J016$26N=2VHS9WH'8+JLTF^&S
ML3)[M)#$,[DC9U_?S7!^1HS6TH#/ZVORQ$ 4QB-H6\NG4(E:J.+)0RDV\V0P
ME39-@C:G<=SDY-C6<QC5=61+[S+X['PUG>?5*E]<_ZW"OOQ+FKBL?' E0+&6
MD5]N$8+P!834UE@4D94V-V>WH7+<A.;8^!Q*??T@='.)3D14UGE;>\9AG4E6
M:Z>TR,"=,%DX@SRUV>0WIW'<%.:!T=E(=?W&XB^G<YS'^P5I6$";T$$LG 1)
M3@KX%!QP80LQ5Z3);:KAMJ>UDVG"!XK%AU):#Y[F#6>Z]I COO+;\CZGG$_K
MT<&[*[K65^4G@JDB@XX@?>2@I%"U!W*&6&<V:\M3%FW&<&Y'9Y?Q^F"H>20>
M&EB%W0+T1D>0";$A=6(.C(^T$:3HP'F,H*61P7OZ2VDS->2'I'49EA\6AKLJ
MJC/DG7Q:+,_(0SU]GL/91'M/_DWM$5+HAW(R [J@R?60IEYW9B:T29(_2%*7
M(?8AD+:[8CI V/O\^3(:>UMN,\)"9"AR O)1R,,M(1$C)H-G@1P6%:1MM,\^
M2%*707(KA VCF'XBXG??N*E,7%GGX\5J7?3)4M%) +G)M&8XL45VF$$M8!+(
MB"_;YL+B(T1U&?,V,V<#*:<CN-WC"KRJ_2EQ]NX\S*;Q;2'R:O.VJ+)5H@3(
M01!_T2OPPEJ(C =,16K#&V6O-R5QW(J=#GRX_177P4Y[O<:^]5&_7F1.:J\1
M%>A"*TTY[RDB<I:6FW#<%1]L;A34/D+5N$4ZHYG /=73CPW<7(*39!EZ)PKD
M*$+U*0PQJ"@L+]%X%!0GF397#S:G<=PV^ =&8R/5=9"$KFS5_Z]GD%]PEM<W
MT4ABTTC87Y_\S-/M-VY\\J+7]/?%G7%V7ANQOO@S?L+YQ_R>UM$+VB9("4HR
MZR.3D'RV53H2O"<D6D[Z,-88+]HDL _+Y[BA4;/D=\=@>>I+:6*U5,I3\&AE
M)O<)C85@3 1E"TM(AL,V:HVY%]GCAF5] GTK578S5W1/EI520OD(!D,=11XM
MH,@>;(PN%Q]KU[ GBMYFD5ROZ-U"E;UT3S___/EB1@S.KD3Y:EX6R],+95X)
M55NGG50&:M-N4!(#H W$7^62%_IC:',NM"&!XT9XS?#80CT=9! >&WMQ] 6G
MLWK4^G*QK!6IURV;KB^[?!N-8;0A,28$-)S1+B$2^!@0./)Z-;EP6]ID&X;B
M8.1>V2W@M<6(DV:Z[@#CK^;T7;15U$%$Q,/$YQS)_I/0<J8@.A#YR+0%[8/C
M4GN?&ET&ND/(R#=]#H"X?23? 7"NQ/*M,]A5N=X\W9,U>3Y=Q=EB=;[,WV1'
M+$F2CP#KZKP@'Q70'F/!*\8X+1N,I<VMR7TI'S<QUM2I/)A".P#PC>FJ?$)^
M+R*+1+L/@:PVK6$7:UC'2@J"IVA=FRZ9-ZD8=Y<]K/X?'G6[G3(Z -+-6>5K
M/HY.:R>&R['E%PSEF)U*4(RB91E*S7,QXBIH7B)7D6&;\_8?DC;N-CLJY(95
MVV X;#43ZNW[OQZ]>?6_CSZ\>OOFZ,WS9T<GKT[>OGSW_L7)BS<?UN_>9F6C
M65 ;?.FP,Z"VY6*@V4]OEQ]Q?MDXGP"R6LRF"2^;ZK^[P=7;<HE;G'W;IZ]W
M9Z4T"\IY8"+722FE@'.$UFA45A:MYXT.G0<A?U\S>77IZ'E>Q>7T\^7CG^%J
MNGI;;E+Q@93V;%:K1UG0Q3MK@5:;N"B%"9E'*(%%6;(52K69.;$]K>/NW8?'
MYUUKVEB[_9O7AS2 MS6PN$\#[^C3L1ZY[V"!!WGNP$9Z>%ET9<=M2#S)H"&E
M1)%Z(4_5>8<@,M-9%(S<M(E<^[#C%VOZLM]8G>A>-?;UXN?UZG8YFF)JK2Q&
M5U,C!M"0D)2*:#7G*:0V97Z;T?<SV.MM</B=O1Y>BQV$8K^O\MOR@F*(4Q+6
M:F(][3&9!=!2$/6" @6*$S2($"WS'AW+;:JL;M,Q;I U/M;VT$H'F'J3_[BQ
M2I:T;9W/XXV]ZKLUPPQJBD0]>,O(KS&>@>?$)(L*E35&LM)J(N5VE(Y[@VA\
M7#;5;/\>ZP]#Z0_US&LGIW33KSYT<N ^CKIR+0UZEI24H*.JJ4\CP3.N 873
MTEB=BFT3\7;A6I[$3SF=SVBWN-V[MA:%US8ZE_.ZOM9SVL6<GGR]-!/::&)1
M( LKH (9@R"DI5\3,B-D;#6#;7>:?P87=!N\?I?S/XRV?P)#_ :7531?\O-\
MAM-9&Y/\W4,.;9P?Y[(K,ZV%*9K3]E\[)H/R6H'WND!RW"8E8D9LT^.J#S-]
M'E;3-,7EU[?+BX%UO^6S3[7TNY[?Y%QK9"[/5)Y]_?[#5Q];;\:3Y#0K/A3(
MZ[C2JPR!EB"%!)K'S++PLDW!R9!<_ RF?!M,?U\ .!(B.H@/K]FYP>71G]/5
M!(-Q22<#W'C:'+FCP"%G6TLR:F22>&[4I_%!DL:NXQL+)0_"=1^5]8"]:_+?
MX"F]_+#$^0K7[5"?+TYQ.I_D$'*]F@M!QU27=1WSX ((Z;PWPGB!C4JB?TA;
M+VC<"P1WH36L1CK V*MW;W_+IR$O)X*E2!Z^!E\B+;E2ULY^ H<1;7*)&VP3
MG'XC863$#*S;NP6A.PFZ X1\<R:.9[A:W5I)3%B9? :&BN(T+Q%<,G6,@HA"
M6,Z5:I,*?9"DL>N*>]D!!U%9!]B[2?_E&N3<25I]-4LKR)'5O-#"\;6 2Q:&
MZW:DC:ZJ?4?+R/9J&"7?K9O;3^(=8.8D+^O=C=M-$B]-;^'(2U%D>K4C XZ>
M@V-" A=%ERA*+*(->!XA:N2ZX#WU?=?R#"3\;G#T[%Y66/18?.T7EJ6KQ4W$
M2B1^9.""6^.\8ZXACNXE:N1BWQ8XVE_XW>#H^%Y6@I3:)V- I+HDN*Z7=4L"
ME"Q)96T@ ]X01_<2->ZY<1,<[2_\;G#T_'Y6BLP%,0*M"P/*.@/., 0LQKKD
M=1"F3<;Z$:+&;:+2!$?["[\;'+VXEY7D?4+%# 3#2412,T G& 2O'&.6HV\5
MT3U,U+@]2IK@:'_A=X"CXW6_GV^C:6L/H,LBL&=?/]!WK$,1+[P0*B40Y/J1
MK$CSZ(,")V7F4F6NO&\3K6U W<@S#GK)%@RNR*[!63FZ7,@R%NG1*:AUB>0
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M^NNWT/]RV1\C/U6F^4H<MY+RD]I31WL?0 5%/XQ3X)2S(".:Q((L"G]TS_E
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M#6&[068#978 T3?S;]_RHDKK W[/B]-Y71-T=I%RJG,IWN#R*_%;_U''OOS
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MY:MG-PJ?"XDJ0/2VU."&\GY-LBPH+:\ED:@:3<G9CM#1EV^U <SFP-Q;>QV
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M;=&RH-=1/N-$!R9IW-O58; YII:.#IR/_/;-!TUBL13"L 26Q4QRIZ3/.Q;
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M\;#:.2XHOBKTM;_P&HM*R;$,T20RNR3I+)!10XFH4]0ARV*&1^(#.L;N2>T
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M"G"4]TD5'\$)K,/NE02/UH!//+.D'.K<9K7;?G3OZ]0V_O;7=[_]MJ 1$75
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MC0D*D'$$5/0;GLZ<T&C4Q2,$C?O W1T&AU!;!^A[5JZ/B?7=38=#,:EN.E7
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M_7YI#2*C$]9"8:[>D"8!Z(L"+:+7@<Y$;S>*EC;J2/[EJ\>M)ASN2-A/IKV
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M1(\6V\Q?;1:+-FN&[C06W4:#>\:B)[.TR2W4U1_47P+9T?_Z?_XO4$L#!!0
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M5F=XB\(T8MR )P0&6$894. 8( NC3-J4S,DL1_DC":1K(6V<:5M@/Q)&H[/
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M_WG_3><NAWZQ)\HMY/2TAXY@_A$,HT4=E(^^OE\.:?6_8FW*!BF7F%!5E7W
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M[2[/@GCTZ7_EY'YO=?E?4$L#!!0    ( &5 ;U/1BWIRP00  #P1   5
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M[LT4LL3LVJC[4[ZI^'>NU7<%\X7C^!]02P,$%     @ 94!O4_@#]8*\!
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M:&<M,C R,3 Y,S N>'-D4$L! A0#%     @ 94!O4P*=6R67*   N;@! !0
M             ( ![K<" &)H9RTR,#(Q,#DS,%]C86PN>&UL4$L! A0#%
M  @ 94!O4ZLGSFNG5   XM$# !0              ( !M^ " &)H9RTR,#(Q
M,#DS,%]D968N>&UL4$L! A0#%     @ 94!O4[5#:S:.^@   L4* !0
M         ( !D#4# &)H9RTR,#(Q,#DS,%]L86(N>&UL4$L! A0#%     @
M94!O4_I@42NME0  1"0' !0              ( !4# $ &)H9RTR,#(Q,#DS
M,%]P<F4N>&UL4$L! A0#%     @ 94!O4V_WU[';!P  Q24  !4
M     ( !+\8$ &5X:&EB:70S,3%?,3$Q-3(Q+FAT;5!+ 0(4 Q0    ( &5
M;U/,:('\TP<  ,HE   5              "  3W.! !E>&AI8FET,S$R7S$Q
M,34R,2YH=&U02P$"% ,4    " !E0&]3T8MZ<L$$   \$0  %0
M    @ %#U@0 97AH:6)I=#,R,5\Q,3$U,C$N:'1M4$L! A0#%     @ 94!O
M4_@#]8*\!   /!$  !4              ( !-]L$ &5X:&EB:70S,C)?,3$Q
=-3(Q+FAT;5!+!08     "@ * ) "   FX 0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
